,Date,Title,Url
0,2019-01-01,한미약품1289402019년01월01일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=140284
1,2019-01-01,신년특집해외시장개척한미약품롤론티스포지오티닙,http://www.bosa.co.kr/news/articleView.html?idxno=2097144
2,2019-01-02,2일한미약품주가462500원,http://www.anewsa.com/detail.php?number=1460376&thread=10r04
3,2019-01-02,한미약품첫글로벌신약美시장진출초읽기,http://news.heraldcorp.com/view.php?ud=20190102000398
4,2019-01-02,임성기회장내실경영으로글로벌한미약품도약하자”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225972
5,2019-01-02,임성기한미약품회장영업사원교육장서신년내실경영강조,http://www.ceoscoredaily.com/news/article.html?no=50496
6,2019-01-02,한미약품임성기회장내실경영으로글로벌한미실현을,http://www.medisobizanews.com/news/articleView.html?idxno=57159
7,2019-01-02,신년사임성기한미약품그룹회장내실경영으로글로벌한미도약하자,http://www.mediapen.com/news/view/405216
8,2019-01-02,신년사임성기한미약품회장제약강국을위해내실경영,http://www.newspim.com/news/view/20190102000399
9,2019-01-02,임성기한미약품그룹회장제약강국이루기위해내실다져야,http://www.newsprime.co.kr/news/article.html?no=441914
10,2019-01-02,임성기한미약품그룹회장내실경영으로글로벌한미도약하자”,http://www.newsway.co.kr/news/view?tp=1&ud=2019010213410142124
11,2019-01-02,한미약품그룹내실경영으로글로벌한미도약하자,http://medipana.com/news/news_viewer.asp?NewsNum=232920&MainKind=A&NewsKind=5&vCount=12&vKind=1
12,2019-01-02,1월2일한미약품오늘주식시세280451000원,http://www.nbntv.co.kr/news/articleView.html?idxno=154897
13,2019-01-02,임성기한미약품회장내실경영으로글로벌한미도약하자,http://www.joseilbo.com/news/news_read.php?uid=367573&class=27&grp=
14,2019-01-02,한미약품그룹임성기회장내실경영으로글로벌한미로도약하자,http://www.k-health.com/news/articleView.html?idxno=41647
15,2019-01-02,한미약품그룹임성기회장내실경영으로글로벌도약하자”,http://www.cnbnews.com/news/article.html?no=395854
16,2019-01-02,신년사임성기한미약품회장내실경영으로글로벌한미도약하자,http://www.ezyeconomy.com/news/articleView.html?idxno=87418
17,2019-01-02,임성기한미약품회장내실경영으로글로벌한미도약하자”,http://www.dailian.co.kr/news/view/762562/?sc=naver
18,2019-01-02,한미약품임성기회장내실경영으로글로벌한미도약”,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019010213365670277
19,2019-01-02,임성기한미약품회장내실경영으로글로벌한미도약,http://www.m-i.kr/news/articleView.html?idxno=484377
20,2019-01-02,임성기한미약품그룹회장내실경영으로글로벌한미도약,http://www.smedaily.co.kr/news/articleView.html?idxno=80530
21,2019-01-02,임성기한미약품회장내실경영으로글로벌한미도약하자,http://www.pressm.kr/news/articleView.html?idxno=21644
22,2019-01-02,신년사임성기한미약품회장제약강국달성위해내실다져야,http://news.mk.co.kr/newsRead.php?year=2019&no=3079
23,2019-01-02,한미약품그룹제약강국이루기위한내실경영,http://www.wikileaks-kr.org/news/articleView.html?idxno=44431
24,2019-01-02,신년사임성기한미약품회장내실다져글로벌기업도약,http://www.newsis.com/view/?id=NISX20190102_0000518918&cID=13001&pID=13000
25,2019-01-02,임성기한미약품회장내실경영으로글로벌한미도약”,http://www.edaily.co.kr/news/newspath.asp?newsid=03617846622353784
26,2019-01-02,신년사임성기한미약품그룹회장내실경영속혁신DNA일깨워제약강국이룩,http://www.insightkorea.co.kr//news/articleView.html?idxno=33184
27,2019-01-02,한미약품임성기회장내실경영으로글로벌한미도약하자”,http://www.fnnews.com/news/201901021526046290
28,2019-01-02,유통오늘한미약품2019년내실경영슬로건선포대웅제약올해키워드책임경영,http://www.sisaon.co.kr/news/articleView.html?idxno=80937
29,2019-01-02,신년사임성기한미약품회장내실경영으로글로벌도약”,http://news.bizwatch.co.kr/article/consumer/2019/01/02/0067/naver
30,2019-01-02,임성기한미약품회장내실경영으로글로벌한미도약하자,http://www.ftoday.co.kr/news/articleView.html?idxno=105687
31,2019-01-02,한미약품임성기회장내실경영통해글로벌한미로도약하자”,http://www.ajunews.com/view/20190102154046568
32,2019-01-02,한미약품1289402019년01월02일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=140553
33,2019-01-02,2019신년사임성기한미약품회장내실경영으로글로벌기업도약,http://www.shinailbo.co.kr/news/articleView.html?idxno=1130873
34,2019-01-02,임성기한미약품그룹회장내실경영으로글로벌한미도약하자”,http://www.ekn.kr/news/article.html?no=407109
35,2019-01-02,임성기한미약품회장내실경영으로글로벌한미도악하자”,http://www.mdtoday.co.kr/mdtoday/index.html?no=343034
36,2019-01-02,JP모건헬스케어2019한미약품2015년영광재현할까,http://kormedi.com/?p=1260210
37,2019-01-02,신년사임성기한미약품그룹회장내실경영강조,http://www.seoulfn.com/news/articleView.html?idxno=329703
38,2019-01-02,2019신년사한미약품임성기회장제약강국위해내실다지자,http://www.news2day.co.kr/117915
39,2019-01-02,임성기한미약품그룹회장글로벌제약강국비전위해내실경영다져야,http://www.techholic.co.kr/news/articleView.html?idxno=179948
40,2019-01-02,신년사임성기한미약품그룹회장내실경영으로글로벌한미도약”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1706579
41,2019-01-02,임성기한미약품회장내실경영으로글로벌한미도약,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003447871
42,2019-01-02,신년사한미약품그룹임성기회장내실경영으로글로벌한미도약하자”,http://www.lawissue.co.kr/view.php?ud=201901021752224244d7f4c63cc6_12
43,2019-01-02,임성기한미약품회장효율과실질로꽉찬한미약품을만들자,http://www.asiatime.co.kr/news/articleView.html?idxno=220954
44,2019-01-02,한미약품그룹임성기회장내실경영으로글로벌한미도약하자,http://www.medigatenews.com/news/669892280
45,2019-01-02,임성기한미약품회장혁신 DNA 일깨워 효율실질로 꽉 채우자,http://www.meconomynews.com/news/articleView.html?idxno=19379
46,2019-01-02,신년사한미약품그룹임성기회장글로벌한미로”,http://www.polinews.co.kr/news/article.html?no=376698
47,2019-01-02,신년사임성기한미약품그룹회장내실경영으로글로벌한미도약하자”,http://daily.hankooki.com/lpage/ittech/201901/dh20190102183342145630.htm
48,2019-01-02,임성기한미약품그룹회장내실탄탄히다져제약강국이루자,https://www.insight.co.kr/news/201927
49,2019-01-02,이정희유한양행신년사해외확대임성기한미약품내실경영,http://www.businesspost.co.kr/BP?command=article_view&num=108601
50,2019-01-02,임성기한미약품회장새해내실경영강조혁신DNA일깨워제약강국구현”,http://news.donga.com/3/all/20190102/93534076/2
51,2019-01-02,임성기한미약품회장내실경영으로글로벌한미도약하자,http://www.newscj.com/news/articleView.html?idxno=588146
52,2019-01-03,한미약품유한양행등2019년엔글로벌시장개척,http://www.rapportian.com/news/articleView.html?idxno=115240
53,2019-01-03,1월3일한미약품주식시세현황444000원144,http://www.nbntv.co.kr/news/articleView.html?idxno=156074
54,2019-01-03,한미약품4제복합개량신약으로새해임상포문,http://www.newstomato.com/ReadNews.aspx?no=867476
55,2019-01-03,한미약품1289402019년01월03일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=140933
56,2019-01-03,기업신년사변화혁신성장고객LGUSK한미약품아모레퍼시픽外,http://www.dailypop.kr/news/articleView.html?idxno=37118
57,2019-01-04,한미약품고혈압고지혈증4제복합신약임상3상진입,http://www.mdtoday.co.kr/mdtoday/index.html?no=343146
58,2019-01-04,토종제약기술수출30년10년새61집중한미약품13건톱,http://www.datanews.co.kr/news/article.html?no=101770
59,2019-01-04,01월04일09시12분기준한미약품128940오늘의주식시세는437000원,http://www.polinews.co.kr/news/article.html?no=376916
60,2019-01-04,주가그래프한미약품주가4일현재442000원,http://www.nbntv.co.kr/news/articleView.html?idxno=157636
61,2019-01-04,1월4일한미약품오늘주식시장172443000원,http://www.nbntv.co.kr/news/articleView.html?idxno=157682
62,2019-01-04,한미약품주가1월4일현재444500원,http://www.gokorea.kr/news/articleView.html?idxno=67144
63,2019-01-04,한미약품1289402019년01월04일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=141346
64,2019-01-04,한미약품2019년01월04일기준전일대비367변동된451500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=581094
65,2019-01-05,기술수출기대되는신약파이프라인①한미약품한미핵심기술랩스커버리적용신약기술수출이뤄질까,http://www.news2day.co.kr/118016
66,2019-01-06,주목관심주한미약품현대중공업등턴어라운드주노려라,http://www.g-enews.com/ko-kr/news/article/news_all/201901042040515464c642673384_1/article.html
67,2019-01-06,주간추천종목∙SK증권고려아연∙한미약품∙현대중공업,http://www.fntimes.com/html/view.php?ud=2019010416521638101d6f57e61a_18
68,2019-01-06,주간추천종목한국콜마락앤락KT카카오한샘한미약품,http://www.ajunews.com/view/20190104172123855
69,2019-01-07,한미약품미FDA승인모멘텀여전현대차,http://news.mt.co.kr/mtview.php?no=2019010707594304418
70,2019-01-07,한미약품신약파이프라인임상순항현대차證,http://www.seoulfn.com/news/articleView.html?idxno=330050
71,2019-01-07,한미약품RD모멘텀보유목표가50만원하이투자증권,http://www.fnnews.com/news/201901070832312194
72,2019-01-07,ET투자뉴스한미약품실적보다는RDBUYMAINTAIN하이투자증권,http://www.etnews.com/20190107000006
73,2019-01-07,퀵리포트한미약품매수유지목표가58만원현대차證,http://www.itooza.com/common/iview.php?no=2019010708052912579
74,2019-01-07,한미약품글로벌파이프라인임상순항중매수유지–현대차증권,http://www.fntimes.com/html/view.php?ud=2019010708452083891d6f57e61a_18
75,2019-01-07,퀵리포트한미약품매수유지목표가50만원하이투자證,http://www.itooza.com/common/iview.php?no=2019010708292115476
76,2019-01-07,ET투자뉴스한미약품LAPSCOVERYBUY현대차증권,http://www.etnews.com/20190107000025
77,2019-01-07,01월07일09시12분기준한미약품128940오늘의주식시세는465000원,http://www.polinews.co.kr/news/article.html?no=377332
78,2019-01-07,한미약품오늘주식시장7일현재450000원,http://www.nbntv.co.kr/news/articleView.html?idxno=159580
79,2019-01-07,주식증권한미약품주가7일현재450500원,http://www.nbntv.co.kr/news/articleView.html?idxno=159640
80,2019-01-07,한미약품주가1월7일현재450500원,http://www.gokorea.kr/news/articleView.html?idxno=67874
81,2019-01-07,한미약품1289402019년01월07일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=141845
82,2019-01-07,한미약품2019년01월07일기준전일대비044변동된453500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=582055
83,2019-01-08,주식주가한미약품주가8일현재449500원,http://www.nbntv.co.kr/news/articleView.html?idxno=162044
84,2019-01-08,01월08일09시12분기준한미약품128940오늘의주식시세는449500원,http://www.polinews.co.kr/news/article.html?no=377690
85,2019-01-08,1월8일한미약품오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=68650
86,2019-01-08,한미약품계열사한미정밀화학300대청년친화강소기업선정,http://www.ekn.kr/news/article.html?no=408175
87,2019-01-08,미JP모건한미약품유한양행이을다음타자는,http://www.ajunews.com/view/20190108132525289
88,2019-01-08,한미약품1289402019년01월08일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=142250
89,2019-01-08,한미약품2019년01월08일기준전일대비099변동된449000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=582748
90,2019-01-08,美FDA승인임상3상한미약품등재도약채비,http://news.hankyung.com/article/2019010843731
91,2019-01-09,한미약품SGLT2메트포르민복합제개발착수,http://www.dailypharm.com/Users/News/NewsView.html?ID=248376&REFERER=NP
92,2019-01-09,더벨한미약품FDA승인신약대기중매출1조회복,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201901080100012040000726
93,2019-01-09,01월09일09시12분기준한미약품128940오늘의주식시세는450500원,http://www.polinews.co.kr/news/article.html?no=378059
94,2019-01-09,한미약품주가1월9일현재454000원,http://www.gokorea.kr/news/articleView.html?idxno=69180
95,2019-01-09,한미약품1289402019년01월09일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=142669
96,2019-01-09,한미약품2019년01월09일기준전일대비067변동된452000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=583386
97,2019-01-10,한미약품SGLT2억제제메트포르민복합당뇨약임상1상진입,http://www.mdtoday.co.kr/mdtoday/index.html?no=343568
98,2019-01-10,한미약품올상반기중국서포지오티닙독자임상신청,http://biz.chosun.com/site/data/html_dir/2019/01/10/2019011000476.html
99,2019-01-10,한미약품JPM서연구개발전략발표포지오티닙中임상추진,http://news.hankyung.com/article/2019011096606
100,2019-01-10,JP모건권세창한미약품대표이중항체4분기글로벌임상개시,http://news1.kr/articles/?3520917
101,2019-01-10,한미약품제37회JP모건컨퍼런스참가,http://www.polinews.co.kr/news/article.html?no=378353
102,2019-01-10,한미약품중국서올해포지오티닙독자임상,http://www.econovill.com/news/articleView.html?idxno=354374
103,2019-01-10,한미약품포지오티닙中독자임상추진,http://kormedi.com/?p=1261148
104,2019-01-10,한미약품JP모건행사서RD전략발표포지오티닙中임상추진,http://view.asiae.co.kr/news/view.htm?idxno=2019011008130501610
105,2019-01-10,가슴아픈중국세계폐암40한미약품항암제공급추진,http://news.heraldcorp.com/view.php?ud=20190110000039
106,2019-01-10,한미약품차세대비만NASH백혈병신약개발속도,http://www.dailypharm.com/Users/News/NewsView.html?ID=248446&REFERER=NP
107,2019-01-10,한미약품올상반기중국서포지오티닙직접임상”,http://www.newsway.co.kr/news/view?tp=1&ud=2019011008120909521
108,2019-01-10,한미약품의3가지핵심RD비만NASH항암제글로벌성과기대,http://www.medisobizanews.com/news/articleView.html?idxno=57306
109,2019-01-10,한미약품포지오티닙중국독자임상추진”2022년시판허가목표,http://www.ajunews.com/view/20190110081301163
110,2019-01-10,한미약품펜탐바디적용신약올해글로벌임상신청,http://news.hankyung.com/article/201901109781f
111,2019-01-10,한미약품비만당뇨NASH항암희귀질환분야서글로벌성과기대,http://www.fnnews.com/news/201901100828239721
112,2019-01-10,한미약품中서포지오티닙직접임상비만희귀질환글로벌성과기대,http://www.newspim.com/news/view/20190110000120
113,2019-01-10,한미약품포지오티닙中독자임상추진JP모건발표,http://medipana.com/news/news_viewer.asp?NewsNum=233252&MainKind=A&NewsKind=5&vCount=12&vKind=1
114,2019-01-10,한미약품美JP모건발표포지오티닙중국임상추진,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019011008262385030
115,2019-01-10,한미약품항암신약포지오티닙中임상직접추진,http://biz.newdaily.co.kr/site/data/html/2019/01/10/2019011000015.html
116,2019-01-10,한미약품JP모건서비만∙당뇨∙NASH∙항암제글로벌성과기대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226218
117,2019-01-10,한미약품목표가3↑53만원제시삼성證,http://www.newspim.com/news/view/20190110000162
118,2019-01-10,퀵리포트한미약품매수유지목표가3↑53만원삼성證,http://www.itooza.com/common/iview.php?no=2019011008554411923
119,2019-01-10,한미약품임상리스크해소로주가반등기대목표가↑삼성증권,http://www.fntimes.com/html/view.php?ud=2019011008471762261d6f57e61a_18
120,2019-01-10,한미약품항암신약포지오티닙중국독자임상추진,http://www.m-i.kr/news/articleView.html?idxno=486554
121,2019-01-10,한미약품JP모건컨퍼런스서올해RD전략및비전발표,http://www.100ssd.co.kr/news/articleView.html?idxno=58767
122,2019-01-10,한미약품JP모건컨퍼런스서RD전략발표,http://www.bosa.co.kr/news/articleView.html?idxno=2097702
123,2019-01-10,한미약품JP모건서비전발표RD글로벌성과기대”,http://www.edaily.co.kr/news/newspath.asp?newsid=01882726622356408
124,2019-01-10,JPM콘퍼런스권세창한미약품사장中서포지오티닙독자임상,http://www.seoulfn.com/news/articleView.html?idxno=330473
125,2019-01-10,한미약품비만당뇨지방간염신약에RD집중,http://news.bizwatch.co.kr/article/consumer/2019/01/10/0012/naver
126,2019-01-10,한미약품비알코올성지방간염신약4분기임상진행예정,http://www.newsprime.co.kr/news/article.html?no=442810
127,2019-01-10,한미약품경구용항암신약오락솔3상환자모집완료,http://www.edaily.co.kr/news/newspath.asp?newsid=02082806622356408
128,2019-01-10,한미약품中기술수출한포지오티닙직접임상으로전환,http://www.edaily.co.kr/news/newspath.asp?newsid=02092646622356408
129,2019-01-10,한미약품항암제포지오티닙중국에직접팔겠다”,http://www.cnbnews.com/news/article.html?no=396709
130,2019-01-10,한미약품JP모건서포지오티닙등연구개발과제소개,http://www.dailian.co.kr/news/view/764294/?sc=naver
131,2019-01-10,한미약품中서폐암신약포지오티닙직접임상,http://news.mt.co.kr/mtview.php?no=2019011009200277850
132,2019-01-10,ET투자뉴스한미약품임상리스크해소를BUY삼성증권,http://www.etnews.com/20190110000045
133,2019-01-10,한미약품JP모건컨퍼런스참가비만당뇨NASH항암희귀질환분야서성과기대”,http://www.ekn.kr/news/article.html?no=408575
134,2019-01-10,한미약품폐암신약포지오티닙중국독자임상,http://www.ceoscoredaily.com/news/article.html?no=50817
135,2019-01-10,1월10일한미약품시세보기447000원111,http://www.nbntv.co.kr/news/articleView.html?idxno=164470
136,2019-01-10,한미약품폐암신약포지오티닙중국독자임상추진,http://www.newstomato.com/ReadNews.aspx?no=868813
137,2019-01-10,한미약품개발중글로벌신약세계곳곳에진출할것,http://www.k-health.com/news/articleView.html?idxno=41802
138,2019-01-10,한미약품제37회JP모건컨퍼런스참가,http://www.nextdaily.co.kr/news/article.html?id=20190110800010
139,2019-01-10,01월10일09시12분기준한미약품128940오늘의주식시세는448500원,http://www.polinews.co.kr/news/article.html?no=378397
140,2019-01-10,한미약품차세대파이프라인은비만∙당뇨∙NASH∙항암∙희귀질환,http://www.etoday.co.kr/news/section/newsview.php?idxno=1709222
141,2019-01-10,한미약품제37회JP모건헬스케어컨퍼런스참가비만당뇨NASH항암희귀질환분야서글로벌성과기대”,http://www.thebigdata.co.kr/view.php?ud=2019011010340912238743e3b5d6_23
142,2019-01-10,한미약품비만당뇨NASH항암희귀질환분야서글로벌성과기대,http://www.sisajournal-e.com/news/articleView.html?idxno=194075
143,2019-01-10,한미약품제37회JP모건컨퍼런스참가비만당뇨NASH항암희귀질환분야서글로벌성과기대”,http://www.marketnews.co.kr/view.php?ud=2019011010525488746cf2d3b5d6_24
144,2019-01-10,한미약품中서폐암신약포지오티닙직접임상2022년시판목표,http://www.newsfc.co.kr/news/articleView.html?idxno=34889
145,2019-01-10,권세창한미약품사장폐암신약포지오티닙중국내독자임상추진,http://www.insightkorea.co.kr//news/articleView.html?idxno=33367
146,2019-01-10,한미약품폐암환자최다중국시장서신약개발,http://www.nocutnews.co.kr/news/5087706
147,2019-01-10,비만당뇨NASH항암희귀질환잡는다한미약품JP모건컨퍼런스참가,http://kpenews.com/View.aspx?No=19236
148,2019-01-10,한미약품제37회JP모건컨퍼런스참가,http://www.pressm.kr/news/articleView.html?idxno=21749
149,2019-01-10,1월10일한미약품종목그래프및주식시황,http://www.gokorea.kr/news/articleView.html?idxno=69959
150,2019-01-10,한미약품비만당뇨NASH항암희귀질환분야서글로벌성과기대,http://www.medigatenews.com/news/1633614782
151,2019-01-10,한미약품올해비만NASH항암주력JP모건컨퍼런스서발표,http://www.inthenews.co.kr/news/article.html?no=12923
152,2019-01-10,한미약품제37회JP모건컨퍼런스참가,http://www.g-enews.com/ko-kr/news/article/news_all/201901101321325486f6d02acec0_1/article.html
153,2019-01-10,한미약품올상반기폐암신약포지오티닙중국임상개시,http://www.etnews.com/20190110000178
154,2019-01-10,한미약품중국서폐암신약출시추진,http://www.finomy.com/news/articleView.html?idxno=61995
155,2019-01-10,한미약품JP모건헬스케어컨퍼런스서올해RD계획발표,http://news.mk.co.kr/newsRead.php?year=2019&no=20780
156,2019-01-10,한미약품JP모건컨퍼런스에서올해전략비전발표,http://www.kpinews.co.kr/news/articleView.html?idxno=87631
157,2019-01-10,한미약품포지오티닙中임상추진,http://www.smedaily.co.kr/news/articleView.html?idxno=80705
158,2019-01-10,한미약품JP모건컨퍼런스참가,http://www.joseilbo.com/news/news_read.php?uid=368187&class=27&grp=
159,2019-01-10,제약워치유한양행한미약품신약개발위한해외움직임본격화,http://www.newswatch.kr/news/articleView.html?idxno=16846
160,2019-01-10,한미약품JP모건컨퍼런스서비만희귀질환글로벌성과기대,http://www.newspost.kr/news/articleView.html?idxno=68020
161,2019-01-10,한미약품JP모건헬스케어컨퍼런스서RD계획발표,http://www.straightnews.co.kr/news/articleView.html?idxno=41133
162,2019-01-10,한미약품비만NASH항암희귀질환분야글로벌성과기대,http://www.asiatime.co.kr/news/articleView.html?idxno=222508
163,2019-01-10,한미약품비만당뇨NASH항암희귀질환분야글로벌성과기대,http://www.wikileaks-kr.org/news/articleView.html?idxno=45083
164,2019-01-10,한미약품1289402019년01월10일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=143063
165,2019-01-10,한미약품JPM콘퍼런스서RD전략발표글로벌성과기대”,http://www.dt.co.kr/contents.html?article_no=2019011002109931102001&ref=naver
166,2019-01-10,한미약품비만지방간염분야글로벌성과기대,http://news.mk.co.kr/newsRead.php?year=2019&no=21470
167,2019-01-10,JP모건컨퍼런스서빛난한미약품삼바,http://www.whosaeng.com/sub_read.html?uid=107328§ion=sc5
168,2019-01-10,한미약품2019년01월10일기준전일대비033변동된450500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=584066
169,2019-01-10,한미약품제37회JP모건컨퍼런스참가,http://www.nbnnews.co.kr/news/articleView.html?idxno=221767
170,2019-01-10,한미약품비만당뇨NASH항암희귀질환분야서글로벌성과기대,http://www.meconomynews.com/news/articleView.html?idxno=19616
171,2019-01-10,한미약품폐암신약포지오티닙중국서직접임상”,http://www.mdtoday.co.kr/mdtoday/index.html?no=343680
172,2019-01-10,한미약품비만백혈병환자들위한신약개발에박차,https://www.insight.co.kr/news/203656
173,2019-01-10,한미약품비만∙당뇨∙NASH∙항암∙희귀질환분야서글로벌성과기대,http://www.techholic.co.kr/news/articleView.html?idxno=180093
174,2019-01-10,한미약품제37회JP모건컨퍼런스참가비만∙당뇨∙NASH∙항암∙희귀질환분야서글로벌성과기대”,http://www.lawissue.co.kr/view.php?ud=201901102145115965d7f4c63cc6_12
175,2019-01-11,한미약품자렐토이어엘리퀴스제네릭도허가,http://www.dailymedi.com/detail.php?number=839029&thread=22r05
176,2019-01-11,한미약품LG화학셀트리온삼성바이오올해RD전략은,http://www.rapportian.com/news/articleView.html?idxno=115412
177,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준,http://www.g-enews.com/ko-kr/news/article/news_all/20190111093835292f6d02acec0_1/article.html
178,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.polinews.co.kr/news/article.html?no=378714
179,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증획득,http://www.fnnews.com/news/201901110946049147
180,2019-01-11,한미약품정보보호경영시스템인증제약업계첫사례,http://kormedi.com/?p=1261302
181,2019-01-11,한미약품업계첫정보보호경영시스템국제표준ISO27001인증,http://biz.newdaily.co.kr/site/data/html/2019/01/11/2019011100024.html
182,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.newsway.co.kr/news/view?tp=1&ud=2019011109504277210
183,2019-01-11,한미약품정보보안국제인증ISO27001획득,http://www.edaily.co.kr/news/newspath.asp?newsid=02013926622356736
184,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.getnews.co.kr/view.php?ud=20190111095338691941d0c69529_16
185,2019-01-11,한미약품정보보호경영시스템국제표준인증업계최초,http://www.newspim.com/news/view/20190111000228
186,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.sisajournal-e.com/news/articleView.html?idxno=194149
187,2019-01-11,한미약품업계최초로정보보호경영시스템ISO27001인증받아,http://news.mk.co.kr/newsRead.php?year=2019&no=22707
188,2019-01-11,유통오늘홈플러스2019년핫딜할인행사한미약품업계첫정보보호경영시스템국제표준인증,http://www.sisaon.co.kr/news/articleView.html?idxno=81267
189,2019-01-11,한미약품제약업계첫정보보호국제표준인증,http://news.heraldcorp.com/view.php?ud=20190111000162
190,2019-01-11,한미약품제약업계최초정보보호경영시스템국제표준인증획득,http://www.newsprime.co.kr/news/article.html?no=442959
191,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.nextdaily.co.kr/news/article.html?id=20190111800019
192,2019-01-11,한미약품정보보호경영시스템국제표준ISO27001인증,http://view.asiae.co.kr/news/view.htm?idxno=2019011110201492388
193,2019-01-11,한미약품제약업계첫정보보호경영시스템인증,http://news1.kr/articles/?3522139
194,2019-01-11,한미약품제약최초ISO27001인증정보보호경영시스템,http://medipana.com/news/news_viewer.asp?NewsNum=233328&MainKind=A&NewsKind=5&vCount=12&vKind=1
195,2019-01-11,한미약품정보보호경영시스템국제표준인증획득제약계최초,http://www.medisobizanews.com/news/articleView.html?idxno=57341
196,2019-01-11,한미약품제약업계첫ISO27001인증획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1709743
197,2019-01-11,한미약품정보보호경영시스템국제표준인증,http://www.medical-tribune.co.kr/news/articleView.html?idxno=83517
198,2019-01-11,한미약품업계최초정보보호경영시스템국제표준인증,http://www.dailian.co.kr/news/view/764609/?sc=naver
199,2019-01-11,01월11일09시12분기준한미약품128940오늘의주식시세는447500원,http://www.polinews.co.kr/news/article.html?no=378744
200,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.dt.co.kr/contents.html?article_no=2019011102109931102002&ref=naver
201,2019-01-11,한미약품정보보호경영시스템국제표준인증,http://biz.chosun.com/site/data/html_dir/2019/01/11/2019011101232.html
202,2019-01-11,올리타실패딛고폐암신약포지오티닙재도전한미약품中서임상독자추진,http://biz.newdaily.co.kr/site/data/html/2019/01/11/2019011100040.html
203,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.mediapen.com/news/view/407177
204,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.ekn.kr/news/article.html?no=408842
205,2019-01-11,한미약품제약업계첫정보보호국제표준ISO27001인증,http://www.wolyo.co.kr/news/articleView.html?idxno=75573
206,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.joseilbo.com/news/news_read.php?uid=368255&class=27&grp=
207,2019-01-11,한미약품영국정보보호경영시스템국제표준인증,http://news.bizwatch.co.kr/article/consumer/2019/01/11/0004/naver
208,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.metroseoul.co.kr/news/newsview?newscd=2019011100024
209,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.medigatenews.com/news/802765252
210,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증4개인증확보,http://www.sisafocus.co.kr/news/articleView.html?idxno=200173
211,2019-01-11,한미약품ISO27001인증국내제약업계최초획득,http://news.heraldcorp.com/view.php?ud=20190111000285
212,2019-01-11,한미약품제약업계첫정보보호국제표준인증획득,http://www.newsworks.co.kr/news/articleView.html?idxno=326705
213,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.insightkorea.co.kr//news/articleView.html?idxno=33411
214,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003457414
215,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증획득,http://www.thebigdata.co.kr/view.php?ud=2019011111320514388743e825e5_23
216,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019011111135554855
217,2019-01-11,한미약품제약업계첫글로벌비즈니스정보보호관리시스템확보,http://www.100ssd.co.kr/news/articleView.html?idxno=58796
218,2019-01-11,한미약품국내제약업계최초ISO27001국제표준인증획득,http://www.whitepaper.co.kr/news/articleView.html?idxno=138031
219,2019-01-11,한미약품제약업계첫정보보호국제표준인증,http://news.kmib.co.kr/article/view.asp?arcid=0012981850&code=61171911&cp=nv
220,2019-01-11,1월11일한미약품주식시세현황444000원144,http://www.nbntv.co.kr/news/articleView.html?idxno=165895
221,2019-01-11,한미약품주가1월11일현재444500원,http://www.gokorea.kr/news/articleView.html?idxno=71011
222,2019-01-11,한미약품정보보호경영시스템국제표준인증,http://www.biospectator.com/view/news_view.php?varAtcId=6937
223,2019-01-11,한미약품업계최초ISO27001인증획득,http://www.hg-times.com/news/articleView.html?idxno=196446
224,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.techholic.co.kr/news/articleView.html?idxno=180097
225,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.vop.co.kr/A00001370063.html
226,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.inthenews.co.kr/news/article.html?no=12949
227,2019-01-11,한미약품국내제약업계첫정보보호경영국제표준ISO27001취득,http://www.koreaittimes.com/news/articleView.html?idxno=88584
228,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.straightnews.co.kr/news/articleView.html?idxno=41227
229,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증획득,http://www.etnews.com/20190111000199
230,2019-01-11,품질환경반부패정보보호까지한미약품ISO27001획득,http://www.meconomynews.com/news/articleView.html?idxno=19649
231,2019-01-11,한미약품정보보호경영시스템국제표준인증,http://www.ebn.co.kr/news/view/968464
232,2019-01-11,한미약품업계최초정보보호경영시스템국제표준인증,http://www.smedaily.co.kr/news/articleView.html?idxno=80730
233,2019-01-11,한미약품업계첫정보보호경영시스템국제표준인증,http://www.newstomato.com/ReadNews.aspx?no=869223
234,2019-01-11,한미약품정보보호경영시스템국제표준인증획득,http://www.weeklytoday.com/news/articleView.html?idxno=71262
235,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.bokuennews.com/news/article.html?no=170554
236,2019-01-11,한미약품정보보안경영시스템국제표준인증획득,http://www.rapportian.com/news/articleView.html?idxno=115434
237,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.marketnews.co.kr/view.php?ud=2019011115461420586cf2d825e5_24
238,2019-01-11,한미약품정보보호경영시스템국제표준인증,http://www.m-i.kr/news/articleView.html?idxno=487149
239,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.pressm.kr/news/articleView.html?idxno=21762
240,2019-01-11,한미약품정보보호경영시스템국제표준인증,http://www.econovill.com/news/articleView.html?idxno=354484
241,2019-01-11,한미약품정보보호경영시스템국제표준인증,http://www.seoulfn.com/news/articleView.html?idxno=330662
242,2019-01-11,한미약품국내제약업계첫ISO27001인증획득,http://www.asiatime.co.kr/news/articleView.html?idxno=222717
243,2019-01-11,한미약품1289402019년01월11일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=143452
244,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.nbnnews.co.kr/news/articleView.html?idxno=222111
245,2019-01-11,한미약품정보보호경영시스템국제표준인증,//www.dailysecu.com/?mod=news&act=articleView&idxno=44201
246,2019-01-11,한미약품업계최초정보보호경영시스템국제표준획득,http://www.mhj21.com/118740
247,2019-01-11,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.mdtoday.co.kr/mdtoday/index.html?no=343768
248,2019-01-11,한미약품업계최초경영시스템국제표준인증,http://www.kpinews.co.kr/news/articleView.html?idxno=87768
249,2019-01-11,한미약품정보보호국제표준ISO27001인증획득,http://news.hankyung.com/article/201901115339f
250,2019-01-11,한미약품2019년01월11일기준전일대비178변동된442500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=584508
251,2019-01-11,한미약품정보보호국제인증획득,http://www.finomy.com/news/articleView.html?idxno=62050
252,2019-01-11,한미약품정보보호경영시스템국제표준인증획득국내제약업계최초,http://www.greened.kr/news/articleView.html?idxno=90448
253,2019-01-11,한미약품제약업계최초로정보보호경영시스템국제표준인증,https://www.insight.co.kr/news/203939
254,2019-01-12,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.gukjenews.com/news/articleView.html?idxno=1052715
255,2019-01-12,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.boannews.com/media/view.asp?idx=76110&kind=
256,2019-01-13,한미약품정보보호시스템국제표준ISO27001인증,http://www.gukjenews.com/news/articleView.html?idxno=1052911
257,2019-01-13,셀트리온한미약품LG화학글로벌신약출시에집중,http://www.finomy.com/news/articleView.html?idxno=62051
258,2019-01-13,한미약품제약업계첫정보보안경영시스템인증,http://www.shinailbo.co.kr/news/articleView.html?idxno=1133502
259,2019-01-13,현장르포생산력신사업확대나선북경한미약품,http://www.fnnews.com/news/201901131409179131
260,2019-01-14,정보보호강화한미약품ISO27001획득,http://www.monews.co.kr/news/articleView.html?idxno=200286
261,2019-01-14,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.mhj21.com/118760
262,2019-01-14,르포증설하는베이징한미약품어린이틈새공략성공적,http://view.asiae.co.kr/news/view.htm?idxno=2019011409201000298
263,2019-01-14,01월14일09시12분기준한미약품128940오늘의주식시세는441500원,http://www.polinews.co.kr/news/article.html?no=379254
264,2019-01-14,르포한미약품中공장24시간가동모자라연내2배로증설,http://news.chosun.com/site/data/html_dir/2019/01/14/2019011401009.html?utm_source=naver&utm_medium=original&utm_campaign=news
265,2019-01-14,개발중인대사질환신약159개한미약품9개로최다,http://www.newsworks.co.kr/news/articleView.html?idxno=327201
266,2019-01-14,한미약품주가종목그래프및주식시황14일현재440500원,http://www.gokorea.kr/news/articleView.html?idxno=72742
267,2019-01-14,1월14일한미약품금일증시045440500원,http://www.nbntv.co.kr/news/articleView.html?idxno=168383
268,2019-01-14,한미약품제약업계첫정보보호경영시스템국제표준인증,http://www.lawissue.co.kr/view.php?ud=201901141425233653d7f4c63cc6_12
269,2019-01-14,한미약품1289402019년01월14일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=144040
270,2019-01-14,글로벌무대밝히는K바이오한미약품비소세포폐암신약포지오티닙中임상추진,http://www.sedaily.com/NewsView/1VE199LIXH
271,2019-01-14,한미약품2019년01월14일기준전일대비113변동된447500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=585437
272,2019-01-14,오늘Who권세창폐암치료제로한미약품중국사업영토넓힌다,http://www.businesspost.co.kr/BP?command=article_view&num=110242
273,2019-01-15,한미약품롤론티스3년내1조원짜리글로벌신약된다,http://www.medisobizanews.com/news/articleView.html?idxno=57379
274,2019-01-15,한미약품주식은제약업종최선호주올해신약개발성과기대,http://www.businesspost.co.kr/BP?command=article_view&num=110287
275,2019-01-15,한미약품포지오티닙중국진출전략급선회배경은,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019011509193163540
276,2019-01-15,1월15일한미약품증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=74571
277,2019-01-15,한미약품투자주식15일현재449500원,http://www.nbntv.co.kr/news/articleView.html?idxno=170624
278,2019-01-15,퀵리포트한미약품매수유지목표가57만원유지하나금투,http://www.itooza.com/common/iview.php?no=2019011513162814871
279,2019-01-15,ET투자뉴스한미약품한미약품의기업가BUY하나금융투자,http://www.etnews.com/20190115000244
280,2019-01-15,한미약품1289402019년01월15일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=144452
281,2019-01-15,한미약품2019년01월15일기준전일대비000변동된447500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=586118
282,2019-01-16,단독한미약품과셀트리온이고용킹혁신의일자리창출파워입증,http://www.news2day.co.kr/118573
283,2019-01-16,RD투자1천억한미약품녹십자유한양행등5곳달할듯,http://www.rapportian.com/news/articleView.html?idxno=115504
284,2019-01-16,단독한미약품작년처방액업계첫5000억돌파,http://news.mt.co.kr/mtview.php?no=2019011514303716122
285,2019-01-16,제약∙바이오연초주목할섹터대웅제약∙한미약품톱픽”,http://www.fntimes.com/html/view.php?ud=2019011608372596251d6f57e61a_18
286,2019-01-16,이엔셀한미약품의항암유전자줄기세포치료제위탁생산,http://news.mk.co.kr/newsRead.php?year=2019&no=32270
287,2019-01-16,퀵리포트한미약품매수유지목표가62만원SK證,http://www.itooza.com/common/iview.php?no=2019011611273014635
288,2019-01-16,한미약품주가1월16일현재438500원,http://www.gokorea.kr/news/articleView.html?idxno=76095
289,2019-01-16,한미약품주식종목시세16일현재438500원,http://www.nbntv.co.kr/news/articleView.html?idxno=172849
290,2019-01-16,제약바이오달라진위상청와대서한미약품셀트리온대표눈길,http://biz.newdaily.co.kr/site/data/html/2019/01/16/2019011600119.html
291,2019-01-16,ET투자뉴스한미약품국내매출호조세매수SK증권,http://www.etnews.com/20190116000264
292,2019-01-16,한미약품1289402019년01월16일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=144917
293,2019-01-16,한미약품2019년01월16일기준전일대비201변동된438500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=586730
294,2019-01-17,이엔셀한미약품뇌종양줄기세포치료제위탁생산,http://biz.chosun.com/site/data/html_dir/2019/01/16/2019011602526.html
295,2019-01-17,이엔셀한미약품의항암유전자줄기세포치료제위탁생산,http://www.starseoultv.com/news/articleView.html?idxno=517202
296,2019-01-17,이엔셀한미약품개발중인항암유전자줄기세포치료제위탁생산,http://news.hankyung.com/article/201901173253f
297,2019-01-17,이엔셀한미약품항암줄기세포치료제위탁생산,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226428
298,2019-01-17,한미약품항암줄기세포치료제임상시험용위탁생산돌입,http://www.ceoscoredaily.com/news/article.html?no=51072
299,2019-01-17,이엔셀한미약품과줄기세포치료제공동개발생산,http://www.newsworks.co.kr/news/articleView.html?idxno=328279
300,2019-01-17,이엔셀한미약품줄기세포치료제생산맡아,http://www.bosa.co.kr/news/articleView.html?idxno=2098081
301,2019-01-17,유한양행한미약품대웅제약등RD성과주시,http://www.choicenews.co.kr/news/articleView.html?idxno=47526
302,2019-01-17,이엔셀한미약품항암유전자줄기세포치료제위탁생산,http://medipana.com/news/news_viewer.asp?NewsNum=233570&MainKind=A&NewsKind=5&vCount=12&vKind=1
303,2019-01-17,이엔셀한미약품항암유전자줄기세포치료제위탁생산,http://biz.newdaily.co.kr/site/data/html/2019/01/17/2019011700076.html
304,2019-01-17,이엔셀한미약품의항암유전자줄기세포치료제위탁생산,http://www.etoday.co.kr/news/section/newsview.php?idxno=1711919
305,2019-01-17,한미약품주가1월17일현재438500원,http://www.gokorea.kr/news/articleView.html?idxno=77290
306,2019-01-17,한미약품처방액5000억돌파전년比166증가,http://www.newsway.co.kr/news/view?tp=1&ud=2019011708403010749
307,2019-01-17,주식종목검색한미약품주가17일현재438500원,http://www.nbntv.co.kr/news/articleView.html?idxno=174062
308,2019-01-17,이엔셀한미약품항암유전자줄기세포치료제위탁생산,http://www.mdtoday.co.kr/mdtoday/index.html?no=344195
309,2019-01-17,이엔셀한미약품유전자줄기세포치료제위탁생산,http://www.edaily.co.kr/news/newspath.asp?newsid=02837206622358704
310,2019-01-17,이엔셀한미약품항암유전자줄기세포치료제위탁생산,http://www.newsis.com/view/?id=NISX20190117_0000533155&cID=13001&pID=13000
311,2019-01-17,이엔셀한미약품과유전자줄기세포치료제위탁생산계약체결,http://news.donga.com/3/all/20190117/93746211/1
312,2019-01-17,한미약품1289402019년01월17일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=145324
313,2019-01-17,이엔셀한미약품항암줄기세포치료제위탁생산,http://www.newstomato.com/ReadNews.aspx?no=870471
314,2019-01-17,한미약품2019년01월17일기준전일대비011변동된438000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=587441
315,2019-01-17,신약아이콘한미약품성장엔진재시동,http://www.sedaily.com/NewsView/1VE2NJHLMD
316,2019-01-17,이엔셀한미약품과의약품위탁생산계약체결,http://news.hankyung.com/article/201901175281f
317,2019-01-18,DataScore임성기한미약품회장상장주식부호13위3계단하락,http://www.ceoscoredaily.com/news/article.html?no=50823
318,2019-01-18,한미약품처방약시장1위등극종근당과양강체제,http://www.dailypharm.com/Users/News/NewsView.html?ID=248653&REFERER=NP
319,2019-01-18,스펙트럼7개제품매각한미약품에긍정적,http://news.hankyung.com/article/2019011869666
320,2019-01-18,이엔셀한미약품의항암유전자줄기세포치료제위탁생산,http://www.outsourcing.co.kr/news/articleView.html?idxno=83794
321,2019-01-18,이엔셀한미약품의항암유전자줄기세포치료제위탁생산,http://www.bokuennews.com/news/article.html?no=170782
322,2019-01-18,1월18일한미약품금일증시441500원080,http://www.nbntv.co.kr/news/articleView.html?idxno=176204
323,2019-01-18,한미약품주가1월18일현재441500원,http://www.gokorea.kr/news/articleView.html?idxno=78852
324,2019-01-18,한미약품1289402019년01월18일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=145793
325,2019-01-18,이엔셀한미약품HM21001위탁생산,http://news.mt.co.kr/mtview.php?no=2019011709335236089
326,2019-01-18,한미약품2019년01월18일기준전일대비183변동된446000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=587798
327,2019-01-20,종목시세LS55700원183한미약품446000원183유수홀딩스7850원182삼성증권33550원182대한방직14050원181↑주식가격주가올라18일장마,http://www.fintechpost.co.kr/news/articleView.html?idxno=17496
328,2019-01-21,한미약품에올인스펙트럼의승부수,http://news.mt.co.kr/mtview.php?no=2019011919175272206
329,2019-01-21,제약기업대해부한미약품①임성기회장왕성한활동합병으로2세경영승계주춧돌,http://www.newsway.co.kr/news/view?tp=1&ud=2018112715423247600
330,2019-01-21,하이로우제이브이엠한미약품과시너지시작투자의견매수,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019012108260941660
331,2019-01-21,제이브이엠한미약품과의시너지효과로매출상승전망,http://www.asiatoday.co.kr/view.php?key=20190121010012320
332,2019-01-21,한미약품주가종목그래프및종목관련동향정보21일현재444000원,http://www.gokorea.kr/news/articleView.html?idxno=80410
333,2019-01-21,한미약품1289402019년01월21일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=146202
334,2019-01-21,한미약품2019년01월21일기준전일대비078변동된442500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=588853
335,2019-01-22,안국약품중앙연구소장에김맹섭전한미약품연구소장영입,http://www.medisobizanews.com/news/articleView.html?idxno=57508
336,2019-01-22,1월22일한미약품증권투자448000원124,http://www.nbntv.co.kr/news/articleView.html?idxno=179311
337,2019-01-22,안국약품한미약품출신김맹섭중앙연구소장영입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1064642
338,2019-01-22,한미약품주가1월22일현재448000원,http://www.gokorea.kr/news/articleView.html?idxno=81780
339,2019-01-22,한미약품1289402019년01월22일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=146683
340,2019-01-22,한미약품2019년01월22일기준전일대비113변동된447500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=589525
341,2019-01-23,2019제약산업이뛴다④한미약품RD결실의해매출1조달성기대,http://www.newsis.com/view/?id=NISX20190117_0000533212&cID=13001&pID=13000
342,2019-01-23,한미약품릴리면역질환신약물질권리반환1보,http://news1.kr/articles/?3531078
343,2019-01-23,한미약품릴리와신약후보물질기술수출계약해지,http://yna.kr/AKR20190123015100017?did=1195m
344,2019-01-23,한미약품美릴리기술수출권리반환1보,http://www.edaily.co.kr/news/newspath.asp?newsid=01318566622360672
345,2019-01-23,한미약품릴리에기술수출한BTK억제제권리반환,http://view.asiae.co.kr/news/view.htm?idxno=2019012307225000241
346,2019-01-23,일라이릴리BTK억제제권리한미약품에반환,http://news.hankyung.com/article/2019012313076
347,2019-01-23,릴리한미약품기술수출면역질환치료제권리반환,http://biz.chosun.com/site/data/html_dir/2019/01/23/2019012300802.html
348,2019-01-23,한미약품릴리에기술수출한신약후보물질계약해지상보,http://view.asiae.co.kr/news/view.htm?idxno=2019012307345470189
349,2019-01-23,한미약품일라이릴리BTK억제제권리반환,http://www.biospectator.com/view/news_view.php?varAtcId=7002
350,2019-01-23,릴리임상중단BTK억제제권리한미약품에반환,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019012307161210350
351,2019-01-23,한미약품릴리기술수출BTK억제제권리반환,http://www.dailypharm.com/Users/News/NewsView.html?ID=248837&REFERER=NP
352,2019-01-23,릴리BTK억제제권리한미약품에반환,http://www.newsway.co.kr/news/view?tp=1&ud=2019012307392131940
353,2019-01-23,한미약품릴리BTK억제제권리반환,http://news.mt.co.kr/mtview.php?no=2019012307351641440
354,2019-01-23,한미약품美기술수출권리반환27개신약개발박차상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01433366622360672
355,2019-01-23,한미약품릴리BTK억제제면역질환신약물질권리반환,http://www.newspim.com/news/view/20190123000052
356,2019-01-23,한미약품릴리와신약후보물질기술수출계약해지종합,http://yna.kr/AKR20190123015151017?did=1195m
357,2019-01-23,한미약품릴리와신약후보물질기술수출계약해지종합,http://view.asiae.co.kr/news/view.htm?idxno=2019012307475325446
358,2019-01-23,한미약품릴리BTK억제제권리반환,http://kormedi.com/?p=1262663
359,2019-01-23,한미약품릴리면역질환신약물질권리반환,http://www.newsis.com/view/?id=NISX20190123_0000537973&cID=13001&pID=13000
360,2019-01-23,한미약품릴리에기술수출한BTK억제제권리반환,http://www.ekn.kr/news/article.html?no=411010
361,2019-01-23,릴리한미약품신약물질권리반환한미직접임상검토상보,http://news1.kr/articles/?3531085
362,2019-01-23,한미약품릴리에기술이전BTK억제제권리반환받아,http://www.medisobizanews.com/news/articleView.html?idxno=57521
363,2019-01-23,한미약품릴리와신약후보물질기술수출계약해지,http://www.asiatoday.co.kr/view.php?key=20190123010014076
364,2019-01-23,공시한미약품릴리BTK억제제권리반환”,http://www.newsway.co.kr/news/view?tp=1&ud=2019012308032460032
365,2019-01-23,공시한미약품릴리BTK억제제권리반환,http://www.newsis.com/view/?id=NISX20190123_0000538011&cID=10401&pID=10400
366,2019-01-23,BTK억제제권리반환됐지만한미약품3년내글로벌신약출시,http://www.medisobizanews.com/news/articleView.html?idxno=57522
367,2019-01-23,한미약품릴리BTK억제제라이센스계약최종파기,http://www.medical-tribune.co.kr/news/articleView.html?idxno=83669
368,2019-01-23,한미약품릴리에기술이전한BTK억제제돌려받는다,http://www.k-health.com/news/articleView.html?idxno=42024
369,2019-01-23,릴리BTK억제제권리한미약품반환계약금5300만불은확보,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226617
370,2019-01-23,릴리한미약품에BTK억제제권리반환직접임상검토,http://medipana.com/news/news_viewer.asp?NewsNum=233778&MainKind=A&NewsKind=5&vCount=12&vKind=1
371,2019-01-23,한미약품릴리BTK억제제권리반환다른신약개발에영향없어,http://www.ekn.kr/news/article.html?no=411011
372,2019-01-23,한미약품릴리면역질환치료신약권리반환종합,http://www.newsis.com/view/?id=NISX20190123_0000538020&cID=13001&pID=13000
373,2019-01-23,릴리BTK억제제권리한미약품에반환,http://www.mdtoday.co.kr/mdtoday/index.html?no=344643
374,2019-01-23,한미약품美릴리7억6500만달러규모기술수출계약해지,http://biz.newdaily.co.kr/site/data/html/2019/01/23/2019012300008.html
375,2019-01-23,한미약품릴리와8000억규모기술수출계약해지직접개발검토,http://www.newspim.com/news/view/20190123000099
376,2019-01-23,한미약품기술수출한BKT억제제계약해지,http://www.sedaily.com/NewsView/1VE5CUEW0Z
377,2019-01-23,릴리BTK억제제권리반환한미약품독자개발상보,http://news.mt.co.kr/mtview.php?no=2019012308095946362
378,2019-01-23,한미약품릴리면역질환신약물질권리반환,http://www.m-i.kr/news/articleView.html?idxno=490302
379,2019-01-23,한미약품릴리BTK억제제기술수출없던일로,http://news.heraldcorp.com/view.php?ud=20190123000066
380,2019-01-23,한미약품릴리BTK저해제후보물질HM71224권리반환,http://news.mk.co.kr/newsRead.php?year=2019&no=46843
381,2019-01-23,BTK억제제권리반환한미약품임상진행검토,http://www.ebn.co.kr/news/view/969794
382,2019-01-23,한미약품류머티스관절염신약후보기술수출취소,http://www.nocutnews.co.kr/news/5093851
383,2019-01-23,한미약품릴리면역질환신약후보물질권리반환,http://www.dailian.co.kr/news/view/767185/?sc=naver
384,2019-01-23,특징주한미약품미국서BTK억제제권리반환급락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1713906
385,2019-01-23,한미약품케이엠제약희비엇갈려한미약품제약사릴리권리반환에4대낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=51078
386,2019-01-23,한미약품릴리BTK억제제권리반환”,http://news.heraldcorp.com/view.php?ud=20190123000081
387,2019-01-23,한미약품글로벌신약개발가속23년내출시,http://www.newsis.com/view/?id=NISX20190123_0000538049&cID=13001&pID=13000
388,2019-01-23,특징주한미약품美릴리기술수출권리반환소식에하락세,http://news.mt.co.kr/mtview.php?no=2019012309071419949
389,2019-01-23,특징주한미약품기술수출한BTK억제제권리반환38↓,http://view.asiae.co.kr/news/view.htm?idxno=2019012309091836898
390,2019-01-23,8700억규모기술상업화포기한릴리한미약품신약개발지속”,http://biz.chosun.com/site/data/html_dir/2019/01/23/2019012301034.html
391,2019-01-23,한미약품23년내글로벌신약내놓겠다”,http://news.heraldcorp.com/view.php?ud=20190123000090
392,2019-01-23,특징주한미약품자사신약물질권리반환약세,http://www.newspim.com/news/view/20190123000154
393,2019-01-23,릴리한미약품에BTK억제제권리반환,http://www.monews.co.kr/news/articleView.html?idxno=200519
394,2019-01-23,한미약품릴리와신약후보물질기술수출계약해지,http://www.asiatime.co.kr/news/articleView.html?idxno=224720
395,2019-01-23,특징주한미약품기술수출한면역질환치료제계약해지에↓,http://www.edaily.co.kr/news/newspath.asp?newsid=01859766622360672
396,2019-01-23,릴리BTK억제제권리한미약품에반환,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1123994&REFERER=NP
397,2019-01-23,특징주한미약품기술수출계약해지에약세,http://yna.kr/AKR20190123035700008?did=1195m
398,2019-01-23,한미약품릴리와작별BTK억제제권리반환,http://www.dailysmart.co.kr/news/articleView.html?idxno=5332
399,2019-01-23,한미약품릴리와BTK억제제기술수출계약해지,http://www.etoday.co.kr/news/section/newsview.php?idxno=1713907
400,2019-01-23,한미약품릴리와신약후보물질기술수출계약해지,http://www.seoulfn.com/news/articleView.html?idxno=331666
401,2019-01-23,한미약품기술수출한면역질환치료제계약해지에약세,http://www.sedaily.com/NewsView/1VE5CN8KDV
402,2019-01-23,특징주한미약품면역질환치료제기술수출계약해지에약세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901230094&t=NN
403,2019-01-23,특징주한미약품BTK억제제권리반환에약세,http://www.ekn.kr/news/article.html?no=411019
404,2019-01-23,한미약품릴리와신약후보물질기술수출계약해지,http://www.dt.co.kr/contents.html?article_no=2019012302109931102002&ref=naver
405,2019-01-23,특징주한미약품면역질환치료제계약해지에약세,http://www.ebn.co.kr/news/view/969800
406,2019-01-23,한미약품면역질환치료제기술수출계약해지하락,http://news.hankyung.com/article/2019012317196
407,2019-01-23,특징주한미약품美릴리기술수출권리반환에약세,http://www.dailian.co.kr/news/view/767218/?sc=naver
408,2019-01-23,한미약품릴리로부터BTK억제제기술수출계약해지,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901230081&t=NN
409,2019-01-23,특징주한미약품기술수출권리반환소식에약세,http://moneys.mt.co.kr/news/mwView.php?no=2019012309228033886
410,2019-01-23,특징주한미약품파트너사권리반환소식에하락세,http://www.newsis.com/view/?id=NISX20190123_0000538133&cID=10401&pID=10400
411,2019-01-23,특징주한미약품BTK억제제권리반환약세,http://www.inews24.com/view/1153099
412,2019-01-23,HotLine한미약품기술수출계약해지소식에약세,http://news.mk.co.kr/newsRead.php?year=2019&no=46994
413,2019-01-23,특징주한미약품기술수출계약해지에장초반약세,http://www.ajunews.com/view/20190123092542066
414,2019-01-23,특징주한미약품BTK억제제권리반환소식에약세,http://www.fetv.co.kr/news/article.html?no=19298
415,2019-01-23,특징주한미약품기술수출계약해지에하락,http://www.asiatime.co.kr/news/articleView.html?idxno=224730
416,2019-01-23,한미약품기술수출한BTK억제제반환신약파이프라인영향없어”,http://www.econovill.com/news/articleView.html?idxno=355216
417,2019-01-23,특징주한미약품신약기술수출해지주가된서리,http://www.g-enews.com/ko-kr/news/article/news_all/201901230932428566c642673384_1/article.html
418,2019-01-23,특징주한미약품면역질환치료제계약해지에주가↓,http://www.newsprime.co.kr/news/article.html?no=444252
419,2019-01-23,특징주한미약품기술수출권리반환소식에약세,http://news1.kr/articles/?3531179
420,2019-01-23,한미약품美릴리에기술수출한면역질환치료제권리반환,http://www.newspost.kr/news/articleView.html?idxno=68266
421,2019-01-23,한미약품8000억원규모BTK저해제기술수출해지,http://news.hankyung.com/article/201901231799f
422,2019-01-23,릴리유효성입증어려워진한미약품BTK억제제권리반환,http://www.kukinews.com/news/article.html?no=625057
423,2019-01-23,한미약품미국릴리기술수출권리반환소식에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=344662
424,2019-01-23,릴리BTK억제제유효성입증못해권리반환한미약품독자개발”,http://ilyo.co.kr/?ac=article_view&entry_id=323422
425,2019-01-23,한미약품릴리BTK억제제권리반환했지만”,http://www.datanews.co.kr/news/article.html?no=101967
426,2019-01-23,릴리임상중단된BTK억제제권리한미약품에반환,http://www.bokuennews.com/news/article.html?no=170940
427,2019-01-23,릴리BTK억제제권리한미약품에반환,http://www.g-enews.com/ko-kr/news/article/news_all/201901230943461061f6d02acec0_1/article.html
428,2019-01-23,한미약품BTK억제제기술수출중도해지돼계약금은유지,http://www.whitepaper.co.kr/news/articleView.html?idxno=140009
429,2019-01-23,릴리BTK억제제권리한미약품에반환신약개발난항,http://www.greened.kr/news/articleView.html?idxno=91778
430,2019-01-23,한미약품기술수출BTK억제제권리반환받아,http://www.ceoscoredaily.com/news/article.html?no=51254
431,2019-01-23,한미약품면역질환치료제기술수출계약해지,http://www.kpinews.co.kr/news/articleView.html?idxno=88693
432,2019-01-23,한미약품릴리에기술수출한BTK억제제반환,http://www.ajunews.com/view/20190123095732127
433,2019-01-23,한미약품美릴리BTK억제제권리반환,http://www.sisajournal-e.com/news/articleView.html?idxno=194698
434,2019-01-23,한미약품릴리기술수출계약해지,http://www.dailymedi.com/detail.php?number=839435&thread=22r05
435,2019-01-23,한미약품류마티스관절염치료제후보로꼽히던BTK억제제권리돌려받아,https://cnbc.sbs.co.kr/article_hub/10000928766?division=NAVER
436,2019-01-23,릴리BTK억제제권리한미약품에반환,http://www.getnews.co.kr/view.php?ud=20190123100310530641d0c69529_16
437,2019-01-23,한미약품릴리면역질환신약후보물질권리반환,http://moneys.mt.co.kr/news/mwView.php?no=2019012309538036020
438,2019-01-23,특징주한미약품기술수출계약해지소식에하락세,http://www.dt.co.kr/contents.html?article_no=2019012302109932048003&ref=naver
439,2019-01-23,한미약품글로벌신약개발23년내출시,http://www.straightnews.co.kr/news/articleView.html?idxno=41957
440,2019-01-23,한미약품릴리기술이전파이프라인임상중단,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019012310172601194&objId=A2019012310172601194&portalCode=naver
441,2019-01-23,한미약품릴리와면역질환치료제기술수출계약해지,http://www.rapportian.com/news/articleView.html?idxno=115638
442,2019-01-23,한미약품임상2상서무너진BTK억제제결국권리반환,http://www.mhj21.com/118973
443,2019-01-23,한미약품릴리BTK억제제권리반환,http://www.joseilbo.com/news/news_read.php?uid=369092&class=27&grp=
444,2019-01-23,릴리BTK억제제권리한미약품에반환,http://www.100ssd.co.kr/news/articleView.html?idxno=59090
445,2019-01-23,한미약품기술수출BTK억제제권리반환,http://www.newsprime.co.kr/news/article.html?no=444278
446,2019-01-23,한미약품8600억규모신약기술수출계약해지,http://www.upinews.kr/news/newsview.php?ncode=1065574365179705
447,2019-01-23,한미약품릴리에기술수출한BTK억제제권리반환,http://www.news2day.co.kr/119236
448,2019-01-23,한미약품류마티스관절염신약개발쓴맛,http://news.bizwatch.co.kr/article/consumer/2019/01/23/0001/naver
449,2019-01-23,특징주한미약품기술수출계약해지소식에약세,http://www.ajunews.com/view/20190123110648281
450,2019-01-23,한미약품릴리BTK억제제권리반환”,http://www.cnbnews.com/news/article.html?no=398021
451,2019-01-23,릴리社한미약품의BTK억제제기술수출계약해지,http://www.inthenews.co.kr/news/article.html?no=13147
452,2019-01-23,한미약품릴리로부터BTK억제제권리반환받아,http://www.medigatenews.com/news/3613613112
453,2019-01-23,한미약품美릴리BTK억제제기술수출계약해지,http://news.donga.com/3/all/20190123/93823126/2
454,2019-01-23,한미약품릴리와7억6500만달러신약후보물질기술수출계약해지,http://www.newsworks.co.kr/news/articleView.html?idxno=330089
455,2019-01-23,한미약품릴리에기술수출한BTK억제제권리반환공시,http://www.insightkorea.co.kr//news/articleView.html?idxno=33635
456,2019-01-23,릴리한미약품에BTK억제제권리반환,http://www.pressm.kr/news/articleView.html?idxno=21898
457,2019-01-23,한미약품美릴리BTK억제제권리반환,http://www.hg-times.com/news/articleView.html?idxno=196891
458,2019-01-23,한미약품릴리BTK억제제권리반환공시,http://www.naeil.com/news_view/?id_art=302075
459,2019-01-23,릴리류마티스관절염치료신약권리한미약품에반환,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1064685
460,2019-01-23,특징주한미약품BTK억제제권리반환에주가약세,http://www.asiatoday.co.kr/view.php?key=20190123010014306
461,2019-01-23,한미약품파트너사릴리BTK억제제권리한미약품에반환,http://www.fntoday.co.kr/news/articleView.html?idxno=178411
462,2019-01-23,릴리와체결한한미약품의자가면역질환신약물질계약해지된이유,http://www.sisaweek.com/news/articleView.html?idxno=117806
463,2019-01-23,한미약품주가1월23일현재432000원,http://www.gokorea.kr/news/articleView.html?idxno=82786
464,2019-01-23,한미약품릴리면역질환BTK억제제권리반환”,http://www.etnews.com/20190123000189
465,2019-01-23,ET투자뉴스한미약품BTKinhibiBUYKTB투자증권,http://www.etnews.com/20190123000213
466,2019-01-23,한미약품릴리에기술수출한면역질환치료제계약해지,http://www.metroseoul.co.kr/news/newsview?newscd=2019012300128
467,2019-01-23,종목이슈한미약품계약해지노출된악재증권가놀랄일아냐,http://www.newspim.com/news/view/20190123000498
468,2019-01-23,부자들은경제신문을읽는다김권진차장한미약품美릴리기술수출권리반환알려진이슈저가매수대응,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019012314485186254
469,2019-01-23,한미약품면역질환치료제기술수출계약해지,http://www.skyedaily.com/news/news_view.html?ID=81189
470,2019-01-23,한미약품릴리면역질환BTK억제제권리반환,http://www.smedaily.co.kr/news/articleView.html?idxno=80959
471,2019-01-23,릴리BTK억제제권리한미약품에반환,http://www.nextdaily.co.kr/news/article.html?id=20190123800026
472,2019-01-23,1월23일수요일특징주한미약품,http://www.leaders.kr/news/articleView.html?idxno=85315
473,2019-01-23,한미약품1289402019년01월23일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=147128
474,2019-01-23,한미약품기술수출해지에삼성바이오폭탄까지제약바이오株털썩,http://www.ekn.kr/news/article.html?no=411161
475,2019-01-23,한미약품릴리기술수출계약해지,http://news.mk.co.kr/newsRead.php?year=2019&no=48522
476,2019-01-23,한미약품해외제약사에기술수출한관절염치료제권리돌려받아,http://www.businesspost.co.kr/BP?command=article_view&num=111475
477,2019-01-23,기술수출에찬물뿌린한미약품8700억계약해지,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901230416&t=NNv
478,2019-01-23,한미약품2019년01월23일기준전일대비291변동된434500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=590183
479,2019-01-23,한미약품27개파이프라인으로23년내글로벌신약내놓겠다,http://www.techholic.co.kr/news/articleView.html?idxno=180270
480,2019-01-23,유가증권시장공시에이블씨엔씨웅진씽크빅한미약품등,http://news.mk.co.kr/newsRead.php?year=2019&no=48641
481,2019-01-23,한미약품또계약해지기술수출이곧신약성공아냐”,http://www.hankookilbo.com/news/npath/201901231176345022?did=NA
482,2019-01-23,갈길머나먼K신약개발한미약품또기술수출계약해지,http://news.hankyung.com/article/2019012344451
483,2019-01-23,기술수출해지암초만난한미약품신약파이프라인시험대,http://www.etoday.co.kr/news/section/newsview.php?idxno=1714320
484,2019-01-23,일라이릴리BTK억제제권리한미약품에반환계약금600억원은확보,https://www.insight.co.kr/news/206349
485,2019-01-24,한미약품기술반환실패아닌재산여전히건재,http://news.mt.co.kr/mtview.php?no=2019012310161181118
486,2019-01-24,한미약품악재만난바이오주믿을건RD성과,http://www.newstomato.com/ReadNews.aspx?no=871626
487,2019-01-24,퀵리포트한미약품매수유지목표가53만원유지삼성證,http://www.itooza.com/common/iview.php?no=2019012407315016294
488,2019-01-24,퀵리포트한미약품매수유지목표가51만원유지NH證,http://www.itooza.com/common/iview.php?no=2019012407323466203
489,2019-01-24,퀵리포트한미약품매수유지목표가57만원유지하나금투,http://www.itooza.com/common/iview.php?no=2019012407381615544
490,2019-01-24,한미약품기술반환예정된악재저가매수기회하나금투,http://www.newstomato.com/ReadNews.aspx?no=871784
491,2019-01-24,한미약품기술수출해지영향은,http://www.etoday.co.kr/news/section/newsview.php?idxno=1714411
492,2019-01-24,I리포트한미약품BTK저해제기술반환이미예정–하나금투,http://www.inews24.com/view/1153383
493,2019-01-24,한미약품목표가51만원유지전일종가43만4500원NH證,http://www.newspim.com/news/view/20190124000084
494,2019-01-24,한미약품목표가53만원유지전일종가43만4500원삼성證,http://www.newspim.com/news/view/20190124000080
495,2019-01-24,한미약품목표가57만원유지전일종가43만4500원하나금투,http://www.newspim.com/news/view/20190124000090
496,2019-01-24,한미약품현재악재보다는신규파이프라인에주목,http://www.asiatoday.co.kr/view.php?key=20190124010015196
497,2019-01-24,한미약품BTK저해제기술반환예상된악재불확실성해소하나,http://www.edaily.co.kr/news/newspath.asp?newsid=01538326622361000
498,2019-01-24,한미약품추가악재가능성낮아매수NH證,http://news.mt.co.kr/mtview.php?no=2019012408073129455
499,2019-01-24,신한금융투자한미약품BTK저해제반환예정된악재,http://www.newsis.com/view/?id=NISX20190124_0000539365&cID=10401&pID=10400
500,2019-01-24,클릭e종목한미약품권리반환이후추가악재가능성낮다매수기회,http://view.asiae.co.kr/news/view.htm?idxno=2019012408304294869
501,2019-01-24,NH투자증권한미약품BTK저해제권리반환은이미반영된악재”,http://www.newsway.co.kr/news/view?tp=1&ud=2019012408291433426
502,2019-01-24,한미약품BTK저해제권리반환으로저가매수기회하나,http://biz.chosun.com/site/data/html_dir/2019/01/24/2019012400595.html
503,2019-01-24,한미약품사도된다관절염치료제반환은이미반영된악재,http://www.businesspost.co.kr/BP?command=article_view&num=111557
504,2019-01-24,한미약품BTK저해제권리반환주가영향미미NH,http://www.ekn.kr/news/article.html?no=411274
505,2019-01-24,하나금투한미약품기술수출해지는반영된악재,http://yna.kr/AKR20190124034400008?did=1195m
506,2019-01-24,HotLine한미약품BTK저해제권리반환보다새파이프라인주목,http://news.mk.co.kr/newsRead.php?year=2019&no=49456
507,2019-01-24,한미약품권리반환은이미반영된악재신규파이프라인주목해야”,http://www.newspim.com/news/view/20190124000133
508,2019-01-24,한미약품BTK저해제반환공식발표로불확실성해소,http://www.nspna.com/news/?mode=view&newsid=334441
509,2019-01-24,한미약품BTK저해제반환은예정된악재불확실성해소–하나금융투자,http://www.fntimes.com/html/view.php?ud=2019012408544662551d6f57e61a_18
510,2019-01-24,한미약품BTK억제제기술이전계약해지로불확실성해소하나금융투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1714477
511,2019-01-24,한미약품BTK저해제권리반환은반영된재료증권계,http://www.choicenews.co.kr/news/articleView.html?idxno=47724
512,2019-01-24,한미약품주가1월24일현재432000원,http://www.gokorea.kr/news/articleView.html?idxno=83054
513,2019-01-24,ET투자뉴스한미약품이미예정되었던BUY하나금융투자,http://www.etnews.com/20190124000058
514,2019-01-24,ET투자뉴스한미약품HM71224계약BUY삼성증권,http://www.etnews.com/20190124000080
515,2019-01-24,폴리텍대일자리특화대학선포한미약품한화큐셀등우수기업선정,http://www.edaily.co.kr/news/newspath.asp?newsid=02981526622361000
516,2019-01-24,한미약품주식종목검색24일현재431500원,http://www.nbntv.co.kr/news/articleView.html?idxno=183455
517,2019-01-24,한미약품인천약사들암투병영업사원십시일반온정,http://www.kpanews.co.kr/article/show.asp?idx=201091&table=article&category=D
518,2019-01-24,ET투자뉴스한미약품추가적인다운사이드BUY유지NH투자증권,http://www.etnews.com/20190124000166
519,2019-01-24,한미약품그룹말기암투병직원치료비4000여만원전달,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=226670
520,2019-01-24,이엔셀한미약품항암줄기세포치료제위탁생산,http://www.sedaily.com/NewsView/1VE5UEN4GR
521,2019-01-24,한미약품추가적인다운사이드리스크는제한적,http://www.newsworks.co.kr/news/articleView.html?idxno=330564
522,2019-01-24,릴리의기술반환예견된수순한미약품기업가치훼손제한적,http://biz.newdaily.co.kr/site/data/html/2019/01/24/2019012400102.html
523,2019-01-24,한미약품BTK저해제HM71224기술반환,http://www.newsworks.co.kr/news/articleView.html?idxno=330611
524,2019-01-24,한미약품1289402019년01월24일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=147530
525,2019-01-24,한미약품또기술수출취소다른후보물질은괜찮나,https://jhealthmedia.joins.com/article/article_view.asp?pno=20050
526,2019-01-24,유한양행한미약품박능후지원등에업고신약기술수출탄력,http://www.businesspost.co.kr/BP?command=article_view&num=111639
527,2019-01-24,한미약품2019년01월24일기준전일대비058변동된432000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=590812
528,2019-01-25,한미약품RD기대감유효목표가하향대신,http://www.newstomato.com/ReadNews.aspx?no=872103
529,2019-01-25,퀵리포트한미약품매수유지목표가3↓57만원대신證,http://www.itooza.com/common/iview.php?no=2019012507324782607
530,2019-01-25,주가그래프한미약품주가25일현재433000원,http://www.nbntv.co.kr/news/articleView.html?idxno=185702
531,2019-01-25,한미약품올해RD비용과신약가치의줄다리기,http://www.newsworks.co.kr/news/articleView.html?idxno=330930
532,2019-01-25,1월25일한미약품종목그래프및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=84294
533,2019-01-25,한미약품연구개발비늘지만신약가치평가받을기대높아,http://www.businesspost.co.kr/BP?command=article_view&num=111794
534,2019-01-25,ET투자뉴스한미약품실적은아쉽지만RBUY대신증권,http://www.etnews.com/20190125000192
535,2019-01-25,한미약품1월31일목18시까지2019년1월수시채용,http://www.ekn.kr/news/article.html?no=411663
536,2019-01-25,한미약품1289402019년01월25일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=148001
537,2019-01-25,한미약품2019년01월25일기준전일대비000변동된432000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=591214
538,2019-01-25,한미약품임종윤사장한국바이오협회신임이사장선임,http://www.g-enews.com/ko-kr/news/article/news_all/201901251745142962f6d02acec0_1/article.html
539,2019-01-25,한국바이오협회신임이사장에임종윤한미약품사장,http://www.dailypharm.com/Users/News/NewsView.html?ID=248963&REFERER=NP
540,2019-01-25,한미약품임종윤사장한국바이오협회신임이사장선임,http://www.medisobizanews.com/news/articleView.html?idxno=57593
541,2019-01-26,신약개발돋보기한미약품美시장노리는호중구감소증치료제롤론티스,http://www.edaily.co.kr/news/newspath.asp?newsid=01318566622361656
542,2019-01-27,제약바이오한주간이모저모한미약품美기술수출권리반환등,http://www.edaily.co.kr/news/newspath.asp?newsid=01203766622361984
543,2019-01-27,한미약품신약개발명암기술반환악재만은아냐,http://www.m-i.kr/news/articleView.html?idxno=491503
544,2019-01-27,한미약품임종윤사장한국바이오協이사장선임,http://www.dailymedi.com/detail.php?number=839563&thread=22r05
545,2019-01-27,한국바이오協신임이사장에임종윤한미약품사장선임,http://www.shinailbo.co.kr/news/articleView.html?idxno=1137475
546,2019-01-27,임종윤한미약품대표한국바이오협회이사장선임,http://www.kpinews.co.kr/news/articleView.html?idxno=89082
547,2019-01-28,한미약품경영2세임종윤의광폭행보,http://news.mt.co.kr/mtview.php?no=2019012713485167656
548,2019-01-28,한미약품임종윤사장한국바이오협회이사장선임,http://www.4th.kr/news/articleView.html?idxno=8418
549,2019-01-28,한국바이오협회신임이사장에임종윤한미약품사장선임,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901250497&t=NN
550,2019-01-28,녹십자한미약품안국약품신풍제약RD강화,http://www.dailymedi.com/detail.php?number=839595&thread=22r05
551,2019-01-28,한미약품임종윤대표한국바이오협회이사장선임,http://www.straightnews.co.kr/news/articleView.html?idxno=42278
552,2019-01-28,한미약품임종윤대표한국바이오협회이사장선임,http://www.fntoday.co.kr/news/articleView.html?idxno=178837
553,2019-01-28,한미약품오늘주식장28일현재432500원,http://www.nbntv.co.kr/news/articleView.html?idxno=188358
554,2019-01-28,한미약품1289402019년01월28일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=148517
555,2019-01-28,한미약품2019년01월28일기준전일대비012변동된432500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=592133
556,2019-01-29,1월29일한미약품증권주식058430000원,http://www.nbntv.co.kr/news/articleView.html?idxno=190674
557,2019-01-29,한미약품주가1월29일현재430500원,http://www.gokorea.kr/news/articleView.html?idxno=86692
558,2019-01-29,2019K바이오이끌기업삼성바이오시밀러글로벌1위우뚝한미약품SK바이오팜신약개발박차,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=59439
559,2019-01-29,한미약품작년연간연결영업익835억전년비17↑,http://www.newspim.com/news/view/20190129000612
560,2019-01-29,컨센초과한미약품작년연간연결영업익835억컨센비98↑,http://www.itooza.com/common/iview.php?no=2019012914535117834
561,2019-01-29,한미약품작년영업익836억전년비2↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=249057&REFERER=NP
562,2019-01-29,한미약품2018년매출1조160억전년比108↑,http://news.mt.co.kr/mtview.php?no=2019012914532831370
563,2019-01-29,한미약품지난해영업이익836억원17증가,http://yna.kr/AKR20190129129600008?did=1195m
564,2019-01-29,ET투자뉴스한미약품18년4분기실적발표,http://www.etnews.com/20190129000329
565,2019-01-29,토종한미약품자체제품으로매출1조160억원,http://www.asiatoday.co.kr/view.php?key=20190129010018621
566,2019-01-29,한미약품자체제품으로매출1조160억원토종제약사의힘”,http://www.ekn.kr/news/article.html?no=412287
567,2019-01-29,한미약품지난해영업익835억전년비17↑,http://news.heraldcorp.com/view.php?ud=20190129000658
568,2019-01-29,한미약품지난해영업익836억전년比2증가1보,http://news1.kr/articles/?3536477
569,2019-01-29,한미약품자체제품만으로매출1조160억원달성,http://medipana.com/news/news_viewer.asp?NewsNum=234084&MainKind=A&NewsKind=5&vCount=12&vKind=1
570,2019-01-29,한미약품작년영업이익835억원전년比17↑,http://news.hankyung.com/article/2019012930426
571,2019-01-29,한미약품3년만에매출1조클럽복귀,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201901290467&t=NN
572,2019-01-29,한미약품지난해매출1조160억전년대비108↑,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019012915061426428
573,2019-01-29,한미약품자체제품으로매출1조원돌파,http://www.edaily.co.kr/news/newspath.asp?newsid=03883526622362640
574,2019-01-29,한미약품지난해당기순익341억원전년비505감소,http://www.seoulwire.com/news/articleView.html?idxno=58269
575,2019-01-29,한미약품자체개발제품판매로매출1조원돌파,http://www.ceoscoredaily.com/news/article.html?no=51484
576,2019-01-29,한미약품자체제품만으로지난해매출1조160억원,http://www.newsway.co.kr/news/view?tp=1&ud=2019012915140886195
577,2019-01-29,한미약품지난해국내매출933자체개발제품으로달성,http://www.fnnews.com/news/201901291519056561
578,2019-01-29,한미약품지난해영업익835억전년比17↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1716441
579,2019-01-29,한미약품매출1조클럽진입자체개발신약의힘”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1716440
580,2019-01-29,한미약품지난해매출1조160억자체개발제품비중93,http://www.newsprime.co.kr/news/article.html?no=445072
581,2019-01-29,실적한미약품지난해매출1조160억자체개발비중933,http://www.ezyeconomy.com/news/articleView.html?idxno=87910
582,2019-01-29,한미약품3년만에1조클럽재입성자체개발제품으로이룬성과,http://www.metroseoul.co.kr/news/newsview?newscd=2019012900190
583,2019-01-29,한미약품지난해매출1조원넘겨,http://www.kukinews.com/news/article.html?no=627310
584,2019-01-29,한미약품지난해매출1조돌파자체개발제품으로이룬성과,http://www.newspim.com/news/view/20190129000658
585,2019-01-29,토종제약사의힘한미약품자체제품으로매출1조원돌파,http://www.medisobizanews.com/news/articleView.html?idxno=57650
586,2019-01-29,한미약품작년매출1조자체개발제품93토종의힘,http://biz.chosun.com/site/data/html_dir/2019/01/29/2019012901876.html
587,2019-01-29,한미약품2018년영업이익836억원전년대비17증가,http://www.polinews.co.kr/news/article.html?no=381134
588,2019-01-29,한미약품지난해매출1조클럽복귀토종제약사의힘,http://www.newstomato.com/ReadNews.aspx?no=873061
589,2019-01-29,한미약품자체품목매출1조160억원RD선구조,http://www.mhj21.com/119119
590,2019-01-29,한미약품작년매출1조160억3년만에1조클럽재진입,http://www.rapportian.com/news/articleView.html?idxno=115776
591,2019-01-29,토종제약사의힘한미약품매출1조원회복,http://news.mk.co.kr/newsRead.php?year=2019&no=60423
592,2019-01-29,한미약품3년만에매출1조탈환자체개발품이실적견인상보,http://news1.kr/articles/?3536585
593,2019-01-29,한미약품제약업계매출1조클럽재진입자체제품성과종합,http://yna.kr/AKR20190129129651008?did=1195m
594,2019-01-29,자체제품팔아1조클럽재가입한미약품작년매출1조160억원,http://news.mk.co.kr/newsRead.php?year=2019&no=60452
595,2019-01-29,한미약품지난해영업익836억원전년비17증가,http://view.asiae.co.kr/news/view.htm?idxno=2019012916021252655
596,2019-01-29,한미약품지난해영업이익836억원17↑,http://www.joseilbo.com/news/news_read.php?uid=369586&class=27&grp=
597,2019-01-29,대한민국토종제약기업의저력한미약품국내매출중자체개발제품933,http://kpenews.com/View.aspx?No=20601
598,2019-01-29,토종제약사의힘한미약품자체제품으로매출1조160억원,http://www.sisajournal-e.com/news/articleView.html?idxno=195015
599,2019-01-29,한미약품지난해영업익836억전년비17↑,http://www.ebn.co.kr/news/view/970734
600,2019-01-29,한미약품자체제품으로지난해매출1조돌파,http://www.m-i.kr/news/articleView.html?idxno=492335
601,2019-01-29,한미약품작년매출1조원돌파자체제품으로1조클럽재입성,http://view.asiae.co.kr/news/view.htm?idxno=2019012916151072932
602,2019-01-29,한미약품1289402019년01월29일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=148933
603,2019-01-29,국민연금한미약품지분율1011→993,http://news.mt.co.kr/mtview.php?no=2019012916262286460
604,2019-01-29,한미약품3년만에1조클럽복귀,http://www.newswatch.kr/news/articleView.html?idxno=17137
605,2019-01-29,한미약품지난해매출1조160억원자체제품93,http://daily.hankooki.com/lpage/ittech/201901/dh20190129162851145630.htm
606,2019-01-29,한미약품1조클럽복귀RD성과,http://www.sisaon.co.kr/news/articleView.html?idxno=81893
607,2019-01-29,한미약품지난해매출1조돌파자체개발제품성과,http://www.newsis.com/view/?id=NISX20190129_0000544604&cID=13001&pID=13000
608,2019-01-29,한미약품2018년매출1조160억원영업이익836억원달성,http://www.medigatenews.com/news/576915230
609,2019-01-29,한미약품지난해매출1조160억자체개발비중933,http://www.pressm.kr/news/articleView.html?idxno=21973
610,2019-01-29,한미약품매출1조클럽재입성,http://www.etnews.com/20190129000422
611,2019-01-29,한미약품계열사JVM2018년매출1036억원,http://medipana.com/news/news_viewer.asp?NewsNum=234089&MainKind=A&NewsKind=5&vCount=12&vKind=1
612,2019-01-29,한미약품RD효과로매출1조달성,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019012916424803280&objId=A2019012916424803280&portalCode=naver
613,2019-01-29,한미약품그룹계열사JVM작년4분기매출307억원영업익284↑,http://www.medisobizanews.com/news/articleView.html?idxno=57655
614,2019-01-29,한미약품지난해매출1조원돌파자체개발제품비중93,http://www.sedaily.com/NewsView/1VE851Q5WJ
615,2019-01-29,한미약품1조클럽재입성지난해자체제품비중933달해,http://biz.newdaily.co.kr/site/data/html/2019/01/29/2019012900181.html
616,2019-01-29,한미약품지난해매출액8000억전년대비10증가,http://www.ajunews.com/view/20190129164125585
617,2019-01-29,한미약품작년매출1조160억영업이익836억,http://www.kpinews.co.kr/news/articleView.html?idxno=89293
618,2019-01-29,한미약품지난해매출1조돌파영업이익836억원,http://www.econonews.co.kr/news/articleView.html?idxno=51922
619,2019-01-29,한미약품이것이토종의힘매출1조원돌파,http://news.bizwatch.co.kr/article/consumer/2019/01/29/0028/naver
620,2019-01-29,한미약품지난해매출1조돌파자체개발제품933,http://www.wikileaks-kr.org/news/articleView.html?idxno=46558
621,2019-01-29,한미약품지난해매출1조160억원자체제품성과,http://www.dailian.co.kr/news/view/768938/?sc=naver
622,2019-01-29,한미약품자체제품만으로매출1조160억원달성,http://www.asiatime.co.kr/news/articleView.html?idxno=226052
623,2019-01-29,자체개발제품의힘한미약품작년매출1조돌파,http://www.newsworks.co.kr/news/articleView.html?idxno=332149
624,2019-01-29,한미약품1조클럽복귀신약개발탄력붙는다,http://kormedi.com/?p=1263439
625,2019-01-29,한미약품자체제품매출1조160억원달성,http://www.straightnews.co.kr/news/articleView.html?idxno=42397
626,2019-01-29,한미약품그룹계열사JVM지난해4분기매출307억원전년比161↑,http://www.sisafocus.co.kr/news/articleView.html?idxno=201390
627,2019-01-29,한미약품자체제품에힘입어2018년매출1조160억,http://www.newspost.kr/news/articleView.html?idxno=68423
628,2019-01-29,한미약품스스로의힘으로1조클럽가입성공”,http://www.cnbnews.com/news/article.html?no=398750
629,2019-01-29,한미약품2019년01월29일기준전일대비069변동된429500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=592777
630,2019-01-29,한미약품그룹계열사JVM작년4분기307억원매출전년비161성장,http://www.ekn.kr/news/article.html?no=412340
631,2019-01-29,한미약품1조클럽재진입지난해영업익835억원,http://www.shinailbo.co.kr/news/articleView.html?idxno=1138229
632,2019-01-29,한미약품3년만에매출1조회복,http://news.mk.co.kr/newsRead.php?year=2019&no=60908
633,2019-01-29,한미약품2018년매출1조돌파,http://www.dailymedi.com/detail.php?number=839662&thread=22r05
634,2019-01-29,한미약품자체개발제품으로3년만에1조클럽복귀,http://www.inthenews.co.kr/news/article.html?no=13269
635,2019-01-29,한미약품매출1조160억원달성자체개발제품비중높아,http://www.econovill.com/news/articleView.html?idxno=355653
636,2019-01-29,한미약품자체제품으로매출1조160억원달성,http://www.mdtoday.co.kr/mdtoday/index.html?no=345218
637,2019-01-29,한미약품매출1조클럽복귀토종제약기업의역할하겠다,http://www.upinews.kr/news/newsview.php?ncode=1065602527148325
638,2019-01-29,한미약품자체개발제품으로매출1조돌파,http://www.news2day.co.kr/119682
639,2019-01-29,한미약품매출1조클럽재가입RD의힘,http://news.mt.co.kr/mtview.php?no=2019012918041117293
640,2019-01-29,자체개발제품으로매출1조돌파한한미약품,http://news.hankyung.com/article/201901294249f
641,2019-01-29,한미약품자체제품만으로매출1조원저력,http://news.donga.com/3/all/20190129/93916704/2
642,2019-01-29,한미약품자체개발의약품으로작년매출1조달성,http://www.businesspost.co.kr/BP?command=article_view&num=112347
643,2019-01-29,한미약품자체개발한제품들로2018년매출1조160억원달성,https://www.insight.co.kr/news/207786
644,2019-01-29,외산품목없이도1조달성한미약품토종저력과시,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1124137&REFERER=NP
645,2019-01-29,한미약품제이브이엠작년매출24감소수출부진영향,http://news.donga.com/3/all/20190129/93917612/2
646,2019-01-29,한미약품임성기회장3년만에매출1조클럽재가입,http://www.newsfc.co.kr/news/articleView.html?idxno=35115
647,2019-01-29,한미약품계열사JVM지난해4분기307억원매출기록161성장,https://cnbc.sbs.co.kr/article_hub/10000929510?division=NAVER
648,2019-01-29,한미약품매출1조원대기록3년만에회복,https://cnbc.sbs.co.kr/article_hub/10000929520?division=NAVER
649,2019-01-29,한미약품자체제품으로매출1조160억원,http://www.newscj.com/news/articleView.html?idxno=597150
650,2019-01-30,한미약품2018년한해매출→1조160억원기록,http://www.gukjenews.com/news/articleView.html?idxno=1061856
651,2019-01-30,한미약품작년기술료수익446억4년간6425억,http://www.dailypharm.com/Users/News/NewsView.html?ID=249072&REFERER=NP
652,2019-01-30,퀵리포트한미약품매수유지목표가57만원유지대신證,http://www.itooza.com/common/iview.php?no=2019013007333824691
653,2019-01-30,퀵리포트한미약품매수유지목표가57만원유지하나금투,http://www.itooza.com/common/iview.php?no=2019013007361526229
654,2019-01-30,퀵리포트한미약품매수유지목표가3↓57만원KTB證,http://www.itooza.com/common/iview.php?no=2019013007355692161
655,2019-01-30,퀵리포트한미약품매수유지목표가9↓53만원한투證,http://www.itooza.com/common/iview.php?no=2019013007373411790
656,2019-01-30,퀵리포트한미약품매수유지목표가62만원유지SK證,http://www.itooza.com/common/iview.php?no=2019013007422919122
657,2019-01-30,한미약품RD성과가시화마일스톤기대매수하나금융투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1716702
658,2019-01-30,한미약품호실적은일시적효과목표주가↓,http://news.hankyung.com/article/2019013050536
659,2019-01-30,퀵리포트한미약품매수유지목표가53만원유지삼성證,http://www.itooza.com/common/iview.php?no=2019013007440411458
660,2019-01-30,한미약품올해기술료수익감소에따라목표가↓RD결실보여야한국,http://www.edaily.co.kr/news/newspath.asp?newsid=01492406622362968
661,2019-01-30,한미약품예상보다좋았던4분기유안타증권,http://www.betanews.net:8080/article/967663.html
662,2019-01-30,한미약품목표가57만원유지전일종가42만9500원대신證,http://www.newspim.com/news/view/20190130000079
663,2019-01-30,한미약품목표가3↓57만원제시KTB證,http://www.newspim.com/news/view/20190130000086
664,2019-01-30,한미약품목표가57만원유지전일종가42만9500원하나금투,http://www.newspim.com/news/view/20190130000088
665,2019-01-30,한미약품목표가9↓53만원제시한투證,http://www.newspim.com/news/view/20190130000097
666,2019-01-30,한미약품목표가62만원유지전일종가42만9500원SK證,http://www.newspim.com/news/view/20190130000108
667,2019-01-30,한미약품목표가53만원유지전일종가42만9500원삼성證,http://www.newspim.com/news/view/20190130000107
668,2019-01-30,한미약품일회성기술료유입으로어닝서프라이즈,http://www.asiatoday.co.kr/view.php?key=20190130010018939
669,2019-01-30,한미약품목표가50만원유지전일종가42만9500원하이투자證,http://www.newspim.com/news/view/20190130000145
670,2019-01-30,퀵리포트한미약품매수유지목표가50만원유지하이투자證,http://www.itooza.com/common/iview.php?no=2019013008091415823
671,2019-01-30,HotLine한미약품작년4분기실적예상보다좋고신약기대감도,http://news.mk.co.kr/newsRead.php?year=2019&no=61522
672,2019-01-30,한미약품목표가51만원유지전일종가42만9500원NH證,http://www.newspim.com/news/view/20190130000154
673,2019-01-30,한미약품목표가53만원유지전일종가42만9500원신한금투,http://www.newspim.com/news/view/20190130000157
674,2019-01-30,퀵리포트한미약품매수유지목표가53만원유지신한금투,http://www.itooza.com/common/iview.php?no=2019013008143629231
675,2019-01-30,퀵리포트한미약품매수유지목표가51만원유지NH證,http://www.itooza.com/common/iview.php?no=2019013008135512336
676,2019-01-30,한미약품목표가8↓53만원제시현대차證,http://www.newspim.com/news/view/20190130000168
677,2019-01-30,퀵리포트한미약품매수유지목표가8↓53만원현대차證,http://www.itooza.com/common/iview.php?no=2019013008212918265
678,2019-01-30,하이투자증권한미약품연구개발비증가에올해영업이익역성장전망풍부한RD이벤트집중”,http://www.g-enews.com/ko-kr/news/article/news_all/201901300823295739c642673384_1/article.html
679,2019-01-30,한미약품체질개선으로수익성확보삼성증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1716729
680,2019-01-30,한미약품자체개발제품으로매출1조원달성,http://news.heraldcorp.com/view.php?ud=20190130000062
681,2019-01-30,하이투자證한미약품올해영업익역성장예상이벤트집중해야,http://www.newsis.com/view/?id=NISX20190130_0000545167&cID=10401&pID=10400
682,2019-01-30,한미약품목표가5↓51만원제시키움證,http://www.newspim.com/news/view/20190130000221
683,2019-01-30,퀵리포트한미약품매수유지목표가61만원유안타證,http://www.itooza.com/common/iview.php?no=2019013008132216140
684,2019-01-30,퀵리포트한미약품Outperform으로하향목표가5↓51만원키움證,http://www.itooza.com/common/iview.php?no=2019013008445612362
685,2019-01-30,한미약품작년4분기예상보다호실적SK증권,http://www.ajunews.com/view/20190130084650971
686,2019-01-30,STOCK한미약품실적보단중장기연구개발역량에주목하길,http://moneys.mt.co.kr/news/mwView.php?no=2019013008398087532
687,2019-01-30,한미약품추가기술료수익기대SK證,http://www.seoulfn.com/news/articleView.html?idxno=332383
688,2019-01-30,ET투자뉴스한미약품4분기실적컨센BUYMAINTAIN하이투자증권,http://www.etnews.com/20190130000013
689,2019-01-30,한미약품4분기영업이익컨센서스42상회,http://www.nspna.com/news/?mode=view&newsid=335836
690,2019-01-30,한미약품작년4분기영업이익기대치상회추정삼성證,http://www.fnnews.com/news/201901300858373916
691,2019-01-30,한미약품연구개발비증가로영업이익역성장전망하이투자증권,http://www.ekn.kr/news/article.html?no=412406
692,2019-01-30,ET투자뉴스한미약품19년은실적보다OUTPERFORMDOWNGRADE,http://www.etnews.com/20190130000029
693,2019-01-30,ET투자뉴스한미약품2019년은내실경BUY현대차증권,http://www.etnews.com/20190130000038
694,2019-01-30,한미약품목표가45만원제시전일종가42만9500원DB금투,http://www.newspim.com/news/view/20190130000288
695,2019-01-30,ET투자뉴스한미약품예상보다좋았던4BUYM유안타증권,http://www.etnews.com/20190130000042
696,2019-01-30,퀵리포트한미약품보유로하향목표가45만원DB금투,http://www.itooza.com/common/iview.php?no=2019013009245410493
697,2019-01-30,2018년한미약품17명대웅제약2명CP위반,http://daily.hankooki.com/lpage/ittech/201901/dh20190130093050145630.htm
698,2019-01-30,ET투자뉴스한미약품의약품사업안정적BUY대신증권,http://www.etnews.com/20190130000046
699,2019-01-30,한미약품주가오를힘다져신약연구개발강화의성과기대,http://www.businesspost.co.kr/BP?command=article_view&num=112368
700,2019-01-30,한미약품2018년실적발표,http://www.fntoday.co.kr/news/articleView.html?idxno=179060
701,2019-01-30,ET투자뉴스한미약품체질개선및기술BUY삼성증권,http://www.etnews.com/20190130000057
702,2019-01-30,ET투자뉴스한미약품양호한4Q실적매수유지신한금융투자,http://www.etnews.com/20190130000066
703,2019-01-30,한미약품4분기실적기대이상RD성과따라올해는실적응답할때,http://www.getnews.co.kr/view.php?ud=20190130095439423d0a8833aad_16
704,2019-01-30,한미약품올해매출및수익성여부주시해야골드만삭스,http://www.choicenews.co.kr/news/articleView.html?idxno=47886
705,2019-01-30,한미약품목표가15↓50만원제시신영證,http://www.newspim.com/news/view/20190130000438
706,2019-01-30,퀵리포트한미약품매수유지목표가15↓50만원신영證,http://www.itooza.com/common/iview.php?no=2019013011093318514
707,2019-01-30,특징주한미약품4분기실적시장기대치상회,http://www.sisaon.co.kr/news/articleView.html?idxno=81926
708,2019-01-30,ET투자뉴스한미약품한미약품의RDBUY하나금융투자,http://www.etnews.com/20190130000168
709,2019-01-30,1월30일한미약품주가그래프429000원012,http://www.nbntv.co.kr/news/articleView.html?idxno=193036
710,2019-01-30,한미약품주가오늘시세및종목관련동향정보30일현재429000원,http://www.gokorea.kr/news/articleView.html?idxno=87892
711,2019-01-30,ET투자뉴스한미약품추정치미반영된기BUYKTB투자증권,http://www.etnews.com/20190130000213
712,2019-01-30,ET투자뉴스한미약품일회성기술료수취BUY유지NH투자증권,http://www.etnews.com/20190130000225
713,2019-01-30,ET투자뉴스한미약품기술수출료유입으로매수유지SK증권,http://www.etnews.com/20190130000261
714,2019-01-30,ET투자뉴스한미약품호실적은반갑지만매수유지한국투자증권,http://www.etnews.com/20190130000268
715,2019-01-30,한미약품1289402019년01월30일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=149391
716,2019-01-30,한미약품글로벌바이오신약에대한기대감,http://www.newsworks.co.kr/news/articleView.html?idxno=332607
717,2019-01-30,개량신약으로다시1조문턱넘어한미약품저력의원인,http://biz.newdaily.co.kr/site/data/html/2019/01/30/2019013000123.html
718,2019-01-30,한미약품2019년01월30일기준전일대비023변동된430500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=593446
719,2019-01-31,한미약품2018년실적발표,http://www.breaknews.com/631180
720,2019-01-31,한국투자증권한미약품매출영업익컨센서스상회매수목표가53만원,http://www.betanews.net:8080/article/968437.html
721,2019-01-31,한미약품목표가8↓54만원제시케이프證,http://www.newspim.com/news/view/20190131000172
722,2019-01-31,퀵리포트한미약품매수유지목표가8↓54만원케이프證,http://www.itooza.com/common/iview.php?no=2019013108185428573
723,2019-01-31,한미약품4분기영업익1035↑국내중국수익성향상케이프투자증권,http://www.ajunews.com/view/20190131090949215
724,2019-01-31,한미약품목표주가하향해외기술수출계약해지반영,http://www.businesspost.co.kr/BP?command=article_view&num=112560
725,2019-01-31,한미약품주가1월31일현재431000원,http://www.gokorea.kr/news/articleView.html?idxno=89147
726,2019-01-31,기업분석한미약품매출1조재진입기술료수익자체신약매출견인,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019013109011197976
727,2019-01-31,한미약품증권매매31일현재432000원,http://www.nbntv.co.kr/news/articleView.html?idxno=195332
728,2019-01-31,ET투자뉴스한미약품내실을다지는시간HOLD하향DB금융투자,http://www.etnews.com/20190131000253
729,2019-01-31,한미약품1289402019년01월31일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=149843
730,2019-01-31,1조클럽한미약품잇단목표주가하향까닭은,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019013116360703831&objId=A2019013116360703831&portalCode=naver
731,2019-01-31,한미약품2019년01월31일기준전일대비081변동된434000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=594139
732,2019-01-31,1조클럽재가입한한미약품올해글로벌성장엔진본격가동,http://www.ekn.kr/news/article.html?no=412834
733,2019-02-01,매출1조넘은한미약품1조근접한종근당도순이익은감소,http://www.kukinews.com/news/article.html?no=628382
734,2019-02-01,한미약품1조클럽가입콜마대웅도입성전망,http://www.dailymedi.com/detail.php?number=839745&thread=22r12
735,2019-02-01,주식장한미약품주가1일현재433500원,http://www.nbntv.co.kr/news/articleView.html?idxno=197676
736,2019-02-01,한미약품1289402019년02월01일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=150339
737,2019-02-03,제약바이오한주간이모저모한미약품3년만에매출1조재돌파,http://www.edaily.co.kr/news/newspath.asp?newsid=01426806622386912
738,2019-02-06,한미약품수익성은확보하반기RD모멘텀기대,http://news.heraldcorp.com/view.php?ud=20190201000674
739,2019-02-07,한미약품주가2월7일현재435000원,http://www.gokorea.kr/news/articleView.html?idxno=92118
740,2019-02-07,한미약품주식종목시세7일현재434500원,http://www.nbntv.co.kr/news/articleView.html?idxno=201377
741,2019-02-07,한미약품1289402019년02월07일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=151084
742,2019-02-07,한미약품2019년02월07일기준전일대비012변동된434000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=595576
743,2019-02-08,한미약품남녀평균근속연수격차2개월로업계에서제일작아,http://www.ceoscoredaily.com/news/article.html?no=51772
744,2019-02-08,제이브이엠한미약품편입효과올해본격화하이투자證,http://news.mt.co.kr/mtview.php?no=2019020807592256555
745,2019-02-08,ET투자뉴스한미약품_상장주식수대비거래량은025로적정수준,http://www.etnews.com/20190208000045
746,2019-02-08,특징주제이브이엠한미약품시너지기대주가상승세,http://www.edaily.co.kr/news/newspath.asp?newsid=02063126622388552
747,2019-02-08,특징주제이브이엠한미약품과시너지기대강세,http://www.inews24.com/view/1156172
748,2019-02-08,2월8일한미약품주식종목검색449500원357,http://www.nbntv.co.kr/news/articleView.html?idxno=203901
749,2019-02-08,취재수첩유한양행한미약품다른듯닮은행보뚝심은통했다,http://biz.newdaily.co.kr/site/data/html/2019/02/08/2019020800069.html
750,2019-02-08,한미약품1289402019년02월08일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=151495
751,2019-02-08,한미약품2월8일주가전일대비346변동된449000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=595965
752,2019-02-08,8일외국인순매수Top10KODEX200209억한미약품56억제일기획41억맥쿼리인프라29억외국인순매수나서코스닥시장에서는바이로메드컴투스엔지켐생명과학상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=20435
753,2019-02-10,권세창정부의신약개발지원에리더한미약품어깨무거워,http://www.businesspost.co.kr/BP?command=article_view&num=113443
754,2019-02-10,FDA승인기대되는한미약품GC녹십자임상3상결과앞둔바이로메드에이치엘비,http://news.hankyung.com/article/2019021037261
755,2019-02-11,SK증권현대중공업한미약품GS건설,http://www.seoulfn.com/news/articleView.html?idxno=333165
756,2019-02-11,특징주한미약품악재충분히반영사흘째↑,http://www.edaily.co.kr/news/newspath.asp?newsid=02013926622389536
757,2019-02-11,한미약품전일대비약4상승한467500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902110230&t=NN
758,2019-02-11,한미약품증권가긍정적평가에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=345957
759,2019-02-11,주식실시간한미약품주가11일현재467500원,http://www.nbntv.co.kr/news/articleView.html?idxno=206270
760,2019-02-11,한미약품주가증권투자정보외매매동향11일현재468000원,http://www.gokorea.kr/news/articleView.html?idxno=94642
761,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.g-enews.com/ko-kr/news/article/news_all/201902111423102315fa075a9870_1/article.html
762,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.nextdaily.co.kr/news/article.html?id=20190211800034
763,2019-02-11,한미약품그룹상장계열사에감사위원회설치투명성제고차원,http://www.ceoscoredaily.com/news/article.html?no=51844
764,2019-02-11,한미약품그룹투명성강화위해계열사에감사위원회설치,http://www.koreaittimes.com/news/articleView.html?idxno=89169
765,2019-02-11,한미약품투명경영추진계열사에감사위원회설치,http://moneys.mt.co.kr/news/mwView.php?no=2019021114258053240
766,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.newsway.co.kr/news/view?tp=1&ud=2019021114331280377
767,2019-02-11,한미약품그룹상장계열사에감사위원회설치투명성제고차원,http://biz.newdaily.co.kr/site/data/html/2019/02/11/2019021100138.html
768,2019-02-11,한미약품그룹상장계열사에감사위원회설치투명성제고차원,http://www.businesskorea.co.kr/news/articleView.html?idxno=29012
769,2019-02-11,한미약품그룹상장계열사에감사위원회설치투명경영강화,http://www.smedaily.co.kr/news/articleView.html?idxno=81268
770,2019-02-11,한미약품그룹상장계열사에감사위원회설치경영균형투명성강화,http://www.sisafocus.co.kr/news/articleView.html?idxno=202190
771,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.fnnews.com/news/201902111440461220
772,2019-02-11,한미약품그룹한미사이언스JVM등상장계열사에감사위원회설치,http://www.ezyeconomy.com/news/articleView.html?idxno=88083
773,2019-02-11,한미약품그룹상장계열사에감사위원회설치”투명성제고차원,http://www.getnews.co.kr/view.php?ud=20190211144808863141d0c69529_16
774,2019-02-11,한미약품상장계열사에감사위원회설치,http://www.etnews.com/20190211000353
775,2019-02-11,한미약품그룹상장계열사감사위원회일괄설치투명성강화,http://www.newsprime.co.kr/news/article.html?no=446216
776,2019-02-11,한미약품상장계열사감사위원회설치투명성제고,http://yna.kr/AKR20190211103000017?did=1195m
777,2019-02-11,한미약품그룹상장계열사에감사위원회일괄설치”경영투명성제고,http://www.etoday.co.kr/news/section/newsview.php?idxno=1720437
778,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.nspna.com/news/?mode=view&newsid=337622
779,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.dailian.co.kr/news/view/771490/?sc=naver
780,2019-02-11,한미약품그룹상장계열사에감사위원회설치투명경영강화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019021114502261539
781,2019-02-11,한미약품그룹상장계열사에감사위원회설치투명성높이기위해,http://www.econovill.com/news/articleView.html?idxno=356322
782,2019-02-11,한미약품그룹상장계열사에감사위원회일괄설치,http://medipana.com/news/news_viewer.asp?NewsNum=234454&MainKind=A&NewsKind=5&vCount=12&vKind=1
783,2019-02-11,한미약품그룹자본2조미만계열사들까지감사위원회설치,http://www.medisobizanews.com/news/articleView.html?idxno=57822
784,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.newspim.com/news/view/20190211000593
785,2019-02-11,한미약품그룹상장계열사감사위원회설치,http://www.dailymedi.com/detail.php?number=839915&thread=22r05
786,2019-02-11,한미약품그룹상장계열사에감사위원회설치”투명성높이겠다,http://www.metroseoul.co.kr/news/newsview?newscd=2019021100145
787,2019-02-11,한미약품그룹감사위원회설치투명성강화차원,http://kormedi.com/?p=1282023
788,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://daily.hankooki.com/lpage/ittech/201902/dh20190211151631145630.htm
789,2019-02-11,한미약품그룹상장계열사에감사위원회설치투명성제고차원,http://www.ekn.kr/news/article.html?no=414210
790,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.joseilbo.com/news/news_read.php?uid=370236&class=27&grp=
791,2019-02-11,한미약품그룹전상장계열사감사委설치,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019021115321002996&objId=A2019021115321002996&portalCode=naver
792,2019-02-11,한미약품그룹상장계열사감사위원회설치투명성↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=249342&REFERER=NP
793,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.ebn.co.kr/news/view/972125
794,2019-02-11,한미약품그룹투명성강화위해계열사에감사위원회설치,http://www.pressm.kr/news/articleView.html?idxno=22063
795,2019-02-11,한미약품그룹투명성제고위해상장계열사에감사위원회설치,http://news.mk.co.kr/newsRead.php?year=2019&no=83238
796,2019-02-11,한미약품상장계열사에감사위원회일괄설치,http://biz.chosun.com/site/data/html_dir/2019/02/11/2019021102054.html
797,2019-02-11,한미약품경영투명성향상,http://www.sedaily.com/NewsView/1VF9TMNB8J
798,2019-02-11,한미약품상장계열사에감사위설치,http://www.newstomato.com/ReadNews.aspx?no=875218
799,2019-02-11,한미약품상장계열사에감사위원회설치투명성제고,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902110496&t=NN
800,2019-02-11,한미약품1289402019년02월11일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=152117
801,2019-02-11,한미약품그룹상장계열사에감사위원회설치투명성제고,http://www.rapportian.com/news/articleView.html?idxno=115944
802,2019-02-11,한미약품그룹상장계열사감사위원회설치투명성제고,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227063
803,2019-02-11,한미약품그룹모든상장계열사에감사위설치,http://www.finomy.com/news/articleView.html?idxno=62820
804,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.4th.kr/news/articleView.html?idxno=8782
805,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.newsis.com/view/?id=NISX20190211_0000554781&cID=13001&pID=13000
806,2019-02-11,한미약품그룹투명성제고위해상장계열사에감사위원회설치,http://www.ajunews.com/view/20190211164720627
807,2019-02-11,한미약품그룹상장계열사감사委설치,http://www.whosaeng.com/107889
808,2019-02-11,한미약품그룹상장계열사內감사위원회설치투명성제고,http://www.shinailbo.co.kr/news/articleView.html?idxno=1140652
809,2019-02-11,한미약품그룹상장계열사에감사위원회일괄설치투명성강화,http://www.dt.co.kr/contents.html?article_no=2019021102109931102007&ref=naver
810,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.medigatenews.com/news/543758935
811,2019-02-11,한미약품그룹한미사이언스등상장계열사에감사위원회설치,http://www.newspost.kr/news/articleView.html?idxno=68647
812,2019-02-11,한미약품그룹상장계열사감사위원회설치,http://view.asiae.co.kr/news/view.htm?idxno=2019021117183061219
813,2019-02-11,한미약품그룹감사위원회설치투명성제고차원,http://www.nbnnews.co.kr/news/articleView.html?idxno=232859
814,2019-02-11,한미약품그룹한미사이언스제이브이엠에감사위원회설치,https://cnbc.sbs.co.kr/article_hub/10000930604?division=NAVER
815,2019-02-11,뉴스투데이L한미약품상장계열사감사위원회설치로투명성제고”,http://www.news2day.co.kr/120222
816,2019-02-11,한미약품2월11일주가전일대비401변동된467000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=596917
817,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://www.biospectator.com/view/news_view.php?varAtcId=7098
818,2019-02-11,한미약품그룹상장계열사에감사위원회설치,http://news.bizwatch.co.kr/article/consumer/2019/02/11/0026/naver
819,2019-02-11,한미약품그룹상장계열사에감사위원회일괄설치,http://www.techholic.co.kr/news/articleView.html?idxno=180550
820,2019-02-11,글로벌도약선제조치한미약품상장계열사감사위원회설치,http://www.iminju.net/news/articleView.html?idxno=43043
821,2019-02-11,한미약품그룹상장계열사에감사위원회일괄설치균형과투명성강화”,http://www.mdtoday.co.kr/mdtoday/index.html?no=346042
822,2019-02-11,한미약품그룹상장계열사에감사위원회설치투명성제고차원,http://www.gukjenews.com/news/articleView.html?idxno=1066953
823,2019-02-11,한미약품그룹상장계열사에감사위원회설치경영투명성제고,http://news.donga.com/3/all/20190211/94061145/2
824,2019-02-11,한미약품그룹상장계열사에감사위원회설치투명성제고차원,http://www.newscj.com/news/articleView.html?idxno=600535
825,2019-02-11,한미약품상장계열사에감사위원회설치투명성제고,http://www.seoulfn.com/news/articleView.html?idxno=333278
826,2019-02-12,한미약품그룹상장계열사에감사위원회설치”투명성제고차원”,http://www.lawissue.co.kr/view.php?ud=201902112354564854d7f4c63cc6_12
827,2019-02-12,DataScore한미약품우종수권세창대표체제호실적바탕시총50이상급증,http://www.ceoscoredaily.com/news/article.html?no=51825
828,2019-02-12,한미약품그룹상장계열사에감사委투명성제고,http://www.bosa.co.kr/news/articleView.html?idxno=2099268
829,2019-02-12,한미약품그룹내상장계열사에감사위원회설치,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065163
830,2019-02-12,한미약품기업경영의투명성위해감사위원회설치,http://www.seoulwire.com/news/articleView.html?idxno=65043
831,2019-02-12,한미약품지주계열사3개사에감사위원회설치,http://www.cnbnews.com/news/article.html?no=399842
832,2019-02-12,한미약품상장계열사에감사위일괄설치,http://www.dailysmart.co.kr/news/articleView.html?idxno=6255
833,2019-02-12,한미약품주가및증권시세및매매동향12일현재464000원,http://www.gokorea.kr/news/articleView.html?idxno=95811
834,2019-02-12,한미약품그룹경영투명성강화박차,http://www.straightnews.co.kr/news/articleView.html?idxno=43125
835,2019-02-12,한미약품1289402019년02월12일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=152568
836,2019-02-12,한미약품2월24일일18시까지2019년수시채용,http://www.ekn.kr/news/article.html?no=414484
837,2019-02-12,한미약품2월12일주가전일대비161변동된459500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=597592
838,2019-02-12,한미약품그룹상장계열사에감사위원회설치투명성제고차원,http://www.meconomynews.com/news/articleView.html?idxno=20376
839,2019-02-13,한미약품당뇨비만바이오신약상반기美2상완료,http://www.medisobizanews.com/news/articleView.html?idxno=57855
840,2019-02-13,녹십자유한양행한미약품등5개제약사작년매출1조돌파,http://www.rapportian.com/news/articleView.html?idxno=115965
841,2019-02-13,한미약품주가및증권시세13일현재464500원,http://www.gokorea.kr/news/articleView.html?idxno=96950
842,2019-02-13,오늘주식시세한미약품주가13일현재464500원,http://www.nbntv.co.kr/news/articleView.html?idxno=210858
843,2019-02-13,한미약품1289402019년02월13일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=153064
844,2019-02-13,유한양행한미약품등제약사올해도RD확대,http://www.kpinews.co.kr/news/articleView.html?idxno=90265
845,2019-02-13,한미약품2월13일주가전일대비239변동된470500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=598277
846,2019-02-13,우종수한미약품우위다지기위해고혈압4제복합제도전,http://www.businesspost.co.kr/BP?command=article_view&num=113987
847,2019-02-14,한미약품주가오늘시세및주체별매매동향14일현재462000원,http://www.gokorea.kr/news/articleView.html?idxno=98130
848,2019-02-14,한미약품1289402019년02월14일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=153483
849,2019-02-14,한미약품2월14일주가전일대비064변동된467500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=598949
850,2019-02-15,몸집커진제약1조클럽한미약품한국콜마가세,http://www.ajunews.com/view/20190214143406481
851,2019-02-15,실적리뷰⑥한미약품롯데칠성예상치웃돈매출증가,http://news.einfomax.co.kr/news/articleView.html?idxno=4016630
852,2019-02-15,2월15일한미약품종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=99299
853,2019-02-15,한미약품오늘주식시장15일현재459000원,http://www.nbntv.co.kr/news/articleView.html?idxno=215384
854,2019-02-15,한미약품주가2월15일현재458500원및증권차트정보,http://www.cctvnews.co.kr/news/articleView.html?idxno=104456
855,2019-02-15,한미약품1289402019년02월15일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=153995
856,2019-02-15,한미약품2월15일주가전일대비160변동된460000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=599418
857,2019-02-17,주목관심주한미약품삼성엔지니어링등파이프라인길목지켜라,http://www.g-enews.com/ko-kr/news/article/news_all/201902152050115986c642673384_1/article.html
858,2019-02-17,주간추천종목SK증권서진시스템한미약품GS건설,http://www.fntimes.com/html/view.php?ud=201902170024446256f09e13944d_18
859,2019-02-18,1조넘긴GC녹십자한미약품1조문턱종근당,http://www.dailymedi.com/detail.php?number=840110&thread=22r05
860,2019-02-18,SK증권서진시스템한미약품GS건설,http://www.seoulfn.com/news/articleView.html?idxno=333880
861,2019-02-18,중견제약사규모로큰한미약품아모잘탄패밀리,http://www.medisobizanews.com/news/articleView.html?idxno=57933
862,2019-02-18,한미약품MPO빛의소리나눔콘서트연다,http://www.g-enews.com/ko-kr/news/article/news_all/20190218100428786fa075a9870_1/article.html
863,2019-02-18,한미약품MPO23일빛의소리나눔콘서트연다,http://www.metroseoul.co.kr/news/newsview?newscd=2019021800037
864,2019-02-18,한미약품MPO빛의소리나눔콘서트개최,http://medipana.com/news/news_viewer.asp?NewsNum=234703&MainKind=A&NewsKind=5&vCount=12&vKind=1
865,2019-02-18,한미약품제7회빛의소리나눔콘서트개최,http://www.edaily.co.kr/news/newspath.asp?newsid=02456726622391832
866,2019-02-18,한미약품MPO빛의소리나눔콘서트7번째자선음악회,http://www.medisobizanews.com/news/articleView.html?idxno=57949
867,2019-02-18,한미약품MPO23일빛의소리나눔콘서트개최,http://www.bosa.co.kr/news/articleView.html?idxno=2099597
868,2019-02-18,한미약품MPO이달23일빛의소리나눔콘서트연다,http://www.newsway.co.kr/news/view?tp=1&ud=2019021810090962861
869,2019-02-18,한미약품MPO빛의소리나눔콘서트개최223,http://www.bokuennews.com/news/article.html?no=171817
870,2019-02-18,한미약품MPO이달23일빛의소리나눔콘서트연다,http://www.nextdaily.co.kr/news/article.html?id=20190218800024
871,2019-02-18,한미약품의사오케스트MPO와빛의소리나눔콘서트개최,http://www.newspost.kr/news/articleView.html?idxno=68828
872,2019-02-18,한미약품MPO빛의소리나눔콘서트통해사랑전파,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227297
873,2019-02-18,한미약품MPO장애아동예술교육기금조성자선음악회,http://www.newsprime.co.kr/news/article.html?no=447136
874,2019-02-18,한미약품MPO빛의소리나눔콘서트개최,http://www.straightnews.co.kr/news/articleView.html?idxno=43481
875,2019-02-18,한미약품서울의대출신현직의사오케스트라자선공연후원,http://www.whitepaper.co.kr/news/articleView.html?idxno=143811
876,2019-02-18,한미약품MPO장애아를위한빛의소리나눔콘서트23일개최,http://www.koreaittimes.com/news/articleView.html?idxno=89317
877,2019-02-18,2월18일한미약품오늘시세및주식시황,http://www.gokorea.kr/news/articleView.html?idxno=100631
878,2019-02-18,2월18일한미약품배당주식098464500원,http://www.nbntv.co.kr/news/articleView.html?idxno=218002
879,2019-02-18,한미약품MPO23일빛의소리나눔콘서트,http://www.dailypharm.com/Users/News/NewsView.html?ID=249559&REFERER=NP
880,2019-02-18,한미약품MPO23일빛의소리나눔콘서트연다,http://www.vop.co.kr/A00001379936.html
881,2019-02-18,한미약품MPO이달23일빛의소리나눔콘서트연다,http://www.pressm.kr/news/articleView.html?idxno=22124
882,2019-02-18,한미약품2월18일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=600266
883,2019-02-18,한미약품메디칼필하모닉오케스트라나눔콘서트6년째동행,http://www.100ssd.co.kr/news/articleView.html?idxno=59488
884,2019-02-18,한미약품빛의소리나눔콘서트23일개최,http://www.smedaily.co.kr/news/articleView.html?idxno=81404
885,2019-02-18,한미약품MPO오는23일빛의소리나눔콘서트개최,http://www.asiatime.co.kr/news/articleView.html?idxno=228982
886,2019-02-18,한미약품MPO23일빛의소리나눔콘서트연다,http://www.getnews.co.kr/view.php?ud=2019021813504243341d0c69529_16
887,2019-02-18,한미약품MPO23일빛의소리나눔콘서트개최,http://www.ezyeconomy.com/news/articleView.html?idxno=88237
888,2019-02-18,음악통해사랑전한다한미약품빛의소리나눔콘서트개최,http://kpenews.com/View.aspx?No=21769
889,2019-02-18,한미약품MPO빛의소리나눔콘서트개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=235510
890,2019-02-18,한미약품MPO23일빛의소리나눔콘서트진행,http://www.k-health.com/news/articleView.html?idxno=42441
891,2019-02-18,한미약품23일빛의소리나눔콘서트개최,http://www.rapportian.com/news/articleView.html?idxno=116055
892,2019-02-18,한미약품MPO23일빛의소리나눔콘서트개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=346675
893,2019-02-18,한미약품MPO이달23일빛의소리나눔콘서트연다,http://www.ekn.kr/news/article.html?no=415479
894,2019-02-18,한미약품현직의사들로구성된오케스트라와자선콘서트개최,http://news.mk.co.kr/newsRead.php?year=2019&no=98712
895,2019-02-18,한미약품MPO23일빛의소리나눔콘서트개최,http://www.obsnews.co.kr/news/articleView.html?idxno=1142487
896,2019-02-18,한미약품1289402019년02월18일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=154488
897,2019-02-18,한미약품의사오케스트라이달23일빛의소리나눔콘서트열어,http://www.inthenews.co.kr/news/article.html?no=13582
898,2019-02-18,한미약품2월18일주가전일대비087변동된464000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=600747
899,2019-02-18,한미약품과의사들따뜻함나누는콘서트연다,http://www.cnbnews.com/news/article.html?no=400559
900,2019-02-18,봄불청객이겨내기한미약품나인나인,https://www.sedaily.com/NewsView/1VFD1G3VBF
901,2019-02-18,제약사매출1조원클럽5개사달성은연구개발덕분한미약품이어유한양행합류,http://www.news2day.co.kr/120692
902,2019-02-18,한미약품MPO장애아동예술교육기금조성나눔콘서트개최,http://www.meconomynews.com/news/articleView.html?idxno=20533
903,2019-02-18,한미약품MPO이달23일빛의소리나눔콘서트연다,http://www.newscj.com/news/articleView.html?idxno=602762
904,2019-02-18,한미약품MPO이달23일빛의소리나눔콘서트연다,http://www.nspna.com/news/?mode=view&newsid=339437
905,2019-02-18,한미약품MPO와함께오는23일빛의소리나눔콘서트열어,http://www.lawissue.co.kr/view.php?ud=201902182258144067d7f4c63cc6_12
906,2019-02-19,한미약품비알콜성지방간염신약가치재조명목표가↑,http://www.asiatoday.co.kr/view.php?key=20190219010008078
907,2019-02-19,한미약품한국의일라이릴리로도약기대목표가↑NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1723735
908,2019-02-19,한미약품목표가13↑58만원제시NH證,http://www.newspim.com/news/view/20190219000043
909,2019-02-19,퀵리포트한미약품매수유지목표가13↑58만원NH證,http://www.itooza.com/common/iview.php?no=2019021908015913003
910,2019-02-19,한미약품한국의일라이릴리로도약기대목표가↑NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01567846622392160
911,2019-02-19,한미약품릴리유사파이프라인보유NH,http://www.fnnews.com/news/201902190826014694
912,2019-02-19,HotLine한미약품한국의일라이릴리될것으로기대목표가↑,http://news.mk.co.kr/newsRead.php?year=2019&no=99919
913,2019-02-19,한미약품韓일라이릴리로도약기대목표가↑NH證,http://www.seoulfn.com/news/articleView.html?idxno=334005
914,2019-02-19,실시간분석한미약품3상승증권사목표가58만원제시,http://www.itooza.com/common/iview.php?no=2019021909282714901
915,2019-02-19,특징주한미약품가치재평가기대에강세,http://www.newsis.com/view/?id=NISX20190219_0000562532&cID=10401&pID=10400
916,2019-02-19,한미약품파이프라인및기술수출로주가13상승여력,http://www.whitepaper.co.kr/news/articleView.html?idxno=144091
917,2019-02-19,한미약품목표주가상향대규모신약기술수출하반기기대,http://www.businesspost.co.kr/BP?command=article_view&num=114776
918,2019-02-19,한미약품전일대비약5상승한488000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201902190203&t=NN
919,2019-02-19,한경로보뉴스한미약품5이상상승주가상승중단기간골든크로스형성,http://news.hankyung.com/article/201902193514L
920,2019-02-19,한미약품한국의일라이릴리로가치재평가분석에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=346760
921,2019-02-19,한미약품MPO이달23일빛의소리나눔콘서트연다,http://daily.hankooki.com/lpage/ittech/201902/dh20190219104713145630.htm
922,2019-02-19,특징주한미약품글로벌사와비슷한파이프라인주목6↑,http://view.asiae.co.kr/news/view.htm?idxno=2019021910530335994
923,2019-02-19,한미약품당뇨병치료제등일라이릴리와파이프라인유사목표가↑,http://www.econovill.com/news/articleView.html?idxno=356842
924,2019-02-19,장애아동위해자선음악회후원나선한미약품,http://www.sisaweek.com/news/articleView.html?idxno=118558
925,2019-02-19,주식현황한미약품주가19일현재488000원,http://www.nbntv.co.kr/news/articleView.html?idxno=220314
926,2019-02-19,ET투자뉴스한미약품_상장주식수대비거래량은03로적정수준,http://www.etnews.com/20190219000156
927,2019-02-19,한미약품2월19일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=601361
928,2019-02-19,ET투자뉴스한미약품한국의EliLiBUY유지NH투자증권,http://www.etnews.com/20190219000193
929,2019-02-19,한미약품1289402019년02월19일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=154984
930,2019-02-19,코스피관망속셀트리온삼성바이오로직스한미약품껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=48333
931,2019-02-19,한미약품최근다른빅파마와차별화된주가흐름을타나내는일라이릴리주목,http://www.newsworks.co.kr/news/articleView.html?idxno=337598
932,2019-02-19,한미약품주가대폭상승신약기술수출기대받아,http://www.businesspost.co.kr/BP?command=article_view&num=114907
933,2019-02-19,한미약품2월19일주가전일대비463변동된485500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=601814
934,2019-02-19,이슈주가한미약품글로벌제약업체와비슷한파이프라인보유로주가상승,http://www.sporbiz.co.kr/news/articleView.html?idxno=314526
935,2019-02-20,주가차트한미약품주가20일현재490500원,http://www.nbntv.co.kr/news/articleView.html?idxno=222603
936,2019-02-20,한미약품2월20일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=602478
937,2019-02-20,한미약품1289402019년02월20일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=155531
938,2019-02-20,한미약품2월20일주가전일대비093변동된490000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=602921
939,2019-02-21,한미약품계열사JVM주당350원현금배당,http://view.asiae.co.kr/news/view.htm?idxno=2019022109494420489
940,2019-02-21,한미약품주가종목그래프21일현재487000원,http://www.gokorea.kr/news/articleView.html?idxno=103911
941,2019-02-21,2월21일한미약품주식종목시세082486000원,http://www.nbntv.co.kr/news/articleView.html?idxno=224803
942,2019-02-21,제약동향1월원외처방한미약품→종근당→대웅제약순바이오의약품보톡스수출감소세,http://www.ezyeconomy.com/news/articleView.html?idxno=88340
943,2019-02-21,한미약품2월21일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=603510
944,2019-02-21,한미약품1289402019년02월21일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=155981
945,2019-02-21,한미약품2월21일주가전일대비051변동된487500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=603994
946,2019-02-22,한미약품주가증권그래프22일현재485000원,http://www.gokorea.kr/news/articleView.html?idxno=105068
947,2019-02-22,2월22일한미약품주식현재가051485000원,http://www.nbntv.co.kr/news/articleView.html?idxno=227122
948,2019-02-22,한미약품2월22일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=604478
949,2019-02-22,한미약품1289402019년02월22일15시12분기준주식시황,http://www.chuksannews.co.kr/news/article.html?no=156493
950,2019-02-22,한미약품2월22일주가전일과동일한487500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=604744
951,2019-02-25,한미약품의외국인지분율14돌파성장성높이평가하는듯,http://www.nspna.com/news/?mode=view&newsid=341010
952,2019-02-25,2월25일한미약품주식종목검색481500원123,http://www.nbntv.co.kr/news/articleView.html?idxno=229734
953,2019-02-25,한미약품2월25일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=605705
954,2019-02-25,한미약품주당500원현금배당,http://yna.kr/AKR20190225108100008?did=1195m
955,2019-02-25,한미약품주당500원현금배당결정,http://www.edaily.co.kr/news/newspath.asp?newsid=03548966622394128
956,2019-02-25,한미약품주당500원현금배당총56억6234만원,http://www.etoday.co.kr/news/section/newsview.php?idxno=1726508
957,2019-02-25,한미약품주당500원현금배당결정,http://news.hankyung.com/article/2019022546316
958,2019-02-25,한미약품주당500원현금배당결정,http://news.heraldcorp.com/view.php?ud=20190225000643
959,2019-02-25,한미약품주당500원현금배당결정,http://view.asiae.co.kr/news/view.htm?idxno=2019022515224811572
960,2019-02-25,한미약품주당500원현금배당,http://www.mdtoday.co.kr/mdtoday/index.html?no=347291
961,2019-02-25,한미약품주당500원현금배당결정,http://www.asiatoday.co.kr/view.php?key=20190225010012409
962,2019-02-25,한미약품3월15일주총우종수사내이사재선임,http://www.whosaeng.com/108206
963,2019-02-25,공시한미약품주당500원현금배당,http://www.newsis.com/view/?id=NISX20190225_0000569091&cID=10401&pID=10400
964,2019-02-25,한미약품주당500원현금배당배당총액57억,http://www.econonews.co.kr/news/articleView.html?idxno=55148
965,2019-02-25,한미약품2월25일주가전일대비113변동된482000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=606164
966,2019-02-25,유가증권시장공시한미약품한미사이언스,http://news.mk.co.kr/newsRead.php?year=2019&no=114794
967,2019-02-26,전일주요공시한샘이연제약한미약품외,http://www.etoday.co.kr/news/section/newsview.php?idxno=1726743
968,2019-02-26,한미약품MPO장애아예술지원빛의소리나눔콘서트7번째공연,http://www.medisobizanews.com/news/articleView.html?idxno=58128
969,2019-02-26,한미약품주가2월26일현재485000원,http://www.gokorea.kr/news/articleView.html?idxno=107346
970,2019-02-26,한미약품증권투자26일현재485000원,http://www.nbntv.co.kr/news/articleView.html?idxno=232105
971,2019-02-26,한미약품졸피드RFID바코드병행부착시범사업,http://www.dailypharm.com/Users/News/NewsView.html?ID=249856&REFERER=NP
972,2019-02-26,한미약품2월26일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=606844
973,2019-02-26,한미약품MPO빛의소리나눔콘서트성료장애아동예술교육지원,http://www.mdtoday.co.kr/mdtoday/index.html?no=347433
974,2019-02-26,600명함께한빛의소리향연”한미약품나눔콘서트성료,http://www.newsway.co.kr/news/view?tp=1&ud=2019022616084389155
975,2019-02-26,한미약품2월26일주가전일대비104변동된487000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=607330
976,2019-02-27,한미약품목표가62만원유지전일종가48만7000원SK證,http://www.newspim.com/news/view/20190227000086
977,2019-02-27,퀵리포트한미약품매수유지목표가62만원유지SK證,http://www.itooza.com/common/iview.php?no=2019022708020112057
978,2019-02-27,한미약품이중항체플랫폼임상결과긍정적매수SK증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1727425
979,2019-02-27,한미약품올해영업이익806억원전망,http://www.nspna.com/news/?mode=view&newsid=341669
980,2019-02-27,한미약품목표가44↑64만원제시한화證,http://www.newspim.com/news/view/20190227000255
981,2019-02-27,퀵리포트한미약품매수로상향목표가44↑64만원한화證,http://www.itooza.com/common/iview.php?no=2019022709495615194
982,2019-02-27,한미약품실시간증시27일현재490000원,http://www.nbntv.co.kr/news/articleView.html?idxno=234498
983,2019-02-27,한미약품2월27일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=607923
984,2019-02-27,ET투자뉴스한미약품이중항체플랫폼팬매수유지SK증권,http://www.etnews.com/20190227000219
985,2019-02-27,종목썰쩐차세대항암치료제이중항체한미약품파멥신주목,http://news.hankyung.com/article/2019022729656
986,2019-02-27,한미약품주가오를힘다져이중항체기술의임상결과긍정적,http://www.businesspost.co.kr/BP?command=article_view&num=116131
987,2019-02-27,한미약품2월27일주가전일대비113변동된492500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=608439
988,2019-02-28,한미약품국가산업경계넘나드는스마트플랜트해외사절단북적북적,http://www.seoulwire.com/news/articleView.html?idxno=77852
989,2019-02-28,한미약품공장에해외사절단몰리는이유는,http://moneys.mt.co.kr/news/mwView.php?no=2019022809238063042
990,2019-02-28,한미약품RFID기반팔탄공장잇단사절방문CDMO확장,http://view.asiae.co.kr/news/view.htm?idxno=2019022809434616570
991,2019-02-28,한미약품스마트플랜트에세계지도자들몰리는까닭은,http://news.heraldcorp.com/view.php?ud=20190228000148
992,2019-02-28,한미약품스마트플랜트에몰리는해외사절단이유는,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227683
993,2019-02-28,해외사절단한미약품스마트공장잇단방문,http://www.newsis.com/view/?id=NISX20190228_0000572634&cID=13001&pID=13000
994,2019-02-28,한미약품스마트플랜트에해외사절단등1400여명견학”,http://www.edaily.co.kr/news/newspath.asp?newsid=02236966622395112
995,2019-02-28,해외사절단한미약품스마트공장잇단방문,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=49997
996,2019-02-28,한미약품팔탄공장에해외사절단방문이줄잇고있다는데,http://www.medisobizanews.com/news/articleView.html?idxno=58172
997,2019-02-28,한미약품스마트플랜트에해외사절단몰리는이유는,http://www.econovill.com/news/articleView.html?idxno=357566
998,2019-02-28,한미약품스마트플랜트찾는해외사절단들ICT기반공정배우자,http://www.newspim.com/news/view/20190228000203
999,2019-02-28,한미약품스마트플랜트해외사절단방문이어져,http://www.newsprime.co.kr/news/article.html?no=448849
1000,2019-02-28,한미약품스마트플랜트에해외사절단몰려왜,http://www.ebn.co.kr/news/view/974563
1001,2019-02-28,한미약품팔탄스마트플랜트공장해외사절단누적방문1400여명,http://www.whitepaper.co.kr/news/articleView.html?idxno=145920
1002,2019-02-28,한미약품스마트플랜트에해외사절단몰리는이유,http://www.getnews.co.kr/view.php?ud=20190228105639464141d0c69529_16
1003,2019-02-28,한미약품스마트플랜트에해외사절단몰리는이유는,http://www.pressm.kr/news/articleView.html?idxno=22247
1004,2019-02-28,한미약품스마트플랜트에해외사절단몰린다왜,http://www.fetv.co.kr/news/article.html?no=21665
1005,2019-02-28,뉴스텔링유한양행한국콜마녹십자한미약품1조클럽의착잡한속내,http://www.cnbnews.com/news/article.html?no=401545
1006,2019-02-28,한미약품스마트플랜트찾는해외사절단,http://www.dailymedi.com/detail.php?number=840494&thread=22r05
1007,2019-02-28,한미약품주가증권투자정보28일현재500000원,http://www.gokorea.kr/news/articleView.html?idxno=109663
1008,2019-02-28,한미약품4차산업혁명맞춤스마트플랜트해외사절단잇단방문,http://biz.newdaily.co.kr/site/data/html/2019/02/28/2019022800086.html
1009,2019-02-28,한미약품2월28일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=608997
1010,2019-02-28,한미약품스마트플랜트에해외사절단몰려,http://www.smedaily.co.kr/news/articleView.html?idxno=81662
1011,2019-02-28,투자주식한미약품주가28일현재499000원,http://www.nbntv.co.kr/news/articleView.html?idxno=236790
1012,2019-02-28,한미약품팔탄공장에스마트플랜트에해외사절단견학잇따라,http://www.metroseoul.co.kr/news/newsview?newscd=2019022800079
1013,2019-02-28,한미약품스마트플랜트에몰리는해외사절단4세대선진사례로각광,http://www.mdtoday.co.kr/mdtoday/index.html?no=347656
1014,2019-02-28,한미약품스마트플랜트해외사절단관심폭발,http://www.datanews.co.kr/news/article.html?no=102307
1015,2019-02-28,한미약품팔탄스마트플랜트에해외사절단몰리는이유는,http://www.ezyeconomy.com/news/articleView.html?idxno=88525
1016,2019-02-28,한미약품6억원제품살리기위한특허소송의의미는,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019022810313136983
1017,2019-02-28,한미약품스마트플랜트에해외사절단몰리는이유는,http://www.4th.kr/news/articleView.html?idxno=9325
1018,2019-02-28,한미약품팔탄스마트플랜트글로벌관심집중,http://www.upinews.kr/news/newsview.php?ncode=1065594397925368
1019,2019-02-28,한미약품팔탄공장에해외사절단방문이늘어나는이유,http://news.donga.com/3/all/20190228/94339367/2
1020,2019-02-28,한미약품2월28일주가전일대비030변동된494000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=609433
1021,2019-02-28,한미약품팔탄스마트플랜트에각국사절단방문이어져,http://www.nbnnews.co.kr/news/articleView.html?idxno=240070
1022,2019-02-28,한미약품스마트플랜트에몰리는해외사절단이유는,http://www.lawissue.co.kr/view.php?ud=201902281744324042d7f4c63cc6_12
1023,2019-02-28,한미약품팔탄스마트플랜트에해외사절단잇단방문,http://www.ajunews.com/view/20190228175046048
1024,2019-02-28,한미약품스마트플랜트에해외사절단몰려,http://www.dailian.co.kr/news/view/776049/?sc=naver
1025,2019-02-28,한미약품스마트플랜에해외사절단몰리는이유는,http://www.newscj.com/news/articleView.html?idxno=606707
1026,2019-03-01,한미약품비정규직소폭증가영업에서연구진까지,http://moneys.mt.co.kr/news/mwView.php?no=2019022716348082164
1027,2019-03-01,한미약품스마트플랜트에몰리는해외사절단이유는,http://www.ekn.kr/news/article.html?no=417891
1028,2019-03-04,스펙트럼한미약품신약상업화역점RD투자확대,http://www.dailypharm.com/Users/News/NewsView.html?ID=249993&REFERER=NP
1029,2019-03-04,한미약품챔픽스물질특허소송제기화이자관련소송준비중,http://www.mdtoday.co.kr/mdtoday/index.html?no=347725
1030,2019-03-04,이지돋보기GC녹십자광동제약유한양행한국콜마한미약품등1조클럽입성수익성생산성숙제,http://www.ezyeconomy.com/news/articleView.html?idxno=88545
1031,2019-03-04,한미약품로벨리토한국인4상결과국제학술지등재,http://medipana.com/news/news_viewer.asp?NewsNum=235331&MainKind=A&NewsKind=5&vCount=12&vKind=1
1032,2019-03-04,한미약품로벨리토4상결과국제학술지등재,http://www.newsway.co.kr/news/view?tp=1&ud=2019030409245090397
1033,2019-03-04,ET투자뉴스한미약품한미약품의소외된BUY하나금융투자,http://www.etnews.com/20190304000040
1034,2019-03-04,한미약품로벨리토임상4상연구결과국제학술지등재,http://www.medisobizanews.com/news/articleView.html?idxno=58207
1035,2019-03-04,한미약품로벨리토4상결과국제학술지등재,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227741
1036,2019-03-04,한미약품스마트플랜트에해외사절단방문,http://www.straightnews.co.kr/news/articleView.html?idxno=44437
1037,2019-03-04,한미약품신약로벨리토임상결과국제학술지등재,http://www.seoulwire.com/news/articleView.html?idxno=79225
1038,2019-03-04,한미약품로벨리토4상결과국제학술지등재,http://www.medigatenews.com/news/4092560774
1039,2019-03-04,한미약품로벨리토한국인환자치료효과확인,http://www.viva100.com/main/view.php?key=20190304010000547
1040,2019-03-04,한미약품로벨리토4상결과국제학술지등재,http://www.dailypharm.com/Users/News/NewsView.html?ID=250009&REFERER=NP
1041,2019-03-04,한미약품로벨리토한국인대상유효성확인,http://www.monews.co.kr/news/articleView.html?idxno=201119
1042,2019-03-04,한미약품로벨리토4상결과국제학술지등재,http://www.bosa.co.kr/news/articleView.html?idxno=2100475
1043,2019-03-04,한미약품스마트플랜트에해외사절단몰리는이유,http://www.sisaweek.com/news/articleView.html?idxno=119011
1044,2019-03-04,골드만삭스유한양행한미약품휴젤3월이벤트주시,http://www.choicenews.co.kr/news/articleView.html?idxno=48625
1045,2019-03-04,3월4일한미약품주가그래프081498000원,http://www.nbntv.co.kr/news/articleView.html?idxno=239454
1046,2019-03-04,한미약품주식살때표적항암제신약의잠재적가치커져,http://www.businesspost.co.kr/BP?command=article_view&num=116661
1047,2019-03-04,한미약품3월4일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=610478
1048,2019-03-04,한미약품주가3월4일현재498000원,http://www.gokorea.kr/news/articleView.html?idxno=111041
1049,2019-03-04,한미약품목표가58만원유지전일종가49만4000원NH證,http://www.newspim.com/news/view/20190304000650
1050,2019-03-04,퀵리포트한미약품매수유지목표가58만원유지NH證,http://www.itooza.com/common/iview.php?no=2019030415480216195
1051,2019-03-04,한국경제TV증시라인신영목의시장을이기는종목HDC현대산업개발한미약품,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903040563&t=NNv
1052,2019-03-04,한미약품목표가57만원유지전일종가49만4000원하나금투,http://www.newspim.com/news/view/20190304000776
1053,2019-03-04,퀵리포트한미약품매수유지목표가57만원유지하나금투,http://www.itooza.com/common/iview.php?no=2019030417063211881
1054,2019-03-04,한미약품로벨리토한국인환자대상유효성확인,http://www.dailymedi.com/detail.php?number=840592&thread=22r05
1055,2019-03-04,한미약품3월4일주가전일대비142변동된501000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=610996
1056,2019-03-04,한미약품염변경의약품특허소송업계구원투수될까,http://www.wolyo.co.kr/news/articleView.html?idxno=78720
1057,2019-03-05,한미약품로벨리토4상서유효성확인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065815
1058,2019-03-05,제약사들글로벌화로승부하라한미약품일동바이오대원제약등글로벌마케팅드라이브,http://www.wikileaks-kr.org/news/articleView.html?idxno=49252
1059,2019-03-05,한미약품美서신규항암제전임상결과발표예정,http://www.asiatoday.co.kr/view.php?key=20190305010001667
1060,2019-03-05,HotLine한미약품지속형주사제플랫폼가치재조명,http://news.mk.co.kr/newsRead.php?year=2019&no=130944
1061,2019-03-05,한미약품주가오를힘다져호중구감소증치료제상업화기대,http://www.businesspost.co.kr/BP?command=article_view&num=116834
1062,2019-03-05,ET투자뉴스한미약품재조명되는LAPSBUY유지NH투자증권,http://www.etnews.com/20190305000106
1063,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227817
1064,2019-03-05,한미약품서울시선정우수납세기업표창,http://www.edaily.co.kr/news/newspath.asp?newsid=02961846622420368
1065,2019-03-05,3월5일한미약품오늘증시030499500원,http://www.nbntv.co.kr/news/articleView.html?idxno=241719
1066,2019-03-05,한미약품주가및증권시세외매매동향5일현재499500원,http://www.gokorea.kr/news/articleView.html?idxno=112131
1067,2019-03-05,한미약품서울시모범∙유공납세기업선정,http://www.nbnnews.co.kr/news/articleView.html?idxno=241306
1068,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.fetv.co.kr/news/article.html?no=22010
1069,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.nextdaily.co.kr/news/article.html?id=20190305800046
1070,2019-03-05,한미약품2019년서울시모범∙유공납세자표창수상기업선정,http://www.seoulwire.com/news/articleView.html?idxno=80809
1071,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://www.newsway.co.kr/news/view?tp=1&ud=2019030513130044721
1072,2019-03-05,한미약품3월5일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=611665
1073,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://www.bosa.co.kr/news/articleView.html?idxno=2100578
1074,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://medipana.com/news/news_viewer.asp?NewsNum=235449&MainKind=A&NewsKind=5&vCount=12&vKind=1
1075,2019-03-05,한미약품서울시모범납세기업에선정,https://www.nocutnews.co.kr/news/5113575
1076,2019-03-05,한미약품서울시모범유공납세기업표창수상,http://www.newspim.com/news/view/20190305000461
1077,2019-03-05,한미약품모범유공납세기업표창,http://www.enewstoday.co.kr/news/articleView.html?idxno=1277435
1078,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.insightkorea.co.kr//news/articleView.html?idxno=34307
1079,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://www.sisajournal-e.com/news/articleView.html?idxno=196504
1080,2019-03-05,한미약품서울시모범납세기업에선정,http://www.smedaily.co.kr/news/articleView.html?idxno=81734
1081,2019-03-05,한미약품서울시선정모범유공납세기업표창받아,http://www.metroseoul.co.kr/news/newsview?newscd=2019030500112
1082,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://www.econovill.com/news/articleView.html?idxno=357848
1083,2019-03-05,1조클럽한미약품랩스커버리등성과가시화,http://www.skyedaily.com/news/news_view.html?ID=82458
1084,2019-03-05,한미약품서울시모범유공납세기업표창,http://www.medisobizanews.com/news/articleView.html?idxno=58242
1085,2019-03-05,우종수한미약품대표성실한세금납부는사회적책임의무모범∙유공납세기업표창수상,http://www.greened.kr/news/articleView.html?idxno=95943
1086,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://www.bokuennews.com/news/article.html?no=172437
1087,2019-03-05,한미약품서울시모범납세기업선정,http://news.mt.co.kr/mtview.php?no=2019030514144710619
1088,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.getnews.co.kr/view.php?ud=20190305142425673141d0c69529_16
1089,2019-03-05,한미약품서울시모범유공납세기업으로선정돼,http://www.koreaittimes.com/news/articleView.html?idxno=89556
1090,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1124820&REFERER=NP
1091,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.pressm.kr/news/articleView.html?idxno=22292
1092,2019-03-05,한미약품서울시모범유공납세자표창수상,http://www.dailypharm.com/Users/News/NewsView.html?ID=250053&REFERER=NP
1093,2019-03-05,한미약품서울시모범유공납세기업선정,http://www.ezyeconomy.com/news/articleView.html?idxno=88609
1094,2019-03-05,한미약품서울시모범유공납세자표창수상,http://news.mk.co.kr/newsRead.php?year=2019&no=132459
1095,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://daily.hankooki.com/lpage/ittech/201903/dh20190305151401145630.htm
1096,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.mhj21.com/119882
1097,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.4th.kr/news/articleView.html?idxno=9458
1098,2019-03-05,한미약품서울시선정모범및유공납세기업표창,http://www.mdtoday.co.kr/mdtoday/index.html?no=347994
1099,2019-03-05,한미약품서울시모범및유공납세기업선정,http://www.fnnews.com/news/201903051545204524
1100,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://www.medigatenews.com/news/920839286
1101,2019-03-05,한미약품서울시모범유공납세기업표창,http://news.bizwatch.co.kr/article/consumer/2019/03/05/0017/naver
1102,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://www.ekn.kr/news/article.html?no=418577
1103,2019-03-05,한미약품서울선정모범∙유공납세기업표창,http://www.asiatime.co.kr/news/articleView.html?idxno=231902
1104,2019-03-05,한미약품서울시선정모범∙유공납세기업,http://www.k-health.com/news/articleView.html?idxno=42720
1105,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://www.newsis.com/view/?id=NISX20190305_0000577529&cID=13001&pID=13000
1106,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.g-enews.com/ko-kr/news/article/news_all/201903051528056039fa075a9870_1/article.html
1107,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.g-enews.com/ko-kr/news/article/news_all/201903051528056039fa075a9870_1/article.html
1108,2019-03-05,한미약품서울시선정모범∙유공납세기업,http://www.ebn.co.kr/news/view/975182
1109,2019-03-05,한미약품모범유공납세기업선정서울시표창,http://www.kpinews.co.kr/news/articleView.html?idxno=91802
1110,2019-03-05,10년간세금잘냈어요한미약품모범납세기업선정,http://moneys.mt.co.kr/news/mwView.php?no=2019030517158073977
1111,2019-03-05,한미약품3월5일주가전일과동일한501000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=612136
1112,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://www.dailian.co.kr/news/view/776934/?sc=naver
1113,2019-03-05,한미약품서울시선정모범및유공납세기업으로선정,http://www.techholic.co.kr/news/articleView.html?idxno=180948
1114,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.businesskorea.co.kr/news/articleView.html?idxno=29709
1115,2019-03-05,한미약품서울시선정모범유공납세기업표창,http://www.newscj.com/news/articleView.html?idxno=608364
1116,2019-03-05,한미약품서울시선정모범∙유공납세기업표창,http://www.lawissue.co.kr/view.php?ud=201903052343429209d7f4c63cc6_12
1117,2019-03-06,한미약품서울시선정모범유공납세기업표창,http://www.gukjenews.com/news/articleView.html?idxno=1078957
1118,2019-03-06,식약처한미약품HM43239개발단계희귀의약품으로지정,http://www.mdtoday.co.kr/mdtoday/index.html?no=348022
1119,2019-03-06,한미약품모범유공납세기업서울시표창,http://www.wikileaks-kr.org/news/articleView.html?idxno=49360
1120,2019-03-06,한미약품개발급성백혈병치료제희귀약지정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1065887
1121,2019-03-06,한미약품서울시선정모범유공납세기업표창 ,http://www.monews.co.kr/news/articleView.html?idxno=201167
1122,2019-03-06,한미약품서울시선정모범유공납세기업표창,http://www.straightnews.co.kr/news/articleView.html?idxno=44609
1123,2019-03-06,한미약품스마트플랜트지구촌잇단발길,http://news.heraldcorp.com/view.php?ud=20190306000362
1124,2019-03-06,한미약품증권매매6일현재492000원,http://www.nbntv.co.kr/news/articleView.html?idxno=243919
1125,2019-03-06,한미약품주가및증권시세및주체별매매동향6일현재491500원,http://www.gokorea.kr/news/articleView.html?idxno=113331
1126,2019-03-06,한미약품3월6일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=612722
1127,2019-03-06,증시분석대웅제약창사이래첫1조클럽유한양행GC녹십자한미약품이어4번째,http://www.news2day.co.kr/121823
1128,2019-03-06,한미약품서울시모범유공납세자선정,http://www.cnbnews.com/news/article.html?no=402215
1129,2019-03-06,신약기술수출액7조3600억원한미약품유한양행이5조원,http://www.medisobizanews.com/news/articleView.html?idxno=58267
1130,2019-03-06,한미약품3월6일주가전일대비180변동된492000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=613210
1131,2019-03-07,15일한미약품시작제약주총개막풍성한배당,http://www.bosa.co.kr/news/articleView.html?idxno=2100698
1132,2019-03-07,이달美암학회바이오바람불까유한양행한미약품신약주목,http://www.newspim.com/news/view/20190305000354
1133,2019-03-07,3월7일한미약품주식장142485000원,http://www.nbntv.co.kr/news/articleView.html?idxno=247044
1134,2019-03-07,한미약품3월7일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=613742
1135,2019-03-07,7일13시바이오시밀러테마주시황오후에이프로젠제약한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=247892
1136,2019-03-07,유한양행한미약품비알콜성지방간염치료제선점경쟁치열,http://www.businesspost.co.kr/BP?command=article_view&num=117334
1137,2019-03-07,한미약품3월7일주가전일대비173변동된483500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=614325
1138,2019-03-08,한미약품차입금1500억증가글로벌임상투입,http://www.dailypharm.com/Users/News/NewsView.html?ID=250153&REFERER=NP
1139,2019-03-08,3월8일한미약품및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=115562
1140,2019-03-08,한미약품3월8일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=614821
1141,2019-03-08,분석한미약품1조160억영업익17증가수출비중41,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=227957
1142,2019-03-08,주식시세현황한미약품주가8일현재484000원,http://www.nbntv.co.kr/news/articleView.html?idxno=249530
1143,2019-03-08,한미약품3월8일주가전일대비021변동된482500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=615106
1144,2019-03-08,8일외국인순매수Top10KODEX200356억신한지주54억삼성에스디에스42억한미약품35억외국인순매수나서코스닥시장에서는아난티컴투스에코프로상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=25408
1145,2019-03-08,8일기관순매도Top10SOil685억LG화학151억현대모비스74억한미약품58억외국인순매도나서코스닥시장에서는바이로메드서울반도체신라젠상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=25411
1146,2019-03-10,한미약품메디톡스바이로메드다시뛰는바이오株,http://news.hankyung.com/article/2019031082791
1147,2019-03-11,주식실시간한미약품주가11일현재477000원,http://www.nbntv.co.kr/news/articleView.html?idxno=251640
1148,2019-03-11,한미약품3월11일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=616124
1149,2019-03-11,한미약품3월11일주가전일대비073변동된479000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=616568
1150,2019-03-12,한미약품화이자상대일전챔픽스특허소송촉각,http://www.dailymedi.com/detail.php?number=840844&thread=22r05
1151,2019-03-12,3월12일한미약품오늘주식063482000원,http://www.nbntv.co.kr/news/articleView.html?idxno=254613
1152,2019-03-12,한미약품주가증권시세12일현재481500원및증권차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=107995
1153,2019-03-12,한미약품3월12일주가전일대비063변동된482000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=617213
1154,2019-03-13,농심한미약품주총줄줄이빨간불,http://news.mk.co.kr/newsRead.php?year=2019&no=149483
1155,2019-03-13,한미약품비만NASH신약빠르면9월내美1상종료,http://www.medisobizanews.com/news/articleView.html?idxno=58386
1156,2019-03-13,기획유한양행대웅제약한미약품1조클럽의힘은안정적캐시카우,http://daily.hankooki.com/lpage/column/201903/dh20190313080014145650.htm
1157,2019-03-13,국민연금현대건설한미약품등11개사에칼의결권행사사전공개,http://www.fntimes.com/html/view.php?ud=201903131115508677f09e13944d_18
1158,2019-03-13,주식창한미약품주가13일현재478500원,http://www.nbntv.co.kr/news/articleView.html?idxno=257000
1159,2019-03-13,국민연금현대글로비스한미약품현대건설주총안건반대하기로,http://www.businesspost.co.kr/BP?command=article_view&num=118162
1160,2019-03-13,한미약품3월13일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=617803
1161,2019-03-13,국민연금정기주총의결권행사미리공개농심한미약품등반대,http://www.mdtoday.co.kr/mdtoday/index.html?no=348717
1162,2019-03-13,한미약품3월13일주가전일대비021변동된483000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=618291
1163,2019-03-14,한미약품화이자상대특허소송,http://www.polinews.co.kr/news/article.html?no=385144
1164,2019-03-14,오늘주식시세한미약품주가14일현재473000원,http://www.nbntv.co.kr/news/articleView.html?idxno=259550
1165,2019-03-14,한미약품3월14일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=618927
1166,2019-03-14,한미약품3월14일주가전일대비228변동된472000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=619382
1167,2019-03-14,국민연금주총안건찬반사전공개현대건설신세계한미약품농심등11곳일부안건반대표,http://www.econonews.co.kr/news/articleView.html?idxno=57481
1168,2019-03-15,제약업계AI인재채용확산한미약품일동제약JW중외제약등직무적합도중점확인,http://www.wikileaks-kr.org/news/articleView.html?idxno=50240
1169,2019-03-15,한미약품주가오를힘갖춰신약후보물질2종개발순항,http://www.businesspost.co.kr/BP?command=article_view&num=118538
1170,2019-03-15,1조매출내용이중요하다광동제약과한미약품들여다보니,http://www.rapportian.com/news/articleView.html?idxno=116560
1171,2019-03-15,바이오시밀러테마오전시황상승률상위종목한미약품117팜스웰바이오보합세한올바이오파마107등,http://www.gokorea.kr/news/articleView.html?idxno=121715
1172,2019-03-15,09시30분바이오시밀러테마주시황오전한미약품팜스웰바이오등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=261109
1173,2019-03-15,국민연금반대에도한미약품사외이사재선임통과속보,http://view.asiae.co.kr/news/view.htm?idxno=2019031508495149860
1174,2019-03-15,사외이사선임반대국민연금졌다한미약품주총종합,http://view.asiae.co.kr/news/view.htm?idxno=2019031510090511975
1175,2019-03-15,한미약품사외이사재선임무색한국민연금반대,http://news.mt.co.kr/mtview.php?no=2019031511191919786
1176,2019-03-15,한미약품글로벌혁신신약창출제약강국향해도전”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228250
1177,2019-03-15,한미약품주주총회개최주주님들께높은기업가치로보답,http://www.sisafocus.co.kr/news/articleView.html?idxno=204815
1178,2019-03-15,한미약품제9기한미사이언스제46기주주총회개최,http://www.pressm.kr/news/articleView.html?idxno=22415
1179,2019-03-15,2019주총한미약품우종수대표사내이사재선임,http://www.newsway.co.kr/news/view?tp=1&ud=2019031512555319034
1180,2019-03-15,한미약품제약강국도전주주님신뢰로가능,http://www.whosaeng.com/108633
1181,2019-03-15,바이오시밀러테마오후시황상승률상위종목한미약품106셀트리온194한올바이오파마201등,http://www.gokorea.kr/news/articleView.html?idxno=122422
1182,2019-03-15,한미약품3월15일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=619879
1183,2019-03-15,13시22분바이오시밀러오후테마시황한미약품팜스웰바이오등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=262406
1184,2019-03-15,한미약품주총제약강국향한도전주주변함없는신뢰덕분”,http://www.g-enews.com/ko-kr/news/article/news_all/201903151326208287fa075a9870_1/article.html
1185,2019-03-15,한미약품제9기한미사이언스제46기주주총회개최,http://www.nextdaily.co.kr/news/article.html?id=20190315800034
1186,2019-03-15,한미약품그룹임종윤한미사이언스대표우종수한미약품대표재선임,http://www.ceoscoredaily.com/news/article.html?no=53137
1187,2019-03-15,한미약품도전정신으로글로벌혁신신약창출할것,http://www.newsprime.co.kr/news/article.html?no=451023
1188,2019-03-15,한미약품한미사이언스제46기주주총회개최,http://www.fnnews.com/news/201903151334123690
1189,2019-03-15,한미약품제9기정기주주총회개최우종수대표이사재선임,http://www.ekn.kr/news/article.html?no=420648
1190,2019-03-15,한미약품우종수대표글로벌혁신신약창출해주주들에게보답,http://www.medisobizanews.com/news/articleView.html?idxno=58467
1191,2019-03-15,한미약품한미사이언스주총개최우종수대표이관순부회장재선임,http://daily.hankooki.com/lpage/ittech/201903/dh20190315134118145630.htm
1192,2019-03-15,한미약품불굴의도전정신으로글로벌혁신신약창출,http://www.dailypharm.com/Users/News/NewsView.html?ID=250447&REFERER=NP
1193,2019-03-15,종목썰쩐옥석가리기시작한제약바이오株한미약품주목,http://news.hankyung.com/article/2019031589856
1194,2019-03-15,한미약품정기주총제약강국향한도전주주님들신뢰덕분”,http://www.metroseoul.co.kr/news/newsview?newscd=2019031500049
1195,2019-03-15,주총현장한미약품국민연금반대에도이동호사외이사선임의결,http://news.mk.co.kr/newsRead.php?year=2019&no=157131
1196,2019-03-15,주총우종수한미약품대표사내이사재선임,http://www.newspim.com/news/view/20190315000431
1197,2019-03-15,한미약품우종수대표부광약품유희원대표재선임,http://www.newsis.com/view/?id=NISX20190315_0000588784&cID=13001&pID=13000
1198,2019-03-15,유통오늘한미약품2019정기주총개최대원제약상반기신입경력공채,http://www.sisaon.co.kr/news/articleView.html?idxno=90578
1199,2019-03-15,한미사이언스임종윤한미약품우종수재선임K바이오선도,http://www.upinews.kr/news/newsview.php?ncode=1065591338770181
1200,2019-03-15,한미약품글로벌혁신신약창출로주주들에보답”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1734149
1201,2019-03-15,주총한미약품제약강국향한도전주주신뢰절대적,http://www.ebn.co.kr/news/view/976669
1202,2019-03-15,바이오시밀러테마마감시황한미약품셀트리온등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=263116
1203,2019-03-15,한미약품제9기한미사이언스주총우종수대표이사재선임,http://www.seoulwire.com/news/articleView.html?idxno=89359
1204,2019-03-15,바이오시밀러테마마감시황상승률상위종목한미약품222셀트리온146한올바이오파마174등,http://www.gokorea.kr/news/articleView.html?idxno=122628
1205,2019-03-15,우종수한미약품대표유희원부광약품대표연임성공,http://biz.newdaily.co.kr/site/data/html/2019/03/15/2019031500135.html
1206,2019-03-15,한미약품정기주주총회제약강국향한도전한다,http://www.getnews.co.kr/view.php?ud=20190315160527436441d0c69529_16
1207,2019-03-15,한미약품제약강국향한도전주주신뢰덕분,http://www.newstomato.com/ReadNews.aspx?no=882504
1208,2019-03-15,한미사이언스임종윤한미약품우종수대표이사재선임,http://www.insightkorea.co.kr//news/articleView.html?idxno=34741
1209,2019-03-15,사드보복롯데철수오리온농심한미약품은성장,http://www.economytalk.kr/news/articleView.html?idxno=181366
1210,2019-03-15,공시한미약품김성훈이동호사외이사재선임,http://www.newsway.co.kr/news/view?tp=1&ud=2019031517151066296
1211,2019-03-15,우종수한미약품사장제약강국향한도전주주들의변함없는신뢰덕분”,http://news.donga.com/3/all/20190315/94564103/2
1212,2019-03-15,한미약품제9기한미사이언스제46기주주총회개최,http://www.inthenews.co.kr/news/article.html?no=14135
1213,2019-03-15,한미약품3월15일주가전일대비222변동된482500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=620161
1214,2019-03-15,주총한미약품우종수대표사내이사재선임글로벌혁신신약창출할것,http://www.wolyo.co.kr/news/articleView.html?idxno=79636
1215,2019-03-15,한미약품이관순우종수사내이사등재선임,http://news.mt.co.kr/mtview.php?no=2019031517444644876
1216,2019-03-15,한미약품제약강국향한도전변함없는신뢰덕분”,http://www.econovill.com/news/articleView.html?idxno=358689
1217,2019-03-15,한미약품제9기정기주주총회개최우종수대표이사재선임,http://www.mdtoday.co.kr/mdtoday/index.html?no=348981
1218,2019-03-15,한미약품주주신뢰등에업고글로벌리딩기업나아갈것,http://www.wikileaks-kr.org/news/articleView.html?idxno=50329
1219,2019-03-15,한미약품파트너사스펙트럼롤론티스美허가신청자진취하,http://www.medigatenews.com/news/2492002094
1220,2019-03-15,한미약품우종수사장제약강국향한도전주주들의변함없는신뢰덕분,http://www.medigatenews.com/news/2062341131
1221,2019-03-15,한미약품주총제약강국K케어리딩기업도약”,http://news.heraldcorp.com/view.php?ud=20190315000596
1222,2019-03-15,한미약품파트너사스펙트럼美FDA신약허가신청취하,http://view.asiae.co.kr/news/view.htm?idxno=2019031518134367128
1223,2019-03-15,한미약품기술수출호중구감소증치료제롤론티스美FDA허가자진취하,http://www.edaily.co.kr/news/newspath.asp?newsid=03453846622423648
1224,2019-03-15,한미약품파트너사스펙트럼롤론티스美허가신청자진취하추후재신청,http://www.etoday.co.kr/news/section/newsview.php?idxno=1734326
1225,2019-03-15,한미약품파트너사스펙트럼롤론티스美FDA허가신청자진취하”,http://www.newsway.co.kr/news/view?tp=1&ud=2019031518152195039
1226,2019-03-15,한미약품롤론티스美FDA생물의약품허가신청취하,http://www.newspim.com/news/view/20190315000745
1227,2019-03-15,스펙트럼한미약품호중구감소증치료제美허가신청취하,http://biz.chosun.com/site/data/html_dir/2019/03/15/2019031502308.html
1228,2019-03-15,한미약품기술수출호중구감소증신약FDA허가신청취하종합,http://yna.kr/AKR20190315154651008?did=1195m
1229,2019-03-15,한미약품파트너사스펙트럼이신약기존허가신청취하,http://news.mt.co.kr/mtview.php?no=2019031518231279947
1230,2019-03-15,한미약품롤론티스美허가신청자진취소23개월내재신청,http://www.newspim.com/news/view/20190315000746
1231,2019-03-15,한미약품파트너사스펙트럼롤론티스美FDA신약허가신청취하,http://www.pressm.kr/news/articleView.html?idxno=22421
1232,2019-03-15,한미약품파트너사스펙트럼호중구감소증치료제롤론티스BLA자진취하,http://www.econovill.com/news/articleView.html?idxno=358694
1233,2019-03-15,美스펙트럼한미약품신약물질허가취하3개월뒤재신청,http://news1.kr/articles/?3572443
1234,2019-03-15,한미약품파트너사스펙트럼롤론티스美허가신청자진취하,http://biz.newdaily.co.kr/site/data/html/2019/03/15/2019031500188.html
1235,2019-03-15,한미약품기술수출신약美허가취하약효문제아냐종합,http://view.asiae.co.kr/news/view.htm?idxno=2019031518290885477
1236,2019-03-15,한미약품파트너사스텍트럼미FDA허가신청자진취하,http://www.insightkorea.co.kr//news/articleView.html?idxno=34756
1237,2019-03-15,한미약품롤론티스허가신청취하자료보완해다시제출할것”,http://news.mk.co.kr/newsRead.php?year=2019&no=158039
1238,2019-03-15,우종수한미약품주총에서제약강국향해도전의길간다,http://www.businesspost.co.kr/BP?command=article_view&num=118695
1239,2019-03-15,한미약품스펙트럼롤론티스美허가신청취하재신청예정”,http://news.donga.com/3/all/20190315/94565441/2
1240,2019-03-15,한미약품파트너사스펙트럼美FDA신약허가신청취하23개월내재신청,http://www.businesskorea.co.kr/news/articleView.html?idxno=30022
1241,2019-03-15,한미약품파트너사스펙트럼롤론티스BLA자진취하23개월내재신청”,http://www.ekn.kr/news/article.html?no=420736
1242,2019-03-15,한미약품스펙트럼롤론티스美허가신청취하재신청예정”,http://www.betanews.net:8080/article/986730.html
1243,2019-03-15,한미약품기술수출치료제美허가지연스펙트럼허가자진취하,http://news.hankyung.com/article/201903150672f
1244,2019-03-15,한미약품우종수대표부광약품유희원대표재선임,http://www.techholic.co.kr/news/articleView.html?idxno=181155
1245,2019-03-15,한미약품파트너스펙트럼FDA에롤론티스BLA자진취하,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228274
1246,2019-03-15,한미약품제9기한미사이언스제46기주주총회개최,http://www.newscj.com/news/articleView.html?idxno=611717
1247,2019-03-15,스펙트럼한미약품호중구감소증신약미국허가신청취하,http://www.seoulfn.com/news/articleView.html?idxno=336821
1248,2019-03-15,한미약품기술수출신약美허가자진취하,http://news.hankyung.com/article/2019031507371
1249,2019-03-15,한미약품파트너사스펙트럼롤론티스美FDA허가신청취하,https://www.sedaily.com/NewsView/1VGLLQDIQI
1250,2019-03-15,한미약품파트너사스펙트럼롤론티스미국허가신청자진취하,http://www.asiatime.co.kr/news/articleView.html?idxno=234000
1251,2019-03-15,한미약품파트너사스펙트럼롤론티스美허가신청취하,http://www.newscj.com/news/articleView.html?idxno=611775
1252,2019-03-15,한미약품파트너사스펙트럼호중구감소증신약FDA허가신청자진취하,http://www.nbnnews.co.kr/news/articleView.html?idxno=245867
1253,2019-03-15,한미약품파트너사스펙트럼호중구감소증신약FDA허가신청취하,http://www.asiatoday.co.kr/view.php?key=20190315002308052
1254,2019-03-15,한미약품주주총회개최＂제약강국향한도전주주님들의변함없는신뢰덕분＂,http://www.nspna.com/news/?mode=view&newsid=345779
1255,2019-03-15,마감한미약품파트너사스펙트럼미국허가신청취하삼성바이오거래소압색에하락,http://www.asiatime.co.kr/news/articleView.html?idxno=234008
1256,2019-03-16,한미약품파트너사스펙트럼롤론티스美허가신청자진취하,http://www.dailian.co.kr/news/view/779916/?sc=naver
1257,2019-03-16,한미약품BLA자진취하,http://www.g-enews.com/ko-kr/news/article/news_all/2019031606372991134e4869c120_1/article.html
1258,2019-03-16,유한양행한미약품종근당휴온스등일제히주총,http://www.cnbnews.com/news/article.html?no=403313
1259,2019-03-16,한미약품롤론티스美FDA허가자진취하데이터보완재신청,http://www.kukinews.com/news/article.html?no=641980
1260,2019-03-16,국민연금반대표힘못썼다신세계농심한미약품원안그대로,http://www.fntimes.com/html/view.php?ud=201903160901107453f09e13944d_18
1261,2019-03-16,한미약품스펙트럼롤론티스BLA자진취하,http://www.ebn.co.kr/news/view/976723
1262,2019-03-16,한미약품파트너사스펙트럼미FDA신약허가신청취하,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003519513
1263,2019-03-16,16일토요일10시현재특징주는한미약품NAVER아난티,http://www.leaders.kr/news/articleView.html?idxno=89152
1264,2019-03-16,한미약품기술수출신약FDA허가신청취하,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031608172953756
1265,2019-03-16,한미약품파트너사스펙트럼롤론티스美허가신청자진취하,http://www.upinews.kr/news/newsview.php?ncode=1065577943480069
1266,2019-03-16,한미약품스펙트럼롤론티스BLA자진취하재신청예정,http://www.getnews.co.kr/view.php?ud=20190316131234964041d0c69529_16
1267,2019-03-16,한미약품제9기한미사이언스제46기주주총회개최,http://www.lawissue.co.kr/view.php?ud=201903161408272867d7f4c63cc6_12
1268,2019-03-16,한미약품공시시점논란롤론티스허가신청자진취하,http://www.dailysmart.co.kr/news/articleView.html?idxno=7805
1269,2019-03-16,한미약품주주총회개최글로벌혁신신약창출해기업가치높일것,http://www.edaily.co.kr/news/newspath.asp?newsid=01781046622423976
1270,2019-03-17,제약바이오한주간이모저모한미약품기술수출롤론티스美허가자진취하등,http://www.edaily.co.kr/news/newspath.asp?newsid=01128326622424304
1271,2019-03-17,한미약품기술수출롤론티스美허가취하”,http://www.viva100.com/main/view.php?key=20190317010005523
1272,2019-03-17,한미약품우종수대표이사재선임,http://www.viva100.com/main/view.php?key=20190317010005529
1273,2019-03-18,한미약품기술수출호중구감소증신약美FDA허가신청취하,http://www.mdtoday.co.kr/mdtoday/index.html?no=349063
1274,2019-03-18,코스피코스닥15일주요공시한미약품파트너사스펙트럼美FDA신약허가신청자진취하등,http://www.betanews.net:8080/article/986938.html
1275,2019-03-18,한미약품우종수등7개제약사대표이사주총서재선임,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228278
1276,2019-03-18,한미약품롤론티스허가신청취하큰문제아냐NH,http://news.hankyung.com/article/2019031841476
1277,2019-03-18,한미약품롤론티스허가신청취하완제문제NH,http://www.fnnews.com/news/201903180731485675
1278,2019-03-18,한미약품롤론티스개발중단아닌시판연기매수하나금융투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1734516
1279,2019-03-18,한미약품롤론티스시판연기불구하반기RD모멘텀견고하나금융투자,http://www.dailian.co.kr/news/view/780093/?sc=naver
1280,2019-03-18,한미약품롤론티스3개월내재신청기대미래에셋대우,http://news.mt.co.kr/mtview.php?no=2019031807493566613
1281,2019-03-18,한미약품목표가57만원유지전일종가48만2500원대신證,http://www.newspim.com/news/view/20190318000059
1282,2019-03-18,퀵리포트한미약품매수유지목표가57만원유지대신證,http://www.itooza.com/common/iview.php?no=2019031808034914773
1283,2019-03-18,한미약품롤론티스허가자진취하불구목표가유지NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01407126622424632
1284,2019-03-18,한미약품목표가57만원유지전일종가48만2500원하나금투,http://www.newspim.com/news/view/20190318000065
1285,2019-03-18,퀵리포트한미약품매수유지목표가57만원유지하나금투,http://www.itooza.com/common/iview.php?no=2019031808072718162
1286,2019-03-18,한미약품목표가64만원유지전일종가48만2500원한화證,http://www.newspim.com/news/view/20190318000078
1287,2019-03-18,퀵리포트한미약품매수유지목표가64만원유지한화證,http://www.itooza.com/common/iview.php?no=2019031808121913015
1288,2019-03-18,미래에셋대우한미약품롤론티스신약허가철회큰악재아냐,http://www.newsis.com/view/?id=NISX20190318_0000590128&cID=10401&pID=10400
1289,2019-03-18,HotLine한미약품롤론티스신약허가철회3개월내재신청기대,http://news.mk.co.kr/newsRead.php?year=2019&no=160396
1290,2019-03-18,한미약품파트너사美FDA허가신청철회주가영향미미KB,http://www.edaily.co.kr/news/newspath.asp?newsid=01482566622424632
1291,2019-03-18,한미약품신약롤론티스지연증권사들영향미미,http://news1.kr/articles/?3573258
1292,2019-03-18,한미약품주가상승가능호중구감소증시판차질영향은미미,http://www.businesspost.co.kr/BP?command=article_view&num=118804
1293,2019-03-18,한미약품우종수권세창공동대표이사체제유지,http://www.bokuennews.com/news/article.html?no=172949
1294,2019-03-18,전일주요공시한미약품크로바하이텍넥스트BT외,http://www.etoday.co.kr/news/section/newsview.php?idxno=1734529
1295,2019-03-18,클릭e종목한미약품허가취소공시단기적으로주가에악영향,http://view.asiae.co.kr/news/view.htm?idxno=2019031808280764816
1296,2019-03-18,롤론티스승인철회한미약품파이프라인가치유효한화,http://www.edaily.co.kr/news/newspath.asp?newsid=01518646622424632
1297,2019-03-18,NH투자한미약품롤론티스FDA신청취하매수기회,http://yna.kr/AKR20190318020700008?did=1195m
1298,2019-03-18,미래에셋대우한미약품롤론티스신약허가철회큰악재아니다”,http://www.newsway.co.kr/news/view?tp=1&ud=2019031808350031706
1299,2019-03-18,NH투자증권한미약품롤론티스허가자진취하주가에영향미미”,http://www.newsway.co.kr/news/view?tp=1&ud=2019031808340008575
1300,2019-03-18,하이로우한미약품롤론티스허가신청철회파이프라인가치영향미미한화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019031808342473604
1301,2019-03-18,한미약품파트너사신약허가신청취하영향미미미래에셋대우,https://www.sedaily.com/NewsView/1VGMY1Z9WA
1302,2019-03-18,한미약품롤론티스시판허가2020년상반기예상,http://www.nspna.com/news/?mode=view&newsid=345859
1303,2019-03-18,한미약품롤론티스허가신청취하큰영향주지못해”KB증권,http://www.fntimes.com/html/view.php?ud=2019031808484995076c0eb6f11e_18
1304,2019-03-18,한미약품롤론티스허가취하마이너이슈NH투자증권,http://www.newstomato.com/ReadNews.aspx?no=882704
1305,2019-03-18,종목썰쩐롤론티스허가신청취하한미약품9890원하락요인,http://news.hankyung.com/article/2019031844166
1306,2019-03-18,퀵리포트한미약품매수유지목표가68만원미래에셋대우,http://www.itooza.com/common/iview.php?no=2019031808080517662
1307,2019-03-18,한미약품스펙트럼롤론티스허가취하영향제한적”하이투자,http://www.newspim.com/news/view/20190318000114
1308,2019-03-18,한미약품롤론티스허가신청자진취하주가에단기적악영향가능성”하이투자증권,http://www.fntimes.com/html/view.php?ud=201903180847422658f09e13944d_18
1309,2019-03-18,한미약품롤론티스허가지연주가영향미미KB증권,http://www.newspim.com/news/view/20190318000105
1310,2019-03-18,한미약품롤론티스BLA자진철회는시판연기일뿐하나,http://www.ebn.co.kr/news/view/976812
1311,2019-03-18,스펙트럼롤론티스허가신청취하한미약품가치에영향없을것하이투자증권,http://www.ajunews.com/view/20190318090056806
1312,2019-03-18,한미약품롤론티스신청취하펀더멘털변화無하이,http://www.edaily.co.kr/news/newspath.asp?newsid=01705606622424632
1313,2019-03-18,한미약품롤론티스허가신청취하에약세,http://news.hankyung.com/article/2019031845076
1314,2019-03-18,특징주한미약품美FDA승인신청철회소식에하락세,http://view.asiae.co.kr/news/view.htm?idxno=2019031809082952854
1315,2019-03-18,한미약품롤론티스신약허가철회큰악재아냐미래에셋대우,http://www.seoulfn.com/news/articleView.html?idxno=336890
1316,2019-03-18,특징주한미약품롤론티스허가신청취하에↓,http://news.mt.co.kr/mtview.php?no=2019031809101120671
1317,2019-03-18,특징주한미약품롤론틴스허가신청취하에약세,http://yna.kr/AKR20190318029800008?did=1195m
1318,2019-03-18,한미약품기술수출호중구감소증신약FDA허가신청취하,http://news.mk.co.kr/newsRead.php?year=2019&no=160595
1319,2019-03-18,특징주한미약품롤론티스허가신청취하소식에약세,http://www.fnnews.com/news/201903180911516532
1320,2019-03-18,특징주한미약품美신약허가자진취하소식에약세,http://moneys.mt.co.kr/news/mwView.php?no=2019031809138043342
1321,2019-03-18,한미약품美FDA승인신청철회소식에약세,https://www.sedaily.com/NewsView/1VGMXRCBZU
1322,2019-03-18,특징주한미약품美FDA승인신청철회소식에약세,http://www.fetv.co.kr/news/article.html?no=23174
1323,2019-03-18,특징주한미약품롤론티스허가취하에하락,http://www.newsway.co.kr/news/view?tp=1&ud=2019031809144024947
1324,2019-03-18,특징주한미약품신약롤론티스허가취하주가된서리,http://www.g-enews.com/ko-kr/news/article/news_all/201903180914073586c642673384_1/article.html
1325,2019-03-18,특징주한미약품롤론티스美FDA승인신철철회에약세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903180107&t=NN
1326,2019-03-18,한미약품롤론틴스허가신청취하에하락,http://www.ekn.kr/news/article.html?no=420953
1327,2019-03-18,한미약품롤론티스허가신청취하에장초반약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=349098
1328,2019-03-18,특징주한미약품롤론티스美허가자진철회소식에약세,http://www.newsis.com/view/?id=NISX20190318_0000590238&cID=10401&pID=10400
1329,2019-03-18,특징주한미약품롤론티스FDA허가신청취하에약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1734580
1330,2019-03-18,특징주한미약품기술수출신약지연에2약세,http://news1.kr/articles/?3573317
1331,2019-03-18,특징주한미약품롤론티스판매허가철회에약세,http://www.dt.co.kr/contents.html?article_no=2019031802109932049002&ref=naver
1332,2019-03-18,ET투자뉴스한미약품롤론티스FDA승BUY유지한화투자증권,http://www.etnews.com/20190318000026
1333,2019-03-18,특징주한미약품신약허가자진취하소식에하락세,http://www.seoulfn.com/news/articleView.html?idxno=336900
1334,2019-03-18,특징주한미약품파트너사美FDA허가신청자진철회소식에약세,http://www.edaily.co.kr/news/newspath.asp?newsid=01971286622424632
1335,2019-03-18,특징주한미약품롤론티스FDA승인자진철회에약세,http://www.ebn.co.kr/news/view/976824
1336,2019-03-18,특징주한미약품미FDA승인신청철회에하락,http://www.inews24.com/view/1164481
1337,2019-03-18,한미약품신약롤론티스지연증권사들영향미미,http://www.fntoday.co.kr/news/articleView.html?idxno=183910
1338,2019-03-18,한미약품128940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903180216&t=NN
1339,2019-03-18,한미약품롤론티스美허가자진철회주가전망은,http://www.choicenews.co.kr/news/articleView.html?idxno=48961
1340,2019-03-18,하나금투한미약품롤론티스시판늦춰져목표가↓,http://www.sentv.co.kr/news/view/550344
1341,2019-03-18,한미약품주총서우종수대표이사재선임,http://www.rapportian.com/news/articleView.html?idxno=116605
1342,2019-03-18,특징주한미약품스펙트럼롤론틴스허가신청취하에약세,http://www.ajunews.com/view/20190318102454940
1343,2019-03-18,한미약품롤론티스美허가신청취하에시장반응은,http://www.ajunews.com/view/20190318102412938
1344,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.newspim.com/news/view/20190318000276
1345,2019-03-18,한미약품한국산텐안구건조증치료제디쿠아스2종판매,http://medipana.com/news/news_viewer.asp?NewsNum=236051&MainKind=A&NewsKind=5&vCount=12&vKind=1
1346,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.asiatoday.co.kr/view.php?key=20190318010010017
1347,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.nextdaily.co.kr/news/article.html?id=20190318800025
1348,2019-03-18,한미약품안구건조증치료제디쿠아스공동판매,http://www.dailypharm.com/Users/News/NewsView.html?ID=250500&REFERER=NP
1349,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매나선다,https://www.sedaily.com/NewsView/1VGMYKD4CE
1350,2019-03-18,한미약품안구건조증치료제2종공동판매,http://www.bosa.co.kr/news/articleView.html?idxno=2101430
1351,2019-03-18,한미약품한국산텐안구건조증치료제2종국내판매,http://www.medisobizanews.com/news/articleView.html?idxno=58498
1352,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.fnnews.com/news/201903181044562469
1353,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228300
1354,2019-03-18,한미약품日산텐제약안구건조증치료제디쿠아스공동판매,http://www.edaily.co.kr/news/newspath.asp?newsid=02496086622424632
1355,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://yna.kr/AKR20190318060900017?did=1195m
1356,2019-03-18,한미약품한국산텐제약안구건조증치료제디쿠아스공동판매,http://www.seoulwire.com/news/articleView.html?idxno=89976
1357,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.newsway.co.kr/news/view?tp=1&ud=2019031810595815170
1358,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://view.asiae.co.kr/news/view.htm?idxno=2019031811063845927
1359,2019-03-18,한미약품한국산텐제약과안구건조증치료제2종공동판매,http://news1.kr/articles/?3573540
1360,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.pressm.kr/news/articleView.html?idxno=22435
1361,2019-03-18,한미약품스펙트럼롤론티스FDA허가신청자진취하문제없을것”,http://www.inthenews.co.kr/news/article.html?no=14142
1362,2019-03-18,한미약품한국산텐과안구건조증치료제2종공동판매,http://biz.newdaily.co.kr/site/data/html/2019/03/18/2019031800071.html
1363,2019-03-18,한미약품한국산텐과안구건조증치료제2종공동판매,http://biz.newdaily.co.kr/site/data/html/2019/03/18/2019031800071.html
1364,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.ekn.kr/news/article.html?no=421013
1365,2019-03-18,한미약품파트너사스펙트럼롤론티스BLA자진취하”,http://www.cnbnews.com/news/article.html?no=403425
1366,2019-03-18,한미약품한국산텐안구건조증치료제2종판매,http://www.ebn.co.kr/news/view/976886
1367,2019-03-18,주식현재가한미약품주가18일현재470500원,http://www.nbntv.co.kr/news/articleView.html?idxno=264435
1368,2019-03-18,한미약품롤론티스BLA신청자진철회”,http://www.wikitree.co.kr/main/news_view.php?id=412169
1369,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.newsis.com/view/?id=NISX20190318_0000590519&cID=13001&pID=13000
1370,2019-03-18,한미약품한국산텐과안구건조증치료제2종공동판매,http://www.opinionnews.co.kr/news/articleView.html?idxno=14394
1371,2019-03-18,한미약품안구건조증치료제한국산텐제약과공동판매,http://www.whitepaper.co.kr/news/articleView.html?idxno=148580
1372,2019-03-18,특징주한미약품롤론틴스허가신청취하에약세증권사들영향크지않을것,http://www.kpinews.co.kr/news/articleView.html?idxno=92595
1373,2019-03-18,한미약품파트너사스펙트럼롤론티스BLA자진취하,http://www.kukinews.com/news/article.html?no=642315
1374,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매계약,http://www.newsprime.co.kr/news/article.html?no=451240
1375,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1125145&REFERER=NP
1376,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.koreaittimes.com/news/articleView.html?idxno=89748
1377,2019-03-18,한미약품안구건조증치료제도입,http://www.whosaeng.com/108671
1378,2019-03-18,증권가한미약품롤론티스허가지연악재아냐,http://www.dailypharm.com/Users/News/NewsView.html?ID=250496&REFERER=NP
1379,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.shinailbo.co.kr/news/articleView.html?idxno=1150269
1380,2019-03-18,한미약품3월18일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=621115
1381,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.metroseoul.co.kr/news/newsview?newscd=2019031800134
1382,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.fetv.co.kr/news/article.html?no=23245
1383,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.sisajournal-e.com/news/articleView.html?idxno=197115
1384,2019-03-18,한미약품한국산텐안구건조증치료제공동판매,http://www.kpinews.co.kr/news/articleView.html?idxno=92596
1385,2019-03-18,한미약품한국산텐제약맞손안구건조증치료제판매계약,http://www.dt.co.kr/contents.html?article_no=2019031802109931102004&ref=naver
1386,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.4th.kr/news/articleView.html?idxno=9896
1387,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.mediapen.com/news/view/420366
1388,2019-03-18,신약허가앞두고삐끗한미약품저점매수기회될까,http://news.mt.co.kr/mtview.php?no=2019031813435434126
1389,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.100ssd.co.kr/news/articleView.html?idxno=60076
1390,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.nbnnews.co.kr/news/articleView.html?idxno=246441
1391,2019-03-18,한미약품한국산텐안구건조증치료제공동판매,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019031814045502327&objId=A2019031814045502327&portalCode=naver
1392,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.bokuennews.com/news/article.html?no=172988
1393,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.smedaily.co.kr/news/articleView.html?idxno=82042
1394,2019-03-18,한미약품한국산텐과안구건조증치료제2종공동판매,http://www.econovill.com/news/articleView.html?idxno=358808
1395,2019-03-18,한미약품롤론티스BLA철회23개월내재허가신청예정”,http://www.wikitree.co.kr/main/news_view.php?id=412270
1396,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201903180451&t=NN
1397,2019-03-18,한미약품한국산텐제약과안구건조증치료제2종공동판매계약,http://news.donga.com/3/all/20190318/94612554/2
1398,2019-03-18,한미약품롤론티스FDA승인자진철회영향미미,http://www.newsprime.co.kr/news/article.html?no=451303
1399,2019-03-18,한미약품한국산텐과안구건조증치료제2종공동판매계약,http://www.hg-times.com/news/articleView.html?idxno=198852
1400,2019-03-18,한미약품롤론티스신약허가철회3개월내재신청기대”,http://www.wikitree.co.kr/main/news_view.php?id=412286
1401,2019-03-18,한미약품한국산텐과안구건조증약공동판매계약,http://www.rapportian.com/news/articleView.html?idxno=116615
1402,2019-03-18,한미약품롤론티스의허가지연기업가치영향미미,http://www.wikitree.co.kr/main/news_view.php?id=412287
1403,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매계약,http://www.mhj21.com/120194
1404,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://daily.hankooki.com/lpage/ittech/201903/dh20190318150536145630.htm
1405,2019-03-18,한미약품산텐제약안구건조증치료제2종공동판매,http://news.bizwatch.co.kr/article/consumer/2019/03/18/0020/naver
1406,2019-03-18,한미약품산텐제약안구건조증약디쿠아스시리즈공동판매키로,http://news.mk.co.kr/newsRead.php?year=2019&no=162312
1407,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.wikileaks-kr.org/news/articleView.html?idxno=50491
1408,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.medigatenews.com/news/3182231667
1409,2019-03-18,3월18일월요일특징주한미약품,http://www.leaders.kr/news/articleView.html?idxno=89296
1410,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.babytimes.co.kr/news/articleView.html?idxno=25984
1411,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.techholic.co.kr/news/articleView.html?idxno=181177
1412,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.seoulfn.com/news/articleView.html?idxno=336982
1413,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.newstomato.com/ReadNews.aspx?no=882916
1414,2019-03-18,한미약품한국산텐안구건조증치료제디쿠아스2종공동판매,http://www.k-health.com/news/articleView.html?idxno=42975
1415,2019-03-18,한미약품9건vsYG엔터1건승리논란보고서기근,http://news1.kr/articles/?3573866
1416,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매안과치료제영역서시너지,http://www.businesskorea.co.kr/news/articleView.html?idxno=30074
1417,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매계약체결,http://www.ezyeconomy.com/news/articleView.html?idxno=88991
1418,2019-03-18,한미약품매출1조160억원제약강국향한도전”,http://www.kukinews.com/news/article.html?no=642432
1419,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.kukinews.com/news/article.html?no=642433
1420,2019-03-18,한미약품3월18일주가전일대비249변동된470500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=621591
1421,2019-03-18,한미약품산텐제약디쿠아스디쿠아스에스공동판매계약체결,http://www.cnbnews.com/news/article.html?no=403514
1422,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.viva100.com/main/view.php?key=20190318010006100
1423,2019-03-18,나른한봄건강지키기한미약품목앤,https://www.sedaily.com/NewsView/1VGN00T3YU
1424,2019-03-18,한미약품한국산텐안구건조증치료제공동판매,http://www.finomy.com/news/articleView.html?idxno=63864
1425,2019-03-18,한미약품한국산텐안구건조증치료제디쿠아스2종판매,http://www.newspost.kr/news/articleView.html?idxno=69704
1426,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://www.getnews.co.kr/view.php?ud=2019031818350891841d0c69529_16
1427,2019-03-18,기업단신SK이노베이션한미약품부영그룹外,http://www.dailypop.kr/news/articleView.html?idxno=38269
1428,2019-03-18,한미약품한국산텐제약과안구건조증치료제공동판매,http://www.dailysmart.co.kr/news/articleView.html?idxno=7881
1429,2019-03-18,써볼까한미약품케어가글‥약사1천명선정구강청결제,http://www.nspna.com/news/?mode=view&newsid=346150
1430,2019-03-18,한미약품한국산텐디쿠아포솔성분디쿠아스®등공동판매계약,http://www.lawissue.co.kr/view.php?ud=201903182231469887d7f4c63cc6_12
1431,2019-03-18,한미약품한국산텐안구건조증치료제2종공동판매,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3784148
1432,2019-03-19,제약한미약품목따끔거릴땐목앤으로상쾌하게,http://news.mk.co.kr/newsRead.php?year=2019&no=163355
1433,2019-03-19,한미약품한국산텐안구건조증치료제2종공동판매,http://www.dailian.co.kr/news/view/780425/?sc=naver
1434,2019-03-19,한미약품한국산텐안구건조증치료제2종공동판매,http://www.g-enews.com/ko-kr/news/article/news_all/201903190912187963fa075a9870_1/article.html
1435,2019-03-19,바이오시밀러테마오전시황상승률상위종목셀트리온149제넥신117한미약품064등,http://www.gokorea.kr/news/articleView.html?idxno=124302
1436,2019-03-19,한미약품한국산텐내달1일부터안구건조증치료제2종공동판매,http://www.newswatch.kr/news/articleView.html?idxno=17796
1437,2019-03-19,한미약품주주총회개최변함없는신뢰덕분,http://www.straightnews.co.kr/news/articleView.html?idxno=45435
1438,2019-03-19,한미약품주가및증권시세및종목관련동향정보19일현재471000원,http://www.gokorea.kr/news/articleView.html?idxno=124656
1439,2019-03-19,3월19일한미약품주식시세현황021471500원,http://www.nbntv.co.kr/news/articleView.html?idxno=266787
1440,2019-03-19,바이오시밀러테마오후시황상승률상위종목셀트리온100한미약품032제넥신117등,http://www.gokorea.kr/news/articleView.html?idxno=125041
1441,2019-03-19,한미약품3월19일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=622238
1442,2019-03-19,바이오시밀러테마마감시황상승률상위종목팜스웰바이오129셀트리온100한미약품053등,http://www.gokorea.kr/news/articleView.html?idxno=125280
1443,2019-03-19,한미약품RD핵심은랩스커버리팬탐바디오라스커버리,http://daily.hankooki.com/lpage/ittech/201903/dh20190319172152145630.htm
1444,2019-03-19,한미약품3월19일주가전일대비053변동된468000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=622734
1445,2019-03-19,한미약품독보적플랫폼기술글로벌오픈이노베이션이끌어,http://biz.newdaily.co.kr/site/data/html/2019/03/19/2019031900211.html
1446,2019-03-19,한미약품개방형혁신통해희귀질환안질환에집중”,http://www.newspim.com/news/view/20190319000833
1447,2019-03-19,한미약품한국산텐과안구건조증치료제2종공동판매계약,http://www.industrynews.co.kr/news/articleView.html?idxno=29832
1448,2019-03-20,대한민국RD1위한미약품미래타깃희귀안과질환,http://www.dailymedi.com/detail.php?number=841126&thread=22r05
1449,2019-03-20,한미약품희귀안질환에서오픈이노베이션확장할것,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1066429
1450,2019-03-20,잡코리아BIOJOBFAIR2019운영한미약품한국머크기업설명회,http://www.etoday.co.kr/news/section/newsview.php?idxno=1735608
1451,2019-03-20,한미약품미래가치창출답은오픈이노베이션”,http://news.bizwatch.co.kr/article/consumer/2019/03/19/0026/naver
1452,2019-03-20,한미약품한국산텐안구건조증치료제2종공동판매,http://www.straightnews.co.kr/news/articleView.html?idxno=45507
1453,2019-03-20,1Q순이익증가율1위제약주는한미약품비결은,http://news.hankyung.com/article/201903203292M
1454,2019-03-20,한미약품주가3월20일현재464000원,http://www.gokorea.kr/news/articleView.html?idxno=125981
1455,2019-03-20,한미약품3월20일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=623295
1456,2019-03-20,3월20일한미약품실시간주식현황096463500원,http://www.nbntv.co.kr/news/articleView.html?idxno=269147
1457,2019-03-20,한미약품세가지오픈이노베이션사례공개희귀질환분야에서계속확대할것,http://www.techholic.co.kr/news/articleView.html?idxno=181228
1458,2019-03-20,한미약품3월20일주가전일대비032변동된466500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=623812
1459,2019-03-21,바이오시밀러테마오전시황상승률상위종목한미약품064셀트리온050이수앱지스047등,http://www.gokorea.kr/news/articleView.html?idxno=126931
1460,2019-03-21,21일09시바이오시밀러오전의테마종목한미약품셀트리온등이상승세주도,http://www.nbntv.co.kr/news/articleView.html?idxno=270768
1461,2019-03-21,3월21일한미약품주식종목214456500원,http://www.nbntv.co.kr/news/articleView.html?idxno=271549
1462,2019-03-21,한미약품3월21일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=624375
1463,2019-03-21,ET투자뉴스한미약품_상장주식수대비거래량은031로적정수준,http://www.etnews.com/20190321000200
1464,2019-03-21,한미약품3월21일주가전일대비225변동된456000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=624877
1465,2019-03-21,파워브랜드한미약품목앤,http://www.seoulfn.com/news/articleView.html?idxno=337373
1466,2019-03-22,청년이미래다한미약품세계첫의약품전자태그도입창조DNA이어갈인재열린채용,http://news.mk.co.kr/newsRead.php?year=2019&no=172504
1467,2019-03-22,바이오시밀러테마오전시황상승률상위종목팜스웰바이오053한올바이오파마030한미약품011등,http://www.gokorea.kr/news/articleView.html?idxno=128360
1468,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.fetv.co.kr/news/article.html?no=23769
1469,2019-03-22,한미약품오너2세들경영승계성큼,http://www.polinews.co.kr/news/article.html?no=386006
1470,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.nextdaily.co.kr/news/article.html?id=20190322800019
1471,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.pressm.kr/news/articleView.html?idxno=22517
1472,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228552
1473,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.edaily.co.kr/news/newspath.asp?newsid=02364886622425944
1474,2019-03-22,한미약품다이어트프로캄슬리미S팻다운하루2정이면보이차39잔효과,http://www.seoulwire.com/news/articleView.html?idxno=94320
1475,2019-03-22,한미약품주가3월22일현재456500원,http://www.gokorea.kr/news/articleView.html?idxno=128636
1476,2019-03-22,한미약품체지방감소체중관리건기식프로캄슬리미S팻다운출시,http://www.medisobizanews.com/news/articleView.html?idxno=58615
1477,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운내놔,http://www.wolyo.co.kr/news/articleView.html?idxno=80036
1478,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.bokuennews.com/news/article.html?no=173283
1479,2019-03-22,한미약품체지방감소위한건기식프로캄슬리미S팻다운출시,http://www.koreaittimes.com/news/articleView.html?idxno=89862
1480,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://medipana.com/news/news_viewer.asp?NewsNum=236341&MainKind=A&NewsKind=5&vCount=12&vKind=1
1481,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019032211224560866
1482,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://daily.hankooki.com/lpage/ittech/201903/dh20190322113021145630.htm
1483,2019-03-22,한미약품체중관리용건강기능식품출시,http://www.rapportian.com/news/articleView.html?idxno=116711
1484,2019-03-22,한미약품프로캄슬리미S팻다운출시,http://www.ezyeconomy.com/news/articleView.html?idxno=89136
1485,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.newsis.com/view/?id=NISX20190322_0000595958&cID=13001&pID=13000
1486,2019-03-22,주식종목한미약품주가22일현재453500원,http://www.nbntv.co.kr/news/articleView.html?idxno=273952
1487,2019-03-22,한미약품체중관리용건기식프로캄슬리미S팻다운출시,http://www.asiatime.co.kr/news/articleView.html?idxno=235328
1488,2019-03-22,한미약품3월22일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=625365
1489,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=349661
1490,2019-03-22,한미약품체중관리용건강기능식품프로캄슬리미S팻다운출시,http://news.mk.co.kr/newsRead.php?year=2019&no=173824
1491,2019-03-22,한미약품보이차추출물갈산포함체중관리건기식선봬,http://www.babytimes.co.kr/news/articleView.html?idxno=26177
1492,2019-03-22,한미약품체중관리건강기능식품프로캄슬리미S팻다운출시,https://www.sedaily.com/NewsView/1VGOTU8EVB
1493,2019-03-22,한미약품체중관리프로캄슬리미S팻다운출시,http://www.smedaily.co.kr/news/articleView.html?idxno=82162
1494,2019-03-22,한미약품체중관리용프로캄슬리미S팻다운출시,http://www.hg-times.com/news/articleView.html?idxno=199045
1495,2019-03-22,한미약품체중관리프로캄슬리미S팻다운약국판매,http://www.fnnews.com/news/201903221504490567
1496,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=50911
1497,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://news.hankyung.com/article/201903224425f
1498,2019-03-22,바이오시밀러테마주시황마감한올바이오파마한미약품등이상승세견인중,http://www.nbntv.co.kr/news/articleView.html?idxno=274958
1499,2019-03-22,바이오시밀러테마마감시황상승률상위종목한올바이오파마179한미약품055팜스웰바이오053등,http://www.gokorea.kr/news/articleView.html?idxno=129249
1500,2019-03-22,한미약품체중관리식품프로캄슬리미S팻다운출시,http://www.ebn.co.kr/news/view/977679
1501,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.joseilbo.com/news/news_read.php?uid=372911&class=27&grp=
1502,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=248648
1503,2019-03-22,한미약품보이차추출물함유한프로캄슬리미S팻다운출시,http://www.kpinews.co.kr/news/articleView.html?idxno=92918
1504,2019-03-22,한미약품3월22일주가전일대비055변동된458500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=625645
1505,2019-03-22,한미약품체중관리용건강기능식품프로캄슬리미S팻다운출시,http://www.techholic.co.kr/news/articleView.html?idxno=181280
1506,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.getnews.co.kr/view.php?ud=20190322173859905041d0c69529_16
1507,2019-03-22,한미약품체중관리건강식품프로캄슬리미S팻다운출시,http://news.donga.com/3/all/20190322/94692065/2
1508,2019-03-22,한미약품유한양행기술수출동국제약다각화기조이어간다,http://daily.hankooki.com/lpage/column/201903/dh20190322191655145650.htm
1509,2019-03-22,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.newscj.com/news/articleView.html?idxno=613905
1510,2019-03-23,한미약품보이차추출물담은프로캄슬리미S팻다운발매,http://www.dailysmart.co.kr/news/articleView.html?idxno=8075
1511,2019-03-24,제약산업단신일동제약대웅제약한미약품한국오츠카제약,http://www.kukinews.com/news/article.html?no=644620
1512,2019-03-24,한미약품프로캄슬리미S팻다운출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019032200111
1513,2019-03-24,민간기업일자리정보CJ그룹SK증권NHNEntertainment주셀트리온한미약품주외공개채용공고발표,http://www.fintechpost.co.kr/news/articleView.html?idxno=28025
1514,2019-03-25,바이오시밀러테마오전시황상승률상위종목셀트리온025한미약품011팜스웰바이오013등,http://www.gokorea.kr/news/articleView.html?idxno=129817
1515,2019-03-25,한미약품프로캄슬리미S팻다운출시,http://www.straightnews.co.kr/news/articleView.html?idxno=45749
1516,2019-03-25,3월25일한미약품증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=130102
1517,2019-03-25,한미약품케어가글코리아팜어워드굿브랜드大賞선정,http://www.insightkorea.co.kr//news/articleView.html?idxno=35066
1518,2019-03-25,한미약품목앤약사가꼽은No1인후염외용제목염증완화및항균이중작용,http://www.greened.kr/news/articleView.html?idxno=98954
1519,2019-03-25,한미약품주가그래프25일현재455000원,http://www.nbntv.co.kr/news/articleView.html?idxno=276744
1520,2019-03-25,뉴스투데이L한미약품목앤미세먼지로인한인후염목쉼에탁월,http://www.news2day.co.kr/123277
1521,2019-03-25,한미약품3월25일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=626578
1522,2019-03-25,한미약품케어가글코리아팜어워드굿브랜드구강위생부문대상,http://www.techholic.co.kr/news/articleView.html?idxno=181299
1523,2019-03-25,한미약품체중관리건기식프로캄슬리미S팻다운출시,http://www.4th.kr/news/articleView.html?idxno=10151
1524,2019-03-25,한미약품체중관리용건기식프로캄슬리미S팻다운출시,http://www.cnbnews.com/news/article.html?no=404395
1525,2019-03-25,한미약품3월25일주가전일대비131변동된452500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=627034
1526,2019-03-25,한미약품스펙트럼롤론티스美FDA허가신청자진취하,https://www.insight.co.kr/news/218617
1527,2019-03-26,3월26일한미약품종목그래프및매매동향,http://www.gokorea.kr/news/articleView.html?idxno=131434
1528,2019-03-26,한미약품안과수술보조제히알루주사1회수폐기조치,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228686
1529,2019-03-26,3월26일한미약품주식현황453500원022,http://www.nbntv.co.kr/news/articleView.html?idxno=279179
1530,2019-03-26,한미약품케어가글약사선정구강위생대상쾌거,http://www.newswatch.kr/news/articleView.html?idxno=17908
1531,2019-03-26,약사가꼽은최고의인후염외용제한미약품목앤,http://www.dailian.co.kr/news/view/782414/?sc=naver
1532,2019-03-26,한미약품타업체팔팔이름지우기이번엔실패,http://www.dailypharm.com/Users/News/NewsView.html?ID=250840&REFERER=NP
1533,2019-03-26,바이오시밀러테마오후시황상승률상위종목한올바이오파마636제넥신571한미약품088등,http://www.gokorea.kr/news/articleView.html?idxno=131833
1534,2019-03-26,한미약품3월26일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=627719
1535,2019-03-26,한미약품인후염치료제목앤황사와미세먼지기승으로인기,http://www.businesspost.co.kr/BP?command=article_view&num=120134
1536,2019-03-26,바이오시밀러테마마감시황상승률상위종목제넥신620한올바이오파마439한미약품088등,http://www.gokorea.kr/news/articleView.html?idxno=132042
1537,2019-03-26,약사가꼽은No1인후염외용제한미약품목앤,http://www.newsway.co.kr/news/view?tp=1&ud=2019032616525123455
1538,2019-03-26,한미약품나인나인한알에하루권장비타민D까지해결한다,http://www.siminilbo.co.kr/news/articleView.html?idxno=616480
1539,2019-03-26,한미약품3월26일주가전일대비088변동된456500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=628173
1540,2019-03-26,한미약품나인나인하루한알로비타민D까지해결,http://www.00news.co.kr/news/articleView.html?idxno=57354
1541,2019-03-27,팔팔상표권무효”한미약품상표권소송나섰지만패소,http://www.mdtoday.co.kr/mdtoday/index.html?no=350034
1542,2019-03-27,3월27일한미약품오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=132745
1543,2019-03-27,3월27일한미약품배당주식022455500원,http://www.nbntv.co.kr/news/articleView.html?idxno=281631
1544,2019-03-27,한미약품목앤약사가꼽은최고의인후염외용제,http://www.munhwa.com/news/view.html?no=2019032701071727107001
1545,2019-03-27,약사가인정한구강청결제한미약품케어가글,http://www.shinailbo.co.kr/news/articleView.html?idxno=1153071
1546,2019-03-27,한미약품3월27일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=628781
1547,2019-03-27,약사가꼽은No1인후염외용제한미약품목앤,http://news.mk.co.kr/newsRead.php?year=2019&no=185381
1548,2019-03-27,한미약품3월27일주가전일대비285변동된443500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=629268
1549,2019-03-28,약사가꼽은No1인후염외용제한미약품목앤,http://www.joseilbo.com/news/news_read.php?uid=373251&class=27&grp=
1550,2019-03-28,바이오잡페어에한미약품등제약바이오기업30여곳참여,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228792
1551,2019-03-28,3월28일한미약품주식추천주442500원023,http://www.nbntv.co.kr/news/articleView.html?idxno=284045
1552,2019-03-28,바이오시밀러테마오후시황상승률상위종목제넥신207팜스웰바이오185한미약품090등,http://www.gokorea.kr/news/articleView.html?idxno=134764
1553,2019-03-28,한미약품3월28일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=629886
1554,2019-03-28,바이오시밀러테마종목종가팜스웰바이오한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=285372
1555,2019-03-28,바이오시밀러테마마감시황상승률상위종목팜스웰바이오318한미약품158제넥신097등,http://www.gokorea.kr/news/articleView.html?idxno=134830
1556,2019-03-28,한미약품3월28일주가전일대비158변동된450500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=630369
1557,2019-03-29,한미약품구강청결제케어가글약국판매1위박하향사과향소비자맞춤”,http://biz.chosun.com/site/data/html_dir/2019/03/29/2019032901200.html
1558,2019-03-29,한미약품오늘주식시장29일현재454500원,http://www.nbntv.co.kr/news/articleView.html?idxno=286467
1559,2019-03-29,바이오시밀러테마오후시황상승률상위종목팜스웰바이오244한올바이오파마195한미약품144등,http://www.gokorea.kr/news/articleView.html?idxno=136033
1560,2019-03-29,한미약품3월29일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=630870
1561,2019-03-29,바이오시밀러테마마감시황상승률상위종목제넥신217한올바이오파마210한미약품122등,http://www.gokorea.kr/news/articleView.html?idxno=136153
1562,2019-03-29,한미약품유한양행복제약가격정책변화로신약개발탄력,http://www.businesspost.co.kr/BP?command=article_view&num=120830
1563,2019-03-29,한미약품지난해4분기연결영업이익158억전년비1024↑,http://www.newspim.com/news/view/20190329001235
1564,2019-03-29,실적속보한미약품지난해4Q영업이익158억전년비1024↑,http://www.itooza.com/common/iview.php?no=2019032917270521202
1565,2019-03-29,한미약품3월29일주가전일대비122변동된456000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=631158
1566,2019-04-01,바이오시밀러테마오전시황상승률상위종목셀트리온028한미약품011에이프로젠제약068등,http://www.gokorea.kr/news/articleView.html?idxno=136797
1567,2019-04-01,09시31분바이오시밀러테마주오전시황팜스웰바이오한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=288719
1568,2019-04-01,한미약품탈모위협하는지루성피부염두피치료제두피앤출시,http://www.seoulwire.com/news/articleView.html?idxno=100365
1569,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.fetv.co.kr/news/article.html?no=24663
1570,2019-04-01,한미약품두피자극줄인지루성피부염치료제두피앤출시,http://news1.kr/articles/?3585430
1571,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.dailian.co.kr/news/view/783962/?sc=naver
1572,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.newspim.com/news/view/20190401000285
1573,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.nextdaily.co.kr/news/article.html?id=20190401800015
1574,2019-04-01,한미약품탈모원인등지루성피부염치료제두피앤출시,http://www.medisobizanews.com/news/articleView.html?idxno=58809
1575,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.rapportian.com/news/articleView.html?idxno=116870
1576,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=228919
1577,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,https://www.hankyung.com/article/201904016728f
1578,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=350526
1579,2019-04-01,한미약품민감피부용치료제두피앤출시,http://www.ebn.co.kr/news/view/978921
1580,2019-04-01,한미약품히알루주사1회수조치,http://www.whosaeng.com/109073
1581,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.ceoscoredaily.com/news/article.html?no=53707
1582,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.sisajournal-e.com/news/articleView.html?idxno=197907
1583,2019-04-01,한미약품가렵고민감한피부용치료제두피앤내놔,http://www.wolyo.co.kr/news/articleView.html?idxno=80673
1584,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://medipana.com/news/news_viewer.asp?NewsNum=236826&MainKind=A&NewsKind=5&vCount=12&vKind=1
1585,2019-04-01,한미약품지루성피무염치료제두피앤출시,https://www.sedaily.com/NewsView/1VHP45LDBT
1586,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.kpinews.co.kr/news/articleView.html?idxno=93394
1587,2019-04-01,한미약품4월1일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=632181
1588,2019-04-01,바이오시밀러테마오후시황상승률상위종목팜스웰바이오244한미약품110셀트리온083등,http://www.gokorea.kr/news/articleView.html?idxno=136875
1589,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.asiatime.co.kr/news/articleView.html?idxno=237219
1590,2019-04-01,13시22분바이오시밀러오후의테마종목팜스웰바이오한미약품등이상승세견인중,http://www.nbntv.co.kr/news/articleView.html?idxno=288830
1591,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.pressm.kr/news/articleView.html?idxno=22624
1592,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019040113495649952
1593,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.joseilbo.com/news/news_read.php?uid=373526&class=27&grp=
1594,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.koreaittimes.com/news/articleView.html?idxno=90040
1595,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.newsrep.co.kr/news/articleView.html?idxno=64804
1596,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.smedaily.co.kr/news/articleView.html?idxno=82370
1597,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.opinionnews.co.kr/news/articleView.html?idxno=15476
1598,2019-04-01,한미약품히알루주사1안전성유효성영향전무,http://www.whosaeng.com/109089
1599,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=252128
1600,2019-04-01,한미약품지루성피부염치료제두피앤약국판매,http://www.fnnews.com/news/201904011527093563
1601,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.etnews.com/20190401000447
1602,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019040100208
1603,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.newscj.com/news/articleView.html?idxno=616776
1604,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=51746
1605,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.hg-times.com/news/articleView.html?idxno=199482
1606,2019-04-01,한미약품지루성피부용치료제두피앤출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1740560
1607,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://news.donga.com/3/all/20190401/94838632/1
1608,2019-04-01,한미약품4월1일주가전일대비022변동된457000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=632746
1609,2019-04-01,한미약품지루성피부염치료제두피앤선봬,http://www.100ssd.co.kr/news/articleView.html?idxno=60397
1610,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.cnbnews.com/news/article.html?no=405255
1611,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://news.mk.co.kr/newsRead.php?year=2019&no=197741
1612,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.newspost.kr/news/articleView.html?idxno=70186
1613,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.getnews.co.kr/view.php?ud=2019040118352772541d0c69529_16
1614,2019-04-01,제약토크가렵고민감한피부용치료제한미약품두피앤,https://www.insight.co.kr/news/220024
1615,2019-04-01,뉴스투데이L한미약품지루성피부염치료제두피앤출시,http://www.news2day.co.kr/123971
1616,2019-04-01,한미약품지루성피부염치료제두피앤출시,http://www.nspna.com/news/?mode=view&newsid=349544
1617,2019-04-01,한미약품가렵고민감한피부용치료제두피앤출시,http://www.lawissue.co.kr/view.php?ud=201904012028225121d7f4c63cc6_12
1618,2019-04-01,한미약품한독JW중외제약등제약바이오기업약30개참가바이오잡페어개최,http://medicalworldnews.co.kr/news/view.php?idx=1510930075
1619,2019-04-02,제약사들RD투자증가‥한미약품비율금액모두최다,http://medipana.com/news/news_viewer.asp?NewsNum=236868&MainKind=A&NewsKind=5&vCount=12&vKind=1
1620,2019-04-02,일간보사창간특집한미약품RD힘중심엔아모잘탄,http://www.bosa.co.kr/news/articleView.html?idxno=2102482
1621,2019-04-02,삼성바이오로직스셀트리온한미약품등제약바이오주상승세,http://www.seoulwire.com/news/articleView.html?idxno=101168
1622,2019-04-02,한미약품두피지루성피부염치료제두피앤출시,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH190401001
1623,2019-04-02,한미약품4월2일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=633312
1624,2019-04-02,한미약품목앤심한미세먼지탓에찾는고객늘어,http://www.enewstoday.co.kr/news/articleView.html?idxno=1287240
1625,2019-04-02,약사가꼽은굿브랜드인후염에한미약품목앤,http://www.koreaittimes.com/news/articleView.html?idxno=90072
1626,2019-04-02,약사가꼽은No1인후염외용제한미약품목앤,http://www.inthenews.co.kr/news/article.html?no=14468
1627,2019-04-02,한미약품인후염치료제목앤황사미세먼지에효과,http://view.asiae.co.kr/news/view.htm?idxno=2019040216343520987
1628,2019-04-02,한미약품4월2일주가전일대비109변동된462000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=633804
1629,2019-04-02,한미약품지루성피부염치료제두피앤출시,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3797567
1630,2019-04-03,제약한미약품프로캄슬리미S팻다운체지방줄여주고장내환경개선도와줘,http://news.mk.co.kr/newsRead.php?year=2019&no=201341
1631,2019-04-03,한미약품가렵고민감한피부용치료제두피앤출시,http://www.straightnews.co.kr/news/articleView.html?idxno=46248
1632,2019-04-03,한미약품4월3일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=634452
1633,2019-04-03,RD선도한미약품10년중심아모잘탄,http://www.doctorsnews.co.kr/news/articleView.html?idxno=128499
1634,2019-04-03,4월3일한미약품배당주식022463000원,http://www.nbntv.co.kr/news/articleView.html?idxno=292060
1635,2019-04-03,대한민국100대CEO임성기한미약품회장신약파이프라인탄탄토종기업자존심,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=203462
1636,2019-04-04,한미약품주가4월4일현재459000원,http://www.gokorea.kr/news/articleView.html?idxno=141515
1637,2019-04-04,주식그래프한미약품주가4일현재461500원,http://www.nbntv.co.kr/news/articleView.html?idxno=293852
1638,2019-04-04,한미약품4월4일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=635246
1639,2019-04-04,ET투자뉴스한미약품_외국인개인순매수기관은순매도한달누적,http://www.etnews.com/20190404000315
1640,2019-04-04,한미약품4월4일주가전일대비108변동된460000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=635705
1641,2019-04-05,상위5개제약사작년RD에7천억투자한미약품압도적1위,http://www.rapportian.com/news/articleView.html?idxno=116947
1642,2019-04-05,ET투자뉴스한미약품_외국인개인순매수기관은순매도한달누적,http://www.etnews.com/20190405000070
1643,2019-04-05,한미약품윤리경영도업계선도전사적CP실천다짐,http://medipana.com/news/news_viewer.asp?NewsNum=237077&MainKind=A&NewsKind=5&vCount=12&vKind=1
1644,2019-04-05,10대제약사연구개발비한미약품매출액의19vs광동제약11,http://www.wsobi.com/news/articleView.html?idxno=71675
1645,2019-04-05,4월5일한미약품실시간주식현황451500원185,http://www.nbntv.co.kr/news/articleView.html?idxno=296312
1646,2019-04-05,한미약품1일자율준수의날기념CP실천서약행사,http://www.dailypharm.com/Users/News/NewsView.html?ID=251248&REFERER=NP
1647,2019-04-05,단독한미약품中진출위한폐암신약물질첫임상돌입,http://news1.kr/articles/?3589851
1648,2019-04-05,주간신상태그설화수연작피죤LF한미약품제주신라호텔외,http://www.newsprime.co.kr/news/article.html?no=453902
1649,2019-04-05,한미약품4월5일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=636208
1650,2019-04-05,2019기업분석제약매출1조달성한한미약품현금돌기시작했다,http://www.sisajournal-e.com/news/articleView.html?idxno=198220
1651,2019-04-05,한미약품4월5일주가전일대비239변동된449000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=636498
1652,2019-04-08,한미약품우아한형제들채용설명회,http://www.gukjenews.com/news/articleView.html?idxno=1097459
1653,2019-04-08,한미약품우아한형제들채용설명회개최,http://view.asiae.co.kr/news/view.htm?idxno=2019040807081955794
1654,2019-04-08,한미약품항암신약오락솔개발10년만에결실가시화,http://www.medisobizanews.com/news/articleView.html?idxno=58951
1655,2019-04-08,한미약품RD모멘텀다수보유매수NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1742499
1656,2019-04-08,I리포트한미약품연구개발비증가로컨센하회예상–NH證,http://www.inews24.com/view/1169696
1657,2019-04-08,한미약품목표가58만원유지전일종가44만9000원NH證,http://www.newspim.com/news/view/20190408000060
1658,2019-04-08,NH투자證한미약품연구개발비증가로1분기실적전망밑돌것,http://www.newsis.com/view/?id=NISX20190408_0000612797&cID=10401&pID=10400
1659,2019-04-08,퀵리포트한미약품매수유지목표가58만원유지NH證,http://www.itooza.com/common/iview.php?no=2019040808093611449
1660,2019-04-08,한미약품RD비용증가에14분기실적시장예상치밑돌것NH,http://www.fnnews.com/news/201904080812056127
1661,2019-04-08,NH투자증권한미약품RD비용증가에1분기컨센서스하회예상”,http://www.newsway.co.kr/news/view?tp=1&ud=2019040808211183872
1662,2019-04-08,한미약품RD비용에1Q실적부진성장잠재력은여전NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01613766622454152
1663,2019-04-08,NH투자한미약품연구개발비로1분기실적부진,http://yna.kr/AKR20190408022800008?did=1195m
1664,2019-04-08,한미약품연구개발비증가로1분기실적부진”NH,http://www.mdtoday.co.kr/mdtoday/index.html?no=351180
1665,2019-04-08,송파구한미약품우아한형제들채용설명회,http://news.heraldcorp.com/view.php?ud=20190408000114
1666,2019-04-08,한미약품연구개발비증가로1분기실적부진,http://www.smedaily.co.kr/news/articleView.html?idxno=82508
1667,2019-04-08,바이오시밀러테마오전시황상승률상위종목셀트리온052한미약품033제넥신025등,http://www.gokorea.kr/news/articleView.html?idxno=145653
1668,2019-04-08,게시판서울송파구청서한미약품우아한형제들채용설명회,http://yna.kr/AKR20190408034100004?did=1195m
1669,2019-04-08,한미약품임직원백혈병환우돕기위해39년째사랑의헌혈참여,http://www.seoulwire.com/news/articleView.html?idxno=104804
1670,2019-04-08,8000명육박한한미약품임직원들의사랑의헌혈나눔,http://www.newsway.co.kr/news/view?tp=1&ud=2019040810114613862
1671,2019-04-08,한미약품사랑의헌혈캠페인39년간임직원8000여명참여,http://view.asiae.co.kr/news/view.htm?idxno=2019040810163475963
1672,2019-04-08,8000명육박한한미약품임직원들의사랑의헌혈나눔,http://www.fetv.co.kr/news/article.html?no=25287
1673,2019-04-08,40여년간진행된한미약품의사랑의헌혈캠페인헌혈임직원8000명고지임박”,https://www.sedaily.com/NewsView/1VHSAFM445
1674,2019-04-08,한미약품임직원사랑의헌혈나눔8000명육박,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229162
1675,2019-04-08,한미약품목표가13↑57만원제시이베스트證,http://www.newspim.com/news/view/20190408000299
1676,2019-04-08,퀵리포트한미약품매수유지목표가13↑57만원이베스트證,http://www.itooza.com/common/iview.php?no=2019040810235616422
1677,2019-04-08,한미약품사랑의헌혈나눔캠페인임직원8000명육박,http://www.wolyo.co.kr/news/articleView.html?idxno=81192
1678,2019-04-08,39년동안헌혈캠페인참가한한미약품임직원8000명육박,http://news.mk.co.kr/newsRead.php?year=2019&no=213578
1679,2019-04-08,한미약품임직원들39년간8000여명헌혈참여,http://www.mhj21.com/120620
1680,2019-04-08,한미약품사랑의헌혈참가임직원8천명에육박,http://www.koreaittimes.com/news/articleView.html?idxno=90172
1681,2019-04-08,한미약품임직원들사랑의헌혈나눔‥누적참여7937명,http://medipana.com/news/news_viewer.asp?NewsNum=237158&MainKind=A&NewsKind=5&vCount=12&vKind=1
1682,2019-04-08,한미약품사랑의헌혈나눔행사임직원8000명육박,http://www.nextdaily.co.kr/news/article.html?id=20190408800017
1683,2019-04-08,GET투자리포트한미약품투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201904081030303577tpgetnews_16
1684,2019-04-08,한미약품의사랑의헌혈39년째임직원8000명육박,http://www.100ssd.co.kr/news/articleView.html?idxno=60568
1685,2019-04-08,한미약품사랑의헌혈참여임직원8000명육박,http://www.econovill.com/news/articleView.html?idxno=360434
1686,2019-04-08,사회공헌한미약품사랑의헌혈캠페인임직원누적8000명육박,http://www.ezyeconomy.com/news/articleView.html?idxno=89635
1687,2019-04-08,한미약품39년재사랑의헌혈캠페인진행,http://www.rapportian.com/news/articleView.html?idxno=116985
1688,2019-04-08,한미약품39년간8000명육박한임직원들의사랑의헌혈나눔,http://www.fnnews.com/news/201904081100483530
1689,2019-04-08,8000명육박한한미약품임직원들의사랑의헌혈나눔,http://www.pressm.kr/news/articleView.html?idxno=22735
1690,2019-04-08,대한민국이좋다한미약품임직원사랑의헌혈나눔,http://www.m-i.kr/news/articleView.html?idxno=511335
1691,2019-04-08,한미약품임직원들의헌혈사랑39년째누적인원수8천명,http://www.medisobizanews.com/news/articleView.html?idxno=58971
1692,2019-04-08,ET투자뉴스한미약품연구개발비증가로BUY유지NH투자증권,http://www.etnews.com/20190408000214
1693,2019-04-08,지금구청은송파구한미약품등채용설명회,http://news.heraldcorp.com/view.php?ud=20190408000439
1694,2019-04-08,8000명육박한한미약품임직원들의사랑의헌혈나눔,http://www.bosa.co.kr/news/articleView.html?idxno=2102878
1695,2019-04-08,4월8일한미약품주식추천주445500원078,http://www.nbntv.co.kr/news/articleView.html?idxno=299165
1696,2019-04-08,한미약품사랑의헌혈참여임직원8000명육박,http://www.etoday.co.kr/news/section/newsview.php?idxno=1742674
1697,2019-04-08,한미약품39년째사랑의헌혈나눔펼쳐,http://www.bokuennews.com/news/article.html?no=174015
1698,2019-04-08,한미약품4월8일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=637503
1699,2019-04-08,한미약품임직원사랑의헌혈8000명육박,http://www.sisajournal-e.com/news/articleView.html?idxno=198296
1700,2019-04-08,한미약품임직원사랑의헌혈8000명육박헌혈증소외계층에기부,http://news.donga.com/3/all/20190408/94947829/1
1701,2019-04-08,한미약품헌혈캠페인참여임직원8000명육박,http://moneys.mt.co.kr/news/mwView.php?no=2019040814218028775
1702,2019-04-08,한미약품임직원들의사랑의헌혈나눔39년간8000명육박,http://www.mdtoday.co.kr/mdtoday/index.html?no=351236
1703,2019-04-08,한미약품8000여명임직원들의사랑의헌혈나눔실천,http://www.getnews.co.kr/view.php?ud=20190408143130861841d0c69529_16
1704,2019-04-08,한미약품헌혈39년째누적인원8000명달해,http://www.whosaeng.com/109264
1705,2019-04-08,39년째진행중인사랑의헌혈한미약품헌혈증은소외계층기부,http://kpenews.com/View.aspx?No=31010
1706,2019-04-08,한미약품목표주가상향의약품판매호조에연구개발도순항,http://www.businesspost.co.kr/BP?command=article_view&num=122113
1707,2019-04-08,NH투자증권한미약품연구개발비증가로1분기실적시장예상치밑돌전망,http://www.econonews.co.kr/news/articleView.html?idxno=60534
1708,2019-04-08,한미약품39년간8000명임직원사랑의헌혈에동참,http://www.metroseoul.co.kr/news/newsview?newscd=2019040800154
1709,2019-04-08,8000명육박한한미약품임직원들의사랑의헌혈나눔,http://www.ekn.kr/news/article.html?no=425279
1710,2019-04-08,한미약품헌혈임직원수8000명육박,http://www.newsis.com/view/?id=NISX20190408_0000613594&cID=13001&pID=13000
1711,2019-04-08,한미약품임직원사랑의헌혈캠페인진행,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH190408004
1712,2019-04-08,한미약품8000명임직원사랑의헌혈나눔,http://www.smedaily.co.kr/news/articleView.html?idxno=82529
1713,2019-04-08,한미약품39년째진행8000명육박사랑의헌혈나눔,http://www.nbnnews.co.kr/news/articleView.html?idxno=254624
1714,2019-04-08,한미약품사랑의헌혈나눔임직원8000명육박,http://www.newscj.com/news/articleView.html?idxno=619225
1715,2019-04-08,한미약품사랑의헌혈참여한임직원6000명육박,http://www.dailian.co.kr/news/view/786101/?sc=naver
1716,2019-04-08,한미약품39년간임직원8000명사랑의헌혈,http://www.fnnews.com/news/201904081657429759
1717,2019-04-08,한미약품헌혈캠페인참여임직원8000명육박,http://www.newsprime.co.kr/news/article.html?no=454180
1718,2019-04-08,뉴스투데이L한미약품8000명헌혈로백혈병환자에게사랑나눔,http://www.news2day.co.kr/124488
1719,2019-04-08,한미약품임직원사랑의헌혈캠페인8천명육박했다,https://www.insight.co.kr/news/221358
1720,2019-04-08,한미약품4월8일주가전일대비145변동된442500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=637953
1721,2019-04-08,한미약품임직원들사랑의헌혈나눔8000여명육박,http://www.vop.co.kr/A00001396120.html
1722,2019-04-08,한미약품39년동안지속된사랑나눔,http://www.k-health.com/news/articleView.html?idxno=43374
1723,2019-04-08,한미약품헌혈참가임직원8000여명육박,http://www.cnbnews.com/news/article.html?no=406092
1724,2019-04-08,한미약품39년째이어오는사랑의헌혈캠페인,http://www.kpinews.co.kr/news/articleView.html?idxno=93836
1725,2019-04-08,한미약품임직원사랑의헌혈8000명눈앞,http://daily.hankooki.com/lpage/ittech/201904/dh20190408184921145630.htm
1726,2019-04-08,한미약품사랑의헌혈참여임직원수8천명달해,http://www.techholic.co.kr/news/articleView.html?idxno=181587
1727,2019-04-08,한미약품임직원들의사랑의헌혈나눔8000명육박,http://www.nspna.com/news/?mode=view&newsid=351217
1728,2019-04-09,송파구한미약품우아한형제들채용설명회개최4월17일송파구청4층대강당,http://weeklytrade.co.kr/news/view.html?section=1&category=160&item=&no=51280
1729,2019-04-09,8000명육박한한미약품임직원들의사랑의헌혈나눔,http://www.gukjenews.com/news/articleView.html?idxno=1098193
1730,2019-04-09,한미약품목표가50만원유지전일종가44만2500원하이투자證,http://www.newspim.com/news/view/20190409000088
1731,2019-04-09,퀵리포트한미약품매수유지목표가50만원유지하이투자證,http://www.itooza.com/common/iview.php?no=2019040908150929037
1732,2019-04-09,I리포트한미약품풍부한RD호재하이證,http://www.inews24.com/view/1170061
1733,2019-04-09,한미약품커져가는RD모멘텀비용부담,http://www.asiatoday.co.kr/view.php?key=20190409010005854
1734,2019-04-09,하이證한미약품비용부담으로1분기역성장,http://www.newsis.com/view/?id=NISX20190409_0000614233&cID=10401&pID=10400
1735,2019-04-09,GET투자리포트한미약품투자의견매수유지하이투자증권,http://www.getnews.co.kr/view.php?ud=201904091030303605tpgetnews_16
1736,2019-04-09,ET투자뉴스한미약품커져가는RD모BUY유지하이투자증권,http://www.etnews.com/20190409000028
1737,2019-04-09,한미약품영업이익역성장에도풍부한RD모멘텀하이투자증권,http://www.ekn.kr/news/article.html?no=425366
1738,2019-04-09,4월9일한미약품시세보기445000원056,http://www.nbntv.co.kr/news/articleView.html?idxno=301522
1739,2019-04-09,4월9일한미약품증권투자정보및매매동향,http://www.gokorea.kr/news/articleView.html?idxno=147931
1740,2019-04-09,한미약품4월9일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=638526
1741,2019-04-09,특징주한미약품연구비증가로1분기역성장했지만추후영업이익상승전망,http://www.sisaon.co.kr/news/articleView.html?idxno=91663
1742,2019-04-09,하이투자증권한미약품1분기역성장기조목표가50만원,https://www.insight.co.kr/news/221549
1743,2019-04-09,한미약품4월9일주가전일대비034변동된441000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=638972
1744,2019-04-09,하이투자증권한미약품비용부담으로1분기역성장,http://www.econonews.co.kr/news/articleView.html?idxno=60730
1745,2019-04-10,한미약품리렉스펜정등성상변경확인하세요,http://www.kpanews.co.kr/article/show.asp?idx=202955&table=article&category=B
1746,2019-04-10,8000명육박한한미약품임직원들의사랑의헌혈나눔,http://www.straightnews.co.kr/news/articleView.html?idxno=46686
1747,2019-04-10,4월10일한미약품증권주식442000원023,http://www.nbntv.co.kr/news/articleView.html?idxno=303898
1748,2019-04-10,한미약품그룹계열사제이브이엠주주들과소통강화기업설명회참가,http://www.ekn.kr/news/article.html?no=425643
1749,2019-04-10,한미약품그룹계열사제이브이엠주주들과소통강화기업설명회참가,http://www.pressm.kr/news/articleView.html?idxno=22772
1750,2019-04-10,한미약품4월10일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=639642
1751,2019-04-10,한미약품4월10일주가전일대비034변동된442500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=640101
1752,2019-04-10,한미약품JVM주주들과소통강화기업설명회참가,http://www.getnews.co.kr/view.php?ud=20190410175010614341d0c69529_16
1753,2019-04-10,한미약품제이브이엠주주들과소통강화기업설명회열어,http://www.wikileaks-kr.org/news/articleView.html?idxno=52596
1754,2019-04-10,한미약품계열사JVM주주들과소통강화글로벌성과창출에역량집중,http://www.thebigdata.co.kr/view.php?ud=201904101758431602d0a8833aad_23
1755,2019-04-10,한미약품JVM글로벌비즈니스성과창출에모든역량집중,http://www.businesskorea.co.kr/news/articleView.html?idxno=30778
1756,2019-04-11,바이오시밀러테마오전시황상승률상위종목셀트리온122한미약품068에이프로젠제약020등,http://www.gokorea.kr/news/articleView.html?idxno=151709
1757,2019-04-11,09시32분바이오시밀러테마주시황오전셀트리온한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=305743
1758,2019-04-11,4월11일한미약품주식현황079446000원,http://www.nbntv.co.kr/news/articleView.html?idxno=306347
1759,2019-04-11,한미약품한미젊은의학자학술상에신현영교수선정,http://www.ebn.co.kr/news/view/980421
1760,2019-04-11,한미약품한국여자의사회공동제정13일서울코리아나호텔서시상식,http://www.pressm.kr/news/articleView.html?idxno=22792
1761,2019-04-11,한미약품한국여자의사회한미젊은의학자학술상에신현영교수선정,http://www.wolyo.co.kr/news/articleView.html?idxno=81556
1762,2019-04-11,한미약품제1회한미젊은의학자학술상에신현영교수선정,http://www.newsprime.co.kr/news/article.html?no=454716
1763,2019-04-11,한미약품첫번째한미젊은의학자학술상에신현영교수선정,http://www.ezyeconomy.com/news/articleView.html?idxno=89753
1764,2019-04-11,바이오시밀러테마오후시황상승률상위종목이수앱지스253셀트리온170한미약품034등,http://www.gokorea.kr/news/articleView.html?idxno=152400
1765,2019-04-11,한미약품4월11일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=640755
1766,2019-04-11,한미약품제1회한미젊은의학자학술상에신현영교수선정,http://www.ekn.kr/news/article.html?no=425947
1767,2019-04-11,한미젊은의학자학술상한미약품한국여자의사회공동제정,http://www.100ssd.co.kr/news/articleView.html?idxno=60616
1768,2019-04-11,한미약품젊은의학자학술상에신현영명지병원교수선정,http://www.seoulfn.com/news/articleView.html?idxno=339549
1769,2019-04-11,한미약품4월11일주가전일대비011변동된443000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=641291
1770,2019-04-11,한미약품한국여자의사회공동제정한미젊은의학자학술상에신현영교수선정,http://www.lawissue.co.kr/view.php?ud=201904112325137948d7f4c63cc6_12
1771,2019-04-12,한미약품제1회한미젊은의학자학술상에신현영교수선정,http://www.wikileaks-kr.org/news/articleView.html?idxno=52735
1772,2019-04-12,한미약품첫번째한미젊은의학자학술상에신현영교수,http://www.gukjenews.com/news/articleView.html?idxno=1100406
1773,2019-04-12,바이오시밀러테마오전시황상승률상위종목이수앱지스468팜스웰바이오133한미약품034등,http://www.gokorea.kr/news/articleView.html?idxno=153725
1774,2019-04-12,한미약품지속가능경영위한환경∙보건∙안전委신설,http://medipana.com/news/news_viewer.asp?NewsNum=237428&MainKind=A&NewsKind=5&vCount=12&vKind=1
1775,2019-04-12,4월12일한미약품증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=154046
1776,2019-04-12,4월12일한미약품오늘증권시세444500원034,http://www.nbntv.co.kr/news/articleView.html?idxno=308809
1777,2019-04-12,바이오시밀러테마오후시황상승률상위종목이수앱지스559팜스웰바이오109한미약품045등,http://www.gokorea.kr/news/articleView.html?idxno=154472
1778,2019-04-12,한미약품4월12일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=641833
1779,2019-04-12,바이오시밀러테마마감시황상승률상위종목이수앱지스457팜스웰바이오145한미약품011등,http://www.gokorea.kr/news/articleView.html?idxno=154714
1780,2019-04-12,RD톱2셀트리온한미약품광동제약꼴찌,http://www.kpinews.co.kr/news/articleView.html?idxno=94132
1781,2019-04-12,한미약품4월12일주가전일대비011변동된443500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=642111
1782,2019-04-14,제약산업소식한미약품사랑의헌혈실시外,http://www.kukinews.com/news/article.html?no=652223
1783,2019-04-15,한미약품1분기실적기대치낮춰야목표가하향키움,http://news.mt.co.kr/mtview.php?no=2019041507532177443
1784,2019-04-15,한미약품RD투자증가실적기대치낮춰야목표가투자의견↓키움,http://www.edaily.co.kr/news/newspath.asp?newsid=01390726622456448
1785,2019-04-15,키움증권한미약품올해RD증가로역성장목표가하향조정”,http://www.newsway.co.kr/news/view?tp=1&ud=2019041508164344818
1786,2019-04-15,HotLine한미약품실적기대치낮춰야투자의견목표가↓,http://news.mk.co.kr/newsRead.php?year=2019&no=230082
1787,2019-04-15,한미약품1분기실적기대치하회할듯목표주가↓키움,http://www.ekn.kr/news/article.html?no=426482
1788,2019-04-15,한미약품목표가13↓44만원제시키움證,http://www.newspim.com/news/view/20190415000151
1789,2019-04-15,GET투자리포트한미약품투자의견매수유지키움증권,http://www.getnews.co.kr/view.php?ud=201904151030303833tpgetnews_16
1790,2019-04-15,한미약품목표가68만원유지전일종가44만3500원미래에셋대우,http://www.newspim.com/news/view/20190415000186
1791,2019-04-15,ET투자뉴스한미약품RD투자기로실BUY유지키움증권,http://www.etnews.com/20190415000012
1792,2019-04-15,퀵리포트한미약품Marketperform으로하향목표가13↓44만원키움證,http://www.itooza.com/common/iview.php?no=2019041508413518574
1793,2019-04-15,한미약품올1분기실적소폭하회목표가하향,http://www.asiatoday.co.kr/view.php?key=20190415010009568
1794,2019-04-15,퀵리포트한미약품매수유지목표가68만원유지미래에셋대우,http://www.itooza.com/common/iview.php?no=2019041508490915505
1795,2019-04-15,한미약품목표가53만원유지전일종가44만3500원삼성證,http://www.newspim.com/news/view/20190415000230
1796,2019-04-15,퀵리포트한미약품매수유지목표가53만원유지삼성證,http://www.itooza.com/common/iview.php?no=2019041509525613421
1797,2019-04-15,한미약품첫번째한미젊은의학자학술상에신현영교수선정,http://www.straightnews.co.kr/news/articleView.html?idxno=46949
1798,2019-04-15,GET투자리포트한미약품투자의견매수유지미래에셋대우,http://www.getnews.co.kr/view.php?ud=201904151030303900tpgetnews_16
1799,2019-04-15,ET투자뉴스한미약품신약개발능력BUY유지미래에셋대우,http://www.etnews.com/20190415000109
1800,2019-04-15,4월15일한미약품증권투자정보및주식시황,http://www.gokorea.kr/news/articleView.html?idxno=156257
1801,2019-04-15,주식현황한미약품주가15일현재431500원,http://www.nbntv.co.kr/news/articleView.html?idxno=311550
1802,2019-04-15,한미약품4월15일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=643182
1803,2019-04-15,한미약품연구개발비늘어올해영업이익급감불가피,http://www.businesspost.co.kr/BP?command=article_view&num=123212
1804,2019-04-15,활력넘치는봄나기한미약품나인나인,https://www.sedaily.com/NewsView/1VHVJPQNG4
1805,2019-04-15,한미약품4월15일주가전일대비282변동된431000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=643671
1806,2019-04-16,바이오시밀러테마오전시황상승률상위종목한미약품046제넥신037이수앱지스063등,http://www.gokorea.kr/news/articleView.html?idxno=158029
1807,2019-04-16,한미약품주가및증권시세16일현재431500원,http://www.gokorea.kr/news/articleView.html?idxno=158321
1808,2019-04-16,주식시세현황한미약품주가16일현재431000원,http://www.nbntv.co.kr/news/articleView.html?idxno=313995
1809,2019-04-16,한미약품4월16일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=644282
1810,2019-04-16,한미약품4월16일주가전일대비023변동된432000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=644778
1811,2019-04-17,GET투자리포트한미약품투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201904171030304005tpgetnews_16
1812,2019-04-17,ET투자뉴스한미약품보톡스콜레라백BUY유지NH투자증권,http://www.etnews.com/20190417000051
1813,2019-04-17,4월17일한미약품투자주식035430500원,http://www.nbntv.co.kr/news/articleView.html?idxno=316339
1814,2019-04-17,한미약품4월17일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=645382
1815,2019-04-17,한미약품기술수출비만치료제하반기임상2상결과기대감UP,http://biz.newdaily.co.kr/site/data/html/2019/04/17/2019041700172.html
1816,2019-04-17,바이오시밀러테마마감시황상승률상위종목에이프로젠제약042셀트리온024한미약품035등,http://www.gokorea.kr/news/articleView.html?idxno=161036
1817,2019-04-17,한미약품4월17일주가전일대비035변동된430500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=645883
1818,2019-04-18,바이오시밀러테마오전시황상승률상위종목팜스웰바이오135한미약품035에이프로젠제약063등,http://www.gokorea.kr/news/articleView.html?idxno=162134
1819,2019-04-18,한미약품주가증권투자정보및주체별매매동향18일현재428000원,http://www.gokorea.kr/news/articleView.html?idxno=162279
1820,2019-04-18,ET투자뉴스한미약품_투심보통거래량침체현재주가는약세,http://www.etnews.com/20190418000131
1821,2019-04-18,4월18일한미약품주식현황425000원128,http://www.nbntv.co.kr/news/articleView.html?idxno=318685
1822,2019-04-18,3월원외처방1위한미약품종근당〉대웅제약順,http://www.dailymedi.com/detail.php?number=842161&thread=22r05
1823,2019-04-18,한미약품4월18일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=646491
1824,2019-04-18,바이오시밀러테마오후시황상승률상위종목에이프로젠제약401팜스웰바이오074한미약품151등,http://www.gokorea.kr/news/articleView.html?idxno=162664
1825,2019-04-18,바이오시밀러테마마감시황상승률상위종목에이프로젠제약084팜스웰바이오025한미약품128등,http://www.gokorea.kr/news/articleView.html?idxno=162740
1826,2019-04-18,한미약품4월18일주가전일대비128변동된425000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=646974
1827,2019-04-19,제약바이오오너배당킹은임성기한미약품회장10억이상수령13명,http://www.etoday.co.kr/news/section/newsview.php?idxno=1746665
1828,2019-04-19,한미약품원외처방1위질주대웅바이오껑충,http://www.dailypharm.com/Users/News/NewsView.html?ID=251760&REFERER=NP
1829,2019-04-19,한미약품JVM전자동의약품분류포장시스템러시아진출,http://www.ebn.co.kr/news/view/981497
1830,2019-04-19,한미약품전자동의약품분류∙포장시스템러시아진출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=229633
1831,2019-04-19,한미약품계열사제이브이엠러에의약품포장시스템공급계약,https://www.sedaily.com/NewsView/1VHXC8AWN0
1832,2019-04-19,한미약품계열JVM의의약품분류포장기러시아진출,http://news.heraldcorp.com/view.php?ud=20190419000145
1833,2019-04-19,한미약품이해외영업맡은JVM전자동의약품분류포장시스템러시아진출,http://www.medisobizanews.com/news/articleView.html?idxno=59201
1834,2019-04-19,한미약품JVM전자동의약품분류포장시스템러시아진출,http://www.opinionnews.co.kr/news/articleView.html?idxno=16485
1835,2019-04-19,한미약품러시아에JVM전자동의약품분류포장시스템공급계약,http://www.newsprime.co.kr/news/article.html?no=456060
1836,2019-04-19,한미약품계열JVM전자동의약품분류포장시스템러진출,http://view.asiae.co.kr/news/view.htm?idxno=2019041910101767831
1837,2019-04-19,한미약품제이브이엠러시아에의약품분류포장시스템ATDPS수출,http://news.mk.co.kr/newsRead.php?year=2019&no=243728
1838,2019-04-19,한미약품JVM전자동의약품분류포장시스템러시아진출,http://www.wolyo.co.kr/news/articleView.html?idxno=82184
1839,2019-04-19,한미약품계열사JVM의전자동의약품분류포장시스템러시아진출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1746936
1840,2019-04-19,한미약품계열JVM전자동의약품분류포장시스템러시아진출,http://www.pressm.kr/news/articleView.html?idxno=22910
1841,2019-04-19,한미약품JVM전자동의약품분류포장시스템러시아진출,http://www.beyondpost.co.kr/view.php?ud=2019041910404861226cf2d9003a_30
1842,2019-04-19,한미약품그룹JVM전자동의약품분류포장시스템러시아진출,http://www.ceoscoredaily.com/news/article.html?no=54542
1843,2019-04-19,한미약품JVM의약포장시스템ATDPS러시아진출,http://www.mhj21.com/120884
1844,2019-04-19,한미약품제이브이엠러시아에전자동의약품분류포장시스템수출,http://www.newspim.com/news/view/20190419000228
1845,2019-04-19,한미약품계열사JVM의전자동의약품분류포장시스템러시아에수출,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201904190229&t=NN
1846,2019-04-19,한미약품계열사JVM전자동의약품분류포장시스템러시아진출,http://www.ezyeconomy.com/news/articleView.html?idxno=89999
1847,2019-04-19,한미약품그룹JVM의약품분류포장시스템러시아진출,http://www.dailysmart.co.kr/news/articleView.html?idxno=9502
1848,2019-04-19,한미약품의약품포장기기러시아진출,http://news.mk.co.kr/newsRead.php?year=2019&no=244063
1849,2019-04-19,한미약품그룹JVM전자동의약품분류포장시스템러시아진출,http://sports.hankooki.com/lpage/economy/201904/sp20190419114607137020.htm
1850,2019-04-19,한미약품그룹계열사JVM의약품분류포장시스템러시아진출,http://www.metroseoul.co.kr/news/newsview?newscd=2019041900032
1851,2019-04-19,한미약품계열사JVM전자동의약품분류시스템러시아수출,http://news1.kr/articles/?3601451
1852,2019-04-19,바이오시밀러테마오후시황상승률상위종목셀트리온295팜스웰바이오159한미약품153등,http://www.gokorea.kr/news/articleView.html?idxno=163492
1853,2019-04-19,한미약품4월19일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=647513
1854,2019-04-19,19일13시바이오시밀러오후의테마종목셀트리온한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=321891
1855,2019-04-19,한미약품과JVM의약품포장기로러시아공략현지업체OMB와ATPDS공급계약,http://kpenews.com/View.aspx?No=31743
1856,2019-04-19,안산시꿈빛학교한미약품화정천환경정화활동,http://www.anewsa.com/detail.php?number=1694034&thread=09r02
1857,2019-04-19,한미약품러시아병원에의약품자동화시스템설치,http://www.businesspost.co.kr/BP?command=article_view&num=123940
1858,2019-04-19,바이오시밀러테마마감시황상승률상위종목셀트리온713한올바이오파마140한미약품118등,http://www.gokorea.kr/news/articleView.html?idxno=163691
1859,2019-04-19,한미약품그룹계열사제이브이엠전자동의약품분류포장시스템러시아진출,http://www.ekn.kr/news/article.html?no=427520
1860,2019-04-19,한미약품JVM전자동의약품분류포장시스템러시아진출,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH190419003
1861,2019-04-19,한미약품그룹JVM전자동의약품분류포장시스템러시아진출,http://www.joseilbo.com/news/news_read.php?uid=374988&class=17&grp=
1862,2019-04-19,한미약품4월19일주가전일대비118변동된430000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=647800
1863,2019-04-19,한미약품JVM의약품자동포장시스템러시아판매,http://news.donga.com/3/all/20190419/95135871/1
1864,2019-04-19,한미약품JVM전자동의약품분류포장시스템러시아진출,http://www.businesskorea.co.kr/news/articleView.html?idxno=31096
1865,2019-04-19,한미약품그룹JVM전자동의약품분류포장시스템ATPDS러시아진출,http://www.lawissue.co.kr/view.php?ud=201904192152013695d7f4c63cc6_12
1866,2019-04-20,JOB리포트LG전자한미약품도참여하는청년장병취업플랜총정리,http://www.news2day.co.kr/125329
1867,2019-04-21,한미약품JVM전자동의약품분류포장시스템ATDPS러시아수출,http://www.polinews.co.kr/news/article.html?no=389654
1868,2019-04-22,한미약품JVM전자동의약품분류포장시스템러시아진출,http://www.irobotnews.com/news/articleView.html?idxno=16981
1869,2019-04-22,4월22일한미약품증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=165277
1870,2019-04-22,한미약품4월22일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=648802
1871,2019-04-22,특집한미약품인후염치료제목앤,http://www.metroseoul.co.kr/news/newsview?newscd=2019042200166
1872,2019-04-22,김강민인천성모병원교수대한뇌혈관외과학회한미약품학술상,http://www.medisobizanews.com/news/articleView.html?idxno=59248
1873,2019-04-22,뇌혈관문합술문제해결실마리마련인천성모병원김강민교수한미약품학술상수상,http://www.k-health.com/news/articleView.html?idxno=43584
1874,2019-04-22,가톨릭대학교인천성모병원김강민신경외과교수제32회대한뇌혈관외과학회정기학술대회한미약품학술상수상,http://www.kyeonggi.com/news/articleView.html?idxno=2088244
1875,2019-04-23,4월23일한미약품종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=167149
1876,2019-04-23,한미약품금일증시23일현재431000원,http://www.nbntv.co.kr/news/articleView.html?idxno=326354
1877,2019-04-23,한미약품4월23일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=649814
1878,2019-04-23,한미약품4월23일주가전일대비035변동된430000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=650321
1879,2019-04-24,4월24일한미약품및증권시세외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=169009
1880,2019-04-24,한미약품아모잘탄패밀리로수젯고혈압고지혈증의확고한치료옵션,http://www.medisobizanews.com/news/articleView.html?idxno=59295
1881,2019-04-24,한미약품아모잘탄패밀리로수젯고혈압∙고지혈증의확고한치료옵션,http://www.pressm.kr/news/articleView.html?idxno=22972
1882,2019-04-24,4월24일한미약품증권플러스116425000원,http://www.nbntv.co.kr/news/articleView.html?idxno=328758
1883,2019-04-24,한미약품고혈압고지혈증치료제임상결과학술발표,http://www.joseilbo.com/news/news_read.php?uid=375285&class=27&grp=
1884,2019-04-24,한미약품아모잘탄패밀리로수젯임상소개근거중심마케팅강화,http://www.asiatoday.co.kr/view.php?key=20190424010016506
1885,2019-04-24,한미약품아모잘탄패밀리∙로수젯임상연구소개,http://www.ebn.co.kr/news/view/982099
1886,2019-04-24,한미약품춘계심혈관통합학술대회산학세션서아모잘탄과로수젯논의,http://www.asiatime.co.kr/news/articleView.html?idxno=241798
1887,2019-04-24,한미약품4월24일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=650927
1888,2019-04-24,한미약품아모잘탄패밀리로수젯고혈압고지혈증확고한치료옵션”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1748604
1889,2019-04-24,한미약품아모잘탄패밀리로수젯고혈압고지혈증의확고한치료옵션,http://www.metroseoul.co.kr/news/newsview?newscd=2019042400127
1890,2019-04-24,한미약품팔탄공장찾은정승일차관,http://news1.kr/photos/view/?3614489
1891,2019-04-24,한미약품팔탄공장둘러보는정승일차관,http://news1.kr/photos/view/?3614490
1892,2019-04-24,한미약품팔탄공장현장방문한정승일차관,http://news1.kr/photos/view/?3614496
1893,2019-04-24,정승일차관바이오기업인한미약품팔탄공장현장방문,http://news1.kr/photos/view/?3614499
1894,2019-04-24,정승일차관한미약품팔탄공장방문,http://www.newsis.com/view/?id=NISI20190424_0015123304
1895,2019-04-24,한미약품팔탄공장방문한정승일차관,http://www.newsis.com/view/?id=NISI20190424_0015123306
1896,2019-04-24,한미약품팔탄공장방문한정승일차관,http://www.newsis.com/view/?id=NISI20190424_0015123305
1897,2019-04-24,한미약품심혈관학회서아모잘탄패밀리로수젯임상소개,https://www.hankyung.com/article/2019042489836
1898,2019-04-24,한미약품아모잘탄패밀리로수젯고혈압의확고한치료옵션,http://www.mdtoday.co.kr/mdtoday/index.html?no=352725
1899,2019-04-24,한미약품아모잘탄로수젯치료효과입증,http://www.dailymedi.com/detail.php?number=842370&thread=22r05
1900,2019-04-24,한미약품전문의약품잘나가네심혈관학술대회서아모잘탄패밀리로수젯인정받아,http://kpenews.com/View.aspx?No=32050
1901,2019-04-24,정승일차관한미약품팔탄공장방문,http://www.fnnews.com/news/201904241552363836
1902,2019-04-24,한미약품아모잘탄로수젯고혈압고지혈증필수치료제로자리매김”,http://news.donga.com/3/all/20190424/95206943/1
1903,2019-04-24,한미약품학술대회에서고혈압과고지혈증치료제유용성재확인,http://www.businesspost.co.kr/BP?command=article_view&num=124558
1904,2019-04-24,한미약품4월24일주가전일대비116변동된425000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=651411
1905,2019-04-24,한미약품아모잘탄패밀리로수젯고혈압∙고지혈증치료효과우수,http://www.thebigdata.co.kr/view.php?ud=20190424183755190d0a8833aad_23
1906,2019-04-24,한미약품아모잘탄패밀리∙로수젯심혈관질환치료예방에큰역할할수있다,https://www.insight.co.kr/news/224371
1907,2019-04-25,4월25일한미약품및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=170808
1908,2019-04-25,4월25일한미약품주식실시간035426500원,http://www.nbntv.co.kr/news/articleView.html?idxno=331137
1909,2019-04-25,구강청결봄철감기예방한미약품구강청결제케어가글,http://www.asiatoday.co.kr/view.php?key=20190425010017488
1910,2019-04-25,한미약품케어가글약국에서사랑받는구강철결제,http://www.newsworker.co.kr/news/articleView.html?idxno=29076
1911,2019-04-25,한미약품드링크제에너지골드인기코리아팜어워드굿브랜드대상받아,http://kpenews.com/View.aspx?No=32108
1912,2019-04-25,한미약품4월25일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=651984
1913,2019-04-25,바이오시밀러테마오후시황상승률상위종목에이프로젠제약102한미약품059팜스웰바이오025등,http://www.gokorea.kr/news/articleView.html?idxno=171165
1914,2019-04-25,13시25분바이오시밀러오후의테마종목에이프로젠제약한미약품등이상승세견인중,http://www.nbntv.co.kr/news/articleView.html?idxno=331937
1915,2019-04-25,한미약품목앤약사가뽑은1등인후염치료제,http://www.newspost.kr/news/articleView.html?idxno=70876
1916,2019-04-25,한미약품에너지골드약사들이뽑은최고의자양강장제,http://daily.hankooki.com/lpage/ittech/201904/dh20190425140204145630.htm
1917,2019-04-25,한미약품임직원들사랑의헌혈나눔8000명육박,http://www.wolyo.co.kr/news/articleView.html?idxno=82658
1918,2019-04-25,한미약품황사미세먼지많아지자목앤마케팅나서,http://www.dailypop.kr/news/articleView.html?idxno=38876
1919,2019-04-25,한미약품주가4월25일현재426500원및오늘거래가는,http://www.cctvnews.co.kr/news/articleView.html?idxno=114460
1920,2019-04-25,한미약품케어가글구강위생부문대상,http://www.econovill.com/news/articleView.html?idxno=361727
1921,2019-04-25,한미약품자체기술결정체아모잘탄으로국내넘어세계를향해,http://www.k-health.com/news/articleView.html?idxno=43649
1922,2019-04-25,한미약품황금알낳는RD투자고혈압복합제아모잘탄우뚝,http://news1.kr/articles/?3606510
1923,2019-04-25,한미약품케어가글코리아팜어워드대상선정,http://www.sisaon.co.kr/news/articleView.html?idxno=92652
1924,2019-04-25,바이오시밀러테마종목종가한미약품에이프로젠제약등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=332457
1925,2019-04-25,바이오시밀러테마마감시황상승률상위종목한미약품047에이프로젠제약102팜스웰바이오110등,http://www.gokorea.kr/news/articleView.html?idxno=171336
1926,2019-04-25,한미약품4월25일주가전일대비047변동된427000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=652517
1927,2019-04-26,개량신약의힘작년원외처방매출1위차지한한미약품,http://www.rapportian.com/news/articleView.html?idxno=117297
1928,2019-04-26,한미약품증권매매26일현재424000원,http://www.nbntv.co.kr/news/articleView.html?idxno=333516
1929,2019-04-26,한미약품4월26일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=652977
1930,2019-04-26,한미약품4월26일주가전일대비047변동된425000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=653264
1931,2019-04-27,주간바이오시밀러테마리포트4월4주차팜스웰바이오팜스웰바이오한미약품등강세,http://www.nbntv.co.kr/news/articleView.html?idxno=334949
1932,2019-04-27,주간코스피코스닥4월바이오시밀러테마주간리포트팜스웰바이오팜스웰바이오한미약품등강세,http://www.anewsa.com/detail.php?number=1712337&thread=10r04
1933,2019-04-29,4월29일한미약품오늘주식장012424500원,http://www.nbntv.co.kr/news/articleView.html?idxno=335846
1934,2019-04-29,한미약품4월29일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=654233
1935,2019-04-29,한미약품주가및증권차트정보29일현재426000원증권시세,http://www.cctvnews.co.kr/news/articleView.html?idxno=114798
1936,2019-04-29,신약개발명가한미약품13개분야공채,http://news.mk.co.kr/newsRead.php?year=2019&no=274382
1937,2019-04-29,한미약품4월29일주가전일대비094변동된429000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=654764
1938,2019-04-30,얀센기술수출한미약품비만당뇨바이오신약임상순항,http://www.medisobizanews.com/news/articleView.html?idxno=59394
1939,2019-04-30,바이오시밀러테마오전시황상승률상위종목이수앱지스141한미약품035한올바이오파마015등,http://www.gokorea.kr/news/articleView.html?idxno=176073
1940,2019-04-30,RD의힘보여준한미약품그중심엔아모잘탄있다,http://www.dt.co.kr/contents.html?article_no=2019043002109923813001&ref=naver
1941,2019-04-30,09시33분바이오시밀러오전테마시황이수앱지스한미약품등이상승세주도,http://www.nbntv.co.kr/news/articleView.html?idxno=337550
1942,2019-04-30,RD힘보여준한미약품그중심엔아모잘탄,http://www.upinews.kr/news/newsview.php?ncode=1065578018799681
1943,2019-04-30,한미약품주식종목시세30일현재429000원,http://www.nbntv.co.kr/news/articleView.html?idxno=338165
1944,2019-04-30,한미약품비타민D영양제나인나인주목받는이유,http://www.straightnews.co.kr/news/articleView.html?idxno=47851
1945,2019-04-30,한미약품케어가글코리아팜어워드굿브랜드구강위생대상,http://www.newsfc.co.kr/news/articleView.html?idxno=36138
1946,2019-04-30,제네릭의반전치매약니세틸시장서한미약품독주,http://www.dailypharm.com/Users/News/NewsView.html?ID=252143&REFERER=NP
1947,2019-04-30,한미약품나인나인비타민D결핍소비자들이찾아,http://www.greendaily.co.kr/news/article.html?id=20190430130008
1948,2019-04-30,바이오시밀러테마오후시황상승률상위종목이수앱지스501한올바이오파마보합세한미약품023등,http://www.gokorea.kr/news/articleView.html?idxno=176675
1949,2019-04-30,한미약품4월30일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=655353
1950,2019-04-30,30일13시바이오시밀러오후의테마종목이수앱지스한미약품등이상승세주도,http://www.nbntv.co.kr/news/articleView.html?idxno=338807
1951,2019-04-30,한미약품인후염치료제목앤봄철미세먼지황사목질환에효과적,http://www.ezyeconomy.com/news/articleView.html?idxno=90285
1952,2019-04-30,한미약품올해1Q연결영업익260억전년비09↓,http://www.newspim.com/news/view/20190430000742
1953,2019-04-30,컨센초과한미약품올해1Q연결영업익260억컨센비234↑,http://www.itooza.com/common/iview.php?no=2019043014391210075
1954,2019-04-30,공시봇한미약품1Q연결영업이익260억원전년대비09감소,http://www.ajunews.com/view/20190430143870255
1955,2019-04-30,실적속보한미약품연결20191Q영업이익260억원전년비09감소,http://www.fntimes.com/html/view.php?ud=2019043014385996455dfa87d382_18
1956,2019-04-30,코스피한미약품2019년1분기누적매출액2746억원영업이익260억원연결기준,http://news.kmib.co.kr/article/view.asp?arcid=0013274695&code=61141211&cp=nv
1957,2019-04-30,한미약품1Q영업익260억원전년비09감소,http://view.asiae.co.kr/news/view.htm?idxno=2019043014451527663
1958,2019-04-30,공시한미약품1Q연결영업익260억원전년比09↓,http://www.newsway.co.kr/news/view?tp=1&ud=2019043014433463946
1959,2019-04-30,한미약품1분기2746억원매출118성장RD엔216투자,http://www.getnews.co.kr/view.php?ud=20190430144534361041d0c69529_16
1960,2019-04-30,한미약품1Q118성장2746억매출RD216투자,http://medipana.com/news/news_viewer.asp?NewsNum=238315&MainKind=A&NewsKind=5&vCount=12&vKind=1
1961,2019-04-30,한미약품1분기2746억원매출RD엔216투자,http://www.nextdaily.co.kr/news/article.html?id=20190430800049
1962,2019-04-30,한미약품1분기2746억원매출RD엔216투자,http://www.pressm.kr/news/articleView.html?idxno=23085
1963,2019-04-30,한미약품1분기영업익260억원09감소,https://www.sedaily.com/NewsView/1VI2FNEGTF
1964,2019-04-30,ET투자뉴스한미약품_외국인과기관은순매도개인은순매수한달누적,http://www.etnews.com/20190430000327
1965,2019-04-30,한미약품1분기영업익260억원09감소,http://yna.kr/AKR20190430129500008?did=1195m
1966,2019-04-30,한미약품1분기2746억원매출RD엔216투자,http://news.mt.co.kr/mtview.php?no=2019043014502653372
1967,2019-04-30,한미약품1분기영업이익260억원전년비09↓,http://news.mt.co.kr/mtview.php?no=2019043014571119459
1968,2019-04-30,한미약품1분기2746억118성장순익55증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230004
1969,2019-04-30,한미약품14분기영업이익260억09↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=353302
1970,2019-04-30,한미약품1분기영업익260억원전년비09↓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201904300392&t=NN
1971,2019-04-30,한미약품1Q영업익260억원전년비1감소1보,http://news1.kr/articles/?3610344
1972,2019-04-30,한미약품1Q매출118성장영업이익은09하락,https://www.nocutnews.co.kr/news/5143627
1973,2019-04-30,한미약품1분기영업이익260억원소폭하락,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019043014562990509
1974,2019-04-30,한미약품1분기2746억원매출RD에593억원투자,http://www.medisobizanews.com/news/articleView.html?idxno=59421
1975,2019-04-30,한미약품1Q연결기준매출2746억달성,http://www.edaily.co.kr/news/newspath.asp?newsid=03493206622461368
1976,2019-04-30,한미약품1분기영업익260억원전년比09감소,http://www.etoday.co.kr/news/section/newsview.php?idxno=1750854
1977,2019-04-30,한미약품1분기영업익260억원RD투자265↑,http://www.dailian.co.kr/news/view/791886/?sc=naver
1978,2019-04-30,한미약품1분기593억RD투자에도영업익260억,http://www.dailypharm.com/Users/News/NewsView.html?ID=252172&REFERER=NP
1979,2019-04-30,한미약품1분기매출12↑2746억원RD에22투자,http://www.newspim.com/news/view/20190430000804
1980,2019-04-30,한미약품1분기영업이익260억원전년동기대비09↓,http://news.mk.co.kr/newsRead.php?year=2019&no=277942
1981,2019-04-30,한미약품1분기2746억원매출전년동기대비118성장,http://www.asiatime.co.kr/news/articleView.html?idxno=243065
1982,2019-04-30,한미약품1분기2746억원매출RD216투자,http://www.newsway.co.kr/news/view?tp=1&ud=2019043015174828540
1983,2019-04-30,한미약품1Q영업익260억원09↓,http://www.ebn.co.kr/news/view/983003
1984,2019-04-30,한미약품1분기영업익09감소했지만실적양호종합,http://yna.kr/AKR20190430129551008?did=1195m
1985,2019-04-30,한미약품1분기RD투자265늘어영업익09감소,http://www.etoday.co.kr/news/section/newsview.php?idxno=1750875
1986,2019-04-30,한미약품1분기영업이익09감소연구개발투자증가,https://www.hankyung.com/article/2019043096056
1987,2019-04-30,한미약품1분기매출2746억원12성장216를RD에,http://news.heraldcorp.com/view.php?ud=20190430000707
1988,2019-04-30,한미약품1Q영업익260억RD에매출의216투자,http://view.asiae.co.kr/news/view.htm?idxno=2019043015333643799
1989,2019-04-30,한미약품올1분기매출2746억원전년대비118↑,http://moneys.mt.co.kr/news/mwView.php?no=2019043015228062724
1990,2019-04-30,한미약품1분기2746억원매출RD에216투자,http://www.enewstoday.co.kr/news/articleView.html?idxno=1296765
1991,2019-04-30,한미약품영업益감소불구연구개발확대RD비중20돌파,http://news.donga.com/3/all/20190430/95322420/1
1992,2019-04-30,한미약품1분기영업익260억원전년비09감소,http://www.ceoscoredaily.com/news/article.html?no=54999
1993,2019-04-30,바이오시밀러테마마감시황이수앱지스한미약품등이상승세견인중,http://www.nbntv.co.kr/news/articleView.html?idxno=339475
1994,2019-04-30,한미약품1Q영업익260억원전년比09↓,http://www.seoulfn.com/news/articleView.html?idxno=341551
1995,2019-04-30,5월채용소식항만공사한미약품제주국제자유도시개발센터포항산업과학연구원 ,http://www.veritas-a.com/news/articleView.html?idxno=152520
1996,2019-04-30,한미약품1Q매출전년보다12증가RD600억투자상보,http://news1.kr/articles/?3610386
1997,2019-04-30,한미약품1분기영업익260억전년比09↓,http://www.seoulwire.com/news/articleView.html?idxno=122202
1998,2019-04-30,한미약품1분기영업익260억전년比09감소,http://biz.newdaily.co.kr/site/data/html/2019/04/30/2019043000212.html
1999,2019-04-30,바이오시밀러테마마감시황상승률상위종목이수앱지스411한미약품128한올바이오파마077등,http://www.gokorea.kr/news/articleView.html?idxno=176836
2000,2019-04-30,한미약품1분기영업익260억전년비09↓,http://news.heraldcorp.com/view.php?ud=20190430000741
2001,2019-04-30,한미약품1분기매출2746억매출액216RD투자,http://www.newstomato.com/ReadNews.aspx?no=892517
2002,2019-04-30,한미약품1분기RD증가로영업이익09감소,http://www.kpinews.co.kr/news/articleView.html?idxno=95342
2003,2019-04-30,한미약품1분기2746억원매출RD엔216투자,http://www.medigatenews.com/news/2691413402
2004,2019-04-30,한미약품1분기영업익260억전년比09↓,http://www.newsprime.co.kr/news/article.html?no=457826
2005,2019-04-30,한미약품1분기2746억원매출RD엔216투자,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55129
2006,2019-04-30,한미약품1분기영업이익09감소한260억RD216투자,http://www.mediapen.com/news/view/430516
2007,2019-04-30,한미약품1분기RD에593억투자글로벌임상다수진행,http://www.rapportian.com/news/articleView.html?idxno=117356
2008,2019-04-30,실적한미약품1Q영업익260억전년比09감소RD투자증가영향,http://www.ezyeconomy.com/news/articleView.html?idxno=90299
2009,2019-04-30,한미약품1분기영업익260억원전년동기대비소폭하락,http://www.viva100.com/main/view.php?key=20190430010010972
2010,2019-04-30,한미약품1분기영업익09감소실적양호,http://www.asiatoday.co.kr/view.php?key=20190430010020973
2011,2019-04-30,한미약품1분기에RD투자265증가매출도118늘어나,http://www.nspna.com/news/?mode=view&newsid=356287
2012,2019-04-30,한미약품1분기영업이익260억전년比09감소,http://www.newspost.kr/news/articleView.html?idxno=71012
2013,2019-04-30,한미약품1분기매출2746억영업이익260억영업이익율95기록,http://www.joseilbo.com/news/news_read.php?uid=375763&class=17&grp=
2014,2019-04-30,한미약품1Q영업이익260억원전년比09↓,http://www.newsis.com/view/?id=NISX20190430_0000637447&cID=13001&pID=13000
2015,2019-04-30,한미약품1분기영업이익260억원전년동기대비09,http://www.sisafocus.co.kr/news/articleView.html?idxno=208770
2016,2019-04-30,한미약품1분기2746억원매출RD216투자,http://www.wolyo.co.kr/news/articleView.html?idxno=83074
2017,2019-04-30,한미약품1분기2746억원매출달성전년比118↑,http://www.inthenews.co.kr/news/article.html?no=15129
2018,2019-04-30,한미약품1Q매출2746억전년比12↑,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019043017113203531&objId=A2019043017113203531&portalCode=naver
2019,2019-04-30,한미약품계열제이브이엠1분기매출253억원전년比126↑,http://www.medisobizanews.com/news/articleView.html?idxno=59427
2020,2019-04-30,한미약품1분기영업이익260억원RD216투자,http://www.metroseoul.co.kr/news/newsview?newscd=2019043000124
2021,2019-04-30,한미약품1분기2746억원매출RD엔216투자,http://www.100ssd.co.kr/news/articleView.html?idxno=61070
2022,2019-04-30,제약사1분기실적보니대웅제약한미약품종근당성공적GC녹십자아쉬움,http://daily.hankooki.com/lpage/ittech/201904/dh20190430172200145630.htm
2023,2019-04-30,한미약품1분기실적공개매출2746억원,http://www.mhj21.com/121090
2024,2019-04-30,한미약품4월30일주가전일대비128변동된434500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=655826
2025,2019-04-30,한미약품1분기매출2746억원RD엔216투자,http://www.shinailbo.co.kr/news/articleView.html?idxno=1163365
2026,2019-04-30,한미약품1분기영업이익260억원연구개발증가로09하락,http://biz.chosun.com/site/data/html_dir/2019/04/30/2019043002506.html
2027,2019-04-30,한미약품1분기매출2746억전년比118증가,http://www.dailymedi.com/detail.php?number=842585&thread=22r05
2028,2019-04-30,한미약품1분기2746억원매출RD엔216투자,http://www.techholic.co.kr/news/articleView.html?idxno=182062
2029,2019-04-30,한미약품1분기매출2746억원기록전년대비118성장,http://www.econovill.com/news/articleView.html?idxno=362158
2030,2019-04-30,한미약품1분기영업익260억원전년보다09↓,http://www.dt.co.kr/contents.html?article_no=2019043002109931102006&ref=naver
2031,2019-04-30,한미약품1분기2746억원매출RD엔216투자,http://www.newscj.com/news/articleView.html?idxno=627316
2032,2019-04-30,한미약품1분기매출늘어연구개발비증가로이익은제자리,http://www.businesspost.co.kr/BP?command=article_view&num=125485
2033,2019-04-30,한미약품1분기매출2746억원전년동기比118↑,http://www.newswatch.kr/news/articleView.html?idxno=19042
2034,2019-04-30,한미약품제이브이엠1분기매출126↑내수수출동반성장,http://news.donga.com/3/all/20190430/95327173/1
2035,2019-05-01,한미약품그룹제이브이엠1분기매출253억전년동기비126성장,http://www.lawissue.co.kr/view.php?ud=201904302350112020d7f4c63cc6_12
2036,2019-05-01,한미약품1분기매출2746억원→전년대비118상승,http://www.gukjenews.com/news/articleView.html?idxno=1110867
2037,2019-05-01,한미약품1분기2746억원매출전년동기대비118성장RD엔216투자,http://www.lawissue.co.kr/view.php?ud=201904302350384304d7f4c63cc6_12
2038,2019-05-01,한미약품내수ETC고공비행2000억RD버팀목,http://www.dailypharm.com/Users/News/NewsView.html?ID=252183&REFERER=NP
2039,2019-05-01,한미약품1분기매출2746억RD에216투자,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067804
2040,2019-05-01,한미약품제이브이엠1분기영업이익31억원전년동기비247급증,http://www.thebigdata.co.kr/view.php?ud=201905010749109228d0a8833aad_23
2041,2019-05-01,한미약품1분기2746억원매출RD216투자,http://www.bokuennews.com/news/article.html?no=175067
2042,2019-05-01,한미약품1분기2746억원매출RD에216투자,http://www.ekn.kr/news/article.html?no=429567
2043,2019-05-01,한미약품그룹계열사제이브이엠1분기매출253억전년비126성장,http://www.ekn.kr/news/article.html?no=429586
2044,2019-05-01,바이오시밀러테마오전시황상승률상위종목이수앱지스411한미약품128한올바이오파마077등,http://www.gokorea.kr/news/articleView.html?idxno=177929
2045,2019-05-01,09시31분바이오시밀러테마주오전시황이수앱지스한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=339774
2046,2019-05-01,한미약품1Q영업익260억전년비09↓RD투자는↑,http://www.sisaweek.com/news/articleView.html?idxno=121289
2047,2019-05-01,한미약품1조클럽유지청신호1Q매출전년比12↑,http://www.upinews.kr/news/newsview.php?ncode=1065578219018109
2048,2019-05-01,국내발기부전치료제시장장악한한미약품과종근당,http://www.dailysmart.co.kr/news/articleView.html?idxno=10051
2049,2019-05-01,바이오시밀러테마오후시황상승률상위종목이수앱지스411한미약품128한올바이오파마077등,http://www.gokorea.kr/news/articleView.html?idxno=177987
2050,2019-05-01,1일13시바이오시밀러오후의테마종목이수앱지스한미약품등이상승세주도,http://www.nbntv.co.kr/news/articleView.html?idxno=339828
2051,2019-05-01,한미약품계열제이브이엠1분기매출13성장,http://news.heraldcorp.com/view.php?ud=20190501000179
2052,2019-05-01,바이오시밀러테마마감시황이수앱지스한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=339874
2053,2019-05-01,한미약품1분기매출2746억RD216투자,http://www.newsrep.co.kr/news/articleView.html?idxno=70028
2054,2019-05-02,퀵리포트한미약품매수유지목표가58만원유지하나금투,http://www.itooza.com/common/iview.php?no=2019050207355711799
2055,2019-05-02,퀵리포트한미약품매수유지목표가53만원유지삼성證,http://www.itooza.com/common/iview.php?no=2019050207374047502
2056,2019-05-02,퀵리포트한미약품매수유지목표가57만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019050207432214490
2057,2019-05-02,퀵리포트한미약품매수유지목표가50만원유지신영證,http://www.itooza.com/common/iview.php?no=2019050207551817502
2058,2019-05-02,한미약품목표가58만원유지전일종가43만4500원하나금투,http://www.newspim.com/news/view/20190502000087
2059,2019-05-02,퀵리포트한미약품매수유지목표가53만원유지한투證,http://www.itooza.com/common/iview.php?no=2019050208040422460
2060,2019-05-02,한미약품1분기어닝서프라이즈주가수준매력적NH,https://www.hankyung.com/article/2019050243446
2061,2019-05-02,한미약품목표가53만원유지전일종가43만4500원삼성證,http://www.newspim.com/news/view/20190502000109
2062,2019-05-02,한미약품목표가57만원유지전일종가43만4500원KTB證,http://www.newspim.com/news/view/20190502000132
2063,2019-05-02,한미약품목표가50만원유지전일종가43만4500원신영證,http://www.newspim.com/news/view/20190502000148
2064,2019-05-02,퀵리포트한미약품매수유지목표가58만원유지NH證,http://www.itooza.com/common/iview.php?no=2019050208092610501
2065,2019-05-02,한미약품1분기깜짝실적학회모멘텀기대매수NH투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1751281
2066,2019-05-02,한미약품목표가53만원유지전일종가43만4500원한투證,http://www.newspim.com/news/view/20190502000167
2067,2019-05-02,한미약품목표가58만원유지전일종가43만4500원NH證,http://www.newspim.com/news/view/20190502000176
2068,2019-05-02,I리포트한미약품1분기어닝서프라이즈–NH證,http://www.inews24.com/view/1175897
2069,2019-05-02,한미약품목표가62만원유지전일종가43만4500원SK證,http://www.newspim.com/news/view/20190502000181
2070,2019-05-02,퀵리포트한미약품매수유지목표가62만원유지SK證,http://www.itooza.com/common/iview.php?no=2019050208152612503
2071,2019-05-02,엇갈리는1분기실적한미약품대웅제약맑음녹십자흐림,http://www.rapportian.com/news/articleView.html?idxno=117361
2072,2019-05-02,한미약품14분기어닝서프라이즈NH,http://www.fnnews.com/news/201905020816105137
2073,2019-05-02,실적속보한미약품올해1Q영업이익대폭상승전분기보다639올라연결잠정,https://www.hankyung.com/article/201905024408L
2074,2019-05-02,한미약품RD비용증가에도1Q깜짝실적NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01869606622484984
2075,2019-05-02,한미약품목표가61만원유지전일종가43만4500원유안타證,http://www.newspim.com/news/view/20190502000232
2076,2019-05-02,퀵리포트한미약품매수유지목표가61만원유지유안타證,http://www.itooza.com/common/iview.php?no=2019050208325814731
2077,2019-05-02,한미약품견고한RD모멘텀신영,http://news.mt.co.kr/mtview.php?no=2019050208224684886
2078,2019-05-02,한미약품주가낙관적전망신약후보물질지속적공개,http://www.businesspost.co.kr/BP?command=article_view&num=125588
2079,2019-05-02,GET투자리포트한미약품투자의견매수유지한국투자증권,http://www.getnews.co.kr/view.php?ud=201905021030304863tpgetnews_16
2080,2019-05-02,한미약품목표가57만원유지전일종가43만4500원대신證,http://www.newspim.com/news/view/20190502000272
2081,2019-05-02,퀵리포트한미약품매수유지목표가57만원유지대신證,http://www.itooza.com/common/iview.php?no=2019050208452710354
2082,2019-05-02,한미약품하반기학회시즌에주가반등가능할것으로예상,http://www.nspna.com/news/?mode=view&newsid=356489
2083,2019-05-02,한미약품RD통한장기적모멘텀예상SK증권,https://www.sedaily.com/NewsView/1VIZH4KZJI
2084,2019-05-02,한미약품목표가60만원유지전일종가43만4500원신한금투,http://www.newspim.com/news/view/20190502000304
2085,2019-05-02,퀵리포트한미약품매수유지목표가60만원유지신한금투,http://www.itooza.com/common/iview.php?no=2019050208531497268
2086,2019-05-02,ET투자뉴스한미약품본업의호조로실적BUY유지한국투자증권,http://www.etnews.com/20190502000031
2087,2019-05-02,GET투자리포트한미약품투자의견매수유지하이투자증권,http://www.getnews.co.kr/view.php?ud=201905021030304894tpgetnews_16
2088,2019-05-02,ET투자뉴스한미약품RD비용증가불BUY유지하이투자증권,http://www.etnews.com/20190502000052
2089,2019-05-02,바이오시밀러테마오전시황상승률상위종목한올바이오파마230한미약품058팜스웰바이오027등,http://www.gokorea.kr/news/articleView.html?idxno=178098
2090,2019-05-02,GET투자리포트한미약품투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=201905021030304905tpgetnews_16
2091,2019-05-02,GET투자리포트한미약품투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=201905021030304916tpgetnews_16
2092,2019-05-02,ET투자뉴스한미약품본업의질적성장에BUY삼성증권,http://www.etnews.com/20190502000078
2093,2019-05-02,GET투자리포트한미약품투자의견매수삼성증권,http://www.getnews.co.kr/view.php?ud=201905011030304933tpgetnews_16
2094,2019-05-02,5월채용소식한미약품흥아해운부산인천울산여수광양항만공사포항산업과학연구원동서울대학교한동대학교제주국제자유도시개발센터한국지방행정연구원육군본부,http://www.economytalk.kr/news/articleView.html?idxno=184539
2095,2019-05-02,GET투자리포트한미약품투자의견매수유지KB증권,http://www.getnews.co.kr/view.php?ud=201904301030305014tpgetnews_16
2096,2019-05-02,한미약품1분기2746억원매출RD엔216투자,http://www.straightnews.co.kr/news/articleView.html?idxno=47939
2097,2019-05-02,한미약품주가정보2일현재443500원,http://www.gokorea.kr/news/articleView.html?idxno=178344
2098,2019-05-02,GET투자리포트한미약품투자의견보유유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201905021030305043tpgetnews_16
2099,2019-05-02,5월2일한미약품주식실시간196443000원,http://www.nbntv.co.kr/news/articleView.html?idxno=340781
2100,2019-05-02,GET투자리포트한미약품투자의견매수유지유안타증권,http://www.getnews.co.kr/view.php?ud=201905021030305059tpgetnews_16
2101,2019-05-02,ET투자뉴스한미약품비용의효율화BUY유지유안타증권,http://www.etnews.com/20190502000222
2102,2019-05-02,한미약품5월2일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=656982
2103,2019-05-02,ET투자뉴스한미약품견조한실적성장을BUY유지KB증권,http://www.etnews.com/20190502000275
2104,2019-05-02,바이오시밀러테마오후시황상승률상위종목한미약품184한올바이오파마092팜스웰바이오013등,http://www.gokorea.kr/news/articleView.html?idxno=178732
2105,2019-05-02,ET투자뉴스한미약품어닝서프라이즈HOLD유지NH투자증권,http://www.etnews.com/20190502000297
2106,2019-05-02,2일13시바이오시밀러테마주시황오후한미약품한올바이오파마등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=341442
2107,2019-05-02,ET투자뉴스한미약품양호했던1Q실적BUY유지신한금융투자,http://www.etnews.com/20190502000475
2108,2019-05-02,ET투자뉴스한미약품컨센서스를상회한BUY유지SK증권,http://www.etnews.com/20190502000485
2109,2019-05-02,ET투자뉴스한미약품_외국인과기관은순매도개인은순매수한달누적,http://www.etnews.com/20190502000491
2110,2019-05-02,금주의채용정보한미약품본사연구센터팔탄공단신입및경력사원채용,http://www.news2day.co.kr/126183
2111,2019-05-02,바이오시밀러테마주시황마감한미약품에이프로젠제약등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=342055
2112,2019-05-02,바이오시밀러테마마감시황상승률상위종목한미약품150에이프로젠제약019한올바이오파마015등,http://www.gokorea.kr/news/articleView.html?idxno=178856
2113,2019-05-02,한미약품5월2일주가전일대비150변동된441000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=657440
2114,2019-05-02,한미약품1분기2746억원매출RD엔216투자,http://www.kukinews.com/news/article.html?no=658511
2115,2019-05-02,잡인사이드한미약품공채속보경력신입채용,http://www.newsinside.kr/news/articleView.html?idxno=675214
2116,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.newsway.co.kr/news/view?tp=1&ud=2019050307443672190
2117,2019-05-03,한미약품단장증후군치료제美FDA서희귀약지정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019050307412418222
2118,2019-05-03,한미약품단장증후군바이오신약美FDA서희귀의약품지정,http://www.medisobizanews.com/news/articleView.html?idxno=59489
2119,2019-05-03,한미약품단장증후군치료신약미국FDA희귀의약품지정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230095
2120,2019-05-03,한미약품단장증후군치료제美FDA희귀의약품지정,http://biz.newdaily.co.kr/site/data/html/2019/05/03/2019050300004.html
2121,2019-05-03,한미약품소장小腸난치병신약美FDA희귀의약품지정,http://news.heraldcorp.com/view.php?ud=20190503000035
2122,2019-05-03,한미약품단장증후군신약美FDA희귀의약품지정,http://view.asiae.co.kr/news/view.htm?idxno=2019050308235915135
2123,2019-05-03,한미약품단장증후군치료신약미FDA희귀의약품지정,http://www.fnnews.com/news/201905030819582387
2124,2019-05-03,한미약품단장증후군신약美FDA희귀의약품지정,http://www.newspim.com/news/view/20190503000144
2125,2019-05-03,한미약품단장증후군신약물질美FDA희귀의약품지정,http://news1.kr/articles/?3612677
2126,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.mdtoday.co.kr/mdtoday/index.html?no=353534
2127,2019-05-03,한미약품단장증후군치료제美FDA희귀의약품지정,http://www.newsis.com/view/?id=NISX20190503_0000640074&cID=13001&pID=13000
2128,2019-05-03,FDA한미약품단장증후군신약희귀의약품지정,http://www.dailypharm.com/Users/News/NewsView.html?ID=252262&REFERER=NP
2129,2019-05-03,한미약품단장증후군치료신약FDA희귀의약품지정,http://medipana.com/news/news_viewer.asp?NewsNum=238439&MainKind=A&NewsKind=5&vCount=12&vKind=1
2130,2019-05-03,한미약품단장증후군신약치료제美FDA희귀의약품지정,http://www.rpm9.com/news/article.html?id=20190503090008
2131,2019-05-03,한미약품단장증후군치료신약美희귀의약품지정,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85481
2132,2019-05-03,한미약품단장증후군신약개발속도빨라진다美희귀의약품지정,http://moneys.mt.co.kr/news/mwView.php?no=2019050308388094171
2133,2019-05-03,한미약품단장증후군치료신약미국FDA희귀의약품지정,http://www.seoulwire.com/news/articleView.html?idxno=122670
2134,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,https://www.sedaily.com/NewsView/1VIZXJZ5ZX
2135,2019-05-03,한미약품단장증후군신약미국희귀의약품지정,http://www.seoulfn.com/news/articleView.html?idxno=341818
2136,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.dailian.co.kr/news/view/792609/?sc=naver
2137,2019-05-03,바이오시밀러테마오전시황상승률상위종목한미약품068에이프로젠제약038이수앱지스025등,http://www.gokorea.kr/news/articleView.html?idxno=178982
2138,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.ekn.kr/news/article.html?no=430010
2139,2019-05-03,한미약품단장증후군치료제美희귀의약품지정,http://news.mt.co.kr/mtview.php?no=2019050309193284560
2140,2019-05-03,한미약품단장증후군신약美희귀의약품지정,https://www.hankyung.com/article/2019050391516
2141,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.ceoscoredaily.com/news/article.html?no=55105
2142,2019-05-03,한미약품단장증후군신약미FDA희귀의약품지정,http://yna.kr/AKR20190503033700017?did=1195m
2143,2019-05-03,한미약품단장증후군신약美FDA희귀의약품지정,http://www.ebn.co.kr/news/view/983364
2144,2019-05-03,3일09시바이오시밀러테마주오전시황제넥신한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=342518
2145,2019-05-03,한미약품단장증후군치료바이오신약美FDA서희귀의약품지정,http://www.sisafocus.co.kr/news/articleView.html?idxno=208986
2146,2019-05-03,한미약품단장증후군신약美FDA희귀의약품지정,http://www.kpinews.co.kr/news/articleView.html?idxno=95501
2147,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.asiatoday.co.kr/view.php?key=20190503000930451
2148,2019-05-03,한미약품단장증후군치료제美FDA희귀의약품선정,http://health.chosun.com/site/data/html_dir/2019/05/03/2019050300759.html
2149,2019-05-03,한미약품단장증후군치료신약美FDA희귀약지정,http://www.viva100.com/main/view.php?key=20190503010000976
2150,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.nextdaily.co.kr/news/article.html?id=20190503800004
2151,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.bokuennews.com/news/article.html?no=175175
2152,2019-05-03,한미약품개발단장증후군신약美FDA희귀의약품지정,http://www.kyeongin.com/main/view.php?key=20190503010001191
2153,2019-05-03,한미약품의단장증후군치료신약美FDA서희귀의약품지정,http://www.asiatime.co.kr/news/articleView.html?idxno=243560
2154,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.pressm.kr/news/articleView.html?idxno=23121
2155,2019-05-03,한미약품단장증후군신약미FDA희귀의약품지정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1751870
2156,2019-05-03,한미약품단장증후군치료신약미FDA희귀의약품지정,http://www.m-economynews.com/news/article.html?no=25273
2157,2019-05-03,한미약품단장증후군신약FDA희귀의약품지정,http://www.upinews.kr/news/newsview.php?ncode=1065573069028204
2158,2019-05-03,GET투자리포트한미약품투자의견매수하나금융투자,http://www.getnews.co.kr/view.php?ud=201905021030305158tpgetnews_16
2159,2019-05-03,한미약품신약FDA희귀의약품지정,http://news.mk.co.kr/newsRead.php?year=2019&no=287965
2160,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.joseilbo.com/news/news_read.php?uid=375926&class=27&grp=
2161,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.polinews.co.kr/news/article.html?no=391291
2162,2019-05-03,한미약품단장증후군치료제미국FDA희귀의약품지정,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905030146&t=NN
2163,2019-05-03,GET투자리포트한미약품투자의견보유유지DB금융투자,http://www.getnews.co.kr/view.php?ud=201905021030305187tpgetnews_16
2164,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://biz.chosun.com/site/data/html_dir/2019/05/03/2019050300992.html
2165,2019-05-03,한미약품단장증후군치료신약HM15912미FDA희귀의약품지정,http://www.100ssd.co.kr/news/articleView.html?idxno=61102
2166,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.techholic.co.kr/news/articleView.html?idxno=182112
2167,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.straightnews.co.kr/news/articleView.html?idxno=48025
2168,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.ezyeconomy.com/news/articleView.html?idxno=90345
2169,2019-05-03,한미약품단장증후군신약美서희귀의약품지정,http://news.bizwatch.co.kr/article/consumer/2019/05/03/0007/naver
2170,2019-05-03,한미약품주가오늘시세및종목관련동향정보3일현재438000원,http://www.gokorea.kr/news/articleView.html?idxno=179228
2171,2019-05-03,한미약품단장증후군신약美FDA서희귀의약품지정,http://www.edaily.co.kr/news/newspath.asp?newsid=02420646622485312
2172,2019-05-03,한미약품단장증후군치료신약미국FDA희귀의약품지정,http://www.newsprime.co.kr/news/article.html?no=458273
2173,2019-05-03,한미약품단장증후군신약美FDA희귀의약품지정,http://www.dailymedi.com/detail.php?number=842681&thread=22r05
2174,2019-05-03,한미약품단장증후군치료바이오신약FDA희귀의약품지정,http://www.dailysmart.co.kr/news/articleView.html?idxno=10172
2175,2019-05-03,한미약품단장증후군치료신약FDA희귀의약품지정,http://www.newstomato.com/ReadNews.aspx?no=893075
2176,2019-05-03,한미약품小腸난치병신약美FDA희귀의약품지정,http://news.heraldcorp.com/view.php?ud=20190503000263
2177,2019-05-03,ET투자뉴스한미약품특별할것없다HOLD유지DB금융투자,http://www.etnews.com/20190503000157
2178,2019-05-03,한미약품증권투자3일현재440500원,http://www.nbntv.co.kr/news/articleView.html?idxno=343147
2179,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55173
2180,2019-05-03,한미약품단장증후군치료신약FDA희귀의약품지정,http://www.rapportian.com/news/articleView.html?idxno=117404
2181,2019-05-03,한미약품단장증후군치료신약FDA희귀의약품지정,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1126239&REFERER=NP
2182,2019-05-03,한미약품단장증후군신약물질美FDA희귀의약품지정,http://www.fntoday.co.kr/news/articleView.html?idxno=188011
2183,2019-05-03,한미약품단장증후군치료제美FDA희귀의약품지정,http://www.wolyo.co.kr/news/articleView.html?idxno=83222
2184,2019-05-03,한미약품단장증후군치료후보물질美서희귀의약품지정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1067913
2185,2019-05-03,바이오시밀러테마오후시황상승률상위종목팜스웰바이오080한올바이오파마031한미약품034등,http://www.gokorea.kr/news/articleView.html?idxno=179547
2186,2019-05-03,한미약품5월3일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=658024
2187,2019-05-03,ET투자뉴스한미약품영업도RD도BUY하나금융투자,http://www.etnews.com/20190503000247
2188,2019-05-03,한미약품단장증후군바이오신약미FDA희귀의약품지정,http://www.etnews.com/20190503000276
2189,2019-05-03,美식품의약국한미약품단장증후군치료신약희귀의약품지정,http://www.sisajournal-e.com/news/articleView.html?idxno=199698
2190,2019-05-03,한미약품의단장증후군치료제美FDA서희귀의약품으로지정,http://news.mk.co.kr/newsRead.php?year=2019&no=289342
2191,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1164259
2192,2019-05-03,한미약품단장증후군치료제美FDA희귀의약품지정,http://www.sporbiz.co.kr/news/articleView.html?idxno=334356
2193,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.metroseoul.co.kr/news/newsview?newscd=2019050300089
2194,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://daily.hankooki.com/lpage/ittech/201905/dh20190503152456145630.htm
2195,2019-05-03,한미약품거듭되는RD투자증가하반기임상결과에쏠리는기대감,http://biz.newdaily.co.kr/site/data/html/2019/05/03/2019050300123.html
2196,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.nspna.com/news/?mode=view&newsid=356966
2197,2019-05-03,한미약품단장증후군신약미FDA희귀의약품지정,http://www.smedaily.co.kr/news/articleView.html?idxno=83145
2198,2019-05-03,한미약품신약미국희귀의약품에지정권세창상용화에속도,http://www.businesspost.co.kr/BP?command=article_view&num=125858
2199,2019-05-03,한미약품단장증후군치료제미국FDA희귀의약품지정,http://www.insightkorea.co.kr//news/articleView.html?idxno=36244
2200,2019-05-03,한미약품개발바이오신약FDA희귀의약품지정역대네번째,http://www.enewstoday.co.kr/news/articleView.html?idxno=1298084
2201,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.getnews.co.kr/view.php?ud=2019050317014373941d0c69529_16
2202,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://news.donga.com/3/all/20190503/95373174/1
2203,2019-05-03,한미약품5월3일주가전일과동일한441000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=658300
2204,2019-05-03,한미약품단장증후군신약FDA희귀의약품지정,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH190503006
2205,2019-05-03,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.newscj.com/news/articleView.html?idxno=628443
2206,2019-05-04,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.lawissue.co.kr/view.php?ud=201905040130502880d7f4c63cc6_12
2207,2019-05-04,주간바이오시밀러테마리포트5월1주차이수앱지스한미약품팜스웰바이오등강세,http://www.nbntv.co.kr/news/articleView.html?idxno=344695
2208,2019-05-04,한미약품단장증후군신약미FDA희귀의약품지정,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3826539
2209,2019-05-04,주간코스피코스닥5월바이오시밀러테마주간리포트이수앱지스한미약품팜스웰바이오등강세,http://www.anewsa.com/detail.php?number=1725886&thread=10r04
2210,2019-05-05,한미약품LAPSGLP2Analog美FDA서희귀의약품지정,http://www.gukjenews.com/news/articleView.html?idxno=1112817
2211,2019-05-05,주간바이오시밀러테마리포트5월1주차이수앱지스한미약품팜스웰바이오등상승,http://www.nbntv.co.kr/news/articleView.html?idxno=344870
2212,2019-05-05,주간코스피코스닥5월바이오시밀러테마주간리포트이수앱지스한미약품팜스웰바이오등강세,http://www.anewsa.com/detail.php?number=1726282&thread=10r04
2213,2019-05-06,연구개발RD투자저력보여주는한미약품,http://weekly.hankooki.com/lpage/economy/201905/wk20190506071356146400.htm
2214,2019-05-06,한미약품단장증후군신약미국FDA희귀의약품지정,http://www.kukinews.com/news/article.html?no=659230
2215,2019-05-06,한미약품단장증후군치료제美FDA가희귀의약품지정,https://www.hankyung.com/article/2019050659721
2216,2019-05-06,한미약품단장증후군신약美FDA희귀의약품지정,http://www.dt.co.kr/contents.html?article_no=2019050702101931102002&ref=naver
2217,2019-05-07,한미약품라본디시장선두SERM오리지널역전,http://www.dailypharm.com/Users/News/NewsView.html?ID=252301&REFERER=NP
2218,2019-05-07,바이오시밀러테마오전시황상승률상위종목팜스웰바이오053셀트리온122한미약품125등,http://www.gokorea.kr/news/articleView.html?idxno=181217
2219,2019-05-07,한미약품단장증후군치료신약FDA희귀의약품지정,http://www.monews.co.kr/news/articleView.html?idxno=202400
2220,2019-05-07,대웅제약한미약품1분기성적순항1조클럽굳히기성공할까,http://www.ekn.kr/news/article.html?no=430373
2221,2019-05-07,5월7일한미약품오늘증권시세436000원113,http://www.nbntv.co.kr/news/articleView.html?idxno=346142
2222,2019-05-07,한미약품5월7일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=659475
2223,2019-05-07,바이오시밀러테마마감시황상승률상위종목셀트리온049한미약품091이수앱지스164등,http://www.gokorea.kr/news/articleView.html?idxno=181981
2224,2019-05-07,한미약품FDA희귀약지정만4건美시장공략남다른전략,http://biz.newdaily.co.kr/site/data/html/2019/05/07/2019050700181.html
2225,2019-05-07,한미약품RD비용조달회사채1000억발행,http://www.fnnews.com/news/201905071654401076
2226,2019-05-07,한미약품㈜2019년인재모집5월13일17시마감,http://www.ekn.kr/news/article.html?no=430667
2227,2019-05-07,한미약품5월7일주가전일대비091변동된437000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=659958
2228,2019-05-07,한미약품계열사제이브이엠1분기好실적발표후주가상승흐름,http://www.nspna.com/news/?mode=view&newsid=357390
2229,2019-05-07,한미약품1년여만에1000억규모회사채발행한다,http://www.mdtoday.co.kr/mdtoday/index.html?no=353842
2230,2019-05-08,바이오시밀러테마오전시황상승률상위종목이수앱지스102한미약품092셀트리온097등,http://www.gokorea.kr/news/articleView.html?idxno=183098
2231,2019-05-08,한미약품5월8일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=660567
2232,2019-05-08,한미약품투자주식8일현재429500원,http://www.nbntv.co.kr/news/articleView.html?idxno=348544
2233,2019-05-08,한미약품5월8일주가전일대비206변동된428000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=661025
2234,2019-05-09,한미약품단장증후군치료신약美FDA희귀의약품지정,http://www.kukinews.com/news/article.html?no=660270
2235,2019-05-09,5월9일한미약품및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=184990
2236,2019-05-09,오늘주식한미약품주가9일현재429500원,http://www.nbntv.co.kr/news/articleView.html?idxno=350802
2237,2019-05-09,AI기반챗봇카미한미약품약국전용화장품프로캄상담,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230280
2238,2019-05-09,바이오시밀러테마오후시황상승률상위종목셀트리온195한미약품105에이프로젠제약143등,http://www.gokorea.kr/news/articleView.html?idxno=185368
2239,2019-05-09,한미약품5월9일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=661673
2240,2019-05-09,AI기반챗봇카미한미약품약국용화장품프로캄상담,http://medipana.com/news/news_viewer.asp?NewsNum=238676&MainKind=A&NewsKind=5&vCount=12&vKind=1
2241,2019-05-09,바이오시밀러테마마감시황상승률상위종목셀트리온219에이프로젠제약184한미약품315등,http://www.gokorea.kr/news/articleView.html?idxno=185490
2242,2019-05-09,한미약품5월9일주가전일대비315변동된414500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=662118
2243,2019-05-10,바이오시밀러테마오전시황상승률상위종목제넥신249한올바이오파마167한미약품133등,http://www.gokorea.kr/news/articleView.html?idxno=185593
2244,2019-05-10,5분만에효과한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.koreaittimes.com/news/articleView.html?idxno=90716
2245,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019051011255765927
2246,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230329
2247,2019-05-10,한미약품국내최초플루르비프로펜스프레이출시,http://medipana.com/news/news_viewer.asp?NewsNum=238730&MainKind=A&NewsKind=5&vCount=12&vKind=1
2248,2019-05-10,한미약품목에뿌리는인후염치료제목앤파워스프레이출시,http://news.mk.co.kr/newsRead.php?year=2019&no=307880
2249,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.newsis.com/view/?id=NISX20190510_0000646722&cID=13001&pID=13000
2250,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://news1.kr/articles/?3618139
2251,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.pressm.kr/news/articleView.html?idxno=23217
2252,2019-05-10,한미약품뿌리는인후염치료소염진통제목앤파워스프레이출시,http://www.medisobizanews.com/news/articleView.html?idxno=59664
2253,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.fnnews.com/news/201905101301224695
2254,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=354161
2255,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019051000033
2256,2019-05-10,한미약품5월10일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=662610
2257,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.newswatch.kr/news/articleView.html?idxno=19378
2258,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.viva100.com/main/view.php?key=20190510010003111
2259,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55260
2260,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.mediapen.com/news/view/432809
2261,2019-05-10,6시간소염진통인후염치료제한미약품목앤파워스프레이출시,http://kpenews.com/View.aspx?No=33089
2262,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.ftoday.co.kr/news/articleView.html?idxno=108520
2263,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201905100325&t=NN
2264,2019-05-10,한미약품인후염치료제목앤파워스프레이출시,http://www.rpm9.com/news/article.html?id=20190510090015
2265,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.ajunews.com/view/20190510141001093
2266,2019-05-10,한미약품인후염진통제목앤파워스프레이출시,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH190510007
2267,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://daily.hankooki.com/lpage/ittech/201905/dh20190510142122145630.htm
2268,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.nextdaily.co.kr/news/article.html?id=20190510800024
2269,2019-05-10,신상품한미약품목앤파워스프레이,http://www.seoulfn.com/news/articleView.html?idxno=342498
2270,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이내놔,http://www.wolyo.co.kr/news/articleView.html?idxno=83717
2271,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.techholic.co.kr/news/articleView.html?idxno=182262
2272,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.100ssd.co.kr/news/articleView.html?idxno=61275
2273,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://news.donga.com/3/all/20190510/95468609/1
2274,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.bokuennews.com/news/article.html?no=175454
2275,2019-05-10,한미약품인후염진통제목앤파워스프레이출시뿌린지5분만에효과,http://www.sisajournal-e.com/news/articleView.html?idxno=199967
2276,2019-05-10,오늘의신상품한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.econovill.com/news/articleView.html?idxno=362813
2277,2019-05-10,바이오시밀러테마마감시황상승률상위종목제넥신279한올바이오파마217한미약품060등,http://www.gokorea.kr/news/articleView.html?idxno=186357
2278,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1300104
2279,2019-05-10,한미약품인후염진통제목앤파워스프레이출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1165947
2280,2019-05-10,한미약품뿌리는인후염소염진통제목앤파워스프레이내놔,http://www.businesspost.co.kr/BP?command=article_view&num=126758
2281,2019-05-10,한미약품약국전용화장품프로캄상담AI마련,http://www.kpanews.co.kr/article/show.asp?idx=203816&table=article&category=D
2282,2019-05-10,한미약품5월13일월17시까지2019년인재모집,http://www.ekn.kr/news/article.html?no=431345
2283,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.asiatime.co.kr/news/articleView.html?idxno=244849
2284,2019-05-10,주간신상태그LG생활건강LF스토케한미약품신라스테이외,http://www.newsprime.co.kr/news/article.html?no=459344
2285,2019-05-10,한미약품5월10일주가전일대비060변동된412000원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=662910
2286,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,https://www.insight.co.kr/news/226850
2287,2019-05-10,한미약품스프레이형인후염치료제목앤파워스프레이,http://www.kpinews.co.kr/news/articleView.html?idxno=96005
2288,2019-05-10,한미약품목앤파워스프레이출시,http://weekly.cnbnews.com/news/article.html?no=127857
2289,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.newspost.kr/news/articleView.html?idxno=71231
2290,2019-05-10,권세창한미약품희귀의약품연구개발에역량집중,http://www.businesspost.co.kr/BP?command=article_view&num=126810
2291,2019-05-10,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.newscj.com/news/articleView.html?idxno=630619
2292,2019-05-11,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.lawissue.co.kr/view.php?ud=201905112256124358d7f4c63cc6_12
2293,2019-05-12,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.nspna.com/news/?mode=view&newsid=358271
2294,2019-05-12,한미약품올하반기임상결과에쏠리는눈실적낙관론솔솔,http://www.ekn.kr/news/article.html?no=431543
2295,2019-05-13,주요제약사7곳중가족친화기업대웅제약한미약품2곳뿐,http://www.ceoscoredaily.com/news/article.html?no=55384
2296,2019-05-13,금주의제약회사종근당78주년한미약품신제품,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=209943
2297,2019-05-13,한미약품주가5월13일현재404500원,http://www.gokorea.kr/news/articleView.html?idxno=187871
2298,2019-05-13,약사가꼽은No1인후염외용제한미약품목앤,http://www.nextdaily.co.kr/news/article.html?id=20190513800030
2299,2019-05-13,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://www.straightnews.co.kr/news/articleView.html?idxno=48524
2300,2019-05-13,한미약품목앤코리아팜어워드굿브랜드인후염외용제부문대상선정,http://www.insightkorea.co.kr//news/articleView.html?idxno=36482
2301,2019-05-13,약국에서사랑받는한미약품자양강장제에너지골드설탕색소무첨가,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=531490
2302,2019-05-13,5월13일한미약품증권투자402500원231,http://www.nbntv.co.kr/news/articleView.html?idxno=354923
2303,2019-05-13,한미약품5월13일현재실시간주식시황,http://www.ggilbo.com/news/articleView.html?idxno=663945
2304,2019-05-13,바이오시밀러테마마감시황상승률상위종목에이프로젠제약042이수앱지스153한미약품255등,http://www.gokorea.kr/news/articleView.html?idxno=188375
2305,2019-05-13,한미약품5월13일주가전일대비255변동된401500원으로장마감,http://www.ggilbo.com/news/articleView.html?idxno=664367
2306,2019-05-14,한미약품목표가46만원신규제시전일종가40만1500원메리츠證,http://www.newspim.com/news/view/20190514000328
2307,2019-05-14,퀵리포트한미약품매수목표가46만원신규제시메리츠證,http://www.itooza.com/common/iview.php?no=2019051409585013276
2308,2019-05-14,14일13시바이오시밀러테마주오후시황팜스웰바이오한미약품등이상승세견인중,http://www.nbntv.co.kr/news/articleView.html?idxno=357421
2309,2019-05-14,바이오시밀러테마마감시황상승률상위종목팜스웰바이오602셀트리온051한미약품050등,http://www.gokorea.kr/news/articleView.html?idxno=189977
2310,2019-05-14,한미약품1분기연결영업이익259억전년비1↓,http://www.newspim.com/news/view/20190514001202
2311,2019-05-14,실적속보한미약품1Q영업이익259억전년비1↓,http://www.itooza.com/common/iview.php?no=2019051417360314162
2312,2019-05-14,임성기한미약품회장내실경영진두지휘실적낙관론우세,http://www.wolyo.co.kr/news/articleView.html?idxno=84022
2313,2019-05-15,한미약품4년여간기술료6534억사이언스1849억,http://www.dailypharm.com/Users/News/NewsView.html?ID=252609&REFERER=NP
2314,2019-05-15,한미약품1Q전년비상품매출↓RD비수출20이상↑,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230462
2315,2019-05-15,원료의약품유럽수출속도↑유한양행동아ST종근당한미약품수혜,http://www.upinews.kr/news/newsview.php?ncode=1065573670469162
2316,2019-05-15,베타新상품한미약품인후염치료제목앤파워스프레이,http://www.betanews.net:8080/article/1009137.html
2317,2019-05-15,한미약품주가5월15일현재409000원증권그래프분석,http://www.cctvnews.co.kr/news/articleView.html?idxno=116988
2318,2019-05-16,바이오시밀러테마오전시황상승률상위종목셀트리온230한미약품097이수앱지스096등,http://www.gokorea.kr/news/articleView.html?idxno=192797
2319,2019-05-16,한미약품뿌리는인후염진통제목앤파워스프레이출시,http://sports.khan.co.kr/news/sk_index.html?art_id=201905161002013&sec_id=561801&pt=nv
2320,2019-05-16,5월16일한미약품실시간주식현황097414500원,http://www.nbntv.co.kr/news/articleView.html?idxno=362003
2321,2019-05-16,바이오시밀러테마오후시황상승률상위종목셀트리온153한미약품085이수앱지스069등,http://www.gokorea.kr/news/articleView.html?idxno=193351
2322,2019-05-16,한미약품셀트리온특허등록증가세으뜸,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019051615084702579&objId=A2019051615084702579&portalCode=naver
2323,2019-05-16,바이오시밀러테마주마감셀트리온한미약품등이상승세견인중,http://www.nbntv.co.kr/news/articleView.html?idxno=362877
2324,2019-05-16,바이오시밀러테마마감시황상승률상위종목셀트리온026한미약품024이수앱지스124등,http://www.gokorea.kr/news/articleView.html?idxno=193551
2325,2019-05-17,바이오톱픽은한미약품유한양행오스코텍도주목미래,http://www.edaily.co.kr/news/newspath.asp?newsid=01538326622489904
2326,2019-05-17,ASCO초록공개한미약품유한양행오스코텍주목”미래에셋대우,http://www.fntimes.com/html/view.php?ud=201905170840373312f09e13944d_18
2327,2019-05-17,바이오시밀러테마오전시황상승률상위종목팜스웰바이오185한미약품098제넥신086등,http://www.gokorea.kr/news/articleView.html?idxno=194656
2328,2019-05-17,한미약품목표가60만원유지전일종가40만9500원신한금투,http://www.newspim.com/news/view/20190517000237
2329,2019-05-17,퀵리포트한미약품매수유지목표가60만원유지신한금투,http://www.itooza.com/common/iview.php?no=2019051710240916390
2330,2019-05-17,5월17일한미약품주가그래프159416000원,http://www.nbntv.co.kr/news/articleView.html?idxno=364345
2331,2019-05-17,바이오시밀러테마오후시황상승률상위종목한미약품110이수앱지스014셀트리온보합세등,http://www.gokorea.kr/news/articleView.html?idxno=195283
2332,2019-05-17,17일13시바이오시밀러오후의테마종목한미약품셀트리온등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=364951
2333,2019-05-17,한미약품유한양행미국임상종양학회발표주시,http://www.choicenews.co.kr/news/articleView.html?idxno=50556
2334,2019-05-17,바이오시밀러테마마감시황한미약품셀트리온등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=365639
2335,2019-05-17,바이오시밀러테마마감시황상승률상위종목한미약품049셀트리온051제넥신058등,http://www.gokorea.kr/news/articleView.html?idxno=195445
2336,2019-05-18,주간바이오시밀러테마리포트5월3주차팜스웰바이오셀트리온한미약품등강세,http://www.nbntv.co.kr/news/articleView.html?idxno=366104
2337,2019-05-18,주간코스피코스닥5월바이오시밀러테마주간리포트팜스웰바이오셀트리온한미약품등강세,http://www.anewsa.com/detail.php?number=1754461&thread=10r04
2338,2019-05-18,주간채권발행한미약품녹십자자금조달결정,http://www.econovill.com/news/articleView.html?idxno=363378
2339,2019-05-19,주간바이오시밀러테마리포트5월3주차팜스웰바이오셀트리온한미약품등상승,http://www.nbntv.co.kr/news/articleView.html?idxno=366284
2340,2019-05-19,주간코스피코스닥5월바이오시밀러테마주간리포트팜스웰바이오셀트리온한미약품등강세,http://www.anewsa.com/detail.php?number=1754877&thread=10r04
2341,2019-05-19,바이오는일자리블루오션한미약품4년새4배↑,https://www.hankyung.com/article/2019051918551
2342,2019-05-20,제이브이엠높아지는한미약품의존도,http://www.etoday.co.kr/news/section/newsview.php?idxno=1757032
2343,2019-05-20,20일09시바이오시밀러테마주오전시황에이프로젠제약한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=366666
2344,2019-05-20,GET투자리포트한미약품투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201905201030306266tpgetnews_16
2345,2019-05-20,ET투자뉴스한미약품상위제약사신제품BUY유지NH투자증권,http://www.etnews.com/20190520000063
2346,2019-05-20,한미약품텐텐스페셜에디션출시장애아동예술교육지원,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230670
2347,2019-05-20,한미약품주가그래프20일현재409000원,http://www.nbntv.co.kr/news/articleView.html?idxno=367327
2348,2019-05-20,한미약품텐텐스페셜에디션출시,http://www.straightnews.co.kr/news/articleView.html?idxno=48957
2349,2019-05-20,한미약품텐텐스페셜에디션출시장애아동예술교육지원,http://www.medisobizanews.com/news/articleView.html?idxno=59849
2350,2019-05-20,한미약품텐텐스페셜에디션출시,http://www.dailymedi.com/detail.php?number=843220&thread=22r05
2351,2019-05-20,한미약품텐텐특별에디션선봬장애아동예술기금지원,http://www.newswatch.kr/news/articleView.html?idxno=19692
2352,2019-05-20,한미약품텐텐스페셜출시장애아동기금조성,http://moneys.mt.co.kr/news/mwView.php?no=2019052013348068496
2353,2019-05-20,한미약품한정판텐텐스페셜에디션출시수익금장애아동지원,http://news.donga.com/3/all/20190520/95606469/1
2354,2019-05-20,한미약품발달장애아지원위한텐텐스페셜에디션출시,http://www.koreaittimes.com/news/articleView.html?idxno=90864
2355,2019-05-20,한미약품장애아동예술기금지원텐텐스페셜에디션출시,http://www.newsprime.co.kr/news/article.html?no=460340
2356,2019-05-20,한미약품텐텐특별에디션출시장애아동예술교육지원,http://www.smedaily.co.kr/news/articleView.html?idxno=83466
2357,2019-05-20,한미약품텐텐스페셜에디션출시,http://daily.hankooki.com/lpage/ittech/201905/dh20190520144036145630.htm
2358,2019-05-20,한미약품텐텐특별에디션출시장애아동예술교육지원,https://kizmom.hankyung.com/news/view.html?aid=201905204659o
2359,2019-05-20,한미약품텐텐스페셜에디션1만개한정판매수익금장애아동예술교육지원,http://www.ezyeconomy.com/news/articleView.html?idxno=90771
2360,2019-05-20,더벨한미약품신약개발순항회사채흥행이끌까,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201905170100029400001840
2361,2019-05-20,한미약품텐텐스페셜에디션출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=355049
2362,2019-05-20,한미약품텐텐스페셜에디션출시장애아동예술교육지원,http://www.ftoday.co.kr/news/articleView.html?idxno=108744
2363,2019-05-20,바이오시밀러테마주마감에이프로젠제약한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=368474
2364,2019-05-20,한미약품장애아동예술기금지원위한텐텐스페셜에디션출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=32017
2365,2019-05-20,바이오시밀러테마마감시황상승률상위종목에이프로젠제약066한미약품207제넥신304등,http://www.gokorea.kr/news/articleView.html?idxno=197709
2366,2019-05-20,한미약품텐텐스페셜에디션출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1168568
2367,2019-05-20,한미약품텐텐스페셜에디션출시,http://www.ebn.co.kr/news/view/985615
2368,2019-05-20,한미약품텐텐스페셜에디션출시,http://www.dailian.co.kr/news/view/796844/?sc=naver
2369,2019-05-20,한미약품텐텐스페셜에디션출시장애아동지원,http://www.finomy.com/news/articleView.html?idxno=65936
2370,2019-05-20,한미약품발달장애작가그림담은텐텐스페셜에디션출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068446
2371,2019-05-20,한미약품텐텐츄정스페셜에디션발매,http://www.dailysmart.co.kr/news/articleView.html?idxno=11108
2372,2019-05-20,한미약품텐텐스페셜에디션1만캔출시,http://www.polinews.co.kr/news/article.html?no=393162
2373,2019-05-20,한미약품텐텐한정판출시수익금장애아동예술교육지원”,http://www.econovill.com/news/articleView.html?idxno=363496
2374,2019-05-20,한미약품발달장애작가5명그림으로꾸민텐텐스페셜에디션출시,http://news.mk.co.kr/newsRead.php?year=2019&no=331600
2375,2019-05-20,한미약품장애아동예술기금위한텐텐스페셜에디션출시,http://www.techholic.co.kr/news/articleView.html?idxno=182405
2376,2019-05-20,한미약품텐텐스페셜에디션출시,http://www.newscj.com/news/articleView.html?idxno=633488
2377,2019-05-20,한미약품텐텐스페셜에디션출시장애아동예술교육지원”,http://www.getnews.co.kr/view.php?ud=20190520221510290641d0c69529_16
2378,2019-05-21,한미약품500대기업순위22계단껑충상승폭업계최고,http://www.ceoscoredaily.com/news/article.html?no=55792
2379,2019-05-21,한미약품주가상승가능신약임상결과에따라3분기주가반등,http://www.businesspost.co.kr/BP?command=article_view&num=128084
2380,2019-05-21,한미약품목표가58만원유지전일종가40만3000원하나금투,http://www.newspim.com/news/view/20190521000304
2381,2019-05-21,퀵리포트한미약품매수유지목표가58만원유지하나금투,http://www.itooza.com/common/iview.php?no=2019052110414115826
2382,2019-05-21,5월21일한미약품주식현황403500원012,http://www.nbntv.co.kr/news/articleView.html?idxno=369737
2383,2019-05-21,한미약품챔픽스염변경품목제조판매힘들어지나,http://www.dailymedi.com/detail.php?number=843268&thread=22r05
2384,2019-05-21,바이오시밀러테마오후시황상승률상위종목제넥신419한올바이오파마273한미약품037등,http://www.gokorea.kr/news/articleView.html?idxno=199536
2385,2019-05-22,2019GreatCompanyAward연구개발강자한미약품투자양성평등업계선도,http://www.ceoscoredaily.com/news/article.html?no=55854
2386,2019-05-22,한미약품주가종목그래프및주체별매매동향22일현재407000원,http://www.gokorea.kr/news/articleView.html?idxno=201092
2387,2019-05-22,한미약품고혈압치료제아모잘탄임상적유용성확인,http://health.chosun.com/site/data/html_dir/2019/05/22/2019052201066.html
2388,2019-05-22,한미약품아모잘탄패밀리고혈압치료에유용성,http://www.medisobizanews.com/news/articleView.html?idxno=59909
2389,2019-05-22,한미약품고혈압약아모잘탄패밀리국내학회서발표,http://moneys.mt.co.kr/news/mwView.php?no=2019052211228064268
2390,2019-05-22,한미약품대한고혈압학회서아모잘탄연구결과발표,http://www.mediapen.com/news/view/435469
2391,2019-05-22,한미약품아모잘탄패밀리임상적유용성확인결과발표,http://www.newsprime.co.kr/news/article.html?no=460656
2392,2019-05-22,한미약품주식종목검색22일현재406000원,http://www.nbntv.co.kr/news/articleView.html?idxno=372249
2393,2019-05-22,한미약품당뇨병약개량신약HCP1704임상1상돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=230775
2394,2019-05-22,한미약품아모잘탄패밀리한알에담은모범고혈압치료제평가,http://www.metroseoul.co.kr/news/newsview?newscd=2019052200088
2395,2019-05-22,ET투자뉴스한미약품_상장주식수대비거래량은024로적정수준,http://www.etnews.com/20190522000137
2396,2019-05-22,한미약품고혈압학회서아모잘탄패밀리연구결과발표,http://www.newsway.co.kr/news/view?tp=1&ud=2019052213454744667
2397,2019-05-22,한미약품아모잘탄패밀리복약편의성우수한효과확인”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1758475
2398,2019-05-22,한미약품아모잘탄패밀리의주요연구결과발표,http://www.nspna.com/news/?mode=view&newsid=360391
2399,2019-05-22,한미약품아모잘탄패밀리임상적유용성발표,http://www.sisajournal-e.com/news/articleView.html?idxno=200479
2400,2019-05-22,한미약품대한고혈압학회서아모잘탄패밀리주요연구결과발표,http://www.medigatenews.com/news/1870910420
2401,2019-05-22,한미약품고혈압치료제아모잘탄패밀리주요연구결과발표,http://www.100ssd.co.kr/news/articleView.html?idxno=61516
2402,2019-05-22,한미약품고혈압학회서아모잘탄효능인정받아,http://news.heraldcorp.com/view.php?ud=20190522000630
2403,2019-05-22,고혈압치료한미약품아모잘탄패밀리한알이답,http://www.ajunews.com/view/20190522154124765
2404,2019-05-22,한미약품대한고혈압학회춘계학술대회서고혈압치료약아모잘탄연구발표,http://www.techholic.co.kr/news/articleView.html?idxno=182448
2405,2019-05-22,한미약품고혈압치료모범답안아모잘탄패밀리”,http://www.dailymedi.com/detail.php?number=843326&thread=22r05
2406,2019-05-22,한미약품고혈압약아모잘탄패밀리누적매출5천억돌파,http://www.rapportian.com/news/articleView.html?idxno=117679
2407,2019-05-22,한미약품아모잘탄패밀리고혈압학회서임상적유용성발표,http://www.newspost.kr/news/articleView.html?idxno=71542
2408,2019-05-22,한미약품블록버스터신약 아모잘탄패밀리유효성입증,http://www.ezyeconomy.com/news/articleView.html?idxno=90876
2409,2019-05-22,한미약품공모채자금조달1000억→1750억증액,http://www.dailypharm.com/Users/News/NewsView.html?ID=252925&REFERER=NP
2410,2019-05-22,한미약품고혈압학회서아모잘탄패밀리유용성발표 ,http://www.monews.co.kr/news/articleView.html?idxno=202720
2411,2019-05-22,유한양행한미약품삼성바이오에피스세계최대암학회서빛날까,https://www.hankyung.com/article/2019052239691
2412,2019-05-22,한미약품NASH치료제임상1상완료임박기술수출가능성높여,http://biz.newdaily.co.kr/site/data/html/2019/05/22/2019052200197.html
2413,2019-05-22,한미약품학술대회서아모잘탄패밀리유용성확인,http://www.mhj21.com/121477
2414,2019-05-22,한미약품아모잘탄패밀리복용편의성개선,http://www.asiatime.co.kr/news/articleView.html?idxno=247118
2415,2019-05-22,한알로고혈압치료”한미약품아모잘탄패밀리주요연구결과공개,http://news.donga.com/3/all/20190522/95649691/1
2416,2019-05-22,한미약품아모잘탄패밀리임상적유용성고혈압학회서공개,http://www.thebigdata.co.kr/view.php?ud=201905221910383373d0a8833aad_23
2417,2019-05-23,우종수한미약품대표이유있는연임수출에서돋보인성장,http://www.datanews.co.kr/news/article.html?no=103170
2418,2019-05-23,초점무역분쟁장기화한미약품등깜짝실적주대응,https://www.hankyung.com/article/2019052360646
2419,2019-05-23,한미약품주가5월23일현재405000원,http://www.gokorea.kr/news/articleView.html?idxno=203189
2420,2019-05-23,한미약품블록버스터아모잘탄3종패밀리임상적유용성재확인,http://www.straightnews.co.kr/news/articleView.html?idxno=49206
2421,2019-05-23,5월23일한미약품주식주가086405000원,http://www.nbntv.co.kr/news/articleView.html?idxno=374547
2422,2019-05-23,바이오시밀러테마마감시황상승률상위종목이수앱지스073에이프로젠제약089한미약품147등,http://www.gokorea.kr/news/articleView.html?idxno=203777
2423,2019-05-24,한미약품비만당뇨치료제미국2상임상완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=355491
2424,2019-05-24,바이오시밀러테마오전시황상승률상위종목한올바이오파마127제넥신044한미약품037등,http://www.gokorea.kr/news/articleView.html?idxno=205010
2425,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.fetv.co.kr/news/article.html?no=29313
2426,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.bosa.co.kr/news/articleView.html?idxno=2105786
2427,2019-05-24,한미약품프로바이오틱스가함유된영유아용선크림출시,http://www.koreaittimes.com/news/articleView.html?idxno=90942
2428,2019-05-24,오늘주식시장한미약품주가24일현재401000원,http://www.nbntv.co.kr/news/articleView.html?idxno=376976
2429,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.pressm.kr/news/articleView.html?idxno=23434
2430,2019-05-24,한미약품프로바이오틱스함유프로캄선크림2종출시,http://www.medisobizanews.com/news/articleView.html?idxno=59981
2431,2019-05-24,한미약품프로바이오틱스함유선크림등출시,http://weekly.cnbnews.com/news/article.html?no=128047
2432,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=56335
2433,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019052413041069245
2434,2019-05-24,바이오시밀러테마오후시황상승률상위종목한올바이오파마362셀트리온보합세한미약품037등,http://www.gokorea.kr/news/articleView.html?idxno=205660
2435,2019-05-24,한미약품프로캄자외선차단제2종출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1170037
2436,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://medipana.com/news/news_viewer.asp?NewsNum=239471&MainKind=A&NewsKind=5&vCount=12&vKind=1
2437,2019-05-24,한미약품바르는영유아용쿠션형선크림출시,http://www.sisajournal-e.com/news/articleView.html?idxno=200627
2438,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.ceoscoredaily.com/news/article.html?no=55998
2439,2019-05-24,한미약품프로캄쿠션스틱형선크림출시,http://news.mk.co.kr/newsRead.php?year=2019&no=346936
2440,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.nextdaily.co.kr/news/article.html?id=20190524800025
2441,2019-05-24,한미약품영유아용쿠션형선크림출시피부보호특허성분함유,http://news.donga.com/3/all/20190524/95682913/1
2442,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1759371
2443,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55481
2444,2019-05-24,한미약품영유아용쿠션형선크림출시,https://www.sedaily.com/NewsView/1VJ9LQQ993
2445,2019-05-24,바이오시밀러테마주시황마감한올바이오파마한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=377743
2446,2019-05-24,바이오시밀러테마마감시황상승률상위종목한올바이오파마307한미약품075셀트리온028등,http://www.gokorea.kr/news/articleView.html?idxno=205880
2447,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1304874
2448,2019-05-24,오늘Who권세창한미약품글로벌매출1조당뇨신약에성큼,http://www.businesspost.co.kr/BP?command=article_view&num=128703
2449,2019-05-24,한미약품한국산텐과안구건조증치료제2종공동판매,http://it.chosun.com/site/data/html_dir/2019/03/18/2019031802787.html
2450,2019-05-24,한미약품서울시선정모범유공납세기업표창,http://it.chosun.com/site/data/html_dir/2019/03/05/2019030502642.html
2451,2019-05-24,한미약품제46기주주총회개최,http://it.chosun.com/site/data/html_dir/2019/03/15/2019031501734.html
2452,2019-05-24,한미약품한미젊은의학자학술상에신현영명지병원교수선정,http://it.chosun.com/site/data/html_dir/2019/04/11/2019041102401.html
2453,2019-05-24,한미약품2018년영업익836억원기록전년比17↑,http://it.chosun.com/site/data/html_dir/2019/01/29/2019012902258.html
2454,2019-05-24,한미약품美릴리에수출한BTK억제제권리반환,http://it.chosun.com/site/data/html_dir/2019/01/23/2019012301623.html
2455,2019-05-24,ICT바이오생산배우자”한미약품스마트플랜트에몰리는해외사절단,http://it.chosun.com/site/data/html_dir/2019/02/28/2019022802401.html
2456,2019-05-24,한미약품업계첫정보보호경영시스템국제표준ISO27001인증,http://it.chosun.com/site/data/html_dir/2019/01/11/2019011101576.html
2457,2019-05-24,한미약품비만당뇨NASH항암희귀질환분야글로벌성과기대”,http://it.chosun.com/site/data/html_dir/2019/01/10/2019011001062.html
2458,2019-05-24,한미약품호중구감소증치료제美FDA시판허가신청,http://it.chosun.com/site/data/html_dir/2018/12/28/2018122801753.html
2459,2019-05-24,2019신년사임성기한미약품회장내실경영으로글로벌한미도약하자”,http://it.chosun.com/site/data/html_dir/2019/01/02/2019010202314.html
2460,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.getnews.co.kr/view.php?ud=20190524165630611541d0c69529_16
2461,2019-05-24,한미약품텐텐스페셜에디션출시발달장애작가5인합작,http://weekly.cnbnews.com/news/article.html?no=128067
2462,2019-05-24,주간신상태그미샤신세계인터내셔날한미약품글래드호텔외,http://www.newsprime.co.kr/news/article.html?no=461070
2463,2019-05-24,한미약품고혈압학회서아모잘탄패밀리우수성소개,http://weekly.cnbnews.com/news/article.html?no=128080
2464,2019-05-24,한미약품영유아용쿠션형선크림프로캄베베선쿠션출시,http://www.asiatime.co.kr/news/articleView.html?idxno=247587
2465,2019-05-24,한미약품프로바이오틱스함유영유아용쿠션형선크림출시,http://www.thebigdata.co.kr/view.php?ud=201905241953595337d0a8833aad_23
2466,2019-05-24,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.newscj.com/news/articleView.html?idxno=634910
2467,2019-05-25,한미약품톡톡바르는영유아용쿠션형선크림출시,http://www.ekn.kr/news/article.html?no=433928
2468,2019-05-26,한미약품복합제제특허출원1위,http://www.dt.co.kr/contents.html?article_no=2019052602109931731001&ref=naver
2469,2019-05-26,한미약품㈜복합제제신약특허출원서압도적1위,http://www.edaily.co.kr/news/newspath.asp?newsid=01508806622492856
2470,2019-05-27,한미약품의특별한텐텐발달장애작가그림더해져,http://weekly.hankooki.com/lpage/economy/201905/wk20190527090146146450.htm
2471,2019-05-27,한미약품톡톡바르는영유아용선크림출시,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH190524013
2472,2019-05-27,증권주식한미약품주가27일현재408500원,http://www.nbntv.co.kr/news/articleView.html?idxno=379782
2473,2019-05-27,한미약품챔픽스물질특허무효심판청구기각,http://www.dailypharm.com/Users/News/NewsView.html?ID=253053&REFERER=NP
2474,2019-05-27,바이오시밀러테마오후시황상승률상위종목한미약품049에이프로젠제약023팜스웰바이오016등,http://www.gokorea.kr/news/articleView.html?idxno=208056
2475,2019-05-27,13시26분바이오시밀러테마주시황오후팜스웰바이오한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=380349
2476,2019-05-27,한미약품프로바이오틱스함유한영유아용쿠션형성인용스틱형선크림출시,http://www.ezyeconomy.com/news/articleView.html?idxno=90986
2477,2019-05-27,바이오시밀러테마마감시황제넥신한미약품등이상승세견인중,http://www.nbntv.co.kr/news/articleView.html?idxno=380982
2478,2019-05-27,바이오시밀러테마마감시황상승률상위종목제넥신088한미약품025팜스웰바이오보합세등,http://www.gokorea.kr/news/articleView.html?idxno=208252
2479,2019-05-27,건강하게여름나기한미약품목앤파워스프레이목안에직접뿌리는인후염진통제,https://www.sedaily.com/NewsView/1VJAZRGOK7
2480,2019-05-28,한미약품유한양행항암제신약개발선구자겨룬다,http://www.sportsseoul.com/news/read/768405
2481,2019-05-28,한미약품오늘증시28일현재403500원,http://www.nbntv.co.kr/news/articleView.html?idxno=382251
2482,2019-05-28,2019년제약사경영분석④한미약품제약업계최대연구개발비10년간2조원,http://www.naeil.com/news_view/?id_art=314469
2483,2019-05-28,한미약품나인나인선봬나인나인한알이면하루권장비타민D충족”,http://www.greendaily.co.kr/news/article.html?id=20190528130002
2484,2019-05-29,바이오시밀러테마오전시황상승률상위종목에이프로젠제약119이수앱지스보합세한미약품012등,http://www.gokorea.kr/news/articleView.html?idxno=211578
2485,2019-05-29,한미약품협력사상생간담회개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231079
2486,2019-05-29,한미약품협력사들상생협력위해한자리에모였다”,http://www.newsway.co.kr/news/view?tp=1&ud=2019052910290313313
2487,2019-05-29,한미약품11개협력사상생협력위해한자리에모였다,http://www.medisobizanews.com/news/articleView.html?idxno=60077
2488,2019-05-29,한미약품협력사상생위해한자리,http://www.medical-tribune.co.kr/news/articleView.html?idxno=85971
2489,2019-05-29,한미약품주가증권투자정보29일현재397000원,http://www.gokorea.kr/news/articleView.html?idxno=211874
2490,2019-05-29,한미약품협력사간담회성료,http://www.dailymedi.com/detail.php?number=843557&thread=22r05
2491,2019-05-29,한미약품협력사상생협력간담회개최,http://www.bokuennews.com/news/article.html?no=176345
2492,2019-05-29,한미약품협력사들상생협력위해한자리에모였다,http://www.bosa.co.kr/news/articleView.html?idxno=2106082
2493,2019-05-29,바이오시밀러테마오후시황상승률상위종목셀트리온161한미약품161이수앱지스232등,http://www.gokorea.kr/news/articleView.html?idxno=212229
2494,2019-05-29,한미약품협력사들상생협력위해한자리,http://www.mdtoday.co.kr/mdtoday/index.html?no=355916
2495,2019-05-29,한미약품중소병원상봉사상에뉴고려병원백민우명예원장선정,http://www.koreaittimes.com/news/articleView.html?idxno=91017
2496,2019-05-29,한미약품장애아동지원텐텐스페셜에디션선봬,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201905291509005&code=900303
2497,2019-05-29,한미약품한미중소병원상봉사상에백민우뉴고려병원명예원장선정,http://www.sporbiz.co.kr/news/articleView.html?idxno=341927
2498,2019-05-29,한미약품협력사들상생협력위해한자리에모였다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55554
2499,2019-05-29,바이오시밀러테마마감시황셀트리온한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=385861
2500,2019-05-29,바이오시밀러테마마감시황상승률상위종목셀트리온027한미약품149이수앱지스159등,http://www.gokorea.kr/news/articleView.html?idxno=212470
2501,2019-05-29,한미약품한미중소병원상봉사상에백민우뉴고려병원명예원장선정,http://news.donga.com/3/all/20190529/95755461/1
2502,2019-05-29,한미약품상생협력위해협력사한자리모여,http://www.monews.co.kr/news/articleView.html?idxno=202863
2503,2019-05-29,한미약품상생협력소통의시간위해협력사들한자리,http://www.techholic.co.kr/news/articleView.html?idxno=182618
2504,2019-05-29,한미약품11개협력사상생협력위해한자리모여,http://www.seoulwire.com/news/articleView.html?idxno=141713
2505,2019-05-29,한미약품복합제제특허15년간총45건출원,http://www.whosaeng.com/110403
2506,2019-05-30,한미약품통큰신약개발시설증축좋지만재무안정성빨간불,http://www.sportsseoul.com/news/read/769565
2507,2019-05-30,바이오시밀러테마오전시황상승률상위종목한올바이오파마266제넥신169한미약품088등,http://www.gokorea.kr/news/articleView.html?idxno=213640
2508,2019-05-30,바이오시밀러테마오후시황상승률상위종목이수앱지스191한올바이오파마152한미약품088등,http://www.gokorea.kr/news/articleView.html?idxno=214319
2509,2019-05-30,바이오시밀러테마마감시황상승률상위종목한올바이오파마266이수앱지스088한미약품038등,http://www.gokorea.kr/news/articleView.html?idxno=214517
2510,2019-05-31,한미약품아모잘탄국제학술지10번째등재,http://www.newsway.co.kr/news/view?tp=1&ud=2019053111020672651
2511,2019-05-31,한미약품아모잘탄미국고혈압저널에10번째등재,http://www.medisobizanews.com/news/articleView.html?idxno=60145
2512,2019-05-31,한미약품고혈압치료제아모잘탄국제학술지10번째등재,http://www.techholic.co.kr/news/articleView.html?idxno=182672
2513,2019-05-31,한미약품아모잘탄고혈압환자新치료방향제시,http://www.bosa.co.kr/news/articleView.html?idxno=2106239
2514,2019-05-31,한미약품아모잘탄국제학술지에10번째등재,http://www.100ssd.co.kr/news/articleView.html?idxno=61717
2515,2019-05-31,한미약품아모잘탄국제학술지10번째등재,http://www.koreaittimes.com/news/articleView.html?idxno=91069
2516,2019-05-31,한미약품아모잘탄임상4상결과美고혈압저널에게재,http://www.rapportian.com/news/articleView.html?idxno=117845
2517,2019-05-31,한미약품발매10주년맞은아모잘탄국제학술지10번째등재,http://www.pressm.kr/news/articleView.html?idxno=23549
2518,2019-05-31,한미약품아모잘탄국제학술지10번째등재,http://www.ebn.co.kr/news/view/987334
2519,2019-05-31,발매10주년한미약품아모잘탄국제학술지10번째등재,http://www.fnnews.com/news/201905311314095299
2520,2019-05-31,한미약품아모잘탄국제학술지10번째등재,http://www.wolyo.co.kr/news/articleView.html?idxno=85392
2521,2019-05-31,한미약품아모잘탄임상4상결과우수한유효성입증,http://www.viva100.com/main/view.php?key=20190531010010294
2522,2019-05-31,한미약품아모잘탄연구국제학술지에10번째등재,http://daily.hankooki.com/lpage/ittech/201905/dh20190531141428145630.htm
2523,2019-05-31,한미약품아모잘탄4상서중심혈압조절효과확인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068897
2524,2019-05-31,한미약품에너지골드약사가뽑은자양강장제대상,http://www.newstomato.com/ReadNews.aspx?no=898956
2525,2019-05-31,한미약품고혈압치료제아모잘탄유용성입증국제학술지등재,http://www.4th.kr/news/articleView.html?idxno=12875
2526,2019-05-31,한미약품발매10주년아모잘탄국제학술지10번째논문등재,http://www.getnews.co.kr/view.php?ud=20190531143251366641d0c69529_16
2527,2019-05-31,한미약품아모잘탄미국고혈압저널에10번째등재,http://www.wikileaks-kr.org/news/articleView.html?idxno=57030
2528,2019-05-31,한미약품케어가글약국에서가장사랑받는구강청결제로꼽혀,http://www.newsworks.co.kr/news/articleView.html?idxno=364706
2529,2019-05-31,한미약품아모잘탄국제학술지10번째등재,http://www.mdtoday.co.kr/mdtoday/index.html?no=356211
2530,2019-05-31,한미약품케어가글굿브랜드대상수상,http://www.koreaittimes.com/news/articleView.html?idxno=91078
2531,2019-05-31,한미약품부족해지기쉬운비타민D보충위한나인나인선봬,http://www.iminju.net/news/articleView.html?idxno=45831
2532,2019-05-31,한미약품나인나인1알이면하루권장비타민D까지해결,http://www.newswatch.kr/news/articleView.html?idxno=20124
2533,2019-05-31,한미약품나인나인한알로하루권장비타민D까지해결,http://www.getnews.co.kr/view.php?ud=20190531145621317041d0c69529_16
2534,2019-05-31,약국에서사랑받는한미약품구강위생자양강장제부문대상,http://www.newsprime.co.kr/news/article.html?no=461968
2535,2019-05-31,한미약품발매10주년맞은고혈압치료제복합신약아모잘탄국제학술지10번째등재,http://www.ezyeconomy.com/news/articleView.html?idxno=91160
2536,2019-05-31,한미약품아모잘탄우수성입증논문국제학술지게재,http://www.upinews.kr/news/newsview.php?ncode=1065590933748720
2537,2019-05-31,발매10주년한미약품아모잘탄매년1개논문국제학술지등재”,http://news.donga.com/3/all/20190531/95789730/1
2538,2019-05-31,한미약품케어가글코리아팜어워드굿브랜드대상선정,http://www.thebigdata.co.kr/view.php?ud=201905311518418886d0a8833aad_23
2539,2019-05-31,한미약품발매10주년아모잘탄해외유명학술지에10번째논문등재,http://www.thebigdata.co.kr/view.php?ud=201905311525026506d0a8833aad_23
2540,2019-05-31,한미약품에너지골드약사들이뽑은자양강장제대상카페인함유선택가능,http://www.updownnews.co.kr/news/articleView.html?idxno=204235
2541,2019-05-31,바이오시밀러테마주마감한미약품제넥신등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=388705
2542,2019-05-31,바이오시밀러테마마감시황상승률상위종목한미약품251제넥신219셀트리온215등,http://www.gokorea.kr/news/articleView.html?idxno=216516
2543,2019-05-31,한미약품나인나인한알이면하루권장비타민D까지해결,http://www.greened.kr/news/articleView.html?idxno=110242
2544,2019-05-31,한미약품케어가글코리아팜어워드굿브랜드구강위생부문대상,http://www.sporbiz.co.kr/news/articleView.html?idxno=342756
2545,2019-05-31,한미약품케어가글코리아팜어워드굿브랜드대상수상,http://www.mediapen.com/news/view/437723
2546,2019-05-31,한미약품아모잘탄임상결과국제학술지게제,http://weekly.cnbnews.com/news/article.html?no=128184
2547,2019-05-31,한국인에게부족한비타민D한미약품나인나인눈길,http://www.asiatime.co.kr/news/articleView.html?idxno=248999
2548,2019-05-31,한미약품케어가글약국에서사랑받는구강청결제,http://www.ftoday.co.kr/news/articleView.html?idxno=109045
2549,2019-05-31,약사가인정한자양강장드링크제한미약품에너지골드,http://www.whitepaper.co.kr/news/articleView.html?idxno=160105
2550,2019-05-31,발매10주년한미약품아모잘탄국제학술지10번째등재,http://www.newspost.kr/news/articleView.html?idxno=71819
2551,2019-05-31,한알에다들었다비타민D포함28종영양성분담은한미약품나인나인,http://www.whitepaper.co.kr/news/articleView.html?idxno=160101
2552,2019-05-31,한미약품나인나인눈길비타민D해결,http://www.ebn.co.kr/news/view/987415
2553,2019-05-31,한미약품케어가글코리아팜어워드굿브랜드위생부문대상,http://www.ebn.co.kr/news/view/987417
2554,2019-05-31,한미약품고혈압약아모잘탄국제학술지10번째등재,http://www.datanews.co.kr/news/article.html?no=103313
2555,2019-05-31,한미약품아모잘탄임상4상결과미국고혈압저널게재,http://health.chosun.com/site/data/html_dir/2019/05/31/2019053102512.html
2556,2019-05-31,한미약품케어가글약국에서사랑받는구강청결제코리아팜어워드굿브랜드대상,http://www.seoulwire.com/news/articleView.html?idxno=143748
2557,2019-05-31,한미약품아모잘탄임상4상결과국제학술지게재,http://www.mhj21.com/121666
2558,2019-05-31,한미약품케어가글코리아팜어워드굿브랜드선정,http://www.lawissue.co.kr/view.php?ud=2019053118222993539817d053b9_12
2559,2019-05-31,한미약품케어가글구강위생부문대상,http://daily.hankooki.com/lpage/ittech/201905/dh20190531182002145630.htm
2560,2019-05-31,한미약품에너지골드약국에서사랑받는드링크제선정,http://daily.hankooki.com/lpage/ittech/201905/dh20190531182154145630.htm
2561,2019-05-31,한미약품아모잘탄임상4상결과미국고혈압저널게재,http://www.dailymedi.com/detail.php?number=843691&thread=22r05
2562,2019-05-31,한미약품나인나인한알이면하루권장비타민D까지해결,http://www.dailysmart.co.kr/news/articleView.html?idxno=11762
2563,2019-05-31,발매10주년한미약품아모잘탄미국고혈압저널에10번째등재,http://www.econovill.com/news/articleView.html?idxno=364457
2564,2019-06-01,한미약품나인나인한알이면하루권장비타민D까지해결,http://www.seoulwire.com/news/articleView.html?idxno=143739
2565,2019-06-01,실력으로만승부”한미약품임원4명중1명은여성,http://www.news2day.co.kr/128648
2566,2019-06-01,주간바이오시밀러테마리포트6월1주차제넥신셀트리온한올바이오파마한미약품등강세,http://www.nbntv.co.kr/news/articleView.html?idxno=389130
2567,2019-06-01,주간코스피코스닥6월바이오시밀러테마주간리포트제넥신셀트리온한올바이오파마한미약품등강세,http://www.anewsa.com/detail.php?number=1787463&thread=18
2568,2019-06-01,바이오시밀러테마리뷰제넥신셀트리온한올바이오파마한미약품등강세,http://aitimes.co.kr/news/view/53435
2569,2019-06-02,한미약품에너지골드약국에서사랑받는드링크제,http://www.seoulwire.com/news/articleView.html?idxno=143745
2570,2019-06-02,주간바이오시밀러테마리포트6월1주차제넥신셀트리온한올바이오파마한미약품등상승,http://www.nbntv.co.kr/news/articleView.html?idxno=389306
2571,2019-06-02,주간코스피코스닥6월바이오시밀러테마주간리포트제넥신셀트리온한올바이오파마한미약품등강세,http://www.anewsa.com/detail.php?number=1787889&thread=18
2572,2019-06-02,바이오시밀러테마주간종가제넥신셀트리온한올바이오파마한미약품종목주도,http://aitimes.co.kr/news/view/53555
2573,2019-06-03,ASCO美스펙트럼한미약품롤론티스올해FDA재허가신청의지,http://news1.kr/articles/?3636390
2574,2019-06-03,한미약품권세창사장글로벌신약신공장올해말완공,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231228
2575,2019-06-03,권세창한미약품대표재미한인제약인협회공로상수상,https://view.asiae.co.kr/news/view.htm?idxno=2019060308350412959
2576,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.newsway.co.kr/news/view?tp=1&ud=2019060308333294083
2577,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://medipana.com/news/news_viewer.asp?NewsNum=240897&MainKind=A&NewsKind=5&vCount=12&vKind=1
2578,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.fetv.co.kr/news/article.html?no=30095
2579,2019-06-03,한미약품케어가글에너지골드코리아팜어워드굿브랜드서대상,http://www.datanews.co.kr/news/article.html?no=103327
2580,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.ebn.co.kr/news/view/987531
2581,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://biz.newdaily.co.kr/site/data/html/2019/06/03/2019060300017.html
2582,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.asiatoday.co.kr/view.php?key=20190603010000711
2583,2019-06-03,한미약품권세창사장재미한인제약인협회공로상,http://www.medisobizanews.com/news/articleView.html?idxno=60167
2584,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1762205
2585,2019-06-03,권세창한미약품대표이사재미한인제약인협회공로상수상,https://www.sedaily.com/NewsView/1VK9VOFQO2
2586,2019-06-03,권세창한미약품대표이사재미한인제약인협회공로상수상,http://www.ezyeconomy.com/news/articleView.html?idxno=91176
2587,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.seoulwire.com/news/articleView.html?idxno=144019
2588,2019-06-03,권세창한미약품사장재미한인제약인협회로부터공로상받아,http://news.mk.co.kr/newsRead.php?year=2019&no=376739
2589,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.bokuennews.com/news/article.html?no=176495
2590,2019-06-03,09시34분바이오시밀러오전의테마종목제넥신한미약품등이상승세주도,http://www.nbntv.co.kr/news/articleView.html?idxno=389563
2591,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.fnnews.com/news/201906030936281142
2592,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.m-i.kr/news/articleView.html?idxno=609221
2593,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.rapportian.com/news/articleView.html?idxno=117871
2594,2019-06-03,한국제약산업발전에공헌인정한미약품권세창사장재미한인제약인협회공로상수상,http://kpenews.com/View.aspx?No=41150
2595,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.ekn.kr/news/article.html?no=435482
2596,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://daily.hankooki.com/lpage/ittech/201906/dh20190603094529145630.htm
2597,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.nextdaily.co.kr/news/article.html?id=20190603800014
2598,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.newsprime.co.kr/news/article.html?no=462080
2599,2019-06-03,발매10주년맞은한미약품아모잘탄국제학술지10번째등재,http://www.nspna.com/news/?mode=view&newsid=362770
2600,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://biz.chosun.com/site/data/html_dir/2019/06/03/2019060300991.html
2601,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.ajunews.com/view/20190603102039225
2602,2019-06-03,권세창한미약품대표재미한인제약인협회공로상수상,http://www.edaily.co.kr/news/newspath.asp?newsid=02335366622518112
2603,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.asiatime.co.kr/news/articleView.html?idxno=249213
2604,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55631
2605,2019-06-03,권세창한미약품대표재미한인제약인협회공로상수상,http://www.sisajournal-e.com/news/articleView.html?idxno=201101
2606,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.wikileaks-kr.org/news/articleView.html?idxno=57165
2607,2019-06-03,권세창한미약품사장재미한인제약인협회공로상,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019060310571901409&objId=A2019060310571901409&portalCode=naver
2608,2019-06-03,한미약품권세창대표재미한인제약인협회공로상수상,https://www.nocutnews.co.kr/news/5160999
2609,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.pressm.kr/news/articleView.html?idxno=23571
2610,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.dt.co.kr/contents.html?article_no=2019060302109931102006&ref=naver
2611,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=356342
2612,2019-06-03,한미약품권사창사장KASBP감사상수상,http://health.chosun.com/site/data/html_dir/2019/06/03/2019060301263.html
2613,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.sportsseoul.com/news/read/771233
2614,2019-06-03,권세창한미약품사장재미한인제약인협회공로상,http://www.dailymedi.com/detail.php?number=843742&thread=22r05
2615,2019-06-03,6월3일한미약품실시간주식현황012408000원,http://www.nbntv.co.kr/news/articleView.html?idxno=389768
2616,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://moneys.mt.co.kr/news/mwView.php?no=2019060313038019778
2617,2019-06-03,동정한미약품권세창사장재미한인제약인협회공로상수상,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1068992
2618,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.dailysmart.co.kr/news/articleView.html?idxno=11847
2619,2019-06-03,동정권세창한미약품사장재미한인제약인협회공로상,https://biz.seoul.co.kr/news/newsView.php?id=20190603500066&wlog_tag3=naver
2620,2019-06-03,한미약품주가상승세권세창사장때문,http://www.ccreview.co.kr/news/articleView.html?idxno=117742
2621,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.wsobi.com/news/articleView.html?idxno=74966
2622,2019-06-03,한미약품권세창사장재미한인제약인협회로부터공로상수상,http://www.koreaittimes.com/news/articleView.html?idxno=91091
2623,2019-06-03,한미약품발매10주년맞은아모잘탄국제학술지10번째등재,http://www.wsobi.com/news/articleView.html?idxno=74967
2624,2019-06-03,한미약품호재에도주가는하락세왜,http://moneys.mt.co.kr/news/mwView.php?no=2019060314248038851
2625,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.wolyo.co.kr/news/articleView.html?idxno=85512
2626,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019060314170065825
2627,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://star.mt.co.kr/stview.php?no=2019060314475331806
2628,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=531840
2629,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://it.chosun.com/site/data/html_dir/2019/06/03/2019060301728.html
2630,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.metroseoul.co.kr/news/newsview?newscd=2019060300180
2631,2019-06-03,권세창한미약품사장KASBP공로상수상,http://www.doctorsnews.co.kr/news/articleView.html?idxno=129458
2632,2019-06-03,한미약품권세창사장재미한인제약인협회공로상,http://www.mhj21.com/121690
2633,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.newsworks.co.kr/news/articleView.html?idxno=365294
2634,2019-06-03,베타CEO동정권세창한미약품사장재미한인제약인협회공로상수상,http://www.betanews.net:8080/article/1015958.html
2635,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.econovill.com/news/articleView.html?idxno=364558
2636,2019-06-03,권세창한미약품발전공로로재미한인제약인협회공로상받아,http://www.businesspost.co.kr/BP?command=article_view&num=129932
2637,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.newstomato.com/ReadNews.aspx?no=899360
2638,2019-06-03,한미약품권세창대표재미한인제약인협회공로상수상,http://www.segye.com/content/html/2019/06/03/20190603509478.html?OutUrl=naver
2639,2019-06-03,2분기실적감소전망에주춤하는한미약품,http://www.mdtoday.co.kr/mdtoday/index.html?no=356390
2640,2019-06-03,바이오시밀러테마마감시황상승률상위종목제넥신245셀트리온158한미약품024등,http://www.gokorea.kr/news/articleView.html?idxno=218903
2641,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.cnbnews.com/news/article.html?no=411939
2642,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.newswatch.kr/news/articleView.html?idxno=20203
2643,2019-06-03,한미약품권세창사장美재미한인제약인협회공로상수상,http://www.whitepaper.co.kr/news/articleView.html?idxno=160369
2644,2019-06-03,권세창한미약품사장재미한인제약인협회공로상,http://www.seoulfn.com/news/articleView.html?idxno=344828
2645,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.getnews.co.kr/view.php?ud=2019060317132250041d0c69529_16
2646,2019-06-03,권세창한미약품대표재미한인제약인협회로부터공로상수상,http://www.thebigdata.co.kr/view.php?ud=201906031715039774d0a8833aad_23
2647,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://news.donga.com/3/all/20190603/95828682/1
2648,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,https://www.sedaily.com/NewsView/1VK9WXF17N
2649,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.newsfc.co.kr/news/articleView.html?idxno=36554
2650,2019-06-03,권세창한미약품대표재미한인제약인협회공로상수상,http://www.shinailbo.co.kr/news/articleView.html?idxno=1172948
2651,2019-06-03,비즈피플권세창한미약품사장재미한인제약인협회공로상수상外2건,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019060316484220963
2652,2019-06-03,권세창한미약품사장재미한인제약인협회공로상,http://www.fnnews.com/news/201906031841493301
2653,2019-06-03,한미약품권세창사장재미한인제약인협회공로상수상,http://www.businesskorea.co.kr/news/articleView.html?idxno=32497
2654,2019-06-03,한미약품발매10주년맞은아모잘탄미국고혈압저널국제학술지10번째등재,http://www.lawissue.co.kr/view.php?ud=201906032211542434d7f4c63cc6_12
2655,2019-06-03,권세창한미약품사장재미한인제약인협회공로상수상,http://www.newscj.com/news/articleView.html?idxno=638021
2656,2019-06-04,권세창한미약품대표이사재미한인제약인協공로상,http://biz.chosun.com/site/data/html_dir/2019/06/04/2019060400088.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2657,2019-06-04,권세창한미약품사장재미한인제약인협회공로상수상,http://www.polinews.co.kr/news/article.html?no=394477
2658,2019-06-04,한미약품권세창사장재미한인제약인協공로상,http://www.medical-tribune.co.kr/news/articleView.html?idxno=86087
2659,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인,http://www.dailysmart.co.kr/news/articleView.html?idxno=11876
2660,2019-06-04,한미약품유전자돌연변이항암물질효과확인,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906040169&t=NN
2661,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인”,http://news.heraldcorp.com/view.php?ud=20190604000181
2662,2019-06-04,한미약품개발벨바라페닙현재승인된항암제없는암종에서효능확인”,https://www.sedaily.com/NewsView/1VKABW6VA5
2663,2019-06-04,한미약품벨바라페닙승인된치료제없는암종서효능확인,http://www.etoday.co.kr/news/section/newsview.php?idxno=1762801
2664,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인,http://www.ceoscoredaily.com/news/article.html?no=56341
2665,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인”,http://daily.hankooki.com/lpage/life/201906/dh20190604100838138950.htm
2666,2019-06-04,한미약품벨바라페닙승인치료제없는암종서효능확인,http://www.medisobizanews.com/news/articleView.html?idxno=60204
2667,2019-06-04,한미약품기술수출한항암신약고형암치료효능확인,http://news1.kr/articles/?3637721
2668,2019-06-04,ASCO2019한미약품벨바라페닙치료제없는암종서효능확인,http://www.econovill.com/news/articleView.html?idxno=364631
2669,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인,http://www.medigatenews.com/news/3392607589
2670,2019-06-04,한미약품이개발한표적항암제ASCO서조명받은이유는,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019060410120597098
2671,2019-06-04,한미약품벨바라페닙돌연변이고형암에효과,http://news.mt.co.kr/mtview.php?no=2019060410034240018
2672,2019-06-04,한미약품벨바라페닙승인된치료제없는암종서효능확인,http://www.ebn.co.kr/news/view/987819
2673,2019-06-04,한미약품벨바라페닙승인된치료제없는고형암에서효능확인”,http://biz.newdaily.co.kr/site/data/html/2019/06/04/2019060400082.html
2674,2019-06-04,한미약품벨바라페닙고형암에서항암효과허용가능한안전성나타내,http://www.newsprime.co.kr/news/article.html?no=462315
2675,2019-06-04,한미약품항암제벨바라페닙미국서효과안전성자료발표,http://www.sportsseoul.com/news/read/771685
2676,2019-06-04,권세창한미약품사장재미한인제약인협회공로상수상,http://www.iminju.net/news/articleView.html?idxno=45936
2677,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인,http://www.asiatoday.co.kr/view.php?key=20190604010001975
2678,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인,http://www.m-i.kr/news/articleView.html?idxno=609705
2679,2019-06-04,한미약품개발벨바라페닙치료제없는암종에서효능확인,http://www.metroseoul.co.kr/news/newsview?newscd=2019060400096
2680,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인,http://www.pressm.kr/news/articleView.html?idxno=23594
2681,2019-06-04,한미약품벨바라페닙승인된치료제없는암종서효능확인,http://www.seoulwire.com/news/articleView.html?idxno=145092
2682,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인,http://www.sisafocus.co.kr/news/articleView.html?idxno=211437
2683,2019-06-04,한미약품항암신약벨바라페닙고형암치료효과확인,http://www.newspim.com/news/view/20190604000647
2684,2019-06-04,한미약품벨바라페닙치료제없는돌연변이암세포에서유효성안전성입증,http://www.ezyeconomy.com/news/articleView.html?idxno=91227
2685,2019-06-04,한미약품미국임상종양학회서벨바라페닙임상1상결과발표,http://www.upinews.kr/news/newsview.php?ncode=1065588973839654
2686,2019-06-04,한미약품미국임상종양학회서벨바라페닙승인된치료제없는암종에서효능확인발표,http://www.techholic.co.kr/news/articleView.html?idxno=182741
2687,2019-06-04,한미약품표적항암제벨바라페닙치료제없는암종에도효능확인,http://www.businesspost.co.kr/BP?command=article_view&num=130138
2688,2019-06-04,한미약품기술수출항암신약임상1상서효능확인”,https://view.asiae.co.kr/news/view.htm?idxno=2019060415115092432
2689,2019-06-04,한미약품항암신약벨바라페닙돌연변이암치료효능임상결과발표,http://news.donga.com/3/all/20190604/95844624/1
2690,2019-06-04,한미약품벨바라페닙승인된치료제없는암종서효능확인,http://www.wolyo.co.kr/news/articleView.html?idxno=85671
2691,2019-06-04,한미약품벨바라페닙승인된치료제없는암종서효능확인,http://www.rapportian.com/news/articleView.html?idxno=117915
2692,2019-06-04,한미약품미국임상종양학회서벨바라페닙연구결과발표,http://www.shinailbo.co.kr/news/articleView.html?idxno=1173291
2693,2019-06-04,한미약품벨바라페닙치료제없는돌연변이암세포에효능확인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=105014
2694,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인,http://www.dailian.co.kr/news/view/800676/?sc=naver
2695,2019-06-04,한미약품벨바라페닙임상1상결과고형암치료효과확인”,http://it.chosun.com/site/data/html_dir/2019/06/04/2019060402617.html
2696,2019-06-04,한미약품벨바라페닙유전자돌연변이암에서효과”,http://weekly.cnbnews.com/news/article.html?no=128245
2697,2019-06-04,한미약품항암치료제벨바라페닙치료제없는돌연변이고형암에효능확인,http://www.4th.kr/news/articleView.html?idxno=12993
2698,2019-06-04,한미약품벨바라페닙승인된치료제없는암종에서효능확인,http://www.businesskorea.co.kr/news/articleView.html?idxno=32557
2699,2019-06-04,한미약품미국임상종양학회서벨바라페닙임상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=384625
2700,2019-06-05,한미약품2019미국임상종양학회서발표벨바라페닙승인된치료제없는암종에서효능확인”,http://www.lawissue.co.kr/view.php?ud=201906050121404782d7f4c63cc6_12
2701,2019-06-05,동정한미약품권세창사장재미한인제약인협회공로상 ,http://www.monews.co.kr/news/articleView.html?idxno=202944
2702,2019-06-05,한미약품권세창사장재미한인제약인협회공로상수상,http://weekly.cnbnews.com/news/article.html?no=128257
2703,2019-06-05,한미약품파트너사들항암신약연구결과잇따라발표,http://www.pressm.kr/news/articleView.html?idxno=23621
2704,2019-06-05,한미약품파트너사들항암신약연구결과잇따라발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231389
2705,2019-06-05,한미약품파트너사들항암신약연구결과잇따라발표,http://www.nextdaily.co.kr/news/article.html?id=20190605800024
2706,2019-06-05,한미약품파트너사들ASCO서항암신약연구결과잇따라발표,http://www.medigatenews.com/news/3569111453
2707,2019-06-05,한미약품파트너사들항암신약연구결과잇따라발표,http://www.sisafocus.co.kr/news/articleView.html?idxno=211533
2708,2019-06-05,한미약품고혈압신약아모잘탄국제학술지10번째등재,http://news.heraldcorp.com/view.php?ud=20190605000358
2709,2019-06-05,한미약품美임상종양학회서벨바라페닙임상1상결과발표,http://health.chosun.com/site/data/html_dir/2019/06/05/2019060500914.html
2710,2019-06-05,한미약품파트너社스펙트럼아테넥스항암신약연구결과발표,http://daily.hankooki.com/lpage/ittech/201906/dh20190605114135145630.htm
2711,2019-06-05,한미약품파트너사들ASCO서항암신약연구결과잇따라발표,http://www.newsway.co.kr/news/view?tp=1&ud=2019060511554268508
2712,2019-06-05,한미약품파트너사들항암신약혁신성연구결과발표,http://www.medisobizanews.com/news/articleView.html?idxno=60254
2713,2019-06-05,6월5일한미약품주식장408500원012,http://www.nbntv.co.kr/news/articleView.html?idxno=392335
2714,2019-06-05,한미약품美파트너사들ASCO에서연구결과발표,http://weekly.cnbnews.com/news/article.html?no=128265
2715,2019-06-05,한미약품스펙트럼아테넥스한미약품독자플랫폼기술접목한항암신약연구결과발표,http://www.techholic.co.kr/news/articleView.html?idxno=182785
2716,2019-06-05,한미약품美파트너사들항암신약연구결과잇따라발표,http://www.businesskorea.co.kr/news/articleView.html?idxno=32584
2717,2019-06-05,한미약품항암신약연구6건미국서잇따라발표,http://www.sportsseoul.com/news/read/772286
2718,2019-06-05,한미약품벨바라페닙안전성내약성우수,http://www.finomy.com/news/articleView.html?idxno=66430
2719,2019-06-05,한미약품파트너사들항암신약연구결과잇따라발표,http://medipana.com/news/news_viewer.asp?NewsNum=241091&MainKind=A&NewsKind=5&vCount=12&vKind=1
2720,2019-06-05,한미약품파트너사들항암신약연구결과잇따라발표,http://www.seoulwire.com/news/articleView.html?idxno=146201
2721,2019-06-05,한미약품美파트너사들ASCO서항암신약연구결과잇따라발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=356625
2722,2019-06-05,한미약품파트너사스펙트럼아테넥스항암신약연구결과잇따라발표,http://www.inthenews.co.kr/news/article.html?no=16037
2723,2019-06-05,미국내한미약품군단들항암신약성과잇따른발표,http://news.heraldcorp.com/view.php?ud=20190605000514
2724,2019-06-05,한미약품롤론티스뉴라스타와안전성약효유사,http://news.mt.co.kr/mtview.php?no=2019060513531798321
2725,2019-06-05,한미약품美파트너사들항암신약연구결과발표,http://www.newspim.com/news/view/20190605000650
2726,2019-06-05,한미약품파트너사들美임상종양학회서항암신약연구결과발표,http://www.sisajournal-e.com/news/articleView.html?idxno=201237
2727,2019-06-05,한미약품파트너사들항암신약연구결과잇따라발표,http://www.ekn.kr/news/article.html?no=436094
2728,2019-06-05,한미약품파트너사들항암신약연구결과잇따라발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55693
2729,2019-06-05,바이오시밀러테마종목종가이수앱지스한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=393003
2730,2019-06-05,바이오시밀러테마마감시황상승률상위종목이수앱지스115한미약품061셀트리온026등,http://www.gokorea.kr/news/articleView.html?idxno=223066
2731,2019-06-05,ASCO2019한미약품플랫폼기술적용파트너사항암신약연구결과발표,http://www.econovill.com/news/articleView.html?idxno=364793
2732,2019-06-05,한미약품美파트너사항암신약연구결과잇단발표”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1763445
2733,2019-06-05,한미약품파트너사들항암신약연구결과잇따라발표,http://www.shinailbo.co.kr/news/articleView.html?idxno=1173613
2734,2019-06-05,한미약품항암신약글로벌무대서혁신성입증,http://www.viva100.com/main/view.php?key=20190605010001548
2735,2019-06-05,한미약품롤론티스뉴라티스와유사한약효안전성,http://www.ajunews.com/view/20190605164050538
2736,2019-06-05,한미약품파트너사들항암신약혁신성연구결과발표,http://www.newsprime.co.kr/news/article.html?no=462630
2737,2019-06-05,한미약품파트너사들미국임상종양학회서연구결과6건발표,http://news.mk.co.kr/newsRead.php?year=2019&no=388135
2738,2019-06-05,한미약품파트너사항암신약연구결과발표 ,http://www.monews.co.kr/news/articleView.html?idxno=203022
2739,2019-06-05,한미약품미국파트너사들항암신약연구결과잇따라발표,http://www.joseilbo.com/news/news_read.php?uid=378010&class=27&grp=
2740,2019-06-05,한미약품美파트너사스펙트럼아테넥스연구결과발표활발,http://www.betanews.net:8080/article/1016979.html
2741,2019-06-05,한미약품파트너사들ASCO서항암신약연구결과발표,http://www.dailian.co.kr/news/view/801015/?sc=naver
2742,2019-06-05,한미약품케어가글약사1000명선정구강위생부문대상,http://www.sisafocus.co.kr/news/articleView.html?idxno=211580
2743,2019-06-05,한미약품파트너사들항암신약연구결과6건잇따라발표,http://www.getnews.co.kr/view.php?ud=20190605175104876041d0c69529_16
2744,2019-06-05,한미약품파트너사들항암신약연구결과잇따라발표,http://www.nspna.com/news/?mode=view&newsid=363617
2745,2019-06-06,한미약품파트너사들ASCO서항암신약연구결과잇따라발표,http://www.gukjenews.com/news/articleView.html?idxno=1128806
2746,2019-06-06,바이오시밀러테마오전시황상승률상위종목이수앱지스115한미약품061셀트리온026등,http://www.gokorea.kr/news/articleView.html?idxno=224240
2747,2019-06-06,6일09시바이오시밀러테마주시황오전이수앱지스한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=393336
2748,2019-06-06,바이오시밀러테마오후시황상승률상위종목이수앱지스115한미약품061셀트리온026등,http://www.gokorea.kr/news/articleView.html?idxno=224362
2749,2019-06-06,6일13시바이오시밀러오후의테마종목이수앱지스한미약품등이상승세견인중,http://www.nbntv.co.kr/news/articleView.html?idxno=393393
2750,2019-06-06,바이오시밀러테마마감시황이수앱지스한미약품등이상승세견인중,http://www.nbntv.co.kr/news/articleView.html?idxno=393437
2751,2019-06-07,한미약품플랫폼기술장착美기업들신약개발박차,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069088
2752,2019-06-08,한미약품파트너사들美스펙트럼美아테넥스항암신약연구결과잇따라발표,http://www.lawissue.co.kr/view.php?ud=201906081629145170d7f4c63cc6_12
2753,2019-06-10,유한양행폐암신약레이저티닙한미약품올리타다른길걷나,http://www.sportsseoul.com/news/read/773770
2754,2019-06-10,약사가가장신뢰하는제약사에한미약품유한양행,http://www.dailypharm.com/Users/News/NewsView.html?ID=253341&REFERER=NP
2755,2019-06-10,한미약품5년내글로벌제약사도약권세창대표,http://www.edaily.co.kr/news/newspath.asp?newsid=01282486622520408
2756,2019-06-10,신약개발의지강화한한미약품RD비중더줄인대웅제약,http://www.datanews.co.kr/news/article.html?no=103273
2757,2019-06-10,바이오시밀러테마오전시황상승률상위종목팜스웰바이오116셀트리온051한미약품049등,http://www.gokorea.kr/news/articleView.html?idxno=226931
2758,2019-06-10,한미약품의비만당뇨NASH글로벌경쟁력확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55728
2759,2019-06-10,한미약품주가6월10일현재409500원,http://www.gokorea.kr/news/articleView.html?idxno=227224
2760,2019-06-10,한미약품비만∙당뇨∙NASH신약글로벌경쟁력확인,http://www.nextdaily.co.kr/news/article.html?id=20190610800021
2761,2019-06-10,한미약품비만∙당뇨∙NASH신약글로벌경쟁력확인,http://medipana.com/news/news_viewer.asp?NewsNum=241197&MainKind=A&NewsKind=5&vCount=12&vKind=1
2762,2019-06-10,한미약품비만∙당뇨∙NASH신약글로벌경쟁력확인,http://www.ebn.co.kr/news/view/988425
2763,2019-06-10,한미약품비만∙당뇨∙NASH신약글로벌경쟁력확인,http://www.pressm.kr/news/articleView.html?idxno=23659
2764,2019-06-10,한미약품비만당뇨NASH신약글로벌경쟁력확인,http://www.ceoscoredaily.com/news/article.html?no=56508
2765,2019-06-10,한미약품비만당뇨NASH글로벌신약부푼꿈,http://www.medisobizanews.com/news/articleView.html?idxno=60319
2766,2019-06-10,한미약품비만∙당뇨∙NASH신약글로벌경쟁력확인,http://www.wikileaks-kr.org/news/articleView.html?idxno=57715
2767,2019-06-10,한미약품미국당뇨병학회서후보물질3종연구결과발표,http://www.newspim.com/news/view/20190610000354
2768,2019-06-10,한미약품미국당뇨병학회서에페글레나타이드4건등총12건발표,http://www.sisajournal-e.com/news/articleView.html?idxno=201407
2769,2019-06-10,한미약품미국당뇨병학회서비만∙당뇨∙비알콜성지방간염신약글로벌경쟁력확인,http://www.dailysmart.co.kr/news/articleView.html?idxno=12096
2770,2019-06-10,한미약품미국당뇨병학회참가연구결과12건발표,http://yna.kr/AKR20190610073200017?did=1195m
2771,2019-06-10,한미약품랩스커버리적용신약글로벌경쟁력확인,http://www.newsprime.co.kr/news/article.html?no=462971
2772,2019-06-10,한미약품美당뇨병학회서비만∙당뇨∙NASH신약연구결과발표,http://www.ajunews.com/view/20190610120454732
2773,2019-06-10,한미약품비만당뇨지방간염신약미당뇨병학회에발표,http://www.joseilbo.com/news/news_read.php?uid=378144&class=27&grp=
2774,2019-06-10,한미약품신약연구결과12건미국당뇨병학회서발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=356874
2775,2019-06-10,한미약품비만당뇨지방간신약글로벌경쟁력확인,http://www.dailymedi.com/detail.php?number=843988&thread=22r05
2776,2019-06-10,한미약품ADA서비만당뇨NASH신약글로벌경쟁력확인,http://www.sporbiz.co.kr/news/articleView.html?idxno=345325
2777,2019-06-10,바이오시밀러테마오후시황상승률상위종목팜스웰바이오249셀트리온076한미약품074등,http://www.gokorea.kr/news/articleView.html?idxno=227541
2778,2019-06-10,한미약품비만당뇨지방간신약글로벌경쟁력확인,http://biz.chosun.com/site/data/html_dir/2019/06/10/2019061001514.html
2779,2019-06-10,한미약품미당뇨병학회참가비만당뇨NASH신약글로벌경쟁력확인,http://www.techholic.co.kr/news/articleView.html?idxno=182880
2780,2019-06-10,한미약품에페글레나타이드공복혈당개선등효과확인,http://news.mt.co.kr/mtview.php?no=2019061011494636005
2781,2019-06-10,한미약품美당뇨병학회서랩스커버리신약임상발표,http://paxnetnews.com/allView?vNewsSetId=6073&articleId=2019061013392201891&objId=A2019061013392201891&portalCode=naver
2782,2019-06-10,한미약품美당뇨병학회서바이오신약연구결과12건발표,https://view.asiae.co.kr/article/2019061013492163283
2783,2019-06-10,한미약품랩스커버리적용당뇨비만NASH신약글로벌경쟁력확인”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1764451
2784,2019-06-10,한미약품비만당뇨NASH신약글로벌경쟁력확인,http://www.newsis.com/view/?id=NISX20190610_0000676170&cID=13001&pID=13000
2785,2019-06-10,한미약품미국당뇨병학회참가연구결과12건발표”,https://www.sedaily.com/NewsView/1VKD49N4AR
2786,2019-06-10,한미약품비만당뇨NASH신약글로벌경쟁력확인,http://www.metroseoul.co.kr/news/newsview?newscd=2019061000124
2787,2019-06-10,한미약품ADA서비만당뇨NASH12건연구결과발표,https://www.hankyung.com/article/2019061024546
2788,2019-06-10,한미약품美당뇨병학회서비만당뇨NASH연구12건발표,http://www.seoulwire.com/news/articleView.html?idxno=148671
2789,2019-06-10,한미약품비만당뇨NASH신약경쟁력확인,http://www.dt.co.kr/contents.html?article_no=2019061002109931102004&ref=naver
2790,2019-06-10,한미약품비만당뇨지방간염신약글로벌경쟁력확인,http://www.wolyo.co.kr/news/articleView.html?idxno=86073
2791,2019-06-10,한미약품당뇨비만지방간등바이오신약12건연구결과발표글로벌경쟁력확인,http://www.ezyeconomy.com/news/articleView.html?idxno=91356
2792,2019-06-10,한미약품비만당뇨NASH신약국제무대서글로벌경쟁력확인,http://it.chosun.com/site/data/html_dir/2019/06/10/2019061001676.html
2793,2019-06-10,한미약품미국당뇨병학회서연구결과12건발표,http://www.asiatoday.co.kr/view.php?key=20190610010005067
2794,2019-06-10,한미약품비만∙당뇨∙NASH신약글로벌경쟁력확인,http://www.asiatime.co.kr/news/articleView.html?idxno=250448
2795,2019-06-10,한미약품미국당뇨병학회참가연구결과12건발표,http://www.etnews.com/20190610000317
2796,2019-06-10,한미약품비만당뇨NASH신약물질글로벌경쟁력확인,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906100511&t=NN
2797,2019-06-10,한미약품비만당뇨NASH신약글로벌경쟁력확인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1310359
2798,2019-06-10,한미약품비만당뇨비알코올성지방간염치료제글로벌경쟁력확인,http://daily.hankooki.com/lpage/ittech/201906/dh20190610152532145630.htm
2799,2019-06-10,비만당뇨지방간바이오신약후보3종한미약품글로벌무대첫소개,http://kpenews.com/View.aspx?No=53918
2800,2019-06-10,한미약품비만∙당뇨∙NASH신약글로벌경쟁력확인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231482
2801,2019-06-10,잘나가는K바이오한미약품등제약바이오업계글로벌무대서경쟁력입증,http://www.g-enews.com/ko-kr/news/article/news_all/20190610154507648269d76442fa_1/article.html
2802,2019-06-10,한미약품美서랩스커버리적용바이오신약연구결과12건발표,http://biz.newdaily.co.kr/site/data/html/2019/06/10/2019061000184.html
2803,2019-06-10,권세창글로벌제약사와협력해한미약품항암신약개발속도높여,http://www.businesspost.co.kr/BP?command=article_view&num=130832
2804,2019-06-10,한미약품비만∙당뇨∙NASH신약글로벌경쟁력확인,http://www.getnews.co.kr/view.php?ud=20190610173314674441d0c69529_16
2805,2019-06-10,한미약품비만당뇨NASH신약글로벌경쟁력확인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1174798
2806,2019-06-10,한미약품비만당뇨NASH신약글로벌경쟁력확인,http://www.medigatenews.com/news/3413741076
2807,2019-06-10,한미약품바이오신약비만∙당뇨∙NASH3종글로벌경쟁력확인,http://www.thebigdata.co.kr/view.php?ud=201906101749094787d0a8833aad_23
2808,2019-06-10,한미약품미국당뇨병학회서신약홍보전,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019061016540158652
2809,2019-06-10,한미약품美ADA에서바이오신약3종연구결과발표,http://weekly.cnbnews.com/news/article.html?no=128345
2810,2019-06-10,한미약품비만지방간염당뇨바이오신약연구결과공개글로벌경쟁력확인”,http://news.donga.com/3/all/20190610/95923810/1
2811,2019-06-10,한미약품ADA참가신약홍보,http://www.finomy.com/news/articleView.html?idxno=66575
2812,2019-06-10,한미약품美당뇨병학회서랩스커버리적용파이프라인연구결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=402172
2813,2019-06-10,한미약품미국당뇨병학회참가비만당뇨NASH신약연구결과발표,http://www.dailypop.kr/news/articleView.html?idxno=39514
2814,2019-06-10,한미약품비만∙당뇨신약세계경쟁력확인,http://www.seoulfn.com/news/articleView.html?idxno=345531
2815,2019-06-10,ADA2019한미약품랩스커버리적용비만당뇨NASH신약글로벌경쟁력확인,http://www.econovill.com/news/articleView.html?idxno=365089
2816,2019-06-10,한미약품미국당뇨병학회서비만∙당뇨∙NASH신약글로벌경쟁력확인,http://www.lawissue.co.kr/view.php?ud=201906102329434825d7f4c63cc6_12
2817,2019-06-11,한미약품美ADA서존재감뽑내,http://www.whosaeng.com/110623
2818,2019-06-11,ADA참가한미약품신약글로벌경쟁력확인,http://www.monews.co.kr/news/articleView.html?idxno=203070
2819,2019-06-12,한미약품주가정보및종목관련동향정보12일현재412000원,http://www.gokorea.kr/news/articleView.html?idxno=231467
2820,2019-06-12,6월12일한미약품오늘주식장411500원000,http://www.nbntv.co.kr/news/articleView.html?idxno=399130
2821,2019-06-12,한미약품비만당뇨신약글로벌경쟁력확인,http://www.wsobi.com/news/articleView.html?idxno=75416
2822,2019-06-12,한미약품파트너사들항암신약연구결과잇따라발표,http://www.wsobi.com/news/articleView.html?idxno=75417
2823,2019-06-12,바이오시밀러테마오후시황상승률상위종목셀트리온050에이프로젠제약035한미약품보합세등,http://www.gokorea.kr/news/articleView.html?idxno=231780
2824,2019-06-12,바이오시밀러테마주시황마감셀트리온한미약품등이주도,http://www.nbntv.co.kr/news/articleView.html?idxno=400250
2825,2019-06-12,바이오시밀러테마마감시황상승률상위종목셀트리온099한미약품024에이프로젠제약보합세등,http://www.gokorea.kr/news/articleView.html?idxno=232047
2826,2019-06-13,잡인사이드한미약품공채속보경력채용,http://www.newsinside.kr/news/articleView.html?idxno=792658
2827,2019-06-13,제약사매출대비인건비한미약품1위vsGC녹십자꼴찌,http://www.ceoscoredaily.com/news/article.html?no=56628
2828,2019-06-13,권세창한미약품대표희귀의약품연구개발에승부수띄운다,http://www.ekn.kr/news/article.html?no=437195
2829,2019-06-13,한미약품친환경경영앞장녹색한미캠페인펼쳐,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231643
2830,2019-06-13,한미약품주가증권투자정보외증시동향13일현재409500원,http://www.gokorea.kr/news/articleView.html?idxno=233520
2831,2019-06-14,대한민국국민약어린이종합영양제선두주자한미약품텐텐,http://www.ftoday.co.kr/news/articleView.html?idxno=109190
2832,2019-06-14,증권매매한미약품주가14일현재407500원,http://nbntv.co.kr/news/view/401756
2833,2019-06-14,바이오시밀러테마오후시황상승률상위종목에이프로젠제약722제넥신164한미약품049등,http://www.gokorea.kr/news/articleView.html?idxno=235928
2834,2019-06-14,바이오시밀러테마마감시황에이프로젠제약한미약품등이상승세견인중,http://nbntv.co.kr/news/view/402538
2835,2019-06-14,바이오시밀러테마마감시황상승률상위종목에이프로젠제약550한미약품012제넥신030등,http://www.gokorea.kr/news/articleView.html?idxno=236179
2836,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231741
2837,2019-06-17,한미약품사랑의헌혈대한적십자사표창‥39년째지속,http://medipana.com/news/news_viewer.asp?NewsNum=241513&MainKind=A&NewsKind=5&vCount=12&vKind=1
2838,2019-06-17,한미약품주가및증권시세외주식시황17일현재408000원,http://www.gokorea.kr/news/articleView.html?idxno=237846
2839,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,http://www.pressm.kr/news/articleView.html?idxno=23765
2840,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.nextdaily.co.kr/news/article.html?id=20190617800023
2841,2019-06-17,한미약품사랑의헌혈캠페인대한적십자사표창수상,http://www.newspim.com/news/view/20190617000491
2842,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,http://www.bosa.co.kr/news/articleView.html?idxno=2107166
2843,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.wolyo.co.kr/news/articleView.html?idxno=86574
2844,2019-06-17,한미약품39년사랑의헌혈캠페인적십자사표창,http://www.medisobizanews.com/news/articleView.html?idxno=60470
2845,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사로부터표창,http://www.econovill.com/news/articleView.html?idxno=365587
2846,2019-06-17,39년헌혈한미약품대한적십자사표창,http://www.whosaeng.com/110789
2847,2019-06-17,한미약품사랑의헌혈대한적십자사표창수상,http://www.asiatime.co.kr/news/articleView.html?idxno=251809
2848,2019-06-17,한미약품39년전통사랑의헌혈캠페인대한적십자사표창수상,http://www.newspost.kr/news/articleView.html?idxno=72158
2849,2019-06-17,한미약품대한적십자사회장표창수상,http://weekly.cnbnews.com/news/article.html?no=128457
2850,2019-06-17,한미약품39년간이어온사랑의헌혈대한적십자사표창,http://www.businesskorea.co.kr/news/articleView.html?idxno=32925
2851,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,http://daily.hankooki.com/lpage/ittech/201906/dh20190617114627145630.htm
2852,2019-06-17,한미약품헌혈문화확대생명나눔실천앞장,http://www.newsprime.co.kr/news/article.html?no=463814
2853,2019-06-17,한미약품대한적십자사표창,http://www.medical-tribune.co.kr/news/articleView.html?idxno=86328
2854,2019-06-17,한미약품세계헌혈자의날대한적십자사표창,http://www.seoulfn.com/news/articleView.html?idxno=346195
2855,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,http://www.metroseoul.co.kr/news/newsview?newscd=2019061700069
2856,2019-06-17,한미약품대한적십자사표창헌혈문화확대기여,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019061711210449517
2857,2019-06-17,한미약품대한적십자사회장표창수상,http://www.newswatch.kr/news/articleView.html?idxno=20634
2858,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.bokuennews.com/news/article.html?no=177142
2859,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,http://www.newsway.co.kr/news/view?tp=1&ud=2019061713521961291
2860,2019-06-17,한미약품39년헌혈켐페인공로로적십자회장표창받아,http://news.mk.co.kr/newsRead.php?year=2019&no=426890
2861,2019-06-17,한미약품39년전통사랑의헌혈대한적십자사표창수상,http://www.joseilbo.com/news/news_read.php?uid=378591&class=27&grp=
2862,2019-06-17,한미약품39년역사사랑의헌혈대한적십자사표창수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1766940
2863,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.sisajournal-e.com/news/articleView.html?idxno=201752
2864,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.100ssd.co.kr/news/articleView.html?idxno=62120
2865,2019-06-17,ET투자뉴스한미약품_상장주식수대비거래량은017로적정수준,http://www.etnews.com/20190617000238
2866,2019-06-17,한미약품사랑의헌혈대한적십자사표창참여인원8000명,http://www.dailysmart.co.kr/news/articleView.html?idxno=12359
2867,2019-06-17,제약오늘한미약품사랑의헌혈대한적십자사표창,http://www.sisaon.co.kr/news/articleView.html?idxno=95548
2868,2019-06-17,한미약품39년째사랑의헌혈캠페인진행대한적십자사표창,http://www.mdtoday.co.kr/mdtoday/index.html?no=357501
2869,2019-06-17,한미약품사랑의헌혈캠페인39년간이어와대한적십자사표창,http://www.wikileaks-kr.org/news/articleView.html?idxno=58245
2870,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.smedaily.co.kr/news/articleView.html?idxno=84059
2871,2019-06-17,한미약품헌혈문화확대및생명나눔실천공로사랑의헌혈대한적십자사표창,http://www.techholic.co.kr/news/articleView.html?idxno=183077
2872,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.cnbnews.com/news/article.html?no=413296
2873,2019-06-17,한미약품39년간헌혈캠페인공로적십자사표창수상,http://www.viva100.com/main/view.php?key=20190617010004985
2874,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.fnnews.com/news/201906171531028001
2875,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.newsfc.co.kr/news/articleView.html?idxno=36694
2876,2019-06-17,한미약품사랑의헌혈캠페인대한적십자사표창,http://www.newstomato.com/ReadNews.aspx?no=902013
2877,2019-06-17,한미약품사랑의헌혈캠페인대한적십자표창수상,http://www.edaily.co.kr/news/newspath.asp?newsid=03079926622522704
2878,2019-06-17,생명나눔대한적십자사표창한미약품사랑의헌혈누적참여인원8000명육박,http://kpenews.com/View.aspx?No=54610
2879,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.enewstoday.co.kr/news/articleView.html?idxno=1312860
2880,2019-06-17,한미약품대한적십자사표창,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55863
2881,2019-06-17,한미약품38년헌혈캠페인공로적십자사표창수상,http://www.rapportian.com/news/articleView.html?idxno=118112
2882,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,http://www.shinailbo.co.kr/news/articleView.html?idxno=1176760
2883,2019-06-17,한미약품사랑의헌혈캠페인대한적십자표창수상,http://biz.chosun.com/site/data/html_dir/2019/06/17/2019061702413.html
2884,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,http://www.ekn.kr/news/article.html?no=438036
2885,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,http://www.getnews.co.kr/view.php?ud=20190617171653793741d0c69529_16
2886,2019-06-17,한미약품헌혈캠페인으로적십자회장표창수상,http://www.finomy.com/news/articleView.html?idxno=66801
2887,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,http://www.upinews.kr/news/newsview.php?ncode=1065601072743488
2888,2019-06-17,건강한여름나기한미약품무조날S네일라카,https://www.sedaily.com/NewsView/1VKGBR33PD
2889,2019-06-17,사회공헌한미약품사랑의헌혈캠페인대한적십자표창수상,http://www.ezyeconomy.com/news/articleView.html?idxno=91547
2890,2019-06-17,한미약품39년역사사랑의헌혈대한적십자사표창,http://www.sportsseoul.com/news/read/777437
2891,2019-06-17,39년역사한미약품사랑의헌혈대한적십자사표창,https://www.insight.co.kr/news/232688
2892,2019-06-17,사랑의헌혈캠페인한미약품대한적십자사표창,http://www.fnnews.com/news/201906171831283480
2893,2019-06-17,한미약품사랑의헌혈대한적십자사표창,http://www.sporbiz.co.kr/news/articleView.html?idxno=347556
2894,2019-06-17,한미약품39년공익캠페인사랑의헌혈대한적십자사표창,http://www.lawissue.co.kr/view.php?ud=20190617213439583d7f4c63cc6_12
2895,2019-06-17,한미약품39년이어진사랑의헌혈캠페인대한적십자사표창수상,http://news.donga.com/3/all/20190617/96038166/1
2896,2019-06-18,퀵리포트한미약품TradingBuy유지목표가46만원유지메리츠證,http://www.itooza.com/common/iview.php?no=2019061808153113420
2897,2019-06-18,바이오시밀러테마마감시황상승률TOP5셀트리온4000원199이수앱지스40원056에이프로젠제약20원130한미약품6500원159제넥신1500원22,http://www.kbsm.net/default/index_view_page.php?idx=245464&part_idx=339
2898,2019-06-18,한미약품오늘증권시세18일현재408000원,http://nbntv.co.kr/news/view/408101
2899,2019-06-18,GET투자리포트한미약품투자의견Trading매수메리츠종금증권,http://www.getnews.co.kr/view.php?ud=201906181030307104tpgetnews_16
2900,2019-06-18,바이오시밀러테마오후시황상승률상위종목한올바이오파마255셀트리온171한미약품124등,http://www.gokorea.kr/news/articleView.html?idxno=240327
2901,2019-06-18,ET투자뉴스한미약품이번ASCO에서TRADINGBUY메리츠종금증권,http://www.etnews.com/20190618000148
2902,2019-06-18,39년역사한미약품사랑의헌혈대한적십자사표창,http://www.nspna.com/news/?mode=view&newsid=365885
2903,2019-06-18,리포트브리핑한미약품이번ASCO에서벨베라페닙오라스커버리그리고포지오티닙까지목표가460000원메리츠종금증권,http://www.newspim.com/news/view/20190618000822
2904,2019-06-18,한미약품주사용항암제를경구용으로바꾸는기술로약물개발순항,http://www.businesspost.co.kr/BP?command=article_view&num=131851
2905,2019-06-18,한미약품39년간사랑의헌혈캠페인대한적십자사표창,http://www.polinews.co.kr/news/article.html?no=396351
2906,2019-06-19,JW크레아젠끌고한미약품밀고교모세포종신약개발탄력,http://www.medisobizanews.com/news/articleView.html?idxno=60520
2907,2019-06-19,한미약품골관절염주사히알루마美본격출시,http://news.heraldcorp.com/view.php?ud=20190619000304
2908,2019-06-19,한미약품골관절염주사제히알루마미국시장본격출시,http://www.viva100.com/main/view.php?key=20190619010005641
2909,2019-06-19,한미약품골관절염주사히알루마미국첫수출,http://moneys.mt.co.kr/news/mwView.php?no=2019061910408053218
2910,2019-06-19,한미약품골관절염주사제히알루마미국본격출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=231842
2911,2019-06-19,한미약품주사용골관절염치료제히알루마美판매개시,http://news.mt.co.kr/mtview.php?no=2019061910430205726
2912,2019-06-19,한미약품골관절염주사제히알루마美출시,http://www.upinews.kr/news/newsview.php?ncode=1065577960793062
2913,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.ceoscoredaily.com/news/article.html?no=56870
2914,2019-06-19,한미약품의골관절염치료제히알루마美전역에서본격시판,https://www.sedaily.com/NewsView/1VKH8M1BTO
2915,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://medipana.com/news/news_viewer.asp?NewsNum=241637&MainKind=A&NewsKind=5&vCount=12&vKind=1
2916,2019-06-19,한미약품골관절염주사제히알루마美출시,https://view.asiae.co.kr/article/2019061911003685377
2917,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.bosa.co.kr/news/articleView.html?idxno=2107326
2918,2019-06-19,한미약품개발골관절염주사제히알루마美본격출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1767807
2919,2019-06-19,한미약품골관절염치료제히알루마미국서본격시판,http://www.medisobizanews.com/news/articleView.html?idxno=60538
2920,2019-06-19,한미약품히알루마美판매개시,http://weekly.cnbnews.com/news/article.html?no=128524
2921,2019-06-19,한미약품골관절염주사제히알루마미국서본격판매,http://www.ajunews.com/view/20190619111125821
2922,2019-06-19,한미약품골관절염주사제히알루마미국서출시,http://www.nextdaily.co.kr/news/article.html?id=20190619800045
2923,2019-06-19,한미약품골관절염주사제히알루마美서본격시판,http://www.ekn.kr/news/article.html?no=438401
2924,2019-06-19,한미약품미국내골관절염주사제출시,http://www.paxnetnews.com/articles/49841
2925,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.bokuennews.com/news/article.html?no=177265
2926,2019-06-19,한미약품골관절염주사제히알루마美본격출시,http://www.newsis.com/view/?id=NISX20190619_0000685240&cID=13001&pID=13000
2927,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.pressm.kr/news/articleView.html?idxno=23803
2928,2019-06-19,한미약품골관절염주사제히알루마미국서출시,http://biz.chosun.com/site/data/html_dir/2019/06/19/2019061901278.html
2929,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906190270&t=NN
2930,2019-06-19,주가차트한미약품주가19일현재413000원,http://nbntv.co.kr/news/view/411003
2931,2019-06-19,한미약품美서골관절염주사제히알루마출시,http://www.biospectator.com/view/news_view.php?varAtcId=7875
2932,2019-06-19,한미약품골관절염치료제히알루마美시장첫선적,http://www.doctorsnews.co.kr/news/articleView.html?idxno=129648
2933,2019-06-19,한미약품골관절염주사제히알루마美출시,http://www.ebn.co.kr/news/view/989679
2934,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://kormedi.com/?p=1295700
2935,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=357754
2936,2019-06-19,바이오시밀러테마오후시황상승률상위종목에이프로젠제약742제넥신456한미약품198등,http://www.gokorea.kr/news/articleView.html?idxno=242330
2937,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069463
2938,2019-06-19,한미약품골관절염주사제히알루마美시장본격출시,http://www.asiatime.co.kr/news/articleView.html?idxno=252408
2939,2019-06-19,한미약품골관절염주사제히알루마미국시판본격화,http://www.ezyeconomy.com/news/articleView.html?idxno=91606
2940,2019-06-19,한미약품골관절염주사제히알루마美본격출시,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=53900
2941,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.techholic.co.kr/news/articleView.html?idxno=183138
2942,2019-06-19,한미약품골관절염주사제히알루마미국서출시,http://www.m-i.kr/news/articleView.html?idxno=614008
2943,2019-06-19,한미약품골관절염주사제히알루마미국서출시,http://www.econovill.com/news/articleView.html?idxno=365798
2944,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.asiatoday.co.kr/view.php?key=20190619010011439
2945,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://yna.kr/AKR20190619106200017?did=1195m
2946,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.newspim.com/news/view/20190619000780
2947,2019-06-19,한미약품미국서골관절염주사제히알루마출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1177431
2948,2019-06-19,한미약품골관절염주사제히알루마美출시파트너사테바통해판매,http://www.sisajournal-e.com/news/articleView.html?idxno=201883
2949,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.mediapen.com/news/view/441594
2950,2019-06-19,한미약품골관절염주사제히알루마美출시,http://www.seoulwire.com/news/articleView.html?idxno=156711
2951,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019061900135
2952,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://www.dailymedi.com/detail.php?number=844360&thread=22r05
2953,2019-06-19,한미약품미국수출용골관절염치료제히알루마첫선적,http://news.mk.co.kr/newsRead.php?year=2019&no=435361
2954,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019061914414775959
2955,2019-06-19,한미약품골관절염주사제히알루마로美시장공략,http://www.sporbiz.co.kr/news/articleView.html?idxno=348358
2956,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.polinews.co.kr/news/article.html?no=396476
2957,2019-06-19,한미약품주사용골관절염치료제히알루마의미국판매시작,http://www.businesspost.co.kr/BP?command=article_view&num=132040
2958,2019-06-19,한미약품골관절염주사제히알루마美출시,http://www.sisafocus.co.kr/news/articleView.html?idxno=212672
2959,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://www.cnbnews.com/news/article.html?no=413558
2960,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.etnews.com/20190619000281
2961,2019-06-19,한미약품골관절염주사제히알루마미국본격판매,http://news1.kr/articles/?3649630
2962,2019-06-19,바이오시밀러테마마감시황상승률상위종목에이프로젠제약781제넥신456한미약품198등,http://www.gokorea.kr/news/articleView.html?idxno=242605
2963,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://biz.newdaily.co.kr/site/data/html/2019/06/19/2019061900157.html
2964,2019-06-19,한미약품골관절염주사제히알루마美출시,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=105665
2965,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://www.smedaily.co.kr/news/articleView.html?idxno=84127
2966,2019-06-19,한미약품골관저염주사제히알루마미국본격출시,http://www.news2day.co.kr/130007
2967,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1313667
2968,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://www.kpanews.co.kr/article/show.asp?idx=204830&table=article&category=D
2969,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.getnews.co.kr/view.php?ud=20190619163129392841d0c69529_16
2970,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=55910
2971,2019-06-19,한미약품골관절염주사제히알루마美전역본격시판,http://www.thebigdata.co.kr/view.php?ud=20190619163506161d0a8833aad_23
2972,2019-06-19,한미약품골관절염주사제히알루마美출시,http://news.bizwatch.co.kr/article/consumer/2019/06/19/0030/naver
2973,2019-06-19,한미약품골관절염주사제히알루미미국판매개시,http://news.donga.com/3/all/20190619/96069523/1
2974,2019-06-19,한미약품골관절염주사제히알루마美본격출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=12466
2975,2019-06-19,한미약품골관절염주사제히알루마美출시,http://daily.hankooki.com/lpage/ittech/201906/dh20190619164911145630.htm
2976,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.medigatenews.com/news/1625236868
2977,2019-06-19,한미약품골관절염치료제히알루마美출시,http://www.finomy.com/news/articleView.html?idxno=66873
2978,2019-06-19,한미약품골관절염주사제히알루마美출시,http://news.mk.co.kr/newsRead.php?year=2019&no=436366
2979,2019-06-19,美환자600여명대상임상실험마쳐한미약품골관절염주사제히알루마출시,http://kpenews.com/View.aspx?No=54916
2980,2019-06-19,한미약품골관절염주사제히알루마美전역에판매시작,http://www.joseilbo.com/news/news_read.php?uid=378768&class=17&grp=
2981,2019-06-19,한미약품골관절염주사제히알루마美출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=58417
2982,2019-06-19,한미약품주사용골관절염치료제히알루마美출시,http://www.rapportian.com/news/articleView.html?idxno=118167
2983,2019-06-19,한미약품골관절염주사제히알루마美본격출시,http://www.wolyo.co.kr/news/articleView.html?idxno=86882
2984,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=33051
2985,2019-06-19,한미약품골관절염주사제히알루마美출시,http://www.monews.co.kr/news/articleView.html?idxno=203255
2986,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://www.newstomato.com/ReadNews.aspx?no=902606
2987,2019-06-19,기업단신NH농협은행한미약품여기어때外,http://www.dailypop.kr/news/articleView.html?idxno=39658
2988,2019-06-19,한미약품새골관절염주사제히알루마2031년까지美판매,http://www.dt.co.kr/contents.html?article_no=2019062002101531102001&ref=naver
2989,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3866034
2990,2019-06-19,한미약품골관절염주사제히알루마미국서출시,https://www.insight.co.kr/news/233021
2991,2019-06-19,한미약품골관절염주사제히알루마미국출시,http://www.sportsseoul.com/news/read/778486
2992,2019-06-19,한미약품골관절염주사제히알루마미국서본격출시,http://www.lawissue.co.kr/view.php?ud=20190619234649821d7f4c63cc6_12
2993,2019-06-20,한미약품골관절염주사제히알루마미국서본격출시,http://www.nspna.com/news/?mode=view&newsid=366378
2994,2019-06-20,한미약품미국시장뚫었다골관절염치료제본격시판,http://www.ggilbo.com/news/articleView.html?idxno=677112
2995,2019-06-20,한미약품골관절염주사제히알루마미국출시,http://www.seoulfn.com/news/articleView.html?idxno=346528
2996,2019-06-20,한화證한미약품하반기RD저력나올것매수의견,http://www.newsis.com/view/?id=NISX20190620_0000686137&cID=10401&pID=10400
2997,2019-06-20,한미약품하반기주가반등전망한화투자증권,http://www.fnnews.com/news/201906200838568955
2998,2019-06-20,한미약품하반기RD저력느낄예정,http://www.newsprime.co.kr/news/article.html?no=464319
2999,2019-06-20,한미약품올해하반기다시한번RD저력보일것,https://www.sedaily.com/NewsView/1VKHPEIQOH
3000,2019-06-20,한미약품기술이전가능성주목한화투자증권,http://www.ajunews.com/view/20190620090255659
3001,2019-06-20,퀵리포트한미약품매수유지목표가64만원유지한화證,http://www.itooza.com/common/iview.php?no=2019062008061920503
3002,2019-06-20,6월20일한미약품오늘시세및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=244130
3003,2019-06-20,6월20일한미약품실시간주식현황416000원097,http://nbntv.co.kr/news/view/413916
3004,2019-06-20,한미약품골관절염주사제히알루마미국시장공략,http://www.sisaon.co.kr/news/articleView.html?idxno=95768
3005,2019-06-20,글로벌제약기업으로자리매김한한미약품골관절염치료제히알루마미국전역에서판매돌입,http://www.updownnews.co.kr/news/articleView.html?idxno=205077
3006,2019-06-20,한미약품골관절염주사제히알루마미국전역본격시판,http://www.ikunkang.com/news/articleView.html?idxno=29333
3007,2019-06-21,6월21일한미약품주식시세현황060421000원,http://nbntv.co.kr/news/view/416720
3008,2019-06-21,바이오시밀러테마오후시황상승률상위종목한미약품072팜스웰바이오050한올바이오파마보합세등,http://www.gokorea.kr/news/articleView.html?idxno=246519
3009,2019-06-21,21일13시바이오시밀러테마주시황오후한미약품팜스웰바이오등이상승세주도,http://nbntv.co.kr/news/view/416903
3010,2019-06-21,한미약품주사용골관절염치료제히알루마미국시장본격출시,http://www.econonews.co.kr/news/articleView.html?idxno=70798
3011,2019-06-21,바이오시밀러테마마감시황상승률상위종목팜스웰바이오100한올바이오파마018한미약품보합세등,http://www.gokorea.kr/news/articleView.html?idxno=246762
3012,2019-06-22,한화증권한미약품하반기에는RD저력나올것매수의견,http://www.econonews.co.kr/news/articleView.html?idxno=71071
3013,2019-06-24,美공략나선한미약품의골관절염치료제,http://weekly.hankooki.com/lpage/economy/201906/wk20190624090142146390.htm
3014,2019-06-24,바이오시밀러테마오전시황상승률상위종목이수앱지스085에이프로젠제약039한미약품036등,http://www.gokorea.kr/news/articleView.html?idxno=247873
3015,2019-06-24,한미약품종목검색24일현재418500원,http://nbntv.co.kr/news/view/419600
3016,2019-06-24,바이오시밀러테마오후시황상승률상위종목팜스웰바이오329한미약품012한올바이오파마037등,http://www.gokorea.kr/news/articleView.html?idxno=248543
3017,2019-06-24,13시27분바이오시밀러테마주시황오후팜스웰바이오한미약품등이주도,http://nbntv.co.kr/news/view/419930
3018,2019-06-24,바이오시밀러테마마감시황상승률상위종목팜스웰바이오181이수앱지스보합세한미약품036등,http://www.gokorea.kr/news/articleView.html?idxno=248802
3019,2019-06-24,증시매매동향6월24일한미약품417000원으로장마감,http://nbntv.co.kr/news/view/421783
3020,2019-06-25,한미약품獨사노피당뇨신약공동연구비중자사분5천만유로감액,http://www.edaily.co.kr/news/newspath.asp?newsid=01400566622525328
3021,2019-06-25,한미약품사노피와기술이전수정계약체결”,http://www.newspim.com/news/view/20190625000056
3022,2019-06-25,한미약품독일사노피와맺은당뇨신약공동연구비감액,https://view.asiae.co.kr/article/2019062508092922884
3023,2019-06-25,한미약품사노피와당뇨신약공동개발비용5천만유로절감,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232046
3024,2019-06-25,한미약품사노피와기술이전계약수정연구비감액,http://news.mt.co.kr/mtview.php?no=2019062508021571860
3025,2019-06-25,한미약품사노피와기술이전수정계약체결,http://yna.kr/AKR20190625026700008?did=1195m
3026,2019-06-25,한미약품사노피에기술이전한당뇨신약공동연구비5000만유로감액,http://biz.newdaily.co.kr/site/data/html/2019/06/25/2019062500014.html
3027,2019-06-25,한미약품사노피와기술이전수정계약체결,http://www.sentv.co.kr/news/view/555879
3028,2019-06-25,한미약품사노피당뇨신약공동연구비감액수정계약,http://www.doctorsnews.co.kr/news/articleView.html?idxno=129730
3029,2019-06-25,한미약품사노피기술이전계약연구비감액,http://news.mk.co.kr/newsRead.php?year=2019&no=452388
3030,2019-06-25,한미약품당뇨신약연구비감액수정계약체결사노피의지재확인,https://www.hankyung.com/it/article/2019062561446
3031,2019-06-25,공시한미약품사노피와기술이전수정계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2019062509085556315
3032,2019-06-25,한미약품사노피와기술이전계약수정연구비5000만유로감액,http://www.seoulwire.com/news/articleView.html?idxno=160330
3033,2019-06-25,한미약품사노피기술수출당뇨신약공동연구비650억원부담금줄어,http://biz.chosun.com/site/data/html_dir/2019/06/25/2019062500785.html
3034,2019-06-25,한미약품사노피와당뇨신약공동연구비660억원절감,http://medipana.com/news/news_viewer.asp?NewsNum=241877&MainKind=A&NewsKind=5&vCount=12&vKind=1
3035,2019-06-25,09시35분바이오시밀러테마주시황오전한올바이오파마한미약품등이상승세주도,http://nbntv.co.kr/news/view/422123
3036,2019-06-25,한미약품독일사노피와기술이전수정계약체결,http://www.newsprime.co.kr/news/article.html?no=464844
3037,2019-06-25,한미약품사노피와기술이전계약수정연구비줄어,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906250124&t=NN
3038,2019-06-25,한미약품사노피기술수출당뇨신약공동연구비부담↓,http://moneys.mt.co.kr/news/mwView.php?no=2019062509488031291
3039,2019-06-25,공시한미약품사노피와기술이전계약수정연구비감액,http://www.newsis.com/view/?id=NISX20190625_0000690662&cID=10401&pID=10400
3040,2019-06-25,한미약품독일사노피와맺은당뇨신약공동연구비5000만유로감액,http://www.mdtoday.co.kr/mdtoday/index.html?no=358195
3041,2019-06-25,한미약품에페글레나타이드공동연구비관련계약수정”,http://www.wikitree.co.kr/main/news_view.php?id=439604
3042,2019-06-25,주식종목시세한미약품주가25일현재413000원,http://nbntv.co.kr/news/view/422769
3043,2019-06-25,한미약품임상부담액650억↓현금유동성숨통,http://www.dailypharm.com/Users/News/NewsView.html?ID=254035&REFERER=NP
3044,2019-06-25,바이오시밀러테마오후시황상승률상위종목한올바이오파마019셀트리온144한미약품144등,http://www.gokorea.kr/news/articleView.html?idxno=250069
3045,2019-06-25,한미약품당뇨신약개발속도낸다,http://news.mk.co.kr/newsRead.php?year=2019&no=454172
3046,2019-06-25,한미약품사노피기술수출당뇨신약연구비650억감액,http://www.viva100.com/main/view.php?key=20190625010007700
3047,2019-06-25,한미약품사노피와기술이전계약수정공동연구비상한액감액,http://www.econonews.co.kr/news/articleView.html?idxno=71642
3048,2019-06-25,한미약품당뇨신약공동연구비650억원감면개발속도↑,http://it.chosun.com/site/data/html_dir/2019/06/25/2019062501787.html
3049,2019-06-25,한미약품공동연구비부담650억줄었다,https://www.hankyung.com/it/article/2019062581631
3050,2019-06-25,25일오늘의증시마감한미약품주가409000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=250672
3051,2019-06-25,한미약품사노피와기술수출신약에페글레나타이드수정계약,http://www.medisobizanews.com/news/articleView.html?idxno=60682
3052,2019-06-25,인기종목종목정보25일한미약품마감증시409000원,http://nbntv.co.kr/news/view/424971
3053,2019-06-26,한미약품기술수출이어글로벌신약상용화이룰까,http://www.sportsseoul.com/news/read/781170
3054,2019-06-26,퀵리포트한미약품매수유지목표가57만원유지이베스트證,http://www.itooza.com/common/iview.php?no=2019062607522417675
3055,2019-06-26,한미약품에페글레나타이드계약조건변경으로비용절감매수NH투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1770147
3056,2019-06-26,퀵리포트한미약품매수유지목표가58만원유지NH證,http://www.itooza.com/common/iview.php?no=2019062608013416722
3057,2019-06-26,퀵리포트한미약품Outperform으로상향목표가4↑46만원키움證,http://www.itooza.com/common/iview.php?no=2019062608023118045
3058,2019-06-26,I리포트한미약품사노피와계약조건변경으로비용감소–NH證,http://www.inews24.com/view/1188793
3059,2019-06-26,RD부담덜어낸한미약품목표가올랐는데주가는,https://www.hankyung.com/finance/article/201906269150e
3060,2019-06-26,한미약품연구개발비용200억감소효과기대영업익상향전망,http://www.asiatoday.co.kr/view.php?key=20190626010015273
3061,2019-06-26,한미약품사노피와수정계약RD비용부담덜어목표가↑키움,http://www.edaily.co.kr/news/newspath.asp?newsid=01476006622525656
3062,2019-06-26,한미약품RD비용부담덜어목표가↑”키움증권,http://www.dailian.co.kr/news/view/805850/?sc=naver
3063,2019-06-26,HotLine한미약품RD비용부담덜어목표가↑,http://news.mk.co.kr/newsRead.php?year=2019&no=456313
3064,2019-06-26,한미약품신약RD비용부담감소,https://www.sedaily.com/NewsView/1VKKF7VNTC
3065,2019-06-26,키움증권한미약품RD비용부담감소컨센서스상회예상”,http://www.newsway.co.kr/news/view?tp=1&ud=2019062608255067835
3066,2019-06-26,더벨한미약품사노피계약수정덕에자금운용숨통,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201906250100042300002678
3067,2019-06-26,키움證한미약품하반기다양한RD일정지켜봐야목표주가↑,http://www.newsis.com/view/?id=NISX20190626_0000691798&cID=10401&pID=10400
3068,2019-06-26,한미약품계약조건변경영업이익추정치상향NH,http://www.ebn.co.kr/news/view/990653
3069,2019-06-26,한미약품RD비용부담감소목표가올려,http://www.smedaily.co.kr/news/articleView.html?idxno=84272
3070,2019-06-26,키움證한미약품RD비용덜어목표가↑”,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201906260072&t=NN
3071,2019-06-26,한미약품연구개발비감소효과기대NH투자,http://www.newstomato.com/ReadNews.aspx?no=903811
3072,2019-06-26,한미약품사노피계약조건변경개발비감소기대NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01669526622525656
3073,2019-06-26,키움증권한미약품연구개발부담감소목표가상향”,http://www.sporbiz.co.kr/news/articleView.html?idxno=350646
3074,2019-06-26,키움증권한미약품RD비용부담감소목표주가투자의견상향조정,http://www.seoulwire.com/news/articleView.html?idxno=161378
3075,2019-06-26,한미약품목표주가상향사노피와계약고쳐연구비용부담덜어,http://www.businesspost.co.kr/BP?command=article_view&num=132928
3076,2019-06-26,퀵리포트한미약품매수유지목표가57만원유지KTB證,http://www.itooza.com/common/iview.php?no=2019062609344517212
3077,2019-06-26,한미약품에페글레나타이드계약조건변경영업이익추정치↑,http://www.newsprime.co.kr/news/article.html?no=465023
3078,2019-06-26,리포트브리핑한미약품RD비용부담덜었다목표가460000원키움증권,http://www.newspim.com/news/view/20190626000340
3079,2019-06-26,GET투자리포트한미약품투자의견Outperform유지키움증권,http://www.getnews.co.kr/view.php?ud=201906261030307344tpgetnews_16
3080,2019-06-26,ET투자뉴스한미약품RD비용부담덜OUTPERFORM유지키움증권,http://www.etnews.com/20190626000093
3081,2019-06-26,한미약품사노피와수정계약줄어든RD비용부담”,http://www.wikitree.co.kr/main/news_view.php?id=439861
3082,2019-06-26,리포트브리핑한미약품에페글레나타이드계약조건변경으로영업이익추정치19상향조정목표가580000원NH투자증권,http://www.newspim.com/news/view/20190626000498
3083,2019-06-26,GET투자리포트한미약품투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201906261030307361tpgetnews_16
3084,2019-06-26,ET투자뉴스한미약품에페글레나타이드계BUY유지NH투자증권,http://www.etnews.com/20190626000198
3085,2019-06-26,한미약품에페글레나타이드계약조건변경으로영업이익추정치19상향조정”,http://www.wikitree.co.kr/main/news_view.php?id=439982
3086,2019-06-26,26일장마감증권시세한미약품417000원마감,http://www.gokorea.kr/news/articleView.html?idxno=252625
3087,2019-06-26,증시매매동향26일한미약품마감증시417000원,http://nbntv.co.kr/news/view/429467
3088,2019-06-27,바이오시밀러테마오전시황상승률상위종목에이프로젠제약120한미약품024팜스웰바이오보합세등,http://www.gokorea.kr/news/articleView.html?idxno=253118
3089,2019-06-27,27일09시바이오시밀러오전의테마종목에이프로젠제약한미약품등이상승세주도,http://nbntv.co.kr/news/view/430870
3090,2019-06-27,WhoIs이관순한미약품부회장,http://www.businesspost.co.kr/BP?command=article_view&num=133112
3091,2019-06-27,6월27일한미약품오늘주식장000417000원,http://nbntv.co.kr/news/view/431546
3092,2019-06-27,바이오시밀러테마오후시황상승률상위종목에이프로젠제약201한미약품012한올바이오파마037등,http://www.gokorea.kr/news/articleView.html?idxno=253705
3093,2019-06-27,13시29분바이오시밀러오후의테마종목에이프로젠제약한미약품등이상승세견인중,http://nbntv.co.kr/news/view/431863
3094,2019-06-27,한미약품의종합영양제나인나인한알로부족한비타민D해결,http://news.mk.co.kr/newsRead.php?year=2019&no=462927
3095,2019-06-27,바이오시밀러테마마감시황에이프로젠제약한미약품등이주도,http://nbntv.co.kr/news/view/432387
3096,2019-06-27,키움증권한미약품듀얼어고니스트의2상결과등하반기다양한RD일정지켜봐야목표주가↑,http://www.econonews.co.kr/news/articleView.html?idxno=72091
3097,2019-06-27,바이오시밀러테마마감시황상승률상위종목에이프로젠제약040한미약품144이수앱지스260등,http://www.gokorea.kr/news/articleView.html?idxno=254126
3098,2019-06-27,한미약품의미네랄비티민나인나인28종영양소를한알에,http://www.kyeonggi.com/news/articleView.html?idxno=2123261
3099,2019-06-27,한미약품경영복귀이관순당뇨병치료제의블록버스터만들기앞장,http://www.businesspost.co.kr/BP?command=article_view&num=133189
3100,2019-06-27,한미약품나인나인하루한알로28종영양소와비타민D까지해결,http://www.wsobi.com/news/articleView.html?idxno=76590
3101,2019-06-27,한미약품에너지골드코리아팜어워드굿브랜드자양강장제부문대상,http://www.wsobi.com/news/articleView.html?idxno=76592
3102,2019-06-27,뉴스투데이L한미약품나인나인한알로하루권장비타민D해결”,http://www.news2day.co.kr/130704
3103,2019-06-27,한미약품에너지골드약국에서사랑받는드링크제,http://www.tfnews.co.kr/news/article.html?no=69248
3104,2019-06-27,한미약품에너지골드약국서사랑받는드링크제선정,http://www.econovill.com/news/articleView.html?idxno=366466
3105,2019-06-27,27일증시종목마감동향한미약품주가411000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=254414
3106,2019-06-27,한미약품에너지골드약국에서사랑받는드링크제,http://www.betanews.net:8080/article/1024622.html
3107,2019-06-28,잡인사이드한미약품공채속보경력채용,http://www.newsinside.kr/news/articleView.html?idxno=844398
3108,2019-06-28,한미약품에너지골드코리아팜어워드수상,http://news.heraldcorp.com/view.php?ud=20190628000036
3109,2019-06-28,바이오시밀러테마오전시황상승률상위종목에이프로젠제약보합세셀트리온025한미약품036등,http://www.gokorea.kr/news/articleView.html?idxno=254891
3110,2019-06-28,한미약품에너지골드약사가뽑은자양강장제대상수상,http://www.finomy.com/news/articleView.html?idxno=67165
3111,2019-06-28,한미약품주가및증권시세28일현재404500원,http://www.gokorea.kr/news/articleView.html?idxno=255187
3112,2019-06-28,6월28일한미약품실시간증시231401500원,http://nbntv.co.kr/news/view/435605
3113,2019-06-28,약사들이인정한자양강장제한미약품에너지골드,http://www.mediapen.com/news/view/443924
3114,2019-06-28,핫클릭신상품정부영양소지침따른한미약품나인나인,http://news.heraldcorp.com/view.php?ud=20190628000465
3115,2019-06-28,한미약품사노피와계약변경으로RD비용여유영업익감소폭줄여,http://biz.newdaily.co.kr/site/data/html/2019/06/28/2019062800143.html
3116,2019-06-28,한미약품나인나인한알로하루권장비타민D해결,http://www.opinionnews.co.kr/news/articleView.html?idxno=19361
3117,2019-06-28,한미약품에너지골드약사가뽑은최고자양강장제1위 ,http://www.opinionnews.co.kr/news/articleView.html?idxno=19359
3118,2019-06-28,28일장마감매매동향한미약품주가404000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=256164
3119,2019-06-28,특징주분석매매동향6월28일한미약품404000원으로장마감,http://nbntv.co.kr/news/view/437689
3120,2019-06-28,28일기관순매도Top10삼성전자909억삼성SDI58억한미약품52억KODEX200선물인버스2X34억외국인순매도나서코스닥시장에서는헬릭스미스제넥신케이엠더블유상위종목으로,http://www.fintechpost.co.kr/news/articleView.html?idxno=45528
3121,2019-06-29,한미약품기술력높게평가한사노피연구비더내겠다”,https://www.sedaily.com/NewsView/1VKLV2YEE4
3122,2019-06-30,에이치엘비사태2016년한미약품과비슷,https://view.asiae.co.kr/article/2019063021572090305
3123,2019-07-01,에이치엘비악재한미약품사태와비슷제약바이오저가매수기회하나금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1771761
3124,2019-07-01,7월1일한미약품오늘주식장297416000원,http://nbntv.co.kr/news/view/440187
3125,2019-07-01,한미약품개발HM15912국내서도희귀약지정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069826
3126,2019-07-01,바이오시밀러테마오후시황상승률상위종목제넥신688한미약품334한올바이오파마301등,http://www.gokorea.kr/news/articleView.html?idxno=257461
3127,2019-07-01,바이오시밀러테마마감시황상승률상위종목제넥신1023한올바이오파마442한미약품347등,http://www.gokorea.kr/news/articleView.html?idxno=257813
3128,2019-07-01,1일장마감매매동향한미약품418000원마감,http://www.gokorea.kr/news/articleView.html?idxno=258194
3129,2019-07-01,특징주분석주가정보7월1일한미약품418000원으로장마감,http://nbntv.co.kr/news/view/442336
3130,2019-07-02,7월2일한미약품오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=258959
3131,2019-07-02,역대최대규모제약채용박람회에유한한미약품뜬다총32개사등록”,https://www.sedaily.com/NewsView/1VLJDW5YFX
3132,2019-07-02,한미약품시세보기2일현재417500원,http://nbntv.co.kr/news/view/444520
3133,2019-07-02,핫클릭新상품정부영양소지침따른한미약품나인나인,http://news.heraldcorp.com/view.php?ud=20190702000500
3134,2019-07-02,유한양행한미약품등32개사제약바이오채용박람회등록,http://biz.chosun.com/site/data/html_dir/2019/07/02/2019070202240.html
3135,2019-07-02,한미약품도비알콜성지방간염치료제기술수출기대품어,http://www.businesspost.co.kr/BP?command=article_view&num=133795
3136,2019-07-02,2일마감주가정보한미약품주가415000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=259915
3137,2019-07-02,인기종목종목정보7월2일한미약품415000원으로장마감,http://nbntv.co.kr/news/view/446562
3138,2019-07-02,한미약품챔픽스특허분쟁끝까지간다,http://www.newsis.com/view/?id=NISX20190702_0000699193&cID=13001&pID=13000
3139,2019-07-03,한미약품주식현황3일현재416000원,http://nbntv.co.kr/news/view/448536
3140,2019-07-03,바이오시밀러테마마감시황상승률상위종목셀트리온049이수앱지스045한미약품012등,http://www.gokorea.kr/news/articleView.html?idxno=261223
3141,2019-07-03,3일오늘의증시마감한미약품414500원마감,http://www.gokorea.kr/news/articleView.html?idxno=261526
3142,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,https://www.hankyung.com/it/article/201907039276f
3143,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.ebn.co.kr/news/view/991767
3144,2019-07-03,한미약품얀센에기술수출했던비만당뇨치료제후보물질HM12525A계약해지속보,https://www.sedaily.com/NewsView/1VLJUNDPPU
3145,2019-07-03,얀센한미약품에비만당뇨치료제권리반환,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56144
3146,2019-07-03,한미약품얀센으로부터비만당뇨치료제권리회수,http://news.mt.co.kr/mtview.php?no=2019070318043517579
3147,2019-07-03,한미약품얀센비만당뇨치료제권리반환혈당조절내부기준미달,http://www.newspim.com/news/view/20190703001184
3148,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.metroseoul.co.kr/news/newsview?newscd=2019070300197
3149,2019-07-03,공시한미약품얀센비만당뇨치료제권리반환”,http://www.newsway.co.kr/news/view?tp=1&ud=2019070318051216308
3150,2019-07-03,한미약품얀센비만당뇨치료제권리반환결정,http://www.edaily.co.kr/news/newspath.asp?newsid=03936006622550912
3151,2019-07-03,얀센비만당뇨치료제판권한미약품에반환,http://www.sportsseoul.com/news/read/785242
3152,2019-07-03,한미약품기술수출또난항얀센비만당뇨병치료제권리반환,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019070318091368662
3153,2019-07-03,얀센한미약품에1조원대비만당뇨신약권리반환,http://news.mt.co.kr/mtview.php?no=2019070318083245166
3154,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.etnews.com/20190703000473
3155,2019-07-03,한미약품얀센에기술수출한비만당뇨치료후보물질권리반환받아,http://news.mk.co.kr/newsRead.php?year=2019&no=484802
3156,2019-07-03,한미약품기술수출1조원물거품되나얀센으로부터권리회수,http://moneys.mt.co.kr/news/mwView.php?no=2019070318108084310
3157,2019-07-03,한미약품얀센기술이전비만당뇨신약권리반환,http://www.dailypharm.com/Users/News/NewsView.html?ID=254350&REFERER=NP
3158,2019-07-03,다국적제약사얀센비만당뇨신약권리한미약품에반환,http://news1.kr/articles/?3661701
3159,2019-07-03,얀센비만당뇨치료제HM12525A권리한미약품에반환,http://www.medigatenews.com/news/786271536
3160,2019-07-03,얀센한미약품비만신약기술반환사실상개발포기,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1127486&REFERER=NP
3161,2019-07-03,한미약품얀센기술수출비만당뇨치료제반환,http://www.biospectator.com/view/news_view.php?varAtcId=7958
3162,2019-07-03,공시한미약품얀센비만당뇨치료제권리한미약품에반환결정,http://www.newsis.com/view/?id=NISX20190703_0000700400&cID=10401&pID=10400
3163,2019-07-03,얀센한미약품비만당뇨치료제권리반환,http://www.seoulfn.com/news/articleView.html?idxno=348167
3164,2019-07-03,한미약품1조원대비만당뇨치료제기술수출계약해지,https://www.sedaily.com/NewsView/1VLJVJO1FU
3165,2019-07-03,한미약품얀센에기술수출한비만당뇨치료제권리반환종합,https://view.asiae.co.kr/article/2019070318252988927
3166,2019-07-03,한미약품얀센비만당뇨치료제권리반환,http://biz.newdaily.co.kr/site/data/html/2019/07/03/2019070300204.html
3167,2019-07-03,한미약품얀센과맺은1조수출계약물거품,http://www.kpinews.co.kr/news/articleView.html?idxno=98996
3168,2019-07-03,한미약품비만당뇨치료제기술수출백지화,http://www.finomy.com/news/articleView.html?idxno=67314
3169,2019-07-03,한미약품얀센에기술수출당뇨비만약계약취소,http://www.medical-tribune.co.kr/news/articleView.html?idxno=86666
3170,2019-07-03,한미약품얀센에기술수출한비만당뇨치료신약개발권반환,http://www.edaily.co.kr/news/newspath.asp?newsid=03975366622550912
3171,2019-07-03,한미약품美얀센기술수출비만당뇨치료제권리회수당뇨치료입증실패”,http://www.donga.com/news/article/all/20190703/96311508/1
3172,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.newsway.co.kr/news/view?tp=1&ud=2019070318043620640
3173,2019-07-03,얀센한미약품비만당뇨치료제기술수출계약해지,http://biz.chosun.com/site/data/html_dir/2019/07/03/2019070302465.html
3174,2019-07-03,한미약품얀센기술수출비만당뇨치료제권리반환,http://www.medisobizanews.com/news/articleView.html?idxno=60875
3175,2019-07-03,얀센비만당뇨치료제HM12525A권리한미약품에반환혈당조절내부기준에못미쳐,http://www.sisafocus.co.kr/news/articleView.html?idxno=214158
3176,2019-07-03,한미약품얀센기술수출비만당뇨신약개발권리반환종합,http://yna.kr/AKR20190703161851008?did=1195m
3177,2019-07-03,한미약품얀센비만당뇨치료제권리반환”계약금1230억원은반환의무無,http://it.chosun.com/site/data/html_dir/2019/07/03/2019070302490.html
3178,2019-07-03,얀센비만당뇨치료제한미약품에권리반환,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232427
3179,2019-07-03,얀센비만당뇨신약권리한미약품에반환,http://www.viva100.com/main/view.php?key=20190703010001387
3180,2019-07-03,한미약품1조원신약기술수출취소얀센반환통보,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907030609&t=NN
3181,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.bosa.co.kr/news/articleView.html?idxno=2108271
3182,2019-07-03,한미약품신약개발권리반환,http://www.ggilbo.com/news/articleView.html?idxno=681785
3183,2019-07-03,한미약품얀센비만당뇨신약개발권리반환,http://www.kyeongin.com/main/view.php?key=20190703010001452
3184,2019-07-03,얀센한미약품비만당뇨신약개발중단,https://www.paxnetnews.com/articles/50241
3185,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.g-enews.com/ko-kr/news/article/news_all/2019070318590371884e4869c120_1/article.html
3186,2019-07-03,얀센한미약품에비만당뇨치료제개발계약해지통보,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069925
3187,2019-07-03,한미약품1조원대비만당뇨치료제HM12525A반환,http://www.newsis.com/view/?id=NISX20190703_0000700439&cID=13001&pID=13000
3188,2019-07-03,얀센한미약품비만당뇨치료제권리반환,http://www.upinews.kr/news/newsview.php?ncode=1065605847133641
3189,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.businesskorea.co.kr/news/articleView.html?idxno=33537
3190,2019-07-03,한미약품얀센기술수출비만당뇨신약개발권리반환,http://www.asiatoday.co.kr/view.php?key=20190703010002618
3191,2019-07-03,한미약품얀센에기술수출한비만당뇨치료제권리반환,http://www.etoday.co.kr/news/section/newsview.php?idxno=1773199
3192,2019-07-03,인기주분석매매동향7월3일한미약품414500원으로장마감,http://nbntv.co.kr/news/view/450498
3193,2019-07-03,한미약품기술수출물거품비만당뇨병치료제계약취소,http://www.econovill.com/news/articleView.html?idxno=366905
3194,2019-07-03,한미약품다국적제약사얀센기술수출비만당뇨신약개발권리반환,http://www.joongboo.com/news/articleView.html?idxno=1366611
3195,2019-07-03,한미약품얀센과비만당뇨치료제기술수출계약해지,http://www.newspim.com/news/view/20190703001214
3196,2019-07-03,한미약품얀센기술수출비만당뇨신약개발권리반환,http://www.asiatoday.co.kr/view.php?key=20190703010002622
3197,2019-07-03,얀센한미약품비만당뇨치료제권리반환혈당조절효능부족,https://cnbc.sbs.co.kr/article_hub/10000947258?division=NAVER
3198,2019-07-03,한미약품얀센에기술이전한비만당뇨치료제권리돌려받아,http://www.businesspost.co.kr/BP?command=article_view&num=134003
3199,2019-07-03,한미약품얀센기술수출비만당뇨신약개발권리반환,http://www.busan.com/view/busan/view.php?code=2019070319430928664
3200,2019-07-03,한미약품얀센1조원대비만당뇨치료제반환득일까실일까,http://www.siminsori.com/news/articleView.html?idxno=213330
3201,2019-07-03,3일공시종합한미약품얀센과비만당뇨치료제기술수출계약해지등,http://www.newspim.com/news/view/20190703001220
3202,2019-07-03,한미약품얀센비만당뇨치료제HM12525A권리반환결정,http://www.m-i.kr/news/articleView.html?idxno=618488
3203,2019-07-03,얀센1조원대비만당뇨치료제신약개발안한다한미약품에반환,http://www.ajunews.com/view/20190703202135958
3204,2019-07-03,한미약품1조원규모기술수출무산,http://www.segye.com/content/html/2019/07/03/20190703514094.html?OutUrl=naver
3205,2019-07-03,얀센한미약품에비만당뇨치료제권리반환,http://www.news2day.co.kr/131091
3206,2019-07-03,한미약품얀센에기술이전한비만치료제반환결정계약금은반환X,https://www.hankyung.com/society/article/201907039504H
3207,2019-07-03,한미약품1조원대당뇨신약기술수출무산,http://news.mk.co.kr/newsRead.php?year=2019&no=485158
3208,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.pressm.kr/news/articleView.html?idxno=24028
3209,2019-07-03,한미약품무슨일안셴비만치료제권리반환,http://www.g-enews.com/ko-kr/news/article/news_all/2019070320190995674a01bf698f_1/article.html
3210,2019-07-03,한미약품얀센에기술수출한신약개빌권반환돼1조수출계약중계약금1200억은수령,http://www.segye.com/content/html/2019/07/03/20190703513983.html?OutUrl=naver
3211,2019-07-03,한미약품비만당뇨치료제개발중단얀센이권리반환통보효과는입증됐다,http://www.newsinside.kr/news/articleView.html?idxno=866304
3212,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.dailian.co.kr/news/view/808107/?sc=naver
3213,2019-07-03,한미약품얀센기술수출비만당뇨치료제개발중단,http://www.inews24.com/view/1191000
3214,2019-07-03,한미약품얀센에1조원대비만당뇨신약기술수출무산,http://ilyo.co.kr/?ac=article_view&entry_id=340166
3215,2019-07-03,한미약품1조원대비만당뇨치료제권리반환,http://www.womennews.co.kr/news/articleView.html?idxno=191513
3216,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.fnnews.com/news/201907032218002199
3217,2019-07-03,한미약품1조원대당뇨신약기술수출무산얀센개발권리반환,http://www.asiatime.co.kr/news/articleView.html?idxno=255566
3218,2019-07-03,마감한미약품1조원대기술수출무산삼성전자SK하이닉스일본반도체수출규제하락,http://www.asiatime.co.kr/news/articleView.html?idxno=255567
3219,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://medipana.com/news/news_viewer.asp?NewsNum=242346&MainKind=A&NewsKind=5&vCount=12&vKind=1
3220,2019-07-03,얀센비만당뇨치료제권리한미약품에반환,http://www.getnews.co.kr/view.php?ud=20190703235028393441d0c69529_16
3221,2019-07-04,얀센비만당뇨치료제권리한미약품에반환,http://www.nspna.com/news/?mode=view&newsid=369334
3222,2019-07-04,한미약품1兆기술수출물거품,http://biz.chosun.com/site/data/html_dir/2019/07/04/2019070400302.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3223,2019-07-04,한미약품챔픽스특허무효에2차도전장,http://www.mdtoday.co.kr/mdtoday/index.html?no=358995
3224,2019-07-04,코스피코스닥3일주요공시한미약품얀센기술수출비만당뇨신약개발권리반환”등,http://www.betanews.net:8080/article/1026752.html
3225,2019-07-04,한미약품1조규모비만당뇨치료제기술수출무산,http://www.polinews.co.kr/news/article.html?no=399001
3226,2019-07-04,한미약품야센1조원대비만당뇨치료제권리반환비만치료효과는입증계약금은돌려주지않아,http://www.econonews.co.kr/news/articleView.html?idxno=73408
3227,2019-07-04,한입뉴스美화웨이여전히블랙리스트경영계최저임금깎자vs노동계1만원으로올리자한미약품1조원규모기술수출엎어져박용만우리는서로비난하기바빠”현대오일뱅크유화사업설비증설에260,http://www.econovill.com/news/articleView.html?idxno=366910
3228,2019-07-04,얀센한미약품비만당뇨치료제권리효능미비로반환결정한미약품입장은,http://www.newsinside.kr/news/articleView.html?idxno=867097
3229,2019-07-04,한미약품얀센에기술수출한비만당뇨치료제권리반환,http://www.newstomato.com/ReadNews.aspx?no=905669
3230,2019-07-04,얀센비만당뇨치료제권리한미약품에반환,https://www.hankyung.com/it/article/2019070498736
3231,2019-07-04,한미약품1조규모신약기술수출무산주가향방초미관심,http://www.seoulwire.com/news/articleView.html?idxno=167815
3232,2019-07-04,큰손국민연금바이오제약주꾸준한매집왜한미약품소폭줄었지만10대유지,http://www.g-enews.com/ko-kr/news/article/news_all/201907040735269254e4869c120_1/article.html
3233,2019-07-04,한미약품RD신뢰회복이중요키움증권,http://news.mt.co.kr/mtview.php?no=2019070407342447011
3234,2019-07-04,퀵리포트한미약품매수유지목표가57만원유지이베스트證,http://www.itooza.com/common/iview.php?no=2019070407462415394
3235,2019-07-04,퀵리포트한미약품중립으로하향목표가미제시한투證,http://www.itooza.com/common/iview.php?no=2019070407503818503
3236,2019-07-04,한미약품1조규모비만당뇨치료제기술수출파기,http://news.bizwatch.co.kr/article/consumer/2019/07/04/0001/naver
3237,2019-07-04,한미약품1조잭팟비만당뇨치료제기술수출무산에이치엘비메지온등파장촉각,http://www.news2day.co.kr/131107
3238,2019-07-04,한미약품비만당뇨치료제기술수출취소1조원→1230억원,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20190704.99099002007
3239,2019-07-04,한미약품당뇨비만치료제파이프라인가치절하메리츠,http://www.edaily.co.kr/news/newspath.asp?newsid=01308726622551240
3240,2019-07-04,한미약품얀센기술이전계약해지주가영향은,http://www.etoday.co.kr/news/section/newsview.php?idxno=1773236
3241,2019-07-04,한미약품얀센1조원대신약개발권리반환개발방향확정할것”,http://www.ajunews.com/view/20190704075536124
3242,2019-07-04,한미약품얀센1조원대비만당뇨신약개발권리반환”,http://sports.khan.co.kr/news/sk_index.html?art_id=201907040805003&sec_id=564001&pt=nv
3243,2019-07-04,한미약품비만당뇨치료제권리반환투자의견중립,http://www.asiatoday.co.kr/view.php?key=20190704010002674
3244,2019-07-04,한미약품얀센계약해지로단기충격불가피목표가↓NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01367766622551240
3245,2019-07-04,한미약품세번째권리반환투자의견보유로하향삼성,http://www.edaily.co.kr/news/newspath.asp?newsid=01377606622551240
3246,2019-07-04,하나금투한미약품신약권리반환으로가치하락불가피,http://yna.kr/AKR20190704023300008?did=1195m
3247,2019-07-04,한미약품1조신약기술수출취소얀센반환통보,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907030628&t=NNv
3248,2019-07-04,퀵리포트한미약품매수유지목표가8↓53만원NH證,http://www.itooza.com/common/iview.php?no=2019070408135319436
3249,2019-07-04,한미약품얀센에기술수출한신약비만엔효능당뇨엔미흡,http://news.heraldcorp.com/view.php?ud=20190704000025
3250,2019-07-04,냉철한투자판단필요한미약품목표가↓하나,http://www.edaily.co.kr/news/newspath.asp?newsid=01416966622551240
3251,2019-07-04,퀵리포트한미약품매수유지목표가13↓50만원하나금투,http://www.itooza.com/common/iview.php?no=2019070408161911665
3252,2019-07-04,속보한미약품와르르얀센권리반환쇼크코스닥코스피바이오주비상,http://www.g-enews.com/ko-kr/news/article/news_all/201907040814426194a01bf698f_1/article.html
3253,2019-07-04,퀵리포트한미약품매수유지목표가12↓50만원대신證,http://www.itooza.com/common/iview.php?no=2019070408182821282
3254,2019-07-04,한미약품얀센권리반환으로급락은과매도NH證,http://news.mt.co.kr/mtview.php?no=2019070408160475373
3255,2019-07-04,한미약품RD신뢰회복이주가향방에관건⋯목표가↓키움증권,http://www.dailian.co.kr/news/view/808118/?sc=naver
3256,2019-07-04,하나금투한미약품치료제권리반환목표가↓,http://www.newsis.com/view/?id=NISX20190704_0000700628&cID=10401&pID=10400
3257,2019-07-04,한미약품신약권리반환으로기업가치하락불가피목표가↓하나금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1773259
3258,2019-07-04,퀵리포트한미약품매수유지목표가9↓61만5000원미래에셋대우,http://www.itooza.com/common/iview.php?no=2019070408295412394
3259,2019-07-04,한미약품얀센비만당뇨치료제권리반환1兆기술수출무산,http://www.sisajournal-e.com/news/articleView.html?idxno=202616
3260,2019-07-04,삼성증권한미약품연이은계약반환투자의견목표주가↓”,http://www.newsway.co.kr/news/view?tp=1&ud=2019070408303959626
3261,2019-07-04,퀵리포트한미약품매수유지목표가6↓60만원한화證,http://www.itooza.com/common/iview.php?no=2019070408320612710
3262,2019-07-04,NH투자證한미약품신약권리반환단기주가충격불가피,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907040061&t=NN
3263,2019-07-04,한미약품1조계약해지로하락불가피10이상은과매도,https://www.hankyung.com/finance/article/2019070400216
3264,2019-07-04,한미약품판권반환이슈로기업가치하향조정”미래에셋대우,http://www.ajunews.com/view/20190704083820193
3265,2019-07-04,한미약품지속적인기술반환우려투자의견중립하향한국,http://www.edaily.co.kr/news/newspath.asp?newsid=01584246622551240
3266,2019-07-04,증시키워드잇따른바이오반도체악재한미약품↓후성↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1773271
3267,2019-07-04,하나금투한미약품신약권리반환에가치하락”목표가↓,http://www.viva100.com/main/view.php?key=20190704010001433
3268,2019-07-04,하나금투한미약품냉철한투자판단필요목표가하향,http://moneys.mt.co.kr/news/mwView.php?no=2019070408308053655
3269,2019-07-04,1조원대기술수출또실패한한미약품,https://www.sedaily.com/NewsView/1VLK9FR8C3
3270,2019-07-04,한미약품기업가치하락불가피목표주가하향,https://www.sedaily.com/NewsView/1VLKA30XK7
3271,2019-07-04,하나금투한미약품신약권리반환으로하락불가피,http://www.kyeongin.com/main/view.php?key=20190704010001565
3272,2019-07-04,한미약품1조기술수출물거품얀센비만당뇨치료제권리반환,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003641811
3273,2019-07-04,1조원기술수출실패한한미약품어려움있어도제약강국위한도전멈추지않을것”,https://www.sedaily.com/NewsView/1VLK9I7OSJ
3274,2019-07-04,하나금투한미약품치료제권리반환에기업가치하락불가피목표가↓”,http://www.sentv.co.kr/news/view/556486
3275,2019-07-04,대신증권한미약품신약개발불확실성증가목표주가↓,http://yna.kr/AKR20190704029000008?did=1195m
3276,2019-07-04,HotLine한미약품네번째기술반환투자의견목표가↓,http://news.mk.co.kr/newsRead.php?year=2019&no=485679
3277,2019-07-04,하이로우한미약품세번째권리반환가치하락불가피하나금융투자,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019070408512579002
3278,2019-07-04,한미약품세번째기술권리반환비만당뇨신약가치하락불가피,http://biz.newdaily.co.kr/site/data/html/2019/07/04/2019070400020.html
3279,2019-07-04,한국투자한미약품글로벌신약개발높은벽주가상승제한적,http://www.whitepaper.co.kr/news/articleView.html?idxno=164581
3280,2019-07-04,또반환한미약품1조규모기술수출취소,http://sports.chosun.com/news/ntype.htm?id=201907050100033660002096&servicedate=20190704
3281,2019-07-04,한미약품주식투자의견중립으로하향수출신약기술계속반환돼,http://www.businesspost.co.kr/BP?command=article_view&num=134022
3282,2019-07-04,한미약품어려움있어도제약강국도전멈추지않겠다”,http://biz.chosun.com/site/data/html_dir/2019/07/04/2019070400728.html
3283,2019-07-04,신약개발벽이렇게높나”증권街한미약품악재에탄식,http://www.edaily.co.kr/news/newspath.asp?newsid=01725286622551240
3284,2019-07-04,한미약품어려움있어도신약개발도전멈추지않겠다,http://www.newsis.com/view/?id=NISX20190704_0000700700&cID=13001&pID=13000
3285,2019-07-04,한미약품신약파이프라인30여개도전멈추지않겠다,http://www.medisobizanews.com/news/articleView.html?idxno=60884
3286,2019-07-04,한미약품제약강국도전멈추지않겠다”,http://www.whosaeng.com/111199
3287,2019-07-04,하나금투한미약품기술반환가치하락불가피목표가↓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907040079&t=NN
3288,2019-07-04,하나금투한미약품신약권리반환으로가치하락불가피,http://www.seoulwire.com/news/articleView.html?idxno=167840
3289,2019-07-04,한미약품20하락전일보다83000원내린331500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907040092&t=NN
3290,2019-07-04,한미약품1兆기술수출물거품소식에목표주가줄줄이하향,http://biz.chosun.com/site/data/html_dir/2019/07/04/2019070400747.html
3291,2019-07-04,한미약품1兆기술수출물거품소식에목표주가줄줄이하향,http://biz.chosun.com/site/data/html_dir/2019/07/04/2019070400747.html
3292,2019-07-04,한미약품기술수출무산도전멈추지않을것,http://www.newspim.com/news/view/20190704000112
3293,2019-07-04,특징주한미약품1조기술수출불발약세,http://www.newspim.com/news/view/20190704000125
3294,2019-07-04,특징주한미약품1조원규모기술수출무산에급락,http://www.ekn.kr/news/article.html?no=441022
3295,2019-07-04,특징주한미약품기술권리반환소식에급락세,http://news.mt.co.kr/mtview.php?no=2019070409024286313
3296,2019-07-04,머니e종목한미약품한미사이언스동반폭락,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019070409011832870
3297,2019-07-04,리포트브리핑한미약품가지많은나무의숙명목표가400000원DB금융투자,http://www.newspim.com/news/view/20190704000146
3298,2019-07-04,한미약품네번째기술반환에투자자들발길돌려당혹19대급락,http://www.econonews.co.kr/news/articleView.html?idxno=73446
3299,2019-07-04,GET투자리포트한미약품투자의견보유유지DB금융투자,http://www.getnews.co.kr/view.php?ud=201907041030307646tpgetnews_16
3300,2019-07-04,특징주한미약품판권반환소식20대급락,http://www.ajunews.com/view/20190704090543255
3301,2019-07-04,하나금투한미약품신약권리반환에가치하락불가피목표가13↓”,http://www.kukinews.com/news/article.html?no=678652
3302,2019-07-04,특징주한미약품비만당뇨치료후보물질기술반환에급락,http://news.mk.co.kr/newsRead.php?year=2019&no=485778
3303,2019-07-04,1조계약해지한미약품체중감량효과입증한셈,http://news.mt.co.kr/mtview.php?no=2019070409020735786
3304,2019-07-04,특징주한미약품1조원대신약개발권리반환소식에장중20급락,https://view.asiae.co.kr/article/2019070409095817463
3305,2019-07-04,특징주한미약품1조원대기술수출계약해지폭락,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907040106&t=NN
3306,2019-07-04,특징주한미약품한미사이언스치료제권리반환에급락,http://www.edaily.co.kr/news/newspath.asp?newsid=01876166622551240
3307,2019-07-04,특징주한미약품1조기술권리반환악재에급락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1773301
3308,2019-07-04,얀센비만당뇨치료제권리한미약품에반환,http://www.shinailbo.co.kr/news/articleView.html?idxno=1182276
3309,2019-07-04,특징주한미약품파트너사의신약권리반환에급락,http://yna.kr/AKR20190704034500008?did=1195m
3310,2019-07-04,기술반환받은한미약품제약강국위한도전계속할것,http://news.mk.co.kr/newsRead.php?year=2019&no=485796
3311,2019-07-04,기술반환받은한미약품제약강국위한도전계속할것,http://news.mk.co.kr/newsRead.php?year=2019&no=485796
3312,2019-07-04,특징주한미약품1조원기술수출무산에급락,http://www.asiatime.co.kr/news/articleView.html?idxno=255597
3313,2019-07-04,특징주한미약품얀센비만당뇨치료제권리반환으로하락,http://www.newstomato.com/ReadNews.aspx?no=905686
3314,2019-07-04,특징주한미약품당뇨신약기술수출무산소식에추락,http://www.cstimes.com/?mod=news&act=articleView&idxno=309275
3315,2019-07-04,기술수출반환된한미약품어려움있어도도전멈추지않을것”,https://view.asiae.co.kr/article/2019070408585134496
3316,2019-07-04,한미약품어려움있어도제약강국위한도전멈추지않겠다”,http://www.dailian.co.kr/news/view/808144/?sc=naver
3317,2019-07-04,한미사이언스한미약품기술반환여파20폭락,http://www.econonews.co.kr/news/articleView.html?idxno=73451
3318,2019-07-04,퀵리포트한미약품Marketperform으로하향목표가23↓35만원키움證,http://www.itooza.com/common/iview.php?no=2019070408274812136
3319,2019-07-04,특징주한미약품기술권리반환소식에장초반급락,http://www.newsis.com/view/?id=NISX20190704_0000700753&cID=10401&pID=10400
3320,2019-07-04,키움증권한미약품목표주가46만원→35만우너하향조정신뢰회복이향후주가에영향,http://www.newsinside.kr/news/articleView.html?idxno=867361
3321,2019-07-04,한미약품제약강국도전지속RD신뢰회복하겠다”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1773305
3322,2019-07-04,특징주한미약품1조원대신약개발권리반환소식에주가폭락,http://www.fntimes.com/html/view.php?ud=2019070409061596296c0eb6f11e_18
3323,2019-07-04,한미약품제약강국위한도전멈추지않겠다,http://www.sisafocus.co.kr/news/articleView.html?idxno=214177
3324,2019-07-04,특징주한미약품얀센의신약권리반환에급락,http://www.ebn.co.kr/news/view/991803
3325,2019-07-04,한미약품글로벌신약어렵지만도전멈추지않겠다,http://www.dailypharm.com/Users/News/NewsView.html?ID=254360&REFERER=NP
3326,2019-07-04,한미약품어려움있어도제약강국위한혁신도전에최선,http://medipana.com/news/news_viewer.asp?NewsNum=242350&MainKind=A&NewsKind=5&vCount=12&vKind=1
3327,2019-07-04,특징주한미약품1조원대당뇨신약기술수출무산소식에급락,http://www.newsway.co.kr/news/view?tp=1&ud=2019070409194886864
3328,2019-07-04,한미약품얀센기술반환소식에52주신저가경신한미사이언스유한양행대웅제약등관련주현황은,http://www.topstarnews.net/news/articleView.html?idxno=642305
3329,2019-07-04,미래에셋대우한미약품비만당뇨치료제판권반환아쉬워목표주가↓”,http://www.lawissue.co.kr/view.php?ud=2019070409143757039817d053b9_12
3330,2019-07-04,한미약품어려움있어도도전멈추지않겠다,http://www.doctorsnews.co.kr/news/articleView.html?idxno=129903
3331,2019-07-04,fnRASSI한미약품거래량확대되며3거래일연속하락,http://www.fnnews.com/news/201907040924269892
3332,2019-07-04,한미약품얀센비만당뇨치료제권리반환,http://www.inews24.com/view/1191079
3333,2019-07-04,자체신약매출국내최대1조한미약품도전은계속된다,http://news.heraldcorp.com/view.php?ud=20190704000107
3334,2019-07-04,특징주한미약품파트너사의신약권리반환에급락,http://www.seoulwire.com/news/articleView.html?idxno=167851
3335,2019-07-04,ET투자뉴스한미약품가지많은나무의HOLD유지DB금융투자,http://www.etnews.com/20190704000032
3336,2019-07-04,특징주한미약품1조대비만당뇨치료제권리반환에급락,http://www.inews24.com/view/1191083
3337,2019-07-04,한미약품비만당뇨치료제권리반환신약개발도전멈추지않겠다”,http://www.econovill.com/news/articleView.html?idxno=366926
3338,2019-07-04,한미약품주가폭락하는이유는도전멈추지않을것,http://www.ggilbo.com/news/articleView.html?idxno=681865
3339,2019-07-04,한미약품기술수출반환쇼크장초반주가하락,http://www.choicenews.co.kr/news/articleView.html?idxno=62247
3340,2019-07-04,장마감후공시한미약품얀센비만당뇨치료제권리한미약품에반환결정外,http://www.ezyeconomy.com/news/articleView.html?idxno=91960
3341,2019-07-04,특징주한미약품권리반환소식에급락세냉철한판단의시점,http://moneys.mt.co.kr/news/mwView.php?no=2019070409158042025
3342,2019-07-04,한미약품주가폭락이유한미약품도전멈추지않을것,http://www.mhns.co.kr/news/articleView.html?idxno=243889
3343,2019-07-04,증시신호등한미약품하락세왜,https://news.imaeil.com/Economy/2019070409343414625
3344,2019-07-04,특징주한미약품파트너사기술권리반환소식에급락,http://www.seoulfn.com/news/articleView.html?idxno=348202
3345,2019-07-04,한미약품1兆신약권리반환소식에52주신저가목표가줄하향,https://view.asiae.co.kr/article/2019070409354527674
3346,2019-07-04,하나금융투자한미약품신약권리반환에가치하락목표가하향”,http://www.sporbiz.co.kr/news/articleView.html?idxno=353620
3347,2019-07-04,한미약품주가폭락왜,http://www.ccreview.co.kr/news/articleView.html?idxno=121874
3348,2019-07-04,특징주한미약품얀센과의신약권리반환에급락,http://www.youthdaily.co.kr/news/articleView.html?idxno=12821
3349,2019-07-04,한미약품128940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907040150&t=NN
3350,2019-07-04,한미약품1조수출된신약기술반환,http://www.ajunews.com/view/20190704093223309
3351,2019-07-04,특징주한미약품기술수출반환소식에급락세,http://news1.kr/articles/?3661956
3352,2019-07-04,한미약품얀센으로부터비만당뇨치료제권리반환소식에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=359023
3353,2019-07-04,한미약품신약권리반환증권사목표가줄줄이하향,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907040070&t=NN
3354,2019-07-04,한미약품제약강국위한도전멈추지않을것,http://www.kpanews.co.kr/article/show.asp?idx=205206&table=article&category=D
3355,2019-07-04,한미약품글로벌신약창출도전멈추지않겠다,http://www.biospectator.com/view/news_view.php?varAtcId=7961
3356,2019-07-04,한미약품비만당뇨치료제권리반환공식입장현재개발중인신약파이프라인들도30여개,http://www.newsinside.kr/news/articleView.html?idxno=868100
3357,2019-07-04,한미약품기술수출또취소내부적으로개발방향검토”,https://jhealthmedia.joins.com/article/article_view.asp?pno=20601
3358,2019-07-04,한미약품제약강국위한무한도전멈추지않을것난관극복의지피력,http://www.segye.com/content/html/2019/07/04/20190704503703.html?OutUrl=naver
3359,2019-07-04,한미약품가능성본비만당뇨치료제개발방향찾을것,http://www.sisaon.co.kr/news/articleView.html?idxno=96683
3360,2019-07-04,특징주한미약품파트너사얀센의신약권리반환에급락,http://www.enewstoday.co.kr/news/articleView.html?idxno=1318450
3361,2019-07-04,특징주한미약품여파에이치엘비등바이오주동반하락세,http://www.asiatime.co.kr/news/articleView.html?idxno=255619
3362,2019-07-04,한미약품얀센권리반환”폭락유사했던과거사례올무티닙사건은,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20190704.99099002054
3363,2019-07-04,얀센한미약품에비만당뇨치료제HM12525A권리반환한미약품추가개발방향확정할것,http://www.ezyeconomy.com/news/articleView.html?idxno=91962
3364,2019-07-04,얀센한미약품에비만당뇨신약권리반환제약강국도전멈추지않겠다,http://www.mediapen.com/news/view/445280
3365,2019-07-04,특징주한미약품1조규모기술수출계약해지소식에급락,http://www.viva100.com/main/view.php?key=20190704010001475
3366,2019-07-04,얀센한미약품비만당뇨치료제HM12525A권리반환,http://www.kukinews.com/news/article.html?no=678694
3367,2019-07-04,한미약품제약강국위한도전멈추지않을것,http://www.newstomato.com/ReadNews.aspx?no=905696
3368,2019-07-04,얀센기술수출반환한미약품한미사이언스장초반주가동반급락세,http://www.queen.co.kr/news/articleView.html?idxno=314851
3369,2019-07-04,한미약품어려움있어도제약강국위한도전멈추지않겠다,http://www.pressm.kr/news/articleView.html?idxno=24034
3370,2019-07-04,리포트브리핑한미약품아쉬운판권반환국내신약개발기술력에대한과도한우려는금물목표가615000원미래에셋대우,http://www.newspim.com/news/view/20190704000247
3371,2019-07-04,GET투자리포트한미약품투자의견매수유지미래에셋대우,http://www.getnews.co.kr/view.php?ud=201907041030307659tpgetnews_16
3372,2019-07-04,특징주한미약품비만치료제HM12525A권리반환소식에급락,http://www.ezyeconomy.com/news/articleView.html?idxno=91966
3373,2019-07-04,이슈주가한미약품얀센권리반환소식에주가급락기업가치하락불가피,http://www.sporbiz.co.kr/news/articleView.html?idxno=353666
3374,2019-07-04,ET투자뉴스한미약품아쉬운판권반환BUY유지미래에셋대우,http://www.etnews.com/20190704000060
3375,2019-07-04,한미약품어려움있어도제약강국위한도전멈추지않겠다,http://www.metroseoul.co.kr/news/newsview?newscd=2019070400040
3376,2019-07-04,코스피미국발훈풍장중2100선회복한미약품장초반급락세,http://www.seoulwire.com/news/articleView.html?idxno=167892
3377,2019-07-04,한미약품제약강국위한도전멈추지않겠다,http://www.nextdaily.co.kr/news/article.html?id=20190704800015
3378,2019-07-04,이번엔한미약품파장제약바이오주어떡해,http://www.choicenews.co.kr/news/articleView.html?idxno=62250
3379,2019-07-04,한미약품신약개발어렵고힘든길이지만묵묵히가겠다,http://www.edaily.co.kr/news/newspath.asp?newsid=02246806622551240
3380,2019-07-04,한미약품제약강국위한도전멈추지않겠다,http://www.straightnews.co.kr/news/articleView.html?idxno=51280
3381,2019-07-04,한미약품3연속기술수출실패신약개발통곡의벽못넘었다,http://moneys.mt.co.kr/news/mwView.php?no=2019070409438065208
3382,2019-07-04,한미약품기술수출반환에주가추풍낙엽10이상하락시과매도,http://www.g-enews.com/ko-kr/news/article/news_all/201907040939465205c642673384_1/article.html
3383,2019-07-04,GET투자리포트한미약품투자의견보유삼성증권,http://www.getnews.co.kr/view.php?ud=201907031030307661tpgetnews_16
3384,2019-07-04,특징주1兆기술수출계약해지한미약품급락세,http://biz.chosun.com/site/data/html_dir/2019/07/04/2019070400958.html
3385,2019-07-04,ET투자뉴스한미약품비만당뇨치료제효HOLD삼성증권,http://www.etnews.com/20190704000063
3386,2019-07-04,얀센비만당뇨치료제권리한미약품에반환,http://www.bokuennews.com/news/article.html?no=177965
3387,2019-07-04,불확실성커진한미약품주가폭락신약기술수출반환악재,https://www.seoul.co.kr/news/newsView.php?id=20190704500022&wlog_tag3=naver
3388,2019-07-04,핫이슈키워드총파업이틀째손정의방한일본수출규제한미약품인천붉은수돗물,https://cnbc.sbs.co.kr/article_hub/10000947322?division=NAVER
3389,2019-07-04,한미약품기술수출무산에단기주가충격불가피목표가↓”NH證,http://www.newspim.com/news/view/20190704000245
3390,2019-07-04,한미약품1조기술수출실패하면서주가20급락,https://www.nocutnews.co.kr/news/5177196
3391,2019-07-04,한미약품얀센비만당뇨치료제권리반환,http://www.rapportian.com/news/articleView.html?idxno=118417
3392,2019-07-04,한미약품파트너사의신약권리반환에주가폭락특징주,http://www.kukinews.com/news/article.html?no=678712
3393,2019-07-04,한미약품한미사이언스두자릿수급락증권가기업가치하락불가피,http://moneys.mt.co.kr/news/mwView.php?no=2019070410108082841
3394,2019-07-04,한미약품제약바이오RD책임감무게절감,http://www.newswatch.kr/news/articleView.html?idxno=21319
3395,2019-07-04,비만당뇨신약권리반환에한미약품도전멈추지않겠다,http://news1.kr/articles/?3662048
3396,2019-07-04,GET투자리포트한미약품투자의견MarketperformDowngrade키움증권,http://www.getnews.co.kr/view.php?ud=201907041030307671tpgetnews_16
3397,2019-07-04,한미약품얀센판권반환에1조원규모기술수출실패,http://www.enewstoday.co.kr/news/articleView.html?idxno=1318478
3398,2019-07-04,리포트브리핑한미약품RD신뢰회복이중요목표가350000원키움증권,http://www.newspim.com/news/view/20190704000382
3399,2019-07-04,기술수출계약해지한미약품반환치료제새로운가능성입증도전멈추지않을것”,http://www.donga.com/news/article/all/20190704/96319295/1
3400,2019-07-04,한미약품주가초반급락얀센의비만당뇨치료제기술반환여파,http://www.businesspost.co.kr/BP?command=article_view&num=134038
3401,2019-07-04,한미약품주가초반급락얀센의비만당뇨치료제기술반환여파,http://www.businesspost.co.kr/BP?command=article_view&num=134038
3402,2019-07-04,특징주분석한미약품주식인기종목1위종목등극PER15415배EPS2144원,http://nbntv.co.kr/news/view/452278
3403,2019-07-04,한미약품제약강국위한도전멈추지않겠다”,http://www.fnnews.com/news/201907041026334747
3404,2019-07-04,한미약품얀센비만당뇨치료제권리반환”종합,http://www.newsway.co.kr/news/view?tp=1&ud=2019070408063922452
3405,2019-07-04,GET투자리포트한미약품투자의견매수하나금융투자,http://www.getnews.co.kr/view.php?ud=201907041030307676tpgetnews_16
3406,2019-07-04,리포트브리핑한미약품얀센의LAPSGLP1GCG권리반환Triple에대한기대감은유효목표가500000원하나금융투자,http://www.newspim.com/news/view/20190704000429
3407,2019-07-04,한미약품비만∙당뇨치료제권리반환에제약강국도전멈추지않겠다”입장표명,http://www.getnews.co.kr/view.php?ud=20190704103636376641d0c69529_16
3408,2019-07-04,ET투자뉴스한미약품RD신뢰회복이MARKETPERFORMDOWNGRAD,http://www.etnews.com/20190704000093
3409,2019-07-04,ET투자뉴스한미약품얀센의LAPSGBUY하나금융투자,http://www.etnews.com/20190704000097
3410,2019-07-04,특징주한미약품장중고가34만3500원기록후33만500원후퇴,http://nbntv.co.kr/news/view/452356
3411,2019-07-04,도전멈추지않겠다”한미약품현재개발중인신약30여개,http://kpenews.com/View.aspx?No=62591
3412,2019-07-04,한미약품주가20대급락기술권리반환소식에,http://www.busan.com/view/busan/view.php?code=2019070410452027134
3413,2019-07-04,한미약품어려움있어도제약강국위한도전멈추지않겠다”,http://www.newsway.co.kr/news/view?tp=1&ud=2019070410434855594
3414,2019-07-04,신약기술반환받은한미약품도전멈추지않을것,http://kormedi.com/?p=1296797
3415,2019-07-04,특징주한미약품하락종목2위등극금일주가33만500원전영업일대비8만4000원하락,http://nbntv.co.kr/news/view/452371
3416,2019-07-04,신약기술수출실패한미약품도전멈추지않겠다주가20급락,http://www.newsfc.co.kr/news/articleView.html?idxno=36904
3417,2019-07-04,GET투자리포트한미약품투자의견NotRated한국투자증권,http://www.getnews.co.kr/view.php?ud=201907041030307678tpgetnews_16
3418,2019-07-04,한미사이언스한미약품비만당뇨치료제권리반환소식에급락,http://www.mdtoday.co.kr/mdtoday/index.html?no=359037
3419,2019-07-04,리포트브리핑한미약품글로벌신약개발의높은벽을이제는인정해야NotRated한국투자증권,http://www.newspim.com/news/view/20190704000462
3420,2019-07-04,한미약품기술수출반환제약강국위한도전멈추지않을것,http://www.wolyo.co.kr/news/articleView.html?idxno=88129
3421,2019-07-04,한미약품어려움있어도제약강국위한도전멈추지않겠다,http://www.techholic.co.kr/news/articleView.html?idxno=183527
3422,2019-07-04,한미약품권리반환으로듀얼어고니스트의기대감은줄어들예상”,http://www.wikitree.co.kr/main/news_view.php?id=442264
3423,2019-07-04,한미약품실패발판삼아신약개발성공이루겠다,http://www.dailymedi.com/detail.php?number=844879&thread=22r05
3424,2019-07-04,한미약품실적개선되나했는데단기충격불가피,http://www.ebn.co.kr/news/view/991830
3425,2019-07-04,기술수출반환쇼크한미약품증권가주가전망은,http://www.kpinews.co.kr/news/articleView.html?idxno=99019
3426,2019-07-04,한미약품기술수출반환도전은멈추지않는다”,http://inthenews.co.kr/article-5133/
3427,2019-07-04,한미약품＂얀센의권리반환불구제약강국위한도전은계속될것＂,http://www.nspna.com/news/?mode=view&newsid=369389
3428,2019-07-04,한미약품얀센임상결과역설적으로비만체중감량효과는검증돼,http://www.4th.kr/news/articleView.html?idxno=13897
3429,2019-07-04,GET투자리포트한미약품투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201907041030307685tpgetnews_16
3430,2019-07-04,개장시황한미약품1289408만4000원2027하락한33만500원에거래중,http://www.anewsa.com/detail.php?number=1860569&thread=10r02
3431,2019-07-04,한미약품실패했지만다양한가능성확인도전멈추지않을것,http://www.ajunews.com/view/20190704110314445
3432,2019-07-04,리포트브리핑한미약품얀센HM12525A권리반환목표가530000원NH투자증권,http://www.newspim.com/news/view/20190704000508
3433,2019-07-04,한미약품제약강국위한도전멈추지않겠다”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232452
3434,2019-07-04,얀센기술반환에한미약품주가20급락,http://news.heraldcorp.com/view.php?ud=20190704000348
3435,2019-07-04,한미약품기술수출4번째고배그래도갈길간다,http://news.bizwatch.co.kr/article/consumer/2019/07/04/0013/naver
3436,2019-07-04,특징주기술수출무산소식에한미약품폭락,http://www.polinews.co.kr/news/article.html?no=399064
3437,2019-07-04,ET투자뉴스한미약품얀센HM1252BUY유지NH투자증권,http://www.etnews.com/20190704000137
3438,2019-07-04,믿었던한미약품너마저바이오株우려커진다,http://news.mt.co.kr/mtview.php?no=2019070411122696588
3439,2019-07-04,특징주한미약품파트너사신약권리반환에급락전일比2678↓,http://www.joongboo.com/news/articleView.html?idxno=1366753
3440,2019-07-04,한미약품얀센이권리반환한비만당뇨치료제효과는입증”,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=532339
3441,2019-07-04,SR경제라이프한미약품얀센신약개발권리반환소식에주가급락,http://www.srtimes.kr/news/articleView.html?idxno=42865
3442,2019-07-04,한미약품얀센의LAPSGLP1GCG권리반환”,http://www.wikitree.co.kr/main/news_view.php?id=442283
3443,2019-07-04,한미약품기술수출세번째삐걱1조원날아갔다,http://www.skyedaily.com/news/news_view.html?ID=86378
3444,2019-07-04,특징주기술수출반환에한미약품초반주가급락세,http://www.sisaon.co.kr/news/articleView.html?idxno=96690
3445,2019-07-04,한미약품1조규모기술수출실패도전멈추지않는다,http://www.economytalk.kr/news/articleView.html?idxno=190423
3446,2019-07-04,한미약품1조기술수출무산신약개발성장통재수출도가능,http://news.mt.co.kr/mtview.php?no=2019070411020618699
3447,2019-07-04,한미약품비만치료제권리반환신약개발멈추지않겠다”,http://www.ebn.co.kr/news/view/991838
3448,2019-07-04,1조원기술수출반환한미약품어려움있더라도혁신통한성장지속,http://www.updownnews.co.kr/news/articleView.html?idxno=205618
3449,2019-07-04,특징주한미약품장중2678폭락1조수출무산,http://www.kyeongin.com/main/view.php?key=20190704001151037
3450,2019-07-04,기술수출선구자한미약품의씁쓸한성적표,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019070411354157151
3451,2019-07-04,한미약품1조잭팟물거품美얀센기술수출반환,https://cnbc.sbs.co.kr/article_hub/10000947359?division=NAVER
3452,2019-07-04,상승출발했던코스피코스닥약세한미약품등제약바이오섹터↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=359044
3453,2019-07-04,한미약품엔아직4곳의든든한파트너있다,http://www.whosaeng.com/111221
3454,2019-07-04,7월4일한미약품주식현황2569308000원,http://nbntv.co.kr/news/view/452718
3455,2019-07-04,한미약품어려움있어도제약강국위한도전멈추지않겠다,http://www.medigatenews.com/news/2392000612
3456,2019-07-04,한미약품주가급락,http://www.ccreview.co.kr/news/articleView.html?idxno=121915
3457,2019-07-04,한미약품연이은신약개발실패,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH190704004
3458,2019-07-04,한미약품이기술수출반환소식에어려움있어도도전멈추지않겠다”고밝혔다,https://www.huffingtonpost.kr/entry/story_kr_5d1d67e0e4b04c48140ec0c5?utm_id=naver
3459,2019-07-04,한미약품당뇨치료제권리반환임상진행바이오주투심악화,http://www.mdtoday.co.kr/mdtoday/index.html?no=359049
3460,2019-07-04,한미약품잇단판권반환에백조서미운오리로전락,http://www.shinailbo.co.kr/news/articleView.html?idxno=1182382
3461,2019-07-04,한미약품비만당뇨치료제권리반환딛고신약개발이어갈것도전은계속된다,http://www.greened.kr/news/articleView.html?idxno=201723
3462,2019-07-04,한미약품1조원기술수출계약해지,http://www.fetv.co.kr/news/article.html?no=32162
3463,2019-07-04,4번째기술반환얀센한미약품에비만당노체료제권리반환,http://www.newsprime.co.kr/news/article.html?no=466149
3464,2019-07-04,한미약품파트너사의신약권리반환에하한가코앞,http://sports.khan.co.kr/news/sk_index.html?art_id=201907041325003&sec_id=564001&pt=nv
3465,2019-07-04,한미약품신약권리반환소식에25↓증권사목표가줄하향,http://www.newsis.com/view/?id=NISX20190704_0000701144&cID=10401&pID=10400
3466,2019-07-04,한미약품어려움있어도제약강국위한도전멈추지않을것”,http://www.etnews.com/20190704000198
3467,2019-07-04,한미약품계약해지는아쉬지만RD역량은높아지는중”,http://www.wikitree.co.kr/main/news_view.php?id=442328
3468,2019-07-04,한미약품신약개발은실패를통해성장하는것”,http://www.datanews.co.kr/news/article.html?no=103705
3469,2019-07-04,한미약품얀센기술수출비만당뇨신약개발권리반환,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3879165
3470,2019-07-04,한미약품폭락제약주까지흔들거리나한미사이언스폭락에유한양행하락까지,http://www.econonews.co.kr/news/articleView.html?idxno=73518
3471,2019-07-04,1조원기술수출실패한미약품제약강국도전멈추지않는다,http://www.youthdaily.co.kr/news/articleView.html?idxno=12876
3472,2019-07-04,증권가1조기술수출불발한미약품목표가잇단하향,http://news1.kr/articles/?3662291
3473,2019-07-04,한미약품1조원대신약수출계약해지소식에하한가근접,http://www.sisajournal.com/news/articleView.html?idxno=188054
3474,2019-07-04,한미약품신약개발과정서빈번히있는일,http://www.bokuennews.com/news/article.html?no=177982
3475,2019-07-04,기술수출실패한미약품20대폭락비만치료제상업적성공가능성에의문,http://www.opinionnews.co.kr/news/articleView.html?idxno=19652
3476,2019-07-04,한미약품글로벌신약개발의높은벽을이제는인정해야”,http://www.wikitree.co.kr/main/news_view.php?id=442349
3477,2019-07-04,부자들은경제신문을읽는다한미약품1조물거품주가변동예의주시해야,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019070413050164602
3478,2019-07-04,한미약품얀센기술반환52주신저가경신증권업계목표가줄하향,http://www.whitepaper.co.kr/news/articleView.html?idxno=164605
3479,2019-07-04,또기술수출무산된한미약품제약바이오날벼락,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907040273&t=NNv
3480,2019-07-04,사설한미약품신약개발통곡의벽그래도멈출수없는이유,http://www.asiatime.co.kr/news/articleView.html?idxno=255753
3481,2019-07-04,연이은악재한미약품신화가흔들린다,http://www.m-i.kr/news/articleView.html?idxno=618765
3482,2019-07-04,제약회사또대형악재한미약품1조원대기술수출무산,http://www.straightnews.co.kr/news/articleView.html?idxno=51292
3483,2019-07-04,열정있었지만한미약품HM12525A반환배경은,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019070415381392203
3484,2019-07-04,특징주한미약품1조원대신약기술수출무산에급락종합,http://yna.kr/AKR20190704034551008?did=1195m
3485,2019-07-04,1조원대신약기술수출무산돼주가폭락중인한미약품,https://www.insight.co.kr/news/235244
3486,2019-07-04,한미약품1조원대신약기술수출무산에주가급락,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3879387
3487,2019-07-04,종목이슈한미약품1조기술수출불발설상가상제약바이오주,http://www.newspim.com/news/view/20190704000903
3488,2019-07-04,한미약품얀센비만당뇨치료제HM12525A권리반환,http://www.dailypop.kr/news/articleView.html?idxno=39874
3489,2019-07-04,특징주한미약품1조원대신약기술수출무산에급락,http://www.kyeongin.com/main/view.php?key=20190704010001820
3490,2019-07-04,1조기술수출불발한미약품급락목표가하향잇따라종합,http://news1.kr/articles/?3662513
3491,2019-07-04,한미약품얀센기술반환에주가폭락2726빠져,http://www.ggilbo.com/news/articleView.html?idxno=682095
3492,2019-07-04,한미약품비만치료제기술반환으로시총13조증발,http://www.newstomato.com/ReadNews.aspx?no=905860
3493,2019-07-04,시황종합外人매수코스피2100회복한미약품악재코스닥↓,http://news1.kr/articles/?3662516
3494,2019-07-04,마감시황外人매수닷새만에코스피2100선상승마감한미약품충격에코스닥소폭하락,http://www.joongboo.com/news/articleView.html?idxno=1366938
3495,2019-07-04,한미약품얀센의권리반환신약개발과정에서빈번한일”,http://daily.hankooki.com/lpage/ittech/201907/dh20190704161147145630.htm
3496,2019-07-04,한미약품1조원대신약기술수출무산에2726급락,http://www.seoulwire.com/news/articleView.html?idxno=168791
3497,2019-07-04,한미약품너마저일주일새줄줄이악재바이오株신음,http://news.mt.co.kr/mtview.php?no=2019070415523827986
3498,2019-07-04,한미약품1조기술수출불발소식에증권가목표가줄줄이하향,http://ilyo.co.kr/?ac=article_view&entry_id=340244
3499,2019-07-04,한미약품실패를통해성장제약강국위한도전멈추지않을것,http://www.dailysmart.co.kr/news/articleView.html?idxno=13096
3500,2019-07-04,한미약품어려움있어도제약강국위한도전멈추지않겠다,http://www.wikileaks-kr.org/news/articleView.html?idxno=59484
3501,2019-07-04,한미약품은기술수출불발제약바이오주잇단악재에눈물,http://www.sisajournal-e.com/news/articleView.html?idxno=202650
3502,2019-07-04,마켓뷰한미약품계약해지로꽁꽁언의약품투자심리,http://biz.chosun.com/site/data/html_dir/2019/07/04/2019070402474.html
3503,2019-07-04,특징주매매동향한미약품증권인기검색1위종목PER14062배EPS2144원동일업종PER은10392배,http://nbntv.co.kr/news/view/453607
3504,2019-07-04,한미약품1조신약기술수출무산에52주신저가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1773571
3505,2019-07-04,한미약품기술반환아닌기술수출이목표제약강국도전계속,http://www.getnews.co.kr/view.php?ud=20190704163154482341d0c69529_16
3506,2019-07-04,한미약품당뇨치료제권리반환소식에52주최저가갱신,http://www.mdtoday.co.kr/mdtoday/index.html?no=359111
3507,2019-07-04,﻿한미약품얀센비만당뇨치료제권리반환에주가급락전일대비2726급락,http://medicalworldnews.co.kr/news/view.php?idx=1510931475
3508,2019-07-04,한미약품주가폭락1조원대신약기술수출무산충격,https://www.seoul.co.kr/news/newsView.php?id=20190704500128&wlog_tag3=naver
3509,2019-07-04,코스피미국금리인하기대감영향2100선회복모나미상한가한미약품급락,http://www.econonews.co.kr/news/articleView.html?idxno=73569
3510,2019-07-04,코스피↑코스닥↓한미약품사이언스52주최저가갱신,http://www.mdtoday.co.kr/mdtoday/index.html?no=359113
3511,2019-07-04,마감시황한미약품12894011만3000원2726하락한30만1500원에거래마쳐,http://www.anewsa.com/detail.php?number=1862507&thread=10r02
3512,2019-07-04,인보사사태이어한미약품쇼크주가27급락,http://www.ajunews.com/view/20190704155648768
3513,2019-07-04,한미약품제약강국위한도전멈추지않을것”,http://www.cnbnews.com/news/article.html?no=415230
3514,2019-07-04,기술수출반환된한미약품그래도도전멈추지않을것,https://view.asiae.co.kr/article/2019070417024596262
3515,2019-07-04,한미약품비만당뇨치료제관련권리반환소식에27급락,http://daily.hankooki.com/lpage/economy/201907/dh20190704170518138110.htm
3516,2019-07-04,코스피2100선회복코스닥한미약품충격690선턱걸이환율27원하락,http://www.seoulwire.com/news/articleView.html?idxno=168802
3517,2019-07-04,1조원기술수출무산에한미약품목표가줄줄이하향,http://www.ekn.kr/news/article.html?no=441186
3518,2019-07-04,한미약품기술수출불발투심잃은제약바이오株,http://www.newsprime.co.kr/news/article.html?no=466266
3519,2019-07-04,한미약품급락1조기술수출불발주가2017년4월이후최저수준,http://www.iloveorganic.co.kr/news/articleView.html?idxno=225942
3520,2019-07-04,4일마감주가정보한미약품주가301500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=263273
3521,2019-07-04,종목인기순위1위종목한미약품128940종목마감주가30만1500원시가총액순위코스피71위,http://nbntv.co.kr/news/view/454178
3522,2019-07-04,코스피주가하락률Top10한미사이언스한미약품갤럭시아에스엠QV제약TOP5ETN에이프로젠제약주가순으로4일장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=46969
3523,2019-07-04,기술수출계약해지에한미약품사이언스폭락,http://news.mk.co.kr/newsRead.php?year=2019&no=489063
3524,2019-07-04,한미약품1조원수출해지주가급락단기충격불가피,http://www.economytalk.kr/news/articleView.html?idxno=190477
3525,2019-07-04,아에이치엘비한미약품바이오새내기수난시대,http://www.etoday.co.kr/news/section/newsview.php?idxno=1773631
3526,2019-07-04,한미약품기술수출권리반환에도도전멈추지않을것”강조,http://www.news2day.co.kr/131187
3527,2019-07-04,네번째기술수출실패신뢰흔들장중하한가로급락한한미약품,https://www.hankyung.com/finance/article/2019070421791
3528,2019-07-04,한미약품어려움있어도제약강국위한도전멈추지않겠다,http://www.gukjenews.com/news/articleView.html?idxno=1142099
3529,2019-07-04,04일외국인거래소에서한미약품2726KTG000등순매도,https://www.hankyung.com/finance/article/201907042413L
3530,2019-07-04,美얀센에1兆기술수출물거품한미약품제약강국도전계속,http://www.fnnews.com/news/201907041840392393
3531,2019-07-04,포커스TV시사포커스경제뉴스인스타그램먹통한미약품최저임금CJ헬로전기차,http://www.sisafocus.co.kr/news/articleView.html?idxno=214305
3532,2019-07-04,특징주분석주가정보4일한미약품마감증시301500원,http://nbntv.co.kr/news/view/454839
3533,2019-07-04,한미약품1조제약기술수출무산위기의바이오,https://news.sbs.co.kr/news/endPage.do?news_id=N1005339262&plink=ORI&cooper=NAVER
3534,2019-07-04,한미약품어려움있어도제약강국위한도전멈추지않겠다,http://www.newscj.com/news/articleView.html?idxno=648460
3535,2019-07-05,4일외국인순매도Top10한미약품208억송원산업61억롯데케미칼40억KODEX레버리지35억외국인순매도나서코스닥시장에서는신라젠SKC코오롱PI솔브레인상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=47091
3536,2019-07-05,4일기관순매도Top10한미약품963억넷마블84억SK67억한국조선해양47억외국인순매도나서코스닥시장에서는펌텍코리아강스템바이오텍민앤지상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=47093
3537,2019-07-05,한미약품다섯번째기술수출실패4조원날아갔다,http://www.sportsseoul.com/news/read/786095
3538,2019-07-05,한미약품신약기술수출4번째고배글로벌업계불신커져,http://www.donga.com/news/article/all/20190704/96334317/1
3539,2019-07-05,한미약품1조원대신약수출무산인보사취소사태코오롱은사과,http://news.kmib.co.kr/article/view.asp?arcid=0924087265&code=11151400&cp=nv
3540,2019-07-05,한미약품연이어주가폭락할까기술수출계약해지역풍,http://www.ggilbo.com/news/articleView.html?idxno=682198
3541,2019-07-05,약에울고웃는제약사②한미약품1조원대규모기술수출무산벌써4번째,http://www.mdtoday.co.kr/mdtoday/index.html?no=359125
3542,2019-07-05,한미약품번번이실패하는기술수출에바이오업계흔들,http://www.newsinside.kr/news/articleView.html?idxno=871755
3543,2019-07-05,한미약품도좌절험난한GLP1이중작용제개발,http://www.dailypharm.com/Users/News/NewsView.html?ID=254390&REFERER=NP
3544,2019-07-05,한미약품1조원대기술수출무산급락증권사목표주가↓,http://www.seoulwire.com/news/articleView.html?idxno=168874
3545,2019-07-05,특징주한미약품기술반환으로급락한지하루만에반등,http://news.mk.co.kr/newsRead.php?year=2019&no=490095
3546,2019-07-05,한미약품한미사이언스전날폭락딛고상승한미사이언스5만원선회복,http://www.econonews.co.kr/news/articleView.html?idxno=73662
3547,2019-07-05,특징주한미약품전날급락뒤반등강세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907050102&t=NN
3548,2019-07-05,특징주한미약품급락하루만에반등성공,http://www.etoday.co.kr/news/section/newsview.php?idxno=1773758
3549,2019-07-05,또한미약품쇼크1조원기술수출삐끗,http://www.monews.co.kr/news/articleView.html?idxno=203546
3550,2019-07-05,제약업종주요종목오전시황1위코오롱생명과학12312위한올바이오파마3643위한미약품299,http://www.anewsa.com/detail.php?number=1862816&thread=18
3551,2019-07-05,09시30분바이오시밀러테마주오전시황한올바이오파마한미약품등이상승세주도,http://nbntv.co.kr/news/view/456240
3552,2019-07-05,특징주한미약품기술수출무산폭락하루만에반등,http://www.asiatime.co.kr/news/articleView.html?idxno=255880
3553,2019-07-05,한미약품기술반환충격완화장중주가반등,http://www.choicenews.co.kr/news/articleView.html?idxno=62284
3554,2019-07-05,한미약품너마저흔들리는제약바이오주,http://moneys.mt.co.kr/news/mwView.php?no=2019070509458094943
3555,2019-07-05,오뉴스한미약품목표가내려잡은증권사들팔아라시그널,https://www.ytn.co.kr/_ln/0102_201907051006232747
3556,2019-07-05,오늘의키워드한미약품수출무산에인보사는취소바이오주울상,https://cnbc.sbs.co.kr/article_hub/10000947477?division=NAVER
3557,2019-07-05,인보사에한미약품사태불똥울고싶은바이오株,http://www.ebn.co.kr/news/view/991978
3558,2019-07-05,특징주분석한미약품증권인기종목4위종목등극PER14272배EPS2144원,http://nbntv.co.kr/news/view/456588
3559,2019-07-05,한미약품기술수출무산급락하루만에반등,http://www.mdtoday.co.kr/mdtoday/index.html?no=359161
3560,2019-07-05,한미약품1조원대신약기술수출좌초,http://www.beyondpost.co.kr/view.php?ud=2019070510302069220145927ff6_30
3561,2019-07-05,한미약품주가7월5일현재301500원,http://www.gokorea.kr/news/articleView.html?idxno=264093
3562,2019-07-05,개장시황특징주한미약품1289404500원149상승한30만6000원에거래,http://www.anewsa.com/detail.php?number=1863186&thread=10r02
3563,2019-07-05,주가그래프한미약품주가5일현재303000원,http://nbntv.co.kr/news/view/456965
3564,2019-07-05,한미약품1조계약무산의약계주식시장파장은,https://www.ytn.co.kr/_ln/0102_201907051344027175
3565,2019-07-05,한미약품얀센기술수출실패에도신약도전은현재진행형,http://www.insightkorea.co.kr//news/articleView.html?idxno=43410
3566,2019-07-05,과학본색인보사허가취소한미약품후폭풍,https://science.ytn.co.kr/program/program_view.php?s_mcd=0082&s_hcd=0017&key=201907051620067956
3567,2019-07-05,한미약품신약개발능력의구심물리치기위해신발끈다시맨다,http://www.businesspost.co.kr/BP?command=article_view&num=134304
3568,2019-07-05,나신평한미약품기술수출반환영향재검토,http://www.etoday.co.kr/news/section/newsview.php?idxno=1774014
3569,2019-07-05,인기주종목정보7월5일한미약품304000원으로장마감,http://nbntv.co.kr/news/view/458951
3570,2019-07-06,한미약품어려움있어도신약개발제약강국위한도전멈추지않겠다,http://www.econonews.co.kr/news/articleView.html?idxno=73822
3571,2019-07-06,나이스신평한미약품얀센기술권리반환신용등급영향모니터링중,http://www.fnnews.com/news/201907061103196115
3572,2019-07-07,주간증시전망日규제한미약품악재속반등모멘텀은,http://www.ebn.co.kr/news/view/992069
3573,2019-07-07,JOB리포트LG유플러스한미약품등주요기업AI면접의3가지포인트,http://www.news2day.co.kr/131258
3574,2019-07-07,권리반환RD끝아니다한미약품남은신약은,http://www.newsis.com/view/?id=NISX20190705_0000702567&cID=13001&pID=13000
3575,2019-07-07,원조기술명가한미약품절치부심,http://www.newstomato.com/ReadNews.aspx?no=906016
3576,2019-07-07,여의도TMI1조원대계약무산한미약품불성실공시인가요,http://www.edaily.co.kr/news/newspath.asp?newsid=01279206622552224
3577,2019-07-07,한미약품어려움있어도도전멈추지않을것,http://www.mhj21.com/122427
3578,2019-07-07,한미약품신약체중감량효과는입증됐다”,http://weekly.cnbnews.com/news/article.html?no=128848
3579,2019-07-08,더벨한미약품4건LO무산에도2600억수익,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201907040100010750000684
3580,2019-07-08,한미약품한미사이언스모두하락세로한미사이언스5만원선무너져,http://www.econonews.co.kr/news/articleView.html?idxno=74290
3581,2019-07-08,한미약품128940종목알파고분석외국인기관실시간수급과추가매수확률은,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907080248&t=NN
3582,2019-07-08,7월8일한미약품금일증시230297000원,http://nbntv.co.kr/news/view/461320
3583,2019-07-08,코오롱인보사사태에한미약품까지바이오드림끝,http://www.bizhankook.com/article/18088
3584,2019-07-08,누가한미약품에돌을던지랴견고한RD로무한도전이어가,http://www.g-enews.com/ko-kr/news/article/news_all/20190708160228708769d76442fa_1/article.html
3585,2019-07-08,한미약품얀센계약해지기대감높은파이프라인은여전,http://biz.newdaily.co.kr/site/data/html/2019/07/08/2019070800213.html
3586,2019-07-08,8일마감증시한미약품주가296000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=267092
3587,2019-07-08,특징주분석종목정보8일한미약품마감증시296000원,http://nbntv.co.kr/news/view/463450
3588,2019-07-09,바이오시밀러테마오전시황상승률상위종목에이프로젠제약139팜스웰바이오058한미약품017등,http://www.gokorea.kr/news/articleView.html?idxno=267626
3589,2019-07-09,9일09시바이오시밀러테마주시황오전에이프로젠제약한미약품등이상승세주도,http://nbntv.co.kr/news/view/464967
3590,2019-07-09,한미약품한미사이언스모두강보합한미약품30만원선회복눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=74455
3591,2019-07-09,국내증권분석코스피상장사한미약품현재298500원대주가형성,http://aitimes.co.kr/news/view/73674
3592,2019-07-09,바이오시밀러테마오후시황상승률상위종목한미약품118팜스웰바이오096제넥신080등,http://www.gokorea.kr/news/articleView.html?idxno=268143
3593,2019-07-09,9일13시바이오시밀러테마주오후시황팜스웰바이오한미약품등이주도,http://nbntv.co.kr/news/view/465666
3594,2019-07-09,증권주식한미약품주가9일현재298500원,http://nbntv.co.kr/news/view/465668
3595,2019-07-09,한미약품얀센의기술반환에도하반기신약개발성과기대유효,http://www.businesspost.co.kr/BP?command=article_view&num=134630
3596,2019-07-09,한미약품기술이전된물질들이다시반환됐지만RD펀더멘탈은견고”,http://www.wikitree.co.kr/main/news_view.php?id=443648
3597,2019-07-09,바이오시밀러테마마감시황팜스웰바이오한미약품등이주도,http://nbntv.co.kr/news/view/466070
3598,2019-07-09,Invest한미약품기술수출권리반환에신용등급하향압력↑,http://www.investchosun.com/?p=3239201
3599,2019-07-09,한신평한미약품신용등급A유지등급전망부정적으로변경,http://www.fnnews.com/news/201907091609433772
3600,2019-07-09,마켓인기술수출계약해지한미약품등급전망부정적하향A등급유지,http://www.edaily.co.kr/news/newspath.asp?newsid=03663766622552880
3601,2019-07-09,시그널한미약품얀센기술수출해지에등급전망부정적,https://signal.sedaily.com/NewsView/1VLML5FKXR
3602,2019-07-09,한신평한미약품신용등급유지전망은부정적변경,http://www.etoday.co.kr/news/section/newsview.php?idxno=1775009
3603,2019-07-09,마켓인사이트기술수출무산된한미약품신용도에도경고등,https://www.hankyung.com/finance/article/201907092471r
3604,2019-07-09,크레딧한미약품잇따른계약해지신용등급강등위기,http://www.newspim.com/news/view/20190709000891
3605,2019-07-09,9일마감주가정보한미약품주가295000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=268855
3606,2019-07-09,인기주분석매매동향9일한미약품마감증시295000원,http://nbntv.co.kr/news/view/467256
3607,2019-07-09,한국신용평가한미약품무보증사채등급전망을부정적으로변경,http://www.businesspost.co.kr/BP?command=article_view&num=134719
3608,2019-07-09,9일외국인순매수Top10삼성전자720억LG전자59억한국금융지주42억한미약품30억외국인순매수나서코스닥시장에서는이지웰페어유비쿼스홀딩스케이엠더블유상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=48439
3609,2019-07-10,9일주요크레딧공시한미약품등급전망부정적하향,http://www.edaily.co.kr/news/newspath.asp?newsid=01430086622553208
3610,2019-07-10,한미약품한미사이언스소폭으로희비엇갈려한미약품30만원선회복힘드네,http://www.econonews.co.kr/news/articleView.html?idxno=74712
3611,2019-07-10,7월10일한미약품주식창295000원000,http://nbntv.co.kr/news/view/469409
3612,2019-07-10,한미약품주가및증권차트분석10일현재296000원및종목차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=125283
3613,2019-07-10,한신평한미약품등급전망부정적으로하향,http://www.mdtoday.co.kr/mdtoday/index.html?no=359547
3614,2019-07-10,기술수출불발한미약품RD진행중인신약후보물질은,http://www.sisajournal-e.com/news/articleView.html?idxno=202908
3615,2019-07-10,10일오늘의증시마감한미약품292500원마감,http://www.gokorea.kr/news/articleView.html?idxno=270693
3616,2019-07-10,증시매매동향10일한미약품마감증시292500원,http://nbntv.co.kr/news/view/471584
3617,2019-07-11,바이오시밀러테마오전시황상승률상위종목팜스웰바이오767에이프로젠제약140한미약품103등,http://www.gokorea.kr/news/articleView.html?idxno=271159
3618,2019-07-11,09시31분바이오시밀러오전테마시황팜스웰바이오한미약품등이주도,http://nbntv.co.kr/news/view/473092
3619,2019-07-11,한미약품한미사이언스모두4거래일만에상승반등기점되나,http://www.econonews.co.kr/news/articleView.html?idxno=74979
3620,2019-07-11,주식시세현황한미약품주가11일현재299000원,http://nbntv.co.kr/news/view/473788
3621,2019-07-11,바이오시밀러테마오후시황상승률상위종목팜스웰바이오1633이수앱지스240한미약품222등,http://www.gokorea.kr/news/articleView.html?idxno=271773
3622,2019-07-11,한미약품주가7월11일현재303000원및오늘거래가는,http://www.cctvnews.co.kr/news/articleView.html?idxno=125478
3623,2019-07-11,바이오시밀러테마종목종가팜스웰바이오한미약품등이상승세견인중,http://nbntv.co.kr/news/view/474574
3624,2019-07-11,바이오시밀러테마마감시황상승률상위종목팜스웰바이오2533한미약품325이수앱지스256등,http://www.gokorea.kr/news/articleView.html?idxno=272140
3625,2019-07-11,11일장마감매매동향한미약품302000원마감,http://www.gokorea.kr/news/articleView.html?idxno=272461
3626,2019-07-11,상장주매매동향11일한미약품마감증시302000원,http://nbntv.co.kr/news/view/475841
3627,2019-07-12,잡인사이드한미약품공채속보경력채용,http://www.newsinside.kr/news/articleView.html?idxno=898269
3628,2019-07-12,잡인사이드한미약품공채속보신입채용,http://www.newsinside.kr/news/articleView.html?idxno=898267
3629,2019-07-12,11일외국인순매수Top10삼성전자1829억아모레퍼시픽75억한미약품55억카카오41억외국인순매수나서코스닥시장에서는에이치엘비테스SK머티리얼즈상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=48952
3630,2019-07-12,퀵리포트한미약품TradingBuy유지목표가26↓34만원메리츠證,http://www.itooza.com/common/iview.php?no=2019071207435913305
3631,2019-07-12,한미약품목표주가낮아져신약후보물질가치하향조정,http://www.businesspost.co.kr/BP?command=article_view&num=135079
3632,2019-07-12,한미약품당뇨치료제권리반환아쉬워신약가치재조정으로목표가↓,http://www.asiatoday.co.kr/view.php?key=20190712010007745
3633,2019-07-12,GET투자리포트한미약품투자의견Trading매수메리츠종금증권,http://www.getnews.co.kr/view.php?ud=201907121030307967tpgetnews_16
3634,2019-07-12,한미약품한미사이언스상승하나싶었는데한미약품4만원선무너져,http://www.econonews.co.kr/news/articleView.html?idxno=75204
3635,2019-07-12,7월12일한미약품증권투자정보외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=273276
3636,2019-07-12,7월12일한미약품시세보기083299500원,http://nbntv.co.kr/news/view/477898
3637,2019-07-12,한신평한미약품연구개발실적최고등급책정,http://www.dailypharm.com/Users/News/NewsView.html?ID=254633&REFERER=NP
3638,2019-07-12,한미약품신라젠에이치엘비제약바이오잔인한7월,http://www.newsway.co.kr/news/view?tp=1&ud=2019071214025837485
3639,2019-07-12,한미약품7월19일금18시까지신입및경력사원채용,http://www.ekn.kr/news/article.html?no=442573
3640,2019-07-12,한미약품HM12525A임상2상최종결과수령후개발방향결정될예정”,http://www.wikitree.co.kr/main/news_view.php?id=444878
3641,2019-07-15,유한양행은웃고코오롱한미약품은울고,http://sports.donga.com/3/all/20190714/96471871/3
3642,2019-07-15,한미약품주사제4개제품이물혼입으로회수조치,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232760
3643,2019-07-15,퀵리포트한미약품매수유지목표가29↓40만원이베스트證,http://www.itooza.com/common/iview.php?no=2019071508492719884
3644,2019-07-15,한미약품한미사이언스희비엇갈려한미약품4만원선다시회복,http://www.econonews.co.kr/news/articleView.html?idxno=75767
3645,2019-07-15,7월15일한미약품주식추천주017300000원,http://nbntv.co.kr/news/view/482455
3646,2019-07-15,바이오시밀러테마오후시황상승률상위종목한미약품067팜스웰바이오052제넥신115등,http://www.gokorea.kr/news/articleView.html?idxno=275480
3647,2019-07-15,13시28분바이오시밀러오후의테마종목팜스웰바이오한미약품등이주도,http://nbntv.co.kr/news/view/482741
3648,2019-07-15,한미약품기술수출료줄고연구비는늘어올해이익감소불가피,http://www.businesspost.co.kr/BP?command=article_view&num=135323
3649,2019-07-15,한미약품국내제약사중가장많은신약파이프라인갖춰”,http://www.wikitree.co.kr/main/news_view.php?id=445360
3650,2019-07-15,7월15일코스피상장사한미약품현재297500원대주가형성,http://aitimes.co.kr/news/view/77759
3651,2019-07-15,바이오시밀러테마주시황마감한미약품한올바이오파마등이주도,http://nbntv.co.kr/news/view/483189
3652,2019-07-15,바이오시밀러테마마감시황상승률상위종목한미약품067한올바이오파마182제넥신247등,http://www.gokorea.kr/news/articleView.html?idxno=276026
3653,2019-07-15,한미약품당뇨항암신약임상3상29개파이프라인가동,https://www.sedaily.com/NewsView/1VLPDWVXXR
3654,2019-07-16,임상시험승인대웅종근당경동한미약품콜마,http://www.dailymedi.com/detail.php?number=845294&thread=22r05
3655,2019-07-16,한미약품2019년상반기원외처방시장1위수성,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56305
3656,2019-07-16,한미약품한미사이언스소폭이지만희비엇갈려한미약품드디어반등하나,http://www.econonews.co.kr/news/articleView.html?idxno=75999
3657,2019-07-16,프랑스∙영국등13개국해외약대생한미약품팔탄스마트플랜트방문,http://www.nextdaily.co.kr/news/article.html?id=20190716800016
3658,2019-07-16,프랑스영국등13개국해외약대생한미약품팔탄스마트플랜트방문,http://www.fnnews.com/news/201907161041171890
3659,2019-07-16,국제약학대학생연합방한단한미약품팔탄스마트플랜트견학,http://news.mk.co.kr/newsRead.php?year=2019&no=526101
3660,2019-07-16,한미약품스마트플랜트방문한해외약대생들글로벌경쟁력확인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003654999
3661,2019-07-16,한미약품글로벌경쟁력최고수준‥해외약대생들감탄,http://medipana.com/news/news_viewer.asp?NewsNum=242906&MainKind=A&NewsKind=5&vCount=12&vKind=1
3662,2019-07-16,영업일수적은6월원외처방액한미약품유한양행상승세,http://medipana.com/news/news_viewer.asp?NewsNum=242903&MainKind=A&NewsKind=5&vCount=12&vKind=1
3663,2019-07-16,프랑스∙영국등13개국해외약대생한미약품팔탄스마트플랜트방문,http://www.pressm.kr/news/articleView.html?idxno=24193
3664,2019-07-16,13개국해외약대생한미약품팔탄스마트플랜트방문,http://www.newsis.com/view/?id=NISX20190716_0000712092&cID=10434&pID=13000
3665,2019-07-16,한미약품스마트플랜트의약품생산글로벌경쟁력확인,http://www.medisobizanews.com/news/articleView.html?idxno=61156
3666,2019-07-16,해외13개국약대생들한미약품팔탄스마트플랜트방문,http://www.insightkorea.co.kr//news/articleView.html?idxno=44823
3667,2019-07-16,佛英등글로벌약대생한미약품팔탄스마트플랜트견학,https://www.sedaily.com/NewsView/1VLPSEBQ0G
3668,2019-07-16,해외약대생들한미약품팔탄스마트플랜트방문후감탄,http://www.asiatime.co.kr/news/articleView.html?idxno=257998
3669,2019-07-16,13개국해외약대생한미약품팔탄스마트플랜트견학,http://news.mt.co.kr/mtview.php?no=2019071611073110278
3670,2019-07-16,해외13개국약대생한미약품팔탄공장견학,http://www.dailypharm.com/Users/News/NewsView.html?ID=254755&REFERER=NP
3671,2019-07-16,국제약대생연맹한미약품팔탄스마트플랜트견학,http://health.chosun.com/site/data/html_dir/2019/07/16/2019071601015.html
3672,2019-07-16,13개국약대생한미약품팔탄스마트플랜트방문,http://www.newspim.com/news/view/20190716000456
3673,2019-07-16,한미약품팔탄스마트플랜트해외약대생도감탄,http://www.bosa.co.kr/news/articleView.html?idxno=2109019
3674,2019-07-16,프랑스영국등13개국해외약대생한미약품팔탄스마트플랜트견학,http://www.cnbnews.com/news/article.html?no=416238
3675,2019-07-16,13개국약대생팔탄스마트플랜트방문한미약품글로벌경쟁력확인,http://kormedi.com/?p=1297616
3676,2019-07-16,미래제약산업가늠자한미약품,http://www.doctorsnews.co.kr/news/articleView.html?idxno=130144
3677,2019-07-16,주가그래프한미약품주가16일현재299500원,http://nbntv.co.kr/news/view/486794
3678,2019-07-16,13개국해외약대생한미약품팔탄스마트플랜트방문,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56322
3679,2019-07-16,13개국약대생한미약품방문글로벌한미경쟁력확인,http://www.viva100.com/main/view.php?key=20190716010005438
3680,2019-07-16,13개국약대생한미약품생산공장견학,http://www.etnews.com/20190716000144
3681,2019-07-16,13개국해외약대생한미약품방문글로벌한미경쟁력확인,http://www.businesskorea.co.kr/news/articleView.html?idxno=33946
3682,2019-07-16,13개국해외약대생한미약품팔탄스마트공장방문,https://www.hankyung.com/it/article/201907167489f
3683,2019-07-16,제약산업미래의꿈을담은한미약품해외약대생들에게글로벌경쟁력과시,http://www.updownnews.co.kr/news/articleView.html?idxno=206067
3684,2019-07-16,한미약품13개국해외약대생한미약품팔탄스마트공장방문,http://www.ekn.kr/news/article.html?no=443127
3685,2019-07-16,한미약품프랑스영국등13개국해외약대생견학글로벌한미경쟁력확인,http://www.techholic.co.kr/news/articleView.html?idxno=183847
3686,2019-07-16,프랑스영국등13개국해외약대생한미약품스마트플랜트방문,http://www.bokuennews.com/news/article.html?no=178454
3687,2019-07-16,한미약품팔탄스마트플랜트에13개국해외약대생방문,http://www.datanews.co.kr/news/article.html?no=103818
3688,2019-07-16,영국등13개국약대생한미약품팔탄스마트플랜트방문,http://www.rapportian.com/news/articleView.html?idxno=118679
3689,2019-07-16,해외13개국약대생한미약품팔탄스마트플랜트방문,http://www.shinailbo.co.kr/news/articleView.html?idxno=1186006
3690,2019-07-16,13개국해외약대생들한미약품팔탄스마트플랜트방문,http://www.newsprime.co.kr/news/article.html?no=467711
3691,2019-07-16,13개국해외약대생한미약품팔탄스마트공장방문,http://www.smedaily.co.kr/news/articleView.html?idxno=84728
3692,2019-07-16,13개국해외약대생한미약품팔탄스마트플랜트견학,http://www.seoulwire.com/news/articleView.html?idxno=176677
3693,2019-07-16,미래제약산업한미약품에서확인했어,http://www.edaily.co.kr/news/newspath.asp?newsid=03480086622555176
3694,2019-07-16,미래제약산업한미약품에서확인”해외약대생들의감탄,http://www.newsway.co.kr/news/view?tp=1&ud=2019071616370597295
3695,2019-07-16,프랑스영국등13개국해외약대생한미약품스마트플랜트방문,http://www.joseilbo.com/news/news_read.php?uid=380401&class=27&grp=
3696,2019-07-16,한미약품13개국해외약대생팔탄스마트플랜트방문,http://www.ebn.co.kr/news/view/993339
3697,2019-07-16,한미약품해외약대생들에게제약산업의미래소개,http://www.g-enews.com/ko-kr/news/article/news_all/20190716122026489869d76442fa_1/article.html
3698,2019-07-16,한미약품화성팔탄공장에해외약대생초청,http://www.finomy.com/news/articleView.html?idxno=67692
3699,2019-07-16,13개국해외약대생한미약품방문글로벌한미경쟁력확인,http://www.dailypop.kr/news/articleView.html?idxno=40030
3700,2019-07-16,16일장마감매매동향한미약품주가299000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=278258
3701,2019-07-16,인기주주가정보16일한미약품마감증시299000원,http://nbntv.co.kr/news/view/488566
3702,2019-07-16,13개국약대생한미약품스마트플랜트방문,http://www.kpanews.co.kr/article/show.asp?idx=205503&table=article&category=D
3703,2019-07-16,해외약대생들한미약품방문글로벌경쟁력확인,http://www.sisaon.co.kr/news/articleView.html?idxno=97440
3704,2019-07-16,한미약품해외13개국에서모인약대생들팔탄스마트플랜트방문,http://www.newscj.com/news/articleView.html?idxno=651947
3705,2019-07-17,바이오시밀러테마오전시황상승률상위종목한올바이오파마073한미약품017이수앱지스032등,http://www.gokorea.kr/news/articleView.html?idxno=278764
3706,2019-07-17,17일09시바이오시밀러오전테마시황한올바이오파마한미약품등이상승세견인중,http://nbntv.co.kr/news/view/489800
3707,2019-07-17,한미약품프랑스영국등13개국해외약대생팔탄스마트플랜트방문RFIDICT접목한스마트생산공정소개,http://www.ezyeconomy.com/news/articleView.html?idxno=92294
3708,2019-07-17,한미약품한미사이언스모두하락세로한미약품30만원회복힘드네,http://www.econonews.co.kr/news/articleView.html?idxno=76236
3709,2019-07-17,WhoIs권세창한미약품대표이사사장,http://www.businesspost.co.kr/BP?command=article_view&num=135651
3710,2019-07-17,7월17일한미약품주식추천주297500원050,http://nbntv.co.kr/news/view/490462
3711,2019-07-17,한미약품주가7월17일현재297500원,http://www.gokorea.kr/news/articleView.html?idxno=279159
3712,2019-07-17,바이오시밀러테마오후시황상승률상위종목제넥신135이수앱지스보합세한미약품033등,http://www.gokorea.kr/news/articleView.html?idxno=279287
3713,2019-07-17,한미약품하반기반등기회노린다주요파이프라인성과임박,http://biz.newdaily.co.kr/site/data/html/2019/07/17/2019071700105.html
3714,2019-07-17,바이오시밀러테마마감시황상승률상위종목제넥신051이수앱지스048한미약품067등,http://www.gokorea.kr/news/articleView.html?idxno=279850
3715,2019-07-17,해외약대생들한미약품팔탄스마트플랜트보고감탄,http://www.seoulfn.com/news/articleView.html?idxno=349625
3716,2019-07-17,인기주종목정보7월17일한미약품297000원으로장마감,http://nbntv.co.kr/news/view/492625
3717,2019-07-18,바이오시밀러테마오전시황상승률상위종목한미약품034이수앱지스032에이프로젠제약050등,http://www.gokorea.kr/news/articleView.html?idxno=280702
3718,2019-07-18,09시38분바이오시밀러테마주오전시황한미약품이수앱지스등이상승세견인중,http://nbntv.co.kr/news/view/493947
3719,2019-07-18,바이오시밀러테마오후시황상승률상위종목팜스웰바이오014한미약품101이수앱지스128등,http://www.gokorea.kr/news/articleView.html?idxno=280852
3720,2019-07-18,증시이슈코스피상장사한미약품현재294500원대주가기록,http://aitimes.co.kr/news/view/80372
3721,2019-07-18,바이오시밀러테마종목종가한올바이오파마한미약품등이상승세주도,http://nbntv.co.kr/news/view/494375
3722,2019-07-18,바이오시밀러테마마감시황상승률상위종목한올바이오파마074한미약품101이수앱지스128등,http://www.gokorea.kr/news/articleView.html?idxno=281129
3723,2019-07-18,＂미래제약산업한미약품에서확인＂해외약대생들의감탄,http://www.nspna.com/news/?mode=view&newsid=372511
3724,2019-07-18,인기주분석주가정보7월18일한미약품294000원으로장마감,http://nbntv.co.kr/news/view/494972
3725,2019-07-19,퀵리포트한미약품매수유지목표가28↓42만원KB證,http://www.itooza.com/common/iview.php?no=2019071907311873594
3726,2019-07-19,HotLine한미약품랩스커버리실패속단은이르다목표가↓,http://news.mk.co.kr/newsRead.php?year=2019&no=540057
3727,2019-07-19,GET투자리포트한미약품투자의견매수유지KB증권,http://www.getnews.co.kr/view.php?ud=201907181030308198tpgetnews_16
3728,2019-07-19,ET투자뉴스한미약품LAPSCOVERYBUY유지KB증권,http://www.etnews.com/20190719000024
3729,2019-07-19,오늘증시한미약품주가19일현재295500원,http://nbntv.co.kr/news/view/496080
3730,2019-07-19,19일주식장마감동향한미약품296000원마감,http://www.gokorea.kr/news/articleView.html?idxno=283481
3731,2019-07-19,상장주주식시세19일한미약품마감증시296000원,http://nbntv.co.kr/news/view/498253
3732,2019-07-20,주간바이오시밀러테마리포트7월3주차한미약품팜스웰바이오제넥신한올바이오파마등강세,http://nbntv.co.kr/news/view/499689
3733,2019-07-20,주간코스피코스닥7월바이오시밀러테마주간리포트한미약품팜스웰바이오제넥신한올바이오파마등강세,http://www.anewsa.com/detail.php?number=1896518&thread=18
3734,2019-07-20,바이오시밀러테마리뷰한미약품팜스웰바이오제넥신한올바이오파마종목주도,http://aitimes.co.kr/news/view/81548
3735,2019-07-21,주간바이오시밀러테마리포트7월3주차한미약품팜스웰바이오제넥신한올바이오파마등상승,http://nbntv.co.kr/news/view/499871
3736,2019-07-21,기자수첩제발저린한미약품의늑장공시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1187338
3737,2019-07-21,주간코스피코스닥7월바이오시밀러테마주간리포트한미약품팜스웰바이오제넥신한올바이오파마등강세,http://www.anewsa.com/detail.php?number=1896890&thread=18
3738,2019-07-21,바이오시밀러테마주간종가한미약품팜스웰바이오제넥신한올바이오파마등강세,http://aitimes.co.kr/news/view/81674
3739,2019-07-22,RD최고한미약품기부금도최고,http://www.datanews.co.kr/news/article.html?no=103734
3740,2019-07-22,잇따른계약해지에휘청이는한미약품신약개발한계30개후보물질경쟁력탄탄,http://news.mk.co.kr/v2/economy/view.php?year=2019&no=549133
3741,2019-07-22,장중수급포착한미약품외국인5일연속순매수행진주가101,http://www.newspim.com/news/view/20190722000318
3742,2019-07-22,한미약품주식증권22일현재300000원,http://nbntv.co.kr/news/view/500965
3743,2019-07-22,바이오시밀러테마오후시황상승률상위종목팜스웰바이오321한올바이오파마200한미약품152등,http://www.gokorea.kr/news/articleView.html?idxno=284757
3744,2019-07-22,한미약품주가7월22일현재299500원,http://www.gokorea.kr/news/articleView.html?idxno=285312
3745,2019-07-22,바이오시밀러테마마감시황상승률상위종목팜스웰바이오423한미약품118한올바이오파마091등,http://www.gokorea.kr/news/articleView.html?idxno=285343
3746,2019-07-22,22일마감정보한미약품주가299500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=285799
3747,2019-07-22,인기주분석주가정보22일한미약품마감증시299500원,http://nbntv.co.kr/news/view/503086
3748,2019-07-23,신약개발선구자한미약품에대한기대,http://www.bosa.co.kr/news/articleView.html?idxno=2109211
3749,2019-07-23,스펙트럼한미약품포지오티닙적응증확대3개임상코호트추가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1779711
3750,2019-07-23,스펙트럼한미약품포지오티닙3개임상코호트추가,https://www.sedaily.com/NewsView/1VLT0Q4GPB
3751,2019-07-23,한미약품포지오티닙적응증확대나선다 ,http://www.monews.co.kr/news/articleView.html?idxno=203949
3752,2019-07-23,한미약품파트너스펙트럼포지오티닙적응증확대3개임상코호트추가,http://www.viva100.com/main/view.php?key=20190723010007737
3753,2019-07-23,3개임상코호트추가한미약품스펙트럼포지오티닙적응증확대,http://kpenews.com/View.aspx?No=81221
3754,2019-07-23,한미약품포지오티닙적응증확대코호트연구3개추가,http://www.medisobizanews.com/news/articleView.html?idxno=61332
3755,2019-07-23,한미약품스펙트럼포지오티닙적응증확대위한임상연구추가,https://view.asiae.co.kr/article/2019072310144218530
3756,2019-07-23,한미약품파트너스펙트럼포지오티닙적응증확대위한임상코호트추가,http://daily.hankooki.com/lpage/ittech/201907/dh20190723101952145630.htm
3757,2019-07-23,한미약품파트너사스펙트럼혁신신약적응증확대추진,http://www.edaily.co.kr/news/newspath.asp?newsid=02505926622557472
3758,2019-07-23,한미약품파트너사스펙트럼포지오티닙적응증확대연구추가,http://www.newspim.com/news/view/20190723000356
3759,2019-07-23,올리타접었던한미약품의반격,http://www.whosaeng.com/111608
3760,2019-07-23,미국스펙트럼한미약품포지오티닙적응증확대위한연구추가,http://news1.kr/articles/?3677268
3761,2019-07-23,한미약품파트너스펙트럼항암신약포지오티닙코호트연구추가,http://www.insightkorea.co.kr//news/articleView.html?idxno=45954
3762,2019-07-23,한미약품파트너사스펙트럼포지오티닙적응증확대위한3개임상코호트추가,http://www.sisajournal-e.com/news/articleView.html?idxno=203494
3763,2019-07-23,한미약품파트너사스펙트럼포지오티닙적응증확대위한임상코호트추가,http://www.ceoscoredaily.com/news/article.html?no=58279
3764,2019-07-23,한미약품파트너사스펙트럼포지오티닙적응증확대위한3개임상코호트추가,http://www.segyefn.com/newsView/20190723001110?OutUrl=naver
3765,2019-07-23,한미약품파트너사스펙트럼포지오티닙적응증확대위한3개임상코호트추가,http://www.etnews.com/20190723000100
3766,2019-07-23,한미약품파트너사스펙트럼항암신약포지오티닙적응증확대연구추진,http://www.g-enews.com/ko-kr/news/article/news_all/20190723103749114069d76442fa_1/article.html
3767,2019-07-23,한미약품파트너사스펙트럼항암신약포지오티닙적응증확대연구,http://www.seoulwire.com/news/articleView.html?idxno=180213
3768,2019-07-23,한미약품포지오티닙적응증확대코호트추가,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907230233&t=NN
3769,2019-07-23,스펙트럼한미약품포지오티닙적응증확대새연구추가,http://www.newsis.com/view/?id=NISX20190723_0000719069&cID=13001&pID=13000
3770,2019-07-23,한미약품파트너사스펙트럼코호트연구3건추가,http://www.dailian.co.kr/news/view/812653/?sc=naver
3771,2019-07-23,한미약품파트너사포지오티닙적응증확대위한코호트추가,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1070520
3772,2019-07-23,한미약품파트너사스펙트럼항암혁신신약적응증확대추진,http://kormedi.com/?p=1298141
3773,2019-07-23,한미약품파트너사스펙트럼포지오티닙적응증확대3건추가,http://www.nspna.com/news/?mode=view&newsid=373133
3774,2019-07-23,7월23일한미약품실시간증시302500원100,http://nbntv.co.kr/news/view/505292
3775,2019-07-23,한미약품폐암치료제포지오티닙적응증확대위해추가연구진행,http://www.businesspost.co.kr/BP?command=article_view&num=136419
3776,2019-07-23,한미약품파트너사스펙트럼포지오티닙적응증확대위한3개임상코호트추가,http://www.pressm.kr/news/articleView.html?idxno=24266
3777,2019-07-23,바이오시밀러테마오후시황상승률상위종목한올바이오파마288제넥신150한미약품083등,http://www.gokorea.kr/news/articleView.html?idxno=287821
3778,2019-07-23,한미약품파트너스펙트럼항암혁신신약포지오티닙적응증확대임상코호트추가,http://www.techholic.co.kr/news/articleView.html?idxno=184045
3779,2019-07-23,스펙트럼한미약품포지오티닙적응증확대코호트연구추가,http://www.ajunews.com/view/20190723142031079
3780,2019-07-23,한미약품美스펙트럼포지오티닙적응증확대위한3개임상추가”,http://biz.newdaily.co.kr/site/data/html/2019/07/23/2019072300136.html
3781,2019-07-23,한미약품포지오티닙적응증확대위해코호트연구3개추가,http://www.ekn.kr/news/article.html?no=444355
3782,2019-07-23,한미약품항암신약美임상시험3건추가사용범위확대목적”,http://biz.chosun.com/site/data/html_dir/2019/07/23/2019072301411.html
3783,2019-07-23,한미약품항암제신약후보포지오티닙폐암내성극복주목,http://www.sportsseoul.com/news/read/794923
3784,2019-07-23,한미약품파트너스펙트럼포지오티닙적응증확대가능성↑,http://news.heraldcorp.com/view.php?ud=20190723000653
3785,2019-07-23,美스펙트럼한미약품항암신약적응증확대연구추진,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019072315075516870
3786,2019-07-23,한미약품파트너사스펙트럼포지오티닙적응증확대코호트추가,http://www.smedaily.co.kr/news/articleView.html?idxno=84909
3787,2019-07-23,한미약품포지오티닙미국임상실험3건추가사용범위확대한다,https://cnbc.sbs.co.kr/article_hub/10000949473?division=NAVER
3788,2019-07-23,한미약품포지오티닙미국임상실험3건추가사용범위확대한다,https://cnbc.sbs.co.kr/article_hub/10000949473?division=NAVER
3789,2019-07-23,한미약품신규항암제포지오티닙코호트연구추가,http://www.4th.kr/news/articleView.html?idxno=14574
3790,2019-07-23,한미약품파트너사스펙트럼항암신약포지오티닙적응증확대박차,http://www.econovill.com/news/articleView.html?idxno=368137
3791,2019-07-23,한미약품파트너사스펙트럼포지오티닙3개임상코호트추가,http://www.wolyo.co.kr/news/articleView.html?idxno=89609
3792,2019-07-23,스펙트럼한미약품포지오티닙적응증확대위한3개임상코호트추가,http://www.wikileaks-kr.org/news/articleView.html?idxno=60895
3793,2019-07-23,한미약품파트너사스펙트럼포지오티닙적응증확대위한임상연구3개추가,http://www.updownnews.co.kr/news/articleView.html?idxno=206363
3794,2019-07-23,한미약품포지오티닙적응증확대위한코호트연구추가,http://www.dailypop.kr/news/articleView.html?idxno=40102
3795,2019-07-23,한미약품포지오티닙적응증확대연구추가,http://weekly.cnbnews.com/news/article.html?no=129142
3796,2019-07-23,스펙트럼한미약품항암신약임상3개연구추가,https://www.sedaily.com/NewsView/1VLT0XHOIJ
3797,2019-07-23,한미약품파트너사스펙트럼포지오티닙적응증확대연구추가,http://www.cnbnews.com/news/article.html?no=417011
3798,2019-07-23,스펙트럼한미약품비소세포폐암치료제포지오티닙적응증확대위한코호트3건임상추가,http://www.ezyeconomy.com/news/articleView.html?idxno=92441
3799,2019-07-23,특징주분석매매동향23일한미약품마감증시299500원,http://nbntv.co.kr/news/view/507477
3800,2019-07-23,23일주가마감정보한미약품299500원마감,http://www.gokorea.kr/news/articleView.html?idxno=289176
3801,2019-07-23,한미약품항암신약포지오티닙적응증확대추진임상2상에신규연구추가,http://www.donga.com/news/article/all/20190723/96661325/1
3802,2019-07-24,바이오시밀러테마오전시황상승률상위종목에이프로젠제약089한미약품017이수앱지스016등,http://www.gokorea.kr/news/articleView.html?idxno=290156
3803,2019-07-24,한미약품항암제포지오티닙적응증확대위한추가연구진행,http://health.chosun.com/site/data/html_dir/2019/07/24/2019072400689.html
3804,2019-07-24,7월24일한미약품주식실시간000299500원,http://nbntv.co.kr/news/view/509694
3805,2019-07-24,바이오시밀러테마오후시황상승률상위종목에이프로젠제약324제넥신066한미약품보합세등,http://www.gokorea.kr/news/articleView.html?idxno=290952
3806,2019-07-24,한미약품주가7월24일현재299000원,http://www.gokorea.kr/news/articleView.html?idxno=291060
3807,2019-07-24,인기주주가정보24일한미약품마감증시298000원,http://nbntv.co.kr/news/view/511853
3808,2019-07-25,7월25일코스피상장사한미약품현재299000원대주가형성,http://aitimes.co.kr/news/view/85859
3809,2019-07-25,증권주식한미약품주가25일현재298000원,http://nbntv.co.kr/news/view/514003
3810,2019-07-25,바이오시밀러테마오후시황상승률상위종목제넥신017한미약품050셀트리온167등,http://www.gokorea.kr/news/articleView.html?idxno=293912
3811,2019-07-25,25일13시바이오시밀러오후테마시황제넥신한미약품등이주도,http://nbntv.co.kr/news/view/514587
3812,2019-07-25,한미약품주가7월25일현재297500원및증권차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=127289
3813,2019-07-25,한미약품주가정보25일현재297500원,http://www.gokorea.kr/news/articleView.html?idxno=294265
3814,2019-07-25,바이오시밀러테마마감시황한미약품제넥신등이상승세주도,http://nbntv.co.kr/news/view/515273
3815,2019-07-25,바이오시밀러테마마감시황상승률상위종목한미약품017제넥신066셀트리온111등,http://www.gokorea.kr/news/articleView.html?idxno=294478
3816,2019-07-25,한미약품제이브이엠2Q영업익19억전년比36↓,http://www.wolyo.co.kr/news/articleView.html?idxno=89800
3817,2019-07-25,한미약품제이브이엠상반기매출142↑국내사업호조,http://www.donga.com/news/article/all/20190725/96698706/1
3818,2019-07-25,특징주분석주가정보25일한미약품마감증시297500원,http://nbntv.co.kr/news/view/516145
3819,2019-07-25,한미약품혁신항암신약포지오티닙적응증확대가능성타진,http://www.industrynews.co.kr/news/articleView.html?idxno=33531
3820,2019-07-26,한미약품개량신약강세아모잘탄라인업성장두드러져,http://medipana.com/news/news_viewer.asp?NewsNum=243409&MainKind=A&NewsKind=5&vCount=12&vKind=1
3821,2019-07-26,실적한미약품계열사제이브이엠2분기영업이익19억전년比364↓RD비용증가영향,http://www.ezyeconomy.com/news/articleView.html?idxno=92540
3822,2019-07-26,7월26일한미약품증권주식118294000원,http://nbntv.co.kr/news/view/518343
3823,2019-07-26,특징주종목정보26일한미약품마감증시292000원,http://nbntv.co.kr/news/view/520465
3824,2019-07-27,주간바이오시밀러테마리포트7월4주차팜스웰바이오한올바이오파마에이프로젠제약한미약품셀트리온등강세,http://nbntv.co.kr/news/view/521895
3825,2019-07-27,바이오시밀러테마리뷰팜스웰바이오한올바이오파마에이프로젠제약한미약품셀트리온등강세,http://aitimes.co.kr/news/view/89564
3826,2019-07-28,주간바이오시밀러테마리포트7월4주차팜스웰바이오한올바이오파마에이프로젠제약한미약품셀트리온등상승,http://nbntv.co.kr/news/view/522079
3827,2019-07-28,바이오시밀러테마주간종가팜스웰바이오한올바이오파마에이프로젠제약한미약품셀트리온종목강세보여,http://aitimes.co.kr/news/view/89699
3828,2019-07-29,바이오시밀러테마오전시황상승률상위종목에이프로젠제약023팜스웰바이오068한미약품086등,http://www.gokorea.kr/news/articleView.html?idxno=299282
3829,2019-07-29,09시33분바이오시밀러오전의테마종목한미약품셀트리온등이주도,http://nbntv.co.kr/news/view/522497
3830,2019-07-29,증시전망코스피상장사한미약품현재290000원대주가형성,http://aitimes.co.kr/news/view/89939
3831,2019-07-29,지난해의약품생산실적1위는한미약품,http://daily.hankooki.com/lpage/ittech/201907/dh20190729102955145630.htm
3832,2019-07-29,한미약품지난해국내의약품생산실적1위전체수출역대최대,http://biz.newdaily.co.kr/site/data/html/2019/07/29/2019072900054.html
3833,2019-07-29,한미약품가브스메트조기출시위한빠른행보,http://medipana.com/news/news_viewer.asp?NewsNum=243503&MainKind=A&NewsKind=5&vCount=12&vKind=1
3834,2019-07-29,7월29일한미약품주식추천주171287000원,http://nbntv.co.kr/news/view/523204
3835,2019-07-29,지난해의약품생산실적한미약품종근당셀트리온대웅제약순,http://medicalworldnews.co.kr/news/view.php?idx=1510931829
3836,2019-07-29,바이오시밀러테마오후시황상승률상위종목팜스웰바이오135한미약품154에이프로젠제약187등,http://www.gokorea.kr/news/articleView.html?idxno=299811
3837,2019-07-29,13시23분바이오시밀러테마주시황오후한미약품에이프로젠제약등이주도,http://nbntv.co.kr/news/view/523720
3838,2019-07-29,7월29일코스피상장사한미약품현재287500원대주가형성,http://aitimes.co.kr/news/view/90813
3839,2019-07-29,바이오시밀러테마마감시황한미약품이수앱지스등이주도,http://nbntv.co.kr/news/view/524439
3840,2019-07-29,한미약품주가종목그래프29일현재286500원,http://www.gokorea.kr/news/articleView.html?idxno=300291
3841,2019-07-29,바이오시밀러테마마감시황상승률상위종목한미약품188이수앱지스244셀트리온324등,http://www.gokorea.kr/news/articleView.html?idxno=300310
3842,2019-07-29,한미약품작년의약품생산실적1위,http://www.finomy.com/news/articleView.html?idxno=68072
3843,2019-07-29,가렵고민감한피부용치료제한미약품두피앤각광,http://kpenews.com/View.aspx?No=82239
3844,2019-07-29,한미약품무조날패밀리로여름철무좀박멸,http://www.newstomato.com/ReadNews.aspx?no=910757
3845,2019-07-29,한미약품여름철가렵고민감한피부용치료제두피앤,http://www.getnews.co.kr/view.php?ud=20190729170032834141d0c69529_16
3846,2019-07-29,한미약품자극완화항염효과등두피앤각광,http://www.wolyo.co.kr/news/articleView.html?idxno=89968
3847,2019-07-29,한미약품여름철무좀무조날패밀리4종으로한번에잡으세요,http://www.newsworks.co.kr/news/articleView.html?idxno=380809
3848,2019-07-29,상장주종목정보29일한미약품마감증시286500원,http://nbntv.co.kr/news/view/525363
3849,2019-07-29,지난해의약품수출역대최대한미약품생산실적1위,http://www.insightkorea.co.kr//news/articleView.html?idxno=47022
3850,2019-07-30,여름철골칫거리무좀잡는한미약품무조날패밀리4종,http://www.etoday.co.kr/news/section/newsview.php?idxno=1782276
3851,2019-07-30,한미약품무조날패밀리4종으로무좀부위상황별케어,http://www.tourtimes.net/112374
3852,2019-07-30,한미약품지루성피부질환예방두피앤출시,http://www.sporbiz.co.kr/news/articleView.html?idxno=362154
3853,2019-07-30,한미약품가볍고민감한피부용치료제두피앤,http://www.ajunews.com/view/20190730102541246
3854,2019-07-30,여름철민감한두피치료한미약품두피앤효과적,http://www.econovill.com/news/articleView.html?idxno=368586
3855,2019-07-30,7월30일한미약품오늘주식052288000원,http://nbntv.co.kr/news/view/527564
3856,2019-07-30,여름철무좀관리한미약품무조날패밀리로지키세요,http://www.metroseoul.co.kr/news/newsview?newscd=2019073000110
3857,2019-07-30,깜짝실적한미약품올해2Q연결영업익231억컨센비449↑,http://www.itooza.com/common/iview.php?no=2019073014395410003
3858,2019-07-30,실적속보한미약품연결20192Q영업이익2311억원,http://www.fntimes.com/html/view.php?ud=2019073014405934165dfa847be5_18
3859,2019-07-30,코스피한미약품2019년2분기누적매출액5450억원영업이익490억원연결기준,http://news.kmib.co.kr/article/view.asp?arcid=0013552125&code=61141211&cp=nv
3860,2019-07-30,한미약품2분기영업이익231억원159증가,http://yna.kr/AKR20190730100400008?did=1195m
3861,2019-07-30,공시한미약품2Q연결영업익231억전년비159↑,http://www.newsway.co.kr/news/view?tp=1&ud=2019073014433381855
3862,2019-07-30,한미약품2Q영업익231억원전년比159↑,http://news.mt.co.kr/mtview.php?no=2019073014471716370
3863,2019-07-30,공시한미약품24분기영업이익231억전년比159↑,http://www.fnnews.com/news/201907301447373030
3864,2019-07-30,한미약품2분기영업이익231억원159증가,http://www.etnews.com/20190730000187
3865,2019-07-30,한미약품2분기영업익231억원전년比159↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1782540
3866,2019-07-30,한미약품2분기2704억원매출영업이익161증가,http://www.metroseoul.co.kr/news/newsview?newscd=2019073000159
3867,2019-07-30,한미약품2Q영업익231억원전년比16증가1보,http://news1.kr/articles/?3683513
3868,2019-07-30,한미약품2Q2704억매출231억영업익前年比영업익161증가,http://www.upinews.kr/news/newsview.php?ncode=1065592110598121
3869,2019-07-30,한미약품2분기매출2704억원전년比121↑,http://www.sisafocus.co.kr/news/articleView.html?idxno=216738
3870,2019-07-30,한미약품올해2Q영업이익231억원159증가,http://www.edaily.co.kr/news/newspath.asp?newsid=03191446622559768
3871,2019-07-30,한미약품2Q영업익231억원전년비16증가,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907300429&t=NN
3872,2019-07-30,한미약품2Q영업익231억원전년比161↑,http://www.enewstoday.co.kr/news/articleView.html?idxno=1326021
3873,2019-07-30,한미약품2분기2704억원매출전년比영업이익161↑,http://www.getnews.co.kr/view.php?ud=20190730145305846941d0c69529_16
3874,2019-07-30,한미약품2분기영업이익231억원전년동기대비161↑,http://news.mk.co.kr/newsRead.php?year=2019&no=581150
3875,2019-07-30,한미약품2분기영업익231억원전년比161↑,http://news.mt.co.kr/mtview.php?no=2019073014524449338
3876,2019-07-30,한미약품2분기영업이익231억원전년비161↑,https://www.hankyung.com/finance/article/2019073006666
3877,2019-07-30,한미약품2Q영업익231억전년비16↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=255281&REFERER=NP
3878,2019-07-30,한미약품2분기매출2704억원영업이익전년比161증가,http://daily.hankooki.com/lpage/ittech/201907/dh20190730145513145630.htm
3879,2019-07-30,한미약품2분기영업이익231억161증가,http://www.mediapen.com/news/view/451613
3880,2019-07-30,한미약품2분기매출2704억원전년比영업익161↑,http://www.fetv.co.kr/news/article.html?no=33566
3881,2019-07-30,한미약품영업이익률전분기대비09p↓매출은횡보영업이익은109↓연결잠정,http://www.newspim.com/news/view/20190730001064
3882,2019-07-30,한미약품2분기2704억원매출전년比영업익161증가,http://www.pressm.kr/news/articleView.html?idxno=24397
3883,2019-07-30,한미약품2분기2704억매출영업익161증가,http://www.mdtoday.co.kr/mdtoday/index.html?no=361081
3884,2019-07-30,한미약품2분기영업익231억전년비161↑,http://www.newstomato.com/ReadNews.aspx?no=910951
3885,2019-07-30,한미약품2분기2704억원매출영업이익161증가,http://www.newsway.co.kr/news/view?tp=1&ud=2019073015020319268
3886,2019-07-30,한미약품2분기영업익231억전년비159↑,http://news.heraldcorp.com/view.php?ud=20190730000599
3887,2019-07-30,한미약품2분기매출2704억전년比121↑,http://www.kpinews.co.kr/news/articleView.html?idxno=100384
3888,2019-07-30,한미약품2분기매출2704억원영업이익161증가,http://www.m-i.kr/news/articleView.html?idxno=625985
3889,2019-07-30,한미약품2분기영업이익전년동기비161증가,http://www.medisobizanews.com/news/articleView.html?idxno=61482
3890,2019-07-30,한미약품2Q영업익231억원전년比159↑,http://www.wolyo.co.kr/news/articleView.html?idxno=90037
3891,2019-07-30,한미약품2Q호실적매출액2704억영업익231억,https://view.asiae.co.kr/article/2019073015073348574
3892,2019-07-30,실적속보한미약품올해2Q영업이익전년동기대비대폭상승158↑연결잠정,https://www.hankyung.com/finance/article/201907300729L
3893,2019-07-30,한미약품2분기영업익231억원전년비161증가,http://www.dailian.co.kr/news/view/814541/?sc=naver
3894,2019-07-30,한미약품2분기매출2704억12영업익161증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233347
3895,2019-07-30,한미약품2Q2704억원매출전년동기比영업이익161증가,http://www.dailysmart.co.kr/news/articleView.html?idxno=13904
3896,2019-07-30,한미약품2분기연결영업익231억전년比161↑,http://www.sportsseoul.com/news/read/797959
3897,2019-07-30,7월30일한미약품오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=303170
3898,2019-07-30,한미약품2분기영업이익231억원159증가종합,http://yna.kr/AKR20190730100451008?did=1195m
3899,2019-07-30,실적한미약품2분기영업익231억전년比161↑공동연구비감액국내매출호조효과,http://www.ezyeconomy.com/news/articleView.html?idxno=92631
3900,2019-07-30,한미약품2분기영업익231억원전년比161↑,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019073015155658309
3901,2019-07-30,한미약품2분기영업익전년比16↑,https://www.paxnetnews.com/articles/50922
3902,2019-07-30,공시한미약품2분기영업익231억전년比16↑,http://www.newsis.com/view/?id=NISX20190730_0000726695&cID=10401&pID=10400
3903,2019-07-30,한미약품사노피연구비감액국내매출호조로호실적,http://www.newsis.com/view/?id=NISX20190730_0000726676&cID=13001&pID=13000
3904,2019-07-30,한미약품2분기영업익161증가사노피와공동연구비감액영향,http://www.newspim.com/news/view/20190730001053
3905,2019-07-30,한미약품2분기영업익231억원전년比161증가,http://www.viva100.com/main/view.php?key=20190730010010348
3906,2019-07-30,한미약품2Q영업익16↑사노피공동연구비감액효과상보,http://news1.kr/articles/?3683552
3907,2019-07-30,한미약품2분기매출2704억원달성전년대비12증가,http://medipana.com/news/news_viewer.asp?NewsNum=243574&MainKind=A&NewsKind=5&vCount=12&vKind=1
3908,2019-07-30,한미약품2분기매출2704억영업이익161증가,http://www.asiatime.co.kr/news/articleView.html?idxno=261153
3909,2019-07-30,한미약품2분기영업익231억개량복합신약매출견인,http://www.rapportian.com/news/articleView.html?idxno=119027
3910,2019-07-30,한미약품2분기영업이익231억원전년比159↑,http://www.nspna.com/news/?mode=view&newsid=374643
3911,2019-07-30,한미약품2분기매출2704억원기록전년동기대비121증가,http://www.econovill.com/news/articleView.html?idxno=368613
3912,2019-07-30,한미약품2분기2704억원매출영업이익전년비161증가,http://www.ceoscoredaily.com/news/article.html?no=58629
3913,2019-07-30,한미약품2분기영업이익16증가,http://www.fnnews.com/news/201907301543292316
3914,2019-07-30,한미약품2Q매출2704억전년比121↑,http://kormedi.com/?p=1298702
3915,2019-07-30,한미약품2분기2704억원매출영업이익161증가,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56566
3916,2019-07-30,한미약품2분기실적호조매출영업이익두자릿수비율증가,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=532825
3917,2019-07-30,한미약품2분기영업익231억전년비161↑,http://www.segyefn.com/newsView/20190730002659?OutUrl=naver
3918,2019-07-30,한미약품2분기영업익231억전년比161증가,http://www.ajunews.com/view/20190730155340626
3919,2019-07-30,공시한미약품1289402Q연결영업익231억전년비159↑,http://www.startuptoday.co.kr/news/articleView.html?idxno=27893
3920,2019-07-30,한미약품2분기호실적달성매출1조클럽바짝,http://www.etoday.co.kr/news/section/newsview.php?idxno=1782578
3921,2019-07-30,한미약품2분기영업익231억원전년比161↑,http://www.seoulwire.com/news/articleView.html?idxno=185624
3922,2019-07-30,한미약품2분기영업이익231억원전년동기대비161증가,http://www.tourtimes.net/112637
3923,2019-07-30,한미약품2분기2704억원매출영업이익161↑,http://www.bokuennews.com/news/article.html?no=179026
3924,2019-07-30,한미약품2분기영업이익231억원달성전년比161증가,http://www.greened.kr/news/articleView.html?idxno=205604
3925,2019-07-30,한미약품상반기영업이익490억원전년比6증가,http://www.donga.com/news/article/all/20190730/96760400/1
3926,2019-07-30,한미약품2분기매출2704억원기록영업이익161증가,http://www.ekn.kr/news/article.html?no=445559
3927,2019-07-30,한미약품2분기영업익231억전년비161증가,http://www.finomy.com/news/articleView.html?idxno=68106
3928,2019-07-30,한미약품2Q영업이익231억원전년比161↑,http://www.inews24.com/view/1197866
3929,2019-07-30,한미약품2Q영업익231억전년비161↑,http://www.ebn.co.kr/news/view/995193
3930,2019-07-30,국내매출상승효과한미약품2분기영업익전년比161↑,http://www.sisaon.co.kr/news/articleView.html?idxno=98281
3931,2019-07-30,한미약품2분기영업이익231억원전년比161↑,http://inthenews.co.kr/article-10047/
3932,2019-07-30,한미약품2분기영업이익231억전년비16↑,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907300509&t=NN
3933,2019-07-30,한미약품2분기매출2704억원영업이익161증가,http://www.shinailbo.co.kr/news/articleView.html?idxno=1190672
3934,2019-07-30,한미약품2분기2704억원매출영업이익161증가,http://www.medigatenews.com/news/1275995165
3935,2019-07-30,한미약품2Q영업익231억전년比16↑,http://www.newsprime.co.kr/news/article.html?no=469600
3936,2019-07-30,한미약품2분기영업이익231억원전년比161증가,http://biz.chosun.com/site/data/html_dir/2019/07/30/2019073001628.html
3937,2019-07-30,한미약품2분기2704억원매출영업이익전년比16↑,http://www.joseilbo.com/news/news_read.php?uid=381310&class=17&grp=
3938,2019-07-30,한미약품2분기영업익231억원전년대비16증가,http://moneys.mt.co.kr/news/mwView.php?no=2019073017008019347
3939,2019-07-30,한미약품2분기매출2704억원121성장,http://www.mhj21.com/123058
3940,2019-07-30,한미약품국내사업호조와공동연구비감소로2분기실적늘어,http://www.businesspost.co.kr/BP?command=article_view&num=137480
3941,2019-07-30,한미약품2분기매출2704억원121성장,http://www.mhj21.com/123058
3942,2019-07-30,한미약품2분기영업이익231억원전년比161↑,http://www.4th.kr/news/articleView.html?idxno=14859
3943,2019-07-30,한미약품2분기영업익231억전년比159증가,http://biz.newdaily.co.kr/site/data/html/2019/07/30/2019073000160.html
3944,2019-07-30,한미약품2분기2704억원매출올해도1조실적순항,http://www.kukinews.com/news/article.html?no=687103
3945,2019-07-30,한미약품2분기2704억원매출영업익161증가,http://www.news2day.co.kr/132974
3946,2019-07-30,한미약품2분기영업익231억원전년比159↑,http://www.dt.co.kr/contents.html?article_no=2019073002109931102002&ref=naver
3947,2019-07-30,한미약품2분기매출2704억원전년동기대비121↑,http://www.dailypop.kr/news/articleView.html?idxno=40239
3948,2019-07-30,한미약품2분기2704억원매출영업이익161증가,http://www.lawissue.co.kr/view.php?ud=201907301804323265204ead0791_12
3949,2019-07-30,한미약품2Q영업익16증가231억개량복합신약덕분,http://www.edaily.co.kr/news/newspath.asp?newsid=04044246622559768
3950,2019-07-30,뉴스워커_한미약품2분기2704억원매출기록,http://www.newsworker.co.kr/news/articleView.html?idxno=34930
3951,2019-07-30,한미약품2Q영업익231억원전년比159증가,http://www.seoulfn.com/news/articleView.html?idxno=350959
3952,2019-07-30,특징주종목정보30일한미약품마감증시290500원,http://nbntv.co.kr/news/view/529681
3953,2019-07-30,한미약품2Q매출2704억원영업이익전년동기比161↑,http://www.newswatch.kr/news/articleView.html?idxno=22145
3954,2019-07-30,30일장마감매매동향한미약품주가290500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=303970
3955,2019-07-30,한미약품2분기2704억원매출영업이익161증가,http://www.thefirstmedia.net/news/articleView.html?idxno=47151
3956,2019-07-31,한미약품2분기매출영업익동반수직상승전년比매출121↑영업익161↑,http://www.g-enews.com/ko-kr/news/article/news_all/20190730162737823569d76442fa_1/article.html
3957,2019-07-31,한미약품2분기영업이익231억전년대비16늘어나,http://www.econonews.co.kr/news/articleView.html?idxno=78679
3958,2019-07-31,한미약품2Q매출2704억영업이익전년비161늘어,https://www.kpanews.co.kr/article/show.asp?idx=205801&category=D
3959,2019-07-31,한미약품의약품생산실적1위되찾았다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233372
3960,2019-07-31,한미약품모멘텀이필요하다한국투자증권,http://news.mt.co.kr/mtview.php?no=2019073107465974775
3961,2019-07-31,I리포트한미약품가시적성과필요–한투證,http://www.inews24.com/view/1197995
3962,2019-07-31,퀵리포트한미약품중립유지목표가미제시한투證,http://www.itooza.com/common/iview.php?no=2019073108063540545
3963,2019-07-31,한미약품사노피수정계약으로RD비용감소한국투자증권,http://www.fnnews.com/news/201907310759072101
3964,2019-07-31,퀵리포트한미약품매수유지목표가40만원유지이베스트證,http://www.itooza.com/common/iview.php?no=2019073108081526046
3965,2019-07-31,한미약품RD펀더멘탈여전히견고저점매수기회하나금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1782783
3966,2019-07-31,HotLine한미약품신약개발의가시적성과필요,http://news.mk.co.kr/newsRead.php?year=2019&no=583063
3967,2019-07-31,한미약품제품매출등본업에충실한영업익한미정밀화학흑자로호조,http://www.asiatoday.co.kr/view.php?key=20190731010019318
3968,2019-07-31,한미약품2분기영업익컨센서스상회투자의견매수신한금융투자,http://www.fntimes.com/html/view.php?ud=201907310817252182f09e13944d_18
3969,2019-07-31,퀵리포트한미약품매수유지목표가32↓42만원SK證,http://www.itooza.com/common/iview.php?no=2019073108400013809
3970,2019-07-31,퀵리포트한미약품매수유지목표가36만원유지신한금투,http://www.itooza.com/common/iview.php?no=2019073108391441362
3971,2019-07-31,NH투자證한미약품롤론티스FDA허가재신청등하반기RD모멘텀유효,http://www.newsis.com/view/?id=NISX20190731_0000727261&cID=10401&pID=10400
3972,2019-07-31,한미약품하반기두건의반등모멘텀목표가↓,http://www.newsprime.co.kr/news/article.html?no=469678
3973,2019-07-31,퀵리포트한미약품매수유지목표가32↓41만원유안타證,http://www.itooza.com/common/iview.php?no=2019073108511550376
3974,2019-07-31,NH證한미약품임상비용감소호실적,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907310074&t=NN
3975,2019-07-31,한미약품하반기영업이익성장힘들어신약모멘텀필요,https://www.sedaily.com/NewsView/1VLWO8WEP5
3976,2019-07-31,한미약품하반기영업이익성장힘들어신약모멘텀필요,https://www.sedaily.com/NewsView/1VLWO8WEP5
3977,2019-07-31,한미약품주가상승가능기술반환에도연구개발기초탄탄해,http://www.businesspost.co.kr/BP?command=article_view&num=137548
3978,2019-07-31,한미약품2분기2704억원매출영업이익161증가,http://www.doctorsnews.co.kr/news/articleView.html?idxno=130320
3979,2019-07-31,한미약품하반기반등모멘텀유효NH투자證,http://www.seoulfn.com/news/articleView.html?idxno=350985
3980,2019-07-31,한미약품2분기2704억원매출영업이익전년동기대비161↑,http://www.wikileaks-kr.org/news/articleView.html?idxno=61615
3981,2019-07-31,한투한미약품호실적에도모멘텀부재신약개발성과없이하반기성장어려워”,http://www.lawissue.co.kr/view.php?ud=2019073109341113189817d053b9_12
3982,2019-07-31,퀵리포트한미약품매수로상향목표가40만원DB금투,http://www.itooza.com/common/iview.php?no=2019073109431392486
3983,2019-07-31,GET투자리포트한미약품투자의견매수상향DB금융투자,http://www.getnews.co.kr/view.php?ud=201907311030308958tpgetnews_16
3984,2019-07-31,리포트브리핑한미약품예상된호실적목표가400000원DB금융투자,http://www.newspim.com/news/view/20190731000236
3985,2019-07-31,GET투자리포트한미약품투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=201907311030308961tpgetnews_16
3986,2019-07-31,리포트브리핑한미약품의약품매출호조RD비용감소로이익개선목표가460000원대신증권,http://www.newspim.com/news/view/20190731000251
3987,2019-07-31,한미약품2분기깜짝실적전망은온도차,http://www.g-enews.com/ko-kr/news/article/news_all/201907310951398391c642673384_1/article.html
3988,2019-07-31,한미약품전일대비약3하락한281500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201907310245&t=NN
3989,2019-07-31,상반기5450억원한미약품외형수익성모두잡아,http://www.monews.co.kr/news/articleView.html?idxno=204123
3990,2019-07-31,리포트브리핑한미약품모멘텀이필요하다중립유지한국투자증권,http://www.newspim.com/news/view/20190731000279
3991,2019-07-31,GET투자리포트한미약품투자의견중립유지한국투자증권,http://www.getnews.co.kr/view.php?ud=201907311030308974tpgetnews_16
3992,2019-07-31,GET투자리포트한미약품투자의견매수KB증권,http://www.getnews.co.kr/view.php?ud=201907301030308980tpgetnews_16
3993,2019-07-31,특징주한미약품하반기RD모멘텀유효,http://www.sisaon.co.kr/news/articleView.html?idxno=98298
3994,2019-07-31,한미약품2Q영업이익16증가에도증권가는중립유지,http://it.chosun.com/site/data/html_dir/2019/07/31/2019073100855.html
3995,2019-07-31,GET투자리포트한미약품투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=201907311030308985tpgetnews_16
3996,2019-07-31,리포트브리핑한미약품RD비용축소로2019년2분기영업이익시장컨센서스상회목표가420000원SK증권,http://www.newspim.com/news/view/20190731000350
3997,2019-07-31,리포트브리핑한미약품견조한탑라인성장세지속과비용감소로어닝서프라이즈시현목표가500000원하나금융투자,http://www.newspim.com/news/view/20190731000368
3998,2019-07-31,GET투자리포트한미약품투자의견매수하나금융투자,http://www.getnews.co.kr/view.php?ud=201907311030308990tpgetnews_16
3999,2019-07-31,GET투자리포트한미약품투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=201907311030309002tpgetnews_16
4000,2019-07-31,리포트브리핑한미약품임상비용감소로호실적시현목표가470000원NH투자증권,http://www.newspim.com/news/view/20190731000437
4001,2019-07-31,투자종목하나금투한미약품견조한탑라인성장세지속비용감소,http://www.newswatch.kr/news/articleView.html?idxno=22148
4002,2019-07-31,한미약품뇌기능개선제카니틸인지기능개선확인,http://medipana.com/news/news_viewer.asp?NewsNum=243636&MainKind=A&NewsKind=5&vCount=12&vKind=1
4003,2019-07-31,GET투자리포트한미약품투자의견매수유안타증권,http://www.getnews.co.kr/view.php?ud=201907311030309019tpgetnews_16
4004,2019-07-31,리포트브리핑한미약품새로운모멘텀이필요하다목표가410000원유안타증권,http://www.newspim.com/news/view/20190731000524
4005,2019-07-31,한미약품뇌기능개선제카니틸국내환자대상인지기능개선확인”,http://www.newsway.co.kr/news/view?tp=1&ud=2019073111251803542
4006,2019-07-31,한미약품카니틸국내환자대상인지기능개선확인,http://www.bosa.co.kr/news/articleView.html?idxno=2109944
4007,2019-07-31,한미약품2분기매출2704억영업익161↑,http://www.whosaeng.com/111743
4008,2019-07-31,한미약품카니틸국내환자대상인지기능개선확인,http://www.medigatenews.com/news/1804701697
4009,2019-07-31,오늘주식한미약품주가31일현재282000원,http://nbntv.co.kr/news/view/531886
4010,2019-07-31,한미약품카니틸인지기능개선확인,http://www.whosaeng.com/111744
4011,2019-07-31,한미약품카니틸인지장애개선전두엽기능유지도움,http://www.medisobizanews.com/news/articleView.html?idxno=61508
4012,2019-07-31,GET투자리포트한미약품투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=201907311030309029tpgetnews_16
4013,2019-07-31,리포트브리핑한미약품RD성과가필요한시점목표가360000원신한금융투자,http://www.newspim.com/news/view/20190731000565
4014,2019-07-31,한미약품카니틸국내환자대상인지기능개선확인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233395
4015,2019-07-31,한미약품매출등실적호조하반기임상결과촉각,http://medipana.com/news/news_viewer.asp?NewsNum=243633&MainKind=A&NewsKind=5&vCount=12&vKind=1
4016,2019-07-31,한미약품뇌기능개선제카니틸4상결과공개,http://www.biospectator.com/view/news_view.php?varAtcId=8160
4017,2019-07-31,GC녹십자한미약품2분기매출증가호실적,http://www.dailymedi.com/detail.php?number=845824&thread=22r05
4018,2019-07-31,한미약품뇌기능개선제카니틸국내치매환자인지기능개선입증,http://www.wikileaks-kr.org/news/articleView.html?idxno=61663
4019,2019-07-31,한미약품그룹상장3사영업익744억합작10↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=255305&REFERER=NP
4020,2019-07-31,한미약품카니틸국내환자대상인지기능개선확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56581
4021,2019-07-31,한미약품카니틸국내환자대상인지기능개선확인,http://www.doctorsnews.co.kr/news/articleView.html?idxno=130335
4022,2019-07-31,한미약품카니틸국내치매환자인지기능개선확인,http://kormedi.com/?p=1298789
4023,2019-07-31,한미약품2분기매출2704억원등호실적기록상반기누적매출5450억달성,http://www.updownnews.co.kr/news/articleView.html?idxno=206661
4024,2019-07-31,한미약품카니틸국내환자인지기능개선확인,http://www.monews.co.kr/news/articleView.html?idxno=204150
4025,2019-07-31,한미약품2분기2704억원매출영업이익161증가,http://www.gukjenews.com/news/articleView.html?idxno=1153282
4026,2019-07-31,GET투자리포트한미약품투자의견매수유지이베스트투자증권,http://www.getnews.co.kr/view.php?ud=201907311030309051tpgetnews_16
4027,2019-07-31,리포트브리핑한미약품2Q19Review목표가400000원이베스트투자증권,http://www.newspim.com/news/view/20190731000720
4028,2019-07-31,한미약품RD펀더멘탈은여전히견고”,http://www.wikitree.co.kr/main/news_view.php?id=450269
4029,2019-07-31,한미약품주가7월31일현재289500원및증권차트분석,http://www.cctvnews.co.kr/news/articleView.html?idxno=128381
4030,2019-07-31,GET투자리포트한미약품투자의견매수메리츠종금증권,http://www.getnews.co.kr/view.php?ud=201907311030309072tpgetnews_16
4031,2019-07-31,리포트브리핑한미약품견고한본업매출목표가340000원메리츠종금증권,http://www.newspim.com/news/view/20190731000955
4032,2019-07-31,한미약품카니틸국내환자대상인지기능개선확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=361211
4033,2019-07-31,한미약품하반기에도주요제품매출증가로외형성장을유지”,http://www.wikitree.co.kr/main/news_view.php?id=450346
4034,2019-07-31,한미약품주가7월31일현재290000원,http://www.gokorea.kr/news/articleView.html?idxno=306246
4035,2019-07-31,오늘Who우종수한미약품개량신약판매늘려신약개발발판다져,http://www.businesspost.co.kr/BP?command=article_view&num=137641
4036,2019-07-31,월요기획불경기속남몰래웃는제약사종근당보령제약한미약품호실적에好好,http://www.wolyo.co.kr/news/articleView.html?idxno=90142
4037,2019-07-31,유한양행GC녹십자한미약품종근당빅4제약사2분기성적은,http://www.insightkorea.co.kr//news/articleView.html?idxno=47542
4038,2019-07-31,한미약품뇌기능개선제카니틸인지기능개선확인”,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1070812
4039,2019-07-31,31일상장기업장마감정보한미약품주가290000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=306512
4040,2019-07-31,인기주분석종목정보31일한미약품마감증시290000원,http://nbntv.co.kr/news/view/534005
4041,2019-07-31,한미약품2분기2704억원매출영업이익161증가,http://www.newscj.com/news/articleView.html?idxno=655815
4042,2019-08-01,한미약품카티닐뇌혈관질환동반치매인지기능개선,http://www.sportsseoul.com/news/read/798925
4043,2019-08-01,바이오인사이트기술수출선구자or실패자한미약품어디로,http://www.econovill.com/news/articleView.html?idxno=368735
4044,2019-08-01,바이오시밀러테마오전시황상승률상위종목한올바이오파마302셀트리온205한미약품190등,http://www.gokorea.kr/news/articleView.html?idxno=307980
4045,2019-08-01,한미약품무좀치료제무조날패밀리라인업구축,http://inthenews.co.kr/article-10345/
4046,2019-08-01,09시30분바이오시밀러테마주오전시황한올바이오파마한미약품등이주도,http://nbntv.co.kr/news/view/535480
4047,2019-08-01,장중수급포착한미약품외국인4일연속순매수행진주가155,http://www.newspim.com/news/view/20190801000367
4048,2019-08-01,8월1일한미약품주식현재가276298000원,http://nbntv.co.kr/news/view/536198
4049,2019-08-01,바이오시밀러테마오후시황상승률상위종목에이프로젠제약301한올바이오파마283한미약품241등,http://www.gokorea.kr/news/articleView.html?idxno=308539
4050,2019-08-01,한미약품주가및종목차트1일현재296500원증권시세,http://www.cctvnews.co.kr/news/articleView.html?idxno=128642
4051,2019-08-01,1일증시종목마감동향한미약품주가296500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=309519
4052,2019-08-01,특징주분석매매동향8월1일한미약품296500원으로장마감,http://nbntv.co.kr/news/view/538357
4053,2019-08-01,NH투자증권한미약품롤론티스미국FDA허가재신청등하반기RD모멘텀유효,http://www.econonews.co.kr/news/articleView.html?idxno=79156
4054,2019-08-01,한미약품카니틸국내환자대상인지기능개선확인,https://www.kpanews.co.kr/article/show.asp?idx=205860&category=D
4055,2019-08-01,한미약품2분기영업이익231억전년比161증가,http://www.polinews.co.kr/news/article.html?no=405293
4056,2019-08-02,바이오시밀러테마오전시황상승률상위종목에이프로젠제약189한미약품270한올바이오파마273등,http://www.gokorea.kr/news/articleView.html?idxno=310605
4057,2019-08-02,8월2일한미약품실시간주식현황293500원101,http://nbntv.co.kr/news/view/540542
4058,2019-08-02,한미약품주가8월2일현재293000원,http://www.gokorea.kr/news/articleView.html?idxno=311462
4059,2019-08-02,바이오시밀러테마오후시황상승률상위종목에이프로젠제약056한올바이오파마보합세한미약품101등,http://www.gokorea.kr/news/articleView.html?idxno=311564
4060,2019-08-02,바이오시밀러테마마감시황상승률상위종목한올바이오파마091에이프로젠제약111한미약품152등,http://www.gokorea.kr/news/articleView.html?idxno=312693
4061,2019-08-02,2일증시종목마감동향한미약품292000원마감,http://www.gokorea.kr/news/articleView.html?idxno=312786
4062,2019-08-02,한미약품뇌기능개선제카니틸국내치매환자대상인지기능개선확인,http://www.industrynews.co.kr/news/articleView.html?idxno=33696
4063,2019-08-03,종근당한미약품2분기실적성장세부각증권가도긍정평가,http://www.nspna.com/news/?mode=view&newsid=375484
4064,2019-08-03,주간바이오시밀러테마리포트8월1주차한미약품에이프로젠제약이수앱지스한올바이오파마등강세,http://nbntv.co.kr/news/view/541819
4065,2019-08-03,바이오시밀러테마리뷰한미약품에이프로젠제약이수앱지스한올바이오파마종목강세보여,http://aitimes.co.kr/news/view/99129
4066,2019-08-04,주간바이오시밀러테마리포트8월1주차한미약품에이프로젠제약이수앱지스한올바이오파마등상승,http://nbntv.co.kr/news/view/542000
4067,2019-08-04,권세창한미약품의하반기신약개발성과로기술반환설욕별러,http://www.businesspost.co.kr/BP?command=article_view&num=138103
4068,2019-08-04,바이오시밀러테마주간종가한미약품에이프로젠제약이수앱지스한올바이오파마등강세,http://aitimes.co.kr/news/view/99268
4069,2019-08-05,5일09시바이오시밀러테마주오전시황한올바이오파마한미약품등이주도,http://nbntv.co.kr/news/view/542273
4070,2019-08-05,8월5일한미약품증권투자정보,http://www.gokorea.kr/news/articleView.html?idxno=315084
4071,2019-08-05,한미약품주가증권그래프5일현재274000원,http://www.gokorea.kr/news/articleView.html?idxno=315086
4072,2019-08-05,13시27분바이오시밀러오후의테마종목한올바이오파마한미약품등이상승세견인중,http://nbntv.co.kr/news/view/542371
4073,2019-08-05,5일증시이슈코스피상장사한미약품현재273500원대주가형성,http://aitimes.co.kr/news/view/100594
4074,2019-08-05,바이오시밀러테마주시황마감한미약품에이프로젠제약등이주도,http://nbntv.co.kr/news/view/542424
4075,2019-08-05,바이오시밀러테마마감시황상승률상위종목한미약품719에이프로젠제약945한올바이오파마1011등,http://www.gokorea.kr/news/articleView.html?idxno=317404
4076,2019-08-06,8월6일한미약품정보외주식시황166변동해,http://www.gokorea.kr/news/articleView.html?idxno=318820
4077,2019-08-06,지속가능한미약품이익보다큰연구개발비2분기영업익161↑,http://news.heraldcorp.com/view.php?ud=20190806000507
4078,2019-08-06,바이오시밀러테마오후시황상승률상위종목셀트리온584팜스웰바이오368한미약품258등,http://www.gokorea.kr/news/articleView.html?idxno=319183
4079,2019-08-06,바이오시밀러테마주시황마감셀트리온한미약품등이주도,http://nbntv.co.kr/news/view/542874
4080,2019-08-06,바이오시밀러테마마감시황상승률상위종목셀트리온069한미약품074팜스웰바이오087등,http://www.gokorea.kr/news/articleView.html?idxno=320190
4081,2019-08-06,6일외국인순매수Top10셀트리온542억한미약품41억더존비즈온29억신성통상26억외국인순매수나서코스닥시장에서는셀트리온헬스케어아난티JYPEnt상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=57273
4082,2019-08-07,한미약품견고한파이프라인으로재도약날개단다,http://www.dailian.co.kr/news/view/816241/?sc=naver
4083,2019-08-07,한미약품카니틸국내환자대상인지기능개선확인,http://www.wsobi.com/news/articleView.html?idxno=79104
4084,2019-08-07,8월7일한미약품및증권시세및종목동정과증시정보019변동,http://www.gokorea.kr/news/articleView.html?idxno=321816
4085,2019-08-07,바이오시밀러테마오후시황상승률상위종목제넥신310셀트리온273한미약품056등,http://www.gokorea.kr/news/articleView.html?idxno=322239
4086,2019-08-07,8월7일한미약품배당주식019268500원,http://nbntv.co.kr/news/view/543994
4087,2019-08-07,상반기실속빠진제약업계승자는한미약품대웅제약,http://weekly.cnbnews.com/news/article.html?no=129416
4088,2019-08-07,인기종목주가정보7일한미약품마감증시267500원,http://nbntv.co.kr/news/view/544924
4089,2019-08-08,한미약품오락솔임상3상고무적효능편의성높이고부작용줄여,http://www.dailysmart.co.kr/news/articleView.html?idxno=14222
4090,2019-08-08,한미약품항암신약오락솔임상3상1차유효성평가통과,https://www.sedaily.com/NewsView/1VMW1JNRDD
4091,2019-08-08,한미약품오락솔임상3상윤곽고무적결과,http://medipana.com/news/news_viewer.asp?NewsNum=243934&MainKind=A&NewsKind=5&vCount=12&vKind=1
4092,2019-08-08,8월8일한미약품오늘증시000267500원,http://nbntv.co.kr/news/view/546558
4093,2019-08-08,한미약품경구용항암신약3상효능편의성높였다,http://news.heraldcorp.com/view.php?ud=20190808000199
4094,2019-08-08,한미약품오락솔효능↑부작용↓FDA에사전미팅신청,http://www.newsis.com/view/?id=NISX20190808_0000735393&cID=13001&pID=13000
4095,2019-08-08,한미약품오락솔임상3상고무적”효능편의성높이고부작용줄여,http://www.newsway.co.kr/news/view?tp=1&ud=2019080810124641740
4096,2019-08-08,한미약품항암신약오락솔임상3상고무적”,http://biz.chosun.com/site/data/html_dir/2019/08/08/2019080800908.html
4097,2019-08-08,한미약품오락솔3상기존항암제대비효능입증,http://news.mt.co.kr/mtview.php?no=2019080810134272399
4098,2019-08-08,한미약품경구용항암신약오락솔임상3상유효성확인,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908080143&t=NN
4099,2019-08-08,한미약품항암신약오락솔효능높이고부작용빈도줄여,https://view.asiae.co.kr/article/2019080810223732031
4100,2019-08-08,한미약품항암신약오락솔효능높이고부작용줄였다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019080810174517819
4101,2019-08-08,한미약품경구용항암신약오락솔임상3상에서효능과편의성입증했다,http://www.ekn.kr/news/article.html?no=447108
4102,2019-08-08,한미약품경구용항암신약오락솔임상3상결과로FDA에NDA신청,http://moneys.mt.co.kr/news/mwView.php?no=2019080810178017690
4103,2019-08-08,한미약품오락솔임상3상효능편의성높이고부작용줄여,http://www.fnnews.com/news/201908081030592453
4104,2019-08-08,한미약품오락솔임상3상서효능입증FDA신약허가신청할것,http://www.newspim.com/news/view/20190808000553
4105,2019-08-08,한미약품항암신약오락솔임상3상서우수한효능,http://www.medisobizanews.com/news/articleView.html?idxno=61673
4106,2019-08-08,한미약품경구항암신약오락솔임상3상고무적,http://www.mhj21.com/123328
4107,2019-08-08,한미약품항암신약물질오락솔임상3상성공적FDA허가신청,http://news1.kr/articles/?3690931
4108,2019-08-08,한미약품오락솔3상서기존항암제대비효능우수성입증,http://www.rapportian.com/news/articleView.html?idxno=119241
4109,2019-08-08,한미약품효능∙편의성높인오락솔임상3상고무적,http://www.ebn.co.kr/news/view/996385
4110,2019-08-08,한미약품오락솔임상3상고무적효능편의성높이고부작용감소,http://www.sisajournal-e.com/news/articleView.html?idxno=204329
4111,2019-08-08,한미약품기술수출항암물질美유방암임상서효과,http://yna.kr/AKR20190808059700017?did=1195m
4112,2019-08-08,한미약품항암신약오락솔임상3상부작용발생빈도감소,http://www.sisafocus.co.kr/news/articleView.html?idxno=217573
4113,2019-08-08,한미약품오락솔임상3상고무적”효능편의성높이고부작용줄여,http://www.ceoscoredaily.com/news/article.html?no=59019
4114,2019-08-08,한미약품경구용항암신약오락솔임상결과고무적”,http://daily.hankooki.com/lpage/ittech/201908/dh20190808110111145630.htm
4115,2019-08-08,한미약품경구용항암제오락솔유방암임상3상서효능높이고부작용줄여,http://www.etoday.co.kr/news/section/newsview.php?idxno=1786036
4116,2019-08-08,한미약품신약오락솔임상3상고무적효능편의성↑부작용↓,http://www.edaily.co.kr/news/newspath.asp?newsid=02624006622585352
4117,2019-08-08,한미약품경구용항암치료제오락솔임상3상유효성효능입증,http://www.ezyeconomy.com/news/articleView.html?idxno=92898
4118,2019-08-08,한미약품오락솔기존치료제보다효능편의성우수부작용↓,http://biz.newdaily.co.kr/site/data/html/2019/08/08/2019080800052.html
4119,2019-08-08,한미약품오락솔임상3상서기존항암제대비효능입증,http://www.seoulwire.com/news/articleView.html?idxno=192136
4120,2019-08-08,오락솔주사항암제보다우수한미약품경구제전환기술합격점,http://www.sportsseoul.com/news/read/802370
4121,2019-08-08,한미약품항암신약오락솔임상3상고무적,http://www.pressm.kr/news/articleView.html?idxno=24545
4122,2019-08-08,한미약품오솔락임상3상서유방암환자에게월등한반응률발견,http://www.asiatime.co.kr/news/articleView.html?idxno=262861
4123,2019-08-08,한미약품항암신약오락솔임상3상효과부작용↓,http://www.ajunews.com/view/20190808112717388
4124,2019-08-08,한미약품항암신약오락솔글로벌임상3상에서우수한효능보여,http://www.businesspost.co.kr/BP?command=article_view&num=138677
4125,2019-08-08,한미약품오락솔임상3상고무적효능우수부작용발생빈도감소,http://www.newsprime.co.kr/news/article.html?no=470714
4126,2019-08-08,한미약품먹는항암신약유방암임상통해효능확인신경병증발생률↓,http://www.donga.com/news/article/all/20190808/96882961/1
4127,2019-08-08,8월8일한미약품128940및증권시세외증시동향019변동,http://www.gokorea.kr/news/articleView.html?idxno=325224
4128,2019-08-08,제약워치한미약품오락솔임상3상고무적효능∙편의성높이고부작용줄여外,http://www.newswatch.kr/news/articleView.html?idxno=22329
4129,2019-08-08,한미약품항암신약오락솔효능∙편의성높이고부작용줄여”,http://www.mdtoday.co.kr/mdtoday/index.html?no=361827
4130,2019-08-08,한미약품항암신약美진출청신호,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1071068
4131,2019-08-08,한미약품경구용항암제오락솔글로벌임상3상고무적,http://www.metroseoul.co.kr/news/newsview?newscd=2019080800124
4132,2019-08-08,한미약품기술수출항암물질미유방암임상서효과,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3908546
4133,2019-08-08,한미약품오락솔신경병증부작용발생빈도17대,http://www.monews.co.kr/news/articleView.html?idxno=204299
4134,2019-08-08,한미약품기술수출항암신약오락솔美유방암임상서효과,http://news.mk.co.kr/newsRead.php?year=2019&no=610981
4135,2019-08-08,한미약품오락솔임상3상효과확인”,http://www.etnews.com/20190808000181
4136,2019-08-08,한미약품경구용항암신약오락솔임상3상서효능편의성↑,http://fn.segye.com/content/html/2019/08/08/20190808508062.html?OutUrl=naver
4137,2019-08-08,오늘주식시장한미약품주가8일현재268500원,http://nbntv.co.kr/news/view/547417
4138,2019-08-08,한미약품경구용항암제오락솔임상3상고무적,https://www.hankyung.com/finance/article/2019080821796
4139,2019-08-08,한미약품기술수출오락솔미국임상서효과확인,http://www.seoulfn.com/news/articleView.html?idxno=352036
4140,2019-08-08,한미약품항암제오락솔임상3상결과청신호,http://health.chosun.com/site/data/html_dir/2019/08/08/2019080801846.html
4141,2019-08-08,한미약품항암신약오락솔임상3상고무적,http://www.smedaily.co.kr/news/articleView.html?idxno=85295
4142,2019-08-08,한미약품오락솔임상3상결과고무적”효능↑부작용↓,http://www.viva100.com/main/view.php?key=20190808010002651
4143,2019-08-08,한미약품오락솔임상3상청신호효능편의성↑부작용↓,http://inthenews.co.kr/article-11546/
4144,2019-08-08,한미약품오락솔임상3상발표기대↑,http://www.cnbnews.com/news/article.html?no=418325
4145,2019-08-08,한미약품파트너사아테넥스경구용항암제오락솔임상3상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=611877
4146,2019-08-08,8일주식장마감동향한미약품268000원마감,http://www.gokorea.kr/news/articleView.html?idxno=326683
4147,2019-08-08,한미약품개발항암제오락솔글로벌임상3상고무적,http://www.dailymedi.com/detail.php?number=846121&thread=22r05
4148,2019-08-08,한미약품항암신약오락솔기존정맥주사용항암제대비효능우수,http://www.updownnews.co.kr/news/articleView.html?idxno=207007
4149,2019-08-08,한미약품항암신약오락솔임상3상서효능입증”,http://www.datanews.co.kr/news/article.html?no=104093
4150,2019-08-08,제약오늘한미약품경구용항암신약오락솔임상3상결과윤곽나와편의성높이고부작용줄여,http://www.sisaon.co.kr/news/articleView.html?idxno=98871
4151,2019-08-08,한미약품항암신약오락솔임상3상고무적,http://www.enewstoday.co.kr/news/articleView.html?idxno=1328196
4152,2019-08-08,먹는항암제한미약품오락솔美임상3상결과발표,http://weekly.cnbnews.com/news/article.html?no=129436
4153,2019-08-08,한미약품경구용항암신약오락솔임상3상결과는,http://www.joseilbo.com/news/news_read.php?uid=381868&class=27&grp=
4154,2019-08-08,특징주분석주가정보8월8일한미약품268000원으로장마감,http://nbntv.co.kr/news/view/548415
4155,2019-08-08,한미약품항암신약오락솔美임상3상성공적,https://cnbc.sbs.co.kr/article_hub/10000951385?division=NAVER
4156,2019-08-08,한미약품항암신약오락솔글로벌임상3상성공예감,http://www.techholic.co.kr/news/articleView.html?idxno=184477
4157,2019-08-09,한미약품오락솔글로벌임상3상고무적효능∙편의성높이고부작용줄여,http://www.thefirstmedia.net/news/articleView.html?idxno=47393
4158,2019-08-09,바이오시밀러테마오전시황상승률상위종목한미약품466셀트리온260한올바이오파마193등,http://www.gokorea.kr/news/articleView.html?idxno=327368
4159,2019-08-09,한미약품5이상상승외국인9일연속순매수66만주,https://www.hankyung.com/finance/article/201908093891L
4160,2019-08-09,9일09시바이오시밀러오전의테마종목한미약품한올바이오파마등이상승세견인중,http://nbntv.co.kr/news/view/549792
4161,2019-08-09,주가정보9일한미약품현재가280000원,http://www.anewsa.com/detail.php?number=1910520&thread=18
4162,2019-08-09,제약업종오전시황상승률상위종목현성바이탈1731코미팜696한미약품597등,http://www.gokorea.kr/news/articleView.html?idxno=327895
4163,2019-08-09,9일국내증시분석코스피상장사한미약품현재282500원대주가형성,http://aitimes.co.kr/news/view/107730
4164,2019-08-09,한미약품주가128940종목그래프및종목동정과증시정보9일오늘가격282000원,http://www.gokorea.kr/news/articleView.html?idxno=328188
4165,2019-08-09,한미약품주식현재가9일현재282000원,http://nbntv.co.kr/news/view/550455
4166,2019-08-09,한미약품한미사이언스모두매수세쏟아져특히한미약품6대급등,http://www.econonews.co.kr/news/articleView.html?idxno=80630
4167,2019-08-09,한미약품709상승중긴하락구간에서주가급등,http://www.newspim.com/news/view/20190809000745
4168,2019-08-09,바이오시밀러테마오후시황상승률상위종목한미약품709팜스웰바이오543한올바이오파마279등,http://www.gokorea.kr/news/articleView.html?idxno=329282
4169,2019-08-09,13시22분바이오시밀러오후의테마종목한미약품팜스웰바이오등이상승세견인중,http://nbntv.co.kr/news/view/551722
4170,2019-08-09,한미약품주가8월9일현재286500원및종목차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=130264
4171,2019-08-09,제약업종오후시황상승률상위종목삼성바이오로직스782한미약품672현성바이탈625등,http://www.gokorea.kr/news/articleView.html?idxno=329516
4172,2019-08-09,한미약품하반기호재에기대감척박해진제약바이오업계희망될까,http://biz.newdaily.co.kr/site/data/html/2019/08/09/2019080900095.html
4173,2019-08-09,제약업종내상승종목한미약품765삼성바이오로직스762이연제약738등,http://aitimes.co.kr/news/view/108296
4174,2019-08-09,9일국내증시분석코스피상장사한미약품현재288000원대주가형성,http://aitimes.co.kr/news/view/108339
4175,2019-08-09,바이오시밀러테마주시황마감한미약품팜스웰바이오등이주도,http://nbntv.co.kr/news/view/551924
4176,2019-08-09,제약업종마감시황상승률상위종목현성바이탈1178삼성바이오로직스802한미약품765등,http://www.gokorea.kr/news/articleView.html?idxno=329708
4177,2019-08-09,바이오시밀러테마마감시황상승률상위종목한미약품765팜스웰바이오543한올바이오파마343등,http://www.gokorea.kr/news/articleView.html?idxno=329827
4178,2019-08-09,또개인이코스피견인삼성SDI삼성바이오한미약품한국조선해양껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=63262
4179,2019-08-09,인기주종목정보8월9일한미약품288500원으로장마감,http://nbntv.co.kr/news/view/552810
4180,2019-08-09,9일기관순매수Top10KODEX레버리지212억KODEX20032억휠라코리아22억한미약품18억기관순매수나서코스닥시장에서는NHN한국사이버결제카페24엠에스오토텍상위종,http://www.fintechpost.co.kr/news/articleView.html?idxno=58547
4181,2019-08-10,주간바이오시밀러테마리포트8월2주차한미약품셀트리온제넥신이수앱지스등강세,http://nbntv.co.kr/news/view/553617
4182,2019-08-10,바이오시밀러테마리뷰한미약품셀트리온제넥신이수앱지스종목주도,http://aitimes.co.kr/news/view/109182
4183,2019-08-11,제약바이오한주간이모저모한미약품신약오락솔임상3상고무적효능편의성↑부,http://www.edaily.co.kr/news/newspath.asp?newsid=01174246622586336
4184,2019-08-11,주간바이오시밀러테마리포트8월2주차한미약품셀트리온제넥신이수앱지스등상승,http://nbntv.co.kr/news/view/553817
4185,2019-08-11,상반기제약업계한미약품대웅제약맑음유한양행흐림,http://www.m-i.kr/news/articleView.html?idxno=629074
4186,2019-08-11,바이오시밀러테마주간종가한미약품셀트리온제넥신이수앱지스종목강세보여,http://aitimes.co.kr/news/view/109326
4187,2019-08-11,한미약품오락솔임상3상고무적효능편의성높이고부작용줄여,http://www.nspna.com/news/?mode=view&newsid=376624
4188,2019-08-12,10조기술수출한미약품반환흑역사지운다신약상용화릴레이주목,http://www.sportsseoul.com/news/read/803828
4189,2019-08-12,유한양행녹십자체면구긴상반기실적한미약품우수,http://www.datanews.co.kr/news/article.html?no=104097
4190,2019-08-12,아통증시12일한미약품현재주가289000원,http://www.anewsa.com/detail.php?number=1912233&thread=18
4191,2019-08-12,바이오시밀러테마오전시황상승률상위종목이수앱지스522한미약품035팜스웰바이오보합세등,http://www.gokorea.kr/news/articleView.html?idxno=330934
4192,2019-08-12,장중수급포착한미약품외국인11일연속순매수행진주가121,http://www.newspim.com/news/view/20190812000375
4193,2019-08-12,한미약품한미사이언스모두13상승특히한미약품30만원회복눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=81048
4194,2019-08-12,오늘주식시장한미약품주가12일현재293000원,http://nbntv.co.kr/news/view/554863
4195,2019-08-12,한미약품주가1289408월12일오늘가격293000원및증권시세및매매동향,http://www.gokorea.kr/news/articleView.html?idxno=331802
4196,2019-08-12,한미약품주가증권시세12일현재292000원증권그래프분석,http://www.cctvnews.co.kr/news/articleView.html?idxno=130682
4197,2019-08-12,한미약품4분기롤론티스허가재신청하반기이슈기대감,http://www.ajunews.com/view/20190812162338857
4198,2019-08-12,12일주가마감정보한미약품주가291000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=333464
4199,2019-08-12,인기주분석주가정보12일한미약품마감증시291000원,http://nbntv.co.kr/news/view/556967
4200,2019-08-13,주식종목13일한미약품현재주식거래가격287000원,http://www.anewsa.com/detail.php?number=1914284&thread=18
4201,2019-08-13,8월13일한미약품증권주식292282500원,http://nbntv.co.kr/news/view/559041
4202,2019-08-13,한미약품주가및증권시세13일현재284500원,http://www.gokorea.kr/news/articleView.html?idxno=334860
4203,2019-08-13,브랜드평판제약상장기업브랜드2019년8월빅데이터분석결과1위셀트리온2위삼성바이오로직스3위한미약품,http://www.futurekorea.co.kr/news/articleView.html?idxno=119976
4204,2019-08-13,제약상장기업브랜드평판2019년8월빅데이터1위셀트리온2위삼성바이오로직스3위한미약품,http://www.betanews.net:8080/article/1040006.html
4205,2019-08-13,제약상장기업브랜드평판2019년8월빅데이터분석결과1위셀트리온2위삼성바이오로직스3위한미약품,http://www.ggilbo.com/news/articleView.html?idxno=694136
4206,2019-08-13,제약바이오상장브랜드3대장셀트리온삼성바이오로직스한미약품,http://www.ttlnews.com/article/life_economy/6332
4207,2019-08-13,13일장마감증권시세한미약품주가283500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=336616
4208,2019-08-13,증시매매동향13일한미약품마감증시283500원,http://nbntv.co.kr/news/view/561147
4209,2019-08-14,장중주가14일한미약품증시현황285000원,http://www.anewsa.com/detail.php?number=1916377&thread=18
4210,2019-08-14,8월14일한미약품오늘증시088281000원,http://nbntv.co.kr/news/view/563366
4211,2019-08-14,8월14일한미약품128940오늘시세및매매동향106변동해,http://www.gokorea.kr/news/articleView.html?idxno=338176
4212,2019-08-14,인기주주가정보8월14일한미약품279500원으로장마감,http://nbntv.co.kr/news/view/565565
4213,2019-08-14,한미약품오락솔임상3상서정맥주사항암제대비압도적우위발현,http://www.industrynews.co.kr/news/articleView.html?idxno=33945
4214,2019-08-14,실적속보한미약품2Q영업이익231억전년비15↑,http://www.itooza.com/common/iview.php?no=2019081422312052348
4215,2019-08-16,한미약품반기RD투자액1천억첫돌파,http://www.biospectator.com/view/news_view.php?varAtcId=8263
4216,2019-08-16,한미약품상반기매출비RD비187수출408,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=233864
4217,2019-08-16,증시실황16일한미약품현재주가276500원,http://www.anewsa.com/detail.php?number=1919149&thread=18
4218,2019-08-16,바이오시밀러테마오전시황상승률상위종목한올바이오파마040셀트리온098한미약품107등,http://www.gokorea.kr/news/articleView.html?idxno=341184
4219,2019-08-16,16일09시바이오시밀러오전의테마종목제넥신한미약품등이주도,http://nbntv.co.kr/news/view/567363
4220,2019-08-16,8월16일한미약품오늘주식시장279500원000,http://nbntv.co.kr/news/view/568062
4221,2019-08-16,8월16일한미약품증권투자정보036변화해,http://www.gokorea.kr/news/articleView.html?idxno=342010
4222,2019-08-16,바이오시밀러테마오후시황상승률상위종목에이프로젠제약126한올바이오파마101한미약품036등,http://www.gokorea.kr/news/articleView.html?idxno=342320
4223,2019-08-16,인기주종목정보16일한미약품마감증시277500원,http://nbntv.co.kr/news/view/570236
4224,2019-08-19,종목상세정보19일한미약품증시현황280500원,http://www.anewsa.com/detail.php?number=1921918&thread=18
4225,2019-08-19,8월19일한미약품증권투자090280000원,http://nbntv.co.kr/news/view/572894
4226,2019-08-19,8월19일한미약품증권투자정보및종목동정과증시정보090변동해,http://www.gokorea.kr/news/articleView.html?idxno=345658
4227,2019-08-19,한미약품주가8월19일현재279500원및종목차트,http://www.cctvnews.co.kr/news/articleView.html?idxno=132021
4228,2019-08-19,무더위뒤건강관리한미약품텐텐10가지필수영양가득,https://www.sedaily.com/NewsView/1VN15V3YHX
4229,2019-08-19,19일장마감증권시세한미약품주가280000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=347423
4230,2019-08-19,특징주종목정보19일한미약품마감증시280000원,http://nbntv.co.kr/news/view/575023
4231,2019-08-20,상반기RD1000억이상투자한미약품셀트리온,http://www.dailymedi.com/detail.php?number=846501&thread=22r05
4232,2019-08-20,셀트리온한미약품반기1000억이상RD투자,http://www.newsis.com/view/?id=NISX20190819_0000744504&cID=13001&pID=13000
4233,2019-08-20,증시현황20일한미약품거래가격281000원,http://www.anewsa.com/detail.php?number=1924412&thread=18
4234,2019-08-20,8월20일한미약품주식장281000원036,http://nbntv.co.kr/news/view/577158
4235,2019-08-20,한미약품상반기RD투자액사상첫1000억넘어,http://news.mt.co.kr/mtview.php?no=2019081914364439807
4236,2019-08-20,상장주주식시세8월20일한미약품281000원으로장마감,http://nbntv.co.kr/news/view/579187
4237,2019-08-20,셀트리온한미약품반기1000억이상RD투자유한양행GC녹십자대웅제약종근당JW중외제약도대폭늘려,http://www.econonews.co.kr/news/articleView.html?idxno=82387
4238,2019-08-21,바이오시밀러테마오전시황상승률상위종목제넥신076한미약품053셀트리온032등,http://www.gokorea.kr/news/articleView.html?idxno=351085
4239,2019-08-21,증시현황21일한미약품거래가격282000원,http://www.anewsa.com/detail.php?number=1926862&thread=18
4240,2019-08-21,21일09시바이오시밀러테마주오전시황한미약품이수앱지스등이주도,http://nbntv.co.kr/news/view/580638
4241,2019-08-21,장중수급포착한미약품외국인4일연속순매수행진주가374,http://www.newspim.com/news/view/20190821000413
4242,2019-08-21,21일국내증시분석코스피상장사한미약품현재292000원대주가기록,http://aitimes.co.kr/news/view/115988
4243,2019-08-21,주식그래프한미약품주가21일현재293000원,http://nbntv.co.kr/news/view/581362
4244,2019-08-21,8월21일한미약품종목그래프463변동,http://www.gokorea.kr/news/articleView.html?idxno=351938
4245,2019-08-21,바이오시밀러테마오후시황상승률상위종목제넥신548한미약품409셀트리온194등,http://www.gokorea.kr/news/articleView.html?idxno=352058
4246,2019-08-21,21일13시바이오시밀러테마주시황오후제넥신한미약품등이주도,http://nbntv.co.kr/news/view/581778
4247,2019-08-21,바이오시밀러테마마감시황제넥신한미약품등이주도,http://nbntv.co.kr/news/view/582420
4248,2019-08-21,바이오시밀러테마마감시황상승률상위종목제넥신624한미약품463이수앱지스147등,http://www.gokorea.kr/news/articleView.html?idxno=352959
4249,2019-08-21,코스피거래급감속IT부진vs한미약품대림산업애경산업껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=63538
4250,2019-08-21,21일장마감매매동향한미약품주가294000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=353797
4251,2019-08-21,특징주분석종목정보8월21일한미약품294000원으로장마감,http://nbntv.co.kr/news/view/583403
4252,2019-08-22,제약사상반기매출성장률한미약품영업이익률셀트리온각각1위,http://www.ceoscoredaily.com/news/article.html?no=59470
4253,2019-08-22,주식시세22일한미약품주가293500원,http://www.anewsa.com/detail.php?number=1929393&thread=18
4254,2019-08-22,세금은매출순아냐화성세무서관내법인세납부경동제약이한미약품앞질러,http://www.sejungilbo.com/news/articleView.html?idxno=17874
4255,2019-08-22,한미약품주가차트22일현재290000원,http://nbntv.co.kr/news/view/585417
4256,2019-08-22,한미약품주가1289408월22일오늘가격289500원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=355307
4257,2019-08-22,바이오시밀러테마마감시황상승률상위종목한올바이오파마095팜스웰바이오146한미약품221등,http://www.gokorea.kr/news/articleView.html?idxno=356651
4258,2019-08-22,인기주분석매매동향22일한미약품마감증시287500원,http://nbntv.co.kr/news/view/587545
4259,2019-08-23,바이오시밀러테마오전시황상승률상위종목한미약품035한올바이오파마058셀트리온066등,http://www.gokorea.kr/news/articleView.html?idxno=357767
4260,2019-08-23,종목추적23일한미약품현재주가285000원,http://www.anewsa.com/detail.php?number=1930981&thread=18
4261,2019-08-23,한미약품주식창23일현재288000원,http://nbntv.co.kr/news/view/589688
4262,2019-08-23,한미약품주가8월23일현재288000원증권그래프및종목동정과증시정보,http://www.gokorea.kr/news/articleView.html?idxno=358596
4263,2019-08-23,바이오시밀러테마오후시황상승률상위종목한올바이오파마038한미약품보합세에이프로젠제약013등,http://www.gokorea.kr/news/articleView.html?idxno=358852
4264,2019-08-23,13시26분바이오시밀러오후테마시황한미약품셀트리온등이상승세주도,http://nbntv.co.kr/news/view/590232
4265,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.nextdaily.co.kr/news/article.html?id=20190823800033
4266,2019-08-23,아픈치질이쏙”한미약품일회용치질약치쏙크림출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234162
4267,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.fetv.co.kr/news/article.html?no=34876
4268,2019-08-23,아픈치질쏙한미약품일회용치질약치쏙크림출시,http://www.straightnews.co.kr/news/articleView.html?idxno=54135
4269,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=35260
4270,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1331213
4271,2019-08-23,한미약품일회용치질치료제치쏙크림출시,http://www.youthdaily.co.kr/news/article.html?no=16121
4272,2019-08-23,아픈치질이쏙한미약품일회용치질약치쏙크림출시,http://moneys.mt.co.kr/news/mwView.php?no=2019082314268043914
4273,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.ekn.kr/news/article.html?no=449528
4274,2019-08-23,한미약품일회용치질약치쏙크림출시,http://fn.segye.com/content/html/2019/08/23/20190823506790.html?OutUrl=naver
4275,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.smedaily.co.kr/news/articleView.html?idxno=85631
4276,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.bosa.co.kr/news/articleView.html?idxno=2111144
4277,2019-08-23,한미약품일회용치질약치쏙크림출시,http://news.mt.co.kr/mtview.php?no=2019082314370248222
4278,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.asiatime.co.kr/news/articleView.html?idxno=265771
4279,2019-08-23,한미약품일회용치질약치쏙크림약국판매,http://www.fnnews.com/news/201908231443183619
4280,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019082314453596415
4281,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.ebn.co.kr/news/view/998237
4282,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.ceoscoredaily.com/news/article.html?no=59615
4283,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.rpm9.com/news/article.html?id=20190823090018
4284,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.bokuennews.com/news/article.html?no=179858
4285,2019-08-23,치질에쓱아픔이쏙한미약품일회용치질약치쏙크림출시,http://www.upinews.kr/news/newsview.php?ncode=1065592965291487
4286,2019-08-23,한미약품일회용치질약치쏙크림출시,http://medipana.com/news/news_viewer.asp?NewsNum=244532&MainKind=A&NewsKind=5&vCount=12&vKind=1
4287,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=56872
4288,2019-08-23,한미약품일회용주입기로편리한치질치료제치쏙크림출시,http://www.medisobizanews.com/news/articleView.html?idxno=62007
4289,2019-08-23,한미약품일회용치질약치쏙크림선봬,http://www.cnbnews.com/news/article.html?no=419558
4290,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=363094
4291,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.ajunews.com/view/20190823153950405
4292,2019-08-23,한미약품일회용치질약치쏙크림출시,http://health.chosun.com/site/data/html_dir/2019/08/23/2019082301719.html
4293,2019-08-23,한미약품일회용치질약치쏙크림출시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201908230296&t=NN
4294,2019-08-23,한미약품일회용치질약치쏙크림출시위생적인1회용기6mm주입기편의성향상,http://www.techholic.co.kr/news/articleView.html?idxno=184847
4295,2019-08-23,한미약품일회용치질치료제치쏙크림출시편의성향상,http://www.hg-times.com/news/articleView.html?idxno=206468
4296,2019-08-23,치질치료편하고간편해진다한미약품치질치료제치쏙크림출시약국에서직접구입도가능,http://www.updownnews.co.kr/news/articleView.html?idxno=207523
4297,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.whosaeng.com/112169
4298,2019-08-23,아픈치질이쏙한미약품일회용치질약치쏙크림출시,http://www.pressm.kr/news/articleView.html?idxno=24763
4299,2019-08-23,한미약품일회용치질약치쏙크림출시위생적1회용기사용6mm주입기편의성향상,http://www.newswatch.kr/news/articleView.html?idxno=22783
4300,2019-08-23,위생적이고간편한사용한미약품일회용치질약치쏙크림선봬,http://www.youthdaily.co.kr/news/article.html?no=16141
4301,2019-08-23,한미약품일회용치질약치쏙크림출시,http://daily.hankooki.com/lpage/ittech/201908/dh20190823165149145630.htm
4302,2019-08-23,위생적으로치질치료하세요”한미약품일회용치질약치쏙크림출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1791217
4303,2019-08-23,한미약품일회용치질치료제치쏙크림출시,http://www.donga.com/news/article/all/20190823/97090423/1
4304,2019-08-23,한미약품위생적치질치료제치쏙크림출시,http://www.kpinews.co.kr/news/articleView.html?idxno=101809
4305,2019-08-23,한미약품일회용치질약치쏙크림내놔,http://www.wolyo.co.kr/news/articleView.html?idxno=91945
4306,2019-08-23,한미약품일회용치질약치쏙크림출시,http://www.lawissue.co.kr/view.php?ud=201908231750312009f4ab64559d_12
4307,2019-08-23,한미약품1회용치질치료제치쏙크림출시,http://www.finomy.com/news/articleView.html?idxno=68722
4308,2019-08-23,오늘의신상품한미약품일회용치질약치쏙크림출시,http://www.econovill.com/news/articleView.html?idxno=370442
4309,2019-08-23,인기종목종목정보23일한미약품마감증시283000원,http://nbntv.co.kr/news/view/591822
4310,2019-08-23,한미약품편의성높인일회용치질치료제치쏙크림내놔,http://www.businesspost.co.kr/BP?command=article_view&num=140775
4311,2019-08-24,한미약품일회용이라더위생적편리한치질약치쏙크림출시,http://www.getnews.co.kr/view.php?ud=20190824113330121741d0c69529_16
4312,2019-08-24,신제품한미약품일회용치질약치쏙크림출시,http://www.todaykorea.co.kr/news/view.php?no=263951
4313,2019-08-24,한미약품일회용치질약치쏙크림출시,http://www.polinews.co.kr/news/article.html?no=412525
4314,2019-08-24,한미약품바르는크림형일회용치질약개발,http://news.heraldcorp.com/view.php?ud=20190824000046
4315,2019-08-24,한미약품바르는크림형일회용치질약개발,http://www.beyondpost.co.kr/view.php?ud=20190824165517602446a9e4dd7f_30
4316,2019-08-25,아픈치질이편하게쏙”한미약품일회용치질약치쏙크림출시,http://www.g-enews.com/ko-kr/news/article/news_all/201908242140539288aca1a8c21a_1/article.html
4317,2019-08-25,한미약품일회용치질약치쏙크림출시,http://www.viva100.com/main/view.php?key=20190825010007464
4318,2019-08-25,한미약품일회용치질약치쏙크림출시,http://www.straightnews.co.kr/news/articleView.html?idxno=54190
4319,2019-08-25,아픈치질이쏙”한미약품일회용치질약치쏙크림출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019082500018
4320,2019-08-25,한미약품편리한일회용주입기에약물담은치질약치쏙크림출시,http://news.mk.co.kr/newsRead.php?year=2019&no=660323
4321,2019-08-26,한미약품챔픽스특허2차전결과10월로연기,http://www.mdtoday.co.kr/mdtoday/index.html?no=363160
4322,2019-08-26,한미약품치질치료제치쏙크림출시,http://weekly.cnbnews.com/news/article.html?no=129757
4323,2019-08-26,26일09시바이오시밀러오전의테마종목팜스웰바이오한미약품등이상승세주도,http://nbntv.co.kr/news/view/593405
4324,2019-08-26,아통증시26일한미약품증시현황278500원,http://www.anewsa.com/detail.php?number=1932109&thread=18
4325,2019-08-26,한미약품일회용치질약치쏙크림출시일회용주입기사용편의성향상,http://www.ezyeconomy.com/news/articleView.html?idxno=93250
4326,2019-08-26,8월26일한미약품주식현재가141279000원,http://nbntv.co.kr/news/view/594124
4327,2019-08-26,한미약품일회용치질약치쏙크림출시,http://www.nspna.com/news/?mode=view&newsid=379112
4328,2019-08-26,한미약품주가증권투자정보26일오늘가격278000원,http://www.gokorea.kr/news/articleView.html?idxno=362125
4329,2019-08-26,바이오시밀러테마오후시황상승률상위종목한올바이오파마039한미약품141팜스웰바이오172등,http://www.gokorea.kr/news/articleView.html?idxno=362265
4330,2019-08-26,한미약품주가및종목차트26일현재276000원주가정보,http://www.cctvnews.co.kr/news/articleView.html?idxno=133435
4331,2019-08-26,바이오시밀러테마종목종가팜스웰바이오한미약품등이주도,http://nbntv.co.kr/news/view/595214
4332,2019-08-26,바이오시밀러테마마감시황상승률상위종목팜스웰바이오259한미약품265한올바이오파마311등,http://www.gokorea.kr/news/articleView.html?idxno=363331
4333,2019-08-26,박성수송파구청장한미약품방문,http://www.newsis.com/view/?id=NISI20190826_0015529388
4334,2019-08-26,한미약품방문한박성수구청장,http://www.newsis.com/view/?id=NISI20190826_0015529387
4335,2019-08-26,한미약품방문한박성수송파구청장,http://news1.kr/photos/view/?3793234
4336,2019-08-26,박성수송파구청장한미약품찾아관내기업방문면담,http://news1.kr/photos/view/?3793235
4337,2019-08-26,26일마감증시한미약품주가275500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=363909
4338,2019-08-26,인기주분석주가정보8월26일한미약품275500원으로장마감,http://nbntv.co.kr/news/view/596205
4339,2019-08-27,송파구우아한형제들한미약품등채용설명회개최,https://view.asiae.co.kr/article/2019082708191686296
4340,2019-08-27,장중시세27일한미약품증시현황277500원,http://www.anewsa.com/detail.php?number=1934558&thread=18
4341,2019-08-27,우아한형제들한미약품송파구내달10일채용설명회,http://news1.kr/articles/?3704672
4342,2019-08-27,게시판우아한형제들한미약품송파구서기업채용설명회,http://yna.kr/AKR20190827058700004?did=1195m
4343,2019-08-27,우아한형제들한미약품송파구기업채용설명회,http://news.heraldcorp.com/view.php?ud=20190827000222
4344,2019-08-27,8월27일한미약품주식그래프276000원018,http://nbntv.co.kr/news/view/597911
4345,2019-08-27,우아한형제들한미약품송파구기업채용설명회,http://www.upkorea.net/news/articleView.html?idxno=621499
4346,2019-08-27,우아한형제들한미약품송파구내달10일채용설명회,http://www.fntoday.co.kr/news/articleView.html?idxno=200744
4347,2019-08-27,한미약품주가증권그래프27일오늘가격275000원거래,http://www.gokorea.kr/news/articleView.html?idxno=365334
4348,2019-08-27,송파구내달2일채용설명회롯데케미칼한미약품참여,http://www.newsis.com/view/?id=NISX20190827_0000752159&cID=10201&pID=10200
4349,2019-08-27,27일상장기업장마감정보한미약품주가271500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=367135
4350,2019-08-28,더벨한미약품재무부담우려에도RD투자꾸준,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908270100047810002948
4351,2019-08-28,증시보고28일한미약품현재가271000원,http://www.anewsa.com/detail.php?number=1937118&thread=18
4352,2019-08-28,8월28일한미약품및증권시세및주체별매매동향110변화해,http://www.gokorea.kr/news/articleView.html?idxno=368655
4353,2019-08-28,인기종목종목정보8월27일한미약품271500원으로장마감,http://nbntv.co.kr/news/view/600023
4354,2019-08-28,주식시세현황한미약품주가28일현재270000원,http://nbntv.co.kr/news/view/602189
4355,2019-08-28,28일마감증시한미약품주가275500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=370320
4356,2019-08-28,상장주매매동향28일한미약품마감증시275500원,http://nbntv.co.kr/news/view/604241
4357,2019-08-29,바이오시밀러테마오전시황상승률상위종목에이프로젠제약147제넥신113한미약품109등,http://www.gokorea.kr/news/articleView.html?idxno=370740
4358,2019-08-29,국내주식시장현황29일한미약품현재주가280000원,http://www.anewsa.com/detail.php?number=1939682&thread=18
4359,2019-08-29,29일09시바이오시밀러오전테마시황한미약품에이프로젠제약등이주도,http://nbntv.co.kr/news/view/605596
4360,2019-08-29,약국에서사랑받는어린이종합비타민한미약품텐텐,http://www.asiatoday.co.kr/view.php?key=20190829010016127
4361,2019-08-29,증권투자한미약품주가29일현재281000원,http://nbntv.co.kr/news/view/606341
4362,2019-08-29,8월29일한미약품오늘시세200,http://www.gokorea.kr/news/articleView.html?idxno=371599
4363,2019-08-29,바이오시밀러테마오후시황상승률상위종목에이프로젠제약389한미약품272셀트리온064등,http://www.gokorea.kr/news/articleView.html?idxno=371727
4364,2019-08-29,13시22분바이오시밀러테마주오후시황에이프로젠제약한미약품등이상승세주도,http://nbntv.co.kr/news/view/606747
4365,2019-08-29,비교되는RD투자한미약품187vs광동제약14,http://www.m-i.kr/news/articleView.html?idxno=633916
4366,2019-08-29,바이오시밀러테마마감시황에이프로젠제약한미약품등이상승세주도,http://nbntv.co.kr/news/view/607603
4367,2019-08-29,바이오시밀러테마마감시황상승률상위종목에이프로젠제약295한미약품127한올바이오파마076등,http://www.gokorea.kr/news/articleView.html?idxno=372944
4368,2019-08-29,한미약품텐텐약국에서사랑받는어린이종합비타민,http://www.straightnews.co.kr/news/articleView.html?idxno=54520
4369,2019-08-29,인기종목주가정보8월29일한미약품279000원으로장마감,http://nbntv.co.kr/news/view/608498
4370,2019-08-29,약국에서사랑받는어린이종합비타민한미약품텐텐,http://www.wsobi.com/news/articleView.html?idxno=80406
4371,2019-08-29,한미약품나인나인한알이면하루권장비타민D까지해결,http://www.wsobi.com/news/articleView.html?idxno=80408
4372,2019-08-30,더벨바이오CMO의재발견한미약품바이오신약도전으로얻은것은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201908230100042180002602
4373,2019-08-30,한미약품나인나인한알이면하루권장비타민D까지해결,http://www.cstimes.com/?mod=news&act=articleView&idxno=314088
4374,2019-08-30,한미약품나인나인하루한알로28종영양소와비타민D까지,http://www.100ssd.co.kr/news/articleView.html?idxno=63764
4375,2019-08-30,국내주식시장주가30일한미약품현재주가282000원,http://www.anewsa.com/detail.php?number=1942366&thread=18
4376,2019-08-30,한미약품텐텐코리아팜어워드굿브랜드대상전연령대복용가능,http://www.kpinews.co.kr/news/articleView.html?idxno=102209
4377,2019-08-30,한미약품텐텐코리아팜어워드굿브랜드대상,http://www.mhj21.com/123921
4378,2019-08-30,약국에서사랑받는어린이종합비타민한미약품텐텐코리아팜어워드굿브랜드대상수상,http://www.g-enews.com/ko-kr/news/article/news_all/20190830101408178469d76442fa_1/article.html
4379,2019-08-30,한미약품텐텐아이들에게사랑받는어린이종합영양제로자리매김,http://www.greened.kr/news/articleView.html?idxno=210843
4380,2019-08-30,8월30일한미약품배당주식054280500원,http://nbntv.co.kr/news/view/610688
4381,2019-08-30,한미약품텐텐약국에서사랑받는어린이종합비타민,http://www.edaily.co.kr/news/newspath.asp?newsid=02469846622592568
4382,2019-08-30,한미약품주가8월30일오늘가격280500원종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=375002
4383,2019-08-30,바이오시밀러테마오후시황상승률상위종목에이프로젠제약208제넥신097한미약품090등,http://www.gokorea.kr/news/articleView.html?idxno=375399
4384,2019-08-30,30일13시바이오시밀러테마주시황오후에이프로젠제약한미약품등이주도,http://nbntv.co.kr/news/view/611528
4385,2019-08-30,바이오시밀러테마마감시황상승률상위종목에이프로젠제약221제넥신077한미약품054등,http://www.gokorea.kr/news/articleView.html?idxno=376491
4386,2019-08-30,특징주분석주가정보30일한미약품마감증시280500원,http://nbntv.co.kr/news/view/612812
4387,2019-08-31,한미약품텐텐코리아팜어워드굿브랜드서어린이종합비타민부문대상선정,http://www.thefirstmedia.net/news/articleView.html?idxno=48005
4388,2019-09-02,가장혁신적인제약사20위권에한미약품대웅제약랭크,http://www.beyondpost.co.kr/view.php?ud=2019090208454951646a9e4dd7f_30
4389,2019-09-02,한미약품대웅제약가장혁신적인제약사20위권랭크,http://www.newsis.com/view/?id=NISX20190901_0000757032&cID=13001&pID=13000
4390,2019-09-02,APAC제약혁신랭킹한미약품대웅제약등포함,http://www.ebn.co.kr/news/view/999313
4391,2019-09-02,한미약품대웅제약APAC의혁신적인대형제약사20위권등극,http://biz.newdaily.co.kr/site/data/html/2019/09/02/2019090200007.html
4392,2019-09-02,장중시세2일한미약품현재주식거래가격281000원,http://www.anewsa.com/detail.php?number=1945567&thread=18
4393,2019-09-02,한미약품대웅제약제넥신휴온스APAC혁신제약사상위20위권내올라,http://www.medigatenews.com/news/1717109172
4394,2019-09-02,09시33분바이오시밀러오전의테마종목한올바이오파마한미약품등이상승세주도,http://nbntv.co.kr/news/view/614727
4395,2019-09-02,한미약품대웅제약등혁신제약사분야에올라,http://www.bosa.co.kr/news/articleView.html?idxno=2111552
4396,2019-09-02,한미약품대웅제약APAC혁신제약사20위권랭크,http://www.seoulwire.com/news/articleView.html?idxno=209397
4397,2019-09-02,클래리베이트분석아시아혁신제약사한미약품대웅제약20위권,http://news1.kr/articles/?3709729
4398,2019-09-02,오늘주식시세한미약품주가2일현재287500원,http://nbntv.co.kr/news/view/615394
4399,2019-09-02,한미약품주가증권투자정보외주식시황2일현재285000원형성,http://www.gokorea.kr/news/articleView.html?idxno=378740
4400,2019-09-02,한미약품대웅제약아태지역혁신제약사선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1200149
4401,2019-09-02,아태지역혁신제약사에한미약품대웅제약각각1112위올라,http://www.sisajournal-e.com/news/articleView.html?idxno=205515
4402,2019-09-02,한미약품아태혁신대형제약사11위,http://news.mk.co.kr/newsRead.php?year=2019&no=689424
4403,2019-09-02,2일코스닥코스피마감정보한미약품주가284000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=380594
4404,2019-09-02,인기주종목정보2일한미약품마감증시284000원,http://nbntv.co.kr/news/view/617477
4405,2019-09-03,국내주식시장현황3일한미약품현재가격283000원,http://www.anewsa.com/detail.php?number=1948368&thread=18
4406,2019-09-03,한미약품오늘증권시세3일현재285000원,http://nbntv.co.kr/news/view/619616
4407,2019-09-03,9월3일한미약품128940정보018,http://www.gokorea.kr/news/articleView.html?idxno=382136
4408,2019-09-03,제약바이오채용박람회한미약품의AI면접체험관등눈길,http://www.news2day.co.kr/135794
4409,2019-09-03,인기주종목정보3일한미약품마감증시282000원,http://nbntv.co.kr/news/view/621789
4410,2019-09-04,국내주식시장주가4일한미약품현재가283500원,http://www.anewsa.com/detail.php?number=1951240&thread=18
4411,2019-09-04,국내주식시장현황4일한미약품현재가283000원,http://www.anewsa.com/detail.php?number=1951235&thread=18
4412,2019-09-04,한미약품의하반기채용키워드글로벌RD영업,http://www.newsway.co.kr/news/view?tp=1&ud=2019090410350034145
4413,2019-09-04,한미약품하반기채용키워드는글로벌RD영업채용박람회서기업설명회멘토링진행,http://www.newswatch.kr/news/articleView.html?idxno=23119
4414,2019-09-04,한미약품하반기채용키워드는글로벌RD영업,http://www.medisobizanews.com/news/articleView.html?idxno=62268
4415,2019-09-04,한미약품그룹영업본사연구플랜트등세자리수규모채용,http://medipana.com/news/news_viewer.asp?NewsNum=245009&MainKind=A&NewsKind=5&vCount=12&vKind=1
4416,2019-09-04,한미약품하반기채용키워드는글로벌RD영업,http://www.straightnews.co.kr/news/articleView.html?idxno=54894
4417,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.monews.co.kr/news/articleView.html?idxno=204775
4418,2019-09-04,한미약품제약바이오산업채용박람회참가비롯한인재확보시동,http://news.mk.co.kr/newsRead.php?year=2019&no=696808
4419,2019-09-04,한미약품의하반기채용키워드글로벌RD영업,http://www.pressm.kr/news/articleView.html?idxno=24914
4420,2019-09-04,한미약품하반기채용키워드글로벌RD영업전문자격증및외국어능통자우대,http://www.ekn.kr/news/article.html?no=451464
4421,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234563
4422,2019-09-04,한미약품올하반기글로벌RD영업채용확대,http://www.m-i.kr/news/articleView.html?idxno=635519
4423,2019-09-04,한미약품하반기채용기업설명회멘토링진행,http://www.4th.kr/news/articleView.html?idxno=16279
4424,2019-09-04,한미약품그룹하반기영업•본사•연구센터•플랜트등세자리수규모채용한다,http://www.businesskorea.co.kr/news/articleView.html?idxno=35674
4425,2019-09-04,한미약품하반기채용계획글로벌RD영업강화,http://www.newsprime.co.kr/news/article.html?no=473978
4426,2019-09-04,한미약품그룹하반기채용키워드글로벌RD영업,http://www.bosa.co.kr/news/articleView.html?idxno=2111825
4427,2019-09-04,한미약품제약바이오산업채용박람회참가,http://www.asiatime.co.kr/news/articleView.html?idxno=268369
4428,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.nextdaily.co.kr/news/article.html?id=20190904800015
4429,2019-09-04,한미약품의하반기채용키워드글로벌RD영업,http://www.fetv.co.kr/news/article.html?no=35705
4430,2019-09-04,9월4일한미약품오늘주식018282500원,http://nbntv.co.kr/news/view/624671
4431,2019-09-04,9월4일한미약품주식종목검색035283000원,http://nbntv.co.kr/news/view/624698
4432,2019-09-04,한미약품하반기글로벌RD영업인재모십니다,http://www.metroseoul.co.kr/news/newsview?newscd=2019090400100
4433,2019-09-04,한미약품의하반기채용키워드는글로벌RD영업,http://www.mdtoday.co.kr/mdtoday/index.html?no=364049
4434,2019-09-04,한미약품그룹올해하반기세자릿수채용한다,http://www.ceoscoredaily.com/news/article.html?no=60076
4435,2019-09-04,한미약품주가1289409월4일오늘가격283500원오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=386376
4436,2019-09-04,9월4일한미약품128940증권투자정보및종목동정과증시정보053변동,http://www.gokorea.kr/news/articleView.html?idxno=386379
4437,2019-09-04,한미약품그룹30일부터RD영업등분야대규모채용,http://news1.kr/articles/?3712176
4438,2019-09-04,한미약품인재채용키워드글로벌RD영업,http://www.doctorsnews.co.kr/news/articleView.html?idxno=130823
4439,2019-09-04,한미약품그룹하반기채용키워드RD30일부터모집,http://biz.chosun.com/site/data/html_dir/2019/09/04/2019090401597.html
4440,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.ebn.co.kr/news/view/999880
4441,2019-09-04,한미약품채용박람회서기업설명회및멘토링진행,http://www.bokuennews.com/news/article.html?no=180363
4442,2019-09-04,한미약품하반기채용키워드는글로벌RD영업,http://www.joseilbo.com/news/news_read.php?uid=383404&class=17&grp=
4443,2019-09-04,한미약품하반기채용키워드는글로벌RD영업,http://www.dailysmart.co.kr/news/articleView.html?idxno=15202
4444,2019-09-04,한미약품글로벌RD영업인재하반기채용,http://health.chosun.com/site/data/html_dir/2019/09/04/2019090401716.html
4445,2019-09-04,한미약품채용박람회서기업설명회및멘토링진행영업본사연구센터플랜트등세자리수규모채용,http://www.updownnews.co.kr/news/articleView.html?idxno=208033
4446,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.viva100.com/main/view.php?key=20190904010001587
4447,2019-09-04,한미약품의하반기채용키워드는글로벌RD영업,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57061
4448,2019-09-04,한미약품하반기채용키워드글로벌RD영업000명채용나서,http://www.wikileaks-kr.org/news/articleView.html?idxno=64700
4449,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.econovill.com/news/articleView.html?idxno=371321
4450,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.smedaily.co.kr/news/articleView.html?idxno=85917
4451,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.techholic.co.kr/news/articleView.html?idxno=185169
4452,2019-09-04,한미약품30일부터하반기채용진행,http://www.cnbnews.com/news/article.html?no=420689
4453,2019-09-04,한미약품그룹30일부터하반기채용 ,http://www.seoulfn.com/news/articleView.html?idxno=354933
4454,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.medigatenews.com/news/2687437392
4455,2019-09-04,한미약품제약바이오채용박람회참가,http://www.finomy.com/news/articleView.html?idxno=69101
4456,2019-09-04,한미약품하반기채용키워드로글로벌RD영업내걸어,http://www.ntoday.co.kr/news/articleView.html?idxno=68356
4457,2019-09-04,한미약품하반기채용키워드는글로벌RD영업,http://www.lawissue.co.kr/view.php?ud=201909041746549840204ead0791_12
4458,2019-09-04,4일주가마감정보한미약품주가285000원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=388728
4459,2019-09-04,한미약품오는30일하반기공채채용규모000명,http://www.donga.com/news/article/all/20190904/97274364/1
4460,2019-09-04,인기주주가정보4일한미약품마감증시285000원,http://nbntv.co.kr/news/view/627903
4461,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.newscj.com/news/articleView.html?idxno=664681
4462,2019-09-04,한미약품하반기채용키워드글로벌RD영업,http://www.thefirstmedia.net/news/articleView.html?idxno=48154
4463,2019-09-05,글로벌RD영업등우수인재모집한미약품의채용박람회,http://kpenews.com/View.aspx?No=89403
4464,2019-09-05,국내주가정보5일한미약품현재가격285500원,http://www.anewsa.com/detail.php?number=1954004&thread=18
4465,2019-09-05,한미약품의하반기채용키워드글로벌RD영업,http://www.aitimes.co.kr/news/articleView.html?idxno=118857
4466,2019-09-05,9월5일한미약품배당주식282500원088,http://nbntv.co.kr/news/view/630085
4467,2019-09-05,한미약품주가128940정보및매매동향5일현재281500원거래,http://www.gokorea.kr/news/articleView.html?idxno=390807
4468,2019-09-05,5일마감증시한미약품280500원마감,http://www.gokorea.kr/news/articleView.html?idxno=392345
4469,2019-09-05,특징주종목정보5일한미약품마감증시280500원,http://nbntv.co.kr/news/view/632213
4470,2019-09-06,하반기채용분석12한미약품의소중한AI면접팁과유한양행의글로벌인재론,http://www.news2day.co.kr/135970
4471,2019-09-06,바이오시밀러테마오전시황상승률상위종목한미약품071한올바이오파마055제넥신036등,http://www.gokorea.kr/news/articleView.html?idxno=393095
4472,2019-09-06,주가정보6일한미약품주가282000원,http://www.anewsa.com/detail.php?number=1956868&thread=18
4473,2019-09-06,리포트브리핑한미약품2019KBKoreaConference참가기업목표가420000원KB증권,http://www.newspim.com/news/view/20190906000439
4474,2019-09-06,GET투자리포트한미약품투자의견매수KB증권,http://www.getnews.co.kr/view.php?ud=2019090610303010948tpgetnews_16
4475,2019-09-06,증권주식한미약품주가6일현재281000원,http://nbntv.co.kr/news/view/634348
4476,2019-09-06,9월6일한미약품128940정보018변화해,http://www.gokorea.kr/news/articleView.html?idxno=393933
4477,2019-09-06,바이오시밀러테마오후시황상승률상위종목한올바이오파마073한미약품보합세셀트리온061등,http://www.gokorea.kr/news/articleView.html?idxno=394027
4478,2019-09-06,6일13시바이오시밀러오후테마시황한올바이오파마한미약품등이주도,http://nbntv.co.kr/news/view/634829
4479,2019-09-06,한미약품亞太혁신제약사11위선정글로벌도약잠재력충분,http://www.newswatch.kr/news/articleView.html?idxno=23206
4480,2019-09-06,혁신제약사한국1위한미약품글로벌도약잠재력충분”,http://www.fetv.co.kr/news/article.html?no=35900
4481,2019-09-06,한미약품혁신제약사국내1위日사와아태정상경쟁”,http://news.heraldcorp.com/view.php?ud=20190906000553
4482,2019-09-06,한미약품아태지역혁신제약사11위차지,http://www.rapportian.com/news/articleView.html?idxno=119852
4483,2019-09-06,국내1위한미약품글로벌혁신신약개발잠재력충분,http://www.medisobizanews.com/news/articleView.html?idxno=62329
4484,2019-09-06,혁신제약사한국1위한미약품글로벌도약잠재력충분”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234683
4485,2019-09-06,한미약품국내1위혁신제약사선정돼글로벌잠재력충분”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1796428
4486,2019-09-06,한미약품한국혁신제약사1위글로벌도약잠재력충분,http://www.koreaittimes.com/news/articleView.html?idxno=92844
4487,2019-09-06,혁신제약사한국1위한미약품글로벌도약잠재력충분”,http://www.shinailbo.co.kr/news/articleView.html?idxno=1202036
4488,2019-09-06,한미약품혁신제약사국내1위일본제약사와나란히경쟁,http://www.mediapen.com/news/view/460421
4489,2019-09-06,한미약품국내1위혁신제약기업선정,http://www.newstomato.com/ReadNews.aspx?no=918794
4490,2019-09-06,한미약품아태11위국내1위혁신제약사,http://news.mt.co.kr/mtview.php?no=2019090614392058605
4491,2019-09-06,혁신제약한국1위한미약품글로벌도약잠재력충분,http://www.bosa.co.kr/news/articleView.html?idxno=2112007
4492,2019-09-06,한미약품클래리베이트선정국내혁신제약사1위,http://www.ceoscoredaily.com/news/article.html?no=60201
4493,2019-09-06,한미약품클래리베이트선정혁신제약사국내1위,http://kormedi.com/?p=1301382
4494,2019-09-06,한미약품아태혁신제약사11위글로벌잠재력충분,https://view.asiae.co.kr/article/2019090615112826681
4495,2019-09-06,한미약품아태지역혁신제약사11위기록”,http://www.etnews.com/20190906000248
4496,2019-09-06,한미약품아태지역혁신제약사11위국내제약사중최고,http://moneys.mt.co.kr/news/mwView.php?no=2019090615108030674
4497,2019-09-06,혁신제약사한국1위한미약품글로벌도약잠재력충분,http://www.medigatenews.com/news/1622170966
4498,2019-09-06,아태지역혁신제약사순위日제약사장악한미약품11위기록,http://www.newsprime.co.kr/news/article.html?no=474384
4499,2019-09-06,아태혁신제약사11위한미약품트로피수상,http://www.newspim.com/news/view/20190906000695
4500,2019-09-06,한미약품아시아태평양혁신제약사순위11위기록,http://www.enewstoday.co.kr/news/articleView.html?idxno=1334249
4501,2019-09-06,한미약품클래리베이트애널리틱스선정아시아태평양지역혁신제약기업1위,https://www.sedaily.com/NewsView/1VO54E6TU5
4502,2019-09-06,한미약품혁신제약사아태지역11위국내1위선정,http://www.donga.com/news/article/all/20190906/97311381/1
4503,2019-09-06,한미약품글로벌도약잠재력충분,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57104
4504,2019-09-06,APAC총괄부사장한미약품글로벌도약잠재력충분”혁신제약사한국1위트로피전달,http://www.getnews.co.kr/view.php?ud=20190906153629521341d0c69529_16
4505,2019-09-06,클래리베이트혁신제약사한국1위한미약품에트로피전달,https://www.hankyung.com/finance/article/2019090657736
4506,2019-09-06,아태지역혁신제약사11위기록한한미약품한국을넘어세계속의제약사로발돋음,http://www.updownnews.co.kr/news/articleView.html?idxno=208190
4507,2019-09-06,한미약품아시아태평양혁신제약사한국1위아태지역11위기록,http://www.pressm.kr/news/articleView.html?idxno=24978
4508,2019-09-06,혁신제약사한국1위한미약품글로벌도약잠재력충분”,http://www.newsway.co.kr/news/view?tp=1&ud=2019090615574169188
4509,2019-09-06,한미약품혁신제약사아태지역11위및국내1위축하트로피받아,http://news.mk.co.kr/newsRead.php?year=2019&no=707933
4510,2019-09-06,혁신제약사한국1위한미약품글로벌도약잠재력충분,http://www.straightnews.co.kr/news/articleView.html?idxno=55096
4511,2019-09-06,한미약품혁신제약사아태11위한국1위선정글로벌도약잠재력충분,http://www.ezyeconomy.com/news/articleView.html?idxno=93616
4512,2019-09-06,한미약품글로벌도약잠재력충분,http://www.doctorsnews.co.kr/news/articleView.html?idxno=130861
4513,2019-09-06,한미약품클래리베이트社선정혁신제약사한국1위아태지역11위,http://www.joseilbo.com/news/news_read.php?uid=383616&class=27&grp=
4514,2019-09-06,한미약품클래리베이트선정혁신제약사등극국내1위APAC11위,http://www.wikileaks-kr.org/news/articleView.html?idxno=64968
4515,2019-09-06,한미약품아태지역혁신제약기업11위선정한국1위,http://www.mdtoday.co.kr/mdtoday/index.html?no=364300
4516,2019-09-06,한미약품혁신제약사아태11위국내1위선정,http://www.seoulwire.com/news/articleView.html?idxno=214028
4517,2019-09-06,한미약품혁신제약사평가에서한국1위권세창신약개발에최선,http://www.businesspost.co.kr/BP?command=article_view&num=142596
4518,2019-09-06,한미약품日기업과치열하게경쟁글로벌잠재력충분”,http://www.dailymedi.com/detail.php?number=847156&thread=22r05
4519,2019-09-06,혁신제약사한국1위한미약품글로벌도약잠재력충분”,http://www.econovill.com/news/articleView.html?idxno=371569
4520,2019-09-06,인기주종목정보9월6일한미약품280500원으로장마감,http://nbntv.co.kr/news/view/636489
4521,2019-09-06,혁신제약사한국1위한미약품글로벌도약잠재력충분,http://www.businesskorea.co.kr/news/articleView.html?idxno=35787
4522,2019-09-06,한미약품클래리베이트선정혁신제약사국내1위,http://www.ebn.co.kr/news/view/1000357
4523,2019-09-06,한미약품국내혁신제약사1위선정,http://www.nextdaily.co.kr/news/article.html?id=20190906800039
4524,2019-09-06,한미약품클래리베이트아태지역총괄트로피전달,https://www.kpanews.co.kr/article/show.asp?idx=206525&category=D
4525,2019-09-06,한미약품클래리베이트평가혁신제약사한국1위에올라,http://www.techholic.co.kr/news/articleView.html?idxno=185284
4526,2019-09-06,클래리베이트애널리틱스社한미약품글로벌제약사도약잠재력충분,http://www.thefirstmedia.net/news/articleView.html?idxno=48279
4527,2019-09-07,＂혁신제약사한국1위한미약품＂클래리베이트애널리틱스,http://www.nspna.com/news/?mode=view&newsid=381934
4528,2019-09-08,한미약품글로벌도약잠재력충분,http://www.dt.co.kr/contents.html?article_no=2019090802109931102002&ref=naver
4529,2019-09-08,혁신제약사한국1위한미약품글로벌도약잠재력충분”,http://www.metroseoul.co.kr/news/newsview?newscd=2019090800074
4530,2019-09-08,한미약품혁신제약사한국1위선정글로벌잠재력충분,http://www.ekn.kr/news/article.html?no=452089
4531,2019-09-09,퀵리포트한미약품보유유지목표가25↓32만원삼성證,http://www.itooza.com/common/iview.php?no=2019090907311858994
4532,2019-09-09,한미약품보유파이프라인기대감저하목표가↓삼성,http://www.edaily.co.kr/news/newspath.asp?newsid=01394006622618480
4533,2019-09-09,한미약품파이프라인가치변경목표가↓삼성증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1796864
4534,2019-09-09,I리포트한미약품파이프라인가치변경목표가↓삼성證,http://www.inews24.com/view/1207271
4535,2019-09-09,미국MD앤더슨암센터한미약품포지오티닙적응증확대모색,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234711
4536,2019-09-09,HotLine한미약품파이프라인가치하락리스크커져목표가↓,http://news.mk.co.kr/newsRead.php?year=2019&no=713507
4537,2019-09-09,한미약품美파트너사포지오티닙연구자임상2상경과공개,http://biz.newdaily.co.kr/site/data/html/2019/09/09/2019090900014.html
4538,2019-09-09,한미약품항암신약 포지오니티닙추가적응증가능성,http://www.medisobizanews.com/news/articleView.html?idxno=62338
4539,2019-09-09,한미약품항암제포지오티닙치료범위7개로확대가능성,http://news.heraldcorp.com/view.php?ud=20190909000066
4540,2019-09-09,한미약품美파트너사포지오티닙연구자임상경과공개적응증확대모색”,https://www.sedaily.com/NewsView/1VO6FK6YN8
4541,2019-09-09,美MD앤더슨암센터한미약품포지오티닙적응증확대가능성모색,http://www.straightnews.co.kr/news/articleView.html?idxno=55184
4542,2019-09-09,한미약품아태지역혁신제약사11위국내사중1위,http://www.sportsseoul.com/news/read/816570
4543,2019-09-09,美MD앤더슨암센터한미약품포지오티닙적응증확대가능성모색,http://www.fetv.co.kr/news/article.html?no=35958
4544,2019-09-09,한미약품美MD앤더슨포지오티닙적응증확대가능성모색,http://biz.chosun.com/site/data/html_dir/2019/09/09/2019090900668.html
4545,2019-09-09,한미약품파트너사스펙트럼포지오티닙적응증확대가능성공개,http://www.newspim.com/news/view/20190909000158
4546,2019-09-09,스펙트럼세계폐암학회서한미약품포지오티닙연구자임상공개,http://www.ceoscoredaily.com/news/article.html?no=60225
4547,2019-09-09,한미약품美스펙트럼포지오티닙적응증확대모색”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1796966
4548,2019-09-09,종목상세정보9일한미약품현재가278500원,http://www.anewsa.com/detail.php?number=1960090&thread=18
4549,2019-09-09,한미약품항암신약포지오티닙미국MD앤더슨서적응증확대모색,http://www.econovill.com/news/articleView.html?idxno=371659
4550,2019-09-09,미국MD앤더슨암센터한미약품포지오티닙적응증확대가능성모색,http://www.fnnews.com/news/201909090951342736
4551,2019-09-09,한미약품포지오티닙타그리소저항환자노린다 ,http://www.monews.co.kr/news/articleView.html?idxno=204850
4552,2019-09-09,한미약품美스펙트럼포지오티닙적응증확대가능성모색,http://www.rapportian.com/news/articleView.html?idxno=119876
4553,2019-09-09,한미약품美MD앤더슨포지오티닙적응증확대가능성모색,https://www.hankyung.com/finance/article/2019090995476
4554,2019-09-09,한미약품포지오티닙美서적응증확장가능성담은연구결과공개예정,http://news.mk.co.kr/newsRead.php?year=2019&no=714120
4555,2019-09-09,한미약품美MD앤더슨포지오티닙적응증확대가능성모색,https://view.asiae.co.kr/article/2019090910252715831
4556,2019-09-09,한미약품포지오티닙연구자임상2상공개추가적응증확대기대,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201909090063&t=NN
4557,2019-09-09,한미약품美MD앤더슨포지오티닙치료질환확대모색,http://news.mt.co.kr/mtview.php?no=2019090909115112816
4558,2019-09-09,한미약품항암신약포지오니티닙적응증확대가능성,http://www.babytimes.co.kr/news/articleView.html?idxno=29815
4559,2019-09-09,한미약품항암신약포지오티닙추가적응증확대기대,http://www.upinews.kr/news/newsview.php?ncode=1065578823491048
4560,2019-09-09,혁신제약사한미약품글로벌도약잠재력충분”,http://www.bokuennews.com/news/article.html?no=180528
4561,2019-09-09,한미약품MD앤더슨포지오티닙새가능성제시,http://www.dailypharm.com/Users/News/NewsView.html?ID=256537&REFERER=NP
4562,2019-09-09,한미약품증권주식9일현재283500원,http://nbntv.co.kr/news/view/639003
4563,2019-09-09,한미약품폐암신약물질포지오티닙적응증확대가능성타진,http://news1.kr/articles/?3716064
4564,2019-09-09,美MD앤더슨암센터한미약품포지오티닙적응증확대가능성모색,http://www.ekn.kr/news/article.html?no=452242
4565,2019-09-09,한미약품美파트너사스펙트럼포지오티닙적응증확대모색,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072072
4566,2019-09-09,9월9일한미약품증권투자정보071변동,http://www.gokorea.kr/news/articleView.html?idxno=397498
4567,2019-09-09,한미약품美파트너사포지오티닙적응증확대가능성모색,http://www.wikileaks-kr.org/news/articleView.html?idxno=65075
4568,2019-09-09,바이오시밀러테마오후시황상승률상위종목한올바이오파마236한미약품053셀트리온030등,http://www.gokorea.kr/news/articleView.html?idxno=397643
4569,2019-09-09,13시26분바이오시밀러테마주오후시황한올바이오파마한미약품등이상승세견인중,http://nbntv.co.kr/news/view/639494
4570,2019-09-09,美MD앤더슨한미약품포지오티닙적응증확대모색,http://www.metroseoul.co.kr/news/newsview?newscd=2019090900124
4571,2019-09-09,한미약품파트너스펙트럼WCLC서포지오티닙임상공개,http://daily.hankooki.com/lpage/ittech/201909/dh20190909140030145630.htm
4572,2019-09-09,한미약품경쟁약물의개발빨라신약후보물질경쟁력약해질수도,http://www.businesspost.co.kr/BP?command=article_view&num=142741
4573,2019-09-09,한미약품비소세포폐암치료제포지오티닙의적응증확대모색,http://www.businesspost.co.kr/BP?command=article_view&num=142765
4574,2019-09-09,한미약품개발항암혁신신약포지오티닙적응증확대가능성모색,http://www.joseilbo.com/news/news_read.php?uid=383732&class=27&grp=
4575,2019-09-09,혁신제약사한국1위한미약품글로벌도약잠재력충분”,http://www.whosaeng.com/112502
4576,2019-09-09,한미약품포지오티닙폐암내성환자치료가능성,https://www.hankyung.com/it/article/2019090909621
4577,2019-09-09,GET투자리포트한미약품투자의견보유유지삼성증권,http://www.getnews.co.kr/view.php?ud=2019090810303010986tpgetnews_16
4578,2019-09-09,9일마감증시한미약품275000원마감,http://www.gokorea.kr/news/articleView.html?idxno=399286
4579,2019-09-09,한미약품포지오티닙치료범위확대추진,http://www.finomy.com/news/articleView.html?idxno=69244
4580,2019-09-09,공모가의함정②코스닥바이오모두가한미약품유한양행꿈꿔,http://www.etoday.co.kr/news/section/newsview.php?idxno=1797356
4581,2019-09-09,특징주종목정보9월9일한미약품275000원으로장마감,http://nbntv.co.kr/news/view/641117
4582,2019-09-09,한미약품항암신약후보포지오티닙치료영역확대될까,http://www.sportsseoul.com/news/read/816961
4583,2019-09-09,미국MD앤더슨한미약품포지오티닙적응증확대모색,http://www.newscj.com/news/articleView.html?idxno=665908
4584,2019-09-09,리포트브리핑한미약품9월경구용GLP1허가로Efpeglenatide가치변경목표가320000원삼성증권,http://www.newspim.com/news/view/20190909001206
4585,2019-09-09,한미약품파트너사스펙트럼포지오티닙연구자임상2상결과공개예정,http://www.mdtoday.co.kr/mdtoday/index.html?no=364485
4586,2019-09-09,美MD앤더슨암센터한미약품개발포지오티닙적응증확대가능성모색,http://www.thefirstmedia.net/news/articleView.html?idxno=48363
4587,2019-09-10,국내주식시장주가10일한미약품거래가격276500원,http://www.anewsa.com/detail.php?number=1962860&thread=18
4588,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://www.nextdaily.co.kr/news/article.html?id=20190910800010
4589,2019-09-10,한미약품스마트플랜트에서글로벌GMP트렌드배워요”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234798
4590,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://medipana.com/news/news_viewer.asp?NewsNum=245273&MainKind=A&NewsKind=5&vCount=12&vKind=1
4591,2019-09-10,한미약품스마트플랜트에서글로벌GMP트렌드배워요,http://www.straightnews.co.kr/news/articleView.html?idxno=55282
4592,2019-09-10,동남아GMP조사관등한미약품팔탄스마트플랜트방문,http://www.medisobizanews.com/news/articleView.html?idxno=62385
4593,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://www.newspim.com/news/view/20190910000418
4594,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://www.viva100.com/main/view.php?key=20190910010003518
4595,2019-09-10,동남아국가9개국및ASEAN사무국관계자들한미약품공장견학,http://www.nspna.com/news/?mode=view&newsid=382278
4596,2019-09-10,아세안9개국GMP조사관한미약품스마트플랜트방문,http://www.newsis.com/view/?id=NISX20190910_0000766637&cID=13001&pID=13000
4597,2019-09-10,한미약품아세안방문단팔탄스마트플랜트서첨단기술배웠다,http://moneys.mt.co.kr/news/mwView.php?no=2019091011148068712
4598,2019-09-10,한미약품스마트플랜트아세안GMP조사관사무국관계자방문글로벌GMP트렌드확인,http://www.newswatch.kr/news/articleView.html?idxno=23307
4599,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://www.ajunews.com/view/20190910111935596
4600,2019-09-10,9월10일한미약품실시간주식현황055276500원,http://nbntv.co.kr/news/view/642385
4601,2019-09-10,한미약품비소세포폐암치료제포지오티닙적응증확대추진세계폐암학회임상2상결과발표,http://www.ezyeconomy.com/news/articleView.html?idxno=93692
4602,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://www.pressm.kr/news/articleView.html?idxno=25023
4603,2019-09-10,한미약품이관순부회장딸,http://www.bosa.co.kr/news/articleView.html?idxno=2112187
4604,2019-09-10,9월10일한미약품및증권시세및증권정보와종목동정036변화,http://www.gokorea.kr/news/articleView.html?idxno=400754
4605,2019-09-10,바이오시밀러테마오후시황상승률상위종목팜스웰바이오478에이프로젠제약039한미약품036등,http://www.gokorea.kr/news/articleView.html?idxno=400895
4606,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://www.businesskorea.co.kr/news/articleView.html?idxno=35890
4607,2019-09-10,13시26분바이오시밀러테마주오후시황팜스웰바이오한미약품등이상승세주도,http://nbntv.co.kr/news/view/642874
4608,2019-09-10,한미약품글로벌GMP트렌드전도사나섰다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201909100230&t=NN
4609,2019-09-10,이관순한미약품부회장딸,http://www.doctorsnews.co.kr/news/articleView.html?idxno=130902
4610,2019-09-10,아세안GMP조사관한미약품팔탄스마트플랜트방문,http://kormedi.com/?p=1301684
4611,2019-09-10,아세안GMP조사관한미약품팔탄스마트플랜트시찰,http://www.m-i.kr/news/articleView.html?idxno=637191
4612,2019-09-10,아세안GMP조사관한미약품팔탄스마트플랜트방문,http://www.shinailbo.co.kr/news/articleView.html?idxno=1203095
4613,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://www.etnews.com/20190910000230
4614,2019-09-10,아세안GMP한미약품스마트플랜트서글로벌트렌드배운다,http://www.ftoday.co.kr/news/articleView.html?idxno=111288
4615,2019-09-10,바이오시밀러테마주시황마감팜스웰바이오한미약품등이상승세주도,http://nbntv.co.kr/news/view/643655
4616,2019-09-10,한미약품투자심리회복이끌까포지오티닙임상결과모멘텀,http://biz.newdaily.co.kr/site/data/html/2019/09/10/2019091000190.html
4617,2019-09-10,뉴스투데이L아세안GMP조사관한미약품팔탄스마트플랜트방문,http://www.news2day.co.kr/136492
4618,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://www.joseilbo.com/news/news_read.php?uid=383849&class=27&grp=
4619,2019-09-10,동남아9개국방문단한미약품팔탄스마트플랜트견학,http://news.mk.co.kr/newsRead.php?year=2019&no=720816
4620,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://www.cnbnews.com/news/article.html?no=421336
4621,2019-09-10,바이오시밀러테마마감시황상승률상위종목팜스웰바이오440한미약품018에이프로젠제약013등,http://www.gokorea.kr/news/articleView.html?idxno=401909
4622,2019-09-10,한미약품아세안9개국GMP조사관스마트플랜트방문,http://www.wolyo.co.kr/news/articleView.html?idxno=93318
4623,2019-09-10,한미약품아세안GMP조사관팔탄공장방문첨단설비에감탄”,http://www.donga.com/news/article/all/20190910/97371754/1
4624,2019-09-10,10일마감증시한미약품주가275500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=402549
4625,2019-09-10,한미약품글로벌의약품제조품질관리기준에아세안관심높아,http://www.techholic.co.kr/news/articleView.html?idxno=185389
4626,2019-09-10,아세안9개국GMP조사관한미약품팔탄스마트플랜트방문,http://www.thefirstmedia.net/news/articleView.html?idxno=48409
4627,2019-09-11,첫기술수출성과낸제약사는1989년한미약품이었다,http://www.rapportian.com/news/articleView.html?idxno=119934
4628,2019-09-11,한미약품국내최초3제복합신약중남미진출,https://view.asiae.co.kr/article/2019091108412448054
4629,2019-09-11,한미약품3제복합신약으로는최초중남미진출,http://www.fnnews.com/news/201909110842572657
4630,2019-09-11,한미약품중남미진출3제복합신약으로는국내최초,http://medipana.com/news/news_viewer.asp?NewsNum=245312&MainKind=A&NewsKind=5&vCount=12&vKind=1
4631,2019-09-11,한미약품고혈압치료3제복합신약2종중남미공략,http://www.ebn.co.kr/news/view/1000865
4632,2019-09-11,한미약품고혈압3제복합신약국내최초중남미진출,https://www.hankyung.com/finance/article/2019091149096
4633,2019-09-11,한미약품고혈압3제국내최초로중남미진출,http://www.ajunews.com/view/20190911083526318
4634,2019-09-11,한미약품아모잘탄플러스아모잘탄큐3제복합신약국내최초중남미진출,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=533692
4635,2019-09-11,한미약품고혈압3제복합신약중남미진출,https://www.sedaily.com/NewsView/1VO7DEXDJR
4636,2019-09-11,한미약품3제복합신약으로는국내최초로중남미진출,http://www.newsway.co.kr/news/view?tp=1&ud=2019091108514857461
4637,2019-09-11,한미약품3제복합신약국내최초로중남미진출,http://www.newsis.com/view/?id=NISX20190911_0000767599&cID=13001&pID=13000
4638,2019-09-11,한미약품 고혈압치료3제복합신약 중남미 진출,http://www.medisobizanews.com/news/articleView.html?idxno=62402
4639,2019-09-11,한미약품고혈압3제복합신약1000만불규모중남미수출,http://www.viva100.com/main/view.php?key=20190911010003848
4640,2019-09-11,한미약품3제복합신약국내최초중남미진출,http://www.fetv.co.kr/news/article.html?no=36176
4641,2019-09-11,한미약품국내최초고혈압치료3제복합신약중남미진출,http://www.wikileaks-kr.org/news/articleView.html?idxno=65229
4642,2019-09-11,한미약품3제복합신약으로국내최초중남미진출,http://www.straightnews.co.kr/news/articleView.html?idxno=55354
4643,2019-09-11,한미약품고혈압3제복합신약국내최초중남미진출,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019091109050839059
4644,2019-09-11,한미약품고혈압고지혈3제복합신약중남미첫개척,http://news.heraldcorp.com/view.php?ud=20190911000103
4645,2019-09-11,한미약품고혈압치료3제복합신약으로멕시코시장진출,http://www.newspim.com/news/view/20190911000088
4646,2019-09-11,증시실황11일한미약품현재주가279500원,http://www.anewsa.com/detail.php?number=1965631&thread=18
4647,2019-09-11,한미약품멕시코제약사와아모잘탄큐플러스공급계약체결,http://news.mk.co.kr/newsRead.php?year=2019&no=722483
4648,2019-09-11,한미약품3제복합신약국내최초로중남미진출,http://www.dailian.co.kr/news/view/825362/?sc=naver
4649,2019-09-11,바이오시밀러테마오전시황상승률상위종목셀트리온182한올바이오파마148한미약품145등,http://www.gokorea.kr/news/articleView.html?idxno=403221
4650,2019-09-11,한미약품3제복합신약중남미진출,http://www.doctorsnews.co.kr/news/articleView.html?idxno=130911
4651,2019-09-11,한미약품고혈압3제복합신약으로중남미진출,http://biz.chosun.com/site/data/html_dir/2019/09/11/2019091100611.html
4652,2019-09-11,한미약품고혈압3제복합신약중남미최초진출,http://moneys.mt.co.kr/news/mwView.php?no=2019091109098065266
4653,2019-09-11,한미약품3제복합신약으로중남미시장진출,http://it.chosun.com/site/data/html_dir/2019/09/11/2019091100614.html
4654,2019-09-11,한미약품고혈압치료3제복합신약으로국내최초중남미진출,http://biz.newdaily.co.kr/site/data/html/2019/09/11/2019091100016.html
4655,2019-09-11,한미약품고혈압치료복합제중남미시장진출,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201909110056&t=NN
4656,2019-09-11,09시33분바이오시밀러오전의테마종목셀트리온한미약품등이상승세주도,http://nbntv.co.kr/news/view/644841
4657,2019-09-11,한미약품고혈압치료3제국내최초중남미진출,http://health.chosun.com/site/data/html_dir/2019/09/11/2019091100658.html
4658,2019-09-11,한미약품3제복합신약으로중남미시장뚫었다국내최초,http://www.edaily.co.kr/news/newspath.asp?newsid=01948326622619136
4659,2019-09-11,한미약품3제복합신약중남미진출아모잘탄플러스등2종,http://www.joseilbo.com/news/news_read.php?uid=383880&class=27&grp=
4660,2019-09-11,한미약품멕시코제약사와1000만달러규모수출계약,http://www.mediapen.com/news/view/461525
4661,2019-09-11,한미약품고혈압치료제3제복합신약멕시코에1000만달러수출계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1798091
4662,2019-09-11,한미약품3제복합신약국내최초중남미진출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234830
4663,2019-09-11,한미약품고혈압치료3제복합제멕시코수출,http://yna.kr/AKR20190911043900017?did=1195m
4664,2019-09-11,한미약품3제복합신약으로는국내최초로중남미진출,http://www.lawissue.co.kr/view.php?ud=201909110947221460204ead0791_12
4665,2019-09-11,한미약품고혈압치료3제복합신약2종중남미시장진출,http://www.upinews.kr/news/newsview.php?ncode=1065573695349740
4666,2019-09-11,한미약품의고혈압3제복합신약중남미진출,http://kormedi.com/?p=1301732
4667,2019-09-11,한미약품고혈압3제복합신약중남미진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=364645
4668,2019-09-11,한미약품멕시코에고혈압복합제2종수출,http://www.dailypharm.com/Users/News/NewsView.html?ID=256615&REFERER=NP
4669,2019-09-11,한미약품고혈압3제복합신약으로중남미입성,http://www.econovill.com/news/articleView.html?idxno=371930
4670,2019-09-11,한미약품아모잘탄플러스아모잘탄큐중남미진출,http://www.bosa.co.kr/news/articleView.html?idxno=2112250
4671,2019-09-11,한미약품3제복합신약국내최초로중남미진출,http://www.ceoscoredaily.com/news/article.html?no=60346
4672,2019-09-11,한미약품고혈압3제복합신약국내최초중남미진출,http://www.seoulwire.com/news/articleView.html?idxno=216541
4673,2019-09-11,한미약품3제복합신약중남미진출,http://www.m-i.kr/news/articleView.html?idxno=637510
4674,2019-09-11,한미약품중남미진출멕시코에3제복합신약2종수출,http://www.4th.kr/news/articleView.html?idxno=16570
4675,2019-09-11,장중수급포착한미약품외국인3일연속순매수행진주가163,http://www.newspim.com/news/view/20190911000443
4676,2019-09-11,한미약품3제복합신약으로는국내처음중남미진출,http://www.nextdaily.co.kr/news/article.html?id=20190911800012
4677,2019-09-11,한미약품3제복합신약으로는국내최초로중남미진출,http://www.ekn.kr/news/article.html?no=452709
4678,2019-09-11,한미약품고혈압치료3제복합신약2종중남미진출,http://www.kpinews.co.kr/news/articleView.html?idxno=103072
4679,2019-09-11,한미약품멕시코제약사와아모잘탄제품군수출계약체결,http://www.sportsseoul.com/news/read/817569
4680,2019-09-11,한미약품3제복합신약아모잘탄플러스아모잘탄큐중남미진출,http://www.insightkorea.co.kr//news/articleView.html?idxno=57256
4681,2019-09-11,한미약품3제복합신약으로는국내최초로중남미진출,http://www.pressm.kr/news/articleView.html?idxno=25044
4682,2019-09-11,한미약품국내최초고혈압3제복합약중남미진출,http://news1.kr/articles/?3718161
4683,2019-09-11,한미약품3제복합신약앞세워중남미시장진출120억원규모수출계약,http://www.donga.com/news/article/all/20190911/97381132/1
4684,2019-09-11,한미약품고혈압치료3제복합제멕시코수출,http://www.seoulfn.com/news/articleView.html?idxno=355661
4685,2019-09-11,한미약품멕시코실라네스사와고혈압신약수출계약,http://news.mt.co.kr/mtview.php?no=2019091110555532414
4686,2019-09-11,글로벌도약잠재력충분”한미약품혁신제약사국내1위,http://news.heraldcorp.com/view.php?ud=20190911000459
4687,2019-09-11,한미약품멕시코제약사실라네스와고혈압치료3제복합신약1000만불수출계약,http://www.sisajournal-e.com/news/articleView.html?idxno=205965
4688,2019-09-11,한미약품고혈압치료3제복합제멕시코수출,http://www.asiatoday.co.kr/view.php?key=20190911010006969
4689,2019-09-11,한미약품오늘주식시세11일현재283000원,http://nbntv.co.kr/news/view/645638
4690,2019-09-11,한미약품아모잘탄플러스등국내최초중남미진출,http://www.ftoday.co.kr/news/articleView.html?idxno=111304
4691,2019-09-11,한미약품고혈압치료3제복합신약으로국내최초중남미진출,http://www.businesspost.co.kr/BP?command=article_view&num=143087
4692,2019-09-11,한미약품고협알3제복합신약국내첫중남미진출,http://www.businesskorea.co.kr/news/articleView.html?idxno=35928
4693,2019-09-11,한미약품3제복합신약으로국내최초고혈압치료제아모잘탄플러스아모잘탄큐중남미진출,http://www.techholic.co.kr/news/articleView.html?idxno=185416
4694,2019-09-11,한미약품주가1289409월11일현재282500원및증권시세및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=404120
4695,2019-09-11,한미약품3제복합신약2종중남미시장진출”,http://sports.hankooki.com/lpage/economy/201909/sp20190911123937137020.htm
4696,2019-09-11,한미약품복합신약앞세워중남미진출,http://www.ezyeconomy.com/news/articleView.html?idxno=93708
4697,2019-09-11,한미약품국내최초3제복합신약으로중남미진출,http://www.shinailbo.co.kr/news/articleView.html?idxno=1203515
4698,2019-09-11,한미약품팔탄스마트플랜트에아세안9개국GMP조사관견학,http://www.polinews.co.kr/news/article.html?no=417379
4699,2019-09-11,바이오시밀러테마오후시황상승률상위종목팜스웰바이오879한올바이오파마519한미약품290등,http://www.gokorea.kr/news/articleView.html?idxno=404260
4700,2019-09-11,한미약품멕시코에고혈압복합제1000만불규모수출,http://news.bizwatch.co.kr/article/consumer/2019/09/11/0017/naver
4701,2019-09-11,한미약품국내최초고혈압치료3제복합신약중남미진출,http://www.newspost.kr/news/articleView.html?idxno=73079
4702,2019-09-11,한미약품세가지고혈압치료성분담은복합제중남미진출,http://www.sisunnews.co.kr/news/articleView.html?idxno=113175
4703,2019-09-11,한미약품고혈압치료3제복합신약으로는국내최초로중남미진출,http://www.koreaittimes.com/news/articleView.html?idxno=92921
4704,2019-09-11,한미약품3제복합신약으로는국내최초로중남미진출,http://www.metroseoul.co.kr/news/newsview?newscd=2019091100124
4705,2019-09-11,한미약품한미사이언스시간지날수록상승폭커져특히한미약품3대상승,http://www.econonews.co.kr/news/articleView.html?idxno=85952
4706,2019-09-11,한미약품3제복합신약2종국내최초중남미진출,http://www.wolyo.co.kr/news/articleView.html?idxno=93385
4707,2019-09-11,한미약품고혈압3제복합신약으로중남미진출쾌거,http://www.betanews.net:8080/article/1049643.html
4708,2019-09-11,한미약품3제복합신약국내최초중남미진출,http://www.medigatenews.com/news/2910051838
4709,2019-09-11,한미약품고혈압치료제중남미수출,https://www.hankyung.com/it/article/2019091162221
4710,2019-09-11,한미약품임질과매독등성병관련약품약국,http://www.ccreview.co.kr/news/articleView.html?idxno=203130
4711,2019-09-11,한미약품고혈압치료제3제복합신약2종중남미시장진출,https://cnbc.sbs.co.kr/article_hub/10000954970?division=NAVER
4712,2019-09-11,바이오시밀러테마마감시황상승률상위종목팜스웰바이오1245한올바이오파마537한미약품290등,http://www.gokorea.kr/news/articleView.html?idxno=405324
4713,2019-09-11,한미약품3제복합신약으로는국내최초로중남미진출,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57170
4714,2019-09-11,한미약품멕시코에1000만달러수출계약,http://www.sisa-news.com/news/article.html?no=120652
4715,2019-09-11,한미약품3제복합신약중남미진출,http://www.fnnews.com/news/201909111629162269
4716,2019-09-11,한미약품3제복합신약중남미진출멕시코실라네스社와1000만불규모수출계약,http://www.newswatch.kr/news/articleView.html?idxno=23341
4717,2019-09-11,11일장마감매매동향한미약품주가283500원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=405994
4718,2019-09-11,한미약품고혈압치료3제복합제멕시코수출,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3934799
4719,2019-09-11,【서울】우아한형제들한미약품등송파구기업채용설명회,http://www.seohaenews.net/news/article.html?no=57820
4720,2019-09-11,한미약품고혈압3제복합제중남미진출,http://weekly.cnbnews.com/news/article.html?no=130155
4721,2019-09-11,한미약품3제복합신약으로는국내최초로중남미진출,http://www.newscj.com/news/articleView.html?idxno=666499
4722,2019-09-11,아세안9개국GMP조사관한미약품팔탄공장방문,https://www.kpanews.co.kr/article/show.asp?idx=206655&category=D
4723,2019-09-11,송파구청서울우아한형제들한미약품등송파구기업채용설명회,http://www.idjnews.kr/news/articleView.html?idxno=93370
4724,2019-09-11,송파구청「우아한형제들한미약품등송파구기업채용설명회」,http://www.whitepaper.co.kr/news/articleView.html?idxno=172783
4725,2019-09-11,서울송파구청우아한형제들한미약품등송파구기업채용설명회,http://www.jejutwn.com/news/article.html?no=55191
4726,2019-09-11,송파구청우아한형제들한미약품등송파구기업채용설명회,http://www.joygm.com/news/articleView.html?idxno=63082
4727,2019-09-11,송파구청서울우아한형제들한미약품등송파구기업채용설명회,http://www.fintechpost.co.kr/news/articleView.html?idxno=69634
4728,2019-09-12,한미약품아모잘탄플러스큐중남미시장진출국내3제복합제로는최초,http://www.g-enews.com/ko-kr/news/article/news_all/20190911175939655669d76442fa_1/article.html
4729,2019-09-12,한미약품고혈압치료제멕시코에1000만달러수출,http://www.donga.com/news/article/all/20190912/97389935/1
4730,2019-09-12,한미약품국내최초로3제복합신약중남미진출,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072191
4731,2019-09-12,종목시세영진약품주가4725원294롯데쇼핑140000원294제주항공24600원293환인제약15850원292한미약품283500원29↑주가주식가격올라11,http://www.fintechpost.co.kr/news/articleView.html?idxno=69930
4732,2019-09-13,본격막열리는하반기공채한미약품등채용,https://www.sedaily.com/NewsView/1VO8B8IZJZ
4733,2019-09-13,한미약품고혈압치료3제복합제멕시코수출,http://www.etnews.com/20190913000033
4734,2019-09-14,빅데이터분석제약상장기업브랜드평판2019년8월빅데이터분석결과1위셀트리온2위삼성바이오로직스3위한미약품,http://www.fintechpost.co.kr/news/articleView.html?idxno=69273
4735,2019-09-14,아세안9개국GMP조사관한미약품의팔탄스마트플랜트방문,http://www.econonews.co.kr/news/articleView.html?idxno=86317
4736,2019-09-15,한미약품고혈압치료3제복합신약으로중남미시장진출한다,http://www.industrynews.co.kr/news/articleView.html?idxno=34409
4737,2019-09-15,한미약품고혈압치료3제복합신약국내최초로중남미진출,http://www.getnews.co.kr/view.php?ud=2019091513453160941d0c69529_16
4738,2019-09-16,한미약품상반기매출2년전비해20가까이상승,http://www.ceoscoredaily.com/news/article.html?no=60336
4739,2019-09-16,한미약품상반기연구개발비1000억돌파매출대비비중제약사톱,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=533686
4740,2019-09-16,주가정보16일한미약품거래가격282000원,http://www.anewsa.com/detail.php?number=1968861&thread=18
4741,2019-09-16,한미약품3제복합신약2품목중남미시장수출계약,http://www.rapportian.com/news/articleView.html?idxno=119968
4742,2019-09-16,한미약품주식종목검색16일현재286500원,http://nbntv.co.kr/news/view/649306
4743,2019-09-16,한미약품주가9월16일오늘가격286500원증권그래프외증시동향,http://www.gokorea.kr/news/articleView.html?idxno=407940
4744,2019-09-16,바이오시밀러테마오후시황상승률상위종목제넥신283한올바이오파마176한미약품141등,http://www.gokorea.kr/news/articleView.html?idxno=408111
4745,2019-09-16,한미약품고혈압3제복합신약국내최초중남미진출,http://www.polinews.co.kr/news/article.html?no=418368
4746,2019-09-16,특징주분석주가정보9월16일한미약품287500원으로장마감,http://nbntv.co.kr/news/view/651046
4747,2019-09-16,한미약품고혈압치료3제복합신약국내최초로중남미진출,http://www.econonews.co.kr/news/articleView.html?idxno=86537
4748,2019-09-17,제일약품유한양행상품매출비중70웃돌아한미약품최저,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=533720
4749,2019-09-17,주가정보17일한미약품현재가295500원,http://www.anewsa.com/detail.php?number=1971603&thread=18
4750,2019-09-17,한미약품5이상상승9월경구용GLP1허가로Efpeglenatide가치변경삼성증권HOLD유지,https://www.hankyung.com/finance/article/201909173695L
4751,2019-09-17,한미약품한미사이언스가파른상승세특히한미약품5대상승에30만원선회복,http://www.econonews.co.kr/news/articleView.html?idxno=86609
4752,2019-09-17,특징주한미약품305000원17일10시0분장시작대비609상승,http://www.getnews.co.kr/view.php?ud=201909171001139194c20b940ba3_16
4753,2019-09-17,한미약품전일대비504외국인4191주순매수,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201909170224&t=NN
4754,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=234935
4755,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차美페인스와파트너십,http://www.upinews.kr/news/newsview.php?ncode=1065578718137826
4756,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201909170242&t=NN
4757,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.fetv.co.kr/news/article.html?no=36364
4758,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.newsway.co.kr/news/view?tp=1&ud=2019091711103715198
4759,2019-09-17,한미약품오픈이노베이션으로면역항암신약개발본격화,http://www.newspim.com/news/view/20190917000564
4760,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.getnews.co.kr/view.php?ud=201909171119426741d0c69529_16
4761,2019-09-17,한미약품오픈이노베이션통한면역항암신약개발박차,http://medipana.com/news/news_viewer.asp?NewsNum=245458&MainKind=A&NewsKind=5&vCount=12&vKind=1
4762,2019-09-17,한미약품미국바이오기업과이중다중항체공동개발,http://yna.kr/AKR20190917080400017?did=1195m
4763,2019-09-17,한미약품이중다중항체기반면역항암신약개발박차,http://www.medisobizanews.com/news/articleView.html?idxno=62469
4764,2019-09-17,한미약품펜탐바디적용면역항암신약개발美기업과오픈이노베이션,http://www.etoday.co.kr/news/section/newsview.php?idxno=1799360
4765,2019-09-17,장중수급포착한미약품기관3일연속순매수행진주가574,http://www.newspim.com/news/view/20190917000603
4766,2019-09-17,한미약품미국바이오기업과이중다중항체공동개발,http://www.asiatoday.co.kr/view.php?key=20190917010008782
4767,2019-09-17,fnRASSI한미약품574오르며거래량증가,http://www.fnnews.com/news/201909171130249761
4768,2019-09-17,한미약품오픈이노베이션레이더망에美페인스포착,http://www.newsis.com/view/?id=NISX20190917_0000771289&cID=13001&pID=13000
4769,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발본격화,http://kormedi.com/?p=1302026
4770,2019-09-17,한미약품오픈이노베이션으로면역항암신약개발한다,http://www.g-enews.com/ko-kr/news/article/news_all/20190917111546723369d76442fa_1/article.html
4771,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.pressm.kr/news/articleView.html?idxno=25089
4772,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.newstomato.com/ReadNews.aspx?no=920406
4773,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.joseilbo.com/news/news_read.php?uid=384080&class=27&grp=
4774,2019-09-17,한미약품이중다중항체기반면역항암분야신약개발박차,http://www.newsprime.co.kr/news/article.html?no=475236
4775,2019-09-17,한미약품오픈이노베이션통해글로벌신약개발가속,https://www.sedaily.com/NewsView/1VOA4JBG4X
4776,2019-09-17,한미약품美바이오기업과이중다중항체공동개발,http://www.smedaily.co.kr/news/articleView.html?idxno=86145
4777,2019-09-17,한미약품미국바이오기업항체도입신약개발적용,http://www.dailypharm.com/Users/News/NewsView.html?ID=256697&REFERER=NP
4778,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.econovill.com/news/articleView.html?idxno=372286
4779,2019-09-17,한미약품오픈이노베이션통해글로벌신약개발본격화,http://www.cnbnews.com/news/article.html?no=421734
4780,2019-09-17,한미약품미국페인스사와이중다중항체공동개발파트너십체결,http://www.koreaittimes.com/news/articleView.html?idxno=92985
4781,2019-09-17,한미약품美페인스항체서열도입이중∙다중면역항암제개발,http://www.biospectator.com/view/news_view.php?varAtcId=8487
4782,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.bosa.co.kr/news/articleView.html?idxno=2112448
4783,2019-09-17,한미약품주가1289409월17일오늘거래가303500원증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=410849
4784,2019-09-17,한미약품美바이오기업페인스개발항체도입면역항암제개발본격화,http://biz.chosun.com/site/data/html_dir/2019/09/17/2019091701275.html
4785,2019-09-17,한미약품오픈이노베이션통한항암신약개발박차,http://news.mt.co.kr/mtview.php?no=2019091711581890190
4786,2019-09-17,한미약품면역항암신약개발박차,http://www.ftoday.co.kr/news/articleView.html?idxno=111384
4787,2019-09-17,바이오시밀러테마오후시황상승률상위종목한미약품557이수앱지스349제넥신343등,http://www.gokorea.kr/news/articleView.html?idxno=411066
4788,2019-09-17,한미약품美바이오기업항체도입면역항암제개발본격화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019091713074821808
4789,2019-09-17,한미약품美페인스사와이중∙다중항체공동개발파트너십,http://www.babytimes.co.kr/news/articleView.html?idxno=29954
4790,2019-09-17,17일13시바이오시밀러오후테마시황한미약품팜스웰바이오등이상승세주도,http://nbntv.co.kr/news/view/651850
4791,2019-09-17,한미약품미국페인스사와면역항암신약개발박차,http://www.seoulwire.com/news/articleView.html?idxno=219390
4792,2019-09-17,한미약품美페인스사와이중∙다중항체공동개발면역항암신약개발박차,http://www.4th.kr/news/articleView.html?idxno=16753
4793,2019-09-17,한미약품미국바이오기업항체도입면역항암제개발본격화,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000051382
4794,2019-09-17,한미약품미국페인스사와이중다중항체공동개발파트너십체결,http://www.fnnews.com/news/201909171335005636
4795,2019-09-17,한미약품미국바이오기업과면역항암신약개발,http://sports.hankooki.com/lpage/economy/201909/sp20190917133929137020.htm
4796,2019-09-17,한미약품美페인트와이중다중항체면역항암신약개발본격화,http://www.viva100.com/main/view.php?key=20190917010005302
4797,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.ekn.kr/news/article.html?no=453442
4798,2019-09-17,한미약품미국페인스사와이중다중항체공동개발파트너십체결,http://www.mediapen.com/news/view/462565
4799,2019-09-17,한미약품美페인스社와이중다중항체공동개발파트너십,http://daily.hankooki.com/lpage/ittech/201909/dh20190917134552145630.htm
4800,2019-09-17,한미약품면역항암제후보물질도입해자체플랫폼펜탐바디와접목키로,http://news.mk.co.kr/newsRead.php?year=2019&no=736399
4801,2019-09-17,한미약품美페인스와이중다중항체공동개발파트너십체결,http://www.ceoscoredaily.com/news/article.html?no=60452
4802,2019-09-17,한미약품외부에서유망기술도입해면역항암신약개발에박차,http://www.businesspost.co.kr/BP?command=article_view&num=143470
4803,2019-09-17,한미약품미국바이오업체항체도입면역항암신약개발착수,http://www.sportsseoul.com/news/read/819597
4804,2019-09-17,한미약품美바이오기업과면역항암신약개발,http://www.youthdaily.co.kr/news/article.html?no=17874
4805,2019-09-17,한미약품美바이오기업과이중다중항체공동개발,https://view.asiae.co.kr/article/2019091714034076609
4806,2019-09-17,한미약품미국바이오기업페인스테라퓨틱스와새항체도입계약,http://www.insightkorea.co.kr//news/articleView.html?idxno=58216
4807,2019-09-17,한미약품美제약사와이중다중항체공동개발추진,http://www.etnews.com/20190917000161
4808,2019-09-17,한미약품미국페인스사와이중다중항체공동개발파트너십체결,http://www.techholic.co.kr/news/articleView.html?idxno=185495
4809,2019-09-17,한미약품美페인스와이중다중항체공동개발파트너십맞손,http://www.ezyeconomy.com/news/articleView.html?idxno=93808
4810,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.m-i.kr/news/articleView.html?idxno=638511
4811,2019-09-17,한미약품오프이노베이션통해이중다중항체기반면역항암신약개발본격화,http://www.mdtoday.co.kr/mdtoday/index.html?no=364909
4812,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.straightnews.co.kr/news/articleView.html?idxno=55652
4813,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.medigatenews.com/news/782367594
4814,2019-09-17,코스피상장사한미약품현재303500원대주가형성,http://www.anewsa.com/detail.php?number=1973875&thread=18
4815,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.metroseoul.co.kr/news/newsview?newscd=2019091700150
4816,2019-09-17,한미약품미국바이오기업항체도입면역항암제개발나서,http://moneys.mt.co.kr/news/mwView.php?no=2019091714588093526
4817,2019-09-17,바이오시밀러테마주시황마감한미약품이수앱지스등이상승세견인중,http://nbntv.co.kr/news/view/651903
4818,2019-09-17,한미약품美페인스사와다중항체개발파트너십체결,http://www.ebn.co.kr/news/view/1001419
4819,2019-09-17,한미약품오픈이노베이션통해면역항암분야글로벌신약개발본격화,http://www.greened.kr/news/articleView.html?idxno=213607
4820,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57218
4821,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발나서,http://www.bokuennews.com/news/article.html?no=180780
4822,2019-09-17,한미약품미국바이오기업과면역항암신약공동개발,http://news.bizwatch.co.kr/article/consumer/2019/09/17/0021/naver
4823,2019-09-17,바이오시밀러테마마감시황상승률상위종목한미약품487이수앱지스428에이프로젠제약278등,http://www.gokorea.kr/news/articleView.html?idxno=412188
4824,2019-09-17,코스피기관매수속삼성바이오종근당한미약품껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=64207
4825,2019-09-17,한미약품美바이오업체페인스항체도입계약면역항암신약개발박차,http://www.donga.com/news/article/all/20190917/97445931/1
4826,2019-09-17,한미약품면역항암신약개발박차美페인스사공동개발파트너십체결,http://kpenews.com/View.aspx?No=96397
4827,2019-09-17,한미약품美페인스와손잡고이중다중항체공동개발본격화,http://www.dailypop.kr/news/articleView.html?idxno=41009
4828,2019-09-17,한미약품美페인스와이중다중항체공동개발,http://www.dt.co.kr/contents.html?article_no=2019091702109931102003&ref=naver
4829,2019-09-17,한미약품美제약사와이중다중항체공동개발,http://www.dailian.co.kr/news/view/826620/?sc=naver
4830,2019-09-17,한미약품美바이오기업과이중다중항체공동개발면역항암제개발본격화,http://it.chosun.com/site/data/html_dir/2019/09/17/2019091702170.html
4831,2019-09-17,한미약품오픈이노베이션통해면역항암글로벌신약개발본격화,http://www.hg-times.com/news/articleView.html?idxno=207492
4832,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.shinailbo.co.kr/news/articleView.html?idxno=1204812
4833,2019-09-17,HotStock한미약품,https://www.hankyung.com/finance/article/2019091754181
4834,2019-09-17,한미약품오픈이노베이션통해면역항암분야글로벌신약개발본격화,http://www.updownnews.co.kr/news/articleView.html?idxno=208552
4835,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.wikileaks-kr.org/news/articleView.html?idxno=65574
4836,2019-09-17,한미약품면역항암신약개발본격화,http://www.fnnews.com/news/201909171839172787
4837,2019-09-17,한미약품미국페인스와혁신이중다중항체공동개발,http://news1.kr/articles/?3721806
4838,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.lawissue.co.kr/view.php?ud=201909171857323213204ead0791_12
4839,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.nextdaily.co.kr/news/article.html?id=20190917800037
4840,2019-09-17,한미약품면역항암신약개발박차美페인스사와이중다중항체공동개발파트너십체결,http://www.newswatch.kr/news/articleView.html?idxno=23461
4841,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.businesskorea.co.kr/news/articleView.html?idxno=36063
4842,2019-09-17,한미약품면역항암제개발본격화,http://www.finomy.com/news/articleView.html?idxno=69479
4843,2019-09-17,17일기관순매수Top10삼성바이오로직스280억한미약품103억휠라코리아47억현대로템36억기관순매수나서코스닥시장에서는네패스셀트리온헬스케어인트론바이오상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=71244
4844,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.newscj.com/news/articleView.html?idxno=667647
4845,2019-09-17,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.thefirstmedia.net/news/articleView.html?idxno=48571
4846,2019-09-18,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.fintechpost.co.kr/news/articleView.html?idxno=71323
4847,2019-09-18,표17일기준코스피기관순매수Top30삼성바이오로직스1위약280억원셀트리온146억원SK하이닉스146억원SK텔레콤106억원한미약품147억원주가순으로기관매수나서일간,http://www.fintechpost.co.kr/news/articleView.html?idxno=71283
4848,2019-09-18,퀵리포트한미약품매수유지목표가46만원유지대신證,http://www.itooza.com/common/iview.php?no=2019091807305241760
4849,2019-09-18,뉴스워커_한미약품 오픈이노베이션통해면역항암신약개발박차,http://www.newsworker.co.kr/news/articleView.html?idxno=41952
4850,2019-09-18,한미약품글로벌파트너십확장면역항암신약개발잰걸음,http://news.heraldcorp.com/view.php?ud=20190918000082
4851,2019-09-18,바이오시밀러테마오전시황상승률상위종목셀트리온146제넥신089한미약품050등,http://www.gokorea.kr/news/articleView.html?idxno=412508
4852,2019-09-18,증시현황18일한미약품현재가302500원,http://www.anewsa.com/detail.php?number=1974400&thread=18
4853,2019-09-18,09시32분바이오시밀러테마주오전시황셀트리온한미약품등이상승세주도,http://nbntv.co.kr/news/view/652035
4854,2019-09-18,GET투자리포트한미약품투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=2019091710303011146tpgetnews_16
4855,2019-09-18,한미약품오픈이노베이션통해면역항암신약개발박차,http://fn.segye.com/content/html/2019/09/18/20190918503697.html?OutUrl=naver
4856,2019-09-18,한미약품아모잘탄SCI급국제학술지에11번째등재,http://www.dailian.co.kr/news/view/826762/?sc=naver
4857,2019-09-18,한미약품한미사이언스희비엇갈려특히한미약품상승제동걸리나,http://www.econonews.co.kr/news/articleView.html?idxno=86769
4858,2019-09-18,한미약품아모잘탄국제학술지11번째등재,https://view.asiae.co.kr/article/2019091810064738712
4859,2019-09-18,한미약품아모잘탄중심혈압조절효과글로벌입증,http://www.medisobizanews.com/news/articleView.html?idxno=62492
4860,2019-09-18,한미약품아모잘탄SCI급국제학술지에11번째등재,http://www.nextdaily.co.kr/news/article.html?id=20190918800008
4861,2019-09-18,한미약품고혈압치료아모잘탄SCI급국제학술지11번째등재,http://daily.hankooki.com/lpage/ittech/201909/dh20190918101335145630.htm
4862,2019-09-18,한미약품아모잘탄세계적권위학술지고혈압저널에등재,https://www.sedaily.com/NewsView/1VOAKWBZE3
4863,2019-09-18,한미약품고혈압복합제아모잘탄임상연구결과SCI급학술지게재,http://news.mk.co.kr/newsRead.php?year=2019&no=739629
4864,2019-09-18,한미약품고혈압복합신약아모잘탄SCI급국제학술지11번째등재치료제우수성입증,http://www.ezyeconomy.com/news/articleView.html?idxno=93836
4865,2019-09-18,한미약품아모잘탄SCI급국제학술지에11번째등재,http://inthenews.co.kr/article-16373/
4866,2019-09-18,한미약품아모잘탄SCI급국제학술지에연구결과등재,http://www.newspim.com/news/view/20190918000410
4867,2019-09-18,한미약품아모잘탄SCI급국제학술지에11번째등재,http://www.wikileaks-kr.org/news/articleView.html?idxno=65622
4868,2019-09-18,한미약품아모잘탄우수성글로벌입증SCI급국제학술지에11번째등재,http://www.dailysmart.co.kr/news/articleView.html?idxno=15651
4869,2019-09-18,한미약품고혈압복합신약아모잘탄우수성글로벌입증SCI급국제학술지11번째등재,http://www.newswatch.kr/news/articleView.html?idxno=23472
4870,2019-09-18,한미약품고혈압약아모잘탄연구국제학술지11차례등재,http://www.sportsseoul.com/news/read/820150
4871,2019-09-18,한미약품아모잘탄SCI급국제학술지에11번째등재우수성입증,http://www.ekn.kr/news/article.html?no=453599
4872,2019-09-18,한미약품고혈압복합제아모잘탄SCI급학술지등재,http://moneys.mt.co.kr/news/mwView.php?no=2019091810438097513
4873,2019-09-18,한미약품아모잘탄우수성글로벌입증SCI급국제학술지에11번째등재,http://www.pressm.kr/news/articleView.html?idxno=25102
4874,2019-09-18,한미약품아모잘탄SCI급국제학술지에11번째등재,http://www.viva100.com/main/view.php?key=20190918010005755
4875,2019-09-18,9월18일한미약품128940및증권시세및종목관련동향정보000변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=412992
4876,2019-09-18,한미약품오픈이노베이션면역항암신약개발나선다,http://www.doctorsnews.co.kr/news/articleView.html?idxno=130965
4877,2019-09-18,한미약품고혈압치료제아모잘탄4상SCI급학술지게재,http://kormedi.com/?p=1302120
4878,2019-09-18,한미약품아모잘탄우수성글로벌입증SCI급국제학술지에11번째등재,http://www.sisajournal-e.com/news/articleView.html?idxno=206196
4879,2019-09-18,한미약품아모잘탄우수성글로벌입증”SCI급학술지11번째등재,http://www.etoday.co.kr/news/section/newsview.php?idxno=1799908
4880,2019-09-18,한미약품면역항암분야글로벌신약개발본격화,http://www.100ssd.co.kr/news/articleView.html?idxno=64078
4881,2019-09-18,한미약품아모잘탄SCI급국제학술지또등재,http://www.newsis.com/view/?id=NISX20190918_0000772506&cID=13001&pID=13000
4882,2019-09-18,한미약품아모잘탄SCI급국제학술지11번째등재,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072295
4883,2019-09-18,한미약품SCI급학술지11번째아모잘탄연구등재,http://www.dailypharm.com/Users/News/NewsView.html?ID=256738&REFERER=NP
4884,2019-09-18,바이오시밀러테마오후시황상승률상위종목셀트리온205팜스웰바이오030한미약품033등,http://www.gokorea.kr/news/articleView.html?idxno=413543
4885,2019-09-18,한미약품오픈이노베이션통해면역항암신약개발박차,http://www.polinews.co.kr/news/article.html?no=418820
4886,2019-09-18,한미약품아모잘탄우수성입증SCI급국제학술지에11번째등재,http://www.metroseoul.co.kr/news/newsview?newscd=2019091800125
4887,2019-09-18,13시27분바이오시밀러오후의테마종목셀트리온한미약품등이상승세견인중,http://nbntv.co.kr/news/view/652145
4888,2019-09-18,한미약품아모잘탄우수성글로벌입증SCI급국제학술지에11번째등재,http://www.techholic.co.kr/news/articleView.html?idxno=185530
4889,2019-09-18,한미약품SCI급국제학술지11번째등재우수성입증,http://www.newsprime.co.kr/news/article.html?no=475502
4890,2019-09-18,한미약품아모잘탄SCI급국제학술지에11번째등재,http://www.mdtoday.co.kr/mdtoday/index.html?no=365048
4891,2019-09-18,한미약품아모잘탄우수성입증SCI급국제학술지에11번째등재,http://www.joseilbo.com/news/news_read.php?uid=384164&class=17&grp=
4892,2019-09-18,한미약품아모잘탄우수성글로벌입증SCI급국제학술지에11번째등재,http://www.fnnews.com/news/201909181514042028
4893,2019-09-18,한미약품고혈압복합신약의국제학술지등재로우수성입증,http://www.businesspost.co.kr/BP?command=article_view&num=143655
4894,2019-09-18,한미약품아모잘탄SCI급국제학술지에11번째등재,http://www.asiatoday.co.kr/view.php?key=20190918010010021
4895,2019-09-18,한미약품오픈이노베이션으로신약개발박차,http://www.kpinews.co.kr/news/articleView.html?idxno=103542
4896,2019-09-18,한미약품아모잘탄연구결과11번째국제학술지등재우수성입증근거추가”,http://www.donga.com/news/article/all/20190918/97466181/1
4897,2019-09-18,한미약품아모잘탄우수성입증SCI급국제학술지에11번째등재,http://www.4th.kr/news/articleView.html?idxno=16820
4898,2019-09-18,한미약품아모잘탄우수성글로벌입증”SCI급국제학술지에11번째등재,http://www.lawissue.co.kr/view.php?ud=201909181804288212204ead0791_12
4899,2019-09-18,한미약품아모잘탄우수성글로벌입증SCI급국제학술지에11번째등재,http://www.thefirstmedia.net/news/articleView.html?idxno=48630
4900,2019-09-19,한미약품아모잘탄SCI급학술지에11번째등재,http://news.heraldcorp.com/view.php?ud=20190919000101
4901,2019-09-19,국내주식시장주가19일한미약품증시현황300500원,http://www.anewsa.com/detail.php?number=1976732&thread=18
4902,2019-09-19,한미약품유럽당뇨병학회서비만당뇨치료등연구결과9건발표,http://www.sisafocus.co.kr/news/articleView.html?idxno=221352
4903,2019-09-19,유럽당뇨병학회서한미약품신약3종주목,http://medipana.com/news/news_viewer.asp?NewsNum=245581&MainKind=A&NewsKind=5&vCount=12&vKind=1
4904,2019-09-19,한미약품NASH비만당뇨신약유럽당뇨학회서주목,http://www.fetv.co.kr/news/article.html?no=36505
4905,2019-09-19,한미약품의NASH비만당뇨신약유럽당뇨학회서주목,http://www.dailysmart.co.kr/news/articleView.html?idxno=15702
4906,2019-09-19,EASD2019한미약품NASH비만당뇨효과효능우수입증,http://www.econovill.com/news/articleView.html?idxno=372473
4907,2019-09-19,한미약품NASH∙비만∙당뇨신약유럽당뇨학회서주목,http://www.getnews.co.kr/view.php?ud=20190919100529393641d0c69529_16
4908,2019-09-19,한미약품유럽당뇨학회서NASH비만당뇨신약경쟁력입증,http://www.viva100.com/main/view.php?key=20190919010006193
4909,2019-09-19,한미약품유럽당뇨학회서신약3종연구결과발표,http://www.newspim.com/news/view/20190919000324
4910,2019-09-19,한미약품유럽당뇨병학회서NASH비만당뇨신약연구결과9건발표,http://news.mk.co.kr/newsRead.php?year=2019&no=744031
4911,2019-09-19,한미약품바이오신약유럽당뇨학회서주목,http://www.enewstoday.co.kr/news/articleView.html?idxno=1336609
4912,2019-09-19,한미약품NASH비만당뇨신약유럽당뇨학회서주목,http://www.ceoscoredaily.com/news/article.html?no=60549
4913,2019-09-19,한미약품NASH비만당뇨신약물질유럽당뇨학회시선집중,http://www.medisobizanews.com/news/articleView.html?idxno=62525
4914,2019-09-19,한미약품랩스커버리신약유럽당뇨병학회서주목,http://www.newsis.com/view/?id=NISX20190919_0000773828&cID=13001&pID=13000
4915,2019-09-19,한미약품유럽당뇨병학회서신약주요연구결과9건발표,https://www.sedaily.com/NewsView/1VOB23JLZV
4916,2019-09-19,한미약품유럽당뇨학회서신약3종연구결과발표,http://www.ebn.co.kr/news/view/1001716
4917,2019-09-19,한미약품의NASH∙비만∙당뇨신약유럽당뇨학회서주목,http://www.nextdaily.co.kr/news/article.html?id=20190919800018
4918,2019-09-19,한미약품NASH비만당뇨신약유럽당뇨학회서큰주목,http://www.newswatch.kr/news/articleView.html?idxno=23526
4919,2019-09-19,한미약품NASH비만당뇨신약유럽당뇨학회서주목,http://fn.segye.com/content/html/2019/09/19/20190919504275.html?OutUrl=naver
4920,2019-09-19,한미약품NASH∙비만∙당뇨신약유럽EASD서공개,http://www.biospectator.com/view/news_view.php?varAtcId=8502
4921,2019-09-19,한미약품주가증권투자정보19일현재301000원거래,http://www.gokorea.kr/news/articleView.html?idxno=414547
4922,2019-09-19,한미약품랩스커버리기반NASH∙비만∙당뇨신약유럽학회서주목,http://www.etoday.co.kr/news/section/newsview.php?idxno=1800371
4923,2019-09-19,한미약품NASH비만당뇨신약유럽학회장식,http://www.doctorsnews.co.kr/news/articleView.html?idxno=131000
4924,2019-09-19,한미약품유럽학회서랩스커버리신약연구결과발표,https://view.asiae.co.kr/article/2019091910594408479
4925,2019-09-19,한미약품NASH∙비만∙당뇨신약유럽당뇨학회서주목,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235040
4926,2019-09-19,한미약품주식주가19일현재299500원,http://nbntv.co.kr/news/view/653020
4927,2019-09-19,한미약품NASH비만당뇨신약글로벌경쟁력지속입증,http://www.newsprime.co.kr/news/article.html?no=475652
4928,2019-09-19,한미약품비알콜성지방간염신약간염증개선효과확인,http://news.mt.co.kr/mtview.php?no=2019091910335686973
4929,2019-09-19,한미약품유럽학회서NASH비만당뇨신약연구주목,http://kormedi.com/?p=1302198
4930,2019-09-19,한미약품NASH비만당뇨신약유럽당뇨학회서주목,http://www.bosa.co.kr/news/articleView.html?idxno=2112596
4931,2019-09-19,한미약품의NASH비만당뇨신약유럽당뇨병학회에서경쟁력선보여,http://www.koreaittimes.com/news/articleView.html?idxno=93022
4932,2019-09-19,한미약품자사NASH비만당뇨신약연구결과EASD서발표,http://inthenews.co.kr/article-16624/
4933,2019-09-19,한미약품NASH비만당뇨신약연구결과유럽당뇨학회서발표,https://www.hankyung.com/finance/article/2019091901256
4934,2019-09-19,한미약품EASD서신약3종연구결과발표 ,http://www.monews.co.kr/news/articleView.html?idxno=205069
4935,2019-09-19,한미약품NASH∙비만∙당뇨신약물질유럽당뇨학회서효과확인,http://news1.kr/articles/?3723400
4936,2019-09-19,유럽당뇨병학회서주목받은한미약품신약,http://www.dailymedi.com/detail.php?number=847494&thread=22r05
4937,2019-09-19,바이오시밀러테마오후시황상승률상위종목팜스웰바이오560한올바이오파마018한미약품083등,http://www.gokorea.kr/news/articleView.html?idxno=415143
4938,2019-09-19,한미약품NASH비만당뇨신약유럽당뇨학회서주목,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=533794
4939,2019-09-19,한미약품NASH∙비만∙당뇨신약유럽당뇨학회서도주목,http://www.mdtoday.co.kr/mdtoday/index.html?no=365166
4940,2019-09-19,한미약품유럽당뇨학회서신약3종연구결과발표,http://www.cnbnews.com/news/article.html?no=422017
4941,2019-09-19,한미약품NASH비만당뇨신약유럽당뇨학회서글로벌경쟁력입증,http://www.ekn.kr/news/article.html?no=453873
4942,2019-09-19,한미약품유럽당뇨병학회서랩스커버리신약연구결과발표,http://www.donga.com/news/article/all/20190919/97481050/1
4943,2019-09-19,한미약품의NASH∙비만∙당뇨신약유럽당뇨학회서주목,http://www.pressm.kr/news/articleView.html?idxno=25125
4944,2019-09-19,한미약품의NASH비만당뇨신약유럽당뇨학회서주목,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57258
4945,2019-09-19,한미약품NASH∙비만∙당뇨신약물질유럽서효과확인,http://www.smedaily.co.kr/news/articleView.html?idxno=86220
4946,2019-09-19,한미약품NASH비만당뇨신약유럽당뇨학회서주목,http://www.straightnews.co.kr/news/articleView.html?idxno=55807
4947,2019-09-19,한미약품NASH비만당뇨신약유럽당뇨학회서주목,http://www.medigatenews.com/news/2732364353
4948,2019-09-19,한미약품NASH비만당뇨신약유럽당뇨학회서주목,http://www.shinailbo.co.kr/news/articleView.html?idxno=1205613
4949,2019-09-19,한미약품NASH비만당뇨신약3종유럽당뇨학회서주목,http://www.asiatime.co.kr/news/articleView.html?idxno=271290
4950,2019-09-19,한미약품유럽당뇨병학회서신약후보물질3종효과발표,http://www.sportsseoul.com/news/read/821131
4951,2019-09-19,한미약품지방간염비만당뇨신약효능확인,http://www.finomy.com/news/articleView.html?idxno=69559
4952,2019-09-19,한미약품유럽당뇨학회에서신약경쟁력입증권세창상용화박차,http://www.businesspost.co.kr/BP?command=article_view&num=143859
4953,2019-09-19,한미약품NASH비만당뇨신약우수성입증유럽당뇨병학회서발표,http://www.4th.kr/news/articleView.html?idxno=16878
4954,2019-09-19,한미약품유럽당뇨학회서신약3종연구결과발표,http://www.joseilbo.com/news/news_read.php?uid=384256&class=27&grp=
4955,2019-09-19,한미약품의NASH∙비만∙당뇨신약유럽당뇨학회서주목,http://www.lawissue.co.kr/view.php?ud=201909191725356602204ead0791_12
4956,2019-09-19,한미약품스페인서주요신약연구결과발표,http://weekly.cnbnews.com/news/article.html?no=130234
4957,2019-09-19,한미약품유럽종양학회서NASH비만당뇨신약주목,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201909190415&t=NN
4958,2019-09-19,환절기건강관리한미약품치쏙크림,https://www.sedaily.com/NewsView/1VOB3838PE
4959,2019-09-19,한미약품NASH비만당뇨신약3종연구결과발표유럽당뇨학회EASD서주목,http://www.techholic.co.kr/news/articleView.html?idxno=185588
4960,2019-09-19,한미약품유럽당뇨학회서NASH비만당뇨신약주목,http://www.newscj.com/news/articleView.html?idxno=668175
4961,2019-09-20,한미약품제55회유럽당뇨학회EASD서신약3종연구결과발표,http://www.thefirstmedia.net/news/articleView.html?idxno=48686
4962,2019-09-20,한미약품하락한RD신뢰회복중NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01400566622622088
4963,2019-09-20,한미약품오락솔포지오티닙등RD모멘텀부각매수NH투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1800701
4964,2019-09-20,한미약품주가상승가능신약임상순항해연구개발신뢰회복,http://www.businesspost.co.kr/BP?command=article_view&num=143942
4965,2019-09-20,HotLine한미약품추락한RD신뢰서서히회복중,http://news.mk.co.kr/newsRead.php?year=2019&no=747878
4966,2019-09-20,주식종목20일한미약품거래가격295500원,http://www.anewsa.com/detail.php?number=1979187&thread=18
4967,2019-09-20,한미약품의NASH∙비만∙당뇨신약유럽당뇨학회서주목,http://www.aitimes.co.kr/news/articleView.html?idxno=119378
4968,2019-09-20,리포트브리핑한미약품RD신뢰회복중목표가470000원NH투자증권,http://www.newspim.com/news/view/20190920000354
4969,2019-09-20,GET투자리포트한미약품투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=2019092010303011231tpgetnews_16
4970,2019-09-20,9월20일한미약품금일증시297500원068,http://nbntv.co.kr/news/view/654439
4971,2019-09-20,9월20일한미약품증권투자정보외매매동향068변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=416352
4972,2019-09-20,한미약품종근당대웅제약등유럽당뇨학회서임상결과발표눈길,http://www.asiatime.co.kr/news/articleView.html?idxno=271516
4973,2019-09-20,바이오시밀러테마마감시황상승률상위종목셀트리온415한올바이오파마071한미약품017등,http://www.gokorea.kr/news/articleView.html?idxno=417560
4974,2019-09-20,서울시醫한미약품한미참의료인상수상후보공모,http://www.rapportian.com/news/articleView.html?idxno=120113
4975,2019-09-22,한미약품고혈압치료복합신약아모잘탄SCI급국제학술지또등재,http://www.econonews.co.kr/news/articleView.html?idxno=87389
4976,2019-09-23,메리츠證한미약품에페글레나타이드경쟁약물FDA허가투자의견중립,http://www.newsis.com/view/?id=NISX20190923_0000776810&cID=10401&pID=10400
4977,2019-09-23,GET투자리포트한미약품투자의견보유메리츠종금증권,http://www.getnews.co.kr/view.php?ud=2019092310303011248tpgetnews_16
4978,2019-09-23,리포트브리핑한미약품2019EASD유럽당뇨병학회와경쟁약물경구용GLP1FDA허가목표가340000원메리츠종금증권,http://www.newspim.com/news/view/20190923000174
4979,2019-09-23,아통경제23일한미약품현재가291000원,http://www.anewsa.com/detail.php?number=1981939&thread=18
4980,2019-09-23,주식그래프한미약품주가23일현재288500원,http://nbntv.co.kr/news/view/656197
4981,2019-09-23,한미약품NASH비만당뇨신약유럽당뇨학회서주목,http://www.wsobi.com/news/articleView.html?idxno=81610
4982,2019-09-23,셀리드한미약품출신장태식전무영입GMP속도,http://news.mt.co.kr/mtview.php?no=2019092313073163415
4983,2019-09-23,화촉한미약품이관순부회장딸,http://www.whosaeng.com/112723
4984,2019-09-23,먹는GLP1당뇨약허가한미약품에페글레나타이드가치하락불가피,http://biz.newdaily.co.kr/site/data/html/2019/09/23/2019092300143.html
4985,2019-09-23,권세창한미약품경쟁약물잇단허가에당뇨치료제효능높이기힘써,http://www.businesspost.co.kr/BP?command=article_view&num=144283
4986,2019-09-23,셀리드GMP공장건설프로젝트책임자에한미약품출신장태식전무영입,http://www.mdtoday.co.kr/mdtoday/index.html?no=365404
4987,2019-09-23,IB토마토셀리드한미약품출신GMP시설전문가영입,http://www.newstomato.com/ReadNews.aspx?no=921820
4988,2019-09-23,경기침체우려속셀트리온유한양행동아에스티대웅제약일동제약GC녹십자이연제약한미약품광동제약등주목,http://www.econonews.co.kr/news/articleView.html?idxno=87589
4989,2019-09-24,단독한미약품항암신약오락솔임상3상결과12월발표한다,http://www.nspna.com/news/?mode=view&newsid=384285
4990,2019-09-24,장중시세24일한미약품현재주식거래가격288000원,http://www.anewsa.com/detail.php?number=1984328&thread=18
4991,2019-09-24,한미약품항암신약오락솔글로벌3상추가데이터발표,http://biz.chosun.com/site/data/html_dir/2019/09/24/2019092400966.html
4992,2019-09-24,한미약품항암신약오락솔추가임상데이터잇따라발표,https://view.asiae.co.kr/article/2019092410201735555
4993,2019-09-24,한미약품경구항암제오락솔병용글로벌3상추가데이터등발표,http://daily.hankooki.com/lpage/ittech/201909/dh20190924101458145630.htm
4994,2019-09-24,한미약품기술수출한오락솔병용임상결과유명학회서잇따라발표,http://www.metroseoul.co.kr/news/newsview?newscd=2019092400063
4995,2019-09-24,한미약품파트너사아테넥스유럽과미국주요학회에서오락솔병용글로벌3상추가데이터발표예정,http://www.updownnews.co.kr/news/articleView.html?idxno=208847
4996,2019-09-24,한미약품신약오락솔글로벌임상결과쏟아진다,http://www.medisobizanews.com/news/articleView.html?idxno=62643
4997,2019-09-24,한미약품항암신약오락솔해외유명학회서연구결과발표,https://www.sedaily.com/NewsView/1VODCQ0Z3C
4998,2019-09-24,한미약품항암신약오락솔해외서연이어연구결과발표,http://news.mt.co.kr/mtview.php?no=2019092410364988900
4999,2019-09-24,한미약품오락솔글로벌3상추가데이터발표,http://www.newsprime.co.kr/news/article.html?no=476291
5000,2019-09-24,한미약품파트너사아테넥스오락솔연구결과연이어발표,http://fn.segye.com/content/html/2019/09/24/20190924504773.html?OutUrl=naver
5001,2019-09-24,한미약품오락솔글로벌3상추가데이터발표,http://www.newspim.com/news/view/20190924000429
5002,2019-09-24,한미약품오락솔병용글로벌3상추가데이터등잇따라발표,http://www.pressm.kr/news/articleView.html?idxno=25193
5003,2019-09-24,한미약품항암신약오락솔병용글로벌3상추가데이터발표”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1801901
5004,2019-09-24,한미약품경구용항암신약오락솔글로벌3상추가데이터발표,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=533873
5005,2019-09-24,한미약품경구용항암신약오락솔해외유명학회서글로벌3상추가데이터발표,http://www.businesskorea.co.kr/news/articleView.html?idxno=36284
5006,2019-09-24,한미약품파트너사아테넥스오락솔병용글로벌3상추가데이터등발표,http://www.sisajournal-e.com/news/articleView.html?idxno=206495
5007,2019-09-24,한미약품항암신약오락솔글로벌3상추가데이터발표,http://www.seoulwire.com/news/articleView.html?idxno=223624
5008,2019-09-24,한미약품오락솔글로벌3상추가발표오는12월예정,http://www.lawissue.co.kr/view.php?ud=201909241134028962f4ab64559d_12
5009,2019-09-24,한미약품항암신약오락솔추가데이터발표,http://kormedi.com/?p=1302523
5010,2019-09-24,한미약품주가9월24일현재287000원증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=501256
5011,2019-09-24,한미약품오락솔병용•글로벌3상추가데이터등잇따라발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235214
5012,2019-09-24,오늘주식장한미약품주가24일현재286500원,http://nbntv.co.kr/news/view/658277
5013,2019-09-24,한미약품항암신약오락솔하반기임상결과발표임박상용화기대감↑,http://www.ezyeconomy.com/news/articleView.html?idxno=94007
5014,2019-09-24,한미약품경구용항암신약오락솔주요임상데이터해외유명학회잇달아발표,http://www.newswatch.kr/news/articleView.html?idxno=23725
5015,2019-09-24,한미약품경구용항암신약오락솔글로벌3상추가데이터발표,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201909240271&t=NN
5016,2019-09-24,한미약품오락솔해외학회서임상3상데이터발표,https://www.hankyung.com/it/article/201909240566f
5017,2019-09-24,한미약품개발경구용파클리탁셀해외유명학회서연이어다뤄져,http://www.sportsseoul.com/news/read/823326
5018,2019-09-24,한미약품경구용항암신약오락솔임상결과를해외학회에서발표,http://www.businesspost.co.kr/BP?command=article_view&num=144395
5019,2019-09-24,한미약품항암신약오락솔글로벌임상3상결과잇따라발표,http://www.wikileaks-kr.org/news/articleView.html?idxno=66047
5020,2019-09-24,한미약품오락솔병용글로벌3상추가데이터등잇따라해외발표,http://www.fnnews.com/news/201909241421516520
5021,2019-09-24,한미약품아테넥스오락솔병용글로벌3상추가데이터발표,http://www.viva100.com/main/view.php?key=20190924010007904
5022,2019-09-24,한미약품항암신약오락솔글로벌3상추가데이터발표잇달아,http://www.joseilbo.com/news/news_read.php?uid=384518&class=27&grp=
5023,2019-09-24,한미약품오락솔병용글로벌3상추가데이터잇따라발표예정,http://www.econovill.com/news/articleView.html?idxno=372934
5024,2019-09-24,한미약품항암신약오락솔병용글로벌3상데이터곧발표,http://www.edaily.co.kr/news/newspath.asp?newsid=03073366622623400
5025,2019-09-24,한미약품오락솔병용글로벌3상추가데이터등잇따라발표,http://www.ceoscoredaily.com/news/article.html?no=60747
5026,2019-09-24,한미약품항암신약오락솔병용글로벌3상데이터발표예정,http://www.ebn.co.kr/news/view/1002347
5027,2019-09-24,한미약품항암신약오락솔국제학회서연구결과잇따라발표,http://www.ajunews.com/view/20190924154922201
5028,2019-09-24,한미약품항암신약오락솔해외유명학회서연구결과발표,http://www.smedaily.co.kr/news/articleView.html?idxno=86329
5029,2019-09-24,바이오시밀러테마마감시황상승률상위종목팜스웰바이오473에이프로젠제약065한미약품035등,http://www.gokorea.kr/news/articleView.html?idxno=502280
5030,2019-09-24,한미약품오락솔병용글로벌3상추가데이터등잇따라발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57340
5031,2019-09-24,한미약품경구용항암신약오락솔주요연구잇따라발표,http://www.cnbnews.com/news/article.html?no=422518
5032,2019-09-24,한미약품경구용항암신약오락솔병용글로벌3상추가데이터등잇따라발표,http://www.techholic.co.kr/news/articleView.html?idxno=185718
5033,2019-09-24,한미약품파트너사아테넥스항암신약3상추가데이터발표,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1072521
5034,2019-09-24,한미약품오락솔병용•글로벌3상추가데이터등잇따라발표,http://www.thefirstmedia.net/news/articleView.html?idxno=48832
5035,2019-09-24,한미약품고유기반기술랩스커버리신약유럽당뇨병학회서주목,http://www.econonews.co.kr/news/articleView.html?idxno=87783
5036,2019-09-25,한미약품파트너사아테넥스오락솔병용글로벌3상추가데이터등발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1337909
5037,2019-09-25,한미약품오락솔잇딴임상데이터발표예정기대감↑,http://www.monews.co.kr/news/articleView.html?idxno=205183
5038,2019-09-25,국내주식시장현황25일한미약품현재주식거래가격285000원,http://www.anewsa.com/detail.php?number=1986704&thread=18
5039,2019-09-25,화촉주외한전한미약품부사장장녀,http://www.yakup.com/news/index.html?mode=view&cat=meet&cat2=33&nid=1700144637
5040,2019-09-25,주외한전한미약품부사장장녀결혼1013,http://medipana.com/news/news_viewer.asp?NewsNum=245894&MainKind=A&NewsKind=5&vCount=12&vKind=1
5041,2019-09-25,주외한한미약품전부사장장녀,http://www.doctorsnews.co.kr/news/articleView.html?idxno=131103
5042,2019-09-25,주외한전한미약품부사장장녀,http://www.bosa.co.kr/news/articleView.html?idxno=2112939
5043,2019-09-25,제약바이오기업들한미약품출신에잇단러브콜,http://www.dailypharm.com/Users/News/NewsView.html?ID=256894&REFERER=NP
5044,2019-09-25,한미약품주가9월25일오늘거래가286000원정보,http://www.gokorea.kr/news/articleView.html?idxno=503160
5045,2019-09-25,오늘주식시세한미약품주가25일현재285500원,http://nbntv.co.kr/news/view/660033
5046,2019-09-26,권세창한미약품대표이사창립50주년맞는2023년까지글로벌혁신신약23개개발목표”,http://news.mk.co.kr/newsRead.php?year=2019&no=768299
5047,2019-09-26,9월26일한미약품증권투자정보124변화,http://www.gokorea.kr/news/articleView.html?idxno=505153
5048,2019-09-26,화촉주외한前한미약품부사장장녀,http://www.whosaeng.com/112830
5049,2019-09-26,9월26일한미약품주식종목검색124285500원,http://nbntv.co.kr/news/view/662220
5050,2019-09-26,바이오시밀러테마오후시황상승률상위종목제넥신219이수앱지스122한미약품106등,http://www.gokorea.kr/news/articleView.html?idxno=505526
5051,2019-09-26,잔탁만일동제약한미약품녹십자까지환자들발암물질사먹었다,http://viewers.heraldcorp.com/news/articleView.html?idxno=45048
5052,2019-09-26,메리츠종금증권한미약품에페글레나타이드경쟁약물FDA허가투자의견중립,http://www.econonews.co.kr/news/articleView.html?idxno=88149
5053,2019-09-27,바이오시밀러테마오전시황상승률상위종목셀트리온030팜스웰바이오029한미약품018등,http://www.gokorea.kr/news/articleView.html?idxno=506527
5054,2019-09-27,27일09시바이오시밀러오전의테마종목팜스웰바이오한미약품등이상승세주도,http://nbntv.co.kr/news/view/663731
5055,2019-09-27,한미약품JVM조제약검수장비비젠컴팩트호평,http://www.ebn.co.kr/news/view/1002818
5056,2019-09-27,한미약품계열사JVM비젠캠팩트조제약자동검수편리해요,http://moneys.mt.co.kr/news/mwView.php?no=2019092709538037222
5057,2019-09-27,한미약품계열사제이브이엠비젠컴팩트조제약자동검수간편,http://www.medisobizanews.com/news/articleView.html?idxno=62727
5058,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.nextdaily.co.kr/news/article.html?id=20190927800017
5059,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.fnnews.com/news/201909271016495412
5060,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://fn.segye.com/content/html/2019/09/27/20190927504213.html?OutUrl=naver
5061,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.dailysmart.co.kr/news/articleView.html?idxno=16006
5062,2019-09-27,한미약품계열JVM첨단조제약자동검수기해외서호평,http://news.heraldcorp.com/view.php?ud=20190927000213
5063,2019-09-27,한미약품그룹하반기공채30일부터서류접수시작,http://medipana.com/news/news_viewer.asp?NewsNum=246033&MainKind=A&NewsKind=5&vCount=12&vKind=1
5064,2019-09-27,한미약품그룹30일부터하반기공채시작,http://www.newspim.com/news/view/20190927000300
5065,2019-09-27,한미약품그룹하반기공채서류접수시작,http://www.ebn.co.kr/news/view/1002828
5066,2019-09-27,한미약품자회사소형조제약검수장비해외서주목,http://www.shinailbo.co.kr/news/articleView.html?idxno=1208242
5067,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.pressm.kr/news/articleView.html?idxno=25257
5068,2019-09-27,한미약품2019하반기공개채용실시,http://news.mt.co.kr/mtview.php?no=2019092710265590641
5069,2019-09-27,한미약품신약연구등5개부문공채서류접수,http://www.medisobizanews.com/news/articleView.html?idxno=62736
5070,2019-09-27,한미약품그룹이달30일부터하반기공채서류접수시작,http://www.mdtoday.co.kr/mdtoday/index.html?no=365863
5071,2019-09-27,한미약품30일부터하반기공채진행,http://www.biospectator.com/view/news_view.php?varAtcId=8568
5072,2019-09-27,한미약품그룹30일부터하반기공채서류접수,http://www.fetv.co.kr/news/article.html?no=37044
5073,2019-09-27,한미약품그룹30일부터하반기공채서류접수,https://view.asiae.co.kr/article/2019092710552674526
5074,2019-09-27,한미약품계열사JVM비젠컴팩트해외서호평조제약자동검수더간편해져,http://www.newswatch.kr/news/articleView.html?idxno=23846
5075,2019-09-27,한미약품계열사제이브이엠첨단조제약자동검수기로해외서주목,https://www.sedaily.com/NewsView/1VOEQ0ZJPN
5076,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.ceoscoredaily.com/news/article.html?no=60892
5077,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.seoulwire.com/news/articleView.html?idxno=226528
5078,2019-09-27,한미약품30일부터하반기공채접수해외사업연구개발영업등모집,http://www.4th.kr/news/articleView.html?idxno=17203
5079,2019-09-27,한미약품2019하반기공개채용서류접수시작,http://www.newsprime.co.kr/news/article.html?no=477005
5080,2019-09-27,한미약품계열사JVM조제약검수장비해외서호평”,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000051442
5081,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.straightnews.co.kr/news/articleView.html?idxno=56356
5082,2019-09-27,한미약품30일부터하반기공채접수온라인채용설명회도진행,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201909270224&t=NN
5083,2019-09-27,취업한미약품그룹2019하반기공채채용이달30일10월20일온라인서류접수,http://www.ezyeconomy.com/news/articleView.html?idxno=94113
5084,2019-09-27,글로벌제약기업으로도약하고있는한미약품2019년하반기공개채용시작,http://www.updownnews.co.kr/news/articleView.html?idxno=209060
5085,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.sportsseoul.com/news/read/825084
5086,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235405
5087,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.sisafocus.co.kr/news/articleView.html?idxno=222140
5088,2019-09-27,한미약품30일하반기공채서류접수시작사업개발연구영업등”,http://sports.hankooki.com/lpage/economy/201909/sp20190927112933137020.htm
5089,2019-09-27,한미약품JVM조제약검수장비비젠컴팩트해외서호평,http://www.seoulwire.com/news/articleView.html?idxno=226542
5090,2019-09-27,한미약품그룹30일부터하반기공채서류접수,http://www.efnews.co.kr/news/articleView.html?idxno=81125
5091,2019-09-27,한미약품그룹30일부터하반기공채서류접수,http://www.cnbnews.com/news/article.html?no=422868
5092,2019-09-27,한미약품그룹30일부터하반기공채서류접수,http://biz.chosun.com/site/data/html_dir/2019/09/27/2019092701517.html
5093,2019-09-27,9월27일한미약품금일증시000281000원,http://nbntv.co.kr/news/view/664441
5094,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.newsway.co.kr/news/view?tp=1&ud=2019092712372091462
5095,2019-09-27,한미약품그룹공채일정확정30일∼10월2일서류접수,http://www.doctorsnews.co.kr/news/articleView.html?idxno=131166
5096,2019-09-27,안내한미약품그룹30일부터하반기공채시작 ,http://www.monews.co.kr/news/articleView.html?idxno=205299
5097,2019-09-27,바이오시밀러테마오후시황상승률상위종목팜스웰바이오276한미약품018셀트리온030등,http://www.gokorea.kr/news/articleView.html?idxno=507576
5098,2019-09-27,13시24분바이오시밀러오후테마시황팜스웰바이오한미약품등이상승세견인중,http://nbntv.co.kr/news/view/664836
5099,2019-09-27,한미약품그룹30일부터하반기공채시작,http://kormedi.com/?p=1302743
5100,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.bosa.co.kr/news/articleView.html?idxno=2113128
5101,2019-09-27,한미약품하반기공채지원서30일부터접수,http://www.seoulfn.com/news/articleView.html?idxno=357303
5102,2019-09-27,한미약품그룹오는30일하반기공채시작000명채용,http://www.donga.com/news/article/all/20190927/97619246/1
5103,2019-09-27,한미약품영업연구등하반기공채실시,http://www.rapportian.com/news/articleView.html?idxno=120272
5104,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.ekn.kr/news/article.html?no=455299
5105,2019-09-27,한미약품그룹하반기공개채용실시,http://www.hg-times.com/news/articleView.html?idxno=208014
5106,2019-09-27,한미약품그룹30일부터하반기공채절차개시,http://news.heraldcorp.com/view.php?ud=20190927000544
5107,2019-09-27,한미약품그룹30일부터하반기공채서류접수,http://www.newswatch.kr/news/articleView.html?idxno=23861
5108,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57417
5109,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.newstomato.com/ReadNews.aspx?no=922878
5110,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.techholic.co.kr/news/articleView.html?idxno=185831
5111,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.aitimes.co.kr/news/articleView.html?idxno=119677
5112,2019-09-27,한미약품그룹30일부터하반기공채서류접수,http://www.smedaily.co.kr/news/articleView.html?idxno=86417
5113,2019-09-27,한미약품30일부터공채서류접수북경한미약품도,http://daily.hankooki.com/lpage/ittech/201909/dh20190927150927145630.htm
5114,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.nspna.com/news/?mode=view&newsid=385243
5115,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작내달20일까지,http://www.100ssd.co.kr/news/articleView.html?idxno=64343
5116,2019-09-27,한미약품2019하반기공채서류접수시작,http://www.youthdaily.co.kr/news/article.html?no=18785
5117,2019-09-27,한미약품그룹2019년하반기공개채용,http://www.kpinews.co.kr/news/articleView.html?idxno=104235
5118,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://inthenews.co.kr/article-17913/
5119,2019-09-27,간편해진조제약검수”한미약품JVM자동검수장비비젠컴팩트출시,http://www.donga.com/news/article/all/20190927/97621832/1
5120,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.joseilbo.com/news/news_read.php?uid=384749&class=27&grp=
5121,2019-09-27,이관순한미약품부회장자녀화촉,http://www.rapportian.com/news/articleView.html?idxno=120279
5122,2019-09-27,한미약품제약산업미래책임질인재모셔요,http://moneys.mt.co.kr/news/mwView.php?no=2019092716488024487
5123,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.ajunews.com/view/20190927172605851
5124,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.lawissue.co.kr/view.php?ud=201909271741585520204ead0791_12
5125,2019-09-27,한미약품2019하반기공채서류접수실시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1338743
5126,2019-09-27,한미약품그룹30일부터하반기공채서류접수시작,http://www.newscj.com/news/articleView.html?idxno=670486
5127,2019-09-28,한미약품그룹하반기공채내달20일까지서류접수,http://www.newsworks.co.kr/news/articleView.html?idxno=398418
5128,2019-09-29,한미약품30일부터하반기공채서류접수시작10월20일까지계속,http://www.g-enews.com/ko-kr/news/article/news_all/20190927164210711269d76442fa_1/article.html
5129,2019-09-29,한미약품그룹이달30일부터하반기공채서류접수,http://www.dailymedi.com/detail.php?number=847852&thread=22r05
5130,2019-09-29,한미약품그룹30일부터하반기공채서류접수시작,http://www.fintechpost.co.kr/news/articleView.html?idxno=74845
5131,2019-09-30,한미약품그룹30일부터하반기공채서류접수시작,http://www.thefirstmedia.net/news/articleView.html?idxno=49017
5132,2019-09-30,우종수한미약품대표등제약산업발전유공자정부포상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235449
5133,2019-09-30,한미약품하반기공채서류접수시작,http://www.wsobi.com/news/articleView.html?idxno=82052
5134,2019-09-30,한미약품그룹30일부터하반기공채서류접수시작,https://www.kpanews.co.kr/article/show.asp?idx=207051&category=D
5135,2019-09-30,종목검색한미약품주가30일현재276500원,http://nbntv.co.kr/news/view/666709
5136,2019-09-30,한미약품종합영양제나인나인하루한알활력충전,http://www.newswatch.kr/news/articleView.html?idxno=23916
5137,2019-09-30,바이오시밀러테마오후시황상승률상위종목팜스웰바이오1486제넥신039한미약품108등,http://www.gokorea.kr/news/articleView.html?idxno=509490
5138,2019-09-30,한미약품텐텐어린이영양제로주목,http://www.sisaon.co.kr/news/articleView.html?idxno=101856
5139,2019-09-30,한미약품어린이종합비타민텐텐코리아팜어워드굿브랜드대상,http://www.ezyeconomy.com/news/articleView.html?idxno=94165
5140,2019-09-30,한미약품종합영향제나인나인영양제시장의대명사로각광,http://www.kyeongin.com/main/view.php?key=20190930010010515
5141,2019-09-30,한미약품어린이종합영양제텐텐인기짱,http://www.kyeongin.com/main/view.php?key=20190930010010508
5142,2019-09-30,한미약품성장기어린이를위한종합비타민텐텐선봬,http://www.iminju.net/news/articleView.html?idxno=49352
5143,2019-09-30,한미약품약국에서사랑받는어린이종합비타민텐텐,http://www.mediapen.com/news/view/465643
5144,2019-09-30,한미약품텐텐코리아팜어워드굿랜드어린이종합비타민부문대상선정,http://www.nspna.com/news/?mode=view&newsid=385505
5145,2019-09-30,한미약품나인나인한알에28종영양소와비타민D함유량750IU함유하루비타민D권장섭취량충족,http://www.updownnews.co.kr/news/articleView.html?idxno=209132
5146,2019-09-30,한미약품28종성분종합비타민나인나인비타민D까지해결,http://www.opinionnews.co.kr/news/articleView.html?idxno=24000
5147,2019-09-30,한미약품부족한비타민D나인나인으로채우세요,http://daily.hankooki.com/lpage/ittech/201909/dh20190930151150145630.htm
5148,2019-09-30,굿잡한미약품그룹하반기공채서류접수시작,http://news.bizwatch.co.kr/article/consumer/2019/09/30/0021/naver
5149,2019-09-30,한미약품텐텐코리아팜어워드굿브랜드대상,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=109616
5150,2019-09-30,바이오시밀러테마마감시황상승률상위종목팜스웰바이오1581제넥신보합세한미약품108등,http://www.gokorea.kr/news/articleView.html?idxno=510176
5151,2019-09-30,한미약품한국인결핍영양소1위비타민D나인나인한알로해결가능,http://www.thefirstmedia.net/news/articleView.html?idxno=49043
5152,2019-09-30,약사도엄지척한미약품어린이종합비타민텐텐,http://www.sisa-news.com/news/article.html?no=120922
5153,2019-10-01,하루한알로비타민D까지해결한미약품나인나인인기,http://www.g-enews.com/ko-kr/news/article/news_all/20190930175332147869d76442fa_1/article.html
5154,2019-10-01,09시31분바이오시밀러테마주오전시황셀트리온한미약품등이상승세주도,http://nbntv.co.kr/news/view/668160
5155,2019-10-01,뉴스투데이L한미약품텐텐코리아팜어워드굿브랜드서대상선정,http://www.news2day.co.kr/138055
5156,2019-10-01,한미약품우리아이성장발육엔텐텐,http://moneys.mt.co.kr/news/mwView.php?no=2019093021458049894
5157,2019-10-01,한미약품99세까지건강하게나인나인하세요,http://moneys.mt.co.kr/news/mwView.php?no=2019093021518093357
5158,2019-10-01,한미약품그룹계열사인적자원개발우수기관인증획득,http://www.ceoscoredaily.com/news/article.html?no=60993
5159,2019-10-01,한미약품고용부로부터인적자원개발우수기관인증받아,https://www.sedaily.com/NewsView/1VPCPN31R5
5160,2019-10-01,한미약품그룹인재채용인적자원분야서우수기관인증,http://medipana.com/news/news_viewer.asp?NewsNum=246221&MainKind=A&NewsKind=5&vCount=12&vKind=1
5161,2019-10-01,한미약품지속적교육기회제공에인재채용∙인적자원관리우수평가,http://www.newslock.co.kr/news/articleView.html?idxno=21829
5162,2019-10-01,한미약품그룹인적자원개발우수기관인증획득,http://www.newspim.com/news/view/20191001000454
5163,2019-10-01,한미약품그룹인재채용인적자원분야도제약업계최고”,http://www.fetv.co.kr/news/article.html?no=37245
5164,2019-10-01,한미약품그룹인재채용인적자원분야도제약업계최고,http://www.straightnews.co.kr/news/articleView.html?idxno=56633
5165,2019-10-01,한미약품그룹인재채용∙인적자원분야도제약업계최고,http://www.pressm.kr/news/articleView.html?idxno=25299
5166,2019-10-01,한미약품한미정밀화학정부인증청년채용∙임직원교육등우수평가,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57457
5167,2019-10-01,한미약품그룹인재채용인적자원분야도제약업계최고,http://www.dailysmart.co.kr/news/articleView.html?idxno=16133
5168,2019-10-01,한미약품그룹BestHRD인증획득 ,http://www.monews.co.kr/news/articleView.html?idxno=205385
5169,2019-10-01,한미약품텐텐코리아팜어워드굿브랜드어린이종합비타민부문大賞,http://www.newswatch.kr/news/articleView.html?idxno=23958
5170,2019-10-01,한미약품그룹인재채용인적자원분야서우수기관인증,http://www.sisajournal-e.com/news/articleView.html?idxno=206854
5171,2019-10-01,한미약품그룹인적자원개발우수기관인증,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910010227&t=NN
5172,2019-10-01,한미약품그룹인재채용인적자원분야업계최고인증,http://www.metroseoul.co.kr/news/newsview?newscd=2019100100077
5173,2019-10-01,한미약품그룹인적자원개발우수기관인증,http://www.fnnews.com/news/201910011108529477
5174,2019-10-01,한미약품인적자원개발우수기관인증,https://www.hankyung.com/it/article/201910016084f
5175,2019-10-01,한미약품그룹정부서인적자원개발우수기관인정,http://www.medisobizanews.com/news/articleView.html?idxno=62815
5176,2019-10-01,한미약품그룹인재채용인적자원개발우수기관정부인증,http://www.sportsseoul.com/news/read/826681
5177,2019-10-01,한미약품그룹BestHRD인증청년채용임직원교육우수평가,http://www.newsprime.co.kr/news/article.html?no=477429
5178,2019-10-01,한미약품한미정밀화학정부서인적자원분야우수기관인증,http://www.businesskorea.co.kr/news/articleView.html?idxno=36555
5179,2019-10-01,뉴스투데이L한미약품그룹인재채용관리모두우수그룹인증,http://www.news2day.co.kr/138081
5180,2019-10-01,한미약품그룹사람이재산글로벌도약주춧돌,http://www.doctorsnews.co.kr/news/articleView.html?idxno=131196
5181,2019-10-01,한미약품그룹인재채용인적자원분야도제약최고,http://www.bosa.co.kr/news/articleView.html?idxno=2113345
5182,2019-10-01,10월1일한미약품시세보기285500원344,http://nbntv.co.kr/news/view/668872
5183,2019-10-01,한미약품인재채용인적자원개발우수기관인증획득,http://www.ezyeconomy.com/news/articleView.html?idxno=94205
5184,2019-10-01,한미약품한미정밀화학인적자원개발우수기관정부인증받아,http://www.newswatch.kr/news/articleView.html?idxno=23959
5185,2019-10-01,한미약품한미정밀화학인재채용인적자원분야정부우수기관인증받아,http://www.insightkorea.co.kr//news/articleView.html?idxno=58752
5186,2019-10-01,한미약품한미정밀화학정부인증청년채용∙임직원교육등우수평가,http://www.mdtoday.co.kr/mdtoday/index.html?no=366159
5187,2019-10-01,한미약품한미정밀화학인적자원개발우수기관인증,http://www.etnews.com/20191001000139
5188,2019-10-01,한미약품그룹정부로부터BestHRD인적자원개발우수기관인증받아,http://www.koreaittimes.com/news/articleView.html?idxno=93263
5189,2019-10-01,한미약품그룹인재채용인적자원분야관리우수평가,http://www.updownnews.co.kr/news/articleView.html?idxno=209203
5190,2019-10-01,한미약품한미정밀화학인적자원개발우수기관정부인증,https://view.asiae.co.kr/article/2019100114492199090
5191,2019-10-01,한미약품정부인증청년채용임직원교육등우수평가,http://www.shinailbo.co.kr/news/articleView.html?idxno=1209465
5192,2019-10-01,한미약품그룹인적자원관리도최고,http://news1.kr/articles/?3733243
5193,2019-10-01,한미약품그룹인재채용∙인적자원분야도제약업계최고”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235564
5194,2019-10-01,한미약품그룹인재채용인적자원분야우수평가,http://daily.hankooki.com/lpage/ittech/201910/dh20191001150741145630.htm
5195,2019-10-01,한미약품한미정밀화학정부인적자원개발우수기관인증받아,http://inthenews.co.kr/article-18464/
5196,2019-10-01,한미약품그룹인적자원개발우수기관인증,http://www.smedaily.co.kr/news/articleView.html?idxno=86502
5197,2019-10-01,한미약품한미정밀화학인정자원개발우수기관인증받아,http://news.mk.co.kr/newsRead.php?year=2019&no=786289
5198,2019-10-01,한미약품그룹인적자원개발우수기관인증,http://www.wikileaks-kr.org/news/articleView.html?idxno=66727
5199,2019-10-01,한미약품그룹정부인증획득청년채용임직원교육등우수평가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1339450
5200,2019-10-01,한미약품한미정밀화학정부인증청년채용∙임직원교육등우수평가,http://www.nextdaily.co.kr/news/article.html?id=20191001800048
5201,2019-10-01,한미약품그룹BestHRD인적자원개발우수기관인증,http://www.lawissue.co.kr/view.php?ud=201910011704554271204ead0791_12
5202,2019-10-01,한미약품한미정밀화학정부인증청년채용임직원교육등우수평가,http://www.medigatenews.com/news/1817063738
5203,2019-10-01,인재채용직원교육제약업계최고한미약품인적자원개발우수기관인증,http://kpenews.com/View.aspx?No=268762
5204,2019-10-01,한미약품그룹인재채용인적자원분야서우수기관인증,http://www.seoulwire.com/news/articleView.html?idxno=229344
5205,2019-10-01,한미약품그룹인적자원개발우수기관인증,http://www.cnbnews.com/news/article.html?no=423284
5206,2019-10-01,한미약품인재채용인적자원우수평가,http://www.ftoday.co.kr/news/articleView.html?idxno=111740
5207,2019-10-01,한미약품그룹임직원교육통해인적자원개발우수기관선정,http://www.econovill.com/news/articleView.html?idxno=373584
5208,2019-10-01,한미약품그룹인적자원개발우수기관정부인증획득,http://www.donga.com/news/article/all/20191001/97682515/1
5209,2019-10-01,1일외국인순매수Top10삼성전기497억KODEX레버리지28억한미약품20억삼성엔지니어링17억외국인순매수나서코스닥시장에서는헬릭스미스켐트로닉스케이엠더블유상위종목으로장,http://www.fintechpost.co.kr/news/articleView.html?idxno=75431
5210,2019-10-01,한미약품그룹인재채용인적자원분야도제약업계최고,http://www.newscj.com/news/articleView.html?idxno=671376
5211,2019-10-01,한미약품그룹인적자원개발우수기관인증서수여인재채용∙인적자원분야도제약업계최고,http://www.thefirstmedia.net/news/articleView.html?idxno=49118
5212,2019-10-02,한미약품그룹인재채용인적자원분야우수기관인증,http://www.youthdaily.co.kr/news/article.html?no=19075
5213,2019-10-02,바이오시밀러테마오전시황상승률상위종목에이프로젠제약028셀트리온058한미약품069등,http://www.gokorea.kr/news/articleView.html?idxno=512771
5214,2019-10-02,2일09시바이오시밀러테마주시황오전셀트리온한미약품등이상승세주도,http://nbntv.co.kr/news/view/670251
5215,2019-10-02,한미약품한미정밀화학청년채용임직원교육등우수평가,http://www.bokuennews.com/news/article.html?no=181446
5216,2019-10-02,한미약품주가12894010월2일오늘거래가286000원및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=513382
5217,2019-10-02,한미약품주식실시간2일현재287000원,http://nbntv.co.kr/news/view/670852
5218,2019-10-02,2019하반기인재모집돌입커리어한미약품신세계그룹교보생명한국무역보험공사등주요기업모집요강소개,http://www.updownnews.co.kr/news/articleView.html?idxno=209264
5219,2019-10-02,커리어한미약품신세계그룹등2019하반기인재모집,http://www.beyondpost.co.kr/view.php?ud=2019100215460778646a9e4dd7f_30
5220,2019-10-02,인기종목주가정보2일한미약품마감증시285000원,http://nbntv.co.kr/news/view/672176
5221,2019-10-04,바이오시밀러테마오전시황상승률상위종목이수앱지스046한미약품018에이프로젠제약보합세등,http://www.gokorea.kr/news/articleView.html?idxno=514754
5222,2019-10-04,한미약품주가10월4일현재282500원증권그래프및매매동향,http://www.gokorea.kr/news/articleView.html?idxno=515320
5223,2019-10-04,한미약품오늘주식시장4일현재282000원,http://nbntv.co.kr/news/view/673082
5224,2019-10-04,국민연금한미약품지분율1026→904축소,http://www.etoday.co.kr/news/section/newsview.php?idxno=1805946
5225,2019-10-04,국민연금한미약품지분율1026→904,http://yna.kr/AKR20191004103300008?did=1195m
5226,2019-10-04,국민연금공단한미약품주식1026→904변동,http://www.mdtoday.co.kr/mdtoday/index.html?no=366502
5227,2019-10-05,한미약품당뇨치료제가브스물질특허회피실패,http://www.dailypharm.com/Users/News/NewsView.html?ID=257364&REFERER=NP
5228,2019-10-07,한미약품능력중심인재채용정부인증,http://weekly.hankooki.com/lpage/economy/201910/wk20191007080024146390.htm
5229,2019-10-07,한미약품계열JVM사업호조파우치롤생산공장2배증설,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=235750
5230,2019-10-07,한미약품계열JVM파우치롤생산공장2배증설,http://www.medisobizanews.com/news/articleView.html?idxno=62931
5231,2019-10-07,한미약품계열제이브이엠파우치롤생산공장2배증설,https://www.sedaily.com/NewsView/1VPFH4974D
5232,2019-10-07,한미약품계열사JVM파우치롤생산공장2배증설75억원투자,http://www.newswatch.kr/news/articleView.html?idxno=24129
5233,2019-10-07,주식종목검색한미약품주가7일현재285500원,http://nbntv.co.kr/news/view/675385
5234,2019-10-07,한미약품계열JVM파우치롤생산공장2배증설,https://www.hankyung.com/it/article/201910077286i
5235,2019-10-07,금주의채용정보한미약품2019년하반기직원모집,http://www.news2day.co.kr/138429
5236,2019-10-07,한미약품제이브이엠파우치롤생산공장2배이상증설,http://www.newslock.co.kr/news/articleView.html?idxno=21961
5237,2019-10-07,한미약품계열사JVM파우치롤생산공장2배증설,http://www.newspim.com/news/view/20191007000586
5238,2019-10-07,JVM사업호조탄력한미약품파우치롤생산공장2배증설,http://www.sisajournal-e.com/news/articleView.html?idxno=207123
5239,2019-10-07,한미약품계열사JVM파우치롤생산공장2배증설나선다,http://inthenews.co.kr/article-18889/
5240,2019-10-07,한미약품계열사제이브이엠파우치롤생산공장증설,https://view.asiae.co.kr/article/2019100713483969037
5241,2019-10-07,한미약품계열사제이브이엠파우치롤생산공장2배증설75억투자,http://www.ezyeconomy.com/news/articleView.html?idxno=94310
5242,2019-10-07,한미약품그룹계열사제이브이엠파우치롤생산공장2배증설해외사업등호조에따른조치,http://www.updownnews.co.kr/news/articleView.html?idxno=209405
5243,2019-10-07,한미약품JVM사업호조탄력파우치롤생산공장2배증설,http://www.asiatoday.co.kr/view.php?key=20191007010003555
5244,2019-10-07,한미약품계열사JVM파우치롤생산공장2배증설,http://biz.chosun.com/site/data/html_dir/2019/10/07/2019100701474.html
5245,2019-10-07,한미약품그룹JVM사업호조파우치롤생산공장2배증설,http://www.newstomato.com/ReadNews.aspx?no=924689
5246,2019-10-07,한미약품계열사제이브이엠파우치롤생산공장2배증설,http://news.mk.co.kr/newsRead.php?year=2019&no=805249
5247,2019-10-07,사업호조탄력한미약품계열사JVM파우치롤생산공장2배증설,http://kpenews.com/View.aspx?No=269325
5248,2019-10-07,한미약품계열사제이브이엠파우치롤생산공장증설에75억투입,http://www.businesspost.co.kr/BP?command=article_view&num=146065
5249,2019-10-07,바이오시밀러테마마감시황상승률상위종목한올바이오파마1215제넥신743한미약품446등,http://www.gokorea.kr/news/articleView.html?idxno=518394
5250,2019-10-07,한미약품계열JVM파우치롤생산공장증설8개월간75억원투입,http://www.donga.com/news/article/all/20191007/97769060/1
5251,2019-10-07,코스피거래급감속LG전자셀트리온한미약품껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=64719
5252,2019-10-07,한미약품계열사JVM약봉투생산공장2배증설,http://www.seoulwire.com/news/articleView.html?idxno=232116
5253,2019-10-07,한미약품JVM사업호조탄력파우치롤생산공장2배증설,http://www.thefirstmedia.net/news/articleView.html?idxno=49250
5254,2019-10-07,한미약품그룹제이브이엠75억투자파우치롤생산공장증설,http://www.4th.kr/news/articleView.html?idxno=17630
5255,2019-10-08,한미약품JVM사업호조탄력파우치롤생산공장2배증설,http://www.newslock.co.kr/news/articleView.html?idxno=21984
5256,2019-10-08,한미약품가브스물질특허회피실패,http://www.mdtoday.co.kr/mdtoday/index.html?no=366726
5257,2019-10-08,바이오시밀러테마오전시황상승률상위종목한올바이오파마525에이프로젠제약165한미약품103등,http://www.gokorea.kr/news/articleView.html?idxno=518554
5258,2019-10-08,퀵리포트한미약품매수유지목표가42만원유지SK證,http://www.itooza.com/common/iview.php?no=2019100809273519002
5259,2019-10-08,한미약품포지오티닙HER2변이에서도효과확인,http://medipana.com/news/news_viewer.asp?NewsNum=246601&MainKind=A&NewsKind=5&vCount=12&vKind=1
5260,2019-10-08,한미약품신약포지오티닙HER2변이암극복가능성,http://www.medisobizanews.com/news/articleView.html?idxno=62972
5261,2019-10-08,한미약품포지오티닙HER2변이에도우수한효과국제학술지등재,https://view.asiae.co.kr/article/2019100810105482139
5262,2019-10-08,한미약품포지오티닙치료어려운HER2변이에서도암극복가능성”,https://www.sedaily.com/NewsView/1VPFXIB9SZ
5263,2019-10-08,한미약품포지오티닙단백질돌연변이발생암치료효과,http://news.mt.co.kr/mtview.php?no=2019100810173754807
5264,2019-10-08,한미약품포지오티닙임상결과암연구학술지에등재,http://www.rapportian.com/news/articleView.html?idxno=120476
5265,2019-10-08,10월8일한미약품및증권시세외주식시황068변동,http://www.gokorea.kr/news/articleView.html?idxno=519174
5266,2019-10-08,한미약품세계암연구학술지에신약포지오티닙등재치료어려운변이암극복가능성제시,http://www.newslock.co.kr/news/articleView.html?idxno=21993
5267,2019-10-08,한미약품항암신약포지오티닙치료어려운HER2변이암도극복가능성제시,http://www.businesskorea.co.kr/news/articleView.html?idxno=36763
5268,2019-10-08,한미약품항암제포지오티닙국제학술지캔서셀에실려,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000051535
5269,2019-10-08,한미약품포지오티닙HER2변이암종활용가능성↑,http://www.monews.co.kr/news/articleView.html?idxno=205553
5270,2019-10-08,한미약품항암약포지오티닙연구결과학술지등재,http://www.kpinews.co.kr/news/articleView.html?idxno=104835
5271,2019-10-08,한미약품포지오티닙세계최고암학술지캔서셀등재,http://www.newspim.com/news/view/20191008000533
5272,2019-10-08,한미약품포지오티닙HER2변이암에도효과,http://health.chosun.com/site/data/html_dir/2019/10/08/2019100801127.html
5273,2019-10-08,증권주식한미약품주가8일현재292000원,http://nbntv.co.kr/news/view/677687
5274,2019-10-08,리포트브리핑한미약품RD모멘텀은여전히남아있어목표가420000원SK증권,http://www.newspim.com/news/view/20191008000611
5275,2019-10-08,GET투자리포트한미약품투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=2019100810303011740tpgetnews_16
5276,2019-10-08,한미약품포지오티닙치료어려운HER2변이암극복가능성제시,http://www.koreaittimes.com/news/articleView.html?idxno=93350
5277,2019-10-08,뉴스투데이L한미약품포지오티닙변이암에서도효과확인,http://www.news2day.co.kr/138555
5278,2019-10-08,한미약품포지오티닙학술지캔서셀등재HER2변이암극복가능성제시”,http://inthenews.co.kr/article-19013/
5279,2019-10-08,한미약품항암신약포지오티닙난치HER2변이암극복가능성제시,http://www.newswatch.kr/news/articleView.html?idxno=24181
5280,2019-10-08,한미약품신약포지오티닙HER2변이에도효과입증,http://www.econovill.com/news/articleView.html?idxno=374109
5281,2019-10-08,한미약품항암신약포지오티닙학술지등재HER2변이암억제효과확인,http://www.4th.kr/news/articleView.html?idxno=17656
5282,2019-10-08,한미약품포지오티닙HER2변이암극복가능성제시”,http://biz.chosun.com/site/data/html_dir/2019/10/08/2019100801358.html
5283,2019-10-08,한미약품포지오티닙세계최고권위암연구학술지캔서셀연구등재,http://www.ceoscoredaily.com/news/article.html?no=61216
5284,2019-10-08,한미약품포지오티닙EGFRHER2변이환자서우수한종양억제요과확인,http://news.mk.co.kr/newsRead.php?year=2019&no=809232
5285,2019-10-08,한미약품항암신약포지오티닙치료어려운HER2변이암극복가능성제시,http://www.pressm.kr/news/articleView.html?idxno=25397
5286,2019-10-08,한미약품제넨턱의기술수출료끝나3분기영업이익뒷걸음,http://www.businesspost.co.kr/BP?command=article_view&num=146216
5287,2019-10-08,한미약품포지오티닙세계적학술지캔서셀에등재,https://www.hankyung.com/it/article/201910081361i
5288,2019-10-08,한미약품포지오티닙HER2변이암에도효과적”,http://www.etnews.com/20191008000189
5289,2019-10-08,한미약품포지오티닙으로변이암극복가능성제시,http://www.asiatime.co.kr/news/articleView.html?idxno=274627
5290,2019-10-08,한미약품포지오티닙HER2유전자변이암에도효과확인,http://news1.kr/articles/?3738898
5291,2019-10-08,한미약품세계최고권위암연구학술지캔서셀포지오티닙연구등재,http://www.techholic.co.kr/news/articleView.html?idxno=186115
5292,2019-10-08,한미약품신약포지오티닙돌연변이종양억제연구결과국제학술지등재,http://www.donga.com/news/article/all/20191008/97786633/1
5293,2019-10-08,한미약품항암신약포지오티닙치료어려운HER2변이암극복가능성제시,http://www.wikileaks-kr.org/news/articleView.html?idxno=67172
5294,2019-10-08,한미약품포지오티닙치료어려운HER2변이암극복가능성제시”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1807237
5295,2019-10-08,한미약품신약포지오티닙연구결과국제학술지캔서셀에등재,http://www.cnbnews.com/news/article.html?no=423811
5296,2019-10-08,한미약품항암신약포지오타닙HER2변이종양억제효과,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910080256&t=NN
5297,2019-10-08,한미약품포지오티닙치료어려운HER2변이암극복가능성제시”,http://www.metroseoul.co.kr/news/newsview?newscd=2019100800163
5298,2019-10-08,HER2유전자변이암에효과확인한미약품포지오티닙암학술지등재,http://kpenews.com/View.aspx?No=269948
5299,2019-10-08,한미약품포지오티닙HER2유전자변이암에도효과확인,http://www.seoulwire.com/news/articleView.html?idxno=233055
5300,2019-10-09,한미약품신약포지오티닙종양억제효과뛰어나,https://www.hankyung.com/it/article/2019100935131
5301,2019-10-10,10월10일한미약품주식실시간289000원137,http://nbntv.co.kr/news/view/680114
5302,2019-10-10,인기주종목정보10일한미약품마감증시291500원,http://nbntv.co.kr/news/view/681502
5303,2019-10-10,한미약품㈜2019년하반기인재모집10월20일17시마감,http://www.ekn.kr/news/article.html?no=457396
5304,2019-10-11,한미약품기술이전물질대부분반환목표가↓하나금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1807994
5305,2019-10-11,하나금투한미약품3분기부터기술료부재목표가↓,http://yna.kr/AKR20191011028500008?did=1195m
5306,2019-10-11,하나금투한미약품3분기부터기술료부재목표가↓,http://www.seoulwire.com/news/articleView.html?idxno=233933
5307,2019-10-11,한미약품3분기부터기술료인식없어목표주가하향,https://www.sedaily.com/NewsView/1VPHAH7A7E
5308,2019-10-11,한미약품목표주가낮아져신약기술반환탓에이익감소불가피,http://www.businesspost.co.kr/BP?command=article_view&num=146542
5309,2019-10-11,한미약품3분기부터기술료인식부재목표가↓하나금투,http://www.seoulfn.com/news/articleView.html?idxno=358640
5310,2019-10-11,하나금투한미약품3분기부터기술료인식부재목표가8↓”,http://www.kukinews.com/news/article.html?no=708490
5311,2019-10-11,리포트브리핑한미약품기술료수익감소를영업부문의성장으로상쇄목표가460000원하나금융투자,http://www.newspim.com/news/view/20191011000183
5312,2019-10-11,GET투자리포트한미약품투자의견매수하나금융투자,http://www.getnews.co.kr/view.php?ud=2019101110303011833tpgetnews_16
5313,2019-10-11,한미약품기술이전물질대부분반환목표주가하향조정하나금융투자,http://www.ekn.kr/news/article.html?no=457454
5314,2019-10-11,한미약품3분기영업이익184억원전망,http://www.nspna.com/news/?mode=view&newsid=387206
5315,2019-10-11,한미약품주가오늘시세외증시동향11일오늘가격289000원형성,http://www.gokorea.kr/news/articleView.html?idxno=522952
5316,2019-10-11,한미약품오늘주식장11일현재288000원,http://nbntv.co.kr/news/view/682470
5317,2019-10-11,한미약품동아에스티기술료감소영업성장으로만회,http://medipana.com/news/news_viewer.asp?NewsNum=246745&MainKind=A&NewsKind=5&vCount=12&vKind=1
5318,2019-10-11,하나금투한미약품3Q부터기술료부재목표가하향조정,http://biz.newdaily.co.kr/site/data/html/2019/10/11/2019101100111.html
5319,2019-10-11,한미약품기술료수익감소분은영업부문성장으로상쇄”,http://www.wikitree.co.kr/main/news_view.php?id=471031
5320,2019-10-14,한미약품기술수출료없지만본업에서양호중립메리츠종금,http://www.etoday.co.kr/news/section/newsview.php?idxno=1808633
5321,2019-10-14,I리포트한미약품3분기컨센서스소폭상회전망–메리츠證,http://www.inews24.com/view/1214463
5322,2019-10-14,한미약품4분기허가관련이벤트로긍정적흐름전망메리츠종금증권,http://www.fntimes.com/html/view.php?ud=2019101408433843196c0eb6f11e_18
5323,2019-10-14,한미약품주가오를힘다져신약임상향한기대다시높아져,http://www.businesspost.co.kr/BP?command=article_view&num=146740
5324,2019-10-14,리포트브리핑한미약품기술수출료는없지만좋은흐름목표가340000원메리츠종금증권,http://www.newspim.com/news/view/20191014000285
5325,2019-10-14,GET투자리포트한미약품투자의견보유메리츠종금증권,http://www.getnews.co.kr/view.php?ud=2019101410303011900tpgetnews_16
5326,2019-10-14,한미약품주가종목그래프및종목동정과증시정보14일현재290000원,http://www.gokorea.kr/news/articleView.html?idxno=524590
5327,2019-10-14,한미약품4분기부터허가관련이벤트예상되어긍정적흐름예상”,http://www.wikitree.co.kr/main/news_view.php?id=471484
5328,2019-10-14,10월14일한미약품오늘주식122290000원,http://nbntv.co.kr/news/view/684753
5329,2019-10-14,바이오시밀러테마마감시황제넥신한미약품등이주도,http://nbntv.co.kr/news/view/686033
5330,2019-10-14,바이오시밀러테마마감시황상승률상위종목제넥신280한미약품157이수앱지스073등,http://www.gokorea.kr/news/articleView.html?idxno=525632
5331,2019-10-14,조국사퇴에한국증시안도삼성전자한미약품한국조선해양활짝,http://www.choicenews.co.kr/news/articleView.html?idxno=64887
5332,2019-10-15,한미약품RD역량향상에따른성과기대⋯목표가↑신한금융투자,http://www.dailian.co.kr/news/view/833603/?sc=naver
5333,2019-10-15,I리포트한미약품경상이익증가RD투자고려목표가↑신한금융투자,http://www.inews24.com/view/1214757
5334,2019-10-15,한미약품내수매출증가로3Q컨센서스상회예상목표가↑,http://www.asiatoday.co.kr/view.php?key=20191015010007647
5335,2019-10-15,한미약품3분기내수매출증가로호실적전망목표가↑신한금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1809241
5336,2019-10-15,한미약품3분기영업이익컨센서스상회전망,http://www.nspna.com/news/?mode=view&newsid=387681
5337,2019-10-15,한미약품3분기실적쑥쑥”신한금융투자,http://www.ajunews.com/view/20191015084925846
5338,2019-10-15,한미약품3분기실적컨센서스상회전망신한금투,http://www.newstomato.com/ReadNews.aspx?no=926134
5339,2019-10-15,한미약품3분기호실적전망신한금융투자,http://www.seoulfn.com/news/articleView.html?idxno=358967
5340,2019-10-15,한미약품34분기실적개선전망목표가↑,https://www.sedaily.com/NewsView/1VPJ609E74
5341,2019-10-15,바이오시밀러테마오전시황상승률상위종목제넥신055한올바이오파마031한미약품017등,http://www.gokorea.kr/news/articleView.html?idxno=525813
5342,2019-10-15,신한금투한미약품3분기실적시장예상치상회목표주가상향,http://www.sportsseoul.com/news/read/833319
5343,2019-10-15,한미약품차별화우수의약품으로건강한의료생태계구축”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236092
5344,2019-10-15,개원내과의사회추계학술대회서한미약품에공로상수여,http://www.fnnews.com/news/201910150956346458
5345,2019-10-15,한미약품 우수의약품으로 건강한의료생태계구축,http://www.medisobizanews.com/news/articleView.html?idxno=63137
5346,2019-10-15,리포트브리핑한미약품3분기실적도좋겠다목표가380000원신한금융투자,http://www.newspim.com/news/view/20191015000262
5347,2019-10-15,한미약품차별화된우수의약품으로건강한의료생태계구축,http://www.nextdaily.co.kr/news/article.html?id=20191015800009
5348,2019-10-15,GET투자리포트한미약품투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=2019101510303011952tpgetnews_16
5349,2019-10-15,한미약품대한개원내과의사회로부터공로상받아,https://www.sedaily.com/NewsView/1VPJ5YGC15
5350,2019-10-15,한미약품대한개원내과의사회추계학술대회서공로상,http://www.ebn.co.kr/news/view/1004815
5351,2019-10-15,한미약품개원내과의사회학술대회서공로상수상,http://medipana.com/news/news_viewer.asp?NewsNum=246898&MainKind=A&NewsKind=5&vCount=12&vKind=1
5352,2019-10-15,한미약품혁신적인의약품개발공로인정받아,http://www.kpinews.co.kr/news/articleView.html?idxno=105190
5353,2019-10-15,한미약품차별화된우수의약품으로건강한의료생태계구축,http://www.sisajournal-e.com/news/articleView.html?idxno=207505
5354,2019-10-15,한미약품대한개원내과의사회추계학술대회서공로상수상,http://www.ceoscoredaily.com/news/article.html?no=61398
5355,2019-10-15,한미약품주가정보15일현재293500원형성,http://www.gokorea.kr/news/articleView.html?idxno=526377
5356,2019-10-15,한미약품대한개원내과의사회추계학술대회서공로상수상,http://www.babytimes.co.kr/news/articleView.html?idxno=30379
5357,2019-10-15,특징주한미약품3분기실적컨센서스상회예상,http://www.sisaon.co.kr/news/articleView.html?idxno=102577
5358,2019-10-15,한미약품대한개원내과의사회추계학술대회서공로상수상,http://daily.hankooki.com/lpage/ittech/201910/dh20191015105136145630.htm
5359,2019-10-15,한미약품대한개원내과의사회로부터공로상수상,http://www.dailysmart.co.kr/news/articleView.html?idxno=16608
5360,2019-10-15,한미약품대한개원내과의사회공로상수상,http://www.newspim.com/news/view/20191015000428
5361,2019-10-15,대한개원내과의사회추계학술대회서한미약품에공로상수여,http://www.dailian.co.kr/news/view/833713/?sc=naver
5362,2019-10-15,한미약품엇갈린실적진단속장중주가강세,http://www.choicenews.co.kr/news/articleView.html?idxno=64910
5363,2019-10-15,한미약품차별화된우수의약품으로건강한의료생태계구축,http://www.pressm.kr/news/articleView.html?idxno=25469
5364,2019-10-15,대한개원내과의사회추계학술대회서한미약품에공로상수여,http://www.straightnews.co.kr/news/articleView.html?idxno=57552
5365,2019-10-15,한미약품대한개원내과의사회추계학술대회공로상수상,http://news.mt.co.kr/mtview.php?no=2019101510421371720
5366,2019-10-15,10월15일한미약품증권매매292500원052,http://nbntv.co.kr/news/view/687048
5367,2019-10-15,한미약품대한개원내과의사회서공로상수상,http://www.mediapen.com/news/view/468848
5368,2019-10-15,한미약품대한개원내과의사회추계학술대회서공로상수상,http://www.medigatenews.com/news/123048209
5369,2019-10-15,한미약품대한개원내과의사회추계학술대회서공로상수상,http://www.wolyo.co.kr/news/articleView.html?idxno=95456
5370,2019-10-15,한미약품대한개원내과의사회학술대회서공로상수여받아,http://www.econovill.com/news/articleView.html?idxno=374694
5371,2019-10-15,개원내과의사회로부터공로상받은한미약품,http://www.dailymedi.com/detail.php?number=848452&thread=22r05
5372,2019-10-15,한미약품대한개원내과의사회추계학술대회서공로상수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1342222
5373,2019-10-15,한미약품대한개원내과의사회로부터의료발전공로상수상,http://www.koreaittimes.com/news/articleView.html?idxno=93500
5374,2019-10-15,한미약품대한개원내과의사회학술대회참여,http://www.g-enews.com/ko-kr/news/article/news_all/20191015113027795569d76442fa_1/article.html
5375,2019-10-15,바이오시밀러테마오후시황상승률상위종목이수앱지스073한미약품069제넥신036등,http://www.gokorea.kr/news/articleView.html?idxno=527178
5376,2019-10-15,한미약품대한개원내과의사회추계학술대회서공로상수상,http://www.newswatch.kr/news/articleView.html?idxno=24358
5377,2019-10-15,13시27분바이오시밀러테마주오후시황이수앱지스한미약품등이상승세견인중,http://nbntv.co.kr/news/view/687735
5378,2019-10-15,한미약품국내최대규모학회대한개원내과의사회로공로상수상,http://www.techholic.co.kr/news/articleView.html?idxno=186289
5379,2019-10-15,한미약품개원내과의사회로부터공로상받아,http://www.rapportian.com/news/articleView.html?idxno=120646
5380,2019-10-15,한미약품대한개원내과의사회공로상수상,https://view.asiae.co.kr/article/2019101513442207057
5381,2019-10-15,한미약품대한개원내과의사회추계학술대회서공로상받아,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910150159&t=NN
5382,2019-10-15,한미약품대한개원내과의사회공로상수상,http://www.etnews.com/20191015000207
5383,2019-10-15,한미약품대한개원내과의사회공로상수상,http://www.viva100.com/main/view.php?key=20191015010004686
5384,2019-10-15,한미약품대한개원내과의사회공로상수상,http://www.seoulwire.com/news/articleView.html?idxno=236272
5385,2019-10-15,한미약품대한개원내과의사회추계학술대회서공로상수상,https://www.hankyung.com/it/article/201910155913i
5386,2019-10-15,한미약품대한개원내과의사회공로상수상,http://www.smedaily.co.kr/news/articleView.html?idxno=86777
5387,2019-10-15,한미약품대한개원내과의사회공로상수상,http://asiatime.co.kr/news/newsview.php?ncode=1065591434400640
5388,2019-10-15,한미약품3분기실적시장기대치넘어설것,http://www.smedaily.co.kr/news/articleView.html?idxno=86778
5389,2019-10-15,한미약품건강한의료생태계구축인정받아대한개원내과의사회로부터공로상수상,http://www.updownnews.co.kr/news/articleView.html?idxno=209727
5390,2019-10-15,한미약품글로벌혁신신약창출통한제약강국도약선도,http://www.newsprime.co.kr/news/article.html?no=479107
5391,2019-10-15,대한개원내과의사회추계학술대회서한미약품에공로상수여,http://www.joseilbo.com/news/news_read.php?uid=385633&class=27&grp=
5392,2019-10-15,뉴스투데이L한미약품대한개원내과의사회로부터공로상수상,http://www.news2day.co.kr/139120
5393,2019-10-15,한미약품개원내과의사회공로상받아,http://news.mk.co.kr/newsRead.php?year=2019&no=834184
5394,2019-10-15,한미약품우수의약품으로건강한의료생태계구축대한개원내과의사회공로상,http://www.dt.co.kr/contents.html?article_no=2019101502109931102005&ref=naver
5395,2019-10-15,대한개원내과의사회추계학술대회서한미약품에공로상수여,http://www.cnbnews.com/news/article.html?no=424398
5396,2019-10-15,대한개원내과의사회추계학술대회서한미약품에공로상수여,http://www.thefirstmedia.net/news/articleView.html?idxno=49486
5397,2019-10-16,한미약품차별화된우수의약품으로건강한의료생태계구축,http://www.nspna.com/news/?mode=view&newsid=387921
5398,2019-10-16,제약한미약품항암신약포지오티닙변이암효과제시,http://news.mk.co.kr/newsRead.php?year=2019&no=835742
5399,2019-10-16,바이오시밀러테마오전시황상승률상위종목제넥신144한올바이오파마141한미약품120등,http://www.gokorea.kr/news/articleView.html?idxno=527716
5400,2019-10-16,16일09시바이오시밀러오전테마시황제넥신한미약품등이상승세견인중,http://nbntv.co.kr/news/view/688707
5401,2019-10-16,장중수급포착한미약품외국인3일연속순매수행진주가342,http://www.newspim.com/news/view/20191016000487
5402,2019-10-16,시세포착한미약품32상승증권사목표가상향제시,http://www.itooza.com/common/iview.php?no=2019101609513811097
5403,2019-10-16,한미약품대한개원내과의사회공로상수상우종수사장차별화된의약품으로건강한의료생태계구축할것,http://www.ezyeconomy.com/news/articleView.html?idxno=94512
5404,2019-10-16,한미약품주가12894010월16일오늘가격301000원정보,http://www.gokorea.kr/news/articleView.html?idxno=528286
5405,2019-10-16,10월16일한미약품실시간증시301500원308,http://nbntv.co.kr/news/view/689398
5406,2019-10-16,바이오시밀러테마오후시황상승률상위종목팜스웰바이오275한미약품256제넥신198등,http://www.gokorea.kr/news/articleView.html?idxno=529055
5407,2019-10-16,한미약품차별화된우수의약품으로건강한의료생태계구축,http://www.shinailbo.co.kr/news/articleView.html?idxno=1213766
5408,2019-10-16,16일13시바이오시밀러테마주오후시황한미약품팜스웰바이오등이상승세주도,http://nbntv.co.kr/news/view/690059
5409,2019-10-16,한미약품건강한의료생태계구축대한개원내과의사회공로상수상,http://www.100ssd.co.kr/news/articleView.html?idxno=64694
5410,2019-10-16,바이오시밀러테마마감시황상승률상위종목한올바이오파마329제넥신306한미약품256등,http://www.gokorea.kr/news/articleView.html?idxno=529362
5411,2019-10-16,16일외국인순매수Top10삼성전자470억LG전자74억DB하이텍32억한미약품25억외국인순매수나서코스닥시장에서는케이엠더블유바이오솔루션메디톡스상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=79771
5412,2019-10-17,바이오시밀러테마오전시황상승률상위종목제넥신332한미약품200셀트리온134등,http://www.gokorea.kr/news/articleView.html?idxno=529520
5413,2019-10-17,17일09시바이오시밀러오전의테마종목한미약품제넥신등이상승세주도,http://nbntv.co.kr/news/view/691016
5414,2019-10-17,장중수급포착한미약품외국인4일연속순매수행진주가267,http://www.newspim.com/news/view/20191017000410
5415,2019-10-17,한미약품주가12894010월17일오늘거래가306000원증권그래프및종목동정과증시정보,http://www.gokorea.kr/news/articleView.html?idxno=530159
5416,2019-10-17,10월17일한미약품주식종목시세307000원233,http://nbntv.co.kr/news/view/691723
5417,2019-10-17,바이오시밀러테마오후시황상승률상위종목한미약품233팜스웰바이오174셀트리온053등,http://www.gokorea.kr/news/articleView.html?idxno=530694
5418,2019-10-17,17일13시바이오시밀러테마주오후시황팜스웰바이오한미약품등이주도,http://nbntv.co.kr/news/view/692188
5419,2019-10-17,바이오시밀러테마마감시황제넥신한미약품등이상승세견인중,http://nbntv.co.kr/news/view/692849
5420,2019-10-17,바이오시밀러테마마감시황상승률상위종목제넥신157한미약품150셀트리온053등,http://www.gokorea.kr/news/articleView.html?idxno=531266
5421,2019-10-17,환절기건강관리한미약품나인나인푹잤는데몸이무겁네피로회복종합영양제,https://www.sedaily.com/NewsView/1VPK3VWLAJ
5422,2019-10-17,17일기관순매수Top10KODEXTop5PlusTR655억한미약품79억SK텔레콤66억현대차42억기관순매수나서코스닥시장에서는바이오솔루션케이엠더블유오스템임플란트상위종,http://www.fintechpost.co.kr/news/articleView.html?idxno=80092
5423,2019-10-18,표17일기준코스피기관순매수Top30삼성전자1위약256억원휠라코리아113억원삼성전자우111억원NAVER87억원한미약품97억원주가순으로기관매수나서일간순매수상,http://www.fintechpost.co.kr/news/articleView.html?idxno=80105
5424,2019-10-18,주식주가한미약품주가18일현재301500원,http://nbntv.co.kr/news/view/693940
5425,2019-10-21,10월21일한미약품128940및증권시세084변동,http://www.gokorea.kr/news/articleView.html?idxno=534080
5426,2019-10-21,시세보기한미약품주가21일현재299500원,http://nbntv.co.kr/news/view/696254
5427,2019-10-21,바이오시밀러테마오후시황상승률상위종목한올바이오파마793한미약품051셀트리온028등,http://www.gokorea.kr/news/articleView.html?idxno=534902
5428,2019-10-21,바이오시밀러테마주마감한올바이오파마한미약품등이주도,http://nbntv.co.kr/news/view/697541
5429,2019-10-21,바이오시밀러테마마감시황상승률상위종목한올바이오파마886한미약품051셀트리온028등,http://www.gokorea.kr/news/articleView.html?idxno=535237
5430,2019-10-21,특징주종목정보10월21일한미약품298500원으로장마감,http://nbntv.co.kr/news/view/697640
5431,2019-10-22,한미약품2년연속처방실적1위예약종근당추격,http://www.dailypharm.com/Users/News/NewsView.html?ID=258033&REFERER=NP
5432,2019-10-22,한미약품파이프라인인허가모멘텀유효매수이베스트투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1812061
5433,2019-10-22,더벨한미약품을움직이는사람들종로5가임성기약국1조제약사로크다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910140100020350001275
5434,2019-10-22,HotLine한미약품기술료수익없이도외형성장지속예상,http://news.mk.co.kr/newsRead.php?year=2019&no=856412
5435,2019-10-22,바이오시밀러테마오전시황상승률상위종목팜스웰바이오105셀트리온082한미약품050등,http://www.gokorea.kr/news/articleView.html?idxno=535463
5436,2019-10-22,리포트브리핑한미약품3Q19Preview목표가400000원이베스트투자증권,http://www.newspim.com/news/view/20191022000303
5437,2019-10-22,GET투자리포트한미약품투자의견매수유지이베스트투자증권,http://www.getnews.co.kr/view.php?ud=2019102210303012189tpgetnews_16
5438,2019-10-22,한미약품주가10월22일오늘가격307000원증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=536053
5439,2019-10-22,단독한미약품당뇨신약재수출핵심임상종료,http://news.mt.co.kr/mtview.php?no=2019102117214464153
5440,2019-10-22,주식종목검색한미약품주가22일현재305500원,http://nbntv.co.kr/news/view/698547
5441,2019-10-22,한미약품전문의약품ETC부문외형개선으로성장세지속”,http://www.wikitree.co.kr/main/news_view.php?id=473947
5442,2019-10-22,특징주한미약품파이프라인인허가관련모멘텀유효목표주가40만원매수의견유지,http://www.shinailbo.co.kr/news/articleView.html?idxno=1215820
5443,2019-10-22,한미약품기술수출료매출인식끝나3분기영업이익감소불가피,http://www.businesspost.co.kr/BP?command=article_view&num=147920
5444,2019-10-23,한미약품당뇨신약임상1상종료재수출위한한단계지났다,http://www.mdtoday.co.kr/mdtoday/index.html?no=368173
5445,2019-10-23,한미약품3분기실적예상치상회투자의견상향키움,http://www.edaily.co.kr/news/newspath.asp?newsid=01413686622655872
5446,2019-10-23,더벨한미약품을움직이는사람들음악처럼하모니이룬오너2세들,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910140100022430001394
5447,2019-10-23,한미약품3Q실적컨센서스상회투자의견↑키움,http://www.edaily.co.kr/news/newspath.asp?newsid=01433366622655872
5448,2019-10-23,한미약품자체제품고른성장으로3분기호실적기대투자의견↑키움증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1812631
5449,2019-10-23,I리포트한미약품안정적실적바탕으로RD모멘텀기대키움증권,http://www.inews24.com/view/1216576
5450,2019-10-23,한미약품ETC판매로3Q시장추정치상회키움,http://news.mt.co.kr/mtview.php?no=2019102308155879463
5451,2019-10-23,한미약품투자의견상향목표가35만원제시키움證,http://www.itooza.com/common/iview.php?no=2019102307374616472
5452,2019-10-23,한미약품3분기실적시장예상치웃돌것투자의견↑”키움증권,http://www.dailian.co.kr/news/view/836162/?sc=naver
5453,2019-10-23,키움증권한미약품3분기실적개선됐을것투자의견↑,http://yna.kr/AKR20191023028400008?did=1195m
5454,2019-10-23,HotLine한미약품자체제품의고른성장이마일스톤감소상쇄,http://news.mk.co.kr/newsRead.php?year=2019&no=861342
5455,2019-10-23,한미약품34분기영업이익컨센서스상회할것투자의견상향,https://www.sedaily.com/NewsView/1VPMTPYD48
5456,2019-10-23,한미약품주식시장수익률상회로상향모든악재주가에이미반영,http://www.businesspost.co.kr/BP?command=article_view&num=148011
5457,2019-10-23,한미약품3분기실적예상치상회투자의견상향키움,http://www.ebn.co.kr/news/view/1005920/?sc=naver
5458,2019-10-23,하이로우한미약품자체제품고른성장마일스톤상쇄키움증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019102308532162358
5459,2019-10-23,한미약품3분기호실적기대키움증권,http://www.ajunews.com/view/20191023090500273
5460,2019-10-23,한미약품자체제품고른성장향후호실적이어나갈전망”키움증권,http://www.fntimes.com/html/view.php?ud=2019102308583891086c0eb6f11e_18
5461,2019-10-23,특징주한미약품3Q실적기대감에강세,http://news.mt.co.kr/mtview.php?no=2019102309185397929
5462,2019-10-23,시세포착한미약품31상승증권사35만원제시,http://www.itooza.com/common/iview.php?no=2019102309132117063
5463,2019-10-23,한미약품장시작후꾸준히올라528이시각3만2726주거래,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910230141&t=NN
5464,2019-10-23,특징주한미약품3분기호실적전망에강세,http://www.inews24.com/view/1216637
5465,2019-10-23,한미약품5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/201910234126L
5466,2019-10-23,특징주한미약품3분기실적기대감에강세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910230149&t=NN
5467,2019-10-23,23일09시바이오시밀러테마주시황오전한미약품제넥신등이상승세견인중,http://nbntv.co.kr/news/view/700086
5468,2019-10-23,특징주한미약품3Q실적호조전망속강세,http://moneys.mt.co.kr/news/mwView.php?no=2019102309328077885
5469,2019-10-23,특징주한미약품3Q호실적전망에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02030326622655872
5470,2019-10-23,특징주한미약품3분기호실적전망강세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1812757
5471,2019-10-23,특징주한미약품3분기호실적전망에강세,http://www.seoulfn.com/news/articleView.html?idxno=359968
5472,2019-10-23,특징주한미약품3Q실적호조전망에상승세,http://inthenews.co.kr/article-21100/
5473,2019-10-23,한미약품2021년롤론티스오락솔힘입어로열티유입기대된다”,http://www.wikitree.co.kr/main/news_view.php?id=474178
5474,2019-10-23,특징주한미약품3Q실적기대감에강세,http://www.ebn.co.kr/news/view/1005959/?sc=naver
5475,2019-10-23,특징주한미약품3분기실적호조전망에강세,http://www.ajunews.com/view/20191023100001374
5476,2019-10-23,리포트브리핑한미약품마일스톤감소를상쇄한자체제품고른성장목표가350000원키움증권,http://www.newspim.com/news/view/20191023000322
5477,2019-10-23,GET투자리포트한미약품투자의견OutperformUpgrade키움증권,http://www.getnews.co.kr/view.php?ud=2019102310303012232tpgetnews_16
5478,2019-10-23,장중수급포착한미약품기관3일연속순매수행진주가446,http://www.newspim.com/news/view/20191023000401
5479,2019-10-23,한미약품마일스톤감소상쇄한자체제품성장,http://www.newsprime.co.kr/news/article.html?no=480132
5480,2019-10-23,특징주한미약품3Q실적기대감에상승세,http://www.rpm9.com/news/article.html?id=20191023090014
5481,2019-10-23,한미약품3분기실적호조기대감에주가상승세,http://www.whitepaper.co.kr/news/articleView.html?idxno=177697
5482,2019-10-23,10월23일한미약품종목그래프462변동해,http://www.gokorea.kr/news/articleView.html?idxno=537913
5483,2019-10-23,한미약품3분기실적호전장중주가껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=65137
5484,2019-10-23,한미약품시세보기23일현재320000원,http://nbntv.co.kr/news/view/700787
5485,2019-10-23,한미약품기술수출료등유입없어도성장기대,http://medipana.com/news/news_viewer.asp?NewsNum=247427&MainKind=A&NewsKind=5&vCount=12&vKind=1
5486,2019-10-23,키움證한미약품3Q실적예상치상회전망4Q실적도긍정적,http://www.viva100.com/main/view.php?key=20191023010007251
5487,2019-10-23,한미약품3분기실적호조전망에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=368222
5488,2019-10-23,바이오시밀러테마오후시황상승률상위종목한미약품495셀트리온470제넥신309등,http://www.gokorea.kr/news/articleView.html?idxno=538593
5489,2019-10-23,23일13시바이오시밀러테마주오후시황한미약품셀트리온등이주도,http://nbntv.co.kr/news/view/701269
5490,2019-10-23,특징주한미약품34분기호실적전망에강세,https://www.sedaily.com/NewsView/1VPMUQO3R3
5491,2019-10-23,바이오시밀러테마주시황마감한미약품제넥신등이주도,http://nbntv.co.kr/news/view/701978
5492,2019-10-23,바이오시밀러테마마감시황상승률상위종목한미약품677제넥신544팜스웰바이오479등,http://www.gokorea.kr/news/articleView.html?idxno=538973
5493,2019-10-23,한미약품34분기호실적전망에23일주가강세나타내,http://www.betanews.net:8080/article/1057549.html
5494,2019-10-24,청년의사주최한미약품후원한미수필문학상공모,http://kor.theasian.asia/archives/243348
5495,2019-10-24, 표23일기준코스피기관순매수Top30셀트리온1위약336억원카카오317억원삼성바이오로직스242억원삼성물산122억원한미약품113억원주가순으로기관매수나서,http://www.fintechpost.co.kr/news/articleView.html?idxno=81967
5496,2019-10-24,표23일기준코스피외국인순매수Top30삼성전자1위약636억원삼성바이오로직스516억원카카오427억원셀트리온385억원한미약품149억원주가순으로외국인매수나서일간순,http://www.fintechpost.co.kr/news/articleView.html?idxno=81969
5497,2019-10-24,더벨한미약품을움직이는사람들이관순부회장최연소연구소장지낸35년한미맨,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910160100027240001703
5498,2019-10-24,빅데이터MSI시장심리톱5한미약품삼성카드동원시스템즈ST중공업대우건설,http://www.newsis.com/view/?id=NISX20191024_0000808417&cID=10401&pID=10400
5499,2019-10-24,바이오시밀러테마오전시황상승률상위종목이수앱지스099제넥신017한미약품031등,http://www.gokorea.kr/news/articleView.html?idxno=539163
5500,2019-10-24,24일09시바이오시밀러테마주시황오전이수앱지스한미약품등이상승세주도,http://nbntv.co.kr/news/view/702325
5501,2019-10-24,특징주한미약품투자의견BUY목표주가42만원,http://www.sisaon.co.kr/news/articleView.html?idxno=103058
5502,2019-10-24,한미약품주가10월24일현재319500원정보및주체별매매동향,http://www.gokorea.kr/news/articleView.html?idxno=539745
5503,2019-10-24,GET투자리포트한미약품투자의견매수유지KB증권,http://www.getnews.co.kr/view.php?ud=2019102310303012325tpgetnews_16
5504,2019-10-24,라니티딘퇴출한미약품대체제시장선점,http://www.ekoreanews.co.kr/news/articleView.html?idxno=40552
5505,2019-10-24,바이오시밀러테마오후시황상승률상위종목한미약품062팜스웰바이오180셀트리온229등,http://www.gokorea.kr/news/articleView.html?idxno=540176
5506,2019-10-24,24일13시바이오시밀러오후테마시황한미약품팜스웰바이오등이주도,http://nbntv.co.kr/news/view/703288
5507,2019-10-24,바이오시밀러테마주시황마감셀트리온한미약품등이주도,http://nbntv.co.kr/news/view/703926
5508,2019-10-24,탐나는키워드이재우의오늘장관심주한미약품128940,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019102415312130780
5509,2019-10-24,바이오시밀러테마마감시황상승률상위종목셀트리온025한미약품015제넥신189등,http://www.gokorea.kr/news/articleView.html?idxno=540832
5510,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.businesskorea.co.kr/news/articleView.html?idxno=37360
5511,2019-10-25,한미약품美스펙트럼호중구감소증치료제롤론티스허가재신청,http://biz.newdaily.co.kr/site/data/html/2019/10/25/2019102500002.html
5512,2019-10-25,한미약품롤론티스미FDA에시판허가재신청,https://www.hankyung.com/finance/article/2019102599066
5513,2019-10-25,공시한미약품호중구감소증치료신약허가재신청,http://www.newsway.co.kr/news/view?tp=1&ud=2019102507585532330
5514,2019-10-25,한미약품美파트너사스펙트럼FDA에롤론티스시판허가재신청,http://news.mk.co.kr/newsRead.php?year=2019&no=871021
5515,2019-10-25,한미약품롤론티스美FDA에시판허가재신청,http://www.ebn.co.kr/news/view/1006290/?sc=naver
5516,2019-10-25,한미약품파트너사신약롤론티스美FDA허가재신청,http://yna.kr/AKR20191025024000008?did=1195m
5517,2019-10-25,한미약품파트너사가美FDA에롤론티스허가재신청,http://www.edaily.co.kr/news/newspath.asp?newsid=01531766622656528
5518,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.econovill.com/news/articleView.html?idxno=375640
5519,2019-10-25,더벨한미약품을움직이는사람들구구팔팔신화만든개량신약전문가우종수사장,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910200100033990002117
5520,2019-10-25,한미약품바이오신약롤론티스美FDA에시판허가재신청,https://view.asiae.co.kr/article/2019102508242686768
5521,2019-10-25,한미약품바이오신약롤론티스FDA시판허가절차재개,http://news.heraldcorp.com/view.php?ud=20191025000028
5522,2019-10-25,공시한미약품스펙트럼롤론티스허가재신청,http://www.newsis.com/view/?id=NISX20191025_0000809632&cID=10401&pID=10400
5523,2019-10-25,한미약품파트너사신약롤론티스미국FDA허가재신청,http://www.newspim.com/news/view/20191025000088
5524,2019-10-25,한미약품롤론티스美FDA에시판허가재신청,http://news.mt.co.kr/mtview.php?no=2019102508203053199
5525,2019-10-25,한미약품파트너사스펙트럼롤론티스美FDA에시판허가재신청,http://www.medisobizanews.com/news/articleView.html?idxno=63444
5526,2019-10-25,한미약품파트너사美FDA에신약롤론티스허가재신청,http://www.etoday.co.kr/news/section/newsview.php?idxno=1813842
5527,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://news.bizwatch.co.kr/article/consumer/2019/10/25/0001/naver
5528,2019-10-25,한미약품파트너사美FDA에신약롤론티스허가재신청,http://www.seoulwire.com/news/articleView.html?idxno=242083
5529,2019-10-25,한미약품미국FDA에롤론티스시판허가재신청,http://www.newsis.com/view/?id=NISX20191025_0000809644&cID=13001&pID=13000
5530,2019-10-25,한미약품롤론티스美FDA에시판허가재신청”,http://www.ajunews.com/view/20191025083629026
5531,2019-10-25,한미약품바이오신약롤론티스美FDA시판허가재신청,http://www.dailysmart.co.kr/news/articleView.html?idxno=17138
5532,2019-10-25,한미약품롤론티스美FDA에시판허가재신청추가자료보완”,https://www.sedaily.com/NewsView/1VPNQUNCML
5533,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.mdtoday.co.kr/mdtoday/index.html?no=368427
5534,2019-10-25,한미약품롤론티스FDA에시판허가재신청,http://medipana.com/news/news_viewer.asp?NewsNum=247528&MainKind=A&NewsKind=5&vCount=12&vKind=1
5535,2019-10-25,한미약품롤론티스美FDA시판허가재신청”,http://www.viva100.com/main/view.php?key=20191025010008147
5536,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.fnnews.com/news/201910250856114094
5537,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.bosa.co.kr/news/articleView.html?idxno=2114729
5538,2019-10-25,한미약품미FDA에바이오신약롤론티스재신청,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910250030&t=NN
5539,2019-10-25,한미약품바이오신약롤론티스美FDA시판허가재신청,http://www.newspim.com/news/view/20191025000103
5540,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청”,http://www.dailian.co.kr/news/view/836922/?sc=naver
5541,2019-10-25,한미약품기술수출신약롤론티스미국허가재신청종합,http://yna.kr/AKR20191025024051008?did=1195m
5542,2019-10-25,특징주한미약품롤론티스허가재신청에강세,http://www.dailian.co.kr/news/view/836928/?sc=naver
5543,2019-10-25,한미약품롤론티스미FDA시판허가절차다시시작,http://www.shinailbo.co.kr/news/articleView.html?idxno=1217084
5544,2019-10-25,특징주한미약품신약美시판허가재신청에강세,http://yna.kr/AKR20191025036500008?did=1195m
5545,2019-10-25,한미약품장시작후꾸준히올라586이시각3만2777주거래,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910250073&t=NN
5546,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청”,http://www.fetv.co.kr/news/article.html?no=38917
5547,2019-10-25,특징주한미약품美FDA에롤론티스BLA재신청소식에강세,http://news.mk.co.kr/newsRead.php?year=2019&no=871267
5548,2019-10-25,한미약품바이오신약롤론티스FDA허가재도전,http://www.edaily.co.kr/news/newspath.asp?newsid=01840086622656528
5549,2019-10-25,한미약품롤론티스미FDA시판허가재신청,https://www.nocutnews.co.kr/news/5233151
5550,2019-10-25,한미약품바이오신약롤론티스FDA허가재도전,http://www.edaily.co.kr/news/newspath.asp?newsid=01840086622656528
5551,2019-10-25,특징주한미약품롤론티스허가재신청에강세,http://news.mt.co.kr/mtview.php?no=2019102509134391177
5552,2019-10-25,한미약품5이상상승마일스톤감소를상쇄한자체제품고른성장키움증권OutperformUpgrade,https://www.hankyung.com/finance/article/201910250204L
5553,2019-10-25,특징주한미약품롤론티스FDA시판허가재신청에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01853206622656528
5554,2019-10-25,한미약품파트너사신약美FDA허가재신청에강세,https://biz.chosun.com/site/data/html_dir/2019/10/25/2019102500657.html
5555,2019-10-25,특징주한미약품롤론티스FDA허가재신청5강세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1813894
5556,2019-10-25,한미약품항암신약롤론티스미국허가재신청,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019102509171297013
5557,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236537
5558,2019-10-25,특징주한미약품신약美시판허가재신청강세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910250084&t=NN
5559,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청”,http://daily.hankooki.com/lpage/ittech/201910/dh20191025091934145630.htm
5560,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청”,http://daily.hankooki.com/lpage/ittech/201910/dh20191025091934145630.htm
5561,2019-10-25,특징주한미약품롤론티스美FDA시판허가재신청에강세,http://www.seoulwire.com/news/articleView.html?idxno=242102
5562,2019-10-25,특징주한미약품미FDA에신약시판허가재신청강세,http://www.inews24.com/view/1217226
5563,2019-10-25,한미약품FDA에바이오신약롤론티스시판허가재신청,http://moneys.mt.co.kr/news/mwView.php?no=2019102508598037761
5564,2019-10-25,한미약품롤론티스美FDA에시판허가재신청,http://kormedi.com/?p=1304332
5565,2019-10-25,한미약품롤론티스FDA에시판허가재신청,https://www.paxnetnews.com/articles/53244
5566,2019-10-25,특징주한미약품파트너사가신약관련서류FDA제출로강세,http://www.youthdaily.co.kr/news/article.html?no=20938
5567,2019-10-25,한미약품美FDA에롤론티스시판허가재신청”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1813864
5568,2019-10-25,한미약품美FDA에롤론티스시판허가재신청,http://www.sisafocus.co.kr/news/articleView.html?idxno=224198
5569,2019-10-25,25일09시바이오시밀러오전의테마종목한미약품셀트리온등이상승세주도,http://nbntv.co.kr/news/view/704557
5570,2019-10-25,한미약품롤론티스FDA허가재신청소식에강세,http://www.ebn.co.kr/news/view/1006339/?sc=naver
5571,2019-10-25,특징주한미약품신약론톤티스FDA허가재신청에급등,http://www.viva100.com/main/view.php?key=20191025010008163
5572,2019-10-25,특징주한미약품롤론티스미FDA허가재신청에강세,http://www.newsway.co.kr/news/view?tp=1&ud=2019102509384237166
5573,2019-10-25,한미약품롤론티스미국FDA시판허가재신청,http://www.dailymedi.com/detail.php?number=848841&thread=22r05
5574,2019-10-25,머니e종목한미약품롤론티스FDA허가재신청에강세,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019102509361029673
5575,2019-10-25,한미약품롤론티스美FDA에시판허가재신청소식에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=368435
5576,2019-10-25,한미약품롤론티스신약미국FDA에시판허가재신청”,http://www.getnews.co.kr/view.php?ud=20191025094238287841d0c69529_16
5577,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57843
5578,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.straightnews.co.kr/news/articleView.html?idxno=58482
5579,2019-10-25,특징주한미약품라이선스아웃신약FDA허가재신청에강세,https://www.sedaily.com/NewsView/1VPNQ7UD3F
5580,2019-10-25,한미약품항암신약롤론티스미국허가재신청,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003758411
5581,2019-10-25,한미약품기술수출신약롤론티스미국허가재신청,http://www.asiatoday.co.kr/view.php?key=20191025010014446
5582,2019-10-25,한미약품기술수출롤론티스FDA시판허가재신청,http://www.biospectator.com/view/news_view.php?varAtcId=8743
5583,2019-10-25,제약업종오전시황상승률상위종목녹십자홀딩스2우2975내츄럴엔도텍2293한미약품355등,http://www.gokorea.kr/news/articleView.html?idxno=541345
5584,2019-10-25,한미약품롤론티스FDA에시판허가재신청추가자료보완,http://kpenews.com/View.aspx?No=300887
5585,2019-10-25,한미약품기술수출롤론티스미국허가재도전”,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000051724
5586,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청”,http://www.newsway.co.kr/news/view?tp=1&ud=2019102510233290898
5587,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청”,http://www.ceoscoredaily.com/news/article.html?no=61778
5588,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.pressm.kr/news/articleView.html?idxno=25651
5589,2019-10-25,한미약품롤론티스美FDA에시판허가재신청돌입”,http://inthenews.co.kr/article-21525/
5590,2019-10-25,10월25일한미약품및증권시세386변화해,http://www.gokorea.kr/news/articleView.html?idxno=541576
5591,2019-10-25,한미약품美FDA에롤론티스시판허가재신청,http://asiatime.co.kr/news/newsview.php?ncode=1065576143165160
5592,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.joseilbo.com/news/news_read.php?uid=386207&class=27&grp=
5593,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청”,https://www.hankyung.com/it/article/201910250612i
5594,2019-10-25,한미약품호중구감소증치료제롤론티스美FDA시판허가재신청,http://www.ezyeconomy.com/news/articleView.html?idxno=94810
5595,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청”,http://www.bokuennews.com/news/article.html?no=182426
5596,2019-10-25,한미약품바이오신약롤론티스미국FDA에시판허가재신청,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=534495
5597,2019-10-25,한미약품롤론티스미국FDA시판허가재도전,http://www.doctorsnews.co.kr/news/articleView.html?idxno=131566
5598,2019-10-25,한미약품FDA에롤론티스시판허가재신청 ,http://www.monews.co.kr/news/articleView.html?idxno=206004
5599,2019-10-25,특징주한미약품롤론티스美시판절차재개소식에상승,http://news1.kr/articles/?3752555
5600,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.medigatenews.com/news/2202644725
5601,2019-10-25,오늘주식시세한미약품주가25일현재338500원,http://nbntv.co.kr/news/view/705195
5602,2019-10-25,한미약품신약FDA허가재신청장중주가껑충,http://www.choicenews.co.kr/news/articleView.html?idxno=65209
5603,2019-10-25,한미약품美FDA에바이오신약롤론티스시판허가재신청,http://www.opinionnews.co.kr/news/articleView.html?idxno=24893
5604,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.sisajournal-e.com/news/articleView.html?idxno=208007
5605,2019-10-25,한미약품호중구감소증신약의미국시판허가재신청,http://www.businesspost.co.kr/BP?command=article_view&num=148384
5606,2019-10-25,한미약품바이오신약롤론티스美FDA시판허가재신청,http://www.babytimes.co.kr/news/articleView.html?idxno=30614
5607,2019-10-25,한미약품개발호중구감소증신약롤론티스미국허가재신청,http://www.sportsseoul.com/news/read/838881
5608,2019-10-25,한미약품스펙트럼롤론티스안정성약효입증”FDA시판허가재신청,http://4th.kr/View.aspx?No=301172
5609,2019-10-25,바이오시밀러테마오후시황상승률상위종목한미약품417한올바이오파마015셀트리온보합세등,http://www.gokorea.kr/news/articleView.html?idxno=542436
5610,2019-10-25,한미약품바이오신약FDA시판허가재신청,http://health.chosun.com/site/data/html_dir/2019/10/25/2019102501309.html
5611,2019-10-25,한미약품바이오신약롤론티스미FDA에시판허가재신청,http://www.newslock.co.kr/news/articleView.html?idxno=22642
5612,2019-10-25,13시28분바이오시밀러테마주시황오후한미약품셀트리온등이주도,http://nbntv.co.kr/news/view/705906
5613,2019-10-25,로스탁한미약품바이오신약롤론티스미국FDA에시판허가재신청,http://www.lawissue.co.kr/view.php?ud=201910251335413854f4ab64559d_12
5614,2019-10-25,한미약품바이오신약롤론티스FDA시판허가절차재개,http://www.updownnews.co.kr/news/articleView.html?idxno=210228
5615,2019-10-25,한미약품롤론티스시판허가절차재개주가강세,http://moneys.mt.co.kr/news/mwView.php?no=2019102513448083501
5616,2019-10-25,한미약품롤론티스美FDA시판허가재신청,http://www.kpinews.co.kr/news/articleView.html?idxno=105915
5617,2019-10-25,한미약품롤론티스미국FDA재신청,http://www.m-i.kr/news/articleView.html?idxno=649090
5618,2019-10-25,한미약품바이오신약롤론티스FDA재신청,http://www.smedaily.co.kr/news/articleView.html?idxno=87056
5619,2019-10-25,한미약품호중구감소증신약美FDA허가재도전,http://news.mk.co.kr/newsRead.php?year=2019&no=873253
5620,2019-10-25,한미약품바이오신약롤론티스美FDA시판허가재도전,http://www.thevaluenews.co.kr/news/view.php?idx=157186
5621,2019-10-25,바이오시밀러테마주시황마감한미약품한올바이오파마등이주도,http://nbntv.co.kr/news/view/706516
5622,2019-10-25,한미약품롤론티스美허가재신청RD신뢰회복기회되나,http://biz.newdaily.co.kr/site/data/html/2019/10/25/2019102500138.html
5623,2019-10-25,한미약품롤린티스미국FDA에시판허가재신청,http://www.newsprime.co.kr/news/article.html?no=480550
5624,2019-10-25,바이오시밀러테마마감시황상승률상위종목한미약품401한올바이오파마보합세셀트리온보합세등,http://www.gokorea.kr/news/articleView.html?idxno=542744
5625,2019-10-25,한미약품바이오신약롤론티스미국에허가재신청,https://cnbc.sbs.co.kr/article_hub/10000959867?division=NAVER
5626,2019-10-25,코스피차별화장세SK하이닉스한미약품급등,http://www.choicenews.co.kr/news/articleView.html?idxno=65220
5627,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청”,http://fn.segye.com/content/html/2019/10/25/20191025510706.html?OutUrl=naver
5628,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.cnbnews.com/news/article.html?no=425553
5629,2019-10-25,한미약품바이오신약롤론티스美FDA시판허가신청잰걸음,http://www.100ssd.co.kr/news/articleView.html?idxno=64963
5630,2019-10-25,한미약품FDA에롤론티스판매허가재신청,http://www.finomy.com/news/articleView.html?idxno=70908
5631,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.nextdaily.co.kr/news/article.html?id=20191025800046
5632,2019-10-25,한미약품롤론티스美FDA에시판허가재신청,http://www.wikileaks-kr.org/news/articleView.html?idxno=68510
5633,2019-10-25,한미약품롤론티스美시판허가재신청,http://www.fnnews.com/news/201910251727165235
5634,2019-10-25,한미약품바이오신약롤론티스FDA허가재신청,https://www.hankyung.com/it/article/2019102520321
5635,2019-10-25,한미약품롤론티스미FDA시판허가재신청,http://www.news2day.co.kr/140181
5636,2019-10-25,오늘공시요약한미약품파트너사신약롤론티스美FDA허가재신청外,http://www.youthdaily.co.kr/news/article.html?no=21018
5637,2019-10-25,美스펙트럼한미약품롤론티스FDA에품목허가재신청,http://news1.kr/articles/?3753093
5638,2019-10-25,한미약품롤론티스미국FDA에시판허가재신청,http://www.newscj.com/news/articleView.html?idxno=677939
5639,2019-10-25,유가증권기업공시25일한미약품등,https://www.hankyung.com/finance/article/2019102525741
5640,2019-10-26,한미약품파트너사스펙트럼롤론티스허가재신청,http://www.econonews.co.kr/news/articleView.html?idxno=92185
5641,2019-10-27,한미약품롤론티스美FDA시판허가재도전,http://www.skyedaily.com/news/news_view.html?ID=92636
5642,2019-10-27,한미약품롤론티스미국FDA에시판허가재신청,http://www.nspna.com/news/?mode=view&newsid=390020
5643,2019-10-28,코스피코스닥25일주요공시한미약품파트너사신약롤론티스美FDA허가재신청”등,http://www.betanews.net:8080/article/1057930.html
5644,2019-10-28,전일주요공시한미약품현대글로비스두산건설등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1814241
5645,2019-10-28,더벨한미약품을움직이는사람들권세창사장5조기술수출랩스커버리개발주역,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910220100039020002433
5646,2019-10-28,한미약품롤론티스시판허가재신청매수한화투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1814527
5647,2019-10-28,Stock한미약품롤론티스시판허가재신청부각,http://moneys.mt.co.kr/news/mwView.php?no=2019102808568031677
5648,2019-10-28,한미약품롤론티스미국FDA에시판허가재신청,http://www.ekn.kr/news/article.html?no=460094
5649,2019-10-28,한미약품심장∙순환기내과전문의들아모잘탄패밀리∙로수젯효과주목,http://www.pressm.kr/news/articleView.html?idxno=25690
5650,2019-10-28,한미약품대한심장학회추계학술대회서산학세션열어,http://www.businesskorea.co.kr/news/articleView.html?idxno=37428
5651,2019-10-28,한미약품대한심장학회추계학술대회서산학세션아모잘탄등유용성소개,https://www.sedaily.com/NewsView/1VPP4YKQQH
5652,2019-10-28,한미약품고혈압신약아모잘탄로수젯효과탁월,http://www.medisobizanews.com/news/articleView.html?idxno=63486
5653,2019-10-28,한미약품아모잘탄패밀리∙로수젯효과주목,http://www.ebn.co.kr/news/view/1006614/?sc=naver
5654,2019-10-28,한미약품대한심장학회추계학술대회서산학세션개최전문의들아모잘탄패밀리로수젯효과주목,http://www.ekn.kr/news/article.html?no=460514
5655,2019-10-28,심장순환기내과전문의한미약품아모잘탄패밀리로수젯효과주목,http://www.econovill.com/news/articleView.html?idxno=375833
5656,2019-10-28,한미약품고혈압복합신약아모잘탄혈압조절효과입증,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910280218&t=NN
5657,2019-10-28,뉴스투데이L한미약품의아모잘탄로수젯효과전문의들사이주목,http://www.news2day.co.kr/140253
5658,2019-10-28,한미약품대한심장학회추계학술대회서복합신약아모잘탄로수젯임상효과발표,http://www.ezyeconomy.com/news/articleView.html?idxno=94849
5659,2019-10-28,한미약품심장학회학술대회서산학세션열어아모잘탄로수젯유용성논의,http://news.mk.co.kr/newsRead.php?year=2019&no=880109
5660,2019-10-28,한미약품아모잘탄패밀리로수젯효과주목,http://www.newsprime.co.kr/news/article.html?no=480710
5661,2019-10-28,한미약품대한심장학회추계학술대회서산학세션열어,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57867
5662,2019-10-28,10월28일한미약품오늘주식시세119333000원,http://nbntv.co.kr/news/view/707633
5663,2019-10-28,한미약품제63차추계학술대회산학세션마련전문의들아모잘탄∙로수젯효과주목,http://www.newslock.co.kr/news/articleView.html?idxno=22692
5664,2019-10-28,한미약품심장내과전문의들아모잘탄패밀리로수젯효과주목”,http://www.metroseoul.co.kr/news/newsview?newscd=2019102800068
5665,2019-10-28,한미약품심장학회서고혈압고지혈제유효성의료진과공유,http://news.heraldcorp.com/view.php?ud=20191028000575
5666,2019-10-28,한미약품비알콜성지방간염치료제임상1상에따라기술수출가능,http://www.businesspost.co.kr/BP?command=article_view&num=148651
5667,2019-10-28,고혈압고지혈증지견공유한미약품대한심장학회추계학술대회개최,http://kpenews.com/View.aspx?No=302734
5668,2019-10-28,한미약품대한심장학회학술대회서아모잘탄로수젯임상적유용성논의,http://www.mdtoday.co.kr/mdtoday/index.html?no=368579
5669,2019-10-28,한미약품고혈압복합신약아모잘탄로수젯우수성발표,http://4th.kr/View.aspx?No=302728
5670,2019-10-28,한미약품대한심장학회추계학술대회서심장순환기내과전문의들아모잘탄패밀리로수젯효과주목,http://www.techholic.co.kr/news/articleView.html?idxno=186675
5671,2019-10-28,한미약품고혈압복합신약아모잘탄로수젯우수성발표,http://www.seoulwire.com/news/articleView.html?idxno=243761
5672,2019-10-28,한미약품아모잘탄패밀리로수젯산학세션열어,http://www.cnbnews.com/news/article.html?no=425699
5673,2019-10-28,리포트브리핑한미약품롤론티스BLA재신청목표가570000원한화투자증권,http://www.newspim.com/news/view/20191028001101
5674,2019-10-28,GET투자리포트한미약품투자의견매수한화투자증권,http://www.getnews.co.kr/view.php?ud=2019102810303012670tpgetnews_16
5675,2019-10-28,로스탁한미약품대한심장학회추계학술대회서산학세션개최아모잘탄패밀리∙로수젯효과주목,http://www.lawissue.co.kr/view.php?ud=201910281740108130f4ab64559d_12
5676,2019-10-28,한미약품아모잘탄로수젯우수한효과전문의들사이주목,http://www.dailypop.kr/news/articleView.html?idxno=41762
5677,2019-10-29,한미약품대한심장학회추계학술대회서산학세션열어아모잘탄패밀리∙로수젯효과주목,http://www.thefirstmedia.net/news/articleView.html?idxno=49985
5678,2019-10-29,한미약품학술대회서고혈압복합신약우수성발표,http://www.youthdaily.co.kr/news/article.html?no=21183
5679,2019-10-29,한미약품심장학회서아모잘탄로수젯홍보,http://www.monews.co.kr/news/articleView.html?idxno=206053
5680,2019-10-29,한미약품아모잘탄로수젯심장순환기내과전문의들호평이어져,http://www.joseilbo.com/news/news_read.php?uid=386360&class=27&grp=
5681,2019-10-29,한미약품주가12894010월29일현재337000원정보,http://www.gokorea.kr/news/articleView.html?idxno=545450
5682,2019-10-29,한미약품실시간주식현황29일현재336000원,http://nbntv.co.kr/news/view/709885
5683,2019-10-29,권세창한미약품사장신약개발성공실패에일희일비하지말아야”,http://www.ajunews.com/view/20191029114101356
5684,2019-10-29,한미약품실적발표영업이익249억원전분기대비79증가연결잠정,http://www.newspim.com/news/view/20191029000830
5685,2019-10-29,실적속보잠정한미약품연결20193Q영업이익24941억원,http://www.fntimes.com/html/view.php?ud=2019102914400966235dfa89111d_18
5686,2019-10-29,코스피한미약품2019년3분기누적매출액8107억원영업이익740억원연결기준,http://news.kmib.co.kr/article/view.asp?arcid=0013871292&code=61141211&cp=nv
5687,2019-10-29,컨센초과한미약품올해3Q연결영업익249억컨센비258↑,http://www.itooza.com/common/iview.php?no=2019102914402110813
5688,2019-10-29,잠정실적한미약품올해3Q매출액2657억13영업이익249억16연결,https://www.hankyung.com/finance/article/201910298945L
5689,2019-10-29,한미약품3Q영업익249억원전년比16증가1보,http://news1.kr/articles/?3755451
5690,2019-10-29,한미약품3Q영업이익249억전년比16↑,http://news.mt.co.kr/mtview.php?no=2019102914481024845
5691,2019-10-29,한미약품3Q영업익249억전년比16↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03043846622657840
5692,2019-10-29,한미약품3분기영업익249억원전년비16↑,http://www.seoulwire.com/news/articleView.html?idxno=244556
5693,2019-10-29,한미약품3Q누적8107억올매출1조클럽가입확실,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236703
5694,2019-10-29,한미약품3분기영업이익249억시장예상치보다34많아,https://www.hankyung.com/finance/article/2019102989826
5695,2019-10-29,한미약품3분기매출영업이익전년比160신장,http://www.sisaon.co.kr/news/articleView.html?idxno=103337
5696,2019-10-29,한미약품3분기매출2657억원기록전년대비129성장,http://www.econovill.com/news/articleView.html?idxno=375993
5697,2019-10-29,한미약품3분기영업익249억원전년비16증가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1815406
5698,2019-10-29,한미약품3분기매출2657억원13늘어,http://medipana.com/news/news_viewer.asp?NewsNum=247724&MainKind=A&NewsKind=5&vCount=12&vKind=1
5699,2019-10-29,한미약품로수젯아모잘탄쌍끌이호조3분기매출영업이익↑,http://www.medisobizanews.com/news/articleView.html?idxno=63545
5700,2019-10-29,한미약품3분기매출영업익대폭성장,http://www.newsway.co.kr/news/view?tp=1&ud=2019102914460983420
5701,2019-10-29,한미약품3Q영업익249억자체개발제품성장덕분,https://view.asiae.co.kr/article/2019102915070290529
5702,2019-10-29,한미약품3분기2657억매출전년동기보다129늘어,http://sports.chosun.com/news/ntype.htm?id=201910300100240520017005&servicedate=20191029
5703,2019-10-29,한미약품3분기실적호조자체개발신약효과,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910290255&t=NN
5704,2019-10-29,한미약품3Q영업익249억전년比16↑,http://www.seoulfn.com/news/articleView.html?idxno=360681
5705,2019-10-29,한미약품3분기연결기준영업익249억160↑,https://view.asiae.co.kr/article/2019102915105007612
5706,2019-10-29,한미약품3분기매출13영업익16성장,http://news.heraldcorp.com/view.php?ud=20191029000678
5707,2019-10-29,한미약품3분기영업이익249억원전년比16성장,https://biz.chosun.com/site/data/html_dir/2019/10/29/2019102901612.html
5708,2019-10-29,한미약품3분기영업익249억원전년比16증가,http://www.ajunews.com/view/20191029150448561
5709,2019-10-29,공시한미약품3분기영업익249억원전년比160↑,http://www.newsway.co.kr/news/view?tp=1&ud=2019102915103093868
5710,2019-10-29,한미약품3분기영업익249억원작년동기대비16증가,https://www.sedaily.com/NewsView/1VPPMHJY85
5711,2019-10-29,한미약품3Q영업익16↑자체개발제품선전,http://www.dailypharm.com/Users/News/NewsView.html?ID=258340&REFERER=NP
5712,2019-10-29,한미약품3분기영업이익249억원16증가종합,http://yna.kr/AKR20191029119751008?did=1195m
5713,2019-10-29,한미약품영업이익249억원전년동기比6↑,http://www.sisafocus.co.kr/news/articleView.html?idxno=224511
5714,2019-10-29,한미약품3분기영업이익249억원전년동기대비16↑,http://news.mk.co.kr/newsRead.php?year=2019&no=885329
5715,2019-10-29,한미약품3분기까지누적매출8107억올해1조달성무난,http://www.rapportian.com/news/articleView.html?idxno=121004
5716,2019-10-29,한미약품3분기영업익전년比16성장자체개발제품이호실적견인,http://www.newspim.com/news/view/20191029000865
5717,2019-10-29,한미약품탄탄한내실경영에3분기매출129영업익16↑,http://www.getnews.co.kr/view.php?ud=20191029151403699141d0c69529_16
5718,2019-10-29,한미약품3Q매출영업익증가자체개발복합제성장영향종합,http://news1.kr/articles/?3755519
5719,2019-10-29,한미약품3분기영업익249억원전년동기대비16증가,http://www.ceoscoredaily.com/news/article.html?no=61891
5720,2019-10-29,한미약품올해매출1조달성예고영업익두자릿수↑,http://www.newsis.com/view/?id=NISX20191029_0000813385&cID=13001&pID=13000
5721,2019-10-29,공시한미약품3분기영업익249억전년比16↑,http://www.newsis.com/view/?id=NISX20191029_0000813406&cID=10401&pID=10400
5722,2019-10-29,한미약품탄탄한내실로3분기실적성장영업이익16증가,http://www.metroseoul.co.kr/news/newsview?newscd=2019102900154
5723,2019-10-29,한미약품3분기영업익249억전년비16증가,http://www.newstomato.com/ReadNews.aspx?no=929599
5724,2019-10-29,한미약품3분기매출2657억원전년比129↑,http://inthenews.co.kr/article-22104/
5725,2019-10-29,한미약품탄탄한내실경영을바탕으로3분기매출2657억원기록전년대비129성장,http://www.ekn.kr/news/article.html?no=460853
5726,2019-10-29,한미약품3Q영업익249억원기록전년동기比16↑,http://it.chosun.com/site/data/html_dir/2019/10/29/2019102901705.html
5727,2019-10-29,한미약품3분기영업이익249억원전년동기比16성장,http://news.tf.co.kr/read/economy/1766841.htm
5728,2019-10-29,한미약품3분기영업익249억원전년비16↑,http://www.ebn.co.kr/news/view/1006858/?sc=naver
5729,2019-10-29,한미약품3분기영업익249억원16증가,http://www.smedaily.co.kr/news/articleView.html?idxno=87144
5730,2019-10-29,한미약품계약금유입종료에도3분기영업익16↑,http://news.mt.co.kr/mtview.php?no=2019102915203275024
5731,2019-10-29,한미약품3Q영업익전년比16↑”자체개발복합제성장”,http://kormedi.com/?p=1304548
5732,2019-10-29,탄탄한내실경영”한미약품3분기영업익전년比160↑,http://www.fetv.co.kr/news/article.html?no=39263
5733,2019-10-29,한미약품3Q전년비比매출13↑영업익16↑올해매출1조원이상무난할듯,http://www.newswatch.kr/news/articleView.html?idxno=24694
5734,2019-10-29,한미약품年매출1조달성하나3Q영업익전년比16↑,http://www.whitepaper.co.kr/news/articleView.html?idxno=178800
5735,2019-10-29,한미약품3분기매출2657억원영업익249억원기록탄탄한성장이어가,http://www.joseilbo.com/news/news_read.php?uid=386400&class=17&grp=
5736,2019-10-29,한미약품3분기영업익249억전년比16증가,http://www.dailysmart.co.kr/news/articleView.html?idxno=17327
5737,2019-10-29,한미약품매출2657억원영업이익249억원,http://www.kukinews.com/news/article.html?no=714300
5738,2019-10-29,한미약품올3분기매출2657억원전년동기대비129증가,https://www.sedaily.com/NewsView/1VPPMF8BON
5739,2019-10-29,한미약품3분기누적매출8107억원달성,https://asiatime.co.kr/news/newsview.php?ncode=1065594980321641
5740,2019-10-29,한미약품3분기매출전년비129↑누적8107억,http://health.chosun.com/site/data/html_dir/2019/10/29/2019102901879.html
5741,2019-10-29,한미약품3분기영업이익249억원10년차고혈압약이견인,https://cnbc.sbs.co.kr/article_hub/10000960249?division=NAVER
5742,2019-10-29,한미약품3분기매출영업익모두성장1조달성무난,http://www.newsprime.co.kr/news/article.html?no=480987
5743,2019-10-29,한미약품3분기영업익16↑자산평가익감소에순이익339↓,https://www.ajunews.com/view/20191029153243611
5744,2019-10-29,한미약품탄탄한내실경영3분기매출영업익대폭성장,http://www.straightnews.co.kr/news/articleView.html?idxno=58841
5745,2019-10-29,2년연속매출1조원달성파란불한미약품3분기까지누적매출8100억원,http://kpenews.com/View.aspx?No=304317
5746,2019-10-29,한미약품3분기호실적영업이익249억원증가,http://www.asiatoday.co.kr/view.php?key=20191029010016664
5747,2019-10-29,한미약품3분기영업익249억원전년동기比16↑,http://www.etnews.com/20191029000374
5748,2019-10-29,한미약품3분기영업이익249억원전년比16↑,http://www.wolyo.co.kr/news/articleView.html?idxno=96635
5749,2019-10-29,한미약품자체개발개량신약판매증가에힘입어3분기실적늘어,http://www.businesspost.co.kr/BP?command=article_view&num=148860
5750,2019-10-29,한미약품누적매출8107억원올해매출1조원달성초읽기,http://www.100ssd.co.kr/news/articleView.html?idxno=65038
5751,2019-10-29,한미약품3분기영업익249억전년比16증가,http://biz.newdaily.co.kr/site/data/html/2019/10/29/2019102900167.html
5752,2019-10-29,한미약품3분기연결영업익249억전년比16증가,http://www.sportsseoul.com/news/read/840908
5753,2019-10-29,한미약품3분기영업이익249억원전년동기대비160성장,http://daily.hankooki.com/lpage/ittech/201910/dh20191029162629145630.htm
5754,2019-10-29,한미약품3분기매출영업익두자릿수성장,http://www.shinailbo.co.kr/news/articleView.html?idxno=1218422
5755,2019-10-29,한미약품3분기매출영업익대폭성장,http://www.techholic.co.kr/news/articleView.html?idxno=186725
5756,2019-10-29,한미약품3분기영업익249억전년比16증가,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019102916363936335
5757,2019-10-29,한미약품3분기영업익249억전년比16증가,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019102916363936335
5758,2019-10-29,한미약품올3분기영업익249억전년비16증가,http://fn.segye.com/content/html/2019/10/29/20191029512367.html?OutUrl=naver
5759,2019-10-29,한미약품3분기영업이익249억원전년比16↑,http://www.kpinews.co.kr/news/articleView.html?idxno=106151
5760,2019-10-29,한미약품3분기매출영업익대폭성장,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57905
5761,2019-10-29,한미약품3분기매출영업익동반성장1조클럽전망,http://www.etoday.co.kr/news/section/newsview.php?idxno=1815411
5762,2019-10-29,한미약품3분기영업익249억원전년比16증가,http://www.youthdaily.co.kr/news/article.html?no=21270
5763,2019-10-29,한미약품자체개발신약덕3Q매출성장쑥,https://www.paxnetnews.com/articles/53363
5764,2019-10-29,한미약품3분기매출2657영업익249억원대폭성장,http://www.newsrep.co.kr/news/articleView.html?idxno=95569
5765,2019-10-29,한미약품3분기매출2657억원영영업이익249억원달성,http://www.medigatenews.com/news/2882634369
5766,2019-10-29,한미약품3분기영업익호실적제품성장덕분,http://www.edaily.co.kr/news/newspath.asp?newsid=03778566622657840
5767,2019-10-29,한미약품3분기매출영업익대폭성장,http://www.dailian.co.kr/news/view/838311/?sc=naver
5768,2019-10-29,한미약품3분기영업이익249억전년比160↑,http://www.wikitree.co.kr/main/news_view.php?id=475866
5769,2019-10-29,한미약품3분기매출영업이익전년동기대비증가,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000051773
5770,2019-10-29,한미약품3분기영업익249억원전년比16↑,http://www.dt.co.kr/contents.html?article_no=2019102902109931102004&ref=naver
5771,2019-10-29,한미약품3Q영업익249억16↑내실경영성장,http://www.biospectator.com/view/news_view.php?varAtcId=8774
5772,2019-10-29,한미약품3분기매출영업익대폭성장연매출1조원달성전망,http://www.ntoday.co.kr/news/articleView.html?idxno=69120
5773,2019-10-29,한미약품3분기영업이익16↑자체개발치료제호조,http://www.donga.com/news/article/all/20191029/98126039/1
5774,2019-10-29,한미약품3분기매출전년대비13증가올해1조원매출전망,http://www.newsworks.co.kr/news/articleView.html?idxno=406838
5775,2019-10-29,한미약품3분기영업익249억1천만원전년比16상승,http://www.mdtoday.co.kr/mdtoday/index.html?no=368732
5776,2019-10-29,한미약품3분기영업익249억전년비16증가,http://www.finomy.com/news/articleView.html?idxno=71043
5777,2019-10-29,한미약품3분기순익89억전년比339↓기술료유입감소등외부영향”,http://4th.kr/View.aspx?No=304508
5778,2019-10-29,한미약품3분기매출2657억원영업익249억원전년동기대비129160↑,http://www.newslock.co.kr/news/articleView.html?idxno=22807
5779,2019-10-29,한미약품3분기호실적,https://www.nocutnews.co.kr/news/5235104
5780,2019-10-29,한미약품3분기매출2657억원올해도매출1조이상무,http://www.news2day.co.kr/140492
5781,2019-10-29,한미약품시장의우려잠재운3분기실적발표,http://www.mrepublic.co.kr/news/articleView.html?idxno=41089
5782,2019-10-29,한미약품3분기매출영업익대폭성장,http://www.newscj.com/news/articleView.html?idxno=678836
5783,2019-10-29,29일기관순매수Top10KODEXTop5PlusTR1184억TIGER20087억한미약품57억오렌지라이프36억기관순매수나서코스닥시장에서는스튜디오드래곤지노믹트리CJE,http://www.fintechpost.co.kr/news/articleView.html?idxno=83932
5784,2019-10-29,한미약품3분기매출2657억원249억원영업이익대폭성장,http://www.thefirstmedia.net/news/articleView.html?idxno=50040
5785,2019-10-30,한미약품3분기매출영입익대폭성장전년동기比129↑160↑,http://www.g-enews.com/ko-kr/news/article/news_all/20191029171129281469d76442fa_1/article.html
5786,2019-10-30,한미약품3분기영업이익249억전년대비16늘어나,http://www.econonews.co.kr/news/articleView.html?idxno=92676
5787,2019-10-30,RD로원가절감한미약품의슬기로운성장전략,http://www.dailypharm.com/Users/News/NewsView.html?ID=258343&REFERER=NP
5788,2019-10-30,한미약품에소메졸PPI시장1위넘본다,http://medipana.com/news/news_viewer.asp?NewsNum=247740&MainKind=A&NewsKind=5&vCount=12&vKind=1
5789,2019-10-30,제약업계단신한미약품차비오텍바이오솔루션인피니트헬스케어,http://www.g-enews.com/ko-kr/news/article/news_all/20191029161320516769d76442fa_1/article.html
5790,2019-10-30,한미약품기술료없이이룬깜짝실적매수하나금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1815615
5791,2019-10-30,한미약품3Q매출영업익두자릿수증가순이익은감소,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1073713
5792,2019-10-30,한미약품스테디셀러제품인기로성장세지속매수하나,http://inthenews.co.kr/article-22191/
5793,2019-10-30,한미약품3분기어닝서프라이즈지금사야할때하나,http://www.edaily.co.kr/news/newspath.asp?newsid=01489126622658168
5794,2019-10-30,한미약품주가상승예상”자체개발개량신약판매호조이어가,http://www.businesspost.co.kr/BP?command=article_view&num=148952
5795,2019-10-30,더벨CompanyWatch한미약품3Q기술료수익급감에도수익성유지,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201910290100054760003402
5796,2019-10-30,한미약품내수매출호조로깜짝실적목표가상향신한금융투자,http://www.dailian.co.kr/news/view/838409/?sc=naver
5797,2019-10-30,HotLine한미약품자체개발제품판매호조로깜짝실적달성,http://news.mk.co.kr/newsRead.php?year=2019&no=887342
5798,2019-10-30,신한금투한미약품내수매출호조로실적개선목표가↑,http://www.straightnews.co.kr/news/articleView.html?idxno=58879
5799,2019-10-30,실적한미약품3Q영업익249억전년比16↑자체개발복합제호실적,http://www.ezyeconomy.com/news/articleView.html?idxno=94917
5800,2019-10-30,한미약품내수매출호조로깜짝실적기록신한,http://www.ebn.co.kr/news/view/1006927/?sc=naver
5801,2019-10-30,한미약품내수매출호조로깜짝실적목표가↑신한금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1815667
5802,2019-10-30,제약바이오잇단악재에도한미약품보령제약등내실경영강화,http://www.rapportian.com/news/articleView.html?idxno=121011
5803,2019-10-30,한미약품올연말까지1조원매출이룬다3분기누적매출8107억원,http://www.todaykorea.co.kr/news/view.php?no=265358
5804,2019-10-30,한미약품12월포지오티닙임상발표이후다수의RD이벤트대기투자의견매수NH투자증권,http://www.fntimes.com/html/view.php?ud=201910300844025424f09e13944d_18
5805,2019-10-30,한미약품내수매출호조로깜짝실적기대”신한금융투자,http://www.fntimes.com/html/view.php?ud=2019103008474946456c0eb6f11e_18
5806,2019-10-30,한미약품2020년영업이익증가율3전망,http://www.nspna.com/news/?mode=view&newsid=390607
5807,2019-10-30,미래에셋대우한미약품경쟁약물등장했지만투자의견매수유지,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910300042&t=NN
5808,2019-10-30,한투證한미약품개선되는펀더멘털밸류에이션부담은여전,http://www.newsis.com/view/?id=NISX20191030_0000813988&cID=10401&pID=10400
5809,2019-10-30,한미약품자체개발제품판매증가로3분기호실적미래에셋대우,http://www.fnnews.com/news/201910300908191626
5810,2019-10-30,한미약품내수매출호조에깜짝실적,http://www.newsprime.co.kr/news/article.html?no=481048
5811,2019-10-30,바이오시밀러테마오전시황상승률상위종목이수앱지스088셀트리온024한미약품075등,http://www.gokorea.kr/news/articleView.html?idxno=546815
5812,2019-10-30,STOCK한미약품내수매출성과에실적호조,http://moneys.mt.co.kr/news/mwView.php?no=2019103009008056085
5813,2019-10-30,RD역량강화한미약품3분기매출영업익두자릿수증가성장선순환구축하나,http://www.updownnews.co.kr/news/articleView.html?idxno=210379
5814,2019-10-30,빅데이터MSI시장심리톱5한미약품한국항공우주기아차LG디스플레이SKC,http://www.newsis.com/view/?id=NISX20191030_0000814051&cID=10401&pID=10400
5815,2019-10-30,특징주한미약품국내영업선전으로컨센서스상회목표주가41만원매수의견유지,http://www.shinailbo.co.kr/news/articleView.html?idxno=1218556
5816,2019-10-30,GET투자리포트한미약품투자의견매수유지DB금융투자,http://www.getnews.co.kr/view.php?ud=2019103010303013032tpgetnews_16
5817,2019-10-30,특징주한미약품내수호조에깜짝실적,http://www.sisaon.co.kr/news/articleView.html?idxno=103373
5818,2019-10-30,GET투자리포트한미약품투자의견매수유지대신증권,http://www.getnews.co.kr/view.php?ud=2019103010303013041tpgetnews_16
5819,2019-10-30,GET투자리포트한미약품투자의견매수유지미래에셋대우,http://www.getnews.co.kr/view.php?ud=2019103010303013046tpgetnews_16
5820,2019-10-30,GET투자리포트한미약품투자의견보유메리츠종금증권,http://www.getnews.co.kr/view.php?ud=2019103010303013051tpgetnews_16
5821,2019-10-30,GET투자리포트한미약품투자의견보유삼성증권,http://www.getnews.co.kr/view.php?ud=2019102910303013057tpgetnews_16
5822,2019-10-30,GET투자리포트한미약품투자의견매수유지신한금융투자,http://www.getnews.co.kr/view.php?ud=2019103010303013064tpgetnews_16
5823,2019-10-30,GET투자리포트한미약품투자의견매수유안타증권,http://www.getnews.co.kr/view.php?ud=2019103010303013069tpgetnews_16
5824,2019-10-30,10월30일한미약품실시간증시335500원015,http://nbntv.co.kr/news/view/712134
5825,2019-10-30,GET투자리포트한미약품투자의견매수유지SK증권,http://www.getnews.co.kr/view.php?ud=2019103010303013095tpgetnews_16
5826,2019-10-30,한미약품34분기호실적내년실적전망개선목표가↑,https://www.sedaily.com/NewsView/1VPQ1VGEGA
5827,2019-10-30,기술수출약발다했나한미약품3Q기술료1천만원,http://www.dailypharm.com/Users/News/NewsView.html?ID=258369&REFERER=NP
5828,2019-10-30,한미약품3분기어닝서프라이즈실적영업부문고성장세지속될것”,http://www.wikitree.co.kr/main/news_view.php?id=476154
5829,2019-10-30,바이오시밀러테마오후시황상승률상위종목한미약품보합세팜스웰바이오015에이프로젠제약046등,http://www.gokorea.kr/news/articleView.html?idxno=548225
5830,2019-10-30,30일13시바이오시밀러오후테마시황한미약품이수앱지스등이상승세주도,http://nbntv.co.kr/news/view/712847
5831,2019-10-30,GET투자리포트한미약품투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=2019103010303013103tpgetnews_16
5832,2019-10-30,한미약품3분기호실적에도순이익은감소세공정가치변동영향”,http://www.wikitree.co.kr/main/news_view.php?id=476232
5833,2019-10-30,바이오시밀러테마종목종가한미약품셀트리온등이상승세주도,http://nbntv.co.kr/news/view/713445
5834,2019-10-30,한미약품복지부상대2심도패소,http://www.newstomato.com/ReadNews.aspx?no=929875
5835,2019-10-30,한미약품매수리포트봇물깜짝실적의약품매출호조영향,http://www.sentv.co.kr/news/view/563043
5836,2019-10-30,바이오시밀러테마마감시황상승률상위종목한미약품015셀트리온073이수앱지스088등,http://www.gokorea.kr/news/articleView.html?idxno=548528
5837,2019-10-30,제약업계RD명가한미약품기술반환악재넘어부활할까,http://news.mk.co.kr/newsRead.php?year=2019&no=890259
5838,2019-10-30,한미약품개량신약이성장동력기대넘는어닝서프라이즈달성,http://biz.newdaily.co.kr/site/data/html/2019/10/30/2019103000173.html
5839,2019-10-30,한미약품롤론티스美FDA재신청을시작으로포지오티닙오락솔까지허가모멘텀존재”,http://www.wikitree.co.kr/main/news_view.php?id=476291
5840,2019-10-30,한미약품계열JVM3분기매출11성장,http://news.heraldcorp.com/view.php?ud=20191030000831
5841,2019-10-30,한미약품제이브이엠3분기영업이익전년比184↓원가율높은제품강세로역성장”,http://4th.kr/View.aspx?No=305900
5842,2019-10-30,GET투자리포트한미약품투자의견매수유지이베스트투자증권,http://www.getnews.co.kr/view.php?ud=2019103010303013137tpgetnews_16
5843,2019-10-30,한미약품3Q영업익249억원전년대비16늘어,https://www.kpanews.co.kr/article/show.asp?idx=208014&category=D
5844,2019-10-30,한미약품계열JVM3분기매출증가불구영업이익184↓,http://www.donga.com/news/article/all/20191030/98143860/1
5845,2019-10-30,한미약품계열사제이브이엠3분기영업익30억전년比184감소,http://kormedi.com/?p=1304632
5846,2019-10-30,한미약품합병시너지에JVM3분기매출전년비比106쑥,http://www.medisobizanews.com/news/articleView.html?idxno=63585
5847,2019-10-30,한미약품그룹계열사JVM3분기매출전년동기대비106성장한278억원,http://www.newscj.com/news/articleView.html?idxno=679222
5848,2019-10-31,복지부Vs한미약품약가인하분쟁2라운드승자는,http://www.bosa.co.kr/news/articleView.html?idxno=2115095
5849,2019-10-31,한미약품먹는항암신약오락솔유럽집행위원회희귀의약품지정,https://view.asiae.co.kr/article/2019103109015133986
5850,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,https://asiatime.co.kr/news/newsview.php?ncode=1065570947555599
5851,2019-10-31,한미약품오락솔유럽서연조직육종희귀의약품지정,http://health.chosun.com/site/data/html_dir/2019/10/31/2019103100752.html
5852,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://it.chosun.com/site/data/html_dir/2019/10/31/2019103100763.html
5853,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.newsis.com/view/?id=NISX20191031_0000815350&cID=13001&pID=13000
5854,2019-10-31,유럽집행위한미약품항암신약오락솔희귀의약품지정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236788
5855,2019-10-31,한미약품항암신약오락솔美이어유럽서희귀의약품지정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1816283
5856,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,https://www.sedaily.com/NewsView/1VPQHRYQ41
5857,2019-10-31,한미약품오락솔유럽서희귀의약품지정,https://www.nocutnews.co.kr/news/5235911
5858,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.nextdaily.co.kr/news/article.html?id=20191031800001
5859,2019-10-31,한미약품 경구용신약오락솔 유럽서희귀의약품지정,http://www.medisobizanews.com/news/articleView.html?idxno=63597
5860,2019-10-31,한미약품항암제오락솔유럽희귀약지정,https://biz.chosun.com/site/data/html_dir/2019/10/31/2019103100823.html
5861,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.newsway.co.kr/news/view?tp=1&ud=2019103109262728674
5862,2019-10-31,한미약품경구용항암신약유럽서희귀의약품지정,http://moneys.mt.co.kr/news/mwView.php?no=2019103109248090263
5863,2019-10-31,한미약품항암신약물질오락솔유럽서희귀약지정,http://news1.kr/articles/?3757253
5864,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.fetv.co.kr/news/article.html?no=39389
5865,2019-10-31,한미약품유럽서경구용항암신약오락솔희귀의약품지정,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201910310086&t=NN
5866,2019-10-31,한미약품먹는항암제오락솔유럽연조직육종희귀의약품지정,http://www.newspim.com/news/view/20191031000186
5867,2019-10-31,한미약품오락솔EC희귀의약품지정,http://medipana.com/news/news_viewer.asp?NewsNum=247832&MainKind=A&NewsKind=5&vCount=12&vKind=1
5868,2019-10-31,한미약품오락솔유럽집행위원회도희귀약지정,http://www.bosa.co.kr/news/articleView.html?idxno=2115129
5869,2019-10-31,한미약품오락솔유럽서연조직육종치료위한희귀의약품지정돼,http://news.mk.co.kr/newsRead.php?year=2019&no=892382
5870,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.viva100.com/main/view.php?key=20191031010010209
5871,2019-10-31,한미약품항암제오락솔유럽희귀의약품지정,http://news.mk.co.kr/newsRead.php?year=2019&no=892476
5872,2019-10-31,한미약품오락솔유럽서희귀의약품지정,http://www.edaily.co.kr/news/newspath.asp?newsid=02217286622658496
5873,2019-10-31,유럽집행위원회한미약품경구용항암신약오락솔희귀의약품지정,http://www.newslock.co.kr/news/articleView.html?idxno=22843
5874,2019-10-31,유럽집행위한미약품오락솔희귀의약품지정,http://www.sisajournal-e.com/news/articleView.html?idxno=208291
5875,2019-10-31,한미약품경구용항암신약오락솔유럽서희귀의약품지정,http://www.newsprime.co.kr/news/article.html?no=481254
5876,2019-10-31,한미약품오락솔유럽서희귀의약품지정,http://www.monews.co.kr/news/articleView.html?idxno=206137
5877,2019-10-31,한미약품오락솔유럽집행위원회희귀의약품지정,http://www.etnews.com/20191031000103
5878,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://fn.segye.com/content/html/2019/10/31/20191031505358.html?OutUrl=naver
5879,2019-10-31,한미약품오락솔유럽희귀의약품지정,http://news.mt.co.kr/mtview.php?no=2019103109105190735
5880,2019-10-31,한미약품경구용항암신약오락솔유럽희귀의약품지정,http://news.tf.co.kr/read/economy/1767026.htm
5881,2019-10-31,한미약품오락솔유럽집행위원회희귀의약품지정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1345977
5882,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.pressm.kr/news/articleView.html?idxno=25778
5883,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.straightnews.co.kr/news/articleView.html?idxno=59010
5884,2019-10-31,한미약품항암제오락솔유럽서희귀의약품지정,http://kormedi.com/?p=1304680
5885,2019-10-31,한미약품나인나인한알이면하루권장비타민D까지섭취,http://www.asiatoday.co.kr/view.php?key=20191031010017991
5886,2019-10-31,한미약품주가12894010월31일오늘가격336000원종목그래프및종목관련동향정보,http://www.gokorea.kr/news/articleView.html?idxno=549268
5887,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.mdtoday.co.kr/mdtoday/index.html?no=368925
5888,2019-10-31,혈관육종환자에신속한반응한미약품오락솔유럽서희귀의약품지정,http://kpenews.com/View.aspx?No=306479
5889,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.ceoscoredaily.com/news/article.html?no=61984
5890,2019-10-31,유럽집행委한미약품먹는항암제오락솔희귀의약품지정,http://news.heraldcorp.com/view.php?ud=20191031000322
5891,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.doctorsnews.co.kr/news/articleView.html?idxno=131895
5892,2019-10-31,10월31일한미약품실시간증시045337000원,http://nbntv.co.kr/news/view/714372
5893,2019-10-31,한미약품경구용항암제오락솔유럽집행위원회희귀의약품지정,http://4th.kr/View.aspx?No=306472
5894,2019-10-31,한미약품항암신약오락솔유럽서희귀의약품지정,http://biz.newdaily.co.kr/site/data/html/2019/10/31/2019103100101.html
5895,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://inthenews.co.kr/article-22429/
5896,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1129930&REFERER=NP
5897,2019-10-31,한미약품경구용항암신약오락솔유럽희귀의약품지정,http://www.ezyeconomy.com/news/articleView.html?idxno=95003
5898,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.bokuennews.com/news/article.html?no=182690
5899,2019-10-31,한미약품오락솔유럽서희귀의약품지정,http://www.biospectator.com/view/news_view.php?varAtcId=8796
5900,2019-10-31,한미약품유럽에서경구용항암신약오락솔의희귀의약품지정받아,http://www.businesspost.co.kr/BP?command=article_view&num=149191
5901,2019-10-31,한미약품오락솔유럽서희귀의약품지정,http://www.ekn.kr/news/article.html?no=461288
5902,2019-10-31,한미약품먹는항암제오락솔유럽집행위원회희귀의약품지정,http://daily.hankooki.com/lpage/ittech/201910/dh20191031140330145630.htm
5903,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=57954
5904,2019-10-31,한미약품오락솔유럽집행위원회로부터희귀의약품으로지정받아,http://www.koreaittimes.com/news/articleView.html?idxno=93836
5905,2019-10-31,한미약품오락솔유럽서희귀의약품지정,http://www.dailysmart.co.kr/news/articleView.html?idxno=17464
5906,2019-10-31,한미약품항암신약오락솔유럽서희귀의약품지정,http://www.kpinews.co.kr/news/articleView.html?idxno=106274
5907,2019-10-31,한미약품신약오락솔유럽희귀의약품지정,http://www.upinews.kr/newsView/upi201910310085
5908,2019-10-31,식약처한미약품과징금1170만원부과,http://www.bokuennews.com/news/article.html?no=182705
5909,2019-10-31,한미약품경구용항암신약오락솔유럽서희귀의약품지정,https://cnbc.sbs.co.kr/article_hub/10000960556?division=NAVER
5910,2019-10-31,한미약품오락솔유럽희귀의약품지정,http://www.seoulfn.com/news/articleView.html?idxno=360990
5911,2019-10-31,한미약품오락솔유럽서희귀의약품지정,http://www.smedaily.co.kr/news/articleView.html?idxno=87216
5912,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.joseilbo.com/news/news_read.php?uid=386554&class=27&grp=
5913,2019-10-31,한미약품경구용항암신약오락솔유럽집행위원회희귀의약품지정,http://www.techholic.co.kr/news/articleView.html?idxno=186810
5914,2019-10-31,한미약품오락솔유럽희귀의약품지정,https://www.paxnetnews.com/articles/53477
5915,2019-10-31,한미약품경구용항암신약오락솔유럽서희귀의약품지정,http://www.econovill.com/news/articleView.html?idxno=376229
5916,2019-10-31,한미약품텐텐코리아팜어워드굿브랜드어린이종합비타민부문대상,http://www.newsworks.co.kr/news/articleView.html?idxno=407528
5917,2019-10-31,한미약품오락솔유럽서희귀의약품지정,http://www.ebn.co.kr/news/view/1007310/?sc=naver
5918,2019-10-31,한미약품텐텐항산화성분코엔자임Q10함유어린이종합영양제로주목,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=534669
5919,2019-10-31,한미약품에너지골드약국최고인기드링크제선정,http://www.newstomato.com/ReadNews.aspx?no=930322
5920,2019-10-31,한미약품오락솔유럽집행위희귀의약품지정,http://www.news2day.co.kr/140740
5921,2019-10-31,한미약품텐텐어린이종합비타민대상선정,http://www.kpinews.co.kr/news/articleView.html?idxno=106301
5922,2019-10-31,한미약품텐텐코리아팜어워드굿브랜드어린이종합비타민부문大賞,http://www.insightkorea.co.kr//news/articleView.html?idxno=62744
5923,2019-10-31,한미약품텐텐코리아팜어워드굿브랜드어린이종합비타민부문대상,http://www.ekoreanews.co.kr/news/articleView.html?idxno=40676
5924,2019-10-31,한미약품기술수출오락솔유럽희귀의약품지정”,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000051784
5925,2019-10-31,한미약품에너지골드텐텐코리아팜어워드굿브랜드대상수상,http://www.ekn.kr/news/article.html?no=461399
5926,2019-10-31,한미약품에너지골드약사1000명이선정한최고자양강장제영예,http://www.seoulwire.com/news/articleView.html?idxno=246294
5927,2019-10-31,한미약품오락솔유럽서희귀의약품지정,http://www.seoulwire.com/news/articleView.html?idxno=246295
5928,2019-10-31,한미약품나인나인하루한알로비타민D권장량충족,http://weekly.hankooki.com/lpage/economy/201910/wk20191031181223146460.htm
5929,2019-10-31,한미약품오락솔유럽서희귀의약품지정,http://www.finomy.com/news/articleView.html?idxno=71107
5930,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.nspna.com/news/?mode=view&newsid=391146
5931,2019-10-31,유럽서희귀의약품지정된한미약품항암제오락솔,http://www.sisaweek.com/news/articleView.html?idxno=127566
5932,2019-10-31,한미약품에너지골드자양강장제부문대상선정,http://www.mediapen.com/news/view/473040
5933,2019-10-31,유럽집행위원회한미약품항암신약오락솔희귀의약품지정,http://www.getnews.co.kr/view.php?ud=20191031204643163641d0c69529_16
5934,2019-10-31,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.newscj.com/news/articleView.html?idxno=679559
5935,2019-11-01,유럽집행위원회한미약품오락솔희귀의약품지정,http://www.thefirstmedia.net/news/articleView.html?idxno=50163
5936,2019-11-01,한미약품약가인하소송서또다시敗9품목집행정지해제통보,http://www.mdtoday.co.kr/mdtoday/index.html?no=368993
5937,2019-11-01,한미약품에너지골드코리아팜어워드굿브랜드서대상,http://www.whitepaper.co.kr/news/articleView.html?idxno=179377
5938,2019-11-01,한미약품텐텐약사들도인정했다,http://news.bizwatch.co.kr/article/consumer/2019/11/01/0002/naver
5939,2019-11-01,한미약품항암신약후보물질오락솔유럽희귀의약품지정,http://www.sportsseoul.com/news/read/842329
5940,2019-11-01,한미약품계열JVM3분기매출278억전년동기대비106증가,http://www.polinews.co.kr/news/article.html?no=430186
5941,2019-11-01,한미약품주가12894011월1일현재333500원정보외주식시황,http://www.gokorea.kr/news/articleView.html?idxno=551185
5942,2019-11-01,식약처의약품위탁제조시관리의무위반한한미약품에과징금1170만원부과,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236872
5943,2019-11-01,한미약품내수매출호조3분기매출영업이익대폭성장,http://www.babytimes.co.kr/news/articleView.html?idxno=30727
5944,2019-11-01,주식그래프한미약품주가1일현재332500원,http://nbntv.co.kr/news/view/716554
5945,2019-11-01,한미약품에너지골드코리아팜어워드대상선정,http://www.wikileaks-kr.org/news/articleView.html?idxno=69062
5946,2019-11-01,한미약품실탄확보로우려잠재울까파이프라인7개,http://www.econovill.com/news/articleView.html?idxno=376337
5947,2019-11-01,주간추천종목하나금융투자현대글로비스한미약품연우,http://www.greened.kr/news/articleView.html?idxno=221331
5948,2019-11-01,빅5제약3Q누적영업실적극명한미약품만전부문성장,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236892
5949,2019-11-01,위클리제약바이오한미약품오락솔유럽희귀의약품지정外,http://www.etoday.co.kr/news/section/newsview.php?idxno=1817227
5950,2019-11-01,기흥화성세무서관내녹십자한미약품경동제약대웅제약맑거나흐리거나,http://www.sejungilbo.com/news/articleView.html?idxno=18805
5951,2019-11-02,주간추천종목하나금융투자현대글로비스한미약품연우,http://www.fntimes.com/html/view.php?ud=2019110203573613696c0eb6f11e_18
5952,2019-11-02,주간추천종목LG화학셀트리온헬스케어한국조선해양스튜디오드래곤카카오만도현대글로비스한미약품연우,http://www.lawissue.co.kr/view.php?ud=2019110210154157369817d053b9_12
5953,2019-11-03,한미약품항암신약오락솔유럽서희귀의약품으로지정,http://www.metroseoul.co.kr/news/newsview?newscd=2019103100159
5954,2019-11-03,실적으로증명된한미약품RD의힘해외공략가속화,http://news.mt.co.kr/mtview.php?no=2019103017091670077
5955,2019-11-03,주간추천종목현대글로비스한미약품연우스튜디오드래곤카카오만도등,http://www.sisaon.co.kr/news/articleView.html?idxno=103609
5956,2019-11-04,빅데이터MSI시장심리톱5네이버LG생활건강카카오한미약품삼성중공업,http://www.newsis.com/view/?id=NISX20191104_0000818370&cID=10401&pID=10400
5957,2019-11-04,바이오시밀러테마오전시황상승률상위종목에이프로젠제약253한올바이오파마090한미약품075등,http://www.gokorea.kr/news/articleView.html?idxno=552447
5958,2019-11-04,한미약품에너지골드프리미엄드링크제전략성공,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019110410352531311
5959,2019-11-04,한미약품주가12894011월4일오늘거래가337000원종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=553010
5960,2019-11-04,11월4일한미약품실시간증시337000원090,http://nbntv.co.kr/news/view/718604
5961,2019-11-04,바이오시밀러테마마감시황상승률상위종목에이프로젠제약759제넥신255한미약품045등,http://www.gokorea.kr/news/articleView.html?idxno=554070
5962,2019-11-05,한미약품박중현상무제11회베스트PR상수상,https://www.kpanews.co.kr/article/show.asp?idx=208157&category=D
5963,2019-11-05,박중현한미약품홍보담당상무베스트PR상수상,http://www.dailypharm.com/Users/News/NewsView.html?ID=258555&REFERER=NP
5964,2019-11-05,한미약품박중현상무제11회베스트PR상수상,http://www.bosa.co.kr/news/articleView.html?idxno=2115387
5965,2019-11-05,한미약품박중현상무제11회베스트PR상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=236990
5966,2019-11-05,한미약품박중현상무제11회베스트PR상수상,http://medipana.com/news/news_viewer.asp?NewsNum=248070&MainKind=A&NewsKind=5&vCount=12&vKind=1
5967,2019-11-05,한미약품박중현상무베스트PR상영예,http://www.whosaeng.com/113740
5968,2019-11-05,한미약품목표주가상향매출늘고신약기술이전기대감도커,http://www.businesspost.co.kr/BP?command=article_view&num=149784
5969,2019-11-05,11월5일한미약품128940증권투자정보및주체별매매동향015변화,http://www.gokorea.kr/news/articleView.html?idxno=554821
5970,2019-11-05,한미약품연간90가까운탑라인성장가능할것연구개발모멘텀기대”,http://www.wikitree.co.kr/main/news_view.php?id=477776
5971,2019-11-05,한미약품주식종목검색5일현재335500원,http://nbntv.co.kr/news/view/720738
5972,2019-11-05,한미약품3분기로수젯아모잘탄등주력제품호조세돋보였다”,http://www.wikitree.co.kr/main/news_view.php?id=477913
5973,2019-11-06,160조규모中제약시장한미약품GC녹십자승승장구,https://asiatime.co.kr/news/newsview.php?ncode=1065588532609921
5974,2019-11-06,한미약품기술료인식부재에도3분기양호한실적”,http://www.wikitree.co.kr/main/news_view.php?id=478161
5975,2019-11-06,한미약품주가12894011월6일오늘거래가333500원종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=556760
5976,2019-11-06,한미약품셀트리온헬스케어에밀려자리내줘2019년10월제약상장기업브랜드평판4위,http://www.futurekorea.co.kr/news/articleView.html?idxno=122725
5977,2019-11-06,한미약품주식창6일현재333000원,http://nbntv.co.kr/news/view/723021
5978,2019-11-06,주가시황한미약품128940현재331500원매매동향,http://www.woodkorea.co.kr/news/articleView.html?idxno=34196
5979,2019-11-06,바이오시밀러테마오후시황상승률상위종목셀트리온025팜스웰바이오146한미약품149등,http://www.gokorea.kr/news/articleView.html?idxno=557447
5980,2019-11-06,바이오시밀러테마마감시황상승률상위종목셀트리온051이수앱지스121한미약품163등,http://www.gokorea.kr/news/articleView.html?idxno=557909
5981,2019-11-07,1조클럽제약사올해는②치고올라오는종근당승승장구한미약품,http://www.mdtoday.co.kr/mdtoday/index.html?no=369516
5982,2019-11-07,11월7일한미약품실시간증시076328500원,http://nbntv.co.kr/news/view/725296
5983,2019-11-07,주식시황한미약품128940현재거래가격328000원매매동향,http://www.woodkorea.co.kr/news/articleView.html?idxno=34553
5984,2019-11-07,바이오시밀러테마오후시황상승률상위종목이수앱지스314한올바이오파마264한미약품076등,http://www.gokorea.kr/news/articleView.html?idxno=559518
5985,2019-11-08,한미약품주가128940증권그래프8일현재323000원,http://www.gokorea.kr/news/articleView.html?idxno=560663
5986,2019-11-08,11월8일한미약품주식그래프198321500원,http://nbntv.co.kr/news/view/727561
5987,2019-11-08,주가동향한미약품128940현재거래가격322000원매매동향,http://www.woodkorea.co.kr/news/articleView.html?idxno=34904
5988,2019-11-08,바이오시밀러테마마감시황상승률상위종목제넥신187팜스웰바이오124한미약품107등,http://www.gokorea.kr/news/articleView.html?idxno=561876
5989,2019-11-11,상장사수익성분석③제약업종수익성개선두각대웅제약한미약품등선방,http://www.etoday.co.kr/news/section/newsview.php?idxno=1820125
5990,2019-11-11,한미약품주가12894011월11일오늘거래가318000원오늘시세,http://www.gokorea.kr/news/articleView.html?idxno=562871
5991,2019-11-11,한미약품실시간주식현황11일현재318500원,http://nbntv.co.kr/news/view/729847
5992,2019-11-12,한미약품폐기물줄이고재활용은급증,http://www.datanews.co.kr/news/article.html?no=105155
5993,2019-11-12,한미약품주가증권투자정보외매매동향12일현재317000원거래,http://www.gokorea.kr/news/articleView.html?idxno=564784
5994,2019-11-12,한미약품주식시세현황12일현재316000원,http://nbntv.co.kr/news/view/732059
5995,2019-11-12,주식동향한미약품12894012시현재316000원종목동정과증시정보,http://www.woodkorea.co.kr/news/articleView.html?idxno=35734
5996,2019-11-12,한미약품신약개발이끄는권세창기술반환상처딛고연임성공할까,http://www.businesspost.co.kr/BP?command=article_view&num=150803
5997,2019-11-13,11월13일한미약품128940정보281,http://www.gokorea.kr/news/articleView.html?idxno=566862
5998,2019-11-13,11월13일한미약품증권주식310000원313,http://nbntv.co.kr/news/view/734355
5999,2019-11-13,한미약품내수호조로3Q실적양호,https://www.paxnetnews.com/articles/53834
6000,2019-11-13,경영스코프기술수출명가한미약품악재에도탄탄한기초체력,http://www.newstomato.com/ReadNews.aspx?no=933070
6001,2019-11-14,임종윤대표한미약품토털헬스케어그룹으로클것,https://view.asiae.co.kr/article/2019111409432660331
6002,2019-11-14,한미약품도살아남기위해오픈이노베이션했다,http://health.chosun.com/site/data/html_dir/2019/11/14/2019111400996.html
6003,2019-11-14,한미약품아모잘탄패밀리고혈압치료병용시우선적권고근거충분,http://www.dailysmart.co.kr/news/articleView.html?idxno=18128
6004,2019-11-14,한미약품고혈압학회서아모잘탄패밀리임상적근거발표,http://www.newspim.com/news/view/20191114000600
6005,2019-11-14,한미약품아모잘탄패밀리고혈압치료병용시우선권고충분,http://www.newslock.co.kr/news/articleView.html?idxno=23330
6006,2019-11-14,11월14일한미약품128940오늘시세및증권정보와종목동정176,http://www.gokorea.kr/news/articleView.html?idxno=568869
6007,2019-11-14,한미약품아모잘탄병용치료시우선권고근거충분”,https://www.paxnetnews.com/articles/53868
6008,2019-11-14,한미약품살아남기위해오픈이노베이션추진했다,http://www.bosa.co.kr/news/articleView.html?idxno=2116003
6009,2019-11-14,한미약품고혈압학회서복합신약시리즈아모잘탄패밀리임상근거발표,https://www.sedaily.com/NewsView/1VQSM6T9Y5
6010,2019-11-14,한미약품아모잘탄패밀리이상적인복합제,http://news.mt.co.kr/mtview.php?no=2019111411000377264
6011,2019-11-14,한미약품아모잘탄패밀리고혈압치료병용시우선적권고근거충분,http://www.pressm.kr/news/articleView.html?idxno=26025
6012,2019-11-14,11월14일한미약품오늘주식시장144316500원,http://nbntv.co.kr/news/view/736599
6013,2019-11-14,한미약품아모잘탄패밀리고혈압치료병용시우선권고근거충분,http://www.econovill.com/news/articleView.html?idxno=377447
6014,2019-11-14,주가시황한미약품128940거래시세317000원,http://www.woodkorea.co.kr/news/articleView.html?idxno=36481
6015,2019-11-14,바이오시밀러테마오후시황상승률상위종목셀트리온276한올바이오파마192한미약품160등,http://www.gokorea.kr/news/articleView.html?idxno=569479
6016,2019-11-14,한미약품아모잘탄3종고혈압치료병용요법우선권고근거충분,http://news1.kr/articles/?3768979
6017,2019-11-14,한미약품아모잘탄패밀리고혈압치료병용시우선적권고근거충분”,http://www.lawissue.co.kr/view.php?ud=20191114141123526204ead0791_12
6018,2019-11-14,한미약품대한고혈압학회서아모잘탄패밀리임상적근거가치발표,http://www.wikileaks-kr.org/news/articleView.html?idxno=70031
6019,2019-11-14,공개석상모습드러내는임성기한미약품회장장남임종윤대표,http://www.mediapen.com/news/view/476621
6020,2019-11-14,한미약품아모잘탄플러스임상근거발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1349295
6021,2019-11-14,한미약품아모잘탄플러스임상적근거발표,http://www.ebn.co.kr/news/view/1009303/?sc=naver
6022,2019-11-14,한미약품아모잘탄패밀리임상적근거발표,http://www.smedaily.co.kr/news/articleView.html?idxno=87587
6023,2019-11-14,한미약품국내외의료진아모잘탄패밀리고혈압치료병용시우선적권고근거충분,http://www.techholic.co.kr/news/articleView.html?idxno=187222
6024,2019-11-14,한미약품아모잘탄패밀리고혈압학회학술대회서임상적근거주목,http://www.newspost.kr/news/articleView.html?idxno=73794
6025,2019-11-14,한미약품3Q실적매출액2069억원전분기대비40감소영업이익206↓개별확정,http://www.newspim.com/news/view/20191114002036
6026,2019-11-14,한미약품아모잘탄패밀리우선권고될고혈압치료제로근거발표,http://www.100ssd.co.kr/news/articleView.html?idxno=65367
6027,2019-11-14,한미약품아모잘탄패밀리고혈압치료병용시우선적권고근거충분,http://www.newscj.com/news/articleView.html?idxno=683446
6028,2019-11-15,한미약품아모잘탄패밀리우선권고근거충분,http://www.monews.co.kr/news/articleView.html?idxno=206473
6029,2019-11-15,바이오시밀러테마오전시황상승률상위종목이수앱지스014한미약품016제넥신018등,http://www.gokorea.kr/news/articleView.html?idxno=570206
6030,2019-11-15,09시35분바이오시밀러오전테마시황한미약품한올바이오파마등이주도,http://nbntv.co.kr/news/view/738113
6031,2019-11-15,한미약품아모잘탄패밀리고혈압치료의임상근거충분,http://www.koreaittimes.com/news/articleView.html?idxno=94099
6032,2019-11-15,바이오시밀러테마오후시황상승률상위종목한올바이오파마329한미약품126제넥신보합세등,http://www.gokorea.kr/news/articleView.html?idxno=570906
6033,2019-11-15,11월15일한미약품증권그래프157변동,http://www.gokorea.kr/news/articleView.html?idxno=570948
6034,2019-11-15,13시26분바이오시밀러오후테마시황한올바이오파마한미약품등이주도,http://nbntv.co.kr/news/view/738788
6035,2019-11-15,11월15일한미약품주식종목검색323000원157,http://nbntv.co.kr/news/view/738970
6036,2019-11-15,바이오시밀러테마주마감한올바이오파마한미약품등이상승세주도,http://nbntv.co.kr/news/view/739422
6037,2019-11-15,바이오시밀러테마마감시황상승률상위종목한올바이오파마313한미약품142제넥신124등,http://www.gokorea.kr/news/articleView.html?idxno=571824
6038,2019-11-16,한미약품대한고혈압학회서아모잘탄플러스효과성강조,https://www.kpanews.co.kr/article/show.asp?idx=208594&category=D
6039,2019-11-17,한미약품오픈이노베이션K바이오위기탈출위한생존전략”발표,http://www.getnews.co.kr/view.php?ud=20191117140451492141d0c69529_16
6040,2019-11-17,한미약품아모잘탄플러스임상적근거발표,http://weekly.cnbnews.com/news/article.html?no=131169
6041,2019-11-18,바이오시밀러테마오전시황상승률상위종목이수앱지스472큐브앤컴퍼니093한미약품062등,http://www.gokorea.kr/news/articleView.html?idxno=572130
6042,2019-11-18,한미약품아모잘탄패밀리고혈압치료병용임상적근거입증,http://www.k-health.com/news/articleView.html?idxno=46275
6043,2019-11-18,장중수급포착한미약품외국인7일연속순매수행진주가186,http://www.newspim.com/news/view/20191118000382
6044,2019-11-18,11월18일한미약품종목그래프및종목관련동향정보248변화해,http://www.gokorea.kr/news/articleView.html?idxno=572714
6045,2019-11-18,한미약품투자주식18일현재330500원,http://nbntv.co.kr/news/view/740994
6046,2019-11-18,바이오시밀러테마오후시황상승률상위종목큐브앤컴퍼니325이수앱지스286한미약품202등,http://www.gokorea.kr/news/articleView.html?idxno=573059
6047,2019-11-18,18일13시바이오시밀러오후테마시황큐브앤컴퍼니한미약품등이상승세주도,http://nbntv.co.kr/news/view/741283
6048,2019-11-18,제약1조클럽3Q중RD비중증가폭셀트리온둔화한미약품꾸준,http://daily.hankooki.com/lpage/ittech/201911/dh20191118160446145630.htm
6049,2019-11-18,바이오시밀러테마마감시황상승률상위종목이수앱지스458에이프로젠제약227한미약품202등,http://www.gokorea.kr/news/articleView.html?idxno=573763
6050,2019-11-18,연말건강관리한미약품나인나인영양제한알로하루권장비타민D섭취도OK,https://www.sedaily.com/NewsView/1VQUHWQ5YM
6051,2019-11-19,한미약품계열사코리중국서대사성질환예방기금설립,http://www.medisobizanews.com/news/articleView.html?idxno=64093
6052,2019-11-19,한미약품그룹中의학재단과대사질환예방기금설립,http://news.mt.co.kr/mtview.php?no=2019111909561344499
6053,2019-11-19,한미약품계열사코리중국서대사성질환예방기금설립,http://www.rapportian.com/news/articleView.html?idxno=121552
6054,2019-11-19,한미약품계열사코리중국서대사성질환예방기금설립,http://yna.kr/PYH20191119050000017?did=1196m
6055,2019-11-19,한미약품그룹계열사코리중국의료기관과임신성당뇨공동연구,http://www.sportsseoul.com/news/read/850708
6056,2019-11-19,한미약품주가증권투자정보19일오늘가격327000원거래,http://www.gokorea.kr/news/articleView.html?idxno=574673
6057,2019-11-19,한미약품계열사코리북경협화의학재단과대사성질환예방전문기금설립,http://www.newspim.com/news/view/20191119000296
6058,2019-11-19,한미약품계열사코리대사성질환예방전문기금설립,http://medipana.com/news/news_viewer.asp?NewsNum=248840&MainKind=A&NewsKind=5&vCount=12&vKind=1
6059,2019-11-19,한미약품주가그래프19일현재329000원,http://nbntv.co.kr/news/view/743261
6060,2019-11-19,한미약품계열코리중국과대사성질환예방전문기금설립,http://news1.kr/articles/?3772561
6061,2019-11-19,한미약품계열사코리임종윤대표대사질환기금설립,http://www.newsis.com/view/?id=NISX20191119_0000834136&cID=13001&pID=13000
6062,2019-11-19,한미약품그룹북경협화의학재단과대사성질환예방전문기금설립,http://www.businesspost.co.kr/BP?command=article_view&num=151673
6063,2019-11-19,한미약품계열사코리임종윤대표中의학재단과대사질환예방기금설립,http://www.pressm.kr/news/articleView.html?idxno=26093
6064,2019-11-19,한미약품계열사코리中북경협화병원과대사성질환예방기금설립협약식,https://biz.chosun.com/site/data/html_dir/2019/11/19/2019111901580.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6065,2019-11-19,한미약품계열사코리북경협화병원의학재단과대사성질환예방전문기금설립,http://4th.kr/View.aspx?No=325271
6066,2019-11-19,한미약품계열사코리대사성질환예방전문기금설립”,http://sports.hankooki.com/lpage/economy/201911/sp20191119122756137020.htm
6067,2019-11-19,제약워치한미약품계열사코리북경협화의학재단과대사성질환예방전문기금설립外,http://www.newswatch.kr/news/articleView.html?idxno=25147
6068,2019-11-19,바이오시밀러테마오후시황상승률상위종목에이프로젠제약1644한미약품015한올바이오파마076등,http://www.gokorea.kr/news/articleView.html?idxno=575479
6069,2019-11-19,13시22분바이오시밀러오후의테마종목에이프로젠제약한미약품등이상승세주도,http://nbntv.co.kr/news/view/743916
6070,2019-11-19,한미약품계열사코리중국서대사성질환예방기금설립,http://www.newsway.co.kr/news/view?tp=1&ud=2019111913401453257
6071,2019-11-19,한미약품그룹북경협화병원과임산부대사질환예방전문기금설립,http://news.mk.co.kr/newsRead.php?year=2019&no=961027
6072,2019-11-19,바이오시밀러테마주마감에이프로젠제약한미약품등이주도,http://nbntv.co.kr/news/view/744553
6073,2019-11-19,한미약품그룹中병원재단과대사질환예방기금설립,http://www.biospectator.com/view/news_view.php?varAtcId=8931
6074,2019-11-19,바이오시밀러테마마감시황상승률상위종목에이프로젠제약756한미약품015한올바이오파마076등,http://www.gokorea.kr/news/articleView.html?idxno=575787
6075,2019-11-19,한미약품계열사북경협화병원대사성질환예방전문기금설립,http://www.etnews.com/20191119000278
6076,2019-11-19,한미약품그룹북경협화의학재단대사성질환예방전문기금설립,http://www.ntoday.co.kr/news/articleView.html?idxno=69495
6077,2019-11-19,한미약품코리임종윤대표북경협화의학재단과대사성질환예방전문기금설립,http://www.thefirstmedia.net/news/articleView.html?idxno=50872
6078,2019-11-19,한미약품그룹북경협화의학재단과손잡고대사성질환예방전문기금설립,http://www.nspna.com/news/?mode=view&newsid=394641
6079,2019-11-20,한미약품라본디수입약밀어내고월매출1위등극,http://www.bosa.co.kr/news/articleView.html?idxno=2116313
6080,2019-11-20,한미약품라본디골다공증시장두각‥원외처방첫1위,http://medipana.com/news/news_viewer.asp?NewsNum=248866&MainKind=A&NewsKind=5&vCount=12&vKind=1
6081,2019-11-20,제약바이오판관비1등한미약품삼성바이오,http://moneys.mt.co.kr/news/mwView.php?no=2019112008208038669
6082,2019-11-20,토종제약사한미약품10년간매출34RD에투자,http://www.datanews.co.kr/news/article.html?no=105182
6083,2019-11-20,한미약품라본디골다공증치료제원외처방첫1위,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132196
6084,2019-11-20,바이오시밀러테마오전시황상승률상위종목큐브앤컴퍼니277한미약품228셀트리온082등,http://www.gokorea.kr/news/articleView.html?idxno=575955
6085,2019-11-20,한국중국산모아기건강챙긴다한미약품그룹기금설립,http://news.heraldcorp.com/view.php?ud=20191120000091
6086,2019-11-20,20일09시바이오시밀러오전의테마종목큐브앤컴퍼니한미약품등이주도,http://nbntv.co.kr/news/view/744890
6087,2019-11-20,우종수한미약품대표이사문화예술진흥위한18년건강한사회만들기앞장,http://news.mk.co.kr/newsRead.php?year=2019&no=963920
6088,2019-11-20,한미약품기록을넘어예술로한국사진떠받쳐온든든한동반자,http://news.mk.co.kr/newsRead.php?year=2019&no=963918
6089,2019-11-20,fnRASSI한미약품425오르며거래량증가,http://www.fnnews.com/news/201911201005060361
6090,2019-11-20,장중수급포착한미약품외국인15582주대량순매수주가334,http://www.newspim.com/news/view/20191120000323
6091,2019-11-20,한미약품계열사코리中서대사성질환예방기금협약,http://news.heraldcorp.com/view.php?ud=20191120000409
6092,2019-11-20,11월20일한미약품오늘주식장243337500원,http://nbntv.co.kr/news/view/745575
6093,2019-11-20,바이오시밀러테마오후시황상승률상위종목큐브앤컴퍼니262한미약품182셀트리온027등,http://www.gokorea.kr/news/articleView.html?idxno=577406
6094,2019-11-20,13시25분바이오시밀러오후의테마종목큐브앤컴퍼니한미약품등이주도,http://nbntv.co.kr/news/view/746246
6095,2019-11-20,살까말까이종목한미약품글로벌임상모멘텀주목,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019112013191166415
6096,2019-11-20,바이오시밀러테마마감시황한미약품셀트리온등이주도,http://nbntv.co.kr/news/view/746878
6097,2019-11-20,바이오시밀러테마마감시황상승률상위종목한미약품167셀트리온054큐브앤컴퍼니046등,http://www.gokorea.kr/news/articleView.html?idxno=577747
6098,2019-11-21,표20일기준코스피외국인순매수Top30KB금융1위약301억원신한지주90억원카카오88억원하나금융지주62억원한미약품101억원주가순으로외국인매수나서일간순매수상위,http://www.fintechpost.co.kr/news/articleView.html?idxno=90496
6099,2019-11-21,팔팔상표함부로못쓴다법원한미약품팔팔인정,http://www.fnnews.com/news/201911211109096487
6100,2019-11-21,팔팔상표함부로못쓴다”한미약품팔팔상표권소송승소,http://www.newsway.co.kr/news/view?tp=1&ud=2019112111095170611
6101,2019-11-21,팔팔상표함부로못쓴다한미약품팔팔상표권소송승소,http://www.straightnews.co.kr/news/articleView.html?idxno=60663
6102,2019-11-21,팔팔은우리시그니처한미약품상표권승소,http://moneys.mt.co.kr/news/mwView.php?no=2019112111118013226
6103,2019-11-21,건기식에팔팔상표함부로못쓴다한미약품특허소송승소,http://www.metroseoul.co.kr/news/newsview?newscd=2019112100041
6104,2019-11-21,한미약품팔팔상표권소송서승소,http://www.biospectator.com/view/news_view.php?varAtcId=8948
6105,2019-11-21,팔팔상표함부로못쓴다한미약품팔팔상표권소송승소,http://www.pressm.kr/news/articleView.html?idxno=26138
6106,2019-11-21,팔팔상표함부로못쓴다한미약품팔팔상표권소송승소,http://www.mediapen.com/news/view/478493
6107,2019-11-21,팔팔상품명못쓴다한미약품팔팔상표권승소,https://biz.chosun.com/site/data/html_dir/2019/11/21/2019112101501.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6108,2019-11-21,한미약품팔팔명성인정건기식팔팔상표함부로못쓴다,http://www.medisobizanews.com/news/articleView.html?idxno=64169
6109,2019-11-21,팔팔상표한미약품만쓸수있어,https://www.sedaily.com/NewsView/1VQVV9BFBI
6110,2019-11-21,한미약품팔팔상표권건소송서승소,http://www.newspim.com/news/view/20191121000474
6111,2019-11-21,실시간증시한미약품주가21일현재323500원,http://nbntv.co.kr/news/view/747901
6112,2019-11-21,팔팔상표함부로못쓴다법원한미약품승소판결,http://news.heraldcorp.com/view.php?ud=20191121000560
6113,2019-11-21,한미약품팔팔상표권소송승소팔팔함부로못쓴다,http://www.newslock.co.kr/news/articleView.html?idxno=23569
6114,2019-11-21,팔팔상표함부로못쓴다법원한미약품팔팔의명성인정,http://www.newsis.com/view/?id=NISX20191121_0000836823&cID=13001&pID=13000
6115,2019-11-21,한미약품팔팔상표함부로못쓴다”법원건기식청춘팔팔상표권무효판결,http://www.viva100.com/main/view.php?key=20191121010007345
6116,2019-11-21,한미약품팔팔상표권승소건기식청춘팔팔상표권무효판결,http://www.babytimes.co.kr/news/articleView.html?idxno=31109
6117,2019-11-21,팔팔상표함부로못쓴다”법원한미약품팔팔주지성⋅식별력인정,http://www.nextdaily.co.kr/news/article.html?id=20191121800021
6118,2019-11-21,한미약품팔팔상표함부로못쓴다,http://www.sisafocus.co.kr/news/articleView.html?idxno=226224
6119,2019-11-21,팔팔상표함부로못쓴다한미약품팔팔상표권소송승소,http://news.mk.co.kr/newsRead.php?year=2019&no=968829
6120,2019-11-21,팔팔상표함부로못쓴다”법원한미약품팔팔명성인정,http://www.fetv.co.kr/news/article.html?no=40924
6121,2019-11-21,한미약품발기부전약팔팔상표함부로못쓴다법원고유성인정,http://news1.kr/articles/?3774731
6122,2019-11-21,팔팔상표함부로못쓴다특허법원한미약품팔팔명성인정,http://www.ezyeconomy.com/news/articleView.html?idxno=95586
6123,2019-11-21,건기식등에팔팔상표함부로못쓴다한미약품상표권소송승소,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074384
6124,2019-11-21,팔팔함부로쓰지마세요한미약품소송이겨,http://www.dailymedi.com/detail.php?number=849812&thread=22r05
6125,2019-11-21,한미약품팔팔상표권소송서승소,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000051993
6126,2019-11-21,팔팔상표함부로못쓴다”법원한미약품팔팔명성인정,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=535167
6127,2019-11-21,팔팔상표함부로못쓴다”법원한미약품팔팔명성인정,http://www.getnews.co.kr/view.php?ud=2019112113163938441d0c69529_16
6128,2019-11-21,한미약품라본디원외처방첫1위”,https://www.kpanews.co.kr/article/show.asp?idx=208796&category=D
6129,2019-11-21,팔팔상표함부로못쓴다법원한미약품손들어줘,http://www.edaily.co.kr/news/newspath.asp?newsid=02870006622688016
6130,2019-11-21,팔팔상표함부로못쓴다한미약품특허소송승소,http://www.econovill.com/news/articleView.html?idxno=378097
6131,2019-11-21,팔팔상표쓰지마”한미약품팔팔상표권소송승소,http://www.etoday.co.kr/news/section/newsview.php?idxno=1825102
6132,2019-11-21,한미약품팔팔명성에얹혀가려구안돼,http://www.bosa.co.kr/news/articleView.html?idxno=2116467
6133,2019-11-21,한미약품팔팔명성우뚝섰다,http://www.whosaeng.com/114132
6134,2019-11-21,팔팔함부로못쓴다한미약품발기부전치료제팔팔상표권인정,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911210315&t=NN
6135,2019-11-21,팔팔상표권함부로못쓴다한미약품팔팔상표권승소,http://kormedi.com/?p=1306218
6136,2019-11-21,한미약품팔팔상표함부로못쓴다 ,http://www.seoulfn.com/news/articleView.html?idxno=363180
6137,2019-11-21,법원한미약품비아그라복제약팔팔에편승한건강기능식품상표권무효,http://news.mk.co.kr/newsRead.php?year=2019&no=969440
6138,2019-11-21,한미약품발기부전치료제팔팔상표권소송승소,http://www.newstomato.com/ReadNews.aspx?no=934944
6139,2019-11-21,한미약품팔팔이름지켰다상표권승소,http://news.mt.co.kr/mtview.php?no=2019112111304991539
6140,2019-11-21,한미약품특허법원판결로팔팔상표권고유성가치인정받아,http://www.rapportian.com/news/articleView.html?idxno=121644
6141,2019-11-21,한미약품손들어준법원팔팔상표함부로못써,https://view.asiae.co.kr/article/2019112114321525923
6142,2019-11-21,법원한미약품팔팔명성인정팔팔상표함부로못쓴다,http://www.newswatch.kr/news/articleView.html?idxno=25199
6143,2019-11-21,한미약품발기부전치료제팔팔상표권소송승소,http://health.chosun.com/site/data/html_dir/2019/11/21/2019112101909.html
6144,2019-11-21,팔팔상표함부로못쓴다한미약품팔팔상표권승소,http://www.sisajournal-e.com/news/articleView.html?idxno=209330
6145,2019-11-21,한미약품팔팔상표권소송승소,http://www.smedaily.co.kr/news/articleView.html?idxno=87726
6146,2019-11-21,제품명에팔팔함부로못쓴다한미약품팔팔상표권승소,http://4th.kr/View.aspx?No=329346
6147,2019-11-21,한미약품팔팔상표권소송승소,http://www.newsian.co.kr/news/articleView.html?idxno=37839
6148,2019-11-21,특허법원한미약품발기부전치료제팔팔의고유상표권인정,http://www.businesspost.co.kr/BP?command=article_view&num=152086
6149,2019-11-21,팔팔상표함부로못쓴다한미약품상표권분쟁승소,http://www.enewstoday.co.kr/news/articleView.html?idxno=1350852
6150,2019-11-21,한미약품팔팔상표권소송승소,http://www.joseilbo.com/news/news_read.php?uid=387732&class=27&grp=
6151,2019-11-21,팔팔상표함부로못쓴다”법원한미약품팔팔의명성인정,http://www.mdtoday.co.kr/mdtoday/index.html?no=370775
6152,2019-11-21,한미약품팔팔상표권소송승소,http://www.ebn.co.kr/news/view/1010250/?sc=naver
6153,2019-11-21,한미약품팔팔상표권소송서승소,http://yna.kr/AKR20191121134900017?did=1195m
6154,2019-11-21,팔팔브랜드저명성주지성공식인정받다한미약품팔팔상표권무단사용업체에승소,http://www.updownnews.co.kr/news/articleView.html?idxno=211406
6155,2019-11-21,한미약품팔팔의명성인정법원팔팔상표함부로못쓴다,http://www.techholic.co.kr/news/articleView.html?idxno=187413
6156,2019-11-21,팔팔건기식에함부로못쓴다한미약품상표권소송승소,http://biz.newdaily.co.kr/site/data/html/2019/11/21/2019112100154.html
6157,2019-11-21,특허법원한미약품팔팔브랜드가치인정,http://www.monews.co.kr/news/articleView.html?idxno=206643
6158,2019-11-21,특허법원한미약품팔팔브랜드가치인정,http://www.monews.co.kr/news/articleView.html?idxno=206643
6159,2019-11-21,발기부전치료제에팔팔상표함부로못쓴다법원한미약품팔팔식별력인정,http://www.ceoscoredaily.com/news/article.html?no=62722
6160,2019-11-21,팔팔상표함부로못쓴다한미약품상표권소송승소,http://www.youthdaily.co.kr/news/article.html?no=23172
6161,2019-11-21,한미약품팔팔상표함부로못쓴다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1226082
6162,2019-11-21,한미약품팔팔상표소송승소법원서명성인정받았다,http://medipana.com/news/news_viewer.asp?NewsNum=249022&MainKind=A&NewsKind=5&vCount=12&vKind=1
6163,2019-11-21,한미약품팔팔상표권소송서승소,http://www.dt.co.kr/contents.html?article_no=2019112102109931102007&ref=naver
6164,2019-11-21,한미약품팔팔상표권분쟁서승소,https://jhealthmedia.joins.com/article/article_view.asp?pno=21118
6165,2019-11-21,팔팔상표함부로못쓴다법원한미약품팔팔의명성인정,http://www.aitimes.com/news/articleView.html?idxno=122139
6166,2019-11-21,한미약품팔팔상표권소송승소건강기능식품등에팔팔상호못써,http://www.nspna.com/news/?mode=view&newsid=395126
6167,2019-11-21,한미약품팔팔상표권소송승소,http://www.cnbnews.com/news/article.html?no=428262
6168,2019-11-21,한미약품팔팔상표권소송서승소,http://www.koreastocknews.com/news/articleView.html?idxno=48235
6169,2019-11-21,한미약품팔팔상표권소송승소,https://www.paxnetnews.com/articles/54112
6170,2019-11-21,팔팔상표함부로못쓴다법원한미약품팔팔의명성인정,http://www.medigatenews.com/news/3199166405
6171,2019-11-21,한미약품팔팔상표권소송승소,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58312
6172,2019-11-21,한미약품팔팔상표권소송승소,http://www.ekn.kr/news/article.html?no=465246
6173,2019-11-21,한미약품팔팔함부로못쓴다,http://www.economytalk.kr/news/articleView.html?idxno=201245
6174,2019-11-21,한미약품팔팔이름지켰다법원주지성인정유사상표위법,http://www.newsworks.co.kr/news/articleView.html?idxno=412889
6175,2019-11-21,팔팔상표함부로못쓴다”법원한미약품상표권승소,http://www.bokuennews.com/news/article.html?no=183593
6176,2019-11-21,팔팔상표함부로못쓴다한미약품팔팔상표권소송서승소,http://www.dailypop.kr/news/articleView.html?idxno=42182
6177,2019-11-21,팔팔상표함부로못쓴다법원한미약품팔팔저명성인정,http://www.wikileaks-kr.org/news/articleView.html?idxno=70546
6178,2019-11-21,한미약품팔팔상표권소송서승소법원명성인정,http://www.seoulwire.com/news/articleView.html?idxno=258188
6179,2019-11-21,팔팔상표함부로못쓴다법원한미약품팔팔의명성인정,http://www.lawissue.co.kr/view.php?ud=201911211902278293204ead0791_12
6180,2019-11-21,한미약품팔팔상표권소송승소상표로서확고한주지성보유,http://www.paxetv.com/news/articleView.html?idxno=82008
6181,2019-11-22,한미약품건기식청춘팔팔상표소송서이겨,https://www.kpanews.co.kr/article/show.asp?idx=208818&category=D
6182,2019-11-22,팔팔상표권수성한미약품6년분쟁서유리한고지,http://www.dailypharm.com/Users/News/NewsView.html?ID=259185&REFERER=NP
6183,2019-11-22,11월22일한미약품주가그래프125317000원,http://nbntv.co.kr/news/view/750180
6184,2019-11-22,바이오시밀러테마마감시황상승률상위종목한올바이오파마172이수앱지스030한미약품016등,http://www.gokorea.kr/news/articleView.html?idxno=581550
6185,2019-11-22,복지부한미약품약가소송대법원까지진행,http://www.yakup.com/news/index.html?mode=view&cat=11&nid=237744
6186,2019-11-23,팔팔상표함부로못쓴다”특허법원한미약품팔팔의명성인정,http://www.g-enews.com/ko-kr/news/article/news_all/20191121151020766269d76442fa_1/article.html
6187,2019-11-24,한미약품팔팔상표권소송승소”,http://weekly.cnbnews.com/news/article.html?no=131273
6188,2019-11-25,한미약품비알콜성지방간염약시장게임체인저,http://www.dailymedi.com/detail.php?number=849902&thread=22r05
6189,2019-11-25,11월25일한미약품주식주가325000원140,http://nbntv.co.kr/news/view/752607
6190,2019-11-26,한미약품주가11월26일현재331500원종목그래프,http://www.gokorea.kr/news/articleView.html?idxno=584216
6191,2019-11-26,주식그래프한미약품주가26일현재332000원,http://nbntv.co.kr/news/view/755213
6192,2019-11-26,권세창미국에서내년신약2개허가받아한미약품능력입증별러,http://www.businesspost.co.kr/BP?command=article_view&num=152706
6193,2019-11-27,한미약품심초음파학회서아모잘탄로수젯임상적장점뽐내,https://www.sedaily.com/NewsView/1VQYL3PRKT
6194,2019-11-27,한미약품심초음파학회학술대회서산학세션개최,http://medipana.com/news/news_viewer.asp?NewsNum=249290&MainKind=A&NewsKind=5&vCount=12&vKind=1
6195,2019-11-27,한미약품한국심초음파학회추계학술대회서산학세션개최,http://www.fnnews.com/news/201911270940557093
6196,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237894
6197,2019-11-27,한미약품한국심초음파학회추계학술대회서산학세션개최,http://daily.hankooki.com/lpage/ittech/201911/dh20191127094314145630.htm
6198,2019-11-27,한미약품이중항체플랫폼펜탐바디임상본격화,http://medipana.com/news/news_viewer.asp?NewsNum=249296&MainKind=A&NewsKind=5&vCount=12&vKind=1
6199,2019-11-27,한미약품한국심초음파학회추계학술대회서산학세션개최,http://www.dailian.co.kr/news/view/847083/?sc=naver
6200,2019-11-27,한미약품한국심초음파학회서아모잘탄패밀리로수젯임상근거발표,http://www.newspim.com/news/view/20191127000220
6201,2019-11-27,한미약품中서펜탐바디임상본격화신약첫환자투여완료,http://www.viva100.com/main/view.php?key=20191127010009321
6202,2019-11-27,한미약품펜탐바디임상개발본격화첫번째환자투여성공,http://kpenews.com/View.aspx?No=335197
6203,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.fetv.co.kr/news/article.html?no=41322
6204,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.straightnews.co.kr/news/articleView.html?idxno=61048
6205,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.metroseoul.co.kr/news/newsview?newscd=2019112700032
6206,2019-11-27,한미약품이중항체플랫폼펜탐바디임상착수,https://www.paxnetnews.com/articles/54273
6207,2019-11-27,한미약품면역표적항암이중항체신약임상본격화,http://news.heraldcorp.com/view.php?ud=20191127000142
6208,2019-11-27,한미약품이중항체플랫폼펜탐바디임상진행,https://asiatime.co.kr/news/newsview.php?ncode=1065573911194648
6209,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.joseilbo.com/news/news_read.php?uid=388013&class=27&grp=
6210,2019-11-27,한미약품이중항체플랫폼펜탐바디中서임상개발본격화,https://www.sedaily.com/NewsView/1VQYMCOUW0
6211,2019-11-27,한미약품중국서이중항체플랫폼펜탐바디임상본격화,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911270145&t=NN
6212,2019-11-27,한미약품 이중항체플랫폼 펜탐바디신약본격임상,http://www.medisobizanews.com/news/articleView.html?idxno=64312
6213,2019-11-27,한미약품심초음파학회산학세션개최아모잘탄패밀리로수젯주목,http://www.metroseoul.co.kr/news/newsview?newscd=2019112700035
6214,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000052080
6215,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발빨라진다,http://news1.kr/articles/?3779183
6216,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.dailypharm.com/Users/News/NewsView.html?ID=259392&REFERER=NP
6217,2019-11-27,한미약품이중항체플랫폼적용표적항암신약임상돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2019112710140969693
6218,2019-11-27,한미약품이중항체플랫폼펜탐바디적용항암신약개발본격화,http://www.etoday.co.kr/news/section/newsview.php?idxno=1827177
6219,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발나선다,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132291
6220,2019-11-27,한미약품자체개발펜탐바디임상개발본격화,http://www.newsprime.co.kr/news/article.html?no=484822
6221,2019-11-27,한미약품이중항체플랫폼임상개발가속,https://view.asiae.co.kr/article/2019112710203558454
6222,2019-11-27,한미약품이중항체플랫폼펜탐바디中임상본격화,http://www.newsis.com/view/?id=NISX20191127_0000842548&cID=13001&pID=13000
6223,2019-11-27,한미약품아모잘탄패밀리로수젯점유율1위근거있네,http://www.medisobizanews.com/news/articleView.html?idxno=64316
6224,2019-11-27,한미약품이중항체플랫폼펜탐바디면역표적항암신약임상본격화,http://inthenews.co.kr/article-25965/
6225,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.gukjenews.com/news/articleView.html?idxno=1205018
6226,2019-11-27,한미약품심초음파학회추계학술대회서산학세션개최,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201911270138&t=NN
6227,2019-11-27,한미약품23일한국심초음파학회추계학술대회서산학세션개최,http://www.nextdaily.co.kr/news/article.html?id=20191127800017
6228,2019-11-27,제약워치한미약품이중항체플랫폼펜탐바디임상개발본격화外,http://www.newswatch.kr/news/articleView.html?idxno=25313
6229,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.dailian.co.kr/news/view/847132/?sc=naver
6230,2019-11-27,한미약품아모잘탄패밀리로수젯근거있는시장점유율1위,http://www.newspost.kr/news/articleView.html?idxno=74033
6231,2019-11-27,한미약품한국심초음파학회추계학술대회서산학세션개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=18730
6232,2019-11-27,한미약품2한국심초음파학회추계학술대회서산학세션개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58419
6233,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58421
6234,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.sisajournal-e.com/news/articleView.html?idxno=209648
6235,2019-11-27,한미약품중국서이중항체펜탐바디적용항암신약임상개발본격화,http://www.newspim.com/news/view/20191127000260
6236,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.dailysmart.co.kr/news/articleView.html?idxno=18736
6237,2019-11-27,11월27일한미약품128940오늘시세105변화,http://www.gokorea.kr/news/articleView.html?idxno=585932
6238,2019-11-27,한미약품아모잘탄패밀리로수젯점유율1위근거있다”,http://sports.hankooki.com/lpage/economy/201911/sp20191127104147137020.htm
6239,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화”,http://sports.hankooki.com/lpage/economy/201911/sp20191127104016137020.htm
6240,2019-11-27,한미약품이중항체펜탐바디항암제임상中서개시,http://news.mt.co.kr/mtview.php?no=2019112710472699305
6241,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://news.mk.co.kr/newsRead.php?year=2019&no=988786
6242,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.m-i.kr/news/articleView.html?idxno=658910
6243,2019-11-27,한미약품펜탐바디임상개발본격돌입 ,http://www.monews.co.kr/news/articleView.html?idxno=206744
6244,2019-11-27,한미약품심초음파학회서아모잘탄패밀리로수젯홍보,http://www.monews.co.kr/news/articleView.html?idxno=206741
6245,2019-11-27,한미약품추계산학세션서아모잘탄패밀리∙로수젯점유율1위근거확인해,http://www.newslock.co.kr/news/articleView.html?idxno=23738
6246,2019-11-27,한미약품이중항체플랫폼펜탐바디中서임상개시,http://www.mdtoday.co.kr/mdtoday/index.html?no=371210
6247,2019-11-27,한미약품이중항체플랫폼펜탐바디기반임상개발시작첫환자투여완료,http://www.newslock.co.kr/news/articleView.html?idxno=23740
6248,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://daily.hankooki.com/lpage/ittech/201911/dh20191127111505145630.htm
6249,2019-11-27,한미약품추계학술대회산학세션개최아모잘탄패밀리로수젯주목,http://www.pressm.kr/news/articleView.html?idxno=26229
6250,2019-11-27,한미약품23일한국심초음파학회추계학술대회서산학세션개최,http://www.lawissue.co.kr/view.php?ud=201911271129581093204ead0791_12
6251,2019-11-27,한미약품아모잘탄패밀리로수젯점유율1위왜,http://www.econovill.com/news/articleView.html?idxno=378596
6252,2019-11-27,11월27일한미약품주식추천주329500원105,http://nbntv.co.kr/news/view/756453
6253,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.pressm.kr/news/articleView.html?idxno=26233
6254,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.bosa.co.kr/news/articleView.html?idxno=2116815
6255,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.techholic.co.kr/news/articleView.html?idxno=187551
6256,2019-11-27,한미약품이중항체플랫폼펜탐바디항암신약임상본격화,http://www.getnews.co.kr/view.php?ud=20191127120235805341d0c69529_16
6257,2019-11-27,한미약품이중항체플랫폼펜탐바디임상돌입,http://www.rapportian.com/news/articleView.html?idxno=121786
6258,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발중국에서본격화,http://www.koreaittimes.com/news/articleView.html?idxno=94315
6259,2019-11-27,한미약품이중항체기술펜탐바디임상1상첫환자투여,https://www.hankyung.com/finance/article/2019112764006
6260,2019-11-27,차세대면역표적항암신약한미약품中서임상시험,https://www.hankyung.com/it/article/201911276449i
6261,2019-11-27,한미약품이중항체플랫폼펜탐바디적용한항암제개발본격화,http://news.mk.co.kr/newsRead.php?year=2019&no=990028
6262,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.smedaily.co.kr/news/articleView.html?idxno=87862
6263,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.ebn.co.kr/news/view/1011024/?sc=naver
6264,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.econovill.com/news/articleView.html?idxno=378611
6265,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.efnews.co.kr/news/articleView.html?idxno=82080
6266,2019-11-27,한미약품이중항체플랫폼펜탐바디적용항암신약임상개시,https://biz.chosun.com/site/data/html_dir/2019/11/27/2019112702065.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6267,2019-11-27,한미약품면역항암이중항체플랫폼펜탐바디임상개발본격화,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=535305
6268,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.fnnews.com/news/201911271433263319
6269,2019-11-27,한미약품이중항체플랫폼펜탐바디중국서임상개발,http://moneys.mt.co.kr/news/mwView.php?no=2019112714448010136
6270,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.bokuennews.com/news/article.html?no=183848
6271,2019-11-27,한미약품이중항체기술적용한항암신약개발을중국에서본격화,http://www.businesspost.co.kr/BP?command=article_view&num=152859
6272,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.medigatenews.com/news/2096255020
6273,2019-11-27,한미약품이중항체항암신약임상개발본격,http://4th.kr/View.aspx?No=335870
6274,2019-11-27,한미약품이중항체플랫폼펜탐바디중국임상본격화,http://www.newstomato.com/ReadNews.aspx?no=936251
6275,2019-11-27,한미약품이중항체플랫폼펜탐바디중국서임상개발,http://www.seoulwire.com/news/articleView.html?idxno=260379
6276,2019-11-27,한미약품이중항체플랫폼펜탐바디적용신약개발본격화,http://www.shinailbo.co.kr/news/articleView.html?idxno=1227846
6277,2019-11-27,한미약품이중항체플랫폼펜탐바디中임상추진,http://www.mhj21.com/125932
6278,2019-11-27,한미약품북경법인항암신약개발본격착수,http://www.edaily.co.kr/news/newspath.asp?newsid=03594886622689984
6279,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.etnews.com/20191127000254
6280,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.lawissue.co.kr/view.php?ud=201911271744147977204ead0791_12
6281,2019-11-27,한미약품중국서이중항체플랫폼펜탐바디개발본격화임상1상첫환자투여,http://www.updownnews.co.kr/news/articleView.html?idxno=211660
6282,2019-11-27,한미약품한국심초음파학회추계학술대회서산학세션열어,https://www.kpanews.co.kr/article/show.asp?idx=209029&category=D
6283,2019-11-27,한미약품中서이중항체플랫폼펜탐바디임상개발,http://www.100ssd.co.kr/news/articleView.html?idxno=65665
6284,2019-11-27,한미약품심초음파학회추계학술대회서산학세션개최,http://www.wikileaks-kr.org/news/articleView.html?idxno=71010
6285,2019-11-27,한미약품중국서이중항체플랫폼펜탐바디임상개발본격화,http://www.wikileaks-kr.org/news/articleView.html?idxno=71011
6286,2019-11-27,한미약품이중항체항암신약임상본격화,http://www.finomy.com/news/articleView.html?idxno=72264
6287,2019-11-27,한미약품펜탐바디적용신약임상본궤도첫환자투여성공,http://www.paxetv.com/news/articleView.html?idxno=82384
6288,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.businesskorea.co.kr/news/articleView.html?idxno=38593
6289,2019-11-27,한미약품중국현지법인이중항체플랫폼펜탐바디임상개발본격화,http://www.kdpress.co.kr/news/articleView.html?idxno=93587
6290,2019-11-27,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.nspna.com/news/?mode=view&newsid=396319
6291,2019-11-27,한미약품한국심초음파학회추계학술대회산학세션개최,http://www.newscj.com/news/articleView.html?idxno=686839
6292,2019-11-28,한미약품한국심초음파학회추계학술대회서산학세션개최,http://www.thefirstmedia.net/news/articleView.html?idxno=51192
6293,2019-11-28,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.thefirstmedia.net/news/articleView.html?idxno=51186
6294,2019-11-28,유한양행도입약팔아외형확대vs한미약품자체개발약품판매집중,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=535312
6295,2019-11-28,한미약품펜탐바디中임상본격화,http://weekly.cnbnews.com/news/article.html?no=131363
6296,2019-11-28,한미약품이중항체플랫폼펜탐바디임상개발본격화,http://www.wsobi.com/news/articleView.html?idxno=85914
6297,2019-11-29,브랜드평판제약상장기업브랜드2019년11월빅데이터분석결과1위셀트리온2위삼성바이오로직스3위한미약품,http://www.futurekorea.co.kr/news/articleView.html?idxno=123881
6298,2019-11-29,제약상장기업브랜드평판2019년11월빅데이터1위셀트리온2위삼성바이오로직스3위한미약품,http://www.betanews.net:8080/article/1107497.html
6299,2019-11-29,한미약품복용간편한시럽제매출증가제품도확대,http://www.ceoscoredaily.com/news/article.html?no=62986
6300,2019-11-29,브랜드평판1위셀트리온2위삼성바이오3위한미약품,http://medipana.com/news/news_viewer.asp?NewsNum=249429&MainKind=A&NewsKind=5&vCount=12&vKind=1
6301,2019-11-29,상장제약사브랜드평판톱3셀트리온삼성바이오한미약품,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=237999
6302,2019-11-29,한미약품에너지골드자양강장제로인기,http://www.sisaon.co.kr/news/articleView.html?idxno=105220
6303,2019-11-29,한미약품에너지골드자양강장제부문대상후드링크제각광,http://www.100ssd.co.kr/news/articleView.html?idxno=65751
6304,2019-11-29,한미약품에너지골드코리아팜어워드굿브랜드자양강장제부문대상,http://www.nspna.com/news/?mode=view&newsid=396724
6305,2019-11-29,약사가선정한드링크제에한미약품에너지골드선정,http://www.ajunews.com/view/20191129144655694
6306,2019-11-29,하루권장비타민D한미약품나인나인으로해결,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=535387
6307,2019-11-29,비타민제로연말가심비공략나선한미약품,http://www.mhj21.com/125978
6308,2019-11-29,한미약품에너지골드약국에서사랑받는드링크제,http://www.nextdaily.co.kr/news/article.html?id=20191129800062
6309,2019-11-29,아통포토한미약품사회봉사부문수상,http://www.anewsa.com/detail.php?number=2025958&thread=01r01
6310,2019-12-01,수확기맞는한미약품RD투자결실,http://www.dt.co.kr/contents.html?article_no=2019120202101531102001&ref=naver
6311,2019-12-02,한미약품텐텐코리아팜어워드어린이종합비타민부문대상,http://www.donga.com/news/article/all/20191201/98615193/1
6312,2019-12-02,2일외국인순매수Top10SK88억하나금융지주18억GS11억한미약품10억외국인순매수나서코스닥시장에서는엠씨넥스에이치엘비국일제지상위종목으로장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=93228
6313,2019-12-02,아통포토임종호전무한미약품제14회대한민국사회공헌대상수상,http://www.anewsa.com/detail.php?number=2027088&thread=01r01
6314,2019-12-03,한미약품에너지골드약국에서사랑받는드링크제,https://www.ajunews.com/view/20191203102806718
6315,2019-12-03,한미약품한미참의료인상시상어두운우리시대에큰울림과위로,http://www.newswatch.kr/news/articleView.html?idxno=25470
6316,2019-12-03,한미약품한미참의료인상시상식개최,http://www.cnbnews.com/news/article.html?no=429481
6317,2019-12-03,한미약품한미참의료인상시상식성료,http://www.g-enews.com/ko-kr/news/article/news_all/20191203142333925969d76442fa_1/article.html
6318,2019-12-03,한미약품서울시의사회와공동제정한미참의료인상시상,http://4th.kr/View.aspx?No=341393
6319,2019-12-03,한미약품한미참의료인상시상식개최,http://www.smedaily.co.kr/news/articleView.html?idxno=87999
6320,2019-12-03,한미약품제18회한미참의료인상시상식개최,http://www.newspim.com/news/view/20191203000695
6321,2019-12-03,한미약품한미참의료인상개최연세의료원의료선교센터등수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=371704
6322,2019-12-03,한미약품한미참의료인상개최,http://www.anewsa.com/detail.php?number=2027579&thread=10r03
6323,2019-12-03,한미약품18회한미참의료인상시상식개최,http://www.ebn.co.kr/news/view/1011888/?sc=naver
6324,2019-12-03,뉴스투데이L한미약품한미참의료인상시상식개최,http://www.news2day.co.kr/143444
6325,2019-12-03,한미약품제18회한미참의료인상시상식개최,http://news.mk.co.kr/newsRead.php?year=2019&no=1010880
6326,2019-12-03,권세창한미약품사장신약개발정보공개글로벌선점위한전략이죠,https://www.hankyung.com/it/article/2019120302551
6327,2019-12-03,한미약품제18회한미참의료인상시상식개최,http://www.lawissue.co.kr/view.php?ud=201912031838304530f4ab64559d_12
6328,2019-12-03,한미약품한미참의료인상시상식개최어두운시대위로하는큰울림”,http://www.donga.com/news/article/all/20191203/98646472/1
6329,2019-12-03,한미약품제18회한미참의료인상어두운우리시대에큰울림과위로,http://www.newscj.com/news/articleView.html?idxno=688413
6330,2019-12-04,지분매입나선한미약품삼진제약오너2세,http://www.dailymedi.com/detail.php?number=850345&thread=22r05
6331,2019-12-04,한미약품경구용면역항암제도입계약체결,http://news.mt.co.kr/mtview.php?no=2019120407431641036
6332,2019-12-04,한미약품경구용면역항암제도입계약체결,http://www.newspim.com/news/view/20191204000063
6333,2019-12-04,한미약품美RAPT와5800만달러규모경구용면역항암제도입계약체결,https://view.asiae.co.kr/article/2019120407584575856
6334,2019-12-04,한미약품640억들여美바이오기업경구용면역항암제기술도입,http://www.newspim.com/news/view/20191204000067
6335,2019-12-04,한미약품CCR4경구용면역항암제한중독점적권리확보,http://www.econovill.com/news/articleView.html?idxno=379178
6336,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입美랩트와공동개발,http://www.viva100.com/main/view.php?key=20191204010001179
6337,2019-12-04,한미약품美서CCR4표적경구용면역항암제도입,http://www.biospectator.com/view/news_view.php?varAtcId=9035
6338,2019-12-04,한미약품美회사경구용면역항암제한중판매권획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01479286622715240
6339,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.lawissue.co.kr/view.php?ud=201912040816391141204ead0791_12
6340,2019-12-04,한미약품美랩트로부터경구용면역항암제690억원에도입,http://biz.newdaily.co.kr/site/data/html/2019/12/04/2019120400007.html
6341,2019-12-04,한미약품세계최초CCR4경구용면역항암제640억원규모로도입,http://news1.kr/articles/?3784785
6342,2019-12-04,한미약품美바이오개발면역항암제후보물질도입,http://www.sportsseoul.com/news/read/857056
6343,2019-12-04,한미약품美바이오텍서새로운메커니즘의면역항암제후보물질도입,http://news.mk.co.kr/newsRead.php?year=2019&no=1011864
6344,2019-12-04,한미약품미국서CCR4표적경구용면역항암제도입,http://moneys.mt.co.kr/news/mwView.php?no=2019120408098077942
6345,2019-12-04,한미약품세계첫경구용면역항암제CCR4도입美와공동개발,http://news.heraldcorp.com/view.php?ud=20191204000039
6346,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.newsway.co.kr/news/view?tp=1&ud=2019120408275910907
6347,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238174
6348,2019-12-04,공시한미약품美회사경구용면역항암제한중판매권획득,http://www.newsway.co.kr/news/view?tp=1&ud=2019120408324134152
6349,2019-12-04,한미약품美경구용면역항암제도입계약,http://news.heraldcorp.com/view.php?ud=20191204000051
6350,2019-12-04,한미약품美서경구용면역항암제기술도입,http://news.mt.co.kr/mtview.php?no=2019120408273243855
6351,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.newsis.com/view/?id=NISX20191204_0000849621&cID=13001&pID=13000
6352,2019-12-04,한미약품美랩트와경구용면역항암제독점권리체결,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912040058&t=NN
6353,2019-12-04,한미약품경구용면역항암제도입,https://www.paxnetnews.com/articles/54517
6354,2019-12-04,한미약품美바이오기업서먹는면역항암제도입,http://yna.kr/AKR20191204029900017?did=1195m
6355,2019-12-04,한미약품세계첫CCR4면역항암제도입美바이오텍과공동개발,http://www.medisobizanews.com/news/articleView.html?idxno=64528
6356,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.ebn.co.kr/news/view/1011943/?sc=naver
6357,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1829928
6358,2019-12-04,한미약품미랩트의세계최초CCR4경구용면역항암제도입,http://www.fnnews.com/news/201912040900383686
6359,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입韓中독점권획득,https://asiatime.co.kr/news/newsview.php?ncode=1065570551893965
6360,2019-12-04,공시한미약품美RAPT와690억원규모면역항암제도입계약,http://www.fnnews.com/news/201912040905420835
6361,2019-12-04,한미약품美랩트서먹는면역항암제후보물질도입,http://www.dt.co.kr/contents.html?article_no=2019120402109931102001&ref=naver
6362,2019-12-04,한미약품美바이오텍과세계최초CCR4경구용면역항암제공동개발,https://biz.chosun.com/site/data/html_dir/2019/12/04/2019120400761.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6363,2019-12-04,한미약품세계첫CCR4경구용면역항암제도입,http://www.seoulwire.com/news/articleView.html?idxno=261222
6364,2019-12-04,한미약품美RAPT와690억원규모면역항암제도입계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1829951
6365,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://daily.hankooki.com/lpage/ittech/201912/dh20191204091141145630.htm
6366,2019-12-04,한미약품美바이오기업서먹는면역항암제도입,http://www.smedaily.co.kr/news/articleView.html?idxno=88016
6367,2019-12-04,한미약품CCR4경구용면역항암제공동개발나선다,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132374
6368,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.pressm.kr/news/articleView.html?idxno=26362
6369,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.fetv.co.kr/news/article.html?no=41913
6370,2019-12-04,한미약품CCR4경구용면역항암제도입세계최초,http://www.m-i.kr/news/articleView.html?idxno=660923
6371,2019-12-04,한미약품美랩트테라퓨틱스와690억원규모면역항암제도입계약,https://www.sedaily.com/NewsView/1VRXZCMO4I
6372,2019-12-04,한미약품美바이오기업에서면역항암제도입공동개발,http://www.edaily.co.kr/news/newspath.asp?newsid=01872886622715240
6373,2019-12-04,한미약품경구용면역항암제도입美바이오기업과공동개발,http://www.ezyeconomy.com/news/articleView.html?idxno=95936
6374,2019-12-04,뉴스투데이L한미약품세계최초경구용면역항암제공동개발나서,http://www.news2day.co.kr/143477
6375,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.ajunews.com/view/20191204092724545
6376,2019-12-04,한미약품경구용면역항암제FLX475도입,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=004&oid=050&aid=0000052132
6377,2019-12-04,한미약품美랩트와경구용면역항암제도입계약공동개발,https://cnbc.sbs.co.kr/article_hub/10000964608?division=NAVER
6378,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.businesskorea.co.kr/news/articleView.html?idxno=38835
6379,2019-12-04,한미약품먹는면역항암제신약기술도입,http://www.hankookilbo.com/news/npath/201912040927335272?did=NA
6380,2019-12-04,한미약품美바이오기업과CCR4경구용면역항암제공동개발,http://www.etnews.com/20191204000035
6381,2019-12-04,한미약품미국바이오기업서경구용면역항암제도입,http://www.mdtoday.co.kr/mdtoday/index.html?no=371778
6382,2019-12-04,한미약품경구용면역항암제기술도입,http://news.mk.co.kr/newsRead.php?year=2019&no=1012275
6383,2019-12-04,한미약품美서세계최초CCR4경구용면역항암제도입,http://kormedi.com/?p=1307038
6384,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입추진,http://www.enewstoday.co.kr/news/articleView.html?idxno=1353429
6385,2019-12-04,한미약품미바이오기업서먹는면역항암제도입,http://www.asiatoday.co.kr/view.php?key=20191204010002407
6386,2019-12-04,한미약품경구용면역항암제도입계약금48억,http://www.dailypharm.com/Users/News/NewsView.html?ID=259629&REFERER=NP
6387,2019-12-04,한미약품세계최초CCR4경구용면역항암제라이센스도입,http://www.getnews.co.kr/view.php?ud=20191204100215824341d0c69529_16
6388,2019-12-04,한미약품美랩트社와면역항암제도입계약체결690억원규모,http://inthenews.co.kr/article-26815/
6389,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.ceoscoredaily.com/news/article.html?no=63245
6390,2019-12-04,한미약품美바이오기업경구용면역항암제신약기술도입,http://www.rapportian.com/news/articleView.html?idxno=121935
6391,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58544
6392,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.metroseoul.co.kr/news/newsview?newscd=2019120400032
6393,2019-12-04,한미약품세계최초CCR4경구용면역항암제공동개발,http://www.bosa.co.kr/news/articleView.html?idxno=2117269
6394,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.nextdaily.co.kr/news/article.html?id=20191204800016
6395,2019-12-04,한미약품美랩트경구용면역항암제도입공동개발,http://www.sisaweek.com/news/articleView.html?idxno=128651
6396,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1130685&REFERER=NP
6397,2019-12-04,한미약품세계첫CCR4경구용면역항암제공동개발키로,https://www.kpanews.co.kr/article/show.asp?idx=209179&category=D
6398,2019-12-04,한미약품CCR4경구용면역항암제도입 ,http://www.monews.co.kr/news/articleView.html?idxno=206878
6399,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.sisajournal-e.com/news/articleView.html?idxno=210050
6400,2019-12-04,한미약품먹는면역항암제도입공동개발,http://www.shinailbo.co.kr/news/articleView.html?idxno=1229996
6401,2019-12-04,한미약품CCR4경구용면역항암제도입,http://www.newsprime.co.kr/news/article.html?no=485743
6402,2019-12-04,세계최초한미약품CCR4경구용면역항암제도입,http://www.koreaittimes.com/news/articleView.html?idxno=94433
6403,2019-12-04,한미약품세계최초CCR4면역항암제공동개발착수,http://www.upinews.kr/newsView/upi201912040036
6404,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.dailysmart.co.kr/news/articleView.html?idxno=19112
6405,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.dailymedi.com/detail.php?number=850362&thread=22r05
6406,2019-12-04,한미약품경구용면역항암제도입공동개발,http://sports.hankooki.com/lpage/economy/201912/sp20191204113412137020.htm
6407,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입700억원규모계약,http://www.donga.com/news/article/all/20191204/98654934/1
6408,2019-12-04,한미약품美랩트社와면역항암제공동개발,http://www.newswatch.kr/news/articleView.html?idxno=25492
6409,2019-12-04,한미약품CCR4경구용면역항암제도입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074871
6410,2019-12-04,한미약품세계최초경구용면역항암제도입,http://www.koreastocknews.com/news/articleView.html?idxno=48537
6411,2019-12-04,한미약품세계최초CCR4경구용면역항암제개발,http://www.bokuennews.com/news/article.html?no=184100
6412,2019-12-04,한미약품미국바이오회사와경구용면역항암제공동개발추진,http://www.businesspost.co.kr/BP?command=article_view&num=153804
6413,2019-12-04,한미약품위암등타깃하는면역항암제도입,http://health.chosun.com/site/data/html_dir/2019/12/04/2019120401504.html
6414,2019-12-04,한미약품세계첫경구용면역항암제기술도입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019120413115832996
6415,2019-12-04,한미약품경구용면역항암제도전,https://www.hankyung.com/it/article/201912041951i
6416,2019-12-04,한미약품면역항암제개발나선다,http://www.whosaeng.com/114431
6417,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입미국랩트사와라이선스계약,http://www.updownnews.co.kr/news/articleView.html?idxno=211928
6418,2019-12-04,한미약품美랩트면역항암제공동개발,http://www.finomy.com/news/articleView.html?idxno=72570
6419,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.insightkorea.co.kr//news/articleView.html?idxno=69122
6420,2019-12-04,한미약품美바이오기업랩트와면역항암제공동개발나선다,http://4th.kr/View.aspx?No=342681
6421,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://fn.segye.com/content/html/2019/12/04/20191204509430.html?OutUrl=naver
6422,2019-12-04,기업분석한미약품대형주위주의시장상황에서주가상승여부주목,http://www.anewsa.com/detail.php?number=2028178&thread=10r03
6423,2019-12-04,한미약품美바이오기업과경구용면역항암제공동개발,http://it.chosun.com/site/data/html_dir/2019/12/04/2019120402021.html
6424,2019-12-04,항암신약결실앞둔한미약품파이프라인강화,http://www.etoday.co.kr/news/section/newsview.php?idxno=1830176
6425,2019-12-04,한미약품미국바이오기업랩트세계최초CCR4경구용면역항암제라이선스계약,http://www.iminju.net/news/articleView.html?idxno=50822
6426,2019-12-04,한미약품세계첫경구용면역항암제CCR4도입美바이오기업과공동개발,http://www.ekn.kr/news/article.html?no=467883
6427,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.newslock.co.kr/news/articleView.html?idxno=23974
6428,2019-12-04,한미약품CCR4경구용면역항암제도입,http://www.wikileaks-kr.org/news/articleView.html?idxno=71583
6429,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.newstomato.com/ReadNews.aspx?no=937698
6430,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=535477
6431,2019-12-04,한미약품美랩트과경구용면역항암제공동개발,http://www.skyedaily.com/news/news_view.html?ID=95062
6432,2019-12-04,한미약품美경구용면역항암제최초도입해공동개발,http://www.100ssd.co.kr/news/articleView.html?idxno=65816
6433,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.techholic.co.kr/news/articleView.html?idxno=187736
6434,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.medigatenews.com/news/2447304363
6435,2019-12-04,한미약품美바이오기업랩트의먹는면역항암제도입,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=111690
6436,2019-12-04,이번엔기술수입한미약품신약개발꿈계속된다,https://www.sedaily.com/NewsView/1VRY0V11TJ
6437,2019-12-04,한미약품美랩트먹는면역항암제도입공동개발,http://www.ntoday.co.kr/news/articleView.html?idxno=69739
6438,2019-12-04,제2회납세자축제납세대상수상자한미약품,http://www.joseilbo.com/news/news_read.php?uid=388502&class=7&grp=
6439,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.nspna.com/news/?mode=view&newsid=397650
6440,2019-12-04,한미약품세계최초CCR4경구용면역항암제도입,http://www.newscj.com/news/articleView.html?idxno=688734
6441,2019-12-05,한미약품세계최초CCR4경구용면역항암제도입고형암대상글로벌임상12상진행,http://www.thefirstmedia.net/news/articleView.html?idxno=51523
6442,2019-12-05,한미약품경구용면역항암제라이선스도입,http://weekly.cnbnews.com/news/article.html?no=131470
6443,2019-12-05,전일주요공시경남제약한미약품롯데쇼핑등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1830389
6444,2019-12-05,한미약품삼진제약오너후계자들회사지분대량매입,http://www.mdtoday.co.kr/mdtoday/index.html?no=371894
6445,2019-12-05,한미약품팔팔연이어승소의약품식품에도못쓴다,http://medipana.com/news/news_viewer.asp?NewsNum=249741&MainKind=A&NewsKind=5&vCount=12&vKind=1
6446,2019-12-05,한미약품팔팔상표권연이은승소의약품식품에도못쓴다,http://kormedi.com/?p=1307136
6447,2019-12-05,한미약품팔팔연이어상표권승소의약품식품에도못쓴다,http://moneys.mt.co.kr/news/mwView.php?no=2019120509498081475
6448,2019-12-05,한미약품팔팔브랜드함부로못쓴다상표권무효소송승소,https://www.sedaily.com/NewsView/1VRYFTHRKX
6449,2019-12-05,의약품∙식품에도팔팔못쓴다한미약품법원기팔팔상표무효판결,https://biz.chosun.com/site/data/html_dir/2019/12/05/2019120500986.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6450,2019-12-05,의약품식품에도팔팔못쓴다한미약품상표권또승소,http://www.econovill.com/news/articleView.html?idxno=379303
6451,2019-12-05,한미약품법원건기식이어일반식품의팔팔상표권도무효로판결,http://news.mk.co.kr/newsRead.php?year=2019&no=1016589
6452,2019-12-05,의약품식품팔팔못쓴다한미약품브랜드위상강화,http://www.dt.co.kr/contents.html?article_no=2019120502109931102001&ref=naver
6453,2019-12-05,의약품식품에도팔팔못쓴다한미약품상표권소송승소,http://www.viva100.com/main/view.php?key=20191205010001715
6454,2019-12-05,한미약품의약품식품서팔팔독점권갖는다,http://www.newspim.com/news/view/20191205000334
6455,2019-12-05,한미약품팔팔상표권소송연승기팔팔도무효판결,http://www.newsis.com/view/?id=NISX20191205_0000851178&cID=13001&pID=13000
6456,2019-12-05,한미약품연이은상표권승소의약품식품에도팔팔못써,http://www.dailysmart.co.kr/news/articleView.html?idxno=19190
6457,2019-12-05,한미약품팔팔유사명칭사용특허소송승소,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912050128&t=NN
6458,2019-12-05,의약품식품에도한미약품브랜드팔팔못쓴다,http://yna.kr/AKR20191205055700017?did=1195m
6459,2019-12-05,법원한미약품팔팔과비슷한기팔팔상표도무효판결,http://www.ceoscoredaily.com/news/article.html?no=63307
6460,2019-12-05,한미약품청춘팔팔이어기팔팔도승소,http://www.newswatch.kr/news/articleView.html?idxno=25514
6461,2019-12-05,의약품과식품에도팔팔못쓴다한미약품남성용건기식청춘팔팔이어승소,http://www.sisaon.co.kr/news/articleView.html?idxno=105531
6462,2019-12-05,식의약품에팔팔못쓴다한미약품청춘팔팔이어기팔팔에도승소,http://kpenews.com/View.aspx?No=343554
6463,2019-12-05,한미약품건기식청춘팔팔이어의약품식품기팔팔도상표권승소,http://daily.hankooki.com/lpage/ittech/201912/dh20191205110711145630.htm
6464,2019-12-05,의약품∙식품도팔팔못쓴다한미약품상표권소송승소,http://www.etoday.co.kr/news/section/newsview.php?idxno=1830566
6465,2019-12-05,한미약품오픈이노베이션확장시동면역항암제중심기술도입,http://biz.newdaily.co.kr/site/data/html/2019/12/05/2019120500076.html
6466,2019-12-05,한미약품팔팔관련상표권승소의약품식품에도팔팔못쓴다,http://www.rapportian.com/news/articleView.html?idxno=121965
6467,2019-12-05,한미약품팔팔또한번지켜냈다의약품식품상표권도승소,http://www.paxetv.com/news/articleView.html?idxno=82842
6468,2019-12-05,일반식품서도팔팔이름못쓴다한미약품상표권소송연승,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1074909
6469,2019-12-05,한미약품상표권소송승소의약품식품에짝퉁팔팔못쓴다,http://www.insightkorea.co.kr//news/articleView.html?idxno=69320
6470,2019-12-05,의약품식품에도팔팔못쓴다한미약품청춘팔팔상표권무효소송승소,http://www.joongboo.com/news/articleView.html?idxno=363382011
6471,2019-12-05,특허법원의약품과식품에서도한미약품팔팔고유상표권인정,http://www.businesspost.co.kr/BP?command=article_view&num=153978
6472,2019-12-05,의약품식품에도팔팔못쓴다법원한미약품손들어줘,https://www.hankyung.com/life/article/2019120547197
6473,2019-12-05,의약품식품에도팔팔못쓴다한미약품소송승소,http://www.ccreview.co.kr/news/articleView.html?idxno=222901
6474,2019-12-05,건강기능식품팔팔단어못쓴다한미약품특허승소,http://www.safetimes.co.kr/news/articleView.html?idxno=78465
6475,2019-12-05,팔팔은한미약품브랜드의약품식품에못쓴다,http://news.kmib.co.kr/article/view.asp?arcid=0014000565&code=61121311&cp=nv
6476,2019-12-05,팔팔은한미약품의것법원기팔팔상표도무효판결,http://www.100ssd.co.kr/news/articleView.html?idxno=65832
6477,2019-12-05,12월5일한미약품정보외주식시황169변화,http://www.gokorea.kr/news/articleView.html?idxno=588018
6478,2019-12-05,한미약품제품명잇단재판승팔팔함부로못쓴다,http://www.edaily.co.kr/news/newspath.asp?newsid=03093046622715568
6479,2019-12-05,한미약품일반식품명에도팔팔못쓴다기팔팔상표권무효판결,http://4th.kr/View.aspx?No=343942
6480,2019-12-05,의약품건기식서팔팔쓰기어려워져한미약품브랜드명팔팔법원서승소,https://asiatime.co.kr/news/newsview.php?ncode=1065591174992403
6481,2019-12-05,의약품식품에도팔팔못쓴다한미약품팔팔브랜드확고히구축,http://news.tf.co.kr/read/economy/1770605.htm
6482,2019-12-05,한미약품발기부전약팔팔이름사용다른제품또상표권무효판결,http://news1.kr/articles/?3786358
6483,2019-12-05,의약품식품에도팔팔못쓴다한미약품법원기팔팔상표무효판결”,http://biz.newdaily.co.kr/site/data/html/2019/12/05/2019120500173.html
6484,2019-12-05,한미약품청춘팔팔이어의약품식품기팔팔에도승소,http://www.newsprime.co.kr/news/article.html?no=485971
6485,2019-12-05,한미약품남성용건기식청춘팔팔이어의약품식품기팔팔에도승소,http://www.techholic.co.kr/news/articleView.html?idxno=187774
6486,2019-12-05,한미약품계열사JVM약국근무환경변화새로운기회,http://www.newspim.com/news/view/20191205000973
6487,2019-12-05,의약품식품에도한미약품팔팔사용금지,http://www.smedaily.co.kr/news/articleView.html?idxno=88057
6488,2019-12-05,한미약품팔팔상표권승소의약품식품에도팔팔못쓴다,http://www.news2day.co.kr/143651
6489,2019-12-05,한미약품건기식청춘팔팔이어의약품식품기팔팔에도승소,http://www.cnbnews.com/news/article.html?no=429802
6490,2019-12-05,의약품식품에팔팔못쓴다한미약품상표권분쟁서승소,http://www.foodnews.co.kr/news/articleView.html?idxno=72159
6491,2019-12-05,법원팔팔은한미약품만기팔팔상표권무효판결,http://www.upinews.kr/newsView/upi201912050104
6492,2019-12-05,한미약품남성용건기식청춘팔팔이어의약품∙식품기팔팔도승소,http://www.babytimes.co.kr/news/articleView.html?idxno=31400
6493,2019-12-05,한미약품세계최초CCR4경구용면역항암제도입,http://www.joseilbo.com/news/news_read.php?uid=388585&class=27&grp=
6494,2019-12-05,한미약품제이브이엠약국근무환경급격한변화JVM엔또다른기회,http://www.newslock.co.kr/news/articleView.html?idxno=24025
6495,2019-12-05,한미약품팔팔의약품식품에도못쓴다법원기팔팔상표도무효판결,http://medicalworldnews.co.kr/news/view.php?idx=1510933385
6496,2019-12-06,건기식은물론의약품식품에도팔팔못쓴다한미약품브랜드고유성강화,http://www.g-enews.com/ko-kr/news/article/news_all/20191205174859621269d76442fa_1/article.html
6497,2019-12-06,한미약품남성용건기식청춘팔팔이어의약품∙식품기팔팔에도법원승소,http://www.thefirstmedia.net/news/articleView.html?idxno=51578
6498,2019-12-06,한미약품그룹제이브이엠기업설명회통해미래성장가능성강조,http://www.thefirstmedia.net/news/articleView.html?idxno=51586
6499,2019-12-06,한미약품로수젯처방매출TOP5의약품첫진입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238275
6500,2019-12-06,한미약품지난해이어올해도기부금액수비중업계톱,http://www.ceoscoredaily.com/news/article.html?no=63327
6501,2019-12-06,한미약품등국내제약사후보물질도입해면역항암제개발속도↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=371987
6502,2019-12-06,한미약품로수젯국내처방매출TOP5의약품첫진입,http://medipana.com/news/news_viewer.asp?NewsNum=249796&MainKind=A&NewsKind=5&vCount=12&vKind=1
6503,2019-12-06,빅데이터MSI시장심리톱5SK이노베이션한미약품현대건설한국항공우주SKC,http://www.newsis.com/view/?id=NISX20191206_0000852262&cID=10401&pID=10400
6504,2019-12-06,한미약품평판지수상승하며빅3재진입2019년11월제약상장기업브랜드평판3위,http://www.futurekorea.co.kr/news/articleView.html?idxno=124253
6505,2019-12-06,한미약품그룹제이브이엠약국근무환경변화가우리에겐기회,http://www.sisaon.co.kr/news/articleView.html?idxno=105647
6506,2019-12-06,12월6일한미약품주식현황323500원062,http://nbntv.co.kr/news/view/760525
6507,2019-12-06,의약품식품에도팔팔못쓴다한미약품기팔팔상표권무효판결,http://www.dailypop.kr/news/articleView.html?idxno=42412
6508,2019-12-09,제약바이오사건사고②고유명사된한미약품팔팔가치↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=372118
6509,2019-12-09,바이오시밀러테마오전시황상승률상위종목이수앱지스016에이프로젠제약047한미약품062등,http://www.gokorea.kr/news/articleView.html?idxno=590705
6510,2019-12-09,바이오시밀러테마09시현재주식시황상승률상위종목이수앱지스10원016에이프로젠제약5원047한미약품2000원062하락,http://www.cctvnews.co.kr/news/articleView.html?idxno=151466
6511,2019-12-09,12월9일한미약품주식현재가322000원062,http://nbntv.co.kr/news/view/761360
6512,2019-12-09,바이오시밀러테마오후시황에이프로젠제약327이수앱지스143한미약품062순,http://www.woodkorea.co.kr/news/articleView.html?idxno=40823
6513,2019-12-09,바이오시밀러테마13시현재주식시황상승률상위종목에이프로젠제약40원374이수앱지스90원143한미약품1500원046하락,http://www.cctvnews.co.kr/news/articleView.html?idxno=151571
6514,2019-12-09,리딩제약사리드하는쌍두마차우종수권세창한미약품대표2019올해의CEO9,https://www.sisa-news.com/news/article.html?no=122473
6515,2019-12-10,사노피한미약품당뇨신약임상3상완료후판매사물색,http://news1.kr/articles/?3789179
6516,2019-12-10,사노피한미약품당뇨주사제글로벌임상3상후판매사물색예정,http://www.newspim.com/news/view/20191210000050
6517,2019-12-10,한미약품사노피당뇨치료제글로벌판매파트너물색”,http://biz.newdaily.co.kr/site/data/html/2019/12/10/2019121000005.html
6518,2019-12-10,한미약품사노피에페글레나타이드판매파트너사물색약효안전성과무관,http://news.mk.co.kr/newsRead.php?year=2019&no=1030547
6519,2019-12-10,한미약품사노피에페글레나타이드글로벌판매파트너물색”,http://www.newsway.co.kr/news/view?tp=1&ud=2019121008233962166
6520,2019-12-10,사노피한미약품당뇨주사제임상3상완료후판매사물색,http://moneys.mt.co.kr/news/mwView.php?no=2019121008098051579
6521,2019-12-10,사노피한미약품개발에페글레나타이드새판매자물색,http://www.medisobizanews.com/news/articleView.html?idxno=64702
6522,2019-12-10,사노피한미약품과라이선스계약세부사항변화없어,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238388
6523,2019-12-10,한미약품사노피에페글레나타이드글로벌3상후판매파트너물색”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1832159
6524,2019-12-10,사노피한미약품도입당뇨치료제3상후판매사물색,http://www.newsis.com/view/?id=NISX20191210_0000855233&cID=13001&pID=13000
6525,2019-12-10,사노피한미약품당뇨주사제임상후판매사물색,http://news.mt.co.kr/mtview.php?no=2019121009031049396
6526,2019-12-10,특징주한미약품사노피당뇨치료제별도판매사물색급락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1832182
6527,2019-12-10,사노피한미약품기술수출당뇨치료제임상3상후판매사물색,https://biz.chosun.com/site/data/html_dir/2019/12/10/2019121000879.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6528,2019-12-10,한미약품한미사이언스갑작스런급락에투자자들어떡하나특히한미약품30만원선붕괴,http://www.econonews.co.kr/news/articleView.html?idxno=97621
6529,2019-12-10,특징주한미약품사노피의에페글레나타이드판매파트너물색소식에급락,http://news.mk.co.kr/newsRead.php?year=2019&no=1030764
6530,2019-12-10,특징주한미약품사노피당뇨치료제판매사물색발표에급락,http://news.mt.co.kr/mtview.php?no=2019121009155823205
6531,2019-12-10,특징주한미약품사노피당뇨치료제별도판매사물색급락,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912100098&t=NN
6532,2019-12-10,사노피한미약품당뇨주사제임상후판매사물색,http://www.seoulwire.com/news/articleView.html?idxno=262005
6533,2019-12-10,특징주한미약품사노피당뇨치료제별도판매사물색소식에급락,http://www.viva100.com/main/view.php?key=20191210010003231
6534,2019-12-10,특징주한미약품사노피에페글레나타이드판매파트너사물색소식에하락세,http://moneys.mt.co.kr/news/mwView.php?no=2019121009328069042
6535,2019-12-10,특징주한미약품사노피당뇨치료제판매사물색에급락,http://www.newstomato.com/ReadNews.aspx?no=938709
6536,2019-12-10,사노피한미약품도입당뇨약임상후판매사물색,http://www.seoulfn.com/news/articleView.html?idxno=365140
6537,2019-12-10,특징주한미약품파트너사신약판매대행사물색소식에약세,http://yna.kr/AKR20191210044900008?did=1195m
6538,2019-12-10,특징주한미약품사노피판매사물색에장초반6대급락,http://www.ebn.co.kr/news/view/1012818/?sc=naver
6539,2019-12-10,특징주한미약품사노피사의판매대행소식에약세,http://www.seoulwire.com/news/articleView.html?idxno=262019
6540,2019-12-10,사노피이슈때문한미약품장초반주가급락,http://www.choicenews.co.kr/news/articleView.html?idxno=66504
6541,2019-12-10,사노피임상3상이후파트너물색계획한미약품과라이선스계약세부사항변화없다,http://www.newslock.co.kr/news/articleView.html?idxno=24140
6542,2019-12-10,한미약품별다른악재없이하락세보여눈길한미사이언스셀트리온유한양행등관련주주가는,http://www.topstarnews.net/news/articleView.html?idxno=706309
6543,2019-12-10,특징주한미약품사노피당뇨치료제별도판매사물색소식에전일比672↓,http://www.joongboo.com/news/articleView.html?idxno=363383242
6544,2019-12-10,한미약품사노피에페글레나타이드글로벌판매파트너물색”,http://www.ajunews.com/view/20191210100156273
6545,2019-12-10,한미약품사노피당뇨치료제판매사물색발표에장초반급락,http://www.whitepaper.co.kr/news/articleView.html?idxno=184452
6546,2019-12-10,10일화요일10시현재특징주는한미약품젬백스에이치엘비,http://www.leaders.kr/news/articleView.html?idxno=136892
6547,2019-12-10,사노피한미약품당뇨치료주사제임상3상완료후판매자물색”,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20191210.99099004572
6548,2019-12-10,특징주한미약품사노피당뇨치료제별도판매사물색소식에하락,https://www.sedaily.com/NewsView/1VS0QMAZ11
6549,2019-12-10,사노피한미약품당뇨치료제임상후판매파트너물색”,http://sports.hankooki.com/lpage/economy/201912/sp20191210101411137020.htm
6550,2019-12-10,사노피한미약품개발한당뇨신약별도판매사찾을것,http://www.metroseoul.co.kr/news/newsview?newscd=2019121000049
6551,2019-12-10,사노피한미약품개발당뇨주사제임상3상완료후판매자물색”,http://www.segye.com/content/html/2019/12/10/20191210504657.html?OutUrl=naver
6552,2019-12-10,사노피한미약품당뇨주사제임상후판매사찾겠다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019121010172431051
6553,2019-12-10,특징주한미약품파트너사사노피신약판매사물색소식에급락,http://www.fntimes.com/html/view.php?ud=201912101009576287f09e13944d_18
6554,2019-12-10,한미약품파트너사사노피에페글레나타이드판매파트너물색,http://4th.kr/View.aspx?No=348110
6555,2019-12-10,한미약품화제가된이유최적의파트너물색할계획,http://www.ggilbo.com/news/articleView.html?idxno=729434
6556,2019-12-10,한미약품사노피전략변화에약세기술수출당뇨약우려한민수의스톡뷰,https://www.hankyung.com/finance/article/2019121038256
6557,2019-12-10,인기주한미약품네이버증권인기검색1위종목차지시가총액3조4895억원시가총액순위코스피67위기록중,http://nbntv.co.kr/news/view/762914
6558,2019-12-10,한미약품사노피당뇨약에페파트너십굳건판매파트너물색중”,http://news.heraldcorp.com/view.php?ud=20191210000263
6559,2019-12-10,사노피한미약품당뇨주사제임상후글로벌판매사물색,http://www.ezyeconomy.com/news/articleView.html?idxno=96103
6560,2019-12-10,사노피한미약품에페글레나타이드판매파트너물색,http://www.fnnews.com/news/201912101045500812
6561,2019-12-10,한미약품한미사이언스급락서흐름엇갈려한미약품7급락반해한미사이언스낙폭줄어들어,http://www.econonews.co.kr/news/articleView.html?idxno=97662
6562,2019-12-10,사노피한미약품도입당뇨병치료제임상후별도판매사물색,http://www.edaily.co.kr/news/newspath.asp?newsid=02548566622717208
6563,2019-12-10,한미약품주가12월10일현재297000원증권그래프및증권정보와종목동정,http://www.gokorea.kr/news/articleView.html?idxno=593071
6564,2019-12-10,주식현재가한미약품주가10일현재296500원,http://nbntv.co.kr/news/view/763274
6565,2019-12-10,한미약품사노피에페글레나타이드판매파트너사물색소식에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=372319
6566,2019-12-10,사노피한미약품당뇨치료제임상3상뒤판매맡을회사물색,http://www.businesspost.co.kr/BP?command=article_view&num=154561
6567,2019-12-10,사노피한미약품당뇨신약글로벌3상후판매맡을파트너물색”,http://www.mdtoday.co.kr/mdtoday/index.html?no=372300
6568,2019-12-10,사노피한미약품도입당뇨병신약3상후판매사물색,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075035
6569,2019-12-10,사노피한미약품과공고한파트너십유지,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132478
6570,2019-12-10,부자들은경제신문을읽는다한미약품사노피별도판매사물색하락시저가매수가능,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019121011415141069
6571,2019-12-10,한미약품급락이어한미사이언스5낙폭한미약품30만원선아직회복못해,http://www.econonews.co.kr/news/articleView.html?idxno=97675
6572,2019-12-10,사노피한미약품당뇨신약임상3상완료후글로벌판매사물색,http://www.pressm.kr/news/articleView.html?idxno=26478
6573,2019-12-10,사노피한미약품에페글레나타이드파트너물색,http://www.monews.co.kr/news/articleView.html?idxno=206987
6574,2019-12-10,특징주한미약품파트너사신약판매대행사물색소식에약세종합,http://yna.kr/AKR20191210044951008?did=1195m
6575,2019-12-10,당뇨신약연구중단한사노피한미약품신약만살린다왜,http://news1.kr/articles/?3789833
6576,2019-12-10,사노피한미약품개발당뇨치료주사제판매자를찾습니다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1232056
6577,2019-12-10,한미약품사노피에페글레나타이드파트너물색,http://www.finomy.com/news/articleView.html?idxno=72840
6578,2019-12-10,한미약품사노피위탁판매사물색소식에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=372362
6579,2019-12-10,표10일코스피주가Top50하락률동원시스템즈우주가하락률1위152내려장마감DB하이텍1우코스모신소재한미약품동양주가순으로상위기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=94424
6580,2019-12-10,10일기관거래소에서KODEX200선물인버스2X099한미약품688등순매도,https://www.hankyung.com/finance/article/201912105672L
6581,2019-12-11,출근길한미약품에페글레나타이드악재될까,http://moneys.mt.co.kr/news/mwView.php?no=2019121016428047906
6582,2019-12-11,한미약품에페글레나타이드불확실성해소저점매수시점,https://www.hankyung.com/finance/article/2019121161596
6583,2019-12-11,한미약품사노피RD우선순위조정악재목표가하향NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01594086622717536
6584,2019-12-11,한미약품에페글레나타이드불확실성목표가↓NH,http://news.mt.co.kr/mtview.php?no=2019121108031635200
6585,2019-12-11,한미약품에페글레나타이드출시불확실성커져NH,http://www.fnnews.com/news/201912110816108826
6586,2019-12-11,한미약품에페글레나타이드글로벌판매사변경매수하나금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1832733
6587,2019-12-11,한미약품에페글레나타이드출시불확실성목표가↓NH투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1832734
6588,2019-12-11,HotLine한미약품에페글레나타이드불확실성해소목표가↓,http://news.mk.co.kr/newsRead.php?year=2019&no=1035065
6589,2019-12-11,한미약품사노피RD전략변경으로불확실성목표가↓NH투자증권,http://www.fntimes.com/html/view.php?ud=201912110824368058f09e13944d_18
6590,2019-12-11,한미약품에페글레나타이드피크점유율5P하향목표가↓,http://www.asiatoday.co.kr/view.php?key=20191211010006603
6591,2019-12-11,한미약품에페글레나타이드의불확실성해소저점매수시기목표주가↓하나금투,http://www.ekn.kr/news/article.html?no=469226
6592,2019-12-11,한미약품사노피판권이전에불확실성확대목표가↓한화투자증권,http://www.fnnews.com/news/201912110834454044
6593,2019-12-11,NH證한미약품사노피전략수정불확실성남아목표가↓,http://www.newsis.com/view/?id=NISX20191211_0000856553&cID=10401&pID=10400
6594,2019-12-11,한미약품당뇨치료제판권이전이슈부각목표가↓한화,http://www.edaily.co.kr/news/newspath.asp?newsid=01784326622717536
6595,2019-12-11,한미약품목표주가하향당뇨치료제출시시점예상보다늦어질듯,http://www.businesspost.co.kr/BP?command=article_view&num=154714
6596,2019-12-11,한미약품사노피의당뇨병사업부전략변경불가피,http://www.nspna.com/news/?mode=view&newsid=398897
6597,2019-12-11,한미약품당뇨신약에페글레나타이드출시불확실성커져,https://www.sedaily.com/NewsView/1VS16A1SIV
6598,2019-12-11,DB금융투자한미약품사노피사업전략변경악재투자의견목표가↓”,http://www.newsway.co.kr/news/view?tp=1&ud=2019121108562749611
6599,2019-12-11,한화證한미약품에페글레나타이드판권이전결정으로불확실성확대”,http://www.newsway.co.kr/news/view?tp=1&ud=2019121109035950461
6600,2019-12-11,한미약품사노피전략변경에신약가치하락투자의견도중립하향DB,http://www.edaily.co.kr/news/newspath.asp?newsid=01954886622717536
6601,2019-12-11,NH투자한미약품사노피대행판매결정목표주가하향조정,http://www.seoulwire.com/news/articleView.html?idxno=262217
6602,2019-12-11,한화證한미약품에페글레나타이드판권이전결정으로불확실성확대”,http://www.newsway.co.kr/news/view?tp=1&ud=2019121109035950461
6603,2019-12-11,미래에셋대우한미약품마케팅파트너변경아쉬워목표가↓”,http://www.newsway.co.kr/news/view?tp=1&ud=2019121108553700773
6604,2019-12-11,리포트브리핑한미약품에페글레나타이드의불확실성해소목표가490000원하나금융투자,http://www.newspim.com/news/view/20191211000134
6605,2019-12-11,GET투자리포트한미약품투자의견매수하나금융투자,http://www.getnews.co.kr/view.php?ud=2019121110303015149tpgetnews_16
6606,2019-12-11,NH투자證한미약품신약시판불확실성남아목표가21↓”,http://www.kukinews.com/news/article.html?no=727059
6607,2019-12-11,한화투자증권한미약품사노피판권이전에불확실성확대목표가하향,http://www.paxetv.com/news/articleView.html?idxno=83134
6608,2019-12-11,특징주한미약품목표가하향조정소식에약세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912110111&t=NN
6609,2019-12-11,특징주한미약품하락사노피신약판매대행사찾아”,http://www.viva100.com/main/view.php?key=20191211010003719
6610,2019-12-11,리포트브리핑한미약품사노피의RD우선순위조정동사에부정적이나선반영목표가370000원NH투자증권,http://www.newspim.com/news/view/20191211000171
6611,2019-12-11,GET투자리포트한미약품투자의견매수유지NH투자증권,http://www.getnews.co.kr/view.php?ud=2019121110303015152tpgetnews_16
6612,2019-12-11,당뇨치료제에페글레나타이드시판불확실NH투자증권한미약품목표가↓,http://www.whitepaper.co.kr/news/articleView.html?idxno=184532
6613,2019-12-11,특징주한미약품다음모멘텀유효목표주가37만원매수의견유지,http://www.shinailbo.co.kr/news/articleView.html?idxno=1232181
6614,2019-12-11,특징주한미약품에페글레나타이드판매사변경소식에이틀째약세,http://news.mk.co.kr/newsRead.php?year=2019&no=1035431
6615,2019-12-11,리포트브리핑한미약품혁신이되어주진못했다목표가330000원DB금융투자,http://www.newspim.com/news/view/20191211000221
6616,2019-12-11,GET투자리포트한미약품투자의견보유하향DB금융투자,http://www.getnews.co.kr/view.php?ud=2019121110303015154tpgetnews_16
6617,2019-12-11,리포트브리핑한미약품변한건반환우려감소와판매파트너뿐목표가350000원키움증권,http://www.newspim.com/news/view/20191211000273
6618,2019-12-11,GET투자리포트한미약품투자의견OutperformMaintain키움증권,http://www.getnews.co.kr/view.php?ud=2019121110303015159tpgetnews_16
6619,2019-12-11,리포트브리핑한미약품마케팅파트너변경은아쉽지만사노피의임상3상의지확인목표가400000원미래에셋대우,http://www.newspim.com/news/view/20191211000357
6620,2019-12-11,GET투자리포트한미약품투자의견매수미래에셋대우,http://www.getnews.co.kr/view.php?ud=2019121110303015163tpgetnews_16
6621,2019-12-11,한미약품사노피당뇨치료제판매사물색소식에이틀째약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=372423
6622,2019-12-11,한미약품사노피당뇨신약개발의지재확인,http://www.consumuch.com/news/articleView.html?idxno=46877
6623,2019-12-11,사노피한미약품에페개발의지확고2021년허가신청계획,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238477
6624,2019-12-11,한미약품사노피에페개발의지확고2021년허가신청계획,http://www.medigatenews.com/news/1767380918
6625,2019-12-11,한미약품사노피임상3상완료의지확인,http://www.choicenews.co.kr/news/articleView.html?idxno=66548
6626,2019-12-11,한미약품사노피에페글레나타이드개발의지확고2021년허가신청”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1832902
6627,2019-12-11,NH투자증권한미약품에페글레나타이드출시불확성에목표주가37만원,http://www.sporbiz.co.kr/news/articleView.html?idxno=399611
6628,2019-12-11,해명나선한미약품사노피개발의지확고2021년허가신청,http://www.newsis.com/view/?id=NISX20191211_0000856876&cID=13001&pID=13000
6629,2019-12-11,한미약품주가신약가치불확실성에화들짝”기술반환아니다”,http://www.g-enews.com/ko-kr/news/article/news_all/201912110946225720c642673384_1/article.html
6630,2019-12-11,한미약품사노피의에페개발의지재확인2021년허가신청계획,http://www.koreaittimes.com/news/articleView.html?idxno=94545
6631,2019-12-11,한미약품세계첫경구용면역항암제기술도입신약공동개발,http://news.heraldcorp.com/view.php?ud=20191211000316
6632,2019-12-11,한미약품사노피에페개발의지확고2021년허가신청계획,http://www.pressm.kr/news/articleView.html?idxno=26505
6633,2019-12-11,사노피신임CEO전략에놀란한미약품에페개발의지확고2021년허가신청계획”,http://it.chosun.com/site/data/html_dir/2019/12/11/2019121101318.html
6634,2019-12-11,권세창한미약품대표사노피의에페글레나타이드개발의지재확인돼,http://news.mk.co.kr/newsRead.php?year=2019&no=1036088
6635,2019-12-11,리포트브리핑한미약품사노피에페글레나타이드판권이전결정목표가480000원한화투자증권,http://www.newspim.com/news/view/20191211000491
6636,2019-12-11,한미약품변한건반환우려감소와판매파트너뿐”,http://www.wikitree.co.kr/main/news_view.php?id=488103
6637,2019-12-11,GET투자리포트한미약품투자의견매수유지한화투자증권,http://www.getnews.co.kr/view.php?ud=2019121110303015175tpgetnews_16
6638,2019-12-11,한미약품오늘증시11일현재295000원,http://nbntv.co.kr/news/view/765504
6639,2019-12-11,한미약품주가12894012월11일오늘거래가294500원증권그래프,http://www.gokorea.kr/news/articleView.html?idxno=595575
6640,2019-12-11,한미약품사노피당뇨병신약개발의지확고2021년허가신청,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019121111335286292
6641,2019-12-11,한미약품당뇨치료제에페글레나타이드의출시시점이늦어질듯”,http://www.wikitree.co.kr/main/news_view.php?id=488110
6642,2019-12-11,한미약품사노피가쌓아온당뇨병시장의입지에기대기어려워졌다”,http://www.wikitree.co.kr/main/news_view.php?id=488113
6643,2019-12-11,뉴스락주식네비12월11일한미약품사노피사업전략변경혁신쉽지않네,http://www.newslock.co.kr/news/articleView.html?idxno=24177
6644,2019-12-11,사노피의한미약품당뇨신약임상완료의지높은가치평가여전,http://biz.newdaily.co.kr/site/data/html/2019/12/11/2019121100102.html
6645,2019-12-11,사노피한미약품신약개발의지확고2021년허가신청목표,http://news1.kr/articles/?3790656
6646,2019-12-11,사노피한미약품당뇨사업축소기조서에페글레나타이드개발의지확고,http://www.newslock.co.kr/news/articleView.html?idxno=24188
6647,2019-12-11,한미약품사노피에페개발의지확고2021년허가신청계획”,http://www.mdtoday.co.kr/mdtoday/index.html?no=372452
6648,2019-12-11,한미약품미국혈액학회서신약후보물질2건연구결과발표,http://www.econovill.com/news/articleView.html?idxno=379831
6649,2019-12-11,한미약품사노피에페개발의지확고2021년허가신청계획”,http://www.newsway.co.kr/news/view?tp=1&ud=2019121113221585811
6650,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.businesskorea.co.kr/news/articleView.html?idxno=39126
6651,2019-12-11,한미약품사노피에페개발의지확고2021년허가신청계획,http://kormedi.com/?p=1307550
6652,2019-12-11,한미약품혈액암신약후보물질항종양효과확인,https://view.asiae.co.kr/article/2019121113334775747
6653,2019-12-11,한미약품혈액암타깃신약후보물질2건연구결과발표,http://medipana.com/news/news_viewer.asp?NewsNum=250094&MainKind=A&NewsKind=5&vCount=12&vKind=1
6654,2019-12-11,한미약품미국혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=535627
6655,2019-12-11,한미약품美혈액학회서혈액암후보물질임상발표,http://www.newsis.com/view/?id=NISX20191211_0000857116&cID=13001&pID=13000
6656,2019-12-11,한미약품美혈액학회서혈액암신약후보물질2건연구결과발표,https://biz.chosun.com/site/data/html_dir/2019/12/11/2019121101768.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6657,2019-12-11,한미약품美ASH서혈액암타깃신약후보물질2건연구결과발표,http://inthenews.co.kr/article-27743/
6658,2019-12-11,한미약품사노피에페개발의지재확인2021년허가신청,http://www.babytimes.co.kr/news/articleView.html?idxno=31512
6659,2019-12-11,한미약품미국서혈액암신약물질항종양효과발표,http://moneys.mt.co.kr/news/mwView.php?no=2019121113378078035
6660,2019-12-11,한미약품미국서혈액암타깃신약후보물질2건연구결과발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238491
6661,2019-12-11,한미약품혈액암타깃신약후보물질2건연구결과발표,http://kormedi.com/?p=1307558
6662,2019-12-11,한미약품美혈액학회서혈액암신약후보물질2건연구결과발표,http://www.getnews.co.kr/view.php?ud=20191211134751919441d0c69529_16
6663,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.newsway.co.kr/news/view?tp=1&ud=2019121113500618143
6664,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질연구발표,http://www.etnews.com/20191211000139
6665,2019-12-11,한미약품혈액암타깃신약후보물질HM43239등2건美혈액학회연구결과발표,http://www.newslock.co.kr/news/articleView.html?idxno=24192
6666,2019-12-11,한미약품에페글레나타이드2021년출시,http://www.finomy.com/news/articleView.html?idxno=72875
6667,2019-12-11,한미약품美혈액학회서혈액암타깃신약2건연구결과발표,http://www.metroseoul.co.kr/news/newsview?newscd=2019121100135
6668,2019-12-11,한미약품혈액암타깃신약후보물질2건연구결과발표,http://www.fetv.co.kr/news/article.html?no=42550
6669,2019-12-11,한미약품사노피당뇨사업축소기조에도에페개발의지재확인”,http://www.getnews.co.kr/view.php?ud=20191211140206285941d0c69529_16
6670,2019-12-11,사노피판매포기에한미약품당뇨병신약가치흔들,http://health.chosun.com/site/data/html_dir/2019/12/11/2019121101859.html
6671,2019-12-11,한미약품미국식품의약국에2011년당뇨치료제허가추진재확인,http://www.businesspost.co.kr/BP?command=article_view&num=154763
6672,2019-12-11,한미약품혈액암타깃신약후보물질2건연구결과발표,http://www.straightnews.co.kr/news/articleView.html?idxno=62173
6673,2019-12-11,한미약품美혈액학회서신약후보물질연구결과발표,http://www.koreastocknews.com/news/articleView.html?idxno=48767
6674,2019-12-11,한미약품美혈액학회서혈액암신약후보물질2건연구결과발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1833014
6675,2019-12-11,한미약품美서혈액암타깃신약후보물질2건연구결과발표,http://www.viva100.com/main/view.php?key=20191211010003928
6676,2019-12-11,한미약품美혈액학회서혈액암신약후보물질2건연구결과발표,http://www.pressm.kr/news/articleView.html?idxno=26510
6677,2019-12-11,한미약품美ASH서혈액암신약후보물질2건연구결과발표,http://www.medisobizanews.com/news/articleView.html?idxno=64759
6678,2019-12-11,한미약품美학회서혈액암치료제후보물질2종연구결과발표,http://www.newspim.com/news/view/20191211000782
6679,2019-12-11,한미약품ASH서혈액암후보물질2건연구결과발표,http://www.dailypharm.com/Users/News/NewsView.html?ID=259878&REFERER=NP
6680,2019-12-11,한미약품혈액암타깃신약후보물질2건연구결과발표,http://it.chosun.com/site/data/html_dir/2019/12/11/2019121101989.html
6681,2019-12-11,한미약품美혈액학회서혈액암타깃2종신약후보물질연구결과발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=372473
6682,2019-12-11,한미약품ASH서혈액암신약후보물질연구결과발표 ,http://www.monews.co.kr/news/articleView.html?idxno=207028
6683,2019-12-11,한미약품미국혈액학회서혈액암치료후보물질2종의전임상결과발표,http://news.mk.co.kr/newsRead.php?year=2019&no=1037344
6684,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건발표,http://www.newspost.kr/news/articleView.html?idxno=74434
6685,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.ceoscoredaily.com/news/article.html?no=63541
6686,2019-12-11,한미약품美혈액학회서혈액암신약연구결과공개,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912110313&t=NN
6687,2019-12-11,한미약품美혈액학회서신약후보물질2건연구결과발표,http://daily.hankooki.com/lpage/ittech/201912/dh20191211151413145630.htm
6688,2019-12-11,한미약품혈액암타깃신약후보물질2건연구결과발표,http://www.insightkorea.co.kr//news/articleView.html?idxno=70526
6689,2019-12-11,한미약품미국혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.mediapen.com/news/view/484204
6690,2019-12-11,한미약품미국혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.techholic.co.kr/news/articleView.html?idxno=187907
6691,2019-12-11,한미약품사노피에페글레나타이드개발의지재확인,http://www.newsprime.co.kr/news/article.html?no=486676
6692,2019-12-11,한미약품美혈액학회서혈액암억제제신약후보물질2종연구결과발표,http://4th.kr/View.aspx?No=350228
6693,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질연구결과발표,http://www.newsprime.co.kr/news/article.html?no=486685
6694,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58693
6695,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.newswatch.kr/news/articleView.html?idxno=25703
6696,2019-12-11,한미약품美혈액학회서신약후보물질2종연구결과발표,http://www.donga.com/news/article/all/20191211/98759576/1
6697,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.medigatenews.com/news/2030278386
6698,2019-12-11,한미약품美학회서혈액암신약물질효과발표,http://www.100ssd.co.kr/news/articleView.html?idxno=65973
6699,2019-12-11,한미약품다종다기혈액암정복솔루션세계의약계공개,http://news.heraldcorp.com/view.php?ud=20191211000758
6700,2019-12-11,한미약품美혈액학회서혈액암신약후보물질2건연구결과발표,http://biz.newdaily.co.kr/site/data/html/2019/12/11/2019121100195.html
6701,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.fnnews.com/news/201912111611235558
6702,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.nextdaily.co.kr/news/article.html?id=20191211800035
6703,2019-12-11,한미약품美학회서혈액암신약물질2건발표,http://www.dailysmart.co.kr/news/articleView.html?idxno=19517
6704,2019-12-11,한미약품미국혈액학회에서항암신약후보물질2건연구결과발표,http://www.businesspost.co.kr/BP?command=article_view&num=154810
6705,2019-12-11,한미약품사노피당뇨병치료제개발의지확고,http://news.mt.co.kr/mtview.php?no=2019121115515749317
6706,2019-12-11,한미약품美혈액학회서신약후보물질2건연구결과발표,http://www.g-enews.com/ko-kr/news/article/news_all/201912111640391000069d76442fa_1/article.html
6707,2019-12-11,한미약품사노피에페개발의지확고2021년허가신청계획,http://www.updownnews.co.kr/news/articleView.html?idxno=212271
6708,2019-12-11,한미약품美혈액학회서혈액암신약후보물질2건연구결과발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1355015
6709,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건결과발표,http://www.ezyeconomy.com/news/articleView.html?idxno=96162
6710,2019-12-11,사노피한미약품당뇨신약개발의지확고,https://www.paxnetnews.com/articles/54788
6711,2019-12-11,한미약품당뇨신약출시불확실성↑vs저점매수기회,http://www.economytalk.kr/news/articleView.html?idxno=202070
6712,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.lawissue.co.kr/view.php?ud=201912111717296421204ead0791_12
6713,2019-12-11,한미약품혈액암신약후보물질ASH에서공개,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132514
6714,2019-12-11,대한민국사랑받는기업LG하우시스SK주한미약품등선정,http://www.getnews.co.kr/view.php?ud=2019121117235558246a6b374224_16
6715,2019-12-11,한미약품美혈액학회서혈액암신약후보2종연구발표,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075088
6716,2019-12-11,한미약품사노피에페글레나타이드판권이전결정”,http://www.wikitree.co.kr/main/news_view.php?id=488249
6717,2019-12-11,NH투자한미약품신약시판불확실성”목표가↓,http://www.skyedaily.com/news/news_view.html?ID=95504
6718,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.thefirstmedia.net/news/articleView.html?idxno=51809
6719,2019-12-11,한미약품미혈액학회서신약후보물질2건연구발표,https://www.kpanews.co.kr/article/show.asp?idx=209392&category=D
6720,2019-12-11,한미약품美혈액학회서혈액암타깃신약후보물질2건연구결과발표,http://www.newscj.com/news/articleView.html?idxno=690577
6721,2019-12-11,한미약품미혈액학회서혈액암타깃신약후보물질2건발표,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4007094
6722,2019-12-12,한미약품당뇨신약에페글레나타이드새파트너는누구,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075113
6723,2019-12-12,한미약품당뇨신약에페글레나타이드판권이전불확실성증폭,http://www.newsian.co.kr/news/articleView.html?idxno=38496
6724,2019-12-12,바이오시밀러테마오전시황상승률상위종목셀트리온091제넥신074한미약품051등,http://www.gokorea.kr/news/articleView.html?idxno=597184
6725,2019-12-12,바이오시밀러테마09시현재주식시황상승률상위종목셀트리온1500원091큐브앤컴퍼니20원070한미약품2000원068상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=152192
6726,2019-12-12,한미약품한미사이언스하락딛고일어서나특히한미약품30만원선회복눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=97880
6727,2019-12-12,추운겨울면역력에비타민D까지챙기는한미약품나인나인,http://www.asiatoday.co.kr/view.php?key=20191212010007547
6728,2019-12-12,12월12일한미약품실시간증시296500원085,http://nbntv.co.kr/news/view/767692
6729,2019-12-12,한미약품주가증권그래프12일현재296500원,http://www.gokorea.kr/news/articleView.html?idxno=598013
6730,2019-12-12,한미약품사노피에페개발의지확고,http://www.whosaeng.com/114653
6731,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.viva100.com/main/view.php?key=20191212010004460
6732,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.pressm.kr/news/articleView.html?idxno=26537
6733,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.whosaeng.com/114658
6734,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,https://view.asiae.co.kr/article/2019121214481467246
6735,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1833573
6736,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238558
6737,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.newspim.com/news/view/20191212000974
6738,2019-12-12,한미약품신약개발RD모멘텀여전에페윈윈전략,http://www.econovill.com/news/articleView.html?idxno=379895
6739,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://medipana.com/news/news_viewer.asp?NewsNum=250164&MainKind=A&NewsKind=5&vCount=12&vKind=1
6740,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://inthenews.co.kr/article-27909/
6741,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.techholic.co.kr/news/articleView.html?idxno=187941
6742,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58727
6743,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.fetv.co.kr/news/article.html?no=42687
6744,2019-12-12,한미약품대한민국사랑받는기업정부포상서국무총리상수상,https://asiatime.co.kr/news/newsview.php?ncode=1065593638103009
6745,2019-12-12,한미약품대한민국사랑받는기업정부포상국무총리표창,http://news.mt.co.kr/mtview.php?no=2019121215362228738
6746,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://fn.segye.com/content/html/2019/12/12/20191212511370.html?OutUrl=naver
6747,2019-12-12,한미약품지속가능경영공로대한민국사랑받는기업국무총리표창,http://www.sisaon.co.kr/news/articleView.html?idxno=106037
6748,2019-12-12,한미약품대한민국사랑받는기업국무총리표창,http://www.medisobizanews.com/news/articleView.html?idxno=64800
6749,2019-12-12,한미약품지속가능경영공로인정대한민국사랑받는기업국무총리표창수상,http://www.newsprime.co.kr/news/article.html?no=486841
6750,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.newsway.co.kr/news/view?tp=1&ud=2019121216002275685
6751,2019-12-12,한미약품주당002주무상증자결정,http://www.edaily.co.kr/news/newspath.asp?newsid=03617846622717864
6752,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.joseilbo.com/news/news_read.php?uid=388940&class=17&grp=
6753,2019-12-12,한미약품1주당002주무상증자결정,http://news.mt.co.kr/mtview.php?no=2019121216110665648
6754,2019-12-12,한미약품사랑받는기업정부포상국무총리표창수상,http://news.mk.co.kr/newsRead.php?year=2019&no=1042386
6755,2019-12-12,한미약품고용공정공헌사랑받는기업국무총리상수상,http://news.heraldcorp.com/view.php?ud=20191212000725
6756,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.monews.co.kr/news/articleView.html?idxno=207062
6757,2019-12-12,한미약품사랑받는기업국무총리표창,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89500
6758,2019-12-12,공시한미약품주당002주무상증자결정,http://www.newsway.co.kr/news/view?tp=1&ud=2019121216214230216
6759,2019-12-12,공시한미약품1주당002주무상증자결정,http://www.fnnews.com/news/201912121618061753
6760,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.mediapen.com/news/view/484529
6761,2019-12-12,한미약품주당002주무상증자결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1833658
6762,2019-12-12,한미약품주당002주무상증자결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1833658
6763,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,https://biz.chosun.com/site/data/html_dir/2019/12/12/2019121202570.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6764,2019-12-12,종근당005주한미사이언스한미약품각002주무상증자,http://medipana.com/news/news_viewer.asp?NewsNum=250165&MainKind=A&NewsKind=5&vCount=12&vKind=1
6765,2019-12-12,한미약품보통주1주당002주무상증자결정,https://view.asiae.co.kr/article/2019121216342804074
6766,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.nextdaily.co.kr/news/article.html?id=20191212800036
6767,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.newstomato.com/ReadNews.aspx?no=939457
6768,2019-12-12,한미약품전경련회관서대한민국사랑받는기업국무총리표창수상,http://www.thefirstmedia.net/news/articleView.html?idxno=51858
6769,2019-12-12,지속가능경영공로인정받다한미약품대한민국사랑받는기업국무총리표창수상,http://www.updownnews.co.kr/news/articleView.html?idxno=212336
6770,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.dailian.co.kr/news/view/852157/?sc=naver
6771,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.getnews.co.kr/view.php?ud=20191212171507305541d0c69529_16
6772,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.medigatenews.com/news/1576238103
6773,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=372626
6774,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.bokuennews.com/news/article.html?no=184529
6775,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://daily.hankooki.com/lpage/ittech/201912/dh20191212175124145630.htm
6776,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.ekn.kr/news/article.html?no=469670
6777,2019-12-12,수출파이프라인임상서잇단고배주가부진한미약품내년회복할까,https://www.hankyung.com/finance/article/2019121220601
6778,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.econovill.com/news/articleView.html?idxno=379970
6779,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.gukjenews.com/news/articleView.html?idxno=1212638
6780,2019-12-12,한미약품제7회대한민국사랑받는기업정부포상국무총리표창윤리경영문화등높이평가,http://www.greened.kr/news/articleView.html?idxno=227899
6781,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.newswatch.kr/news/articleView.html?idxno=25743
6782,2019-12-12,한미약품제7회대한민국사랑받는기업국무총리표창수상,http://www.newslock.co.kr/news/articleView.html?idxno=24232
6783,2019-12-12,한미약품대한민국사랑받는기업국무총리표창수상,http://www.newscj.com/news/articleView.html?idxno=690878
6784,2019-12-13,한미약품대한민국사랑받는기업국무총리표창수상,http://www.bosa.co.kr/news/articleView.html?idxno=2117935
6785,2019-12-13,한미약품보통주1주당002주무상증자결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=372651
6786,2019-12-13,전일주요공시한미약품종근당GS건설한국큐빅등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1833743
6787,2019-12-13,한미약품대한민국사랑받는기업국무총리표창수상,http://moneys.mt.co.kr/news/mwView.php?no=2019121308158016241
6788,2019-12-13,종근당한미약품한미사이언스무상증자결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=372666
6789,2019-12-13,한미약품미학회서혈액암타깃신약후보물질2건연구결과발표,http://www.nspna.com/news/?mode=view&newsid=399522
6790,2019-12-13,한미약품대한민국사랑받는기업국무총리표창수상,http://www.nspna.com/news/?mode=view&newsid=399526
6791,2019-12-13,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238583
6792,2019-12-13,한미약품온가족이사용하는프레쉬핸드워시출시,http://kormedi.com/?p=1307735
6793,2019-12-13,한미약품감염병예방위한온가족사용저자극프레쉬핸드워시출시,http://www.newslock.co.kr/news/articleView.html?idxno=24253
6794,2019-12-13,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.nextdaily.co.kr/news/article.html?id=20191213800030
6795,2019-12-13,온가족이사용하세요한미약품프레쉬핸드워시출시,http://www.koreaittimes.com/news/articleView.html?idxno=94600
6796,2019-12-13,한미약품온가족이사용하는프레쉬핸드워시출시,http://medipana.com/news/news_viewer.asp?NewsNum=250201&MainKind=A&NewsKind=5&vCount=12&vKind=1
6797,2019-12-13,한미약품저자극손세정제프레시핸드워시출시,http://news.mt.co.kr/mtview.php?no=2019121311270415092
6798,2019-12-13,12월13일한미약품실시간증시296500원068,http://nbntv.co.kr/news/view/769856
6799,2019-12-13,한미약품저자극손세정제프레쉬핸드워시출시,http://www.medisobizanews.com/news/articleView.html?idxno=64837
6800,2019-12-13,한미약품주가12월13일오늘가격296000원정보,http://www.gokorea.kr/news/articleView.html?idxno=600523
6801,2019-12-13,한미약품항균∙보습력갖춘온가족이사용하는프레쉬핸드워시출시,http://www.techholic.co.kr/news/articleView.html?idxno=187962
6802,2019-12-13,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.bosa.co.kr/news/articleView.html?idxno=2117979
6803,2019-12-13,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=39219
6804,2019-12-13,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.fetv.co.kr/news/article.html?no=42756
6805,2019-12-13,한미약품저자극세정제프레쉬핸드워시출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=19629
6806,2019-12-13,한미약품저자극손세정제한미프레쉬핸드워시출시,http://news1.kr/articles/?3792628
6807,2019-12-13,한미약품온가족이사용하는손세정제프레쉬핸드워시출시,http://www.asiaarts.net/view.php?ud=201912131314435218992c145ca5_38
6808,2019-12-13,한미약품저자극손세정제프레쉬핸드워시출시,http://www.pressm.kr/news/articleView.html?idxno=26558
6809,2019-12-13,한미약품온가족위한프레쉬핸드워시출시,http://bravo.etoday.co.kr/view/atc_view.php?varAtcId=10119
6810,2019-12-13,한미약품산자부주관대한민국사랑받는기업국무총리표창수상,http://www.news2day.co.kr/144295
6811,2019-12-13,한미약품저자극세정제프레쉬핸드워시출시,http://www.econovill.com/news/articleView.html?idxno=380049
6812,2019-12-13,한미약품손세정제프레쉬핸드워시출시,http://weekly.cnbnews.com/news/article.html?no=131591
6813,2019-12-13,한미약품저자극손세정제프레쉬핸드워시출시,http://news.mk.co.kr/newsRead.php?year=2019&no=1045556
6814,2019-12-13,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.newsway.co.kr/news/view?tp=1&ud=2019121314394437528
6815,2019-12-13,한미약품저자극손세정제한미프레쉬핸드워시출시,http://4th.kr/View.aspx?No=353295
6816,2019-12-13,한미약품프레쉬핸드워시출시,http://www.ebn.co.kr/news/view/1013439/?sc=naver
6817,2019-12-13,한미약품프레쉬핸드워시출시,http://www.ebn.co.kr/news/view/1013449/?sc=naver
6818,2019-12-13,한미약품프레쉬핸드워시출시식중독독감균항균력인증,http://www.100ssd.co.kr/news/articleView.html?idxno=66069
6819,2019-12-13,한미약품온가족사용프레쉬핸드워시출시,http://www.dailymedi.com/detail.php?number=850743&thread=22r05
6820,2019-12-13,주간신상태그에스쁘아클루젝시믹스한미약품신라호텔외,http://www.newsprime.co.kr/news/article.html?no=486989
6821,2019-12-13,한미약품온가족사용가능세정제프레쉬핸드워시출시,http://www.getnews.co.kr/view.php?ud=2019121316414696141d0c69529_16
6822,2019-12-13,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=372696
6823,2019-12-13,한미약품한미프레쉬핸드워시출시,http://www.finomy.com/news/articleView.html?idxno=72999
6824,2019-12-13,한미약품프레쉬핸드워시출시항균보습력갖춰,http://www.greened.kr/news/articleView.html?idxno=228113
6825,2019-12-13,뷰티단신한미약품닥터지랄라블라外,http://www.dailypop.kr/news/articleView.html?idxno=42530
6826,2019-12-13,한미약품저자극손세정제프레쉬핸드워시출시,http://www.donga.com/news/article/all/20191213/98796457/1
6827,2019-12-13,손씻기로독감예방한미약품프레쉬핸드워시출시,http://www.news2day.co.kr/144355
6828,2019-12-14,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58749
6829,2019-12-14,종목현미경판권불확실성한미약품목표가줄하향,http://news1.kr/articles/?3792844
6830,2019-12-14,한미약품저자극손세정제프레쉬핸드워시출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075155
6831,2019-12-14,한미약품손세정제프레쉬핸드워시선봬,https://www.kpanews.co.kr/article/show.asp?idx=209468&category=D
6832,2019-12-14,한미약품프레쉬핸드워시로온가족가염병예방,http://www.efnews.co.kr/news/articleView.html?idxno=82362
6833,2019-12-15,한미약품온가족이사용하는프레쉬핸드워시선봬,http://www.g-enews.com/ko-kr/news/article/news_all/20191213153144467769d76442fa_1/article.html
6834,2019-12-15,한미약품저자극세정제한미프레쉬핸드워시출시,https://asiatime.co.kr/news/newsview.php?ncode=1065590731088416
6835,2019-12-15,한미약품온가족용프레쉬핸드워시출시,http://www.viva100.com/main/view.php?key=20191215010005070
6836,2019-12-15,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.metroseoul.co.kr/news/newsview?newscd=2019121500016
6837,2019-12-16,제2회납세대상수상기업한미약품매출액20RD투자30여개신약후보물질임상순항,http://www.joseilbo.com/news/news_read.php?uid=389018&class=17&grp=
6838,2019-12-16,한미약품저자극세정제프레쉬핸드워시출시,http://www.babytimes.co.kr/news/articleView.html?idxno=31577
6839,2019-12-16,12월16일한미약품주식증권034296500원,http://nbntv.co.kr/news/view/771819
6840,2019-12-16,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.thefirstmedia.net/news/articleView.html?idxno=51989
6841,2019-12-17,오늘주식한미약품주가17일현재295000원,http://nbntv.co.kr/news/view/773737
6842,2019-12-17,중국이탈리아날아간임종윤대표한미약품그룹제2막열었다,http://news1.kr/articles/?3795187
6843,2019-12-18,제약업계단신한미약품종근당동아쏘시오홀딩스일동제약,http://www.g-enews.com/ko-kr/news/article/news_all/20191217164236920469d76442fa_1/article.html
6844,2019-12-18,12월18일한미약품실시간증시298500원119,http://nbntv.co.kr/news/view/775885
6845,2019-12-18,18일데일리증권한미약품128940오후2시26분기준및증권정보와종목동정,https://www.dailysecu.com/news/articleView.html?idxno=88298
6846,2019-12-19,10대제약사중6곳연구개발비상승한미약품투자액투자비중최고,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=535649
6847,2019-12-19,한미약품임성기회장흔들림없이신약개발매진”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238785
6848,2019-12-19,임성기한미약품그룹회장흔들림없이신약개발매진”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1836185
6849,2019-12-19,한중회참석한임성기한미약품그룹회장흔들림없이신약개발매진”,http://www.fetv.co.kr/news/article.html?no=43253
6850,2019-12-19,한미약품임성기회장퇴직임원모임송년회참석흔들림없이신약개발매진,http://sports.chosun.com/news/ntype.htm?id=201912200100142130009091&servicedate=20191219
6851,2019-12-19,한미약품그룹임성기회장흔들림없이신약개발매진,http://medipana.com/news/news_viewer.asp?NewsNum=250493&MainKind=A&NewsKind=5&vCount=12&vKind=1
6852,2019-12-19,임성기한미약품회장흔들림없이신약개발매진”,http://www.econovill.com/news/articleView.html?idxno=380491
6853,2019-12-19,한미약품신약개발매진글로벌제약사로도약,http://www.medisobizanews.com/news/articleView.html?idxno=65025
6854,2019-12-19,퇴직임원들품은임성기한미약품회장신약개발매진,http://news1.kr/articles/?3797137
6855,2019-12-19,임성기한미약품그룹회장한중회참석흔들림없이신약개발매진,http://biz.newdaily.co.kr/site/data/html/2019/12/19/2019121900098.html
6856,2019-12-19,한중회한미약품퇴직임원모임참석한임성기회장흔들림없이신약개발매진”,http://www.wikitree.co.kr/main/news_view.php?id=490555
6857,2019-12-19,한미약품퇴직임원모임참석한임성기회장흔들림없이신약개발매진,https://biz.chosun.com/site/data/html_dir/2019/12/19/2019121901520.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6858,2019-12-19,한미약품임성기회장흔들림없이신약개발매진,http://www.economytalk.kr/news/articleView.html?idxno=202336
6859,2019-12-19,임성기한미약품회장흔들림없이신약개발매진,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132633
6860,2019-12-19,임성기한미약품퇴직임원모임에서신약개발흔들림없이매진”,http://www.businesspost.co.kr/BP?command=article_view&num=155965
6861,2019-12-19,한미약품실시간증시19일현재299000원,http://nbntv.co.kr/news/view/778076
6862,2019-12-19,한미약품임성기회장퇴직임원모임참석감사와격려전달,http://www.metroseoul.co.kr/news/newsview?newscd=2019121900109
6863,2019-12-19,임성기한미약품그룹회장한중회참석퇴직임원에감사와격려,http://www.newswatch.kr/news/articleView.html?idxno=25895
6864,2019-12-19,임성기한미약품회장흔들림없이신약개발매진”,http://www.viva100.com/main/view.php?key=20191219010007151
6865,2019-12-19,19일데일리주식정보한미약품128940오후3시19분기준외매매동향,https://www.dailysecu.com/news/articleView.html?idxno=88837
6866,2019-12-19,한중회참석한임성기한미약품회장흔들림없이신약개발매진,http://www.wsobi.com/news/articleView.html?idxno=87086
6867,2019-12-19,임성기한미약품그룹회장최근어렵지만흔들림없이신약개발매진할것,http://news.mk.co.kr/newsRead.php?no=1066456&year=2019
6868,2019-12-19,한미약품임성기회장어려워도신약개발매진하겠다,http://health.chosun.com/site/data/html_dir/2019/12/19/2019121902841.html
6869,2019-12-19,시그널한미약품신용등급부정적투자금회수불확실여파,https://signal.sedaily.com/NewsView/1VS4W4SQV8
6870,2019-12-19,나신평한미약품등급전망부정적하향,http://www.newsway.co.kr/news/view?tp=1&ud=2019121917071542982
6871,2019-12-19,11년간이어진한미약품그룹임원가족들의따뜻한나눔,http://www.fetv.co.kr/news/article.html?no=43324
6872,2019-12-19,한미약품임원가족모임한미부인회11년째자선바자회열어,http://www.metroseoul.co.kr/news/newsview?newscd=2019121900209
6873,2019-12-19,마켓인한미약품신용등급전망안정적→부정적하향,http://www.edaily.co.kr/news/newspath.asp?newsid=03827766622720160
6874,2019-12-19,임성기한미약품회장신약개발매진할것”,http://www.newsway.co.kr/news/view?tp=1&ud=2019121917404310233
6875,2019-12-19,임성기한미약품그룹회장한중회참석흔들림없이신약개발매진,http://www.m-i.kr/news/articleView.html?idxno=666057
6876,2019-12-19,한미약품임원가족모임한미부인회11년째나눔행사열어,http://www.pressm.kr/news/articleView.html?idxno=26707
6877,2019-12-19,한미약품퇴직임원모임참석임성기회장흔들림없이신약개발,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4014068
6878,2019-12-19,한미약품그룹임원가족들따뜻한나눔‥11년째지속,http://medipana.com/news/news_viewer.asp?NewsNum=250543&MainKind=A&NewsKind=5&vCount=12&vKind=1
6879,2019-12-19,한미약품프레쉬핸드워시동절기감염병예방위한손씻기도우미로눈길,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=535877
6880,2019-12-19,나이스신평한미약품신용등급전망부정적하향,http://www.econovill.com/news/articleView.html?idxno=380561
6881,2019-12-19,한미약품39년째헌혈캠페인참여직원8천2백여명,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89618
6882,2019-12-19,한미약품텐텐어린이종합비타민부문대상,http://www.newsprime.co.kr/news/article.html?no=487707
6883,2019-12-19,11년간이어진한미약품그룹임원가족들의따뜻한나눔,http://www.mdtoday.co.kr/mdtoday/index.html?no=373257
6884,2019-12-19,한미약품헌혈캠페인연4회로확대누적참여8218명,http://www.econovill.com/news/articleView.html?idxno=380575
6885,2019-12-19,한미약품부인회자선바자회열어수익금전액소외계층에기부,http://www.econovill.com/news/articleView.html?idxno=380577
6886,2019-12-19,한미약품올해임직원헌혈활동연4회로확대39년간8218명참여,http://www.donga.com/news/article/all/20191219/98882946/1
6887,2019-12-19,한미약품그룹임원가족나눔행사진행,http://www.lawissue.co.kr/view.php?ud=201912191905274146204ead0791_12
6888,2019-12-19,나이스신용평가한미약품등급전망을부정적으로내려,http://www.businesspost.co.kr/BP?command=article_view&num=156089
6889,2019-12-19,한미약품헌혈캠페인 연4회로확대누적참여자8218명,http://www.medisobizanews.com/news/articleView.html?idxno=65064
6890,2019-12-19,11년간이어온온정한미약품그룹임원가족들나눔의사랑,http://www.medisobizanews.com/news/articleView.html?idxno=65065
6891,2019-12-19,한미약품그룹11년간이어진나눔행사수익금소외계층기부,http://www.newsprime.co.kr/news/article.html?no=487714
6892,2019-12-19,한미약품사랑의헌혈캠페인연4회확대운영,http://www.newsprime.co.kr/news/article.html?no=487709
6893,2019-12-19,한미약품임직원헌혈캠페인누적참여자8218명나눔실천하는따뜻한연말,http://www.anewsa.com/detail.php?number=2036929&thread=09r02
6894,2019-12-19,한미약품한미부인회자산바자회통한수익금전액소외계층에기부,http://www.anewsa.com/detail.php?number=2036932&thread=10r03
6895,2019-12-19,한미약품임원가족모임한미부인회자선바자회,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4014241
6896,2019-12-19,한미약품사랑의헌혈연4회로확대누적참여자8218명,http://www.thefirstmedia.net/news/articleView.html?idxno=52172
6897,2019-12-20,녹십자한미약품대웅제약등제약업계퇴직사우모임활발,http://www.rapportian.com/news/articleView.html?idxno=122275
6898,2019-12-20,39년째진행되고있는한미약품사랑의헌혈연4회로확대,http://www.bokuennews.com/news/article.html?no=184814
6899,2019-12-20,사회공헌한미약품헌혈캠페인연4회로확대누적참여자8218명,http://www.ezyeconomy.com/news/articleView.html?idxno=96416
6900,2019-12-20,한미약품헌혈캠페인연4회확대누적참여자8218명,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238840
6901,2019-12-20,한미약품순차입금늘어신용등급부정적,http://www.koreastocknews.com/news/articleView.html?idxno=49026
6902,2019-12-20,셀트리온한미약품미국서K바이오알린다JP모건헬스케어콘퍼런스,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912200079&t=NNv
6903,2019-12-20,한미약품헌혈캠페인확대참여임직원누적8200명,http://www.upinews.kr/newsView/upi201912200026
6904,2019-12-20,한미약품혈액수급확대위해헌혈캠페인연4회확대누적참여자8218명,http://www.newslock.co.kr/news/articleView.html?idxno=24459
6905,2019-12-20,주식그래프한미약품주가20일현재300000원,http://nbntv.co.kr/news/view/779359
6906,2019-12-20,한미약품올해헌혈캠페인에임직원600여명참여,http://www.rapportian.com/news/articleView.html?idxno=122282
6907,2019-12-20,한미약품12894020일017변동폭보여증권투자정보및매매가,http://www.gokorea.kr/news/articleView.html?idxno=606440
6908,2019-12-20,한미약품임원가족모임한미부인회자선바자회,http://www.mbn.co.kr/pages/vod/programContents.php?progCode=683&menuCode=4385&bcastSeqNo=1231053
6909,2019-12-20,한미약품올해4번째헌혈캠페인진행누적8218명참여,http://www.meconomynews.com/news/articleView.html?idxno=36411
6910,2019-12-20,한미약품헌혈누적참여자8218명,http://www.koreaittimes.com/news/articleView.html?idxno=94736
6911,2019-12-20,한미약품순차입금3년만에167배↑RD투자회수되나,http://moneys.mt.co.kr/news/mwView.php?no=2019122015418088212
6912,2019-12-20,나이스신용평가한미약품신용등급전망부정적하향조정,http://www.mdtoday.co.kr/mdtoday/index.html?no=373338
6913,2019-12-20,한미약품헌혈캠페인연4회로확대누적참여자8218명,http://www.newsian.co.kr/news/articleView.html?idxno=38811
6914,2019-12-20,오늘Who한미약품재무구조악화임성기혁신신약개발계속밀까,http://www.businesspost.co.kr/BP?command=article_view&num=156247
6915,2019-12-20,한미약품공정위CP등급AA6년간유지제약업계최장기,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=238880
6916,2019-12-20,한미약품공정위CP등급6년연속AA등급획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912200385&t=NN
6917,2019-12-20,한미약품공정위CP등급AA6년간인증제약계최장기록,http://www.medisobizanews.com/news/articleView.html?idxno=65111
6918,2019-12-20,한미약품공정위CP등급AA6년연속획득업계최장기록,http://www.newspim.com/news/view/20191220001022
6919,2019-12-20,한미약품공정위CP등급AA6년간유지업계최장기기록,http://medipana.com/news/news_viewer.asp?NewsNum=250602&MainKind=A&NewsKind=5&vCount=12&vKind=1
6920,2019-12-20,한미약품CP재평가서AA등급받아,http://news.mk.co.kr/newsRead.php?no=1070175&year=2019
6921,2019-12-20,한미약품공정위CP등급AA6년간유지업계최장기기록,http://www.newslock.co.kr/news/articleView.html?idxno=24503
6922,2019-12-20,한미약품CP문화통해지속가능하고건강한성장도모공정위CP등급AA6년간유지,http://www.updownnews.co.kr/news/articleView.html?idxno=212742
6923,2019-12-20,한미약품CP등급AA재획득6년간유지,http://www.newspost.kr/news/articleView.html?idxno=74726
6924,2019-12-20,한미약품공정위CP등급AA유지,http://www.newsway.co.kr/news/view?tp=1&ud=2019122017104257889
6925,2019-12-20,한미약품공정위CP등급AA획득,http://news.mt.co.kr/mtview.php?no=2019122017253096376
6926,2019-12-20,한미약품CPAA등급6년째획득,http://weekly.cnbnews.com/news/article.html?no=131751
6927,2019-12-20,한미약품공정경쟁최고수준AA등급재획득,http://www.rapportian.com/news/articleView.html?idxno=122299
6928,2019-12-20,한미약품공정위CP등급AA6년간유지”업계최장기기록”,http://www.getnews.co.kr/view.php?ud=20191220181144816741d0c69529_16
6929,2019-12-20,한미약품공정위CP등급6년연속AA등급획득,http://www.econovill.com/news/articleView.html?idxno=380679
6930,2019-12-20,한미약품공정위CP등급AA6년간유지,http://www.enewstoday.co.kr/news/articleView.html?idxno=1357128
6931,2019-12-20,한미약품공정위컴플라이언스프로그램등급평가AA재획득,http://4th.kr/View.aspx?No=361323
6932,2019-12-20,한미약품공정위공정거래자율준수프로그램AA등급6년간유지,http://www.businesspost.co.kr/BP?command=article_view&num=156299
6933,2019-12-20,한미약품공정위CP등급AA재인증6년간유지,http://www.biospectator.com/view/news_view.php?varAtcId=9162
6934,2019-12-20,한미약품공정위CP등급AA6년간유지업계CP문화확산기여,http://www.newswatch.kr/news/articleView.html?idxno=25935
6935,2019-12-20,한미약품한미부인회11년째자선바자회열어,http://www.newscj.com/news/articleView.html?idxno=693201
6936,2019-12-20,한미약품공정위CP등급AA6년간유지,https://www.kpanews.co.kr/article/show.asp?idx=209641&category=D
6937,2019-12-21,나신평한미약품등급전망부정적하향조정,http://www.fnnews.com/news/201912210852080009
6938,2019-12-21,한미약품공정위CP등급AA6년간유지,http://www.ebn.co.kr/news/view/1014499/?sc=naver
6939,2019-12-22,한미약품공정위CP등급AA획득업계최장6년유지”,http://www.viva100.com/main/view.php?key=20191222010007697
6940,2019-12-22,한미약품공정위기준준법경영CP등급AA6년간유지제약업계최장기기록,http://www.greened.kr/news/articleView.html?idxno=229329
6941,2019-12-22,한미약품공정거래도파란신호등최고등급AA최장기기록,http://news.heraldcorp.com/view.php?ud=20191222000132
6942,2019-12-22,한미약품사노피와파트너관계양호,http://www.anewsa.com/detail.php?number=2037919&thread=10r03
6943,2019-12-23,한미약품공정위CP등급AA획득업계최장,http://moneys.mt.co.kr/news/mwView.php?no=2019122308348014864
6944,2019-12-23,장중수급포착한미약품외국인5일연속순매수행진주가200,http://www.newspim.com/news/view/20191223000316
6945,2019-12-23,한미약품CPAA등급6년간유지,http://www.monews.co.kr/news/articleView.html?idxno=207235
6946,2019-12-23,12월23일한미약품시황정보250변동,http://www.gokorea.kr/news/articleView.html?idxno=608022
6947,2019-12-23,12월23일한미약품주식추천주250307000원,http://nbntv.co.kr/news/view/781749
6948,2019-12-23,겨울관련주테마오후시황상승률상위종목유한양행228신일산업224한미약품217등,http://www.gokorea.kr/news/articleView.html?idxno=608530
6949,2019-12-23,겨울관련주테마13시현재주식시황상승률상위종목유한양행6500원269신일산업45원252한미약품6000원200상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=153936
6950,2019-12-23,겨울관련주테마종목종가신일산업한미약품등이주도,http://nbntv.co.kr/news/view/782986
6951,2019-12-23,한미약품공정위CP등급AA재획득업계최장기기록달성,http://www.dailypop.kr/news/articleView.html?idxno=42676
6952,2019-12-23,겨울관련주테마마감시황상승률상위종목신일산업224한미약품200SPC삼립152등,http://www.gokorea.kr/news/articleView.html?idxno=609137
6953,2019-12-23,한미약품공정위CP등급AA6년간유지＂업계최장기기록＂,http://www.nspna.com/news/?mode=view&newsid=401511
6954,2019-12-23,건강한겨울나기한미약품프레쉬핸드워시,https://www.sedaily.com/NewsView/1VS6QL3CF6
6955,2019-12-24,한미약품증권투자24일현재304000원,http://nbntv.co.kr/news/view/784165
6956,2019-12-24,한미약품12894024일065변화오늘시세및거래동향,http://www.gokorea.kr/news/articleView.html?idxno=609960
6957,2019-12-25,대기업매출액대비연구개발비용증가삼성전자연간20조네이버셀트리온한미약품비중높아,http://www.greened.kr/news/articleView.html?idxno=229787
6958,2019-12-25,한미약품과일동제약고혈압과고지혈증4제복합제개발경쟁치열,http://www.businesspost.co.kr/BP?command=article_view&num=156800
6959,2019-12-26,희귀의약품의경제학②녹십자한미약품이희귀약에서성장동력찾는까닭은,http://www.edaily.co.kr/news/newspath.asp?newsid=01256246622722456
6960,2019-12-26,12월26일한미약품주식시황000변동,http://www.gokorea.kr/news/articleView.html?idxno=612058
6961,2019-12-26,증권주식한미약품주가26일현재303500원,http://nbntv.co.kr/news/view/786531
6962,2019-12-27,한미약품포지오티닙비소세포폐암ORR1차평가지표미충족,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912270025&t=NN
6963,2019-12-27,한미약품포지오티닙첫환자군대상임상서1차지표목표치미충족,http://news.mk.co.kr/newsRead.php?no=1087612&year=2019
6964,2019-12-27,한미약품온가족이사용하는프레쉬핸드워시출시,http://www.ajunews.com/view/20191227080113575
6965,2019-12-27,한미약품포지오티닙임상7개중1개유효성입증실패,http://news.mt.co.kr/mtview.php?no=2019122707452050075
6966,2019-12-27,한미약품포지오티닙임상쓴잔비소세포폐암임상1차지표미충족”,http://www.viva100.com/main/view.php?key=20191227010009408
6967,2019-12-27,하이로우한미약품포지오티닙첫임상목표치미충족향후임상도낙관어려워KB,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019122708144524265
6968,2019-12-27,한미약품항암신약포지오티닙임상7개중1개유효성입증실패,http://moneys.mt.co.kr/news/mwView.php?no=2019122708178076768
6969,2019-12-27,한미약품포지오티닙비소세포폐암임상서1차평가변수미충족,http://biz.newdaily.co.kr/site/data/html/2019/12/27/2019122700004.html
6970,2019-12-27,한미약품포지오티닙임상2상첫환자군1차평가미충족”,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019122708344311162
6971,2019-12-27,한미약품포지오티닙임상2상7개연구중1개실패,http://www.newspim.com/news/view/20191227000104
6972,2019-12-27,한미약품포지오티닙임상7개중1개유효성입증못해,http://www.econovill.com/news/articleView.html?idxno=381107
6973,2019-12-27,한미약품파트너스펙트럼포지오티닙1차평가변수미충족”,http://daily.hankooki.com/lpage/ittech/201912/dh20191227084546145630.htm
6974,2019-12-27,한미약품포지오티닙임상첫번째환자군1차평가변수미충족,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239050
6975,2019-12-27,한미약품포지오티닙임상2상첫환자군서1차평가변수미충족,http://www.newstomato.com/ReadNews.aspx?no=942325
6976,2019-12-27,美기술수출한한미약품포지오티닙임상1차목표미충족,https://biz.chosun.com/site/data/html_dir/2019/12/27/2019122700654.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6977,2019-12-27,한미약품포지오티닙첫환자군임상서1차변수미충족,http://www.newsway.co.kr/news/view?tp=1&ud=2019122708351174663
6978,2019-12-27,한미약품000VI발동,https://biz.chosun.com/site/data/html_dir/2019/12/27/2019122700679.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6979,2019-12-27,특징주한미약품포지오티닙유효성입증실패소식에하락세,http://news.mt.co.kr/mtview.php?no=2019122709051518593
6980,2019-12-27,특징주한미약품포지오티닙유효성입증실패에하락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1838707
6981,2019-12-27,한미약품한미사이언스가파른하락에투자자들어떡하나특히한미약품갑작스런7급락,http://www.econonews.co.kr/news/articleView.html?idxno=100395
6982,2019-12-27,특징주한미약품항암신약임상1차평가미충족에약세,http://yna.kr/AKR20191227032900008?did=1195m
6983,2019-12-27,특징주한미약품포지오티닙임상목표치미충족소식에약세,http://news.mk.co.kr/newsRead.php?no=1087875&year=2019
6984,2019-12-27,한미약품포지오티닙임상첫환자군1차변수미충족”,http://www.ebn.co.kr/news/view/1015119/?sc=naver
6985,2019-12-27,특징주한미약품포지오티닙유효성목표미달에급락,http://www.inews24.com/view/1231791
6986,2019-12-27,한미약품항암신약포지오티닙임상일부1차평가미충족,http://yna.kr/AKR20191227025600017?did=1195m
6987,2019-12-27,한미약품항암신약후보물질포지오티닙임상1차지표미충족,http://www.sportsseoul.com/news/read/865848
6988,2019-12-27,머니e종목한미약품한미사이언스포지오티닙임상실패에하락세,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019122709175717483
6989,2019-12-27,한미약품스펙트럼포지오티닙임상1차평가변수미충족,http://it.chosun.com/site/data/html_dir/2019/12/27/2019122700814.html
6990,2019-12-27,특징주한미약품항암신약임상1차평가미충족에약세,https://www.sedaily.com/NewsView/1VS8JR4F0O
6991,2019-12-27,특징주한미약품포지오티닙유효성입증실패소식에급락세,http://www.viva100.com/main/view.php?key=20191227010009424
6992,2019-12-27,특징주한미약품포지오티닙유효성입증실패에하락,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572531884879
6993,2019-12-27,특징주한미약품항암신약임상1차평가미충족약세,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912270099&t=NN
6994,2019-12-27,한미약품포지오티닙유효성입증실패소식에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=373763
6995,2019-12-27,한미약품포지오티닙비소세포폐암임상첫번째환자군1차평가변수미충족”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1838701
6996,2019-12-27,특징주한미약품항암신약임상2상서평가미충족소식에하락,http://www.ajunews.com/view/20191227092456694
6997,2019-12-27,한미약품포지오티닙코호트1임상실패,http://www.kmedinfo.co.kr/news/articleView.html?idxno=58954
6998,2019-12-27,특징주한미약품항암신약임상1차평가미충족에하락세↓,http://www.sporbiz.co.kr/news/articleView.html?idxno=404073
6999,2019-12-27,한미약품항암신약포지오티닙유효성입증실패주가하락세,http://moneys.mt.co.kr/news/mwView.php?no=2019122709268057207
7000,2019-12-27,특징주한미약품포지오티닙임상2상유효성입증실패에약세,http://www.edaily.co.kr/news/newspath.asp?newsid=01899126622722784
7001,2019-12-27,한미약품항암신약포지오티닙임상일부1차평가미충족,http://www.asiatoday.co.kr/view.php?key=20191227010016228
7002,2019-12-27,신약임상목표치미달한미약품장초반주가약세,http://www.choicenews.co.kr/news/articleView.html?idxno=66938
7003,2019-12-27,한미약품항암신약포지오티닙유효성입증실패에급락,http://www.whitepaper.co.kr/news/articleView.html?idxno=186360
7004,2019-12-27,특징주한미약품항암신약임상1차평가미충족에약세,http://www.dailian.co.kr/news/view/856217/?sc=naver
7005,2019-12-27,특징주한미약품포지오티닙임상목표미충족에약세,http://www.newstomato.com/ReadNews.aspx?no=942341
7006,2019-12-27,한미약품항암신약유효성입증실패하락세주력제품은,http://www.ccreview.co.kr/news/articleView.html?idxno=231238
7007,2019-12-27,특징주한미약품항암신약임상1차미충족에↓메디톡스오창공장압색에↓,http://www.kdfnews.com/news/articleView.html?idxno=41233
7008,2019-12-27,한미약품스펙트럼포지오티닙임상첫번째환자군1차평가변수미충족”,http://www.mdtoday.co.kr/mdtoday/index.html?no=373759
7009,2019-12-27,특징주한미약품배당락일신약임상실패소식더해져급락,http://www.seoulwire.com/news/articleView.html?idxno=264261
7010,2019-12-27,한미약품포지오티닙임상목표미충족,http://www.seoulfn.com/news/articleView.html?idxno=367044
7011,2019-12-27,주가하락한미약품항암신약포지오티닙임상서유효성미달,http://sports.chosun.com/news/ntype.htm?id=201912280100189350012184&servicedate=20191227
7012,2019-12-27,한미약품포지오티닙임상1차평가미충족,http://www.kukinews.com/news/article.html?no=731780
7013,2019-12-27,한미약품포지오티닙임상첫환자군1차평가변수미충족”,http://news1.kr/articles/?3802839
7014,2019-12-27,27일금요일10시현재특징주는삼성전자에이치엘비한미약품,http://www.leaders.kr/news/articleView.html?idxno=138708
7015,2019-12-27,한미약품텐텐코리아팜어워드굿브랜드어린이종합비타민부문대상,http://www.newspim.com/news/view/20191227000323
7016,2019-12-27,한미약품기술수출신약글로벌임상쓴잔급락세,http://www.upinews.kr/newsView/upi201912270026
7017,2019-12-27,한미약품포지오티닙임상2상첫환자군1차평가미충족,https://www.sedaily.com/NewsView/1VS8JY63B6
7018,2019-12-27,한미약품스펙트럼포지오티닙임상첫번째환자군1차평가변수미충족,http://kormedi.com/?p=1308478
7019,2019-12-27,한미약품항암신약포지오티닙임상1차평가변수미충족,http://www.etnews.com/20191227000037
7020,2019-12-27,한미약품하락세그이유는항암신약유효성입증실패했기때문,http://www.ggilbo.com/news/articleView.html?idxno=734401
7021,2019-12-27,한미약품파트너사포지오티닙1차목표미충족,http://www.shinailbo.co.kr/news/articleView.html?idxno=1237034
7022,2019-12-27,한미약품하락세이유는항암신약후보물질임상목표치미달,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20191227.99099012910
7023,2019-12-27,TF특징주한미약품항암신약임상평가미충족에장초반약세,http://news.tf.co.kr/read/economy/1773328.htm
7024,2019-12-27,인기주분석한미약품네이버주식인기5위종목등극주가28만6000원498,http://nbntv.co.kr/news/view/788547
7025,2019-12-27,한미약품파트너사스펙트럼포지오티닙임상첫번째환자군1차평가변수미충족,http://www.sisafocus.co.kr/news/articleView.html?idxno=228717
7026,2019-12-27,한미약품롤론티스미국FDA사전검토통과상용화한발짝,http://news1.kr/articles/?3802893
7027,2019-12-27,한미약품포지오티닙첫번째임상서1차평가지표미충족,http://www.rapportian.com/news/articleView.html?idxno=122404
7028,2019-12-27,한미약품호중구감소신약FDA본심사개시1차관문통과,http://www.newsis.com/view/?id=NISX20191227_0000872601&cID=13001&pID=13000
7029,2019-12-27,한미약품기술수출한포지오티닙美임상서목표치미달,https://www.nocutnews.co.kr/news/5264532
7030,2019-12-27,한미약품항암신약임상1차평가미충족,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4019630
7031,2019-12-27,한미약품항암신약포지오티닙첫번째환자군1차평가변수미충족,http://www.seoulwire.com/news/articleView.html?idxno=264302
7032,2019-12-27,특징주한미약품항암신약임상2상평가미충족소식에급락,http://www.fntimes.com/html/view.php?ud=2019122710451230866c0eb6f11e_18
7033,2019-12-27,12월27일한미약품종목정보449변동,http://www.gokorea.kr/news/articleView.html?idxno=614600
7034,2019-12-27,한미약품포지오티닙엑손20변이임상1차목표실패,http://health.chosun.com/site/data/html_dir/2019/12/27/2019122701315.html
7035,2019-12-27,특징주한미약품항암신약포지오티닙임상1차평가미충족에↓,http://www.newsway.co.kr/news/view?tp=1&ud=2019122711095610471
7036,2019-12-27,한미약품항암신약포지오티닙임상일부1차평가미충족”,http://www.ajunews.com/view/20191227111208820
7037,2019-12-27,한미약품포지오티닙임상첫번째환자군1차평가변수미충족”,http://sports.hankooki.com/lpage/economy/201912/sp20191227112304137020.htm
7038,2019-12-27,한미약품기술수출신약롤론티스미국FDA심사개시,http://yna.kr/AKR20191227067100017?did=1195m
7039,2019-12-27,주식증권한미약품주가27일현재288000원,http://nbntv.co.kr/news/view/788883
7040,2019-12-27,美FDA한미약품롤론티스시판허가본심사착수,http://news.mk.co.kr/newsRead.php?no=1088784&year=2019
7041,2019-12-27,한미약품롤론티스미국FDA1차관문통과,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239063
7042,2019-12-27,한미약품항암신약포지오티닙임상1차평가변수미충족”,http://inthenews.co.kr/article-29504/
7043,2019-12-27,한미약품美FDA서기술수출신약롤론티스심사개시”,https://www.sedaily.com/NewsView/1VS8KEGLLZ
7044,2019-12-27,한미약품비타민나인나인연말연시소비자心공략,http://www.newsis.com/view/?id=NISX20191227_0000872736&cID=13001&pID=13000
7045,2019-12-27,한미약품롤론티스글로벌신약승인첫허들넘었다,http://www.medisobizanews.com/news/articleView.html?idxno=65299
7046,2019-12-27,한미약품항암신약포지오티닙1차지표달성실패,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075588
7047,2019-12-27,美FDA한미약품롤론티스허가심사착수내년10월결론,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075596
7048,2019-12-27,한미약품비소세포폐암치료제의적응증확장첫임상에서목표미달,http://www.businesspost.co.kr/BP?command=article_view&num=157075
7049,2019-12-27,한미약품주가초반약세비소세포폐암치료제임상결과기대이하,http://www.businesspost.co.kr/BP?command=article_view&num=157080
7050,2019-12-27,특징주한미약품290500원27일12시50분장시작대비602상승,http://www.getnews.co.kr/view.php?ud=201912271251362898c20b9ae7fc_16
7051,2019-12-27,한미약품호중구감소증신약롤론티스FDA1차관문통과,http://www.kukinews.com/news/article.html?no=731880
7052,2019-12-27,한미약품롤론티스FDA1차관문통과본심사개시”,http://moneys.mt.co.kr/news/mwView.php?no=2019122713258079894
7053,2019-12-27,한미약품기술수출신약롤론티스미국FDA심사개시,http://www.asiatoday.co.kr/view.php?key=20191227010016386
7054,2019-12-27,한미약품일회용치질약치쏙크림출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019122713563559786
7055,2019-12-27,한미약품포지오티닙임상서1차평가변수미충족”,http://www.news2day.co.kr/145255
7056,2019-12-27,치질통증이쏙한미약품일회용치질약치쏙크림출시,http://news1.kr/articles/?3803159
7057,2019-12-27,한미약품항암제후보포지오티닙임상2상일부서1차지표미충족,http://www.edaily.co.kr/news/newspath.asp?newsid=02840486622722784
7058,2019-12-27,한미약품기술수출롤론티스FDA본심사개시,http://www.edaily.co.kr/news/newspath.asp?newsid=02860166622722784
7059,2019-12-27,한미약품호중구감소증신약미국식품의약국판매허가심사시작,http://www.businesspost.co.kr/BP?command=article_view&num=157092
7060,2019-12-27,어린이부터노인까지사용한미약품프레쉬핸드워시출시,http://news1.kr/articles/?3803176
7061,2019-12-27,美FDA한미약품신약롤론티스허가본심사개시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1838858
7062,2019-12-27,한미약품신약포지오티닙임상시험목표달성못해,http://www.segye.com/content/html/2019/12/27/20191227507537.html?OutUrl=naver
7063,2019-12-27,한미약품어린이비타민텐텐코리아팜어워드대상수상,http://news1.kr/articles/?3803188
7064,2019-12-27,한미약품저자극손세정제라인업프레쉬핸드워시출시,http://www.newsis.com/view/?id=NISX20191227_0000872970&cID=13001&pID=13000
7065,2019-12-27,위클리제약바이오한미약품포지오티닙냉탕롤론티스온탕오가外,http://www.etoday.co.kr/news/section/newsview.php?idxno=1838898
7066,2019-12-27,한미약품스펙트럼항암신약포지오티닙임상서환자군1차평가변수미충족,http://www.newslock.co.kr/news/articleView.html?idxno=24649
7067,2019-12-27,한미약품파트너사스펙트럼항암제후보포지오티닙임상첫번째환자군1차평가변수미충족,http://www.techholic.co.kr/news/articleView.html?idxno=188274
7068,2019-12-27,한미약품항암신약포지오티닙첫환자군임상서목표미충족,http://www.newsian.co.kr/news/articleView.html?idxno=38962
7069,2019-12-27,한미약품항암신약임상목표치미달에약세마감,http://www.newstomato.com/ReadNews.aspx?no=942523
7070,2019-12-27,한미약품항암신약포지오티닙美임상1차평가변수미충족했지만일부긍정결과,http://www.cnbnews.com/news/article.html?no=432135
7071,2019-12-27,한미약품롤론티스미국FDA사전검토통과,http://www.newsway.co.kr/news/view?tp=1&ud=2019122715593594411
7072,2019-12-27,한미약품신약롤론티스미국FDA심사개시,http://www.smedaily.co.kr/news/articleView.html?idxno=88501
7073,2019-12-27,한미약품손감염균977잡았다저자극손세정제프레쉬핸드워시출시,https://www.sisa-news.com/news/article.html?no=122837
7074,2019-12-27,한미약품기술수출신약롤론티스미국FDA심사개시,http://www.fntoday.co.kr/news/articleView.html?idxno=209988
7075,2019-12-27,한미약품마저포지오티닙2상실패,https://www.sedaily.com/NewsView/1VS8KDJKKT
7076,2019-12-27,한미약품롤론티스미국FDA본심사개시,http://www.mdtoday.co.kr/mdtoday/index.html?no=373789
7077,2019-12-27,한미약품기술수출롤론티스미국FDA심사개시,http://www.seoulfn.com/news/articleView.html?idxno=367153
7078,2019-12-27,한미약품스펙트럼포지오티닙임상첫번째환자군1차평가변수미충족,http://www.newscj.com/news/articleView.html?idxno=694937
7079,2019-12-28,제약바이오이모저모한미약품기술수출롤론티스FDA본심사개시,http://www.edaily.co.kr/news/newspath.asp?newsid=01164406622723112
7080,2019-12-29,빅데이터분석제약상장기업브랜드평판2019년11월빅데이터분석결과1위셀트리온2위삼성바이오로직스3위한미약품 ,http://www.fintechpost.co.kr/news/articleView.html?idxno=96011
7081,2019-12-29,기술수출한신약임상에울고웃는한미약품,http://moneys.mt.co.kr/news/mwView.php?no=2019122717198056443
7082,2019-12-29,한미약품포지오티닙임상목표미달기술반환가능성은無,https://www.asiatime.co.kr/news/newsview.php?ncode=1065587013077600
7083,2019-12-29,한미약품이대로괜찮을까신약개발잇단적신호,http://www.econovill.com/news/articleView.html?idxno=381234
7084,2019-12-29,한미약품美기술수출포지오티닙임상1차목표미달,http://www.skyedaily.com/news/news_view.html?ID=96528
7085,2019-12-29,한미약품온가족사용할수있는손세정제라인업프레쉬핸드워시출시,http://www.econonews.co.kr/news/articleView.html?idxno=100795
7086,2019-12-30,한미약품호중구감소증치료신약롤론티스美FDA심사시작,http://www.ekn.kr/news/article.html?no=472527
7087,2019-12-30,한미약품나인나인국내최다성분종합비타민,http://moneys.mt.co.kr/news/mwView.php?no=2019122711078027665
7088,2019-12-30,아픈치질이쏙”한미약품일회용치질약치쏙크림출시,http://www.edaily.co.kr/news/newspath.asp?newsid=01312006622723768
7089,2019-12-30,한미약품의일회용치질약치쏙크림출시,http://www.mediapen.com/news/view/488055
7090,2019-12-30,한미약품텐텐약사선정어린이종합비타민대상,http://moneys.mt.co.kr/news/mwView.php?no=2019122711108037830
7091,2019-12-30,편리함에위생더했다한미약품치쏙크림추천,http://moneys.mt.co.kr/news/mwView.php?no=2019122711148041306
7092,2019-12-30,동절기감염병예방에좋아한미약품프레쉬핸드워시추천,http://moneys.mt.co.kr/news/mwView.php?no=2019122711178016882
7093,2019-12-30,한미약품포지오티닙실패아니다여전히매력적,https://www.hankyung.com/finance/article/2019123096666
7094,2019-12-30,한미약품아모잘탄패밀리연간매출1천억돌파,http://www.biospectator.com/view/news_view.php?varAtcId=9217
7095,2019-12-30,한미약품최근기술이전한물질대부분반환,http://www.nspna.com/news/?mode=view&newsid=402349
7096,2019-12-30,한미약품목표주가하향비소세포폐암치료제의출시지연,http://www.businesspost.co.kr/BP?command=article_view&num=157276
7097,2019-12-30,한미약품포지오티닙출시시점지연목표가↓하나금융,http://www.etoday.co.kr/news/section/newsview.php?idxno=1839301
7098,2019-12-30,한미약품포지오티닙임상2상완전실패는아냐하나,http://www.edaily.co.kr/news/newspath.asp?newsid=01548166622723768
7099,2019-12-30,I리포트한미약품리스크공유전략목표가↓–하나금투,http://www.inews24.com/view/1232197
7100,2019-12-30,한미약품아모잘탄패밀리올해연간매출액1000억원돌파,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2019123008304522618
7101,2019-12-30,한미약품고혈압약아모잘탄연매출1000억원돌파,http://moneys.mt.co.kr/news/mwView.php?no=2019123008148028813
7102,2019-12-30,한미약품여전히투자매력있으나신약개발역량의구심커져목표주가↓하나금투,http://www.ekn.kr/news/article.html?no=472761
7103,2019-12-30,한미약품아모잘탄年매출1000억돌파,https://view.asiae.co.kr/article/2019123008243244134
7104,2019-12-30,주간증시일정한미약품한진휠라코리아등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1839305
7105,2019-12-30,한미약품아모잘탄패밀리매출1000억돌파,http://www.lawissue.co.kr/view.php?ud=201912300843467975204ead0791_12
7106,2019-12-30,한미약품아모잘탄패밀리발매10년만에연간매출1000억원돌파,http://biz.newdaily.co.kr/site/data/html/2019/12/30/2019123000014.html
7107,2019-12-30,한미약품아모잘탄출시10년만에매출1000억원돌파,http://www.viva100.com/main/view.php?key=20191230010010072
7108,2019-12-30,한미약품아모잘탄패밀리연매출1천억돌파,http://www.dailypharm.com/Users/News/NewsView.html?ID=260439&REFERER=NP
7109,2019-12-30,한미약품고혈압약아모잘탄패밀리연매출1000억돌파,http://news.mt.co.kr/mtview.php?no=2019123008535541497
7110,2019-12-30,한미약품일회용치질약치쏙크림출시,http://www.newstomato.com/ReadNews.aspx?no=942357
7111,2019-12-30,한미약품아모잘탄패밀리2019연간매출액1000억돌파,http://www.anewsa.com/detail.php?number=2041234&thread=10r03
7112,2019-12-30,한미약품아모잘탄패밀리발매10주년1000억돌파,http://medipana.com/news/news_viewer.asp?NewsNum=250900&MainKind=A&NewsKind=5&vCount=12&vKind=1
7113,2019-12-30,한미약품아모잘탄패밀리연매출1000억돌파,http://www.ebn.co.kr/news/view/1015357/?sc=naver
7114,2019-12-30,리포트브리핑한미약품한미약품의리스크쉐어전략목표가480000원하나금융투자,http://www.newspim.com/news/view/20191230000175
7115,2019-12-30,리포트한미약품임상실패했다고보긴성급해”목표주가하향,http://www.polinews.co.kr/news/article.html?no=446736
7116,2019-12-30,한미약품아모잘탄패밀리올해연간매출액1000억원돌파,http://www.newsway.co.kr/news/view?tp=1&ud=2019123008383396065
7117,2019-12-30,한미약품아모잘탄패밀리올매출1000억돌파,http://www.newsis.com/view/?id=NISX20191230_0000874179&cID=13001&pID=13000
7118,2019-12-30,한미약품발매10주년1000억돌파한아모잘탄패밀리,http://www.fnnews.com/news/201912300934120706
7119,2019-12-30,한미약품아모잘탄패밀리발매10년만에올1000억매출돌파,http://www.medisobizanews.com/news/articleView.html?idxno=65324
7120,2019-12-30,출시10년한미약품아모잘탄연간매출1000억돌파,http://www.newspim.com/news/view/20191230000126
7121,2019-12-30,한미약품아모잘탄연간매출1000억첫돌파,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201912300113&t=NN
7122,2019-12-30,발매10주년한미약품아모잘탄패밀리연간매출1000억돌파,http://www.newspost.kr/news/articleView.html?idxno=74935
7123,2019-12-30,발매10년만에1000억원매출돌파한한미약품아모잘탄패밀리,http://www.sisajournal-e.com/news/articleView.html?idxno=211340
7124,2019-12-30,한미약품저자극손세정제프레쉬핸드워시출시,http://www.newsfc.co.kr/news/articleView.html?idxno=39263
7125,2019-12-30,한미약품아모잘탄패밀리2019년年매출1천억돌파,http://www.m-i.kr/news/articleView.html?idxno=668454
7126,2019-12-30,제약브랜드평판1위삼성바이오로직스종근당한미약품최상위,http://www.medisobizanews.com/news/articleView.html?idxno=65329
7127,2019-12-30,하나금투한미약품포지오티닙임상2상완전실패아니다”,http://www.econovill.com/news/articleView.html?idxno=381310
7128,2019-12-30,출시10주년한미약품아모잘탄패밀리연간매출1천억돌파,http://www.dailysmart.co.kr/news/articleView.html?idxno=20360
7129,2019-12-30,한미약품발매10주년고혈압치료제아모잘탄패밀리매출1000억돌파,http://www.newslock.co.kr/news/articleView.html?idxno=24679
7130,2019-12-30,한미약품나인나인한알이면하루권장비타민D까지해결,http://www.sisajournal-e.com/news/articleView.html?idxno=211348
7131,2019-12-30,한미약품고혈압치료제아모잘탄연간매출1천억돌파,http://www.mediapen.com/news/view/488631
7132,2019-12-30,한미약품아모잘탄패밀리연매출1000억원돌파,http://www.shinailbo.co.kr/news/articleView.html?idxno=1237612
7133,2019-12-30,한미약품고혈압복합제아모잘탄3종연간매출1000억달성,http://news1.kr/articles/?3804541
7134,2019-12-30,한미약품아모잘탄패밀리연매출1000억돌파,http://bravo.etoday.co.kr/view/atc_view.php?varAtcId=10160
7135,2019-12-30,하나금융투자한미약품투자하기매력적인종목,http://www.mediasr.co.kr/news/articleView.html?idxno=56148
7136,2019-12-30,12월30일한미약품오늘주식장293000원174,http://nbntv.co.kr/news/view/791333
7137,2019-12-30,한미약품임상2상실패는아냐장중주가급반등,http://www.choicenews.co.kr/news/articleView.html?idxno=66991
7138,2019-12-30,한미약품발매10주년아모잘탄패밀리1000억돌파,http://www.businesskorea.co.kr/news/articleView.html?idxno=39664
7139,2019-12-30,한미약품아모잘탄패밀리연매출1000억원돌파,http://weekly.cnbnews.com/news/article.html?no=131906
7140,2019-12-30,한미약품아모잘탄패밀리연매출1천억돌파,http://www.rapportian.com/news/articleView.html?idxno=122451
7141,2019-12-30,한미약품리스크쉐어전략매력적포지오티닙실망이르다,http://medipana.com/news/news_viewer.asp?NewsNum=250934&MainKind=A&NewsKind=5&vCount=12&vKind=1
7142,2019-12-30,한미약품아모잘탄패밀리출시10년연간매출1000억원돌파,http://www.etnews.com/20191230000106
7143,2019-12-30,한미약품아모잘탄패밀리연간매출1000억돌파,https://www.kpanews.co.kr/article/show.asp?idx=209838&category=D
7144,2019-12-30,한미약품고혈압치료제매출1천억달성우종수기술로도약,http://www.businesspost.co.kr/BP?command=article_view&num=157316
7145,2019-12-30,한미약품고혈압치료제아모잘탄3종연매출1천억돌파,http://yna.kr/AKR20191230082600017?did=1195m
7146,2019-12-30,한미약품비소세포폐암치료제포지오티닙의출시지연”,http://www.wikitree.co.kr/main/news_view.php?id=493082
7147,2019-12-30,한미약품고혈압치료제아모잘탄3종연매출1000억돌파,http://www.smedaily.co.kr/news/articleView.html?idxno=88538
7148,2019-12-30,한미약품아모잘탄출시10년연간매출1000억돌파,http://www.pressm.kr/news/articleView.html?idxno=26849
7149,2019-12-30,한미약품아모잘탄3종출시10년만에연처방액1000억원돌파,http://www.metroseoul.co.kr/news/newsview?newscd=2019123000100
7150,2019-12-30,한미약품아모잘탄패밀리연매출1000억돌파,http://www.newstomato.com/ReadNews.aspx?no=942755
7151,2019-12-30,한미약품아모잘탄패밀리발매10년만에연매출1000억돌파,http://www.etoday.co.kr/news/section/newsview.php?idxno=1839522
7152,2019-12-30,한미약품자체개발복합신약아모잘탄패밀리매출1000억돌파,http://4th.kr/View.aspx?No=640450
7153,2019-12-30,한미약품고혈압치료제아모잘탄패밀리연매출1000억돌파,http://www.edaily.co.kr/news/newspath.asp?newsid=03027446622723768
7154,2019-12-30,한미약품고혈압약아모잘탄3종연매출1000억돌파,http://www.seoulfn.com/news/articleView.html?idxno=367332
7155,2019-12-30,한미약품고혈압치료제아모잘탄3종年매출1000억돌파,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=112497
7156,2019-12-30,한미약품아모잘탄패밀리1000억돌파발매10주년의쾌거,http://www.nextdaily.co.kr/news/article.html?id=20191230800029
7157,2019-12-30,한미약품아모잘탄패밀리연매출1천억돌파,http://www.finomy.com/news/articleView.html?idxno=73597
7158,2019-12-30,한미약품10주년고혈압약아모잘탄연매출1000억,http://health.chosun.com/site/data/html_dir/2019/12/30/2019123002033.html
7159,2019-12-30,10주년맞은한미약품아모잘탄패밀리연매출1000억돌파,http://www.updownnews.co.kr/news/articleView.html?idxno=213074
7160,2019-12-30,한미약품아모잘탄패밀리올해발매10주년연매출1000억돌파,http://www.newsian.co.kr/news/articleView.html?idxno=39041
7161,2019-12-30,한미약품항암신약포지오티닙우려보다기대커,http://news.mt.co.kr/mtview.php?no=2019122713433847225
7162,2019-12-30,하나금융한미약품파트너사와리스크공유투자매력적,http://www.anewsa.com/detail.php?number=2041674&thread=10r03
7163,2019-12-30,한미약품고혈압약아모잘탄국산약최초로국내年매출1000억,https://www.hankyung.com/it/article/201912300573i
7164,2019-12-31,한미약품신약연매출1000억돌파,http://www.donga.com/news/article/all/20191231/99022477/1
7165,2019-12-31,한미약품아모잘탄패밀리매출1000억넘었다,http://www.doctorsnews.co.kr/news/articleView.html?idxno=132749
7166,2019-12-31,한미약품고혈압치료복합신약아모잘탄패밀리연매출1000억원돌파,http://www.dailypop.kr/news/articleView.html?idxno=42770
7167,2019-12-31,한미약품겨울철온가족사용가능프레쉬핸드워시출시,http://www.getnews.co.kr/view.php?ud=20191227095947959741d0c69529_16
7168,2019-12-31,한미약품아픈치질이쏙”일회용치질약치쏙크림출시,http://www.getnews.co.kr/view.php?ud=2019122709522969441d0c69529_16
7169,2019-12-31,한미약품그룹임원승진인사단행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239151
7170,2019-12-31,한미약품그룹6개사18명승진임원인사단행,http://www.medisobizanews.com/news/articleView.html?idxno=65402
7171,2019-12-31,한미약품그룹,http://www.bosa.co.kr/news/articleView.html?idxno=2119063
7172,2019-12-31,한미약품그룹상무에고선진등임원승진인사,http://medipana.com/news/news_viewer.asp?NewsNum=251005&MainKind=A&NewsKind=5&vCount=12&vKind=1
7173,2019-12-31,한미약품그룹6개사임원승진인사,http://www.mdtoday.co.kr/mdtoday/index.html?no=374053
7174,2019-12-31,한미약품그룹임원인사,http://www.rapportian.com/news/articleView.html?idxno=122485
7175,2019-12-31,한미약품그룹,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89779
7176,2019-12-31,인사한미약품임원승진인사11,http://www.dailypharm.com/Users/News/TodayFocus.html?mode=View&nKind=2&ID=16845
7177,2019-12-31,2020년한미약품그룹신년임원승진인사,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59002
7178,2019-12-31,인사한미약품그룹임원승진,http://www.whosaeng.com/115011
7179,2019-12-31,표30일기준코스피외국인순매수Top30삼성전자우1위약121억원LG화학69억원호텔신라52억원KB금융48억원한미약품59억원주가순으로외국인매수나서일간순매수상위,http://www.fintechpost.co.kr/news/articleView.html?idxno=97711
